<SEC-DOCUMENT>0001821268-25-000250.txt : 20251124
<SEC-HEADER>0001821268-25-000250.hdr.sgml : 20251124
<ACCEPTANCE-DATETIME>20251121191226
ACCESSION NUMBER:		0001821268-25-000250
CONFORMED SUBMISSION TYPE:	N-2ASR
PUBLIC DOCUMENT COUNT:		26
FILED AS OF DATE:		20251124
DATE AS OF CHANGE:		20251121
EFFECTIVENESS DATE:		20251124

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
		CENTRAL INDEX KEY:			0001380936
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		N-2ASR
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-21982
		FILM NUMBER:		251509319

	BUSINESS ADDRESS:	
		STREET 1:		227 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-827-0100

	MAIL ADDRESS:	
		STREET 1:		227 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLAYMORE/GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
		DATE OF NAME CHANGE:	20090630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Claymore/Guggenheim Strategic Opportunities Fund
		DATE OF NAME CHANGE:	20070605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Claymore Strategic Opportunities Fund
		DATE OF NAME CHANGE:	20061113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
		CENTRAL INDEX KEY:			0001380936
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		N-2ASR
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-291739
		FILM NUMBER:		251509318

	BUSINESS ADDRESS:	
		STREET 1:		227 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-827-0100

	MAIL ADDRESS:	
		STREET 1:		227 WEST MONROE STREET
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CLAYMORE/GUGGENHEIM STRATEGIC OPPORTUNITIES FUND
		DATE OF NAME CHANGE:	20090630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Claymore/Guggenheim Strategic Opportunities Fund
		DATE OF NAME CHANGE:	20070605

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Claymore Strategic Opportunities Fund
		DATE OF NAME CHANGE:	20061113
<IS-FILER-A-NEW-REGISTRANT>N
<IS-FILER-A-WELL-KNOWN-SEASONED-ISSUER>N
<FILED-PURSUANT-TO-GENERAL-INSTRUCTION-A2>Y
<IS-FUND-24F2-ELIGIBLE>N
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-2ASR
<SEQUENCE>1
<FILENAME>gugg89389n2asr.htm
<DESCRIPTION>GOF
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:GOF="http://guggenheiminvestments.com/20251121">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_CEF%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_03F_GOF_guggenheiminvestments.com_20251121 -->
<!-- Field: Set; Name: xdx; ID: xdx_04F_20251121_20251121 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0001380936 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000004" name="dei:EntityCentralIndexKey">0001380936</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="xdx2ixbrl0010" name="dei:EntityFileNumber">333-000000</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="xdx2ixbrl0012" name="dei:DocumentType">N-2ASR</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-11-21" id="xdx2ixbrl0035" name="dei:EntityWellKnownSeasonedIssuer">No</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gof-20251121.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-11-21">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-06-012025-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-06-01</xbrli:startDate>
        <xbrli:endDate>2025-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-012025-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-01</xbrli:startDate>
        <xbrli:endDate>2025-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-12-012025-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-12-01</xbrli:startDate>
        <xbrli:endDate>2025-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-012024-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-01</xbrli:startDate>
        <xbrli:endDate>2024-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-06-012024-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-06-01</xbrli:startDate>
        <xbrli:endDate>2024-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-03-012024-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-03-01</xbrli:startDate>
        <xbrli:endDate>2024-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-12-012024-02-29">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-01</xbrli:startDate>
        <xbrli:endDate>2024-02-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-09-012023-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-09-01</xbrli:startDate>
        <xbrli:endDate>2023-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-06-012023-08-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-01</xbrli:startDate>
        <xbrli:endDate>2023-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_PrincipalRisksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:PrincipalRisksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:MarketDiscountAndPriceVolatilityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:DebtOverlayStrategyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:SyntheticAutocallableELNStrategyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-11-21</xbrli:startDate>
        <xbrli:endDate>2025-11-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000043" toRefs="Footnote000053"/>
  <ix:relationship fromRefs="Fact000044" toRefs="Footnote000053 Footnote000054"/>
  <ix:relationship fromRefs="Fact000045" toRefs="Footnote000055"/>
  <ix:relationship fromRefs="Fact000048" toRefs="Footnote000056 Footnote000057"/>
  <ix:relationship fromRefs="Fact000049" toRefs="Footnote000056 Footnote000058"/>
  <ix:relationship fromRefs="Fact000050" toRefs="Footnote000056 Footnote000059"/>
  <ix:relationship fromRefs="Fact000051" toRefs="Footnote000056 Footnote000060"/>
  <ix:relationship fromRefs="Fact000052" toRefs="Footnote000061"/>
  <ix:relationship fromRefs="Fact000064" toRefs="Footnote000068"/>
  <ix:relationship fromRefs="Fact000065" toRefs="Footnote000068"/>
  <ix:relationship fromRefs="Fact000066" toRefs="Footnote000068"/>
  <ix:relationship fromRefs="Fact000067" toRefs="Footnote000068"/>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As filed with the Securities and Exchange Commission
on November 21, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Securities Act File No.&#160;<span id="xdx_90E_edei--EntityFileNumber_dxL_c20251121__20251121_zLPJI76bj7Ga" title="::XDX::333-000000"><span style="-sec-ix-hidden: xdx2ixbrl0010">333</span></span>-________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Investment Company Act File No.&#160;<span id="xdx_906_edei--InvestmentCompanyActFileNumber_c20251121__20251121_zuAwIIGeSF92"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000011" name="dei:InvestmentCompanyActFileNumber">811-21982</ix:nonNumeric></span></b></p>

<p style="font: 4pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 0.75pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>FORM&#160;<span id="xdx_905_edei--DocumentType_dxL_c20251121__20251121_zDek3AEhcEi7" title="::XDX::N-2ASR"><span style="-sec-ix-hidden: xdx2ixbrl0012">N-2</span></span></b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Registration Statement</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>under</i></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="width: 96%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 12pt"><b><i>the Securities Act of 1933</i></b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_90C_edei--DocumentRegistrationStatement_dbT_c20251121__20251121_zD1bj5yFxSHb"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000013" name="dei:DocumentRegistrationStatement">&#9746;</ix:nonNumeric></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 12pt"><b>Pre-Effective&#160;Amendment No. </b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#9744;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 12pt"><b>Post-Effective Amendment No.</b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#9744;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>and/or</b></p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Registration Statement</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><i>Under</i></b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="width: 96%; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; width: 1%; text-align: center">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 12pt"><b><i>the Investment Company Act of 1940</i></b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span id="xdx_902_edei--InvestmentCompanyActRegistration_c20251121__20251121_zJ9U2H4ixsD1"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000014" name="dei:InvestmentCompanyActRegistration">&#9746;</ix:nonNumeric></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 12pt"><b>Amendment No. <span id="xdx_90B_edei--InvestmentCompanyRegistrationAmendmentNumber_c20251121__20251121_zU2sarImQORe"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000015" name="dei:InvestmentCompanyRegistrationAmendmentNumber">35</ix:nonNumeric></span></b></span></td>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_903_edei--InvestmentCompanyRegistrationAmendment_c20251121__20251121_zSLzIFykNf4g"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000016" name="dei:InvestmentCompanyRegistrationAmendment">&#9746;</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 24pt"><b><span id="xdx_90E_edei--EntityRegistrantName_c20251121__20251121_z2o6U84adhji"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000017" name="dei:EntityRegistrantName">Guggenheim Strategic
Opportunities Fund</ix:nonNumeric></span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(Exact Name of Registrant as Specified in Charter)</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_908_edei--EntityAddressAddressLine1_c20251121__20251121_zuGaO693rR26"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000018" name="dei:EntityAddressAddressLine1">227 West Monroe Street</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20251121__20251121_z2itxOu4xA93"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000019" name="dei:EntityAddressCityOrTown">Chicago</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressStateOrProvince_c20251121__20251121_z56Est7azL45"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt-sec:stateprovnameen" id="Fact000020" name="dei:EntityAddressStateOrProvince">Illinois</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20251121__20251121_ziTWCcB3qt7k"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000021" name="dei:EntityAddressPostalZipCode">60606</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(Address of Principal Executive Offices)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b><span id="xdx_904_edei--CityAreaCode_c20251121__20251121_z4FUZ0AUejGa"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000022" name="dei:CityAreaCode">(312)</ix:nonNumeric></span> <span id="xdx_90B_edei--LocalPhoneNumber_c20251121__20251121_zcfIlLOeLKL"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000023" name="dei:LocalPhoneNumber">827-0100</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(Registrant&#8217;s Telephone Number, Including Area
Code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Amy J. Lee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Guggenheim Funds Investment
Advisors, LLC</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>227 West Monroe Street</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><b>Chicago, Illinois 60606</b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(Name and Address of Agent for Service)</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b><i>Copies to:</i></b></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b><i></i></b></p>

<p style="font: 6pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 100%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Julien Bourgeois</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Allison M. Fumai</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Dechert LLP</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>1900 K Street, N.W.</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 1pt; text-align: center"><b>Washington, DC 20006</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><b>Approximate Date of Commencement of Proposed Public Offering</b>:
<span id="xdx_904_edei--ApproximateDateOfCommencementOfProposedSaleToThePublic_c20251121__20251121_zXGjVJpSHC3"><ix:nonNumeric contextRef="AsOf2025-11-21" id="Fact000024" name="dei:ApproximateDateOfCommencementOfProposedSaleToThePublic">From time to time after the effective date of this Registration Statement.</ix:nonNumeric></span></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, check the following box&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_904_edei--DividendOrInterestReinvestmentPlanOnly_c20251121__20251121_z6HIipHD8zC"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000025" name="dei:DividendOrInterestReinvestmentPlanOnly">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If any securities being registered on this Form will be offered
on a delayed or continuous basis in reliance on Rule 415 under the Securities Act of 1933 (&#8220;Securities Act&#8221;), other than securities
offered in connection with a dividend reinvestment plan, check the following box.&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_909_edei--DelayedOrContinuousOffering_c20251121__20251121_zIKlRpBbKZVa"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000026" name="dei:DelayedOrContinuousOffering">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If this Form is a registration statement pursuant to General Instruction
A.2 or a post-effective amendment thereto, check the following box&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_902_ecef--PrimaryShelfFlag_c20251121__20251121_zouf08sGaRBd"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000027" name="cef:PrimaryShelfFlag">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If this Form is a registration statement pursuant to General Instruction
B or a post-effective amendment thereto that will become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities
Act, check the following box&#160; <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_905_edei--EffectiveUponFiling462e_c20251121__20251121_z0LrnvuIg3Q4"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000028" name="dei:EffectiveUponFiling462e">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">If this Form is a post-effective amendment to a registration statement
filed pursuant to General Instruction B to register additional securities or additional classes of securities pursuant to Rule 413(b)
under the Securities Act, check the following box&#160;&#160;<span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90B_edei--AdditionalSecuritiesEffective413b_c20251121__20251121_ztFuIMK9E945"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000029" name="dei:AdditionalSecuritiesEffective413b">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">It is proposed that this filing will become effective (check appropriate
box):</p>

<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90C_edei--EffectiveWhenDeclaredSection8c_c20251121__20251121_zBJOUhTeIB69"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000030" name="dei:EffectiveWhenDeclaredSection8c">&#9744;</ix:nonNumeric></span></span></td>
    <td>when declared effective pursuant to section 8(c) of the Securities Act</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Check each box that appropriately characterizes the Registrant:</p>

<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90A_ecef--RegisteredClosedEndFundFlag_c20251121__20251121_zeUiXeN64GHl"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000031" name="cef:RegisteredClosedEndFundFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td>Registered Closed-End Fund (closed-end company that is registered under the Investment Company Act of 1940 (the &#8220;Investment Company Act&#8221;)).</td></tr>
  </table>
<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_908_ecef--BusinessDevelopmentCompanyFlag_c20251121__20251121_zulcwR7s61S5"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000032" name="cef:BusinessDevelopmentCompanyFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td>Business Development Company (closed-end company that intends or has elected to be regulated as a business development company under the Investment Company Act.</td></tr>
  </table>
<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_906_ecef--IntervalFundFlag_c20251121__20251121_z4jGGrm25cL3"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000033" name="cef:IntervalFundFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td>Interval Fund (Registered Closed-End Fund or a Business Development Company that makes periodic repurchase offers under Rule 23c-3 under the Investment Company Act).</td></tr>
  </table>
<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_904_ecef--PrimaryShelfQualifiedFlag_c20251121__20251121_zqdN0K2GWitb"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleantrue" id="Fact000034" name="cef:PrimaryShelfQualifiedFlag">&#9746;</ix:nonNumeric></span></span></td>
    <td>A.2 Qualified (qualified to register securities pursuant to General Instruction A.2 of this Form).</td></tr>
  </table>
<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_908_edei--EntityWellKnownSeasonedIssuer_dbT_c20251121__20251121_zKDquWO0gJog"><span style="-sec-ix-hidden: xdx2ixbrl0035">&#9746;</span></span></span></td>
    <td>Well-Known Seasoned Issuer (as defined by Rule 405 under the Securities Act). </td></tr>
  </table>
<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20251121__20251121_z2uX3uSSLCOh"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000036" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td>Emerging Growth Company (as defined by Rule 12b-2 under the Securities and Exchange Act of 1934).</td></tr>
  </table>
<p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">If an Emerging Growth Company, indicate by check mark if the registrant
    has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
    to Section&#160;7(a)(2)(B) of the Securities Act.</p>
    <p style="font: 6pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90B_ecef--NewCefOrBdcRegistrantFlag_c20251121__20251121_zlHbswoNKhU3"><ix:nonNumeric contextRef="AsOf2025-11-21" format="ixt:booleanfalse" id="Fact000037" name="cef:NewCefOrBdcRegistrantFlag">&#9744;</ix:nonNumeric></span></span></td>
    <td>New Registrant (registered or regulated under the Investment Company Act for less than 12 calendar months preceding this filing).</td></tr>
  </table>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>PROSPECTUS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center"><b>&#160;<img src="guggenheimlogonew2.jpg" alt=""/></b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>Guggenheim Strategic Opportunities Fund</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>$1,000,000,000</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>Common Shares<br/>
________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Objective and Philosophy. </i>Guggenheim
Strategic Opportunities Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. The Fund&#8217;s investment
objective is to maximize total return through a combination of current income and capital appreciation. The Fund pursues a relative value-based
investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities
that deviate from their perceived fair value and/or historical norms. The Fund&#8217;s sub-adviser seeks to combine a credit-managed fixed-income
portfolio with access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is
predicated upon the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform
benchmark indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes. The Fund
cannot ensure investors that it will achieve its investment objective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Portfolio. </i>The Fund seeks to
achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income
Securities&#8221;) selected from a variety of sectors and credit qualities, including, but not limited to, corporate bonds, loans and
loan participations, structured finance investments, U.S. government and agency securities and sovereign or supranational debt obligations,
mezzanine and preferred securities and convertible securities, and in common stocks, limited liability company interests, trust certificates
and other equity investments (&#8220;Common Equity Securities&#8221;) that the Fund&#8217;s sub-adviser believes offer attractive yield
and/or capital appreciation potential, including employing a strategy of writing (selling) covered call options and may, from time to
time, buy or sell put options on individual Common Equity Securities and, to a lesser extent, on indices of securities and sectors of
securities. The Fund may also invest in asset-backed securities (&#8220;ABS&#8221;) and mortgage-related securities. These securities
may include complex instruments, such as collateralized mortgage obligations, real estate investment trusts (&#8220;REITs&#8221;) (including
debt and preferred stock issued by REITs), and other real estate-related securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Offering. </i>The Fund may offer, from time
to time, up to $1,000,000,000 aggregate initial offering price of the Fund&#8217;s common shares of beneficial interest, par value $0.01
per share (&#8220;Common Shares&#8221;), in one or more offerings in amounts, at prices and on terms set forth in one or more supplements
to this Prospectus (each, a &#8220;Prospectus Supplement&#8221;). You should read this Prospectus and any related Prospectus Supplement
carefully before you decide to invest in the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer Common Shares (1) directly
to one or more purchasers, (2) through agents that the Fund may designate from time to time or (3) to or through underwriters or dealers.
The Prospectus Supplement relating to a particular offering of Common Shares will identify any agents or underwriters involved in the
sale of Common Shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and
agents or underwriters or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Common Shares
through agents, underwriters or dealers without delivery of this Prospectus and the Prospectus Supplement describing the method and terms
of the offering of Common Shares. See &#8220;Plan of Distribution.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>Investing in the Fund&#8217;s Common Shares
involves certain risks, including the risks associated with the Fund&#8217;s use of leverage. An investment in the Fund is subject to
investment risk, including the possible loss of the entire principal amount that you invest. See &#8220;Risks&#8221; on page 31 of this
Prospectus and the section of the Fund&#8217;s most recent annual report on Form N-CSR entitled &#8220;Additional Information Regarding
the Fund</b>&#8212;<b>Principal Risks of the Fund,&#8221; which is incorporated by reference herein. You should carefully consider these
risks together with all of the other information contained in this Prospectus before making a decision to purchase the Fund&#8217;s Common
Shares.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">i&#160;</p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>Neither the Securities and Exchange Commission
(&#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these securities or determined if this Prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Prospectus dated November 21, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Investment Adviser and Sub-Adviser. </i>Guggenheim
Funds Investment Advisors, LLC (the &#8220;Investment Adviser&#8221;) acts as the Fund&#8217;s investment adviser and is responsible for
the management of the Fund. Guggenheim Partners Investment Management, LLC (the &#8220;Sub-Adviser&#8221;) is responsible for the management
of the Fund&#8217;s portfolio of securities. Each of the Investment Adviser and the Sub-Adviser is a wholly-owned subsidiary of Guggenheim
Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial services firm with wealth management,
capital markets, investment management and proprietary investing businesses, the clients of which are a mix of individuals, family offices,
endowments, investment funds, foundations, insurance companies and other institutions that have entrusted Guggenheim Partners with the
supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners is headquartered in Chicago and New
York with a global network of offices throughout the United States, Europe, and Asia. The Investment Adviser and the Sub-Adviser are referred
to herein collectively as the &#8220;Adviser.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"><i>Investment Policies. </i>The Fund may allocate
its assets among a wide variety of Income Securities and Common Equity Securities. The Fund may invest without limitation in below-investment
grade securities (e.g., securities rated below Baa3 by Moody&#8217;s Investors Service, Inc., below BBB- by Standard &amp; Poor&#8217;s
Ratings Group or Fitch Ratings or comparably rated by another nationally recognized statistical rating organization or, if unrated, determined
by the Sub-Adviser to be of comparable quality). Below investment grade securities are commonly referred to as &#8220;high-yield&#8221;
or &#8220;junk&#8221; bonds and are considered speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal.
The Fund&#8217;s investments in any of the sectors and types of Income Securities in which the Fund may invest may include, without limitation,
below-investment grade securities. Under normal market conditions, the Fund will not invest more than: 50% of its total assets in Common
Equity Securities consisting of common stock; 30% of its total assets in other investment companies, including registered investment companies,
private investment funds and/or other pooled investment vehicles; 20% of its total assets in non-U.S. dollar-denominated Income Securities
of corporate and governmental issuers located outside the United States; and 10% of its total assets in Income Securities of issuers in
emerging markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Shares. </i>The Fund&#8217;s currently
outstanding Common Shares are, and the Common Shares offered in this Prospectus will be, subject to notice of issuance, listed on the
New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221; The net asset value of the Common Shares at the close
of business on November 14, 2025 was $11.38 per share and the last sale price of the Common Shares on the NYSE on such date was $12.91,
representing a premium to net asset value of 13.44%. See &#8220;Market and Net Asset Value Information.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Financial Leverage. </i>The Fund may seek
to enhance total returns as well as the level of its current distributions by utilizing financial leverage through, among other things:
(i) the issuance of preferred shares (&#8220;Preferred Shares&#8221;), (ii) borrowing or the issuance of commercial paper or other forms
of debt (&#8220;Borrowings&#8221;), (iii) reverse repurchase agreements, dollar rolls or similar transactions or (iv) a combination of
the foregoing (&#8220;leveraged transactions&#8221; and collectively, &#8220;Financial Leverage&#8221;). The Fund may utilize Financial
Leverage up to the limits imposed by the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;); however, the aggregate
amount of Financial Leverage is not currently expected to exceed 33 <span style="font-size: 8.5pt">1</span>/<span style="font-size: 8.5pt">3</span>%
of the Fund&#8217;s Managed Assets (as defined herein) after such issuance and/or borrowing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund maintains a committed facility agreement
with BNP Paribas Prime Brokerage International, Ltd. (&#8220;BNP Paribas&#8221;), pursuant to which the Fund may borrow up to $150 million.
The maximum amount available to borrow under the committed facility may change from time to time pursuant to the terms of the agreement
governing the committed facility. As of May 31, 2025, outstanding Borrowings under the Fund&#8217;s committed facility agreement were
approximately $50 million, representing approximately 2% of the Fund&#8217;s Managed Assets as of such date, and there was approximately
$329 million in reverse repurchase agreements outstanding, representing approximately 14% of the Fund&#8217;s Managed Assets as of such
date. As of May 31, 2025, the Fund&#8217;s total Financial Leverage represented approximately 16% of the Fund&#8217;s Managed Assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">ii</p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s use of leverage through reverse
repurchase agreements, dollar rolls and economically similar transactions will be included when calculating the Fund&#8217;s Financial
Leverage and therefore will be limited by the Fund&#8217;s maximum overall Financial Leverage levels, and may be further limited by the
applicable requirements of the SEC discussed herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act, and will not be included in calculating the aggregate amount of the Fund&#8217;s
Financial Leverage, but the Fund&#8217;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s total Financial Leverage may
vary significantly over time based on, among other factors, the Sub-Adviser&#8217;s assessment of market and economic conditions, available
investment opportunities and cost of Financial Leverage. The Fund has at times used greater levels of Financial Leverage than on May 31,
2025. The Fund may in the future increase Financial Leverage up to the parameters set forth herein. Although the use of Financial Leverage
by the Fund may create an opportunity for increased total return for the Common Shares, it also results in additional risks and can magnify
the effect of any losses. Financial Leverage involves risks and special considerations for shareholders, including the likelihood of greater
volatility of net asset value, market price of, and dividends on, the Common Shares. To the extent the Fund increases its amount of Financial
Leverage outstanding, it will be more exposed to these risks. The cost of Financial Leverage, including the portion of the investment
advisory fee attributable to the assets purchased with the proceeds of Financial Leverage, is borne by Common Shareholders. To the extent
the Fund increases its amount of Financial Leverage outstanding, the Fund&#8217;s annual expenses as a percentage of net assets attributable
to Common Shares will increase. There can be no assurance that a leveraging strategy will be utilized or, if utilized, will be successful.
See &#8220;Use of Leverage&#8221; and the section of <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">the
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks
of the Fund&#8212;Financial Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein, for a discussion
of associated risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">You should read this Prospectus (and documents
incorporated by reference herein), which contains important information about the Fund, together with any Prospectus Supplement, before
deciding whether to invest in the Common Shares of the Fund, and retain these documents for future reference. A Statement of Additional
Information (File No. 811-21982), dated November 21, 2025 (the &#8220;SAI&#8221;), as supplemented from time to time, containing additional
information about the Fund, has been filed with the SEC and is incorporated by reference in its entirety into this Prospectus. The SEC
maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file
electronically with the SEC (http://www.sec.gov). You may request a free copy of the SAI or request other
information about the Fund (including the Fund&#8217;s annual and semi-annual reports) or make shareholder inquiries by calling (800)
345-7999 or by writing to the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago, Illinois 60606,
or you may obtain a copy (and other information regarding the Fund) from the SEC&#8217;s website (www.sec.gov). Free copies of the Fund&#8217;s
reports and the SAI will also be available from the Fund&#8217;s website at www.guggenheiminvestments.com/gof. The information contained
in, or that can be accessed through, the Fund&#8217;s website is not part of this Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The Fund&#8217;s Common Shares do not represent
a deposit or obligation of, and are not guaranteed or endorsed by, any bank or other insured depository institution and are not federally
insured by the Federal Deposit Insurance Corporation, the Federal Reserve Board or any other government agency. Investors could lose money
by investing in the Fund.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;*</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">iii</p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>You should rely only on
the information contained or incorporated by reference into this Prospectus and any accompanying Prospectus Supplement in making your
investment decisions. The Fund has not authorized any other person to provide you with different information. If anyone provides you with
different or inconsistent information, you should not rely on it. The Fund is not making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted. You should assume that the information appearing in this Prospectus is accurate only as of the
date of this Prospectus. The Fund&#8217;s business, financial conditions and prospects may have changed since such date. The Fund will
advise investors of any material changes to the extent required by applicable law.</b></p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>Table
of Contents</b></span></p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: right"><b>Page</b></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProSummary">Prospectus Summary</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProSummaryFundExp">Summary of Fund Expenses</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">7</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProFinancialHighlights">Financial Highlights</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">9</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProSeniorHighlights">Senior Securities</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProTheFund">The Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProUseProceeds">Use of Proceeds</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProMarketNetAssetInfo">Market and Net Asset Value Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">11</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProObjPolicies">Investment Objective and Policies</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">12</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProUseLeverage">Use of Leverage</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProRisks">Risks</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">31</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProManagementFund">Management of the Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">34</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProNetAssetValue">Net Asset Value</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">36</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProDistributions">Distributions</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">39</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProDividend">Dividend Reinvestment Plan</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProDescCapStruct">Description of Capital Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">40</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProAntiTakeover">Anti-Takeover and Other Provisions in the Fund&#8217;s Governing Documents</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">43</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProClosedEndFundStruct">Closed-End Fund Structure</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProRepurchaseConversion">Repurchase of Common Shares; Conversion to Open-End Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">44</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProUSFedIncTax">U.S. Federal Income Tax Considerations</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">45</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProPlanDistributions">Plan of Distribution</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">48</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProCustAdminTransAgDiv">Custodian, Administrator, Transfer Agent and Dividend Disbursing Agent</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">50</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProLegalMatters">Legal Matters</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProIndRegPubAcctFirm">Independent Registered Public Accounting Firm</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProAdditionalInfo">Additional Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProPrivacy">Privacy Principles of the Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#ProIncorp">Incorporation By Reference</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">51</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase"><b>Forward-Looking
Statements</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">This Prospectus, including
documents incorporated by reference herein, contains or incorporates by reference forward-looking statements, within the meaning of the
federal securities laws, that involve risks and uncertainties. These statements describe the Fund&#8217;s plans, strategies, and goals
and the Fund&#8217;s beliefs and assumptions concerning future economic and other conditions and the outlook for the Fund, based on currently
available information. In this Prospectus, words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;objectives,&#8221;
&#8220;goals,&#8221; &#8220;future,&#8221; &#8220;intends,&#8221; &#8220;seeks,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;could,&#8221;
&#8220;should,&#8221; and similar expressions are used in an effort to identify forward-looking statements, although some forward-looking
statements may be expressed differently. The Fund is not entitled to the safe harbor for forward-looking statements pursuant to Section
27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">iv</p>


<!-- Field: Page; Sequence: 6 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProSummary"></span>Prospectus Summary</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>This is only a summary of information contained
elsewhere in this Prospectus. This summary does not contain all of the information that you should consider before investing in the Fund&#8217;s
common shares of beneficial interest, par value $0.01 per share (&#8220;Common Shares&#8221;). You should carefully read the more detailed
information contained elsewhere in this Prospectus and any related Prospectus Supplement(s) prior to making an investment in the Fund,
especially the information set forth under the headings &#8220;Investment Objective and Policies&#8221; and &#8220;Risks.&#8221; You may
also wish to request a copy of the Fund&#8217;s Statement of Additional Information dated November 21, 2025 (the &#8220;SAI&#8221;), as
supplemented from time to time, which contains additional information about the Fund.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>&#160;</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>The Fund</b></td>
    <td style="width: 75%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Guggenheim Strategic Opportunities Fund (the &#8220;Fund&#8221;) is a diversified, closed-end management investment company that commenced operations on July 26, 2007. The Fund&#8217;s objective is to maximize total return through a combination of current income and capital appreciation. The Fund pursues a relative value-based investment philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate from their perceived fair value and/or historical norms.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund&#8217;s common shares of beneficial interest, par value $0.01 per share, are called &#8220;Common Shares&#8221; and the holders of Common Shares are called &#8220;Common Shareholders&#8221; <span style="background-color: white">throughout this Prospectus and any accompanying Prospectus Supplement(s)</span>.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>The Offering</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund may offer, from time to time, up to $1,000,000,000 aggregate initial offering price of Common Shares, in one or more offerings in amounts, at prices and on terms to be set forth in one or more supplements to this Prospectus (each, a &#8220;Prospectus Supplement&#8221;).</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund may offer Common Shares (1) directly to one or more purchasers, (2) through agents that the Fund may designate from time to time, or (3) to or through underwriters or dealers. The Prospectus Supplement relating to a particular offering will identify any agents or underwriters involved in the sale of Common Shares, and will set forth any applicable purchase price, fee, commission or discount arrangement between the Fund and agents or underwriters or among underwriters or the basis upon which such amount may be calculated. The Fund may not sell Common Shares through agents, underwriters or dealers without delivery of this Prospectus and a Prospectus Supplement describing the method and terms of the offering of Common Shares. See &#8220;Plan of Distribution.&#8221;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Use of Proceeds</b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 75%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Unless otherwise specified in a prospectus supplement, the Fund intends to invest the net proceeds of the offering of Common Shares
    in accordance with its investment objective and policies as stated below or otherwise invest the
    net proceeds as follows. It is currently anticipated that the Fund will be able to invest most of the net proceeds of an offering of
    Common Shares in accordance with its investment objective and policies within three months after the receipt of such proceeds.
    Pending such investment, it is anticipated that the proceeds will be invested in U.S. government securities or high quality,
    short-term money-market securities. The Fund may also use the proceeds for working capital purposes, including the payment of
    distributions, interest and operating expenses. A portion of the cash held by the Fund, including net proceeds of the offering, is
    usually used to pay distributions in accordance with the Fund&#8217;s distribution policy and may be a return of capital, which is
    in effect a partial return of the amount a Common Shareholder invested in the Fund. Common Shareholders who receive the payment of a
    distribution consisting of a return of capital may be under the impression that they are receiving net investment income or profit
    when they are not. The Fund&#8217;s distributions may be greater than the Fund&#8217;s net investment income or profit. The offering
    of Common Shares supports the Fund&#8217;s asset level and if the Fund does not offer or sell Common Shares, the Fund may not be
    able to maintain historical distribution levels for extended periods of time.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>&#160;</i></p>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 25%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Objective</b></span></td>
  <td style="width: 75%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Fund&#8217;s investment objective
  is to maximize total return through a combination of current income and capital appreciation. The Fund cannot ensure investors that
  it will achieve its investment objective. The Fund&#8217;s investment objective is considered fundamental and may not be changed without
  the approval of Common Shareholders.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Principal Investment Strategies</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
  most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Investment Strategies
  and Portfolio Composition&#8212;Principal Investment Strategies,&#8221; which is incorporated by reference herein, for a discussion
  of the Fund&#8217;s principal investment strategies. You should carefully consider this information together with all of the other
  information contained in this Prospectus, including the section of this Prospectus entitled &#8220;Principal Investment Strategies&#8221;
  beginning on page 12, before making a decision to purchase the Fund&#8217;s Common Shares.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Investment Portfolio</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
  most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Investment Strategies
  and Portfolio Composition&#8212;Portfolio Composition,&#8221; which is incorporated by reference herein, for a discussion of the types
  of securities and other instruments in which the Fund will or may ordinarily invest. You should carefully consider this information
  together with all of the other information contained in this Prospectus, including the section of this Prospectus entitled &#8220;Additional
  Information About the Fund&#8217;s Principal Investment Strategies &amp; Portfolio Composition&#8221; beginning on page 13, before
  making a decision to purchase the Fund&#8217;s Common Shares.</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial Leverage and Leveraged Transactions</b></span></td>
  <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund may seek to enhance total returns as well as the level of
its current distributions by utilizing financial leverage through, among other things: (i) the issuance of preferred shares (&#8220;Preferred
Shares&#8221;), (ii) borrowing or the issuance of commercial paper or other forms of debt (&#8220;Borrowings&#8221;), (iii) reverse repurchase
agreements, dollar rolls or similar transactions or (iv) a combination of the foregoing (&#8220;leveraged transactions&#8221; and collectively,
&#8220;Financial Leverage&#8221;). The Fund may utilize Financial Leverage up to the limits imposed by the Investment Company Act of 1940,
as amended (the &#8220;1940 Act&#8221;); however, the aggregate amount of Financial Leverage is not currently expected to exceed 33 1/3%
of the Fund&#8217;s Managed Assets (as defined herein) after such issuance and/or borrowing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund maintains a committed facility agreement with BNP Paribas
Prime Brokerage International, Ltd., pursuant to which the Fund may borrow up to $150 million. The maximum amount available to borrow
under the committed facility may change from time to time pursuant to the terms of the agreement governing the committed facility. As
of May 31, 2025, outstanding Borrowings under the Fund&#8217;s committed facility agreement were approximately $50 million, which represented
approximately 2% of the Fund&#8217;s Managed Assets as of such date, and there was approximately $329 million in reverse repurchase agreements
outstanding, which represented approximately 14% of the Fund&#8217;s Managed Assets as of such date. As of May 31, 2025, the Fund&#8217;s
total Financial Leverage represented approximately 16% of the Fund&#8217;s Managed Assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">The Fund&#8217;s use of leverage through reverse
repurchase agreements, dollar rolls and economically similar transactions will be included when calculating the Fund&#8217;s Financial
Leverage and therefore will be limited by the Fund&#8217;s maximum overall Financial Leverage levels, and may be further limited by the
applicable requirements of the SEC discussed herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">In addition, the Fund may engage in certain derivatives transactions that
have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be considered indebtedness
for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#8217;s Financial Leverage,</p>
</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 25%">&#160;</td>
  <td style="width: 75%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">but the Fund&#8217;s use of such transactions may
be limited by Rule 18f-4 under the 1940 Act and the applicable requirements of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">The Fund&#8217;s total Financial Leverage may vary significantly over time
based on, among other factors, the Sub-Adviser&#8217;s assessment of market and economic conditions, available investment opportunities
and cost of Financial Leverage. The Fund has at times used greater levels of Financial Leverage than on May 31, 2025. The Fund may in
the future increase Financial Leverage up to the parameters set forth herein. Although the use of Financial Leverage and leveraged transactions
by the Fund may create an opportunity for increased total return for Common Shares, it also results in additional risks and can magnify
the effect of any losses. Financial Leverage and the use of leveraged transactions involve risks and special considerations for shareholders,
including the likelihood of greater volatility of net asset value, market price of, and dividends on, the Common Shares. To the extent
the Fund increases its amount of Financial Leverage and leveraged transactions outstanding, it will be more exposed to these risks. The
cost of Financial Leverage and leveraged transactions, including the portion of the investment advisory fee attributable to the assets
purchased with the proceeds of Financial Leverage and leveraged transactions, is borne by Common Shareholders. To the extent the Fund
increases its amount of Financial Leverage outstanding, the Fund&#8217;s annual expenses as a percentage of net assets attributable to
Common Shares will increase. There can be no assurance that a leveraging strategy will be utilized or, if utilized, will be successful.
See &#8220;Use of Leverage&#8221; and the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks of the Fund&#8212;Financial
Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein for a discussion of associated risks.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Temporary Investments</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At any time when a temporary posture is believed by the
  Sub-Adviser to be warranted (a &#8220;temporary period&#8221;), the Fund may, without limitation, hold cash or invest its assets in
  money market instruments and repurchase agreements in respect of those instruments. The Fund may not achieve its investment objective
  during a temporary period or be able to sustain its historical distribution levels. See &#8220;The Fund&#8217;s Investments&#8212;Temporary
  Investments.&#8221;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Management of the Fund</b></span></td>
  <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guggenheim Funds Investment Advisors, LLC (the &#8220;Investment
  Adviser&#8221;) acts as the Fund&#8217;s investment adviser pursuant to an advisory agreement with the Fund (the &#8220;Advisory Agreement&#8221;).
  Pursuant to the Advisory Agreement, the Investment Adviser is responsible for the management of the Fund and administers the affairs
  of the Fund to the extent requested by the board of trustees of the Fund (the &#8220;Board of Trustees&#8221; or the &#8220;Board&#8221;).
  As compensation for its services, the Fund pays the Investment Adviser a fee, payable monthly in arrears at an annual rate equal to
  1.00% of the Fund&#8217;s average daily Managed Assets. &#8220;Managed Assets&#8221; for purposes of calculating the fees payable under
  the Advisory and Sub-Advisory Agreements (as defined herein) means the total assets of the Fund (other than assets attributable to
  any investments by the Fund in Affiliated Investment Funds), including the assets attributable to the proceeds from any borrowings
  or other forms of Financial Leverage, minus liabilities, other than liabilities related to any Financial Leverage. &#8220;Affiliated
  Investment Funds&#8221; means investment companies, including registered investment companies, private investment funds and/or other
  pooled investment vehicles, advised or managed by the Fund&#8217;s investment Sub-Adviser or any of its affiliates. &#8220;Managed
  Assets&#8221; for all other purposes means the total assets of the Fund, including the assets attributable to the proceeds from any
  borrowings or other forms of Financial Leverage, minus liabilities, other than liabilities related to any Financial Leverage. Please
  refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
  most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks of the
  Fund,&#8221; which is incorporated by reference herein, for a discussion of associated risks of the Fund&#8217;s use of Financial Leverage.</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 25%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="width: 75%; padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Guggenheim Partners Investment Management, LLC (the &#8220;Sub-Adviser&#8221;) acts as the Fund&#8217;s sub-adviser pursuant to a sub-advisory agreement with the Fund and the Investment Adviser (the &#8220;Sub-Advisory Agreement&#8221;). Pursuant to the Sub-Advisory Agreement, the Sub-Adviser is responsible for the management of the Fund&#8217;s portfolio of securities. As compensation for its services, the Investment Adviser pays the Sub-Adviser a fee, payable monthly in arrears at an annual rate equal to 0.50% of the Fund&#8217;s average daily Managed Assets, less 0.50% of the Fund&#8217;s average daily assets attributable to any investments by the Fund in Affiliated Investment Funds.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Each of the Investment Adviser and the Sub-Adviser are wholly-owned
    subsidiaries of Guggenheim Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial services
    firm with wealth management, capital markets, investment management and proprietary investing businesses, the clients of which are a mix
    of individuals, family offices, endowments, investment funds, foundations, insurance companies and other institutions that have entrusted
    Guggenheim Partners with the supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners is headquartered
    in Chicago and New York with a global network of offices throughout the United States, Europe, and Asia.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">References to the &#8220;Adviser&#8221; may include the Investment
    Adviser or the Sub-Adviser, as applicable.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">See &#8220;Management of the Fund.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Distributions</b></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund intends to pay substantially all of its net investment income
    to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any net realized long-term capital gains
    to Common Shareholders as long-term capital gain dividends at least annually. The Fund expects that distributions paid on the Common Shares
    will generally consist of (i) investment company taxable income expected to be taxed as ordinary income, which includes, among other things,
    investment income, short-term capital gains and income from certain hedging and interest rate transactions, (ii) long-term capital gains
    and (iii) return of capital. Distributions may be paid by the Fund from any permitted source and, from time to time, all or a portion
    of a distribution may be a return of capital. To the extent the Fund receives dividends with respect to its investments in Common Equity
    Securities that consist of qualified dividend income (income from domestic and certain foreign corporations), a portion of the Fund&#8217;s
    distributions to its Common Shareholders may consist of qualified dividend income. The Fund cannot assure you, however, as to what percentage
    of the dividends paid on Common Shares, if any, will consist of qualified dividend income or long-term capital gains, which are taxed
    at lower rates for individuals than ordinary income. In certain circumstances, the Fund may elect to retain income or capital gain and
    pay income or excise tax on such undistributed amount. Alternatively, the distributions paid by the Fund for any particular month may
    be more than the amount of net investment income from that monthly period. As a result, all or a portion of a distribution may be a return
    of capital, which is in effect a partial return of the amount a Common Shareholder invested in the Fund. For U.S. federal income tax purposes,
    a return of capital distribution is generally not taxable up to the amount of the Common Shareholder&#8217;s tax basis in their Common
    Shares and would reduce such tax basis, and any amounts exceeding such basis will be treated as a gain from the sale of their Common Shares.
    Although a return of capital may not be taxable, it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the
    Common Shareholder&#8217;s potential loss, on any subsequent sale or other disposition of Common Shares. Common Shareholders who receive
    the payment of a distribution consisting of a return of capital may be under the impression that they are receiving net investment income
    or profits when they are not. Common Shareholders should not assume that the source of a distribution from the Fund is net investment
    income or profit. See &#8220;Distributions&#8221; and &#8220;U.S. Federal Income Tax Considerations.&#8221;</p>
    </td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt; width: 25%">&#160;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; width: 75%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Distributions paid on the Common Shares that consist of
    investment company taxable income and/or long-term capital gains are taxable even if they are paid from income or gains earned by
    the Fund before your investment in the Fund (and thus were included in the price paid for your Common Shares). These distributions
    are likely to occur in respect of Common Shares purchased at a time when the Fund&#8217;s net asset value (&#8220;NAV&#8221;)
    reflects earnings realized but not distributed. These distributions may be taxable despite constituting an economic return of your
    investment.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">The Fund&#8217;s distribution rate is not constant and the amount
    of distributions, when declared by the Fund&#8217;s Board of Trustees, is subject to change. There is no guarantee of any future distribution
    or that the current returns and distribution rate will be maintained.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">If you hold your Common Shares in your own name or if you hold your
    Common Shares with a brokerage firm that participates in the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan&#8221;), unless
    you elect to receive cash, all dividends and distributions that are declared by the Fund (net of withholding) will be automatically reinvested
    in additional Common Shares of the Fund pursuant to the Plan. If you hold your Common Shares with a brokerage firm that does not participate
    in the Plan, you will not be able to participate in the Plan and any dividend reinvestment may be effected on different terms than those
    described above. Consult your financial advisor for more information. See &#8220;Dividend Reinvestment Plan.&#8221;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Listing and Symbol</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund&#8217;s currently outstanding Common Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221; The net asset value of the Common Shares at the close of business on November 14, 2025 was $11.38 per share and the last reported sale price of the Common Shares on the NYSE on such date was $12.91, representing a premium to net asset value of 13.44%.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Special Risk Considerations</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">An investment in Common Shares of the Fund involves special risk considerations. Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks of the Fund,&#8221; which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund. You should carefully consider these risks together with all of the other information contained in this Prospectus, including the section of this Prospectus entitled &#8220;Risks&#8221; beginning on page 31, before making a decision to purchase the Fund&#8217;s Common Shares.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Anti-Takeover Provisions in the Fund&#8217;s Governing Documents</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Fund&#8217;s Amended and Restated Agreement and Declaration of Trust (the &#8220;Declaration of Trust&#8221;) and the Fund&#8217;s Bylaws, each as may be amended and/or restated from time to time (collectively, the &#8220;Governing Documents&#8221;), include provisions that could limit the ability of other entities or persons to acquire control of the Fund or convert the Fund to an open-end fund. These provisions could have the effect of depriving the Common Shareholders of opportunities to sell their Common Shares at a premium over the then-current market price of the Common Shares. See &#8220;Anti-Takeover and Other Provisions in the Fund&#8217;s Governing Documents&#8221; and &#8220;Risks&#8212;Anti-Takeover Provisions.&#8221;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt"><b>Administrator, Custodian, Transfer Agent and Dividend Disbursing Agent</b></td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">The Bank of New York Mellon (&#8220;BNY&#8221;) acts as the custodian of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the custodian holds the Fund&#8217;s assets in compliance with the 1940 Act. For its services, the custodian receives a monthly fee based upon, among other things, the average value of the total assets of the Fund, plus certain securities transactions.</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt">Computershare Inc. acts as the Fund&#8217;s dividend disbursing agent, transfer agent and registrar with respect to the Common Shares of the Fund, and Computershare Trust Company, N.A. acts as agent under the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan Agent&#8221;).</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt; width: 25%">&#160;</td>
    <td style="padding-right: 5.75pt; padding-bottom: 6pt; padding-left: 5.75pt; width: 75%">MUFG Investor Services (US) LLC (&#8220;MUFG&#8221;) acts as the Fund&#8217;s administrator and fund accounting agent. Pursuant to an administration agreement, MUFG provides certain administrative services to the Fund. Pursuant to an accounting and administration agreement, MUFG is responsible for maintaining the books and records of the Fund&#8217;s securities and cash. For its services, MUFG receives a monthly fee based upon the average daily Managed Assets of the Fund. </td></tr>
  </table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<p style="margin: 0">&#160;<i>&#160;</i></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center"><span id="ProSummaryFundExp"></span>Summary of Fund
Expenses</p>

<p id="xdx_981_ecef--PurposeOfFeeTableNoteTextBlock_c20251121__20251121_ztVGolSfVsp7" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000038" name="cef:PurposeOfFeeTableNoteTextBlock">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of May 31, 2025. The following table should not be considered a representation of the Fund&#8217;s future expenses. Actual expenses
may be greater or less than shown. The following table shows estimated Fund expenses as a percentage of average net assets attributable
to Common Shares, and not as a percentage of Managed Assets. See &#8220;Management of the Fund.&#8221;</ix:nonNumeric></p>

<ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000040" name="cef:ShareholderTransactionExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_884_ecef--ShareholderTransactionExpensesTableTextBlock_dD_zz77PYEUFEuf" summary="xdx: Disclosure - ShareholderTransactionExpenses" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 77%; padding-right: 5.75pt; padding-left: 5.75pt"><b>Shareholder Transaction Expenses</b></td>
    <td style="width: 23%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Sales load paid by you (<span id="xdx_90C_ecef--BasisOfTransactionFeesNoteTextBlock_c20251121__20251121_zz07hEA50uO7"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000042" name="cef:BasisOfTransactionFeesNoteTextBlock">as a percentage of offering price</ix:nonNumeric></span>) <span style="background-color: #CCEEFF"><sup>(</sup></span><sup>1)</sup></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt"><span style="background-color: #CCEEFF">&#160;&#160;<span id="xdx_908_ecef--SalesLoadPercent_d0_c20251121__20251121_fKDEp_zyfdVofshWLe"><ix:nonFraction name="cef:SalesLoadPercent" contextRef="AsOf2025-11-21" id="Fact000043" format="ixt:zerodash" decimals="INF" unitRef="Ratio">&#8212;</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Offering expenses borne by the Fund (as a percentage of offering price) <span style="font-size: 8.5pt"><sup>(1),(2)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt"><span id="xdx_90C_ecef--OtherTransactionExpensesPercent_c20251121__20251121_fKDEpICgyKQ_____zUpO5bKA7Gz1"><ix:nonFraction name="cef:OtherTransactionExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000044" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.60</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Dividend Reinvestment Plan fees<span style="font-size: 8.5pt"><sup>(3)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 0.5pt"><span id="xdx_906_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20251121__20251121_fKDMp_zQMeiEuGd3m6"><ix:nonFraction name="cef:DividendReinvestmentAndCashPurchaseFees" contextRef="AsOf2025-11-21" id="Fact000045" format="ixt-sec:numwordsen" decimals="0" unitRef="USD">None</ix:nonFraction></span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000047" name="cef:AnnualExpensesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88A_ecef--AnnualExpensesTableTextBlock_zBYwZFwGJFMa" summary="xdx: Disclosure - AnnualExpenses" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 60%; padding-right: 5.75pt; padding-left: 5.75pt"><b>Annual Expenses</b></td>
    <td style="vertical-align: bottom; width: 40%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>As a Percentage of Average Net Assets Attributable to Common Shares<span style="font-size: 8.5pt"><sup>(4)</sup></span></b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Management fees<span style="font-size: 8.5pt"><sup>(5)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_906_ecef--ManagementFeesPercent_c20251121__20251121_fKDQpICg1KQ_____zfKKvMdVxobj"><ix:nonFraction name="cef:ManagementFeesPercent" contextRef="AsOf2025-11-21" id="Fact000048" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.21</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Acquired fund fees and expenses<sup>(6)</sup></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_908_ecef--AcquiredFundFeesAndExpensesPercent_c20251121__20251121_fKDQpICg2KQ_____za6zbiqFfCJ7"><ix:nonFraction name="cef:AcquiredFundFeesAndExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000049" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.05</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Interest expenses<span style="font-size: 8.5pt"><sup>(7)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90E_ecef--InterestExpensesOnBorrowingsPercent_c20251121__20251121_fKDQpICg3KQ_____zebqI9YnDV3g"><ix:nonFraction name="cef:InterestExpensesOnBorrowingsPercent" contextRef="AsOf2025-11-21" id="Fact000050" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">1.08</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Other expenses<span style="font-size: 8.5pt"><sup>(8)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90D_ecef--OtherAnnualExpensesPercent_c20251121__20251121_fKDQpICg4KQ_____zl8YdKj8vxs8"><ix:nonFraction name="cef:OtherAnnualExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000051" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">0.10</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Total annual expenses<sup>(9)</sup></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_901_ecef--TotalAnnualExpensesPercent_c20251121__20251121_fKDkp_z3N7wjCi6Bg2"><ix:nonFraction name="cef:TotalAnnualExpensesPercent" contextRef="AsOf2025-11-21" id="Fact000052" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.44</ix:nonFraction>%</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0B_zB0wb4NSDeh2" style="font-size: 8.5pt">(1)</span></td><td id="xdx_F1D_zWWCyYSNsh9f"><ix:footnote id="Footnote000053" xml:lang="en-US">If Common Shares to which this Prospectus relates are sold to or through underwriters, the Prospectus Supplement will set forth any
applicable sales load to be paid by investors and the estimated offering expenses borne by the Fund.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0E_zsZupdkPFN17" style="font-size: 8.5pt">(2)</span></td><td id="xdx_F10_zsxKgtKFNcJ4"><ix:footnote id="Footnote000054" xml:lang="en-US">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#8217;s registration statement and any
offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under this registration statement,
to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#8217;s behalf in an amount up
to the lesser of the Fund&#8217;s actual offering costs or 0.60% of the total offering price of the Common Shares sold in such offerings.
Amounts in excess of 0.60% of the total offering price of shares sold pursuant to this registration statement will not be subject to recoupment
from the Fund. This agreement will be in effect for the life of the registration statement with respect to all Common Shares sold pursuant
to the registration statement and may only be terminated by the Board of Trustees of the Fund.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0D_zSpvd9dkyEbl" style="font-size: 8.5pt">(3)</span></td><td id="xdx_F13_zk5QQAfnk3ia"><ix:footnote id="Footnote000055" xml:lang="en-US">Common Shareholders will pay brokerage charges if they direct Computershare Trust Company, N.A. (the &#8220;Plan Agent&#8221;) to
sell Common Shares held in a dividend reinvestment account. See &#8220;Dividend Reinvestment Plan.&#8221;</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0F_z4imM8SAy7qf" style="font-size: 8.5pt">(4)</span></td><td id="xdx_F1E_zFEdt6hzhRe2"><ix:footnote id="Footnote000056" xml:lang="en-US">Based upon average net assets attributable to Common Shares during the fiscal year ended May 31, 2025.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0F_zqkBhLwwOD1j" style="font-size: 8.5pt">(5)</span></td><td id="xdx_F11_zu8C29ZCS6Ue"><ix:footnote id="Footnote000057" xml:lang="en-US">The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to 1.00% of the Fund&#8217;s average daily Managed
Assets (as defined herein). Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with
the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other forms of debt (&#8220;Borrowings&#8221;)
or reverse repurchase agreements, dollar rolls or similar transactions or a combination of the foregoing (collectively &#8220;Financial
Leverage&#8221;), which means that Common Shareholders effectively bear the entire advisory fee. Because <span style="background-color: white">the
management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#8217;s Managed Assets, the management fee as
a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial Leverage. If Financial
Leverage of more than 16% of the Fund&#8217;s Managed Assets is used, the management fee shown would be higher.</span></ix:footnote></td></tr></table>



<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0A_zZOhlEM5jBoj" style="font-size: 8.5pt">(6)</span></td><td><span id="xdx_F10_zi3b7EJNOGGk" style="background-color: white"><ix:footnote id="Footnote000058" xml:lang="en-US">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the Fund
as an investor in other investment companies during the fiscal year ended May 31, 2025.</ix:footnote></span></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F01_z5m2XdkdcT79" style="font-size: 8.5pt">(7)</span></td><td id="xdx_F1D_zBdXHeixEAOl"><ix:footnote id="Footnote000059" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is estimated based upon the Fund&#8217;s outstanding Borrowings as of May 31, 2025, which included Borrowings under the Fund&#8217;s
committed facility agreement in an amount equal to 2.08% of the Fund&#8217;s Managed Assets, at an average interest rate of 5.08%. Interest
expense on reverse repurchase agreements is estimated based on the Fund&#8217;s outstanding reverse repurchase agreements as of May 31,
2025, which included leverage in the form of reverse repurchase agreements in an amount equal to 13.77% of the Fund&#8217;s Managed Assets,
at a weighted average interest rate cost to the Fund of 4.52%. The actual amount of interest payments and expenses borne by the Fund will
vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</ix:footnote></td></tr></table>
<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F0F_zAFFRu5MiiVl" style="font-size: 8.5pt">(8)</span></td><td id="xdx_F18_zqoGLNiIOWUk"><ix:footnote id="Footnote000060" xml:lang="en-US">Other expenses are based on estimated amounts for the current fiscal year.</ix:footnote></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span id="xdx_F02_zOjeB2lUA8ec" style="font-size: 8.5pt">(9)</span></td><td id="xdx_F1F_zYI75h2P1wrc"><ix:footnote id="Footnote000061" xml:lang="en-US">The total annual expenses in this fee table may not correlate to the expense ratios in the Fund&#8217;s financial highlights and financial
statements because the financial highlights and financial statements reflect only the operating expenses of the Fund and do not include
Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly by the Fund through its investments in certain underlying
investment companies.</ix:footnote></td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center">Example</p>
<div id="xdx_885_ecef--ExpenseExampleTableTextBlock_zfMarCMPJRni"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000063" name="cef:ExpenseExampleTableTextBlock">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As required by relevant SEC regulations, the
following example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual
expenses&#8221; of 2.44% of net assets attributable to Common Shares and (2) a 5% annual return*:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>1 Year</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>3 Years</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>5 Years</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>10 Years</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Total Annual Expense Paid by Common Shareholders</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90A_ecef--ExpenseExampleYear01_c20251121__20251121_fKCop_zxndvVx0QlR1">$<ix:nonFraction name="cef:ExpenseExampleYear01" contextRef="AsOf2025-11-21" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25</ix:nonFraction></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_901_ecef--ExpenseExampleYears1to3_c20251121__20251121_fKCop_zd3IUPNP5Oy9">$<ix:nonFraction name="cef:ExpenseExampleYears1to3" contextRef="AsOf2025-11-21" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">76</ix:nonFraction></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_906_ecef--ExpenseExampleYears1to5_c20251121__20251121_fKCop_zvSbJWqyJnU8">$<ix:nonFraction name="cef:ExpenseExampleYears1to5" contextRef="AsOf2025-11-21" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">130</ix:nonFraction></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90B_ecef--ExpenseExampleYears1to10_c20251121__20251121_fKCop_z3yX9gJWOFyh">$<ix:nonFraction name="cef:ExpenseExampleYears1to10" contextRef="AsOf2025-11-21" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">277</ix:nonFraction></span></td></tr>
  </table></ix:nonNumeric></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">______________________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td id="xdx_F02_zMtVB4eXxIF4" style="width: 0.4in">*</td><td><b id="xdx_F16_z2fqmEdRNMsg"><ix:footnote id="Footnote000068" xml:lang="en-US">The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed and shown. Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown
in the example. The example assumes that all dividends and distributions are reinvested at net asset value. See &#8220;Distributions&#8221;
and &#8220;Dividend Reinvestment Plan.&#8221;</ix:footnote></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.4in">The example does not include sales loads or estimated
offering costs which, if reflected, would result in higher expenses. In connection with an offering of Common Shares, the Prospectus Supplement
will set forth an example including sales load and estimated offering costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.4in">The above table and example and the assumption
in the example of the 5% annual return are provided to assist in your understanding of the various costs and expenses that an investor
in the Fund will bear directly or indirectly. The assumed 5% annual return is not a prediction of, and does not represent, the projected
or actual performance of the Fund&#8217;s Common Shares.</p>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center"><span id="ProFinancialHighlights"></span>Financial Highlights</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The financial highlights table is intended to
help you understand the Fund&#8217;s financial performance. The information in this table is derived from the Fund&#8217;s financial statements
and has been audited by Ernst &amp; Young LLP, independent registered public accounting firm for the Fund. The Fund&#8217;s audited financial
statements appearing in the Fund&#8217;s annual report to shareholders for the year ended May 31, 2025, including the report of Ernst
&amp; Young LLP thereon and accompanying notes thereto, are incorporated by reference in the SAI.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2025</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2024</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2023</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2022</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Per Share Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, beginning of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 11.95</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 12.34</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.33</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.05</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 15.29</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Income from investment operations:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income<sup>(a)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.82</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.82</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.75</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.80</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.95</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net gain (loss) on investments (realized and unrealized)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.85</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.98</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.55)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.33)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">3.00</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total from investment operations</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.67</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.80</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.20</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.53)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">3.95</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Less distributions from:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.70)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.81)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.76)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.04)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.97)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Capital gains</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.15)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.18)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Return of capital</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.49)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.23)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.25)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.96)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.22)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total distributions to shareholders</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 11.43</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 11.95</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 12.34</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.33</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.05</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.73</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 14.68</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 15.69</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.92</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 20.90</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Total Return<sup>(b)</sup></b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">15.09%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">15.72%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">2.09%<sup>(f)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(3.99%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">27.20%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">16.48%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">9.77%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.80%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(3.48%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">45.59%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Ratios/Supplemental Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net assets, end of period (in thousands)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 2,008,816</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 1,703,619</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 1,473,694</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 1,492,615</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 878,041</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Ratio to average net assets of:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income, including interest expense</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">6.95%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">6.79%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.81%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">4.75%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.72%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total expenses, including interest expense<sup>(c)(d)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.40%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.90%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.88%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">1.83%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.83%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Portfolio turnover rate</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">25%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">30%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">26%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">47%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">64%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Senior Indebtedness</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total Borrowings outstanding (in thousands)<sup>(g)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 378,321</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 361,456</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 343,500</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 128,000</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 38,501</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Asset Coverage per $1,000 of indebtedness<sup>(e)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 6,310</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 5,713</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 5,290</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 12,661</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 23,806</span></td></tr>
  </table>
<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in; text-indent: -0.4in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(a)</span></td><td>Based on average shares outstanding.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(b)</span></td><td>Total return is calculated assuming a purchase of a Common Share at the beginning of the period and a sale on the last day of the
period reported either at net asset value (&#8220;NAV&#8221;) or market price per share. Dividends and distributions are assumed to be
reinvested at NAV for NAV returns or the prices obtained under the Fund&#8217;s Dividend Reinvestment Plan for market value returns. Total
return does not reflect brokerage commissions. A return calculated for a period of less than one year is not annualized.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(c)</span></td><td>The ratios of total expenses to average net assets applicable to common shares do not reflect fees and expenses incurred indirectly
by the Fund as a result of its investment in shares of other investment companies. If these fees were included in the expense ratios,
for the years ended May 31, the expense ratios would increase by:</td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 8%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2025</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 9%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2024</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2023</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2022</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2021</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2020</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2019</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2018</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2017</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2016</i></b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.05%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.07%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.07%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.06%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.06%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.09%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.08%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.00%</i>*</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.00%</i>*</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>0.00%</i>*</span></td></tr>
  </table>
<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in; text-indent: -0.4in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(d)</span></td><td>Excluding interest expense, the operating expense ratios for the years ended May 31, would be:</td></tr></table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 8%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2025</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2024</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2023</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2022</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2021</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2020</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2019</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2018</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2017</i></b></span></td>
    <td style="border-bottom: black 1.5pt solid; width: 10%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><b><i>2016</i></b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.32%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.39%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.44%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.51%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.55%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.17%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.15%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.33%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.62%</i></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="font-size: 9pt"><i>1.74%</i></span></td></tr>
  </table>
<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in; text-indent: -0.4in">&#160;</p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 8.5pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.4in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 9in">
  <tr style="vertical-align: bottom">
    <td style="width: 40%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2020</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2019</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2018</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2017</span></td>
    <td style="width: 12%; padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">For the Year Ended May 31, 2016</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Per Share Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, beginning of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.91</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.12</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.78</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.50</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.61</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Income from investment operations:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income<sup>(a)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.89</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.97</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.23</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.61</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.40</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net gain (loss) on investments (realized and unrealized)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.32)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.01</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.30</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.86</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.33)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total from investment operations</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.43)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.98</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.53</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">4.47</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.07</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Less distributions from:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.86)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.12)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.01)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.18)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.82)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Capital gains</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.16)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.18)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.01)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.36)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Return of capital</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(1.33)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(0.91)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total distributions to shareholders</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.19)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">(2.18)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">15.29</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">17.91</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">19.12</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">19.78</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">17.50</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value, end of period</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 16.20</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19.96</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 21.29</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 20.94</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 17.61</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Total Return<sup>(b)</sup></b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net asset value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(2.79%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.43%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">8.02%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">26.76%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">0.80%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Market value</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 19.15pt"><span style="font-size: 9pt">(7.96%)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">4.94%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">13.31%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">33.33%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">-6.07%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Ratios/Supplemental Data:</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net assets, end of period (in thousands)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 648,892</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 641,825</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 530,250</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 410,465</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 310,246</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Ratio to average net assets of:</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Net investment income, including interest expense</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">5.29%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">5.26%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">6.27%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">8.55%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">7.79%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total expenses, including interest expense<sup>(c) (d)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center; text-indent: 21.65pt"><span style="font-size: 9pt">1.21%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.17%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">1.52%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.35%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">2.38%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Portfolio turnover rate</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">41%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">38%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">48%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">41%</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">116%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt"><b>Senior Indebtedness</b></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Total borrowings outstanding (in thousands)</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 19,300</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 16,705</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 9,355</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt"><span style="font-size: 9pt">Asset coverage per $1,000 of indebtedness<sup>(e)</sup></span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 34,621</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">N/A</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 25,571</span></td>
    <td style="padding-top: 0.75pt; padding-right: 0.75pt; padding-left: 0.75pt; text-align: center"><span style="font-size: 9pt">$ 34,164</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(e)</span></td><td>Calculated by subtracting the Fund&#8217;s total liabilities (not including the borrowings) from the Fund&#8217;s total assets and
dividing by the borrowings. Effective August 19, 2022, the Fund&#8217;s obligations under reverse repurchase agreement transactions are
treated as senior securities representing indebtedness for purposes of the 1940 Act. Accordingly, for the years ended May 31, 2025, May
31, 2024 and May 31, 2023, Asset Coverage is calculated by subtracting the Fund&#8217;s total liabilities (not including the borrowings
or reverse repurchase agreements) from the Fund&#8217;s total assets and dividing by the sum of the borrowings and reverse repurchase
agreements.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(f)</span></td><td>The net increase from the payment by the Investment Adviser totaling $216,351 relating to an operational issue contributed 0.01% to
total return at net asset value for the year ended May 31, 2023.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">(g)</span></td><td>Effective August 19, 2022, the Fund&#8217;s obligations under reverse repurchase agreement transactions are treated as senior securities
representing indebtedness for purposes of the 1940 Act.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><span style="font-size: 8.5pt">*</span></td><td><span style="background-color: white">Less than 0.01%.</span></td></tr></table>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProSeniorHighlights"></span>Senior Securities</p>

<p id="xdx_98A_ecef--SeniorSecuritiesNoteTextBlock_c20251121__20251121_zz3gIUi0CpRe" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000069" name="cef:SeniorSecuritiesNoteTextBlock">For information about the Fund&#8217;s senior
securities as of the end of the last ten fiscal years, please refer to the section of the<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Other Information (unaudited)&#8212;Senior Securities&#8221;
which is incorporated by reference herein. Information regarding the Fund&#8217;s senior securities is also contained in the Financial
Highlights in the Fund&#8217;s most recent annual report on Form N-CSR, which has been audited by Ernst &amp; Young LLP for the last five
fiscal years. The Fund&#8217;s audited financial statements, including the report of Ernst &amp; Young LLP thereon and accompanying notes
thereto, are included in the Fund&#8217;s most recent annual report to shareholders and incorporated by reference in the SAI. A copy of
the report is available upon request and without charge by calling (888) 991-0091 or by writing the Fund at 227 West Monroe Street, Chicago,
Illinois 60606.</ix:nonNumeric></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProTheFund"></span>The Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Guggenheim Strategic Opportunities Fund (the
&#8220;Fund&#8221;) is a diversified, closed-end management investment company registered under the Investment Company Act of 1940, as
amended (the &#8220;1940 Act&#8221;), that commenced operations on July 26, 2007. The Fund was organized as a statutory trust on November
13, 2006, pursuant to a Certificate of Trust, and is governed by the laws of the State of Delaware. Its principal office is located at
227 West Monroe Street, Chicago, Illinois 60606, and its telephone number is (312) 827-0100.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Except as otherwise noted, all percentage limitations
set forth in this Prospectus apply immediately after a purchase or initial investment and any subsequent change in any applicable percentage
resulting from market fluctuations does not require any action.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProUseProceeds"></span>Use
of Proceeds</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Unless otherwise specified in a prospectus
supplement, the Fund intends to invest the net proceeds of the offering of Common Shares in accordance with its investment objective
and policies as stated above or otherwise invest the net proceeds as follows. It is currently
anticipated that the Fund will be able to invest most of the net proceeds of an offering of Common Shares in accordance with its
investment objective and policies within three months after the receipt of such proceeds. Pending such investment, it is anticipated
that the proceeds will be invested in U.S. government securities or high quality, short-term money-market securities. The Fund may
also use the proceeds for working capital purposes, including the payment of distributions, interest and operating expenses. A
portion of the cash held by the Fund, including net proceeds of the offering, is usually used to pay distributions in accordance
with the Fund&#8217;s distribution policy and may be a return of capital, which is in effect a partial return of the amount a Common
Shareholder invested in the Fund. Common Shareholders who receive the payment of a distribution consisting of a return of capital
may be under the impression that they are receiving net investment income or profit when they are not. The Fund&#8217;s
distributions may be greater than the Fund&#8217;s net investment income or profit. The offering of Common Shares supports the
Fund&#8217;s asset level and if the Fund does not offer or sell Common Shares, the Fund may not be able to maintain historical
distribution levels for extended periods of time. There is no guarantee that the Fund will sell all of the Common Shares available
for sale under its shelf registration statement or that there will be any sales of common shares thereunder and, from time to time,
the Fund may be unable to sell its common shares under its shelf registration statement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-transform: uppercase; text-align: center"><span id="ProMarketNetAssetInfo"></span>Market and Net
Asset Value Information</p>

<div id="xdx_88E_ecef--SharePriceTableTextBlock_zKSe7xNRTiY5"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000071" name="cef:SharePriceTableTextBlock"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s currently outstanding Common
Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(the &#8220;NYSE&#8221;) under the symbol &#8220;GOF&#8221;. The Fund&#8217;s Common Shares commenced trading on the NYSE on July 27,
2007.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Common Shares have traded both at a premium
and at a discount in relation to the Fund&#8217;s net asset value per share. Although the Common Shares recently have generally traded
at a premium to net asset value, there can be no assurance that this will continue after the offering nor that the Common Shares will
not trade at a discount in the future. Shares of closed-end investment companies frequently trade at a premium or discount to net asset
value and the market price for the Common Shares will change based on a variety of factors. The net asset value and market price of the
Common Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market
price of the Common Shares will either be above (premium) or below (discount) their net asset value. The Fund cannot predict whether the
Common Shares will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a
variety of factors. The Fund&#8217;s net asset value would be reduced following an offering of the Common Shares due to the costs of such
</p>

<ix:exclude><!-- Field: Page; Sequence: 17; Value: 1 -->
    <div id="xdx_234_zSRe7QbZety8" style="margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_23C_zDj5Z4qCpbkg" style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div id="xdx_232_zokwCLDusBH" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p id="xdx_230_zy0elSGdSa5d" style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">offering, to the extent those costs are borne by the Fund. The sale of Common Shares by the Fund (or the perception that such sales may
occur) may increase the volatility of or have an adverse effect on prices of Common Shares in the secondary market. An increase in the
number of Common Shares available may put downward pressure on the market price for Common Shares. See &#8220;Risks&#8212;Market Discount
and Price Volatility Risk.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table sets forth, for each of the
periods indicated, the high and low closing market prices for the Common Shares on the NYSE, as well as the net asset value per Common
Share and the premium or discount to net asset value per Common Share at which the Common Shares were trading on the date of the high
and low closing prices. The Fund calculates its net asset value as of the close of business, usually 4:00 p.m. Eastern Time, every day
on which the NYSE is open. See &#8220;Net Asset Value&#8221; for information as to the determination of the Fund&#8217;s net asset value.</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">&#160;</td>
    <td id="xdx_481_ecef--HighestPriceOrBid_zxfWIoRT9Bf6" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_483_ecef--LowestPriceOrBid_zdEkVbWyTsC2" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_48A_ecef--HighestPriceOrBidNav_z3at9YAoAYga" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_485_ecef--LowestPriceOrBidNav_zNwfcMYcaK3l" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_488_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zVx38qbKKH76" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_487_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zvgFwov0feRl" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Fiscal Quarter Ended</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Market Price</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>NAV per Common<br/>
Share on Date of Market<br/>
Price High and Low<span style="font-size: 8.5pt"><sup>(1)</sup></span></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Premium/(Discount) on<br/>
Date of Market Price</b><br/>
<b>High and Low<span style="font-size: 8.5pt"><sup>(2)</sup></span></b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td></tr>
  <tr id="xdx_414_20250601__20250831_z1ahzOQZabn7" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-06-012025-08-31" id="Fact000072" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.10</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-06-012025-08-31" id="Fact000073" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.55</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-06-012025-08-31" id="Fact000074" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.50</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-06-012025-08-31" id="Fact000075" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.38</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-06-012025-08-31" id="Fact000076" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">31.30</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-06-012025-08-31" id="Fact000077" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">27.86</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_410_20250301__20250531_zarexPXdOTR6" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2025-03-012025-05-31" id="Fact000078" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.91</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2025-03-012025-05-31" id="Fact000079" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.74</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2025-03-012025-05-31" id="Fact000080" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.67</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2025-03-012025-05-31" id="Fact000081" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.06</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-03-012025-05-31" id="Fact000082" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">36.33</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2025-03-012025-05-31" id="Fact000083" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">24.23</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41E_20241201__20250228_z2M1HcaTxGDg" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 28, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-12-012025-02-28" id="Fact000084" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.99</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-12-012025-02-28" id="Fact000085" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.00</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-12-012025-02-28" id="Fact000086" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.01</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-12-012025-02-28" id="Fact000087" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.74</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-12-012025-02-28" id="Fact000088" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">33.14</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-12-012025-02-28" id="Fact000089" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">27.77</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41E_20240901__20241130_zQH4n0ppKR71" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-09-012024-11-30" id="Fact000090" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.03</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-09-012024-11-30" id="Fact000091" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.26</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-09-012024-11-30" id="Fact000092" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.99</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-09-012024-11-30" id="Fact000093" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.01</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-09-012024-11-30" id="Fact000094" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">33.69</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-09-012024-11-30" id="Fact000095" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">27.06</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41C_20240601__20240831_z4g8GRppMwa2" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-06-012024-08-31" id="Fact000096" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.75</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-06-012024-08-31" id="Fact000097" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.65</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-06-012024-08-31" id="Fact000098" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.06</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-06-012024-08-31" id="Fact000099" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.93</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-06-012024-08-31" id="Fact000100" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">30.60</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-06-012024-08-31" id="Fact000101" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">22.80</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_41F_20240301__20240531_zU0ZoA2jKCi9" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2024-03-012024-05-31" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.90</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2024-03-012024-05-31" id="Fact000103" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">13.80</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2024-03-012024-05-31" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.26</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2024-03-012024-05-31" id="Fact000105" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.82</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-03-012024-05-31" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">21.53</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2024-03-012024-05-31" id="Fact000107" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">16.75</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_411_20231201__20240229_zsKPfS7pKMdg" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 29, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-12-012024-02-29" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">14.29</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-12-012024-02-29" id="Fact000109" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.67</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-12-012024-02-29" id="Fact000110" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.12</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-12-012024-02-29" id="Fact000111" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.34</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-12-012024-02-29" id="Fact000112" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">17.90</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-12-012024-02-29" id="Fact000113" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">2.67</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_414_20230901__20231130_zIECh2mE4rS2" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-09-012023-11-30" id="Fact000114" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.96</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-09-012023-11-30" id="Fact000115" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.16</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-09-012023-11-30" id="Fact000116" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.30</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-09-012023-11-30" id="Fact000117" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.71</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-09-012023-11-30" id="Fact000118" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">29.76</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">-<ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-09-012023-11-30" id="Fact000119" format="ixt:numdotdecimal" decimals="INF" scale="-2" sign="-" unitRef="Ratio">4.70</ix:nonFraction>%</span></td></tr>
  <tr id="xdx_418_20230601__20230831_z36VwxvLer89" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBid" contextRef="From2023-06-012023-08-31" id="Fact000120" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">16.28</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBid" contextRef="From2023-06-012023-08-31" id="Fact000121" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">15.51</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:HighestPriceOrBidNav" contextRef="From2023-06-012023-08-31" id="Fact000122" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.48</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$<ix:nonFraction name="cef:LowestPriceOrBidNav" contextRef="From2023-06-012023-08-31" id="Fact000123" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">12.30</ix:nonFraction></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:HighestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-06-012023-08-31" id="Fact000124" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">30.45</ix:nonFraction>%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D"><ix:nonFraction name="cef:LowestPriceOrBidPremiumDiscountToNavPercent" contextRef="From2023-06-012023-08-31" id="Fact000125" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">26.10</ix:nonFraction>%</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(1)</td><td>Based on the Fund&#8217;s computations.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(2)</td><td>Calculated based on the information presented. Percentages are rounded.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The last reported market price, net asset value
per Common Share and percentage premium to net asset value per Common Share as of November 14, 2025 was $12.91, $11.38 and <span id="xdx_907_ecef--LatestPremiumDiscountToNavPercent_c20251121__20251121_zgaiJFfUo8j5"><ix:nonFraction name="cef:LatestPremiumDiscountToNavPercent" contextRef="AsOf2025-11-21" id="Fact000126" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Ratio">13.44</ix:nonFraction>%</span>, respectively.
The Fund cannot predict whether its Common Shares will trade in the future at a premium to or discount from net asset value, or the level
of any premium or discount. Shares of closed-end investment companies frequently trade at a discount from net asset value. The Fund&#8217;s
Common Shares have in the past traded both above and below their net asset value. As of November 14, 2025, 199,267,847 Common Shares of
the Fund were outstanding.</p></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProObjPolicies"></span>Investment Objective
and Policies</p>

<p id="xdx_986_ecef--InvestmentObjectivesAndPracticesTextBlock_c20251121__20251121_gBFIOAPTB-ITSRA_zbLN8deY8oUd" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><ix:nonNumeric contextRef="AsOf2025-11-21" continuedAt="ConU000154-01" escape="true" id="Fact000154" name="cef:InvestmentObjectivesAndPracticesTextBlock">Investment Objective</ix:nonNumeric></p>

<div id="xdx_C0D_gBFIOAPTB-ITSRA_zalQ15PqtsDf"><ix:continuation continuedAt="ConU000154-02" id="ConU000154-01"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Investment Objective,&#8221; which is
incorporated by reference herein, for a discussion of the investment objective of the Fund.</span></p></ix:continuation></div>

<div id="xdx_C0F_gBFIOAPTB-ITSRA_znaBhDj9vo1b"><ix:continuation continuedAt="ConU000154-03" id="ConU000154-02"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Policies</p></ix:continuation></div>

<div id="xdx_C0C_gBFIOAPTB-ITSRA_zgpCzZzGC5Wj"><ix:continuation continuedAt="ConU000154-04" id="ConU000154-03"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Principal Investment Strategies and Portfolio
Composition</span><span style="font-weight: normal">&#8212;Investment Policies<span style="color: windowtext">&#8221; which is incorporated
by reference herein, for a discussion of the investment policies of the Fund. With respect to the Fund&#8217;s policies relating to rated
fixed-income securities, please refer to Appendix A to the SAI for more information regarding Moody&#8217;s and S&amp;P&#8217;s ratings.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><span style="color: windowtext">Rating agencies, such as Moody&#8217;s or S&amp;P, are private services that provide ratings of the credit quality of debt obligations.
Ratings assigned by an NRSRO are not absolute standards of credit quality but represent the opinion of the NRSRO as to the quality of
the obligation. Ratings do not evaluate market risks or the liquidity of securities. Rating agencies may fail to make timely changes in
credit ratings and an issuer&#8217;s current financial condition may be better or worse than a rating indicates. To the extent that the
issuer of a security pays an NRSRO for the analysis of its security, an inherent conflict of interest may exist that could affect the
reliability of the rating. Ratings are relative and subjective and, although ratings may be useful in evaluating the safety of interest
and principal payments, they do not evaluate the market value risk of such obligations. Although these ratings may be an initial criterion
for selection of portfolio investments, the Sub-Adviser also will independently evaluate these securities and the ability of the issuers
of such securities to pay interest and principal. To the extent that the Fund invests in unrated lower grade securities, the Fund&#8217;s
ability to achieve its investment objective will be more dependent on the Sub-Adviser&#8217;s credit analysis than would be the case when
the Fund invests in rated securities.</span></span></p></ix:continuation></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<div id="xdx_C04_gBFIOAPTB-ITSRA_zV0nfgqlFtYa"><ix:continuation continuedAt="ConU000154-05" id="ConU000154-04"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Principal Investment Strategies</b></p></ix:continuation></div>

<div id="xdx_C05_gBFIOAPTB-ITSRA_znhSEiqTaXhe"><ix:continuation continuedAt="ConU000154-06" id="ConU000154-05"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund pursues a relative value-based investment
philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate
from their perceived fair value and/or historical norms. The Sub-Adviser seeks to combine a credit managed fixed-income portfolio with
access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is predicated</p></ix:continuation></div>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0E_gBFIOAPTB-ITSRA_zhB6ZEdOBpth"><ix:continuation continuedAt="ConU000154-07" id="ConU000154-06"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> upon
the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform benchmark
indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes.</p></ix:continuation></div>

<div id="xdx_C04_gBFIOAPTB-ITSRA_z73UZtduuY04"><ix:continuation continuedAt="ConU000154-08" id="ConU000154-07"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s analysis of a fixed-income
security&#8217;s credit quality is comprised of multiple elements, including, but not limited to: (i) sector analysis, including regulatory
developments and sector health, (ii) collateral, business, and counterparty risk, which includes payment history, collateral performance,
and borrower credit profile, (iii) structural analysis, which includes securitization structure review and forms of credit enhancement,
and (iv) stress analysis, including historical collateral performance during extreme market stress and identifying tail risks. This analysis
is applied against the macroeconomic outlook, geopolitical issues as well as considerations that more directly affect the company&#8217;s
industry to determine the Sub-Adviser&#8217;s internal judgment as to the security&#8217;s credit quality. In addition to the process
described above, the Sub-Adviser selects securities using a rigorous portfolio construction approach designed to tightly control independent
risk exposures such as fixed income sector weights, sector specific yield curves, credit spreads, prepayment risks, and other risk exposures
the Sub-Adviser deems relevant. Within those risk constraints, the Sub-Adviser estimates the relative value of different securities to
select individual securities that, in the Sub-Adviser&#8217;s judgment, may provide risk-adjusted outperformance.</p></ix:continuation></div>

<div id="xdx_C0A_gBFIOAPTB-ITSRA_z1KVqwH1Hk27"><ix:continuation continuedAt="ConU000154-09" id="ConU000154-08"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s process for determining
whether to buy or sell a security is a collaborative effort between various groups including: (i) economic research, which focus on key
economic themes and trends, regional and country-specific analysis, and assessments of event-risk and policy impacts on asset prices,
(ii) the Portfolio Construction Group, which utilizes proprietary portfolio construction and risk modeling tools to determine allocation
of assets among a variety of sectors, (iii) its Sector Specialists, who are responsible for identifying investment opportunities in particular
securities within these sectors, including the structuring of certain securities directly with the issuers or with investment banks and
dealers involved in the origination of such securities, and (iv) portfolio managers, who determine which securities best fit the Fund
based on the Fund&#8217;s investment objective and top-down sector allocations. In managing the Fund, the Sub-Adviser uses a process for
selecting securities for purchase and sale that is based on intensive credit research and involves extensive due diligence on each issuer,
region and sector. The Sub-Adviser also considers macroeconomic outlook and geopolitical issues.</p></ix:continuation></div>

<div id="xdx_C0E_gBFIOAPTB-ITSRA_zx70dlyWzVhf"><ix:continuation continuedAt="ConU000154-10" id="ConU000154-09"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser generally decides which securities
to sell for the Fund based on one of three factors:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In the Sub-Adviser&#8217;s judgment, the relative value measure of the instrument no longer indicates that the instrument is cheap
relative to similar instruments and a substitution of the instrument with a similar but cheaper instrument enhances the risk-adjusted
return potential of the portfolio.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental analysis suggests that the embedded credit risk in an instrument has increased and the instrument
no longer properly compensates the holder for this increased risk.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental sector allocation decisions result in the rebalancing of existing positions to achieve the Sub-Adviser&#8217;s
desired sector exposures.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Additional Information About
the Fund&#8217;s Principal Investment Strategies &amp; Portfolio Composition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>In seeking to achieve its investment objective,
the Fund will or may ordinarily invest in, among other investment categories, the following categories of investments:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Income Securities Strategy. </i>The Fund seeks
to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income
Securities&#8221;) selected from a variety of sectors and credit qualities. The Fund may invest in non-U.S. dollar-denominated Income Securities issued by sovereign entities and corporations, including Income
Securities of issuers in emerging market countries. The Fund may invest in Income Securities of any credit quality,
including, without limitation, Income Securities rated below-investment grade (commonly referred to as &#8220;high-yield&#8221; or &#8220;junk&#8221;
bonds), which are considered speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal. The sectors
and types of Income Securities in which the Fund may invest, include, but are not limited to:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Corporate bonds;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Loans and loan participations (including senior secured floating rate loans, &#8220;second lien&#8221; secured floating rate loans, and other types of secured and unsecured loans with fixed and variable interest rates, including &#8220;debtor-in-possession&#8221; financings) (collectively, &#8220;Loans&#8221;);</td></tr>
  </table></ix:continuation></div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>
<div id="xdx_C04_gBFIOAPTB-ITSRA_zi4RrS5ba9Ra"><ix:continuation continuedAt="ConU000154-11" id="ConU000154-10">
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Structured finance investments (including residential and commercial mortgage-related securities, asset- backed securities, collateralized debt obligations and risk-linked securities);</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">U.S. government and agency securities and sovereign or supranational debt obligations;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Mezzanine and preferred securities; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Convertible securities.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Debt Overlay Strategy. </i>As part of its
Income Securities strategy, the Fund may employ a strategy of investing in a basket of debt securities and other instruments (the &#8220;Debt
Overlay Basket&#8221;) and writing (selling) out-of-the-money call options (i.e., call options for which the current price of the underlying
asset is below the strike price) or near at-the-money call options (i.e., call options for which the current price of the underlying asset
is close to the strike price) on a fixed-income ETF (the &#8220;Underlying Bond ETF&#8221;) in an amount that creates a notional exposure
approximately equal to the investment exposure created by the Debt Overlay Basket (the &#8220;Debt Overlay Strategy&#8221;). The Debt
Overlay Strategy is intended to generate current income in the form of options premiums.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The composition of the Debt Overlay Basket and
the Underlying Bond ETF are expected to be generally similar (i.e., a portfolio of high yield corporate bonds), although they would have
differences. The Fund considers an ETF to be eligible to be an Underlying Bond ETF for purposes of the Debt Overlay Strategy when the
ETF is passively managed and consists of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. or if the ETF is designed
to track an index (or subset thereof) that provides a representation of the U.S. dollar-denominated high yield corporate bond market.
GPIM seeks to select investments for the Debt Overlay Basket with the objective of constructing a Debt Overlay Basket that is designed
to achieve, before fees and expenses, returns that exceed those of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Debt Overlay Basket is intended
to outperform the Underlying Bond ETF (and the performance of the Debt Overlay Basket is otherwise intended to generally be correlated
with that of the Underlying Bond ETF), the options sold as part of the Debt Overlay Strategy are not intended to be &#8220;covered,&#8221;
meaning that the Fund will generally not hold shares in the Underlying Bond ETF as part of the Debt Overlay Strategy (or have an absolute
and immediate right to purchase the Underlying Bond ETF&#8217;s shares) in the amount necessary to meet the Fund&#8217;s contingent obligation
to deliver cash or shares of the Underlying Bond ETF to the Fund&#8217;s options counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Equity Securities and Covered Call
Options Strategy. </i>The Fund may also invest in common stocks, limited liability company interests, trust certificates and other equity
investments (&#8220;Common Equity Securities&#8221;) that the Sub-Adviser believes offer attractive yield and/or capital appreciation
potential. As part of its Common Equity Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered
call options and may, from time to time, buy or sell put options on individual Common Equity Securities. In addition to its covered call
option strategy, the Fund may, to a lesser extent, pursue a strategy that includes the sale (writing) of both covered call and put options
on indices of securities and sectors of securities. This covered call option strategy is intended to generate current gains from option
premiums as a means to generate total returns as well as to enhance distributions payable to the Common Shareholders. As the Fund writes
covered calls over more of its portfolio, its ability to benefit from capital appreciation becomes more limited. As part of Common Equity
Securities strategy, the Fund may not sell &#8220;naked&#8221; call options on individual Common Equity securities. A substantial portion
of the options written by the Fund may be over-the-counter options (&#8220;OTC options&#8221;). Under current market conditions, the Fund
implements its covered call writing strategy primarily by investing in exchange-traded funds (&#8220;ETFs&#8221;) or index futures which
provide exposure to Common Equity Securities and writing covered call options on those ETFs or index futures, and the Fund may also write
call options on individual securities, securities indices, ETFs futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Autocallable ELN Strategy.</i> The
Fund may employ a synthetic autocallable equity linked-note (&#8220;ELN&#8221;) strategy designed to generate current income based on
equity market performance rather than traditional fixed income and credit factors, such as duration and interest rates (the &#8220;Synthetic
Autocallable ELN Strategy&#8221;). The Synthetic Autocallable ELN Strategy is designed to convert equity market performance into an income
source, which may provide the potential for higher income than traditional fixed income assets and which exposes the Fund to risks such
as those associated with the autocallable structure and equity markets such as market downturns interrupting coupon payments or resulting
in principal loss as described below. As part of the Synthetic Autocallable </p></ix:continuation></div>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0C_gBFIOAPTB-ITSRA_z818kOMw2Eti"><ix:continuation continuedAt="ConU000154-12" id="ConU000154-11"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">ELN Strategy, the Fund intends to synthetically replicate
exposure similar to autocallable ELNs by investing in derivatives instruments, such as swaps (&#8220;Synthetic Autocallable Contracts&#8221;),
and will typically not invest directly in autocallable ELNs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An autocallable ELN (i.e., the instrument that
the Fund intends to synthetically replicate by investing in derivatives instruments) is a debt instrument with coupon payments (i.e.,
income) made at regular intervals and linked to equity market performance. The autocallable ELNs that the Fund seeks to replicate synthetically,
as further described below, are typically linked to one or more broad-based equity market indexes (e.g., the S&amp;P 500 Index, Russell
2000 Index, or &#8220;worst of&#8221; two or more indices) (the &#8220;Autocallable ELN Reference Index&#8221;). These autocallable ELNs
provide coupon payments at predefined intervals (which may be deferred to maturity) so long as the value of the Autocallable ELN Reference
Index does not fall below certain prescribed thresholds at specified dates. In such circumstances, the autocallable ELNs would be automatically
called (i.e., cancelled without further coupon payments and with principal returned) or no coupon payment will be made, respectively.
Autocallable ELNs may also provide for the return of a reduced amount of principal when the Autocallable ELN Reference Index falls below
a certain prescribed threshold at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable Contracts are designed
to provide exposure similar to autocallable ELNs, with the value of the Autocallable ELN Reference Index at the beginning of the Synthetic
Autocallable Contract defining when a contract is automatically called, when the counterparty will make its coupon payment(s) for such
period, when no coupon payments are made for such period and a &#8220;Maturity Barrier&#8221; (as defined below) below which the Fund
would be exposed to a loss corresponding to a reduced return of principal. A Synthetic Autocallable Contract is a bespoke product agreed
to between the Fund as &#8220;buyer&#8221; and its counterparty as &#8220;seller". The description below is generally representative
of Synthetic Autocallable Contracts, but the Fund&#8217;s Synthetic Autocallable Contracts may be structured differently. Additionally,
notwithstanding the description below, the Fund&#8217;s Synthetic Autocallable Contracts will typically provide for a single net payment
at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">At each payment date, the buyer will owe to the
Synthetic Autocallable Contract counterparty a financing amount based on a financing rate (which may be a fixed rate or otherwise). At
any payment date prior to the final scheduled payment date, the buyer will receive scheduled coupon payments and potentially an early
principal payment (as applicable, a &#8220;Coupon Payment&#8221; and a &#8220;Principal Payment&#8221;) net of the financing amount owed
to the counterparty, subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Autocall Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index reaches or exceeds
a certain level, typically the initial value of the Autocallable ELN Reference Index at the time of the Synthetic Autocallable Contract
(the &#8220;Autocall Barrier"), then the Synthetic Autocallable Contract will automatically terminate early and the buyer will receive
both a Coupon Payment for the observation period and the Principal Payment, but will not receive future Coupon Payments for that Synthetic
Autocallable Contract.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Coupon Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index equals or exceeds a
certain level (the &#8220;Coupon Barrier&#8221;) but is below the Autocall Barrier, the buyer will receive a Coupon Payment for the observation
period. The Synthetic Autocallable Contract will not automatically terminate early (and the buyer will not receive an early Principal
Payment).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>No-Coupon Zone</i>. If on a specified observation date the price level of the Synthetic Autocallable Contract Reference Index is
below the Coupon Barrier, the buyer will not receive a Coupon Payment for the observation period (such unpaid coupon, a &#8220;Missed
Coupon&#8221;), but the buyer would still be obligated to pay the financing amount to the counterparty. Certain Synthetic Autocallable
Contracts may have memory features in which the buyer may receive a Missed Coupon if the price level of the Synthetic Autocallable ELN
Reference Index equals or exceeds the Coupon Barrier at a subsequent observation date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Synthetic Autocallable Contract has not
been terminated early, then at the maturity date of the Synthetic Autocallable Contract, the buyer will receive a Principal Payment and
Coupon Payment subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Full Principal Zone</i>. If on the final specified observation date the price level of the Autocallable ELN Reference Index is
above a certain level (the &#8220;Maturity Barrier&#8221;), which may be the same as the Coupon Barrier, the buyer will receive the scheduled
Principal Payment.</td></tr></table></ix:continuation></div>
<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<div id="xdx_C00_gBFIOAPTB-ITSRA_zDSGJfjh5Fd7"><ix:continuation continuedAt="ConU000154-13" id="ConU000154-12"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Reduced Principal Zone</i>. If on the final specified observation date/maturity date the price level of the Autocallable ELN Reference
Index is below the Maturity Barrier, the buyer will receive a reduced Principal Payment, which will result in losses to the buyer.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Real Property Asset Companies. </i>The Fund
may invest in Income Securities and Common Equity Securities issued by companies that own, produce, refine, process, transport and market
&#8220;real property assets,&#8221; such as real estate and the natural resources upon or within real estate (&#8220;Real Property Asset
Companies&#8221;). These Real Property Asset Companies include:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real
estate (or that have assets primarily invested in such real estate), including real estate investment trusts (&#8220;REITs&#8221;); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in energy, natural resources and basic materials businesses and companies engaged in associated businesses. These
companies include, but are not limited to, those engaged in businesses such as oil and gas exploration and production, gold and other
precious metals, steel and iron ore production, energy services, forest products, chemicals, coal, alternative energy sources and environmental
services, as well as related transportation companies and equipment manufacturers.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Personal Property Asset Companies. </i>The
Fund may invest in Income Securities and Common Equity Securities issued by companies that seek to profit primarily from the ownership,
rental, leasing, financing or disposition of personal (as opposed to real) property assets (&#8220;Personal Property Asset Companies&#8221;).
Personal (as opposed to real) property includes any tangible, movable property or asset. The Fund will typically seek to invest in Income
Securities and Common Equity Securities of Personal Property Asset Companies the investment performance of which is not expected to be
highly correlated with traditional market indexes because the personal property asset held by such company is non-correlated with traditional
debt or equity markets. Such personal property assets include special situation transportation assets (e.g., railcars, airplanes and ships)
and collectibles (e.g., antiques, wine and fine art).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Private Securities. </i>The Fund may invest
in privately issued Income Securities and Common Equity Securities of both public and private companies (&#8220;Private Securities&#8221;),
including those issued on a private placement basis pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or securities eligible for resale pursuant to Rule 144A thereunder. Private Securities have additional risk considerations
in addition to those of comparable public securities, including the availability of financial information about the issuer and valuation
and liquidity issues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Funds. </i>As an alternative to holding
investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities by investing in other
investment companies, including registered investment companies, private investment funds and/or other pooled investment vehicles (collectively,
&#8220;Investment Funds&#8221;), which may be managed by the Investment Adviser, Sub-Adviser and/or their affiliates. The Fund may invest
up to 30% of its total assets in Investment Funds that primarily hold (directly or indirectly) investments in which the Fund may invest
directly. The 1940 Act generally limits a registered investment company&#8217;s investments in other registered investment companies to
10% of its total assets. However, pursuant to exemptions set forth in the 1940 Act and rules and regulations promulgated under the 1940
Act, the Fund may invest in excess of this and other applicable limitations provided that the conditions of such exemptions are met. The
Fund will invest in private investment funds, commonly referred to as &#8220;hedge funds,&#8221; or &#8220;private equity funds&#8221;
(including &#8220;single asset continuation funds&#8221;) only to the extent permitted by applicable rules, regulations and interpretations
of the SEC and the NYSE. The Fund may invest up to the lower of 10% of its total assets or 15% of its net assets, measured at the time
of investment, in private investment funds that provide exposure to Common Equity Securities of private companies (i.e., exposure to private
equity investments). Investments in other Investment Funds involve operating expenses and fees at the Investment Fund level that are in
addition to the expenses and fees borne by the Fund and are borne indirectly by holders of the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Investments. </i>As an alternative
to holding investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities through
the use of customized derivative instruments (including swaps, options, forwards, futures (including, but not limited to, futures on rates
such as Secured Overnight Financing Rate (&#8220;SOFR&#8221;), securities, indices, currencies and other investments) or other financial
instruments) to seek to replicate, modify or replace the economic attributes associated with an investment in Income Securities and Common
Equity Securities (including interests in Investment Funds). The Fund may be</p></ix:continuation></div>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C01_gBFIOAPTB-ITSRA_znL1sEufFJsa"><ix:continuation continuedAt="ConU000154-14" id="ConU000154-13"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> exposed to certain additional risks to the extent the Sub-Adviser
uses derivatives as a means to synthetically implement the Fund&#8217;s investment strategies, including a lack of liquidity in such derivative
instruments and additional expenses associated with using such derivative instruments. If the Fund enters into a derivative instrument
whereby it agrees to receive the return of a security or financial instrument or a basket of securities or financial instruments, it will
typically contract to receive such returns for a predetermined period of time. During such period, the Fund may not have the ability to
increase or decrease its exposure. In addition, such customized derivative instruments will likely be highly illiquid, and it is possible
that the Fund will not be able to terminate such derivative instruments prior to their expiration date or that the penalties associated
with such a termination might impact the Fund&#8217;s performance in a material adverse manner. Furthermore, certain derivative instruments
contain provisions giving the counterparty the right to terminate the contract upon the occurrence of certain events. Such events may
include a decline in the value of the reference securities and material violations of the terms of the contract or the portfolio guidelines
as well as other events negotiated between the parties. If a termination were to occur, the Fund&#8217;s return could be adversely affected
as it would lose the benefit of the indirect exposure to the reference securities and it may incur significant termination expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the event the Fund seeks to obtain investment
exposure to Investment Funds (including private investment funds) through the use of such synthetic derivative instruments, the Fund will
not acquire any voting interests or other shareholder rights that would be acquired with a direct investment in the underlying Investment
Fund. Accordingly, the Fund will not participate in matters submitted to a vote of the shareholders. In addition, the Fund may not receive
all of the information and reports to shareholders that the Fund would receive with a direct investment in such Investment Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Further, the Fund will pay the counterparty to
any such customized derivative instrument structuring fees and ongoing transaction fees, which will reduce the investment performance
of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Finally, certain tax aspects of such customized
derivative instruments are uncertain and a Common Shareholder&#8217;s return could be adversely affected by an adverse tax ruling.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>Portfolio Contents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>The Fund&#8217;s investment portfolio consists
of investments in the following types of securities:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Corporate Bonds. </i>Corporate bonds are debt
obligations issued by corporations and other business entities. Corporate bonds may be either secured or unsecured. Collateral used for
secured debt includes, but is not limited to, real property, machinery, equipment, accounts receivable, stocks, bonds or notes. If a bond
is unsecured, it is known as a debenture. Bondholders, as creditors, have a priority legal claim over common and preferred stockholders as
to both income and assets of the corporation for the principal and interest due them and may have a prior claim over other creditors if
liens or mortgages are involved. Interest on corporate bonds may be fixed or floating, or the bonds may be zero coupons. Interest on corporate
bonds is typically paid semi-annually and is fully taxable to the bondholder. Corporate bonds contain elements of both interest-rate risk
and credit risk and are subject to the risks associated with Income Securities, among other risks. The market value of a corporate bond
generally is expected to rise and fall inversely with interest rates and be affected by the credit rating of the corporation, the corporation&#8217;s
performance and perceptions of the corporation in the marketplace. <i>Investment Grade Bonds. </i>The Fund may invest in a wide variety
of fixed-income, floating or variable rate securities rated or determined by the Sub-Adviser to be investment grade quality that are issued
by corporations and other non-governmental entities and issuers (&#8220;Investment Grade Bonds&#8221;). Investment Grade Bonds are subject
to market and credit risk. Market risk relates to changes in a security&#8217;s value. Investment Grade Bonds have varying levels of sensitivity
to changes in interest rates and varying degrees of credit quality. In general, bond prices rise when interest rates fall, and fall when
interest rates rise. Longer-term and zero coupon bonds are generally more sensitive to interest rate changes. Credit risk relates to the
ability of the issuer to make payments of principal and interest. The values of Investment Grade Bonds, like those of other fixed-income
securities, may be affected by changes in the credit rating or financial condition of an issuer. Investment Grade Bonds are generally
considered medium- and high-quality securities. Some, however, may possess speculative characteristics, and may be more sensitive to economic
changes and changes in the financial condition of issuers. The market prices of Investment Grade Bonds in the lowest investment grade
categories may fluctuate more than higher-quality securities and may decline significantly in periods of general or regional economic
difficulty or other adverse issuer-specific or market developments. Investment Grade Bonds in the lowest investment grade categories may
be thinly traded, making them difficult to sell promptly at an acceptable price. Investment Grade Bonds include certain investment grade
quality mortgage-related securities, asset-backed </p></ix:continuation></div>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0D_gBFIOAPTB-ITSRA_znzWS1UdiWb8"><ix:continuation continuedAt="ConU000154-15" id="ConU000154-14"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">securities, and other hybrid securities and instruments that are treated as debt obligations
for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Below-Investment Grade Bonds. </i>The Fund
may invest without limitation in a wide variety of fixed-income securities that are rated or determined by the Sub-Adviser to be below-investment
grade quality (&#8220;Below-Investment Grade Bonds&#8221;). The credit quality of most Below-Investment Grade Bonds reflects a greater
than average possibility that adverse changes in the financial condition of an issuer, or in general economic conditions, or both, may
impair the ability of the issuer to make payments of interest and principal. The inability (or perceived inability) of issuers to make
timely payment of interest and principal would likely make the values of Below-Investment Grade Bonds held by the Fund more volatile and
could limit the Fund&#8217;s ability to sell such Bonds at favorable prices. In the absence of a liquid trading market for its Below-Investment
Grade Bonds, the Fund may have difficulties determining the fair market value of such investments. Below-Investment Grade Bonds include
certain below-investment grade quality mortgage-related securities, asset-backed securities, and other hybrid securities and instruments
that are treated as debt obligations for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition to pre-existing outstanding debt
obligations of below-investment grade issuers, the Fund may also invest in &#8220;debtor-in-possession&#8221; or &#8220;DIP&#8221; financings
newly issued in connection with &#8220;special situation&#8221; restructuring and refinancing transactions. DIP financings are Loans to
a debtor-in-possession in a proceeding under the U.S. Bankruptcy Code that have been approved by the bankruptcy court. DIP financings
are typically fully secured by a lien on the debtor&#8217;s otherwise unencumbered assets or secured by a junior lien on the debtor&#8217;s
encumbered assets (so long as the Loan is fully secured based on the most recent current valuation or appraisal report of the debtor).
The bankruptcy court can authorize the debtor to grant the DIP lender a claim with super-priority over administrative expenses incurred
during bankruptcy and of other claims, thus a DIP financing may constitute senior debt even if not secured. DIP financings are often required
to close with certainty and in a rapid manner in order to satisfy existing creditors and to enable the issuer to emerge from bankruptcy
or to avoid a bankruptcy proceeding. These financings allow the entity to continue its business operations while reorganizing under Chapter
11 of the U.S. Bankruptcy Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Distressed and Defaulted Securities. </i>The
Fund may invest in the securities of financially distressed and bankrupt issuers. Such debt obligations may be in covenant or payment
default. Such investments generally trade significantly below par and are considered speculative. The repayment of defaulted obligations
is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy workout or bankruptcy proceedings, during
which the issuer might not make any interest or other payments. Typically such workout or bankruptcy proceedings result in only partial
recovery of cash payments or an exchange of the defaulted obligation for other debt or equity securities of the issuer or its affiliates,
which may in turn be illiquid or speculative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Structured Finance Investments. </i>The Fund
may invest in structured finance investments, which are Income Securities and Common Equity Securities typically issued by special purpose
vehicles that hold income-producing securities (e.g., mortgage loans, consumer debt payment obligations and other receivables) and other
financial assets. Structured finance investments are designed to meet certain financial goals of investors. Typically, these investments
provide investors with the potential for capital protection, income generation and/or the opportunity to generate capital growth. The
Sub-Adviser believes that structured finance investments may provide attractive risk-adjusted returns, frequent sector rotation opportunities
and prospects for adding value through security selection. For purposes of the Fund&#8217;s investment policies, structured finance investments
are not deemed to be &#8220;private investment funds&#8221; (as discussed below). Structured finance investments primarily include (among
others):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Mortgage-Related Securities</span>. Mortgage-related securities
are a form of derivative collateralized by pools of commercial or residential mortgages. Pools of mortgage loans are assembled as securities
for sale to investors by various governmental, government-related and private organizations. These securities may include complex instruments
such as collateralized mortgage obligations, REITs (including debt and preferred stock issued by REITs), and other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates, and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential and
commercial mortgage-related securities issued by governmental entities (i.e., agency mortgage-related securities) and private issuers
(i.e. non-agency mortgage-related securities), including subordinated mortgage-related securities. The underlying assets of certain mortgage-related
securities are subject to prepayments, which shorten the weighted average maturity and may lower the</p></ix:continuation></div>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0D_gBFIOAPTB-ITSRA_z2rd4hXRKYg7"><ix:continuation continuedAt="ConU000154-16" id="ConU000154-15"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> return of such securities, and extension,
which lengthens expected maturity as payments on principal may occur at a slower rate or later than expected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Asset-Backed Securities</span>. Asset-backed securities (&#8220;ABS&#8221;)
are a form of structured debt obligation. ABS are payment claims that are securitized in the form of negotiable paper that is issued by
a financing company (generally called a special purpose vehicle). Collateral assets are brought into a pool according to specific diversification
rules. A special purpose vehicle is founded for the purpose of securitizing these payment claims and the assets of the special purpose
vehicle are the diversified pool of collateral assets. The special purpose vehicle issues marketable securities that are intended to represent
a lower level of risk than an underlying collateral asset individually, due to the diversification in the pool. The redemption of the
securities issued by the special purpose vehicle takes place out of the cash flow generated by the collected assets. A special purpose
vehicle may issue multiple securities with different priorities to the cash flows generated and the collateral assets. The collateral
for ABS may include, among other assets, home equity loans, automobile and credit card receivables, boat loans, computer leases, airplane
leases, mobile home loans, recreational vehicle loans and hospital account receivables. The Fund may invest in these and other types of
ABS that may be developed in the future. There is the possibility that recoveries on the underlying collateral may not, in some cases,
be available or may be insufficient to support payments on these securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Collateralized Debt Obligations</span>. A collateralized debt
obligation (&#8220;CDO&#8221;) is an asset-backed security whose underlying collateral is typically a portfolio of bonds, bank loans,
other structured finance securities and/or synthetic instruments. Where the underlying collateral is a portfolio of bonds, a CDO is referred
to as a collateralized bond obligation (&#8220;CBO&#8221;). Where the underlying collateral is a portfolio of bank loans, a CDO is referred
to as a collateralized loan obligation (&#8220;CLO&#8221;). Investors in CBOs and CLOs bear the credit risk of the underlying collateral.
Multiple tranches of securities are issued by the CLO, offering investors various maturity and credit risk characteristics. Tranches are
categorized as senior, mezzanine, and subordinated/ equity, according to their degree of risk. If there are defaults or the CLO&#8217;s
collateral otherwise underperforms, scheduled payments to senior tranches take precedence over those of mezzanine tranches, and scheduled
payments to mezzanine tranches take precedence over those to subordinated/equity tranches. This prioritization of the cash flows from
a pool of securities among the several tranches of the CLO is a key feature of the CLO structure. If there are funds remaining after each
tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar
covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions
are referred to as the &#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other
obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition,
for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which
are different for each CLO. If a CLO breaches one of these tests excess cash flow that would otherwise be available for distribution to
the subordinated tranche investors is diverted to prepay CLO debt investors in order of seniority until such time as the covenant breach
is cured. If the covenant breach is not or cannot be cured, the subordinated tranche investors (and potentially other investors in lower
priority rated tranches) may experience a partial or total loss of their investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">CLOs are subject to the same risk of prepayment and
extension described with respect to certain mortgage-related and asset-backed securities. The value of CLOs may be affected by, among
other developments, changes in the market&#8217;s perception of the creditworthiness of the servicing agent for the pool, the originator
of the pool, or the financial institution or fund providing the credit support or enhancement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The Fund may invest in senior, rated tranches as well as mezzanine
and subordinated tranches of CLOs. Investment in the subordinated tranche is subject to additional risks. The subordinated tranche does
not receive ratings and is considered the riskiest portion of the capital structure of a CLO because it bears the bulk of defaults from
the loans in the CLO and serves to protect the other, more senior tranches from default in many but not all circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Risk-Linked Securities</span>. Risk-linked securities (&#8220;RLS&#8221;)
are a form of derivative issued by insurance companies and insurance-related special purpose vehicles that apply securitization techniques
to catastrophic property and casualty damages. RLS are typically debt obligations for which the return of principal and the payment of
interest are contingent on the non-occurrence of a pre-defined &#8220;trigger event.&#8221; Depending on the specific terms and structure
of the RLS, this trigger could be the result of a hurricane, earthquake or some other catastrophic event. Insurance companies securitize
this risk to transfer to the capital markets the truly catastrophic part of the risk exposure. A typical RLS provides for income and return
of capital similar to other fixed-income investments, but would involve full or partial default if losses resulting from a certain catastrophe
exceeded a predetermined amount. RLS typically have relatively high yields compared with similarly rated fixed-income securities, and
also have low correlation with the returns of traditional securities. The Sub-Adviser believes that inclusion of RLS in the Fund&#8217;s
portfolio could lead to significant improvement in its overall risk-return profile. Investments in RLS may be linked to a broad range
of insurance risks, which can be broken down into three major categories: natural risks (such as hurricanes and earthquakes), weather
risks (such as insurance based on a regional average temperature) and non-natural events (such as aerospace and shipping catastrophes).
Accordingly, depending on the specific terms and structure of the RLS, this trigger could be the result of a hurricane, earthquake or
some other</p></ix:continuation></div>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C08_gBFIOAPTB-ITSRA_zJbYtxgXM5hc"><ix:continuation continuedAt="ConU000154-17" id="ConU000154-16"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> catastrophic event. Although property-casualty RLS have been in existence for over a decade, significant developments have
started to occur in securitizations done by life insurance companies. In general, life insurance industry securitizations could fall into
a number of categories. Some are driven primarily by the desire to transfer risk to the capital markets, such as the transfer of extreme
mortality risk (mortality bonds). Others, while also including the element of risk transfer, are driven by other considerations. For example,
a securitization could be undertaken to relieve the capital strain on life insurance companies caused by the regulatory requirements of
establishing very conservative reserves for some types of products. Another example is the securitization of the stream of future cash
flows from a particular block of business, including the securitization of embedded values of life insurance business or securitization
for the purpose of funding acquisition costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Senior Loans. </i>Senior Loans are floating
rate Loans made to corporations and other non-governmental entities and issuers. Senior Loans typically hold the most senior position
in the capital structure of the issuing entity, are typically secured with specific collateral and typically have a claim on the assets
of the borrower, including stock owned by the borrower in its subsidiaries, that is senior to that held by junior lien creditors, subordinated
debt holders and stockholders of the borrower. The proceeds of Senior Loans primarily are used to finance leveraged buyouts, recapitalizations,
mergers, acquisitions, stock repurchases, dividends, and, to a lesser extent, to finance internal growth and for other corporate purposes.
Senior Loans typically have rates of interest that are redetermined daily, monthly, quarterly or semi-annually by reference to a base
lending rate, plus a premium or credit spread. Base lending rates in common usage today are primarily SOFR, and secondarily the prime
rate offered by one or more major U.S. banks (the &#8220;Prime Rate&#8221;) and the certificate of deposit (&#8220;CD&#8221;) rate or
other base lending rates used by commercial lenders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Second Lien Loans. </i>Second Lien Loans are
Loans made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Second Lien Loans
are second in right of payment to one or more Senior Loans of the related borrower. Second Lien Loans typically are secured by a second
priority security interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the Loan and typically
have similar protections and rights as Senior Loans. Second Lien Loans are not (and by their terms cannot) become subordinate in right
of payment to any obligation of the related borrower other than Senior Loans of such borrower. Second Lien Loans, like Senior Loans, typically
have floating rate interest payments. Because Second Lien Loans are second to Senior Loans, they present a greater degree of investment
risk but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below-investment grade
quality. Other than their subordinated status, Second Lien Loans have many characteristics and risks similar to Senior Loans discussed
above. In addition, Second Lien Loans and debt securities of below-investment grade quality share many of the risk characteristics of
Non-Investment Grade Bonds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Subordinated Secured Loans. </i>Subordinated
secured Loans are made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Subordinated
secured Loans may rank lower in right of payment to one or more Senior Loans and Second Lien Loans of the borrower. Subordinated secured
Loans typically are secured by a lower priority security interest or lien to or on specified collateral securing the borrower&#8217;s
obligation under the Loan, and typically have more subordinated protections and rights than Senior Loans and Second Lien Loans. Subordinated
secured Loans may become subordinated in right of payment to more senior obligations of the borrower issued in the future. Subordinated
secured Loans may have fixed or floating rate interest payments. Because Subordinated secured Loans may rank lower as to right of payment
than Senior Loans and Second Lien Loans of the borrower, they may present a greater degree of investment risk than Senior Loans and Second
Lien Loans but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below investment
grade quality. Other than their more subordinated status, such investments have many characteristics and risks similar to Senior Loans
and Second Lien Loans discussed above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Unsecured Loans. </i>Unsecured Loans are loans
made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Unsecured Loans generally
have lower priority in right of payment compared to holders of secured debt of the borrower. Unsecured Loans are not secured by a security
interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the loan. Unsecured Loans by their terms
may be or may become subordinate in right of payment to other obligations of the borrower, including Senior Loans, Second Lien Loans and
Subordinated Secured Loans. Unsecured Loans may have fixed or floating rate interest payments. Because unsecured Loans are subordinate
to the secured debt of the borrower, they present a greater degree of investment risk but often pay interest at higher rates reflecting
this additional risk. Such investments generally are of below investment grade quality. Other than their subordinated and unsecured status,
</p></ix:continuation></div>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0F_gBFIOAPTB-ITSRA_zPYl43AuXwg7"><ix:continuation continuedAt="ConU000154-18" id="ConU000154-17"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">such investments have many characteristics and risks similar to Senior Loans, Second Lien Loans and Subordinated Secured Loans discussed
above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Mezzanine Investments. </i>The Fund may invest
in certain lower grade securities known as &#8220;Mezzanine Investments,&#8221; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Convertible Securities. </i>Convertible securities
include bonds, debentures, notes, preferred stocks and other securities that entitle the holder to acquire common stock or other equity
securities of the issuer. Convertible securities have general characteristics similar to both debt and equity securities. A convertible
security generally entitles the holder to receive interest or preferred dividends paid or accrued until the convertible security matures
or is redeemed, converted or exchanged. Before conversion, convertible securities have characteristics similar to non-convertible debt
obligations. Convertible securities rank senior to common stock in a corporation&#8217;s capital structure and, therefore, generally entail
less risk than the corporation&#8217;s common stock, although the extent to which such risk is reduced depends in large measure upon the
degree to which the convertible security sells above its value as a debt obligation. A convertible security may be subject to redemption
at the option of the issuer at a predetermined price. If a convertible security held by the Fund is called for redemption, the Fund would
be required to permit the issuer to redeem the security and convert it to underlying common stock, or would sell the convertible security
to a third party, which may have an adverse effect on the Fund&#8217;s ability to achieve its investment objective. The price of a convertible
security often reflects variations in the price of the underlying common stock in a way that non-convertible debt may not. The value of
a convertible security is a function of (i) its yield in comparison to the yields of other securities of comparable maturity and quality
that do not have a conversion privilege and (ii) its worth if converted into the underlying common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Stocks. </i>Preferred stocks represent
the senior residual interest in the assets of an issuer after meeting all claims, with priority to corporate income and liquidation payments
over the issuer&#8217;s common stock. As such, preferred stock is inherently more risky than the bonds and loans of the issuer, but less
risky than its common stock. Preferred stocks often contain provisions that allow for redemption in the event of certain tax or legal
changes or at the issuers&#8217; call. Preferred stocks typically do not provide any voting rights, except in cases when dividends are
in arrears beyond a certain time period. Preferred stock in some instances is convertible into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although they are equity securities, preferred
stocks have certain characteristics of both debt and common stock. They are debt-like in that their promised income is contractually fixed.
They are common stock-like in that they do not have rights to precipitate bankruptcy proceedings or collection activities in the event
of missed payments. Furthermore, they have many of the key characteristics of equity due to their subordinated position in an issuer&#8217;s
capital structure and because their quality and value are heavily dependent on the profitability of the issuer rather than on any legal
claims to specific assets or cash flows. In order to be payable, dividends on preferred stock must be declared by the issuer&#8217;s board
of directors. In addition, distributions on preferred stock may be subject to deferral and thus may not be automatically payable. Income
payments on some preferred stocks are cumulative, causing dividends and distributions to accrue even if not declared by the board of directors
or otherwise made payable. Other preferred stocks are non-cumulative, meaning that skipped dividends and distributions do not continue
to accrue. There is no assurance that dividends on preferred stocks in which the Fund invests will be declared or otherwise made payable.
If the Fund owns preferred stock that is deferring its distributions, the Fund may be required to report income for U.S. federal income
tax purposes while it is not receiving cash payments corresponding to such income. When interest rates fall below the rate payable on
an issue of preferred stock or for other reasons, the issuer may redeem the preferred stock, generally after an initial period of call
protection in which the stock is not redeemable. Preferred stocks may be significantly less liquid than many other securities, such as
U.S. Government securities, corporate bonds and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>U.S. Government Securities. </i>The Fund may
invest in debt securities issued or guaranteed by the U.S. government, its agencies or instrumentalities including: (1) U.S. Treasury
obligations, which differ in their interest rates, maturities and times of issuance, such as U.S. Treasury bills (maturity of one year
or less), U.S. Treasury notes (maturity of one to ten years), and U.S. Treasury bonds (generally maturities of greater than ten years),
including the principal components or the interest components issued by the U.S. government under the separate trading of registered interest
and principal securities program (i.e., &#8220;STRIPS&#8221;), all of which are backed by the full faith and</p></ix:continuation></div>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C00_gBFIOAPTB-ITSRA_zJFvs9bYnRo6"><ix:continuation continuedAt="ConU000154-19" id="ConU000154-18"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> credit of the United States;
and (2) obligations issued or guaranteed by U.S. government agencies or instrumentalities, including government guaranteed mortgage-related
securities, some of which are backed by the full faith and credit of the U.S. Treasury, some of which are supported by the right of the
issuer to borrow from the U.S. government, and some of which are backed only by the credit of the issuer itself.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Securities. </i>While the Fund invests
primarily in securities of U.S. issuers, the Fund may invest up to 20% of its total assets in non-U.S. dollar-denominated fixed-income
securities of corporate and governmental issuers located outside the United States, including up to 10% in emerging markets. Foreign securities
include securities issued or guaranteed by companies organized under the laws of countries other than the United States and securities
issued or guaranteed by foreign governments, their agencies or instrumentalities and supra-national governmental entities, such as the
World Bank. Foreign securities also may be traded on foreign securities exchanges or in over-the-counter capital markets. The value of
foreign securities and obligations is affected by, among other factors, changes in currency rates, foreign tax laws (including withholding
tax), government policies (in this country or abroad), relations between nations and trading, settlement, custodial and other operational
risks. In addition, the costs of investing abroad are generally higher than in the United States, and foreign securities markets may be
less liquid, more volatile and less subject to governmental supervision than markets in the United States. Foreign investments also could
be affected by other factors not present in the United States, including expropriation, armed conflict, confiscatory taxation, lack of
uniform accounting and auditing standards, less publicly available financial and other information and potential difficulties in enforcing
contractual obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Since the Fund may invest in securities and obligations
that are denominated or quoted in currencies other than the U.S. dollar, the Fund may be affected by changes in foreign currency exchange
rates (and exchange control regulations) which affect the value of investments in the Fund and the accrued income and appreciation or
depreciation of the investments in U.S. dollars. Changes in foreign currency exchange rates relative to the U.S. dollar will affect the
U.S. dollar value of the Fund&#8217;s assets denominated in that currency and the Fund&#8217;s return on such assets as well as any temporary
uninvested reserves in bank deposits in foreign currencies. In addition, the Fund will incur costs in connection with conversions between
various currencies. The Fund may seek to hedge its exposures to foreign currencies but may, at the discretion of the Sub-Adviser, at any
time limit or eliminate foreign currency hedging activity. See &#8220;&#8212;Derivative Transactions&#8212;Foreign Currency Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sovereign and Supranational Obligations. </i>The
Fund may invest in sovereign debt securities, which are debt securities issued or guaranteed by foreign governmental entities, such as
foreign government debt or foreign treasury bills. Investments in sovereign debt securities involve special risks in addition to those
risks usually associated with investments in debt securities, including risks associated with economic or political uncertainty and the
risk that the governmental authority that controls the repayment of sovereign debt may be unwilling or unable to repay the principal and/or
interest when due. The Fund may also invest in securities or other obligations issued or backed by supranational organizations, which
are international organizations that are designated or supported by government entities or banking institutions typically to promote economic
reconstruction or development. These obligations are subject to the risk that the government(s) on whose support the organization depends
may be unable or unwilling to provide the necessary support. With respect to both sovereign and supranational obligations, the Fund may
have little recourse against the foreign government or supranational organization that issues or backs the obligation in the event of
default. These obligations may be denominated in foreign currencies and the prices of these obligations may be more volatile than corporate
debt obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Sovereign debt instruments in which the Fund
may invest may involve great risk and may be deemed to be the equivalent in terms of credit quality to securities rated below investment
grade by Moody&#8217;s and S&amp;P. Governmental entities may depend on expected disbursements from foreign governments, multilateral
agencies and international organizations to reduce principal and interest arrearages on their debt obligations. The commitment on the
part of these governments, agencies and others to make such disbursements may be conditioned on a governmental entity&#8217;s implementation
of economic or other reforms and/or economic performance and the timely service of the governmental entity&#8217;s obligations. Failure
to implement such reforms, achieve such levels of economic performance or repay principal or interest when due may result in the cancellation
of the commitments to lend funds or other aid to the governmental entity, which may further impair the governmental entity&#8217;s ability
or willingness to service its debts in a timely manner. Some of the countries in which the Fund may invest have encountered difficulties
in servicing their sovereign debt obligations and have withheld payments of interest and/or principal of sovereign debt. These difficulties
have also led to agreements to restructure external debt obligations, which may result in costs to the holders of the sovereign debt.
Consequently, a government obligor may default on its obligations and/or the values of its obligations may decline significantly.</p></ix:continuation></div>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<div id="xdx_C0F_gBFIOAPTB-ITSRA_zypZinuYzW6b"><ix:continuation continuedAt="ConU000154-20" id="ConU000154-19"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Stocks and Other Common Equity Securities.
</i>The Fund may also invest in common stocks and other Common Equity Securities that the Sub-Adviser believes offer attractive yield
and/or capital appreciation potential. Common stock represents the residual ownership interest in the issuer. Holders of common stocks
and other Common Equity Securities are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred stockholders are satisfied. The Fund may invest in companies of any market capitalization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Options. </i>As part of its Common Equity
Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered call options and may, from time to time,
buy or sell put options on individual Common Equity Securities. In addition to its covered call option strategy, the Fund may, to a lesser
extent, pursue a strategy that includes the sale (writing) of both covered call and put options on indices of securities and sectors of
securities. This covered call option strategy is intended to generate current gains from option premiums as a means to generate total
returns as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. The Fund may also write call options and
put options on individual securities, securities indices, ETFs, futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An option on a security is a contract that gives
the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the
writer of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option
on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or
to pay the exercise price upon delivery of the underlying security. The buyer of an option acquires the right, but not the obligation,
to buy (a call option) or sell (a put option) a certain quantity of a security (the underlying security) or instrument, including a futures
contract or swap, at a certain price up to a specified point in time or on expiration, depending on the terms. For certain types of options,
the writer of the option will have no control over the time when it may be required to fulfill its obligation under the option. Certain
options, known as &#8220;American style&#8221; options may be exercised at any time during the term of the option. Other options, known
as &#8220;European style&#8221; options, may be exercised only on the expiration date of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If an option written by the Fund expires unexercised,
the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written.
If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier
of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series
(type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction
can be effected when the Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net
gain or loss depending on whether the amount realized on the sale is more or less than the premium and other transaction costs paid on
the put or call option when purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing
option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium
received from a closing sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or,
if it is less, the Fund will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains
which, for U.S. federal income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will follow a strategy known as &#8220;covered
call option writing,&#8221; which is a strategy designed to generate current gains from option premiums as a means to generate total returns
as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. As the Fund writes covered calls over more of its
portfolio, its ability to benefit from capital appreciation becomes more limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Except as disclosed further below and in connection
with the Fund&#8217;s Debt Overlay Strategy, the Fund may not sell &#8220;naked&#8221; call options on individual securities (i.e., options
representing more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#8220;covered&#8221;
if the Fund owns the security <span style="background-color: white">or instrument</span> underlying the call or has an absolute and immediate
right to acquire that security <span style="background-color: white">or instrument</span> without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Sub-Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Sub-Adviser
as described above.</p></ix:continuation></div>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<div id="xdx_C0B_gBFIOAPTB-ITSRA_zvcLoo21hB98"><ix:continuation continuedAt="ConU000154-21" id="ConU000154-20"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Put options are contracts that give the holder
of the option, in return for a premium, the right to sell to the writer of the option the security underlying the option at a specified
exercise price at a specific time or times during the term of the option. These strategies may produce a considerably higher return than
the Fund&#8217;s primary strategy of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will write (sell) put options on individual
Common Equity securities only if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221;
if the Fund segregates or earmarks assets determined to be liquid by the Sub-Adviser, as described above, equal to the exercise price.
A put option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held
is (i) equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided
the difference is maintained by the Fund in segregated or earmarked assets determined to be liquid by the Sub-Adviser, as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell (covered and uncovered) put
and call options on indices of securities, futures on indices of securities, and index ETFs. Options on an index or index ETF differ from
options on securities because (i) the exercise of an index option requires cash payments and does not involve the actual purchase or sale
of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the index
upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option
and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather than price fluctuations
in a single security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may purchase and write exchange-listed
and OTC options. Options written by the Fund with respect to non-U.S. securities, indices or sectors and other instruments generally will
be OTC options. OTC options differ from exchange-listed options in several respects. They are transacted directly with the dealers and
not with a clearing corporation, and therefore entail the risk of nonperformance by the dealer. OTC options are available for a greater
variety of securities and for a wider range of expiration dates and exercise prices than are available for exchange-traded options. Because
OTC options are not traded on an exchange, pricing is done normally by reference to information from a market maker. OTC options are subject
to heightened counterparty, credit, liquidity and valuation risks. The Fund&#8217;s ability to terminate OTC options is more limited than
with exchange-traded options and may involve the risk that broker-dealers participating in such transactions will not fulfill their obligations.
The hours of trading for options may not conform to the hours during which the underlying securities are traded. The Fund&#8217;s options
transactions will be subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which
such options are traded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Restricted and Illiquid Securities. </i>The
Fund may invest in securities for which there is no readily available trading market or that are otherwise illiquid. Illiquid securities
include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2)
and Rule 144A securities may, however, be treated as liquid by the Investment Adviser after consideration of factors such as trading activity,
availability of market quotations and number of dealers willing to purchase the security. If the Fund invests in Rule 144A securities,
the level of portfolio illiquidity may be increased to the extent that eligible buyers become uninterested in purchasing such securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">It may be difficult to sell such securities at
a price representing the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable
period may elapse between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be
able to obtain as favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through
private placements under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent
their sale at a time when such sale would otherwise be desirable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Government Sponsored Investment Programs</i>.
From time to time, the Fund may seek to invest in credit securities through one or more programs that may from time to time be sponsored,
established or operated by the U.S. Department of the Treasury, the Board of Governors of the Federal Reserve System and other governmental
agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Derivatives Transactions</i>. The Fund may
purchase and sell various derivative instruments (which derive their value by reference to another instrument, asset or index), such as
swaps, futures, options and other derivatives contracts, for investment purposes, such as obtaining investment exposure to an investment
category; risk management purposes, such as hedging against fluctuations in asset prices, currencies or interest rates; </p></ix:continuation></div>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0B_gBFIOAPTB-ITSRA_zS3NPu4o2hW2"><ix:continuation continuedAt="ConU000154-22" id="ConU000154-21"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">diversification
purposes; or to change the duration of the Fund. The Fund may, but is not required to, use various strategic transactions in swaps, futures,
options and other derivative contracts in order to seek to earn income, facilitate portfolio management and mitigate risks. These strategies
may be executed through the use of derivative contracts. In the course of pursuing these investment strategies, the Fund may purchase
and sell exchange-listed and OTC put and call options on securities, equity and fixed-income indices and other instruments, purchase and
sell futures contracts and options thereon, and enter into various transactions such as swaps, caps, floors or collars. In addition, derivative
transactions may also include new techniques, instruments or strategies that are permitted as regulatory changes occur. In order to help
protect the soundness of derivative transactions and outstanding derivative positions, the Sub-Adviser generally requires derivative counterparties
to have a minimum credit rating of A3 from Moody&#8217;s (or a comparable rating from another NRSRO) and monitors such rating on an ongoing
basis. In addition, the Sub-Adviser seeks to allocate derivatives transactions to limit exposure to any single counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is required to trade derivatives and
other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions)
subject to value-at-risk (&#8220;VaR&#8221;) leverage limits and derivatives risk management program and reporting requirements. Generally,
these requirements apply unless the Fund satisfies a &#8220;limited derivatives users&#8221; exception that is included in Rule 18f-4
under the 1940 Act. The Fund is not classified as a &#8220;limited derivatives user&#8221; and, as required by Rule 18f-4, has implemented
a Derivatives Risk Management Program, which is reasonably designed to manage the Fund&#8217;s derivatives risks and to reasonably segregate
the functions associated with the Derivatives Risk Management Program from the portfolio management of the Fund. The Board, including
a majority of the trustees who are not &#8220;interested persons&#8221; of the Fund, as such term is defined in the 1940 Act, approved
the designation of a Derivatives Risk Manager, which is responsible for administering the Derivatives Risk Management Program for the
Fund. To facilitate the Board&#8217;s oversight, the Board reviews, no less frequently than annually, a written report on the effectiveness
of the Derivatives Risk Management Program and also more frequent reports regarding certain derivatives risk matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse
repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation
of whether a fund satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase
agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions
or not. SEC guidance regarding the use of securities lending collateral may limit the Fund&#8217;s securities lending activities. In addition,
the Fund is permitted to invest in a security on a when issued or forward-settling basis, or with a non-standard settlement cycle, and
the transaction will be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction
and (ii) the transaction will settle within 35 days of its trade date (the &#8220;Delayed-Settlement Securities Provision&#8221;). The
Fund may otherwise engage in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long
as the Fund treats any such transaction as a &#8220;derivatives transaction&#8221; for purposes of compliance with Rule 18f-4. Furthermore,
under the rule, the Fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not
be subject to the asset coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement,
that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Credit Derivatives. </i>Credit default derivatives
are linked to the price of reference securities or loans after a default by the issuer or borrower, respectively. Market spread derivatives
are based on the risk that changes in market factors, such as credit spreads, can cause a decline in the value of a security, loan or
index. There are three basic transactional forms for credit derivatives: swaps, options and structured instruments. The use of credit
derivatives is a highly specialized activity which involves strategies and risks different from those associated with ordinary portfolio
security transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest in credit default swap transactions
and credit-linked notes (described below) for hedging and investment purposes. The &#8220;buyer&#8221; in a credit default swap contract
is obligated to pay the &#8220;seller&#8221; a periodic stream of payments over the term of the contract provided that no event of default
on an underlying reference obligation has occurred. If an event of default occurs, the seller must pay the buyer the full notional value,
or &#8220;par value,&#8221; of the reference obligation. Credit default swap transactions are either &#8220;physical delivery&#8221; settled
or </p></ix:continuation></div>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0B_gBFIOAPTB-ITSRA_zC7Aei1pNyvf"><ix:continuation continuedAt="ConU000154-23" id="ConU000154-22"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#8220;cash&#8221; settled. Physical delivery entails the actual delivery of the reference asset to the seller in exchange for the
payment of the full par value of the reference asset. Cash settled entails a net cash payment from the seller to the buyer based on the
difference of the par value of the reference asset and the current value of the reference asset that may, after a default, have lost some,
most, or all of its value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may be either the buyer or seller in
a credit default swap transaction and generally will be a buyer in instances in which the Fund actually owns the underlying debt security
and seeks to hedge against the risk of default in that debt security. If the Fund is a buyer and no event of default occurs, the Fund
will have made a series of periodic payments (in an amount more or less than the value of the cash flows received on the underlying debt
security) and recover nothing of monetary value. However, if an event of default occurs, the Fund (if the buyer) will receive the full
notional value of the reference obligation either through a cash payment in exchange for such asset or a cash payment in addition to owning
the reference asset. The Fund generally will be a seller when it seeks to take the credit risk of a particular debt security and, as a
seller, the Fund receives a fixed rate of income throughout the term of the contract, which typically is between six months and ten years,
provided that there is no event of default. If an event of default occurs, the seller must pay the buyer the full notional value of the
reference obligation through either physical settlement and/or cash settlement. Credit default swap transactions involve greater risks
than if the Fund had invested in the reference obligation directly, including counterparty credit risk and leverage risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Currency Transactions. </i>The Fund
may (but is not required to) hedge some or all of its exposure to non-U.S. currencies through the use of forward foreign currency exchange
contracts, options on foreign currencies, foreign currency futures contracts and swaps and other derivatives transactions. Suitable hedging
transactions may not be available in all circumstances and there can be no assurance that the Fund will engage in such transactions at
any given time or from time to time when they would be beneficial. Although the Fund has the flexibility to engage in such transactions,
the Investment Adviser or Sub-Adviser may determine not to do so or to do so only in unusual circumstances or market conditions. These
transactions may not be successful and may eliminate any chance for the Fund to benefit from favorable fluctuations in relevant foreign
currencies. The Fund may also use derivatives transactions for purposes of increasing exposure to a foreign currency or to shift exposure
to foreign currency fluctuations from one currency to another.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Sub-Adviser seeks to use derivatives
to further the Fund&#8217;s investment objective, there is no assurance that the use of derivatives will achieve this result. For a more
complete discussion of the Fund&#8217;s investment practices involving transactions in derivatives and certain other investment techniques,
see &#8220;Investment Objective and Policies&#8212;Derivative Instruments&#8221; in the Fund&#8217;s SAI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Municipal Securities</i>. The Fund may invest
directly or indirectly in municipal securities. Municipal securities include securities issued by or on behalf of states, territories
and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the
payments from which, in the opinion of bond counsel to the issuer, are excludable from gross income for federal income tax purposes. Municipal
securities also include taxable securities issued by such issuers. Municipal bonds may include those backed by, among other things, state
taxes and essential service revenues as well as health care and higher education issuers, among others, or be supported by dedicated revenue
streams and/or statutory liens.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Temporary Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">At any time when a temporary posture is believed
by the Sub-Adviser to be warranted (a &#8220;temporary period&#8221;), the Fund may, without limitation, hold cash or invest its assets
in money market instruments and repurchase agreements in respect of those instruments. The money market instruments in which the Fund
may invest are obligations of the U.S. government, its agencies or instrumentalities; commercial paper rated A-1 or higher by S&amp;P
or Prime-1 by Moody&#8217;s; and certificates of deposit and bankers&#8217; acceptances issued by domestic branches of U.S. banks that
are members of the Federal Deposit Insurance Corporation. During a temporary period, the Fund may also invest in shares of money market
mutual funds. Money market mutual funds are investment companies, and the investments in those companies by the Fund are in some cases
subject to the 1940 Act&#8217;s limitations on investments in other investment companies. See &#8220;Investment Restrictions&#8221; in
the Fund&#8217;s SAI. As a shareholder in a mutual fund, the Fund will bear its ratable share of its expenses, including management fees,
and will remain subject to payment of the fees to the Investment Adviser, with respect to assets so invested. See &#8220;Management of
the Fund.&#8221; The Fund may not achieve its investment objective during a temporary period or be able to sustain its historical distribution
levels.</p></ix:continuation></div>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<div id="xdx_C04_gBFIOAPTB-ITSRA_za8NTl9L7u33"><ix:continuation continuedAt="ConU000154-24" id="ConU000154-23"><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Certain Other Investment Practices</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>When Issued, Delayed Delivery Securities
and Forward Commitments</i>. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#8220;when
issued&#8221; or &#8220;delayed delivery&#8221; basis, in excess of customary settlement periods for the type of security involved. In
some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a
merger, corporate reorganization or debt restructuring (i.e., a when, as and if issued security). When such transactions are negotiated,
the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after
the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security,
the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are
subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Forward commitments involve
a risk of loss if the value of the security to be purchased declines prior to the settlement date, which risk is in addition to the risk
of decline in value of the Fund&#8217;s other assets. In addition, FINRA rules include mandatory margin requirements that require the
Fund to post collateral in connection with certain of these transactions. There is no similar requirement that the Fund&#8217;s counterparties
post collateral in connection with such transactions. The required collateralization of these transactions could increase the cost of
such transactions to the Fund and impose added operational complexity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Loans of Portfolio Securities</i>. To seek
to increase income, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions if (i) the loan
is collateralized in accordance with applicable regulatory requirements and (ii) no loan will cause the value of all loaned securities
to exceed 33 1/3% of the value of the Fund&#8217;s total assets. If the borrower fails to maintain the requisite amount of collateral,
the loan automatically terminates and the Fund could use the collateral to replace the securities while holding the borrower liable for
any excess of replacement cost over the value of the collateral. As with any extension of credit, there are risks of delay in recovery
and in some cases even loss of rights in collateral should the borrower of the securities fail financially. There can be no assurance
that borrowers will not fail financially. On termination of the loan, the borrower is required to return the securities to the Fund, and
any gain or loss in the market price during the period of the loan would inure to the Fund. If the other party to the loan petitions for
bankruptcy or becomes subject to the United States Bankruptcy Code, the law regarding the rights of the Fund is unsettled. As a result,
under extreme circumstances, there may be a restriction on the Fund&#8217;s ability to sell the collateral and the Fund would suffer a
loss. See &#8220;Investment Objective and Policies Loans of Portfolio Securities&#8221; in the Fund&#8217;s SAI.<br/>
<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Offsetting. </i>In the normal course of business,
the Fund enters into transactions subject to enforceable master netting arrangements or other similar arrangements. Generally, the right
to offset in those agreements allows the Fund to counteract the exposure to a specific counterparty with collateral received from or delivered
to that counterparty based on the terms of the arrangements. These arrangements provide for the right to liquidate upon the occurrence
of an event of default, credit event upon merger or additional termination event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In order to better define its contractual rights
and to secure rights that will help the Fund mitigate its counterparty risk, the Fund may enter into an International Swaps and Derivatives
Association, Inc. Master Agreement (&#8220;ISDA Master Agreement&#8221;) or similar agreement with its derivative contract counterparties.
An ISDA Master Agreement is a bilateral agreement between the Fund and a counterparty that governs OTC derivatives, including foreign
exchange contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default
and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default
(close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">For derivatives traded under an ISDA Master
Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement
and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty. For financial reporting purposes,
cash collateral that has been pledged to cover obligations of the Fund and cash collateral received from the counterparty, if any, are
reported separately on the Statement of Assets and Liabilities as segregated cash from broker/receivable for variation margin, or segregated
cash due to broker/payable for variation margin. Generally, the amount of collateral due from or to a counterparty must exceed a minimum
transfer amount threshold before a transfer is required to be made. To the extent amounts due to the Fund from its counterparties are
not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The </p></ix:continuation></div>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0E_gBFIOAPTB-ITSRA_zPidNgc5yZi3"><ix:continuation continuedAt="ConU000154-25" id="ConU000154-24"><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Fund attempts
to mitigate counterparty risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring
the financial stability of those counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Repurchase Agreements</i>. The Fund may enter
into bilateral and tri-party repurchase agreements. Repurchase agreements may be seen as loans by the Fund collateralized by underlying
debt securities. Under the terms of a typical repurchase agreement, the Fund buys an underlying debt obligation or other security subject
to an obligation of the seller to repurchase, and the Fund to resell, the obligation at an agreed price and time (usually not more than
one week later). This arrangement results in a fixed rate of return to the Fund. In the event of the insolvency of the counterparty to
a repurchase agreement, recovery of the repurchase price owed to the Fund may be delayed. Such an insolvency may result in a loss to the
extent that the value of the purchased securities or other assets decreases during the delay or that value has otherwise not been maintained
at an amount equal to the repurchase price. The Sub-Adviser reviews the creditworthiness of the counterparties with which the Fund enters
into repurchase agreements to evaluate these risks and monitors on an ongoing basis the value of the securities subject to repurchase
agreements to ensure that the value is maintained at the required level. The Fund will not enter into repurchase agreements with the Investment
Adviser, the Sub-Adviser or their affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">Repurchase agreements collateralized fully by
cash items, U.S. government securities or by securities issued by an issuer that the Investment Adviser or the Sub-Adviser has determined
at the time the repurchase agreement is entered into has an exceptionally strong capacity to meet its financial obligations (&#8220;Qualifying
Collateral&#8221;) and meet certain liquidity standards generally may be deemed to be &#8220;collateralized fully&#8221; and may be deemed
to be investments in the underlying securities for certain purposes. The Fund may accept collateral other than Qualifying Collateral determined
by the Investment Adviser or the Sub-Adviser to be in the best interests of the Fund to accept as collateral for such repurchase agreement
(which may include high yield debt instruments that are rated below investment grade) (&#8220;Alternative Collateral&#8221;). Repurchase
agreements secured by Alternative Collateral are not deemed to be &#8220;collateralized fully&#8221; under applicable regulations and
the repurchase agreement is therefore considered a separate security issued by the counterparty to the Fund. Accordingly, the Fund must
include repurchase agreements that are not &#8220;collateralized fully&#8221; in its calculations of securities issued by the selling
institution held by the Fund for purposes of various portfolio diversification and concentration requirements applicable to the Fund.
In addition, Alternative Collateral may not qualify as permitted or appropriate investments for the Fund under the Fund&#8217;s investment
strategies and limitations. Accordingly, if a counterparty to a repurchase agreement defaults and the Fund takes possession of Alternative
Collateral, the Fund may need to promptly dispose of the Alternative Collateral (or other securities held by the Fund, if the Fund exceeds
a limitation on a permitted investment by virtue of taking possession of the Alternative Collateral). The Alternative Collateral may be
particularly illiquid, especially in times of market volatility or in the case of a counterparty insolvency or bankruptcy, which may restrict
the Fund&#8217;s ability to dispose of Alternative Collateral received from the counterparty. Depending on the terms of the repurchase
agreement, the Fund may determine to sell the collateral during the term of the repurchase agreement and then purchase the same collateral
at the market price at the time of the resale. In tri-party repurchase agreements, an unaffiliated third-party custodian maintains accounts
to hold collateral for the Fund and its counterparties and, therefore, the Fund may be subject to the credit risk of those custodians.
Securities subject to repurchase agreements (other than tri-party repurchase agreements) and purchase and sale contracts will be held
by the Fund&#8217;s custodian (or sub-custodian) in the Federal Reserve/Treasury book-entry system or by another authorized securities
depository.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Reverse Repurchase Agreements</i>. The Fund
may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund sells a portfolio instrument to another party,
such as a bank or broker-dealer, in return for cash or other assets. At the same time, the Fund agrees to repurchase the instrument at
an agreed upon time and price (which may be effected by an exchange of the repurchased instrument for assets other than cash), for which
the effective difference in price reflects an interest payment. Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and Fund expenses associated with the repurchase agreement,
that the market value of the securities or other assets sold by the Fund may decline below the price at which the Fund is obligated to
repurchase such securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements
can be successfully employed. In the event of the insolvency of the counterparty to a reverse repurchase agreement, recovery of the securities
or other assets sold by the Fund may be delayed. The counterparty&#8217;s insolvency may result in a loss equal to the amount by which
the value of the securities or other assets sold by the Fund exceeds the repurchase price payable by the Fund; if the value of the purchased
securities or other assets increases during such a delay, that loss </p></ix:continuation></div>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0C_gBFIOAPTB-ITSRA_z4pnMDfaFrae"><ix:continuation continuedAt="ConU000154-26" id="ConU000154-25"><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">may also be increased. When the Fund enters into a reverse repurchase
agreement, any fluctuations in the market value of either the instruments transferred to another party or the instruments in which the
proceeds may be invested would affect the market value of the Fund&#8217;s assets. As a result, such transactions may increase fluctuations
in the net asset value of the Fund&#8217;s Common Shares. Because reverse repurchase agreements may be considered to be the practical
equivalent of borrowing funds, they constitute a form of leverage. If the Fund reinvests the proceeds of a reverse repurchase agreement
at a rate lower than the cost of the agreement, entering into the agreement will lower the Fund&#8217;s cash available for distribution.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Sleeve Structure.
</i>The Sub-Adviser may from time to time utilize a sleeve structure in managing the Fund. In this structure, the Sub-Adviser implements
the Fund&#8217;s investment strategies using component sleeves of investments comprising distinct sub-strategies or grouping similar investments
in sub-accounts of the Fund that, collectively, comprise the Fund&#8217;s overall portfolio and investment strategies. This approach facilitates
internal allocations and tracking of investments within a portfolio. </span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Interest Rate <span style="color: windowtext">Transactions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Interest Rate Transactions,&#8221;
which is incorporated by reference herein, for a discussion of the Fund&#8217;s use of interest rate transactions in connection with the
Fund&#8217;s use of Financial Leverage.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Portfolio Turnover</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will buy and sell securities to seek
to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover
rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities
owned during the year (excluding securities whose maturities at acquisition were one year or less). The Fund&#8217;s portfolio turnover
rate may vary greatly from year to year. Higher portfolio turnover may decrease the after-tax return to individual investors in the Fund
to the extent it results in a decrease of the long-term capital gains portion of distributions to shareholders. For the fiscal years ended
May 31, 2025 and May 31, 2024, the Fund&#8217;s portfolio turnover rate was 25% and 30%, respectively.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Restrictions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has adopted certain other investment
limitations. These limitations are fundamental and may not be changed without the approval of the holders of a majority of the outstanding
Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together as a single class). See &#8220;Investment Restrictions&#8221;
in the SAI for a complete list of the fundamental investment policies of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="ProUseLeverage"></span>Use of Leverage</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Use of Leverage,&#8221; which is incorporated
by reference herein, for a discussion of the Fund&#8217;s use of leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">See the section of <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">the
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks
of the Fund&#8212;Financial Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein, for a discussion
of associated risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Borrowing</i>. The Fund is authorized to borrow
or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund
may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, the Fund generally is not permitted to
issue commercial paper or notes or engage in other Borrowings, other than temporary borrowings as defined under the 1940 Act, unless,
immediately after the Borrowing, the Fund would have asset coverage (as defined in the 1940 Act) of less than 300%, as measured at the
time of borrowing and calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness not represented
by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness. In addition,
other than with respect to privately arranged Borrowings, the Fund generally is not permitted to declare any cash dividend or other distribution
on any class of the Fund&#8217;s capital stock, including the Common Shares, or purchase any such capital stock, unless, at the time of
such declaration, the Fund would have asset coverage (as described above) of at least 300% after deducting the </p></ix:continuation></div>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C01_gBFIOAPTB-ITSRA_z7cD4KGMPVAk"><ix:continuation continuedAt="ConU000154-27" id="ConU000154-26"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">amount of such dividend
or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal amount
of any outstanding commercial paper, notes or other Borrowings to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The terms of any such Borrowings may require
the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any
such requirements would increase the cost of such Borrowings over the stated interest rate. Such lenders would have the right to receive
interest on and repayment of principal of any such Borrowings, which right will be senior to those of the Common Shareholders. Any such
Borrowings may contain provisions limiting certain activities of the Fund, including the payment of dividends to Common Shareholders in
certain circumstances. Any Borrowings will likely be ranked senior or equal to all other existing and future Borrowings of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain types of Borrowings subject the Fund
to covenants in credit agreements relating to asset coverage and portfolio composition requirements. Certain Borrowings issued by the
Fund also may subject the Fund to certain restrictions on investments imposed by guidelines of one or more rating agencies, which may
issue ratings for such Borrowings. Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent
than those imposed by the 1940 Act. It is not anticipated that these covenants or guidelines will impede the Sub-Adviser from managing
the Fund&#8217;s portfolio in accordance with the Fund&#8217;s investment objective and policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The 1940 Act grants to the holders of senior
securities representing indebtedness issued by the Fund, other than with respect to privately arranged Borrowings, certain voting rights
in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements
under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Borrowings under the committed
facility provided to the Fund by BNP Paribas are collateralized by portfolio assets which are maintained by the Fund in a separate account
with the Fund&#8217;s custodian for the benefit of the lender, which collateral exceeds the amount borrowed. Securities deposited in the
collateral account may, subject to certain conditions, be rehypothecated by the lender up to the amount of the loan balance outstanding
and subject to the terms and conditions of the facility agreements. The Fund continues to receive dividends and interest on rehypothecated
securities. The Fund also has the right to recall rehypothecated securities on demand and such securities shall be returned to the collateral
account within the ordinary settlement cycle. In the event a recalled security is not returned by the lender, the loan balance outstanding
will be reduced by the amount of the recalled security failed to be returned. The Fund receives a portion of the fees earned by BNP Paribas
in connection with the rehypothecation of portfolio securities. Rehypothecation of the Fund&#8217;s pledged portfolio securities entails
risks, including the risk that the lender will be unable or unwilling to return rehypothecated securities which could result in, among
other things, the Fund&#8217;s inability to find suitable investments to replace the unreturned securities, thereby impairing the Fund&#8217;s
ability to achieve its investment objective. In the event of a default by the Fund under the committed facility, the lender has the right
to sell such collateral assets to satisfy the Fund&#8217;s obligation to the lender. The amounts drawn under the committed facility may
vary over time and such amounts will be reported in the Fund&#8217;s audited and unaudited financial statements contained in the Fund&#8217;s
annual and semi-annual reports to shareholders. The committed facility agreement includes usual and customary covenants. These covenants
impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations.
These covenants place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional indebtedness with a party other
than BNP Paribas, (ii) change its fundamental investment policy, or (iii) pledge to any other party, other than to the counterparty, securities
owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information to
the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) greater
than 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#8220;closed-end
management investment company&#8221; as defined in the 1940 Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#8217;s
Financial Leverage, but the Fund&#8217;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Reverse Repurchase Agreements and Dollar Roll
Transactions. </i>The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund temporarily transfers
possession of a portfolio instrument to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund
</p></ix:continuation></div>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C03_gBFIOAPTB-ITSRA_z3yRhANiVEYk"><ix:continuation id="ConU000154-27"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">agrees to repurchase the instrument at an agreed upon time and price, which reflects an interest payment. Such agreements have the economic
effect of borrowings. The Fund may enter into reverse repurchase agreements when the Sub-Adviser believes it is able to invest the cash
acquired at a rate higher than the cost of the agreement, which would increase earned income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Borrowings may be made by the Fund through dollar
roll transactions. A dollar roll transaction involves a sale by the Fund of a mortgage-backed or other fixed-income security concurrently
with an agreement by the Fund to repurchase a similar security at a later date at an agreed-upon price. The securities that are repurchased
will bear the same interest rate and stated maturity as those sold, but pools of mortgages collateralizing those securities may have different
prepayment histories than those sold. During the period between the sale and repurchase, the Fund will not be entitled to receive interest
and principal payments on the securities sold. Proceeds of the sale will be invested in additional instruments for the Fund, and the income
from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation and gain or
loss that would have been realized on the securities sold as part of the dollar roll, the use of this technique will diminish the investment
performance of the Fund compared with what the performance would have been without the use of dollar rolls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">With respect to any reverse repurchase agreement,
dollar roll or similar transaction, the Fund&#8217;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to
a counterparty in such a transaction, in addition to the value of the underlying asset as of the relevant measuring date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Shares.</i> The Fund&#8217;s Governing
Documents provide that the Board may authorize and issue Preferred Shares with rights as determined by the Board, by action of the Board
without prior approval of the holders of the Common Shares. Common Shareholders have no preemptive right to purchase any Preferred Shares
that might be issued. Any such Preferred Share offering would be subject to the limits imposed by the 1940 Act. Although the Fund has
no present intention to issue Preferred Shares, it may in the future utilize Preferred Shares to the maximum extent permitted by the 1940
Act. Under the 1940 Act, the Fund may not issue Preferred Shares if, immediately after issuance, the Fund would have asset coverage (as
defined in the 1940 Act) of less than 200%, calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness
plus the aggregate liquidation preference of any outstanding shares of preferred stock. In addition, the Fund generally is not permitted
to declare any cash dividend or other distribution on the Fund&#8217;s Common Shares, or purchase any such Common Shares, unless, at the
time of such declaration, the Fund would have asset coverage (as described above) of at least 200% after deducting the amount of such
dividend or other distribution. The 1940 Act grants to the holders of senior securities representing stock issued by the Fund certain
voting rights. Failure to maintain certain asset coverage requirements under the 1940 Act could entitle the holders of Preferred Shares
to elect a majority of the Board.</p></ix:continuation></div>

<p id="xdx_981_ecef--EffectsOfLeverageTextBlock_c20251121__20251121_zigMTKo52Jdh" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000155" name="cef:EffectsOfLeverageTextBlock"><span style="font-weight: normal"><i>Effects
of Financial Leverage</i><span style="color: windowtext">. Please refer to the section of the </span></span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Effects of Leverage,&#8221; which is
incorporated by reference herein, for a discussion of the effects of leverage.</span></ix:nonNumeric></p>

<p id="ProRisks" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center">Risks</p>

<p id="xdx_98B_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--PrincipalRisksMember_zah3cIGdGcG2" style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left; text-indent: 0.5in"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_PrincipalRisksMember" escape="true" id="Fact000156" name="cef:RiskTextBlock"><span style="font-weight: normal; text-transform: none">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal; text-transform: none">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; text-transform: none">entitled &#8220;Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; text-transform: none">Principal Risks of the Fund,&#8221;
which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund, in addition to the
following.</span></ix:nonNumeric></p>

<p id="xdx_985_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--MarketDiscountAndPriceVolatilityRiskMember_gBFRTB-WLIQJ_z61GNRCWGUC8" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember" continuedAt="ConU000159-01" escape="true" id="Fact000159" name="cef:RiskTextBlock"><b>Market Discount and Price Volatility Risk</b></ix:nonNumeric></p>

<div id="xdx_C08_gBFRTB-WLIQJ_zf7y0KauFE1b"><ix:continuation continuedAt="ConU000159-02" id="ConU000159-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The net asset value and market price of the Common
Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market price
of the Common Shares may experience volatility (sometimes high volatility) driven by market forces that may be unrelated to changes in
the Fund&#8217;s net asset value or other internal Fund factors. The market price of the Common Shares will either be above (premium)
or below (discount) their net asset value. Although the net asset value of Common Shares is often</p></ix:continuation></div>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C0A_gBFRTB-WLIQJ_zsPfrl575Ich"><ix:continuation id="ConU000159-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> considered in determining whether to
purchase or sell shares, whether investors will realize gains or losses upon the sale of Common Shares will depend upon whether the market
price of Common Shares at the time of sale is above or below the investor&#8217;s purchase price, taking into account transaction costs
for the Common Shares, and is not directly dependent upon the Fund&#8217;s net asset value. Market price movements of Common Shares are
thus material to investors and may result in losses, even when net asset value has increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund cannot predict whether the Common Shares
will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a variety of factors.
If the Common Shares are trading at a premium to net asset value at the time you purchase Common Shares, the net asset value per share
of the Common Shares purchased will be less than the purchase price paid. Shares of closed-end investment companies frequently trade at
a discount from their net asset value, but in some cases have traded above net asset value. The risk of the Common Shares trading at a
discount is a risk separate and distinct from the risk of a decline in the Fund&#8217;s net asset value as a result of the Fund&#8217;s
investment activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Because the market price of the Common Shares
will be determined by factors such as net asset value, dividend and distribution levels (which are dependent, in part, on expenses), supply
of and demand for Common Shares, stability of dividends or distributions, trading volume of Common Shares, general market and economic
conditions and other factors beyond the Fund&#8217;s control, the Fund cannot predict whether the Common Shares will trade at, below or
above net asset value, or at, below or above the public offering price for the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s net asset value would be reduced
following an offering of the Common Shares due to the costs of such offering, to the extent those costs are borne by the Fund. The sale
of Common Shares by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of Common Shares in the
secondary market, including by resulting in increased trading of the Common Shares, which may increase volatility in the market price
of the Common Shares. An increase in the number of Common Shares available may put downward pressure on the market price for Common Shares.
The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of Common Shares
at a price below the Fund&#8217;s then-current net asset value, subject to certain conditions, and such sales of Common Shares at price
below net asset value, if any, may increase downward pressure on the market price for Common Shares. These sales, if any, also might make
it more difficult for the Fund to sell additional Common Shares in the future at a time and price it deems appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is designed for long-term investors
and investors in Common Shares should not view the Fund as a vehicle for trading purposes.</p></ix:continuation></div>

<p id="xdx_98F_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--DebtOverlayStrategyRiskMember_gBFRTB-LYMVH_zAqLpP08vJU7" style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt; text-align: justify"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember" continuedAt="ConU000162-01" escape="true" id="Fact000162" name="cef:RiskTextBlock"><b>Debt Overlay Strategy Risk</b></ix:nonNumeric></p>

<div id="xdx_C06_gBFRTB-LYMVH_zAqqVKz92K67"><ix:continuation continuedAt="ConU000162-02" id="ConU000162-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Debt Overlay Strategy is subject
to risks associated with investing in the investments comprising the Debt Overlay Basket as well as the risks associated with selling
call options on the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The risks of the Debt Overlay Strategy include,
among others, Income Securities Risk, Corporate Bond Risk, Below Investment Grade Securities Risk, Investment Funds Risk, Derivatives
Transactions Risk and Options Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Additionally, the Debt Overlay Strategy is subject
to imperfect matching or price correlation between the Underlying Bond ETF and the Debt Overlay Basket, which could reduce the Fund&#8217;s
returns and expose the Fund to additional losses. In particular, the Debt Overlay Strategy is subject to the risk of loss associated with
the Underlying Bond ETF outperforming the Debt Overlay Basket because the Fund&#8217;s obligation under the options on the Underlying
Bond ETF at expiration is determined by the market price of the shares of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s potential gain in selling a
call option on the Underlying Bond ETF is the premium received from the purchaser of the option; however, the Fund risks a loss equal
to the entire exercise price of the option minus the call premium (although the extent of such loss could be offset by the performance
of the Debt Overlay Basket).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The call options sold as part of the Debt Overlay
Strategy are generally not &#8220;covered.&#8221; For cash-settled call options sold by the Fund referencing the Underlying Bond ETF,
if the market price of the Underlying Bond ETF is above the strike price of the options, the Fund would owe the difference between the
market price of the shares of the Underlying Bond ETF and the strike price of the options. For physically-settled call options sold by
the Fund</p></ix:continuation></div>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<div id="xdx_C03_gBFRTB-LYMVH_z70vzTZBOeBl"><ix:continuation id="ConU000162-02"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> referencing the Underlying Bond ETF, if the options are exercised and assigned, the Fund will be obligated to sell to the options&#8217;
counterparty shares of the Underlying Bond ETF at the strike price. Pursuant to this sale upon assignment, the Fund will not be able to
deliver the Debt Overlay Basket to satisfy its delivery obligations and will be required to buy shares of the Underlying Bond ETF at the
prevailing market price, which may be greater in aggregate cost than the value of the corresponding Debt Overlay Basket. To the extent
that the market price of the shares of the Underlying Bond ETF experiences proportionately greater appreciation than the value of the
Debt Overlay Basket, the Fund is subject to additional risks associated with selling &#8220;naked&#8221; call options on the Underlying
Bond ETF. Selling naked, or uncovered, call options can be considerably riskier than selling covered call options. Although the Debt Overlay
Basket is intended to outperform the Underlying Bond ETF and the performance of the Debt Overlay Basket is otherwise intended to generally
be correlated with that of the Underlying Bond ETF, it is possible that the market price of the shares of the Underlying Bond ETF will
experience greater appreciation than the value of the Debt Overlay Basket, subjecting the Fund to the risk of a loss that is uncovered
by the Debt Overlay Basket. The potential appreciation of the market price of the shares of the Underlying Bond ETF is theoretically unlimited,
and the Fund is therefore subject to the risk of total loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the market price of the shares
of the Underlying Bond ETF experience less appreciation than the Debt Overlay Basket, the Fund is subject to risks similar to those described
in &#8220;Risks Associated with the Fund&#8217;s Covered Call Option Strategy and Put Options,&#8221; including the risk of losing the
ability to benefit from the capital appreciation of its Debt Overlay Basket (i.e., net of any losses from the call options sold by the
Fund referencing the Underlying Bond ETF). Additionally, for certain types of options, the Fund has no control over the time when it may
be required to fulfill its obligation under the option. There can be no assurance that a liquid market will exist for the options if and
when the Fund seeks to close out an option position.</p></ix:continuation></div>

<p id="xdx_984_ecef--RiskTextBlock_c20251121__20251121__cef--RiskAxis__custom--SyntheticAutocallableELNStrategyRiskMember_gBFRTB-QJQJ_zqVAqhEKWde8" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in"><ix:nonNumeric contextRef="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember" continuedAt="ConU000165-01" escape="true" id="Fact000165" name="cef:RiskTextBlock"><b>Synthetic Autocallable ELN Strategy Risk</b></ix:nonNumeric></p>

<div id="xdx_C06_gBFRTB-QJQJ_zVqSoLNxF5F4"><ix:continuation continuedAt="ConU000165-02" id="ConU000165-01"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Synthetic Autocallable ELN Strategy
is subject to risks associated with investing in autocallable ELNs directly, derivatives instruments on the Autocallable ELN Reference
Index, including Common Equity Securities Risk, Synthetic Investments Risk, Derivatives Transactions Risk, Counterparty Risk and Swap
Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable ELN Strategy is also
subject to certain additional or heightened risks, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Contingent Income Risk. Coupon Payments from the Synthetic Autocallable Contract are not guaranteed and will not be made if the price
level of the Autocallable ELN Reference Index falls below the Coupon Barrier on one or more observation dates. This means the Fund may
generate significantly less income than anticipated from a Synthetic Autocallable Contract during equity market downturns. The Coupon
Payments of Synthetic Autocallable Contracts are not linked to the performance of the Autocallable ELN Reference Index at any time other
than on maturity dates&#160;and observation dates. Moreover, because the payoff of the Synthetic Autocallable Contract is linked to the
price level of the Autocallable ELN Reference Index, the Fund is exposed to the market risk of the Autocallable ELN Reference Index and
may not receive any return on the Synthetic Autocallable Contract and may lose&#160;a portion or all of the notional value of the Synthetic
Autocallable Contract even if the performance of one or more of component securities of the Autocallable ELN Reference Index has exceeded&#160;the
initial value of such security.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Early Redemption Risk. Synthetic Autocallable Contracts may be called (i.e., cancelled) before their scheduled maturity if the Autocallable
ELN Reference Index reaches or exceeds the Autocall Barrier on an observation date. Synthetic Autocallable Contracts limit the positive
investment return that can be achieved due to this automatic call feature. This automatic early redemption could result in significantly
less income than anticipated from a Synthetic Autocallable Contract and force reinvestment of that principal investment amount at less
advantageous terms based on prevailing market conditions. For example, if the automatic call feature is triggered, the Fund would forego
any remaining Coupon Payments and may be unable to invest in another Synthetic Autocallable Contract (or other investment) with a similar
level of risk and comparable return potential. If the automatic call feature is not triggered, and the&#160;Maturity Barrier has been
breached as of the maturity date, the Fund will receive less than the initial notional amount&#160;regardless of any outperformance of
the Autocallable ELN Reference Index (or any component security thereof) throughout the term of the Synthetic Autocallable Contract.&#160;</td></tr></table>
</ix:continuation></div>
<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

    <div id="xdx_C0D_gBFRTB-QJQJ_zLuykVMNuTL7"><ix:continuation id="ConU000165-02">
    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">


<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Barrier Risk. The Coupon Barrier and Maturity Barrier levels of a Synthetic Autocallable Contract set forth the threshold amount&#160;of
loss the Autocallable ELN Reference Index could experience before the Fund&#160;would forfeit Coupon Payments and/or pay a portion or
all of the initial notional amount of such contract.&#160;If the Coupon Barrier level is breached on an observation date, the Fund will
not receive the Coupon Payment for such period (subject to any features that may provide the Fund to receive a Missed Coupon under certain
conditions).&#160;Accordingly, it is possible that the Fund may not receive any Coupon Payments under a Synthetic Autocallable Contract.
If the&#160;Maturity Barrier level is breached on the maturity date, the Fund may be required to pay a percentage of the initial notional
amount of the Synthetic Autocallable Contract. If the Autocallable ELN Reference Index falls below the Maturity Barrier at the maturity
of a Synthetic Autocallable Contract, the Fund is exposed to the negative performance of the Autocallable ELN Reference Index from a specified
level. This could result in sudden, significant losses if the Maturity Barrier is breached. Under some Synthetic Autocallable Contracts,
it is possible that the Fund could be required to pay the entire initial notional amount, in addition to forfeiting some or all&#160;of
the Coupon Payments.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Limited Available Counterparty Risk. Synthetic Autocallable Contracts are bespoke contracts and the Fund may have limited available
counterparties. The Fund will be subject to credit and default risk with respect to the counterparties to the Synthetic Autocallable Contracts
entered into by the Fund. If a Synthetic Autocallable Contract counterparty becomes bankrupt or otherwise fails to perform its obligations,
the Fund may experience significant delays in obtaining any recovery, may obtain only a limited recovery, or may obtain no recovery at
all. The Fund may have substantial exposure to one or a limited number of counterparties, which may result in the Fund being more susceptible
to a single economic or regulatory occurrence affecting such counterparty(ies).</td></tr></table></ix:continuation></div>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProManagementFund"></span>Management of
the Fund</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Trustees and Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees is broadly responsible
for the management of the Fund, including general supervision of the duties performed by the Investment Adviser and the Sub-Adviser. The
names and business addresses of the Trustees and officers of the Fund and their principal occupations and other affiliations during the
past five years are set forth under &#8220;Management of the Fund&#8221; in the SAI.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Advisers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Adviser</i>. Guggenheim Funds Investment
Advisors, LLC acts as the Fund&#8217;s Investment Adviser pursuant to the Advisory Agreement (as defined below). The Investment Adviser
is a registered investment adviser and acts as investment adviser to a number of closed-end and open-end management investment companies.
The Investment Adviser is a Delaware limited liability company, with its principal offices located at 227 West Monroe Street, Chicago,
Illinois 60606. The Investment Adviser is responsible for the management of the Fund. The Investment Adviser furnishes office facilities
and equipment and clerical, bookkeeping and administrative services on behalf of the Fund and oversees the activities of the Fund&#8217;s
Sub-Adviser. The Investment Adviser provides all services through the medium of any directors, officers or employees of the Investment
Adviser or its affiliates as the Investment Adviser deems appropriate in order to fulfill its obligations. The Investment Adviser pays
the compensation of all officers and Trustees of the Fund who are its affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sub-Adviser</i>. Guggenheim Partners Investment
Management, LLC acts as the Fund&#8217;s Sub-Adviser pursuant to the Sub-Advisory Agreement (as defined below). The Sub-Adviser is a Delaware
limited liability company, with its principal offices located at 100 Wilshire Boulevard, Santa Monica, California 90401. The Sub-Adviser,
under the oversight and supervision of the Board of Trustees and the Investment Adviser, manages the investment of the assets of the Fund
in accordance with its investment policies, places orders to purchase and sell securities on behalf of the Fund, and, at the request of
the Investment Adviser, consults with the Investment Adviser as to the overall management of the assets of the Fund and its investment
policies and practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Investment Adviser and Sub-Adviser make investment
decisions for the assets of the Fund and continuously review,&#160;supervise and administer the Fund&#8217;s investment program. In carrying
out these functions, the personnel of the Investment&#160;Adviser and Sub-Adviser operate in teams with various roles. For example, the
macroeconomic research team develops&#160;the outlook for key economic themes and trends; a sector/security research team selects specific
securities for investment consideration and identifies the outlook for different sectors; a portfolio construction team targets investment
portfolio positionings and sector weightings; and the portfolio </p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">management team provides portfolio monitoring and implementation and risk
management services.&#160;The Investment Adviser and Sub-Adviser have created a fixed-income&#160;investment process designed around the
specialization of functions and advances in behavioral finance in an&#160;effort&#160;to make investment decisions that seek to avoid
behavioral anomalies and cognitive biases. To accomplish this, the&#160;Investment Adviser and Sub-Adviser have disaggregated the primary
functions of investment management into four specialized teams that work in a systematic process. The teams are (1)&#160;Macroeconomic
Research and Market Strategy,&#160;(2) Sector Teams,&#160;(3) Portfolio Construction, and (4) Portfolio Management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Each of the Investment Adviser and the Sub-Adviser
is a wholly-owned subsidiary of Guggenheim Partners, LLC (&#8220;Guggenheim Partners&#8221;). Guggenheim Partners is a diversified financial
services firm with wealth management, capital markets, investment management and proprietary investing businesses, the clients of which
are a mix of individuals, family offices, endowments, investment funds, foundations, insurance companies and other institutions that have
entrusted Guggenheim Partners with the supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners
is headquartered in Chicago and New York with a global network of offices throughout the United States, Europe, and Asia.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#8220;Guggenheim Investments&#8221; refers to
the global asset management and investment advisory division of Guggenheim Partners and includes the Investment Adviser, the Sub-Adviser
and other affiliated investment management businesses of Guggenheim Partners.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Advisory Agreement and Sub-Advisory
Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to an investment advisory agreement
between the Fund and the Investment Adviser (the &#8220;Advisory Agreement&#8221;), the Fund pays the Investment Adviser a fee, payable
monthly in arrears at an annual rate equal to 1.00% of the Fund&#8217;s average daily Managed Assets (from which the Investment Adviser
pays the Sub-Adviser&#8217;s fees), as described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to an investment sub-advisory agreement
among the Fund, the Investment Adviser and the Sub-Adviser (the &#8220;Sub-Advisory Agreement&#8221;), the Investment Adviser pays the
Sub-Adviser a fee, payable monthly in arrears at an annual rate equal to 0.50% of the Fund&#8217;s average daily Managed Assets, less
0.50% of the Fund&#8217;s average daily assets attributable to any investments by the Fund in Affiliated Investment Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A discussion regarding the basis for the most
recent approval of the Advisory Agreement and the Sub-Advisory Agreement by the Board of Trustees is available in the Fund&#8217;s annual
report to shareholders for the period ending May 31, 2025.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Portfolio Management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s personnel primarily responsible
for the day-to-day management of the Fund&#8217;s portfolio are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Anne B. Walsh, Managing Partner, Chief Investment
Officer and Portfolio Manager of Guggenheim Investments.</i> Ms. Walsh joined Guggenheim Investments (or its affiliate or predecessor)
in 2007. Ms. Walsh provides the vision guiding the firm&#8217;s investment strategies and leads the investment process to include the
macroeconomic outlook, portfolio design, sector allocation, and risk management. She also chairs the Environmental, Social, and Governance
(ESG) Oversight Committee and the Alternatives Investment Committee. Ms. Walsh, whose career in financial services spans nearly four decades,
is highly regarded for her active fixed-income, alternatives, and insurance portfolio management expertise in addition to deep background
in credit and liability managed investment.&#160;She is&#160;also a member of the Investor Advisory Committee on Financial Markets (IACFM),
an advisory body to the President of the New York Fed.&#160;Ms. Walsh holds a BSBA and MBA from Auburn University, and a JD from the University
of&#160;Miami School of Law. She has earned the right to use the Chartered Financial Analyst&#174;&#160;designation and is a member of
the CFA Institute.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Steven H. Brown, CFA, Chief Investment Officer,
Fixed Income, and Senior Managing Director and Portfolio Manager of Guggenheim Investments</i>. Mr. Brown joined Guggenheim Investments
(or its affiliate or predecessor) in 2010. Mr. Brown works with the Chief Investment Officer&#160;the Sector Teams, Portfolio Management,
Macroeconomic Research,&#160;and the Portfolio Construction Group&#160;to develop and execute investment strategy. Mr. Brown was previously
a&#160;member of&#160;the structured credit sector team at Guggenheim. Prior to joining Guggenheim, Mr. Brown held roles focused on structured
products at Bank of America and ABN AMRO. Mr. Brown received a B.S.&#160;in Finance from&#160;Indiana University's Kelley School of Business.
He has earned the right to use the Chartered Financial Analyst&#174;&#160;designation and is a member of the CFA Institute.</p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Adam J. Bloch, Managing Director and Portfolio
Manager of Guggenheim Investments</i>. Mr. Bloch joined&#160;Guggenheim Investments in 2012 and is a Portfolio Manager for the firm's
Active Fixed Income and Total Return mandates.&#160;He oversees strategy implementation, working with research analysts and traders to
generate trade ideas&#160;and manage day-to-day risk. Mr. Bloch works with the Chief Investment Officers, the Sector Teams, the&#160;Macroeconomic
Research and Market Strategy Group, and the Portfolio Construction Group to develop and execute investment strategy.&#160;Prior to joining
Guggenheim Investments, he worked in Leveraged Finance at Bank of America&#160;Merrill Lynch&#160;where he structured high-yield bonds
and leveraged loans for leveraged buyouts, restructurings, and&#160;corporate refinancings across multiple industries. Mr. Bloch graduated
with a&#160;B.A.&#160;in Philosophy, Politics, and Economics from the University of Pennsylvania.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Evan L. Serdensky, Managing Director and Portfolio
Manager of Guggenheim Investments</i>. Mr. Serdensky joined&#160;Guggenheim in 2018 and is a Portfolio Manager for Guggenheim&#8217;s
Active Fixed Income and Total Return mandates. Previously, Mr. Serdensky was a Trader on the Investment Grade Corporate team at Guggenheim
Investments, where he was responsible for identifying and executing investment opportunities across corporate securities. Prior to joining
Guggenheim, Mr. Serdensky was a Vice President and Portfolio Manager at BlackRock, responsible for actively managing High Yield and Multi-Sector
Credit portfolios. Mr. Serdensky started his career at PIMCO supporting Total Return and Alternative strategies. Mr. Serdensky completed
his B.S. in Finance from the University&#160;of Maryland and earned his M.S. in Finance from the Washington University in St. Louis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The SAI provides additional information about
the portfolio managers&#8217; compensation, other accounts managed by the portfolio managers and the portfolio managers&#8217; ownership
of securities of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProNetAssetValue"></span>Net Asset Value</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The net asset value of the Common Shares is calculated
by subtracting the Fund&#8217;s total liabilities (including from Borrowings) and the liquidation preference of any outstanding Preferred
Shares from total assets (the current market value of the securities the Fund holds plus cash and other assets). The per share net asset
value is calculated by dividing its net asset value by the number of Common Shares outstanding and rounding the result to the nearest
full cent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund generally calculates its net asset value
once each day on which there is a regular trading session on the NYSE as of the scheduled close of normal trading on the &#8220;NYSE&#8221;
(normally 4:00 p.m., Eastern time). The NYSE is open Monday through Friday, except on observation of the following holidays: New Year&#8217;s
Day, Martin Luther King, Jr. Day, President&#8217;s Day, Good Friday, Memorial Day, Juneteenth, Independence Day, Labor Day, Thanksgiving
Day and Christmas Day. If the NYSE has an earlier closing time (scheduled or unscheduled), such as on days in advance of holidays generally
observed by the NYSE, the Fund may calculate its net asset value as of the earlier closing time or calculate its net asset value as of
the normally scheduled close of regular trading on the NYSE for that day, so long as the Investment Adviser, with the assistance of the
Sub-Adviser, believes there generally remains an adequate market to obtain reliable and accurate market quotations. The Fund generally
does not calculate its net asset value on any day that the NYSE is not open for business. However, if the NYSE is closed for any other
reason on a day it would normally be open for business, the Fund may calculate its net asset value as of the normally scheduled close
of regular trading on the NYSE for that day, so long as the Investment Adviser, with the assistance of the Sub-Adviser, believes there
generally remains an adequate market to obtain reliable and accurate market quotations. The Fund discloses its net asset value on a daily
basis. Information that becomes known to the Fund or its agent after the Fund&#8217;s net asset value has been calculated on a particular
day will not be used to retroactively adjust the price of a security or the Fund&#8217;s previously determined net asset value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees has adopted policies and
procedures for the valuation of the Fund&#8217;s investments (the &#8220;Fund Valuation Procedures&#8221;). Pursuant to Rule 2a-5 under
the 1940 Act, the Board designated the Investment Adviser as the valuation designee to perform fair valuation determinations for the Fund
with respect to all Fund investments and/or other assets. As the Fund&#8217;s valuation designee pursuant to Rule 2a-5, the Investment
Adviser has adopted separate procedures (the &#8220;Valuation Designee Procedures&#8221; and collectively with the Fund Valuation Procedures,
the &#8220;Valuation Procedures&#8221;) reasonably designed to prevent violations of the requirements of Rule 2a-5 and Rule 31a-4 under
the 1940 Act. The Investment Adviser, in its role as valuation designee, utilizes the assistance of a valuation committee, consisting
of representatives from Guggenheim&#8217;s investment management, fund administration, legal and compliance departments (the &#8220;Valuation
Committee&#8221;), in determining fair value of the Fund&#8217;s securities and/or other assets. The Valuation Procedures permit the Fund
to use a variety of valuation methodologies in connection with valuing the Fund&#8217;s investments. The methodology used for a specific
type of investment may vary based on available market data or other relevant considerations. As a general matter, valuing </p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">securities and
assets accurately is difficult and can be based on inputs and assumptions, which may not always be accurate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In general, portfolio securities and assets of
the Fund will be valued on the basis of readily available market quotations at their current market value. With respect to portfolio securities
and assets of the Fund for which market quotations are not readily available, or are deemed unreliable by the Investment Adviser, the
Fund will fair value those securities and assets in good faith in accordance with the Valuation Procedures. Valuations in accordance with
these methods are intended to reflect each security&#8217;s (or asset&#8217;s or liability&#8217;s) &#8220;fair value.&#8221; Fair value
represents a good faith approximation of the value of a security. Fair value determinations may be based on limited inputs and involve
the consideration of a number of subjective factors, an analysis of applicable facts and circumstances, and the exercise of judgment.
Each such determination is based on a consideration of all relevant factors, which are likely to vary from one pricing context to another.
Examples of such factors may include, but are not limited to: market prices; sale prices; broker quotes; and models which derive prices
based on inputs such as prices of securities with comparable maturities and characteristics, or based on inputs such as anticipated cash
flows or collateral, spread over U.S. Treasury securities, and other information analysis. As a result, it is possible that the fair value
for a security determined in good faith in accordance with the Valuation Procedures may differ from valuations for the same security determined
by other funds using their own valuation procedures. Although the Valuation Procedures are designed to value a portfolio security or asset
at the price the Fund may reasonably expect to receive upon its sale in an orderly transaction, there can be no assurance that any fair
value determination thereunder would, in fact, approximate the amount that the Fund could reasonably expect to receive upon the sale of
the portfolio security or asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Equity securities listed or traded on a recognized
U.S. securities exchange or the Nasdaq Stock Market (&#8220;NASDAQ&#8221;) are generally valued on the basis of the last sale price on
the primary U.S. exchange or market on which the security is listed or traded; provided, however, that securities listed on NASDAQ will
be valued at the NASDAQ official closing price, which may not necessarily represent the last sale price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Open-end investment companies are valued at their
net asset value as of the close of the NYSE, on the valuation date. Exchange-traded funds and closed-end investment companies are generally
valued at the last quoted sale price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Commercial paper and discount notes with a maturity
of greater than 60 days at acquisition are valued at prices that are obtained from independent
third party pricing services, which may consider the trade activity, treasury spreads, yields or prices of bonds of comparable quality,
coupon, maturity, and type, as well as prices quoted by dealers who make markets in such securities. Commercial paper and discount notes
with a maturity of 60 days or less at acquisition are valued at amortized cost, unless the Investment Adviser concludes that amortized
cost does not represent the fair value of the applicable asset in which case it will be valued using an independent third party pricing
service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">CLOs, CDOs, MBS, ABS, and other structured finance
securities are generally valued using an independent third&#160;party pricing service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">U.S. Government securities are valued by independent
third party pricing services, using the last traded fill price, or at the reported bid price at the close of business on the valuation
date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Typically, loans are valued using information
provided by an independent third party pricing service that uses broker quotes, among other inputs. If the independent third party pricing
service cannot or does not provide a valuation for a particular loan, or such valuation is deemed unreliable by the Investment Adviser,
such investment is valued based on a quote from a broker-dealer or is fair valued by the Investment Adviser. The Fund invests in loans
and asset-backed securities as part of its investment strategies and has a significant amount of these instruments that are fair valued
by the Investment Adviser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Repurchase agreements are generally valued at
amortized cost, provided such amounts approximate market value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Exchange-traded options are valued at the mean
of the bid and ask prices on the principal exchange on which they are traded. Over-the-counter (&#8220;OTC&#8221;) options and options
on swaps (&#8220;swaptions&#8221;) are valued using a price provided by a pricing service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Futures contracts are valued on the basis of
the last sale price as of 4:00 p.m. on the valuation date. In the event that the exchange for a specific futures contract closes earlier
than 4:00 p.m., the futures contract is valued at </p>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">the official settlement price of the exchange. However, the underlying securities from
which the futures contract value is derived are monitored until 4:00 p.m. to determine if fair valuation would provide a more accurate
valuation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Interest rate swap agreements entered into by
the Fund are valued on the basis of the last sale price on the primary exchange on which the swap is traded. Other swap agreements entered
into by the Fund are generally valued using an evaluated price provided by an independent third party pricing service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Forward foreign currency exchange contracts are
valued daily based on the applicable exchange rate of the underlying currency.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Generally, trading in foreign securities markets
is substantially completed each day at various times prior to the close of the NYSE. The values of foreign securities are determined as
of the close of such foreign markets or the close of the NYSE, if earlier. All investments quoted in foreign currencies are valued in
U.S. dollars on the basis of the foreign currency exchange rates prevailing at the close of U.S. business at 4:00 p.m. E.T. Investments
in foreign securities may involve risks not present in domestic investments. The Investment Adviser will determine the current value of
such foreign securities by taking into consideration certain factors which may include those discussed above, as well as the following
factors, among others: the value of the securities traded on other foreign markets, American Depository Receipt trading, closed-end fund
trading, foreign currency exchange activity, and the trading prices of financial products that are tied to foreign securities. In addition,
under the Valuation Procedures , the Investment Adviser is authorized to use prices and other information supplied by an independent third-party
pricing vendor in valuing foreign securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may also fair value securities and other
assets when a significant event is deemed to have occurred after the time of a market quotation including for securities and assets traded
on foreign markets and securities and assets for which market quotations are provided by independent third party pricing services as of
a time that is prior to the time when the Fund determines its NAV. There can be no assurance in each case that significant events will
be identified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Valuations of the Fund&#8217;s securities and
other assets are supplied primarily by independent third-party pricing services appointed pursuant to the processes set forth in the Valuation
Designee Procedures. Valuations provided by the independent third-party pricing services are generally based on methods designed to approximate
the amount that the Fund could reasonably expect to receive upon the sale of the portfolio security or asset. When providing valuations
to the Fund, independent third-party pricing services use various inputs, methods, models and assumptions, which may include information
provided by broker-dealers and other market makers. Independent third-party pricing services face the same challenges as the Fund in valuing
securities and assets and may rely on limited available information. If the independent third-party pricing service cannot or does not
provide a valuation for a particular investment, or such valuation is deemed unreliable, such investment is fair valued by the Investment
Adviser. The Fund may also use third party service providers to model certain securities, using models to determine fair market value.
While the Fund&#8217;s use of fair valuation is intended to result in calculation of net asset value that fairly reflects values of the
Fund&#8217;s portfolio securities as of the time of pricing, the Fund cannot guarantee that any fair valuation will, in fact, approximate
the amount the Fund would actually realize upon the sale of the securities in question.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Quotes from broker-dealers (i.e., prices provided
by a broker-dealer or other market participant, which may or may not be committed to trade at that price), adjusted for fluctuations in
criteria such as credit spreads and interest rates, may also be used to value the Fund&#8217;s securities and other assets. Quotes from
broker-dealers and vendor prices based on broker quotes can vary in terms of depth (e.g., provided by a single broker-dealer) and frequency
(e.g., provided on a daily, weekly, or monthly basis, or any other regular or irregular interval). Although quotes from broker-dealers
and vendor prices based on broker quotes are typically received from established market participants, the Fund may not have the transparency
to view the underlying inputs which support such quotes. Significant changes in a quote from a broker-dealer would generally result in
significant changes in the fair value of the security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Proportions of the Fund&#8217;s investments that
are fair valued vary from time to time and the Fund may fair value a significant amount of its portfolio securities and other assets.
The Fund&#8217;s shareholder reports contain more information about the Fund&#8217;s holdings that are fair valued. Investors should consult
these reports for additional information. For underlying funds in which the Fund may invest, additional information about the circumstances
</p>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">when those underlying funds may use fair value pricing may be found in each underlying fund&#8217;s respective prospectus.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProDistributions"></span>Distributions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund intends to pay substantially all of
its net investment income, if any, to Common Shareholders through monthly distributions. In addition, the Fund intends to distribute any
net long-term capital gains to Common Shareholders at least annually. The Fund expects that distributions paid on Common Shares will generally
consist of (i) investment company taxable income taxed as ordinary income, which includes, among other things, dividend and interest income
accrued on portfolio assets, short-term capital gain and income from certain hedging and interest rate transactions, (ii) long-term capital
gain and (iii) return of capital. To the extent the Fund receives dividends with respect to its investments in Common Equity Securities
that consist of qualified dividend income (income from domestic and certain foreign corporations), a portion of the Fund&#8217;s distributions
to its Common Shareholders may consist of qualified dividend income. Qualified dividend income and long-term capital gains of certain
non-corporate U.S. Common Shareholders (including individuals) will be taxable at reduced maximum rates. The Fund cannot assure you, however,
as to what percentage of the dividends paid on Common Shares, if any, will consist of qualified dividend income or long-term capital gains.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to the requirements of the 1940 Act,
in the event the Fund makes distributions from sources other than income, a notice will accompany each monthly distribution with respect
to the estimated source of the distribution made. Such notices will describe the portion, if any, of the monthly dividend which, in the
Fund&#8217;s good faith judgment, constitutes long-term capital gain, short-term capital gain, investment company taxable income or a
return of capital. The actual character of such dividend distributions for U.S. federal income tax purposes, however, will only be determined
finally by the Fund at the close of its fiscal year, based on the Fund&#8217;s full year performance and its actual net investment company
taxable income and net capital gains for the year, which may result in a recharacterization of amounts distributed during such fiscal
year from the characterization in the monthly estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s distributions may be greater
than the Fund&#8217;s net investment income or profit. As a result, all or a portion of a distribution may be a return of capital, which
is in effect a partial return of the amount a Common Shareholder invested in the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Fund&#8217;s total distributions in any
year exceed the amount of its investment company taxable income and net capital gain for the year, any such excess would generally be
characterized as a return of capital for U.S. federal income tax purposes, to the extent such amounts exceed the Fund&#8217;s current
and accumulated earning and profits. For example, because of the nature of the Fund&#8217;s investments, the Fund may distribute net short-term
capital gains early in the calendar year, but incur net short-term capital losses later in the year, thereby offsetting the short-term
net capital gains for which distributions have already been made by the Fund. In such a situation, the amount by which the Fund&#8217;s
total distributions exceed the Fund&#8217;s current and accumulated earning and profits would generally be treated as a tax-free return
of capital up to the amount of the Common Shareholder&#8217;s tax basis in their Common Shares, which would reduce such tax basis, with
any amounts exceeding such basis treated as a gain from the sale of their Common Shares. Although a return of capital may not be taxable,
it will generally increase the Common Shareholder&#8217;s potential gain, or reduce the Common Shareholder&#8217;s potential loss, on
any subsequent sale or other disposition of Common Shares. Common Shareholders who receive the payment of a distribution consisting of
a return of capital may be under the impression that they are receiving net investment income or profits when they are not. Common Shareholders
should not assume that the source of a distribution from the Fund is net investment income or profit.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund expects that over time it will distribute
all of its investment company taxable income. The investment company taxable income of the Fund will consist of all dividend and interest
income accrued on portfolio assets, short-term capital gain and income from certain hedging and interest rate transactions, less all expenses
of the Fund. Expenses of the Fund will be accrued each day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To permit the Fund to maintain more stable monthly
distributions, the Fund may distribute more or less than the entire amount of the net investment income earned in a particular period.
As a result, the distributions paid by the Fund for any particular monthly period may be more or less than the amount of net investment
income actually earned by the Fund during the period, and, to pay distributions, the Fund may have to use net proceeds of an offering
or sell a portion of its investment portfolio to make a distribution at a time when independent investment judgment might not dictate
such action. Any undistributed net investment income may be available to supplement future distributions. Undistributed net investment
income is included in the Common Shares&#8217; net asset value, and, </p>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">correspondingly, distributions from net investment income will reduce
the Common Shares&#8217; net asset value. In certain circumstances, the Fund may elect to retain income or capital gain and pay income
or excise tax on such undistributed amount. During the Fund&#8217;s fiscal year ended May 31, 2025, the Fund paid excise tax of $0. See
&#8220;U.S. Federal Income Tax Considerations.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Distributions paid on the Common Shares
that consist of investment company taxable income and/or long-term capital gains are taxable even if they are paid from income or
gains earned by the Fund before your investment in the Fund (and thus were included in the price paid for your Common Shares). These
distributions are likely to occur in respect of Common Shares purchased at a time when the Fund&#8217;s net asset value
(&#8220;NAV&#8221;) reflects earnings realized but not distributed. These distributions may be taxable despite constituting an
economic return of your investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s distribution rate is not constant
and the amount of distributions, when declared by the Board of Trustees, is subject to change. There is no guarantee of any future distribution
or that the current returns and distribution rates will be maintained. The Fund reserves the right to change its distribution policy and
the basis for establishing the rate of distributions at any time and may do so without prior notice to Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If you hold your Common Shares in your own name
or if you hold your Common Shares with a brokerage firm that participates in the Fund&#8217;s Dividend Reinvestment Plan (the &#8220;Plan&#8221;),
unless you elect to receive cash, all dividends and distributions that are declared by the Fund will be automatically reinvested in additional
Common Shares of the Fund pursuant to the Plan. If you hold your Common Shares with a brokerage firm that does not participate in the
Plan, you will not be able to participate in the Plan and any dividend reinvestment may be effected on different terms than those described
below. Consult your financial adviser for more information. See &#8220;Dividend Reinvestment Plan.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProDividend"></span>Dividend Reinvestment
Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left; text-indent: 0.5in"><span style="font-weight: normal; text-transform: none">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal; text-transform: none">Fund&#8217;s most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; text-transform: none">entitled &#8220;Dividend Reinvestment
Plan,&#8221; which is incorporated by reference herein, for a discussion of the Fund&#8217;s dividend reinvestment plan.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProDescCapStruct"></span>Description of
Capital Structure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is an unincorporated statutory trust
organized under the laws of Delaware pursuant to a Certificate of Trust, dated as of November 13, 2006, and pursuant to an Amended and
Restated Agreement and Declaration of Trust, dated as of February 29, 2024, as amended and/or restated from time to time (the &#8220;Declaration
of Trust&#8221;). The following is a brief description of the terms of the Common Shares, Borrowings and Preferred Shares which may be
issued by the Fund. This description does not purport to be complete and is qualified by reference to the Fund&#8217;s Governing Documents.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Common Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is an unincorporated statutory trust
organized under the laws of Delaware pursuant to a Certificate of Trust, dated as of November 13, 2006. Pursuant to the Declaration of
Trust, the Fund is authorized to issue an unlimited number of common shares of beneficial interest, par value $0.01 per share. Each Common
Share has one vote (fractional Common Shares are entitled to a vote of such fraction) and, when issued and paid for in accordance with
the terms of this offering, will be fully paid and non-assessable, except that the Board of Trustees shall have the power to cause shareholders
to pay certain expenses of the Fund by setting off charges due from shareholders from declared but unpaid dividends or distributions owed
the shareholders and/or by reducing the number of Common Shares owned by each respective shareholder. <span id="xdx_902_ecef--SecurityDividendsTextBlock_c20251121__20251121_zysde0WyOE8"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000166" name="cef:SecurityDividendsTextBlock">All Common Shares are equal as to
dividends, assets and voting privileges and shall not entitle the holders to preference, preemptive, appraisal, conversion or exchange
rights, except as otherwise required by law or permitted by the Declaration of Trust.</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under Delaware law applicable to the Fund as
of August 1, 2022, if a shareholder acquires direct or indirect ownership or power to direct the voting of shares of the Fund in an amount
that equals or exceeds certain percentage thresholds specified under Delaware law (beginning at 10% or more of shares of the Fund), the
shareholder&#8217;s ability to vote certain of these shares may be limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will send annual and semi-annual reports,
including financial statements, to all Common Shareholders, as required by applicable law or regulation.</p>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any additional offerings of Common Shares will
require approval by the Board of Trustees. Any additional offering of Common Shares will be subject to the requirements of the 1940 Act,
which provides that shares may not be issued at a price below the then current net asset value, exclusive of distributing commissions
or discounts, except in connection with an offering to existing Common Shareholders, with the consent of a majority of the Fund&#8217;s
outstanding voting securities or as otherwise permitted under the 1940 Act.</p>

<p id="xdx_984_ecef--SecurityVotingRightsTextBlock_c20251121__20251121_zijhTm2Bua4b" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000167" name="cef:SecurityVotingRightsTextBlock"><i>Voting
Rights</i>. Until any Preferred Shares are issued, holders of the Common Shares will vote as a single class to elect the
Fund&#8217;s Board of Trustees and on additional matters with respect to which the 1940 Act mandates a vote by the Fund&#8217;s
shareholders. If Preferred Shares are issued, holders of Preferred Shares will have a right to elect at least two of the
Fund&#8217;s Trustees, and will have certain other voting rights. See &#8220;Anti-Takeover Provisions in the Fund&#8217;s Governing
Documents.&#8221;</ix:nonNumeric></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Issuance of Additional Common Shares. </i>The
provisions of the 1940 Act generally require that the public offering price (less underwriting commissions and discounts) of common shares
sold by a closed-end investment company must equal or exceed the net asset value of such company&#8217;s common shares (calculated within
48 hours of the pricing of such offering, excluding Sundays and holidays), unless such sale is made with the consent of a majority of
its common shareholders and under certain other enumerated circumstances. The Fund may, from time to time, seek the consent of Common
Shareholders to permit the issuance and sale by the Fund of Common Shares at a price below the Fund&#8217;s then-current net asset value,
subject to certain conditions. If such consent is obtained, the Fund may, contemporaneous with and in no event more than one year following
the receipt of such consent, sell Common Shares at a price below net asset value in accordance with any conditions adopted in connection
with the giving of such consent. Additional information regarding any consent of Common Shareholders obtained by the Fund and the applicable
conditions imposed on the issuance and sale by the Fund of Common Shares at a price below net asset value will be disclosed in the Prospectus
Supplement relating to any such offering of Common Shares at a price below net asset value. Until such consent of Common Shareholders,
if any, is obtained (or other applicable 1940 Act requirements are met), the Fund may not sell Common Shares at a price below net asset
value. Because the Fund&#8217;s advisory fee and sub-advisory fee are based upon average Managed Assets, the Investment Adviser&#8217;s
and the Sub-Adviser&#8217;s interests in recommending the issuance and sale of Common Shares at a price below net asset value may conflict
with the interests of the Fund and its Common Shareholders.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Borrowings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">The Fund is
permitted, without prior approval of the Common Shareholders, to borrow money. The Fund may issue notes or other evidence of indebtedness
(including bank borrowings or commercial paper) and may secure any such Borrowings by mortgaging, pledging or otherwise subjecting the
Fund&#8217;s assets as security. In connection with such Borrowings, the Fund may be required to maintain minimum average balances with
the lender or to pay a commitment or other fee to maintain a line of credit. Any such requirements will increase the cost of borrowing
over the stated interest rate.</span></p>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-weight: normal"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Limitations</i>.
Borrowings by the Fund are subject to certain limitations under the 1940 Act, including the amount of asset coverage required. In addition,
agreements related to the Borrowings may also impose certain requirements, which may be more stringent than those imposed by the 1940
Act. See &#8220;Use of Leverage.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Distribution
Preference</i>. The rights of lenders to the Fund to receive interest on, and repayment of, principal of any such Borrowings will be senior
to those of the Common Shareholders, and the terms of any such Borrowings may contain provisions which limit certain activities of the
Fund, including the payment of dividends to Common Shareholders in certain circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Voting Rights</i>.
The 1940 Act does (in certain circumstances) grant to the lenders to the Fund certain voting rights in the event of default in the payment
of interest on, or repayment of, principal. Any Borrowings will likely be ranked senior or equal to all other existing and future borrowings
of the Fund.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Preferred Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">The Fund&#8217;s
Governing Documents provide that the Board of Trustees may authorize and issue Preferred Shares with rights as determined by the Board
of Trustees, by action of the Board of Trustees without prior approval of the holders of the Common Shares. Common Shareholders have no
preemptive right to purchase any Preferred Shares that might be issued. Under the 1940 Act, the Fund may not issue Preferred Shares if,
immediately after issuance, the Fund would have asset coverage (as defined in the 1940 Act) of less than 200%, calculated as the ratio
of the Fund&#8217;s total assets (less all liabilities and indebtedness not represented by senior securities) over the aggregate amount
of the Fund&#8217;s outstanding senior securities representing indebtedness plus the aggregate liquidation preference of any outstanding
shares of preferred stock. In addition, the Fund generally is not permitted to declare any cash dividend or other distribution on the
Fund&#8217;s Common Shares, or purchase any such Common Shares, unless, at the time of such declaration, the Fund would have asset coverage
(as described above) of at least 200% after deducting the amount of such dividend or other distribution. The 1940 Act grants to the holders
of senior securities representing stock issued by the Fund certain voting rights. Failure to maintain certain asset coverage requirements
under the 1940 Act could entitle the holders of Preferred Shares to elect a majority of the Board. If the Fund issues and has Preferred
Shares outstanding, the Common Shareholders will generally not be entitled to receive any distributions from the Fund unless all accrued
dividends on Preferred Shares have been paid. Issuance of Preferred Shares would constitute financial leverage and would entail special
risks to the Common Shareholders. The Fund has no present intention to issue Preferred Shares.</span></p>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<div id="xdx_885_ecef--OutstandingSecuritiesTableTextBlock_zJ86giUZd4c6"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000169" name="cef:OutstandingSecuritiesTableTextBlock"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Capitalization</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table provides information about
the outstanding securities of the Fund as of November 14, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in">&#160;</p>

<table cellspacing="0" cellpadding="0" summary="xdx: Disclosure - Capitalization" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 37%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Title of Class</b></td>
    <td style="width: 19%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount</b><br/>
<b>Authorized</b></td>
    <td style="width: 24%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Held by the<br/>
Fund or for its Account</b></td>
    <td style="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Outstanding</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_904_ecef--OutstandingSecurityTitleTextBlock_c20251121__20251121_zkUzmOJ13as9"><ix:nonNumeric contextRef="AsOf2025-11-21" escape="true" id="Fact000170" name="cef:OutstandingSecurityTitleTextBlock">Common shares of beneficial interest, par value $0.01 per share</ix:nonNumeric></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Unlimited</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#8212;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90D_ecef--OutstandingSecurityAuthorizedShares_c20251121__20251121_zPkprTPwwap7"><ix:nonFraction name="cef:OutstandingSecurityAuthorizedShares" contextRef="AsOf2025-11-21" id="Fact000171" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">199,267,847</ix:nonFraction></span></td></tr>
  </table></ix:nonNumeric></div>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-transform: uppercase; text-align: center"><span id="ProAntiTakeover"></span>Anti-Takeover and
Other Provisions in the Fund&#8217;s Governing Documents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund presently has provisions in its Governing
Documents which could have the effect of limiting, in each case, (i) the ability of other entities or persons to acquire control of the
Fund, (ii) the Fund&#8217;s freedom to engage in certain transactions or (iii) the ability of the Fund&#8217;s Board of Trustees or shareholders
to amend the Governing Documents or effectuate changes in the Fund&#8217;s management. These provisions of the Governing Documents of
the Fund may be regarded as &#8220;anti-takeover&#8221; provisions. The Board of Trustees is divided into two classes, with the terms
of one class expiring at each annual meeting of shareholders. At each annual meeting, one class of Trustees is elected to a two-year term.
This provision could delay for up to one year the replacement of a majority of the Board of Trustees. A Trustee may be removed from office,
for cause only, and not without cause, by the action of a majority of the remaining Trustees followed by a vote of the holders of at least
75% of the shares then entitled to vote for the election of the respective Trustee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Declaration of Trust requires
the affirmative vote or consent of a majority of the Board of Trustees followed by the affirmative vote of the holders of at least 75%
of the outstanding shares of each affected class or series of the Fund, voting separately as a class or series, to approve, adopt or authorize
certain transactions with 5% or greater holders of a class or series of shares and their associates, unless the transaction has been approved
by at least 80% of the Board Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221; (as defined in the
1940 Act) of the Fund shall be required. For purposes of these provisions, a 5% or greater holder of a class or series of shares (a &#8220;Principal
Shareholder&#8221;) refers to any person who, whether directly or indirectly and whether alone or together with its affiliates and associates,
beneficially owns 5% or more of the outstanding shares of any class or series of shares of beneficial interest of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The 5% holder transactions subject to these special
approval requirements are:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the merger or consolidation of the Fund or any subsidiary of the Fund with or into any Principal Shareholder;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the issuance of any securities of the Fund to any Principal Shareholder for cash (other than pursuant to any automatic dividend reinvestment
plan);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the sale, lease or exchange of all or any substantial part of the assets of the Fund to any Principal Shareholder, except assets having
an aggregate fair market value of less than $1,000,000, aggregating for purpose of such computation all assets sold, leased or exchanged
in any series of similar transactions within a twelve-month period; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the sale, lease or exchange to the Fund or any subsidiary of the Fund, in exchange for securities of the Fund, of any assets of any
Principal Shareholder, except assets having an aggregate fair market value of less than $1,000,000, aggregating for purposes of such computation
all assets sold, leased or exchanged in any series of similar transactions within a twelve-month period.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To liquidate the Fund, the Declaration of Trust
requires the affirmative vote of a majority of the Board of Trustees followed by the affirmative vote of the holders of at least 75% of
the outstanding shares of each affected class or series of the Fund, voting separately as a class or series, unless such liquidation has
been approved by at least 80% of Board of Trustees, in which case &#8220;a majority of the outstanding voting securities&#8221; (as defined
in the 1940 Act) of the Fund shall be required.</p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">For the purposes of calculating &#8220;a majority
of the outstanding voting securities&#8221; under the Declaration of Trust, each class and series of the Fund shall vote together as a
single class, except to the extent required by the 1940 Act or the Declaration of Trust with respect to any class or series of shares.
If a separate vote is required, the applicable proportion of shares of the class or series, voting as a separate class or series, also
will be required. A &#8220;majority of the outstanding voting securities&#8221; means the lesser of (i) 67% or more of the Fund&#8217;s
voting securities present at a meeting, if the holders of more than 50% of the Fund&#8217;s outstanding voting securities are present
or represented by proxy; or (ii) more than 50% of the Fund&#8217;s outstanding voting securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees has determined that provisions
with respect to the Board of Trustees and the shareholder voting requirements described above, which voting requirements are greater than
the minimum requirements under Delaware law or the 1940 Act, are in the best interest of shareholders generally. Reference should be made
to the Declaration of Trust on file with the SEC for the full text of these provisions. See &#8220;Additional Information.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Declaration of Trust contains
provisions relating to forum selection. For example, the Fund&#8217;s Declaration of Trust provides that, unless the Fund consents in
writing to the selection of an alternative forum, any claims, suits, actions or proceedings arising under the Securities Act shall be
exclusively brought in the federal district courts of the United States of America. The designation of exclusive forum may make it more
expensive for a shareholder to bring a suit and may limit a shareholder&#8217;s ability to litigate a claim in a jurisdiction or forum
that may be more convenient and that a shareholder believes is favorable to the shareholder for the claim.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProClosedEndFundStruct"></span>Closed-End Fund
Structure</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Closed-end management investment companies (&#8220;closed-end
funds&#8221;) differ from open-end management investment companies (commonly referred to as &#8220;mutual funds&#8221;) in that closed-end
funds generally list their shares for trading on a securities exchange and do not redeem their shares at the option of the shareholder.
By comparison, mutual funds issue securities redeemable at net asset value at the option of the shareholder and typically engage in a
continuous offering of their shares. Mutual funds are subject to continuous asset in-flows and out-flows that can complicate portfolio
management, whereas closed-end funds generally can stay more fully invested in securities consistent with the closed-end fund&#8217;s
investment objective and policies. In addition, in comparison to open-end funds, closed-end funds have greater flexibility in their ability
to make certain types of investments, including investments in illiquid securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">However, shares of closed-end funds listed for
trading on a securities exchange frequently trade at a discount from net asset value, but in some cases trade at a premium. The market
price may be affected by trading volume of the shares, general market and economic conditions and other factors beyond the control of
the closed-end fund. The foregoing factors may result in the market price of the Common Shares being greater than, less than or equal
to net asset value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund reserves the right to merge or reorganize
with another fund, liquidate or convert into an open-end fund, in each case subject to applicable approvals by shareholders and the Fund&#8217;s
Board of Trustees as required by law and the Fund&#8217;s Governing Documents. The Board of Trustees has reviewed the structure of the
Fund in light of its investment objective and policies and has determined that the closed-end structure is in the best interests of the
shareholders. Investors should assume that it is unlikely that the Board of Trustees would vote to convert the Fund to an open-end management
investment company.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProRepurchaseConversion"></span>Repurchase of
Common Shares; Conversion to Open-End Fund</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Repurchase of Common Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Board of Trustees will review periodically
the trading range and activity of the Fund&#8217;s shares with respect to its net asset value and may take certain actions to seek to
reduce or eliminate any such discount. Such actions may include open market repurchases or tender offers for the Common Shares at net
asset value. There can be no assurance that the Board of Trustees will decide to undertake any of these actions or that, if undertaken,
such actions would result in the Common Shares trading at a price equal to or closer to net asset value per Common Share.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Conversion to Open-End Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To convert the Fund to an open-end management
investment company, the Declaration of Trust requires the favorable vote of a majority of the Board of Trustees followed by the favorable
vote of the holders of at least </p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">75% of the outstanding shares of each affected class or series of shares of the Fund, voting separately
as a class or series, unless such action has been approved by at least 80% of the Board of Trustees, in which case &#8220;a majority of
the outstanding voting securities&#8221; (as defined in the 1940 Act) of the Fund shall be required. A &#8220;majority of the outstanding
voting securities&#8221; means the lesser of (i) 67% or more of the Fund&#8217;s voting securities present at a meeting, if the holders
of more than 50% of the Fund&#8217;s outstanding voting securities are present or represented by proxy; or (ii) more than 50% of the Fund&#8217;s
outstanding voting securities. The foregoing vote would satisfy a separate requirement in the 1940 Act that any conversion of the Fund
to an open-end management investment company be approved by the shareholders. If approved in the foregoing manner, conversion of the Fund
to an open-end management investment company could not occur until 90 days after the shareholders&#8217; meeting at which such conversion
was approved and would also require at least 30 days&#8217; prior notice to all shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the event of conversion, the Common Shares
would cease to be listed on the NYSE or other national securities exchange or market system. If the Fund were converted to an open-end
management investment company, it is likely that new Common Shares would be sold at net asset value plus a sales load. The Board of Trustees
believes, however, that the closed-end structure is desirable, given the Fund&#8217;s investment objective and policies. Investors should
assume, therefore, that it is unlikely that the Board of Trustees would vote to convert the Fund to an open-end management investment
company. Shareholders of an open-end management investment company may require the company to redeem their shares at any time (except
in certain circumstances as authorized by or under the 1940 Act) at their net asset value, less such redemption charge, if any, as might
be in effect at the time of a redemption. In the event of conversion, the Fund would expect to pay all such redemption requests in cash,
but would intend to reserve the right to pay redemption requests in a combination of cash or securities. If such partial payment in securities
were made, investors could incur brokerage costs in converting such securities to cash.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProUSFedIncTax"></span>U.S. Federal
Income Tax Considerations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="background-color: white">The following
discussion is a brief summary of certain U.S. federal income tax considerations affecting the Fund and the ownership and disposition of
the Fund&#8217;s Common Shares. A more complete discussion of the tax rules applicable to the Fund and its Common Shareholders can be
found in the SAI that is incorporated by reference into this Prospectus. Except as otherwise noted, this discussion assumes you are a
taxable U.S. person (as defined for U.S. federal income tax purposes) and that you hold your Common Shares as capital assets for U.S.
federal income tax purposes (generally, assets held for investments). This discussion is based upon current provisions of the Internal
Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations promulgated thereunder and judicial and administrative authorities,
all of which are subject to change or differing interpretations by the courts or the Internal Revenue Service (the &#8220;IRS&#8221;),
possibly with retroactive effect. No attempt is made to present a detailed explanation of all U.S. federal tax concerns affecting the
Fund and its Common Shareholders (including Common Shareholders subject to special treatment under U.S. federal income tax law). No assurance
can be given that the IRS would not assert, or that the court would not sustain, a position contrary to any of the tax aspects set forth
below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The discussion set forth herein does not constitute
tax advice and potential investors are urged to consult their own tax advisers to determine the specific U.S. federal, state, local and
foreign tax consequences to them of investing in the Fund.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of the Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has elected to be treated and intends
to continue to qualify annually as a regulated investment company (&#8220;RIC&#8221;) under Subchapter M of the Code. Accordingly, the
Fund must, among other things, meet certain income, asset diversification and distribution requirements:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(i)</td><td>The Fund must derive in each taxable year at least 90% of its gross income from the following sources: (a) dividends, interest (including
tax-exempt interest), payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities
or foreign currencies, or other income (including gain from options, futures and forward contracts) derived with respect to its business
of investing in such stock, securities or foreign currencies; and (b) net income derived from interests in &#8220;qualified publicly traded
partnerships&#8221; (as defined in the Code). Generally, a qualified publicly traded partnership includes a partnership the interests
of which are traded on an established securities market or readily tradable on a secondary market (or the substantial equivalent thereof)
and that derives less than 90% of its gross income from the items described in (a) above.</td></tr></table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in">(ii)</td><td>The Fund must diversify its holdings so that, at the end of each quarter of each taxable year, (a) at least 50% of the market value
of the Fund&#8217;s total assets is represented by cash and cash items, including receivables, </td></tr></table>
<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"/><td> U.S. government securities, the securities
of other RICs and other securities, with such other securities limited, in respect of any one issuer, to an amount not greater than 5%
of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities of such issuer and (b) not more
than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. government securities and
the securities of other RICs) of (I) any one issuer, (II) any two or more issuers that the Fund controls and that are determined to be
engaged in the same business or similar or related trades or businesses or (III) any one or more &#8220;qualified publicly traded partnerships&#8221;
(as defined in the Code).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As long as the Fund qualifies as a RIC, the Fund
generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its Common Shareholders, provided
that it distributes each taxable year at least the sum of (i) 90% of the Fund&#8217;s investment company taxable income (which includes,
among other items, dividends, interest, the excess of any net short-term capital gain over net long-term capital loss, and other taxable
income, other than any net capital gain (defined below), reduced by deductible expenses) determined without regard to the deduction for
dividends and distributions paid and (ii) 90% of the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest
over certain disallowed deductions). The Fund intends to distribute substantially all of such income each year. The Fund will be subject
to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will either distribute or retain for
reinvestment all or part of its net capital gain (which consists of the excess of its net long-term capital gain over its net short-term
capital loss). If any such gain is retained, the Fund will be subject to a corporate income tax (at regular corporate rates) on such retained
amount. In that event, the Fund may report the retained amount as undistributed capital gain in a notice to its Common Shareholders, each
of whom, if subject to U.S. federal income tax on long-term capital gains, (i) will be required to include in income for U.S. federal
income tax purposes as long-term capital gain its share of such undistributed amounts, (ii) will be entitled to credit its proportionate
share of the tax paid by the Fund against its U.S. federal income tax liability and to claim refunds to the extent that the credit exceeds
such liability and (iii) will increase its basis in its Common Shares by the amount of undistributed capital gain included in such Common
Shareholder&#8217;s gross income net of the tax deemed paid by the shareholder under clause (ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Code imposes a 4% nondeductible excise tax
on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income
(not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss
(adjusted for certain ordinary losses) for a one-year period generally ending on October 31 of the calendar year. In addition, the minimum
amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to reflect any under-distribution
or over-distribution, as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed
any income on which it paid federal income tax in the taxable year ending within the calendar year. While the Fund intends to distribute
any income and capital gain in order to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that amounts
of the Fund&#8217;s taxable income and capital gain will be distributed to entirely avoid the imposition of the excise tax. In that event,
the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain of the Fund&#8217;s investment practices
are subject to special and complex U.S. federal income tax provisions that may, among other things, (i) disallow, suspend or otherwise
limit the allowance of certain losses or deductions, (ii) convert lower taxed long-term capital gains or &#8220;qualified dividend income&#8221;
into higher taxed short-term capital gains or ordinary income, (iii) convert an ordinary loss or a deduction into a capital loss (the
deductibility of which is more limited), (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash, (v)
adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization
of certain complex financial transactions and (vii) produce income that will not be &#8220;qualified&#8221; income for purposes of the
90% gross income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing and character
of distributions to Common Shareholders. The Fund intends to structure and monitor its transactions and may make certain tax elections
and may be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a
RIC (which may adversely affect the net after-tax return to the Fund).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If for any taxable year the Fund does not qualify
as a RIC, all of its taxable income (including its net capital gain) will be subject to tax at regular corporate rates without any deduction
for distributions to Common Shareholders, and such distributions will be taxable to the Common Shareholders as ordinary dividends to the
extent</p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> of the Fund&#8217;s current or accumulated earnings and profits. Provided that certain holding period and other requirements are
met, such dividends, however, would generally be eligible (i) to be treated as qualified dividend income in the case of U.S. Common Shareholders
taxed as individuals and (ii) for the dividends-received deduction in the case of U.S. Common Shareholders taxed as corporations. The
Fund could be required to recognize unrealized gains, pay taxes and make distributions (which could be subject to interest charges) before
requalifying for taxation as a RIC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of Common Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Distributions. </i>Distributions paid to you
by the Fund from its net capital gains, which is the excess of net long-term capital gain over net short-term capital loss, if any, that
the Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable as long-term capital gains, regardless
of how long you have held your Common Shares. All other dividends paid to you by the Fund from its current or accumulated earnings and
profits (including dividends from short-term capital gains) (&#8220;ordinary income dividends&#8221;) are generally subject to tax as
ordinary income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the case of corporate shareholders, properly
reported ordinary income dividends paid by the Fund generally will be eligible for the dividends received deduction to the extent that
the Fund&#8217;s income consists of dividend income from U.S. corporations and certain holding period requirements are satisfied by both
the Fund and the corporate shareholders. In the case of individuals, any properly reported ordinary income dividend that you receive from
the Fund generally will be eligible for taxation at the rates applicable to long-term capital gains to the extent that (i) the ordinary
income dividend is attributable to &#8220;qualified dividend income&#8221; (i.e., generally dividends paid by U.S. corporations and certain
foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements with respect to the
stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements with respect
to your Common Shares. Qualified dividend income eligible for these special rules is not actually treated as capital gains, however, and
thus will not be included in the computation of your net capital gain and generally cannot be used to offset any capital losses. In general,
you may include as qualified dividend income only that portion of the dividends that may be and are so reported by the Fund as qualified
dividend income. Dividend income from &#8220;passive foreign investment companies&#8221; (as defined in the Code) and, in general, dividend
income from REITs is not eligible for the reduced rate for qualified dividend income and is taxed as ordinary income. There can be no
assurance as to what portion of the Fund&#8217;s distributions will qualify for favorable treatment as qualified dividend income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any distributions you receive that are in excess
of the Fund&#8217;s current and accumulated earnings and profits will be treated as a tax-free return of capital to the extent of your
adjusted tax basis in your Common Shares, and thereafter as capital gain from the sale of Common Shares. The amount of any Fund distribution
that is treated as a tax-free return of capital will reduce your adjusted tax basis in your Common Shares, thereby increasing your potential
gain or reducing your potential loss on any subsequent sale or other disposition of your Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Dividends and other taxable distributions are
taxable to you even if they are reinvested in additional Common Shares of the Fund. Dividends and other distributions paid by the Fund
are generally treated as received by you at the time the dividend or distribution is made. If, however, the Fund pays you a dividend in
January that was declared in the previous October, November or December and you were the Common Shareholder of record on a specified date
in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid by the Fund and received
by you on December 31 of the year in which the dividend was declared.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will send you information after the
end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sale of Common Shares. </i>The sale or other
disposition of Common Shares of the Fund will generally result in capital gain or loss to you and will be long-term capital gain or loss
if you have held such Common Shares for more than one year. Any loss upon the sale or other disposition of Common Shares held for six
months or less will be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited
as an undistributed capital gain) by you with respect to such Common Shares. Any loss you recognize on a sale or other disposition of
Common Shares will be disallowed if you acquire other Common Shares (whether through the automatic reinvestment of dividends or otherwise)
within a 61-day period beginning 30 days before and ending 30 days after your sale or exchange of the Common Shares. In such case, your
tax basis in Common Shares acquired will be adjusted to reflect the disallowed loss.</p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Current U.S. federal income tax law taxes both
long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term
capital gain is currently taxed at rates applicable to ordinary income, while long-term capital gain generally is taxed at reduced maximum
rates. The deductibility of capital losses is subject to limitations under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund or your financial intermediary (if any)
will be required to report to you and the IRS annually on Form 1099-B not only the gross proceeds of Common Shares sold but also, for
Common Shares purchased on or after January 1, 2012, their cost basis. You should consult with your tax advisors to determine the appropriate
cost basis method for your tax situation and to obtain more information about the cost basis reporting rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Medicare Tax</i>. Certain U.S. Common Shareholders
who are individuals, estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all
or part of their &#8220;net investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale
or other disposition of the Fund&#8217;s stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Backup Withholding. </i>The Fund may be required
to withhold, for U.S. federal backup withholding tax purposes, a portion of the dividends, distributions and redemption proceeds payable
to non-corporate Common Shareholders who fail to provide the Fund (or its agent) with their correct taxpayer identification number (in
the case of individuals, generally, their social security number) or to make required certifications, or who are otherwise subject to
backup withholding. Backup withholding is not an additional tax and any amount withheld may be refunded or credited against your U.S.
federal income tax liability, if any, provided that you timely furnish the required information to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The foregoing is a general and abbreviated
summary of the provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its
Common Shareholders. These provisions are subject to change by legislative or administrative action, and any such change may be retroactive.
A more complete discussion of the tax rules applicable to the Fund and its Common Shareholders can be found in the SAI that is incorporated
by reference into this Prospectus. Common Shareholders are urged to consult their tax advisers regarding specific questions as to U.S.
federal, state, local and foreign income or other taxes.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProPlanDistributions"></span>Plan of Distribution</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell up to $1,000,000,000 aggregate
initial offering price of Common Shares from time to time under this Prospectus and any related Prospectus Supplement (1) directly to
one or more purchasers; (2) through agents; (3) through underwriters; (4) through dealers; or (5) pursuant to the Plan. Each Prospectus
Supplement relating to an offering of Common Shares will state the terms of the offering, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the names of any agents, underwriters or dealers;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any sales loads or other items constituting underwriters&#8217; compensation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any discounts, commissions, or fees allowed or paid to dealers or agents;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the public offering or purchase price of the offered Common Shares and the net proceeds the Fund will receive from the sale; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any securities exchange on which the offered Common Shares may be listed.</td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Direct Sales</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell Common Shares directly to,
and solicit offers from, institutional investors or others who may be deemed to be underwriters as defined in the Securities Act for any
resales of the securities. In this case, no underwriters or agents would be involved. The Fund may use electronic media, including the
internet, to sell offered securities directly. The Fund will describe the terms of any of those sales in the Prospectus Supplement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">By Agents</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer Common Shares through agents
that the Fund may designate. The Fund will name any agent involved in the offer and sale and describe any commissions payable by the Fund
in the Prospectus Supplement. Unless otherwise indicated in the Prospectus Supplement, the agents will be acting on a best efforts basis
for the period of their appointment.</p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">By Underwriters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer and sell Common Shares from
time to time to one or more underwriters who would purchase the Common Shares as principal for resale to the public, either on a firm
commitment or best efforts basis. If the Fund sells Common Shares to underwriters, the Fund will execute an underwriting agreement with
them at the time of the sale and will name them in the Prospectus Supplement. In connection with these sales, the underwriters may be
deemed to have received compensation from the Fund in the form of underwriting discounts and commissions. The underwriters also may receive
commissions from purchasers of Common Shares for whom they may act as agent. Unless otherwise stated in the Prospectus Supplement, the
underwriters will not be obligated to purchase the Common Shares unless the conditions set forth in the underwriting agreement are satisfied,
and if the underwriters purchase any of the Common Shares, they will be required to purchase all of the offered Common Shares. The underwriters
may sell the offered Common Shares to or through dealers, and those dealers may receive discounts, concessions or commissions from the
underwriters as well as from the purchasers for whom they may act as agent. Any public offering price and any discounts or concessions
allowed or reallowed or paid to dealers may be changed from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Prospectus Supplement so indicates, the
Fund may grant the underwriters an option to purchase additional Common Shares at the public offering price, less the underwriting discounts
and commissions, within 45 days from the date of the Prospectus Supplement, to cover any overallotments.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">By Dealers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer and sell Common Shares from
time to time to one or more dealers who would purchase the securities as principal. The dealers then may resell the offered Common Shares
to the public at fixed or varying prices to be determined by those dealers at the time of resale. The Fund will set forth the names of
the dealers and the terms of the transaction in the Prospectus Supplement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">General Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Agents, underwriters, or dealers participating
in an offering of Common Shares may be deemed to be underwriters, and any discounts and commission received by them and any profit realized
by them on resale of the offered Common Shares for whom they act as agent, may be deemed to be underwriting discounts and commissions
under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may offer to sell securities either
at a fixed price or at prices that may vary, at market prices prevailing at the time of sale, at prices related to prevailing market prices
or at negotiated prices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To facilitate an offering of Common Shares in
an underwritten transaction and in accordance with industry practice, the underwriters may engage in transactions that stabilize, maintain,
or otherwise affect the market price of the Common Shares or any other security. Those transactions may include overallotment, entering
stabilizing bids, effecting syndicate covering transactions, and reclaiming selling concessions allowed to an underwriter or a dealer.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>An overallotment in connection with an offering creates a short position in the common stock for the underwriter&#8217;s own account.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>An underwriter may place a stabilizing bid to purchase the Common Shares for the purpose of pegging, fixing, or maintaining the price
of the Common Shares.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Underwriters may engage in syndicate covering transactions to cover overallotments or to stabilize the price of the Common Shares
by bidding for, and purchasing, the Common Shares or any other securities in the open market in order to reduce a short position created
in connection with the offering.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The managing underwriter may impose a penalty bid on a syndicate member to reclaim a selling concession in connection with an offering
when the Common Shares originally sold by the syndicate member is purchased in syndicate covering transactions or otherwise.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any of these activities may stabilize or maintain
the market price of the Common Shares above independent market levels. The underwriters are not required to engage in these activities,
and may end any of these activities at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any underwriters to whom the offered Common Shares
are sold for offering and sale may make a market in the offered Common Shares, but the underwriters will not be obligated to do so and
may discontinue any market-</p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">making at any time without notice. There can be no assurance that there will be a liquid trading market for
the offered Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under agreements entered into with the Fund,
underwriters and agents may be entitled to indemnification by the Fund against certain civil liabilities, including liabilities under
the Securities Act, or to contribution for payments the underwriters or agents may be required to make.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The underwriters, agents, and their affiliates
may engage in financial or other business transactions with the Fund in the ordinary course of business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to a requirement of the Financial Industry
Regulatory Authority, Inc., or FINRA, the maximum compensation to be received by any FINRA member or independent broker-dealer may not
be greater than eight percent (8%) of the gross proceeds received by the Fund for the sale of any securities being registered pursuant
to SEC Rule 415 under the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The aggregate offering price specified on the
cover of this Prospectus relates to the offering of the Common Shares not yet issued as of the date of this Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent permitted under the 1940 Act and
the rules and regulations promulgated thereunder, the underwriters may from time to time act as a broker or dealer and receive fees in
connection with the execution of portfolio transactions on behalf of the Fund after the underwriters have ceased to be underwriters and,
subject to certain restrictions, each may act as a broker while it is an underwriter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A Prospectus and accompanying Prospectus Supplement
in electronic form may be made available on the websites maintained by underwriters. The underwriters may agree to allocate a number of
Common Shares for sale to their online brokerage account holders. Such allocations of Common Shares for internet distributions will be
made on the same basis as other allocations. In addition, Common Shares may be sold by the underwriters to securities dealers who resell
Common Shares to online brokerage account holders.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Dividend Reinvestment Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may issue and sell Common Shares pursuant
to the Plan.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProCustAdminTransAgDiv"></span>Custodian, Administrator,
Transfer Agent and Dividend Disbursing Agent</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Bank of New York Mellon (&#8220;BNY&#8221;)
acts as the custodian of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement, the custodian holds the
Fund&#8217;s assets in compliance with the 1940 Act. For its services, the custodian receives a monthly fee based upon, among other things, the average value of the total assets of the Fund, plus certain securities transactions. The
Bank of New York Mellon is located at 101 Barclay Street, New York, New York 10286.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left; text-indent: 0.5in"><span style="font-weight: normal; text-transform: none">Computershare
Inc. acts as the Fund&#8217;s dividend disbursing agent, transfer agent and registrar for the Common Shares of the Fund. Computershare
Inc. is located at 250 Royall Street, Canton, MA 02021. Computershare Trust Company, N.A. acts as Plan Agent under the Fund&#8217;s Dividend
Reinvestment Plan. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">MUFG Investor Services (US) LLC (&#8220;MUFG&#8221;),
acts as the Fund&#8217;s administrator. Pursuant to an accounting and administration agreement, MUFG is responsible for providing administrative
services to the Fund, including assisting the Fund with regulatory filings. For these services, the Fund pays MUFG a fee, accrued daily
and paid monthly, at the annual rate equal to 0.0275% of the first $200 million in average daily Managed Assets, 0.0200% of the next $300
million in average daily Managed Assets, 0.0150% of the next $500 million in average daily Managed Assets, and 0.0100% of average daily
Managed Assets above $1 billion, along with an annual fixed fee ranging from $500 to $11,000 for assisting the Fund with certain regulatory
filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">MUFG also acts as fund accounting agent to the
Fund. Pursuant to an accounting and administration agreement, MUFG performs certain accounting services to the Fund. For the services,
the Fund pays MUFG a fee, accrued daily and paid monthly, at the annual rate equal to 0.0300% of the first $200 million in average daily
Managed Assets, 0.0150% of the next $300 million in average daily Managed Assets, 0.0100% of the next $500 million in average daily Managed
Assets, and 0.0075% of average daily Managed Assets above $1 billion, subject to a minimum fee of $50,000 per year, and reimburses MUFG
for certain out-of-pocket expenses.</p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProLegalMatters"></span>Legal Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: left"><span style="font-weight: normal; text-transform: none">Certain
legal matters will be passed on by Dechert LLP as counsel to the Fund in connection with the offering of the Common Shares. If certain
legal matters in connection with an offering of Common Shares are passed upon by counsel for the underwriters of such offering, that counsel
will be named in the Prospectus Supplement related to that offering.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProIndRegPubAcctFirm"></span>Independent Registered
Public Accounting Firm</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Ernst &amp; Young LLP, 1775 Tysons Blvd, Tysons,
Virginia 22102, is the independent registered public accounting firm of the Fund. The Fund&#8217;s independent registered public accounting
firm is expected to render an opinion annually on the financial statements of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProAdditionalInfo"></span>Additional Information</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">This Prospectus constitutes part of a Registration
Statement filed by the Fund with the SEC under the Securities Act and the 1940 Act. This Prospectus omits certain of the information contained
in the Registration Statement, and reference is hereby made to the Registration Statement and related exhibits for further information
with respect to the Fund and the Common Shares offered hereby. Any statements contained herein concerning the provisions of any document
are not necessarily complete, and, in each instance, reference is made to the copy of such document filed as an exhibit to the Registration
Statement or otherwise filed with the SEC. Each such statement is qualified in its entirety by such reference. The complete Registration
Statement, other documents incorporated by reference, and other information the Fund has filed electronically with the SEC, may be obtained
from the SEC upon payment of the fee prescribed by its rules and regulations or free of charge through the SEC website (http://www.sec.gov),
by calling (800) 345-7999, by writing to the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago,
Illinois 60606, or by visiting our website at www.guggenheiminvestments.com.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProPrivacy"></span>Privacy Principles
of the Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is committed to maintaining the privacy
of its shareholders and to safeguarding their non-public personal information. The following information is provided to help you understand
what personal information the Fund collects, how the Fund protects that information and why, in certain cases, the Fund may share information
with select other parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Generally, the Fund does not receive any non-public
personal information relating to its shareholders, although certain non-public personal information of its shareholders may become available
to the Fund. The Fund does not disclose any non-public personal information about its shareholders or former shareholders to anyone, except
as permitted by law or as is necessary in order to service shareholder accounts (for example, to a transfer agent or third party administrator).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund restricts access to non-public personal
information about its shareholders to employees of the Fund&#8217;s Investment Adviser and its delegates and affiliates with a legitimate
business need for the information. The Fund maintains physical, electronic and procedural safeguards designed to protect the non-public
personal information of its shareholders.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center"><span id="ProIncorp"></span>Incorporation
By Reference</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">As noted above, this Prospectus is part of a registration
statement that has been filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221; the information that it files
with the SEC, which means that the Fund can disclose important information to you by referring you to those documents. The information
incorporated by reference is considered to be part of this Prospectus, and later information that the Fund files with the SEC will automatically
update and supersede this information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">The Fund incorporates by reference any future filings
it will make with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended, or pursuant to
Section 30(b)(2) under the 1940 Act, until the Fund has sold all of the offered securities to which this Prospectus, the SAI and any accompanying
Prospectus Supplement relate, or the offering is otherwise terminated. The documents incorporated by reference herein include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Fund&#8217;s SAI, dated November 21, 2025, filed with this Prospectus;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000173/gug88924gof.htm">Fund&#8217;s annual report on Form
N-CSR for the fiscal year ended May 31, 2025</a>, filed with the SEC on August 4, 2025;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000077/cef-def14a.htm">Fund&#8217;s definitive proxy statement
on Schedule 14A, filed with the SEC on February 28, 2025</a>; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000134100407001955/chi551212.htm">description of the Fund&#8217;s common
shares contained in its Registration Statement on Form 8-A</a> (File No. 001-33565), filed with the SEC on June 27, 2007, including any
amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">To obtain copies of these filings, see &#8220;Additional Information.&#8221;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="font-size: 18pt"><b>Guggenheim Strategic
Opportunities Fund</b></span><br/>
<b>__________________________<br/>
Statement of Additional Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Guggenheim Strategic Opportunities Fund
(the &#8220;Fund&#8221;) is a diversified, closed-end management investment company. The Fund&#8217;s investment objective is to
maximize total return through a combination of current income and capital appreciation. The Fund seeks to achieve its investment
objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income Securities&#8221;)
selected from a variety of sectors and credit qualities, including, but not limited to, corporate bonds, loans and loan
participations, structured finance investments, U.S. government and agency securities and sovereign or supranational debt
obligations, mezzanine and preferred securities and convertible securities, and in common stocks, limited liability company
interests, trust certificates and other equity investments (&#8220;Common Equity Securities&#8221;) that the Fund&#8217;s
sub-adviser believes offer attractive yield and/or capital appreciation potential, including employing a strategy of writing
(selling) covered call options and may, from time to time, buy or sell put options on individual Common Equity Securities and, to a
lesser extent, on indices of securities and sectors of securities. The Fund may also invest in asset-backed securities
(&#8220;ABS&#8221;) and mortgage-related securities. These securities may include complex instruments such as collateralized
mortgage obligations, real estate investment trusts (&#8220;REITs&#8221;) (including debt and preferred stock issued by REITs), and
other real estate-related securities. There can be no assurance that the Fund&#8217;s investment objective will be achieved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">This Statement of Additional Information (&#8220;SAI&#8221;)
relating to the offering, from time to time, of up to $1,000,000,000 aggregate initial offering price of the Fund&#8217;s common shares
of beneficial interest, par value $0.01 per share (&#8220;Common Shares&#8221;), in one or more offerings, is not a prospectus, but should
be read in conjunction with the prospectus for the Fund dated November 21, 2025 (the &#8220;Prospectus&#8221;), and any related supplement
to the Prospectus (each, a &#8220;Prospectus Supplement&#8221;). Investors should obtain and read the Prospectus and any related Prospectus
Supplement prior to purchasing Common Shares. A copy of the Prospectus and any related Prospectus Supplement may be obtained without charge,
by calling the Fund at (800) 345-7999.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">You may also obtain a copy of the Prospectus
on the Securities and Exchange Commission&#8217;s (the &#8220;SEC&#8221;) website (http://www.sec.gov) at no charge. The Prospectus and
this SAI omit certain information contained in the Fund&#8217;s registration statement filed with SEC, which is also available on the
SEC&#8217;s website at no charge. Capitalized terms used but not defined herein have the meanings ascribed to them in the Prospectus.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="text-transform: uppercase"><b>Table of
Contents</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><b>Page</b></p>

<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 90%; text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAITheFund">The Fund</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0in; padding-bottom: 0pt">S-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIInvestmentObj">Investment Objective and Policies</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIInvestmentRestrictions">Investment Restrictions</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-17</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIManagementFund">Management of the Fund</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-18</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIPortTransactions">Portfolio Transactions</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIUSFederalIncTaxCons">U.S. Federal Income Tax Considerations</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-30</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIGeneralInfo">General Information</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-37</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIFinancialStatements">Financial Statements</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">S-38</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIAppendixA">Appendix A Description of Securities Ratings</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">A-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-top: 0in; padding-bottom: 0pt; padding-left: 0in"><a href="#SAIAppendixB">Appendix B Guggenheim Partners Investment Management, LLC</a></td>
    <td style="text-align: right; padding-top: 0in; padding-bottom: 0pt">B-1</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0.5in 0 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-size: 10pt">Statement of Additional
Information dated November 21, 2025.</span></p>


<!-- Field: Page; Sequence: 59 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; color: red; text-transform: uppercase; text-indent: 0in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAITheFund"></span>The
Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is a diversified, closed-end management
investment company registered under the Investment Company Act of 1940, as amended (the &#8220;1940 Act&#8221;). The Fund was organized
as a statutory trust on November 13, 2006, pursuant to a Certificate of Trust, and is governed by the laws of the State of Delaware. The
Fund&#8217;s currently outstanding Common Shares are, and the Common Shares offered by the Prospectus will be, subject to notice of issuance,
listed on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the symbol &#8220;GOF.&#8221; The Fund commenced operations on July
27, 2007. Guggenheim Funds Investment Advisors, LLC (the &#8220;Investment Adviser&#8221;) acts as the Fund&#8217;s investment adviser
and is responsible for the management of the Fund. Guggenheim Partners Investment Management LLC acts as the sub-adviser to the Fund (the
&#8220;Sub-Adviser&#8221;) and is responsible for the management of the Fund&#8217;s portfolio securities. References to the &#8220;Adviser&#8221;
or &#8220;Advisers&#8221; may include the Investment Adviser and/or the Sub-Adviser, as applicable.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIInvestmentObj"></span>Investment
Objective and Policies</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Additional Investment Policies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following information supplements the discussion
of the Fund&#8217;s investment objective, policies and techniques that are described in the Prospectus. The Fund may make the following
investments or use the following techniques, among others, some of which are part of its principal investment strategies and some of which
are not. The principal risks of the Fund&#8217;s principal investment strategies are discussed in the Prospectus. The Fund may not buy
all of the types of securities or use all of the investment techniques that are described.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Mortgage-Related Securities. </i>Mortgage-related
securities include structured debt obligations collateralized by pools of commercial or residential mortgages. Pools of mortgage loans
and mortgage-related loans such as mezzanine loans are assembled as securities for sale to investors by various governmental, government-related
and private organizations. Mortgage-related securities include complex instruments such as collateralized mortgage obligations (&#8220;CMOs&#8221;),
stripped mortgage-backed securities, mortgage pass-through securities, interests in real estate mortgage investment conduits (&#8220;REMICs&#8221;),
real estate investment trusts (&#8220;REITs&#8221;), including debt and preferred stock issued by REITs, as well as other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential mortgage-backed
securities (&#8220;RMBS&#8221;) and commercial mortgage-backed securities (&#8220;CMBS&#8221;), including residual interests, issued by
governmental entities and private issuers, including subordinated mortgage-related securities. The Fund may invest in sub-prime mortgages
or mortgage-related securities that are backed by sub-prime mortgages. Certain mortgage-related securities that the Fund may invest in
are described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Mortgage-Backed Securities</span>. The risks
associated with mortgage-backed securities include, but are not limited to: (1) credit risk associated with the performance of the underlying
mortgage properties and of the borrowers owning these properties; (2) adverse changes in economic conditions and circumstances are likely
to have an adverse impact on mortgage-backed securities secured by loans on certain types of commercial properties than on those secured
by loans on residential properties; (3) prepayment risk, which can lead to significant fluctuations in the value of the mortgage-backed
security; (4) extension risk, which may reduce the value of the Fund&#8217;s investment in mortgage-backed securities and may prevent
the Fund from receiving higher interest rates on proceeds reinvested in other instruments; (5) loss of all or part of the premium, if
any, paid; and (6) decline in the market value of the security, whether resulting from changes in interest rates, prepayments on the underlying
mortgage collateral or perceptions of the credit risk associated with the underlying mortgage collateral.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Mortgage-backed securities represent an interest
in a pool of mortgages. When market interest rates decline, more mortgages are refinanced and the securities are paid off earlier than
expected. Prepayments may also occur on a scheduled basis or due to foreclosure. When market interest rates increase, the market values
of mortgage-backed securities decline. At the same time, however, mortgage refinancings and prepayments slow, which lengthens the effective
maturities of these securities. As a result, the negative effect of the rate increase on the market value of mortgage-backed securities
is usually more pronounced than it is for other types of debt securities. In addition, due to increased instability in the credit markets,
the market for some mortgage-backed securities has at times experienced reduced liquidity and greater volatility with respect to the value
of such securities, making it more </p>

<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">difficult to value and sell such securities. The Fund may invest in sub-prime mortgages or mortgage-backed
securities that are backed by sub-prime mortgages.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Moreover, the relationship between prepayments
and interest rates may give some high-yielding mortgage-related and asset-backed securities less potential for growth in value than conventional
bonds with comparable maturities. In addition, in periods of falling interest rates, the rate of prepayments tends to increase. During
such periods, the reinvestment of prepayment proceeds by the Fund will generally be at lower rates than the rates that were carried by
the obligations that have been prepaid. Because of these and other reasons, mortgage-related and asset-backed security&#8217;s total return
and maturity may be difficult to predict precisely. To the extent that the Fund purchases mortgage-related and asset-backed securities
at a premium, prepayments (which may be made without penalty) may result in loss of the Fund&#8217;s principal investment to the extent
of premium paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Residential Mortgage-Backed Securities</span>.
RMBS are securities the payments on which depend (except for rights or other assets designed to assure the servicing or timely distribution
of proceeds to holders of such securities) primarily on the cash flow from residential mortgage loans made to borrowers that are secured
(on a first priority basis or second priority basis, subject to permitted liens, easements and other encumbrances) by residential real
estate (one- to four-family properties) the proceeds of which are used to purchase real estate and purchase or construct dwellings thereon
(or to refinance indebtedness previously so used). Residential mortgage loans are obligations of the borrowers thereunder only and are
not typically insured or guaranteed by any other person or entity. The ability of a borrower to repay a loan secured by residential property
is dependent upon the income or assets of the borrower. A number of factors, including a general economic downturn, acts of God, terrorism,
social unrest and civil disturbances, may impair borrowers&#8217; abilities to repay their loans.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Commercial Mortgage-Backed Securities</span>.
CMBS generally are multi-class debt or pass-through certificates secured or backed by mortgage loans on commercial properties. CMBS generally
are structured to provide protection to the senior class investors against potential losses on the underlying mortgage loans. This protection
generally is provided by having the holders of subordinated classes of securities (&#8220;Subordinated CMBS&#8221;) take the first loss
if there are defaults on the underlying commercial mortgage loans. Other protection, which may benefit all of the classes or particular
classes, may include issuer guarantees, reserve funds, additional Subordinated CMBS, cross-collateralization and over-collateralization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest in Subordinated CMBS issued
or sponsored by commercial banks, savings and loan institutions, mortgage bankers, private mortgage insurance companies and other non-governmental
issuers. Subordinated CMBS have no governmental guarantee and are subordinated in some manner as to the payment of principal and/or interest
to the holders of more senior mortgage-related securities arising out of the same pool of mortgages. The holders of Subordinated CMBS
typically are compensated with a higher stated yield than are the holders of more senior mortgage-related securities. On the other hand,
Subordinated CMBS typically subject the holder to greater risk than senior CMBS and tend to be rated in a lower rating category, and frequently
a substantially lower rating category, than the senior CMBS issued in respect of the same mortgage pool. Subordinated CMBS generally are
likely to be more sensitive to changes in prepayment and interest rates and the market for such securities may be less liquid than is
the case for traditional income securities and senior mortgage-related securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition to the foregoing risks, CMBS are
subject to particular risks, including lack of standardized terms, shorter maturities than residential mortgage loans and payment of all
or substantially all of the principal only at maturity rather than regular amortization of principal. In addition, commercial lending
generally is viewed as exposing the lender to a greater risk of loss than one-to-four family residential lending. Commercial lending,
for example, typically involves larger loans to single borrowers or groups of related borrowers than residential one-to-four family mortgage
loans. In addition, the repayment of loans secured by income producing properties typically is dependent upon the successful operation
of the related real estate project and the cash flow generated therefrom. Net operating income of an income-producing property can be
affected by, among other things: tenant mix, success of tenant businesses, property management decisions, property location and condition,
competition from comparable types of properties, changes in laws that increase operating expense or limit rents that may be charged, any
need to address environmental contamination at the property, the occurrence of any uninsured casualty at the property, changes in national,
regional or local economic conditions and/or specific industry segments, declines in regional or local real estate values, declines in
regional or local rental or occupancy rates, increases in interest rates, real estate tax rates and other operating expenses, change in
governmental rules, regulations and fiscal policies, including environmental legislation, acts of God, terrorism, social unrest and civil
disturbances. Consequently, adverse </p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">changes in economic conditions and circumstances are likely to have an adverse impact on mortgage-related
securities secured by loans on commercial properties than on those secured by loans on residential properties. Economic downturns, rises
in unemployment, tightening lending standards, increased interest and lending rates, developments adverse to the commercial real estate
markets, and other developments that limit or reduce the activities of and demand for commercial retail and office spaces (including continued
or expanded remote working arrangements) as well as increased maintenance or tenant improvement costs and costs to convert properties
for other uses adversely impact these investments. Additional risks may be presented by the type and use of a particular commercial property.
Special risks are presented by hospitals, nursing homes, hospitality properties and certain other property types. Commercial property
values and net operating income are subject to volatility, which may result in net operating income becoming insufficient to cover debt
service on the related mortgage loan. The exercise of remedies and successful realization of liquidation proceeds relating to CMBS may
be highly dependent on the performance of the servicer or special servicer. There may be a limited number of special servicers available,
particularly those that do not have conflicts of interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Government Agency Securities</span>. Mortgage-related
securities issued by the Government National Mortgage Association (&#8220;GNMA&#8221;) include GNMA Mortgage Pass-Through Certificates
(also known as &#8220;Ginnie Maes&#8221;) which are guaranteed as to the timely payment of principal and interest by GNMA and such guarantee
is backed by the full faith and credit of the United States. GNMA is a wholly owned U.S. Government corporation within the Department
of Housing and Urban Development. GNMA certificates also are supported by the authority of GNMA to borrow funds from the U.S. Treasury
to make payments under its guarantee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Government-Related Securities</span>. Mortgage-related
securities issued by the Federal National Mortgage Association (&#8220;FNMA&#8221;) include FNMA Guaranteed Mortgage Pass-Through Certificates
(also known as &#8220;Fannie Maes&#8221;) which are solely the obligations of FNMA and are not backed by or entitled to the full faith
and credit of the United States. FNMA is a privately owned government-sponsored organization. The FNMA guarantees Fannie Maes as to timely
payment of principal and interest. Mortgage-related securities issued by the Federal Home Loan Mortgage Corporation (&#8220;FHLMC&#8221;)
include FHLMC Mortgage Participation Certificates (also known as &#8220;Freddie Macs&#8221; or &#8220;PCs&#8221;). Freddie Macs are not
guaranteed by the United States or by any Federal Home Loan Bank and do not constitute a debt or obligation of the United States or of
any Federal Home Loan Bank. Freddie Macs entitle the holder to timely payment of interest, which FHLMC guarantees. FHLMC guarantees either
ultimate collection or timely payment of all principal payments on the underlying mortgage loans. When FHLMC does not guarantee timely
payment of principal, FHLMC may remit the amount due on account of its guarantee of ultimate payment of principal at any time after default
on an underlying mortgage, but in no event later than one year after it becomes payable. On September 7, 2008, the Federal Housing Finance
Agency (&#8220;FHFA&#8221;), an independent regulatory agency, placed FNMA and FHLMC into conservatorship. At the same time, the U.S.
Treasury agreed to acquire $1 billion of senior preferred stock of each instrumentality and obtained warrants for the purchase of common
stock of each instrumentality. Under these Senior Preferred Stock Purchase Agreements (&#8220;SPAs&#8221;), as amended, the U.S. Treasury
has pledged to provide financial support to Fannie Mae or Freddie Mac in any quarter which the respective entity has a net worth deficit
as defined in the respective SPA, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Also in December 2009, the U.S. Treasury amended
the SPAs to provide Fannie Mae and Freddie Mac with some additional flexibility to meet the requirement to reduce their mortgage portfolios.
The actions of the U.S. Treasury are intended to ensure that Fannie Mae and Freddie Mac maintain a positive net worth and meet their financial
obligations, preventing mandatory triggering of receivership. No assurance can be given that the U.S. Treasury initiatives will be successful.
Other U.S. government securities the Fund may invest in include (but are not limited to) securities issued or guaranteed by the Federal
Housing Administration, Farmers Home Loan Administration, Export-Import Bank of the U.S., Small Business Administration, General Services
Administration, Central Bank for Cooperatives, Federal Farm Credit Banks, Federal Intermediate Credit Banks, Federal Land Banks, Maritime
Administration, Tennessee Valley Authority, District of Columbia Armory Board and Student Loan Marketing Association. Because the U.S.
government is not obligated by law to provide support to an instrumentality it sponsors, the Fund will invest in obligations issued by
such an instrumentality only if the Adviser determines that the credit risk with respect to the instrumentality does not make its securities
unsuitable for investment by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">No assurance can be given as to whether the U.S.
government will continue to support Fannie Mae and Freddie Mac. In addition, the future for Fannie Mae and Freddie Mac remains uncertain.
Congress has considered proposals to reduce the U.S. government&#8217;s role in the mortgage market of both Fannie Mae and Freddie Mac,
including proposals as to whether Fannie Mae and Freddie Mac should be nationalized, privatized, restructured or</p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> eliminated altogether.
Should the federal government adopt any such proposal, the value of the Fund&#8217;s investments in securities issued by Fannie Mae or
Freddie Mac would be impacted. Fannie Mae and Freddie Mac are also the subject of continuing legal actions and investigations which may
have an adverse effect on these entities. In the event that Fannie Mae and Freddie Mac are taken out of conservatorship, it is unclear
whether the U.S. Treasury would continue to enforce its rights or perform its obligations under the SPAs. It is also unclear how the capital
structure of Fannie Mae and Freddie Mac would be constructed post-conservatorship, and what effects, if any, the privatization of the
enterprises will have on their creditworthiness and guarantees of certain MBS. Accordingly, should the FHFA take the enterprises out of
conservatorship, there could be an adverse impact on the value of their securities, which could cause the Fund to lose value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under a letter agreement entered into in January
2021, each enterprise is permitted to retain earnings and raise private capital to enable them to meet the minimum capital requirements
under the FHFA&#8217;s Enterprise Regulatory Capital Framework. The letter agreement also permits each enterprise to develop a plan to
exit conservatorship, but may not do so until all litigation involving the conservatorships is resolved and each enterprise has the minimum
capital required by FHFA&#8217;s rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any controversy or ongoing uncertainty regarding
the status of negotiations in the U.S. Congress to increase the statutory debt ceiling may impact the creditworthiness of the U.S. Government
and the liquidity and/or market value of U.S. government debt securities held by the Fund. If the U.S. Congress is unable to negotiate
an adjustment to the statutory debt ceiling, there is also the risk that the U.S. government may default on payments on certain U.S. government
securities (including U.S. Treasury securities), including those held by the Fund, which could have a material negative impact on the
Fund. These types of situations could result in higher interest rates, lower prices of U.S. Treasury and other U.S. government securities
and could adversely affect the Fund&#8217;s investments, including in other types of debt instruments or other investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Private Entity Securities</span>. These mortgage-related
securities are issued by commercial banks, savings and loan institutions, mortgage bankers, private mortgage insurance companies and other
non-governmental issuers (referred to as &#8220;non-agency&#8221; MBS). Timely payment of principal and interest on mortgage-related securities
backed by pools created by non-governmental issuers often is supported partially by various forms of insurance or guarantees, including
individual loan, title, pool and hazard insurance. The insurance and guarantees are issued by government entities, private insurers and
the mortgage poolers. There can be no assurance that the private insurers or mortgage poolers can or will meet their obligations under
the policies, so that if the issuers default on their obligations the holders of the security could sustain a loss. No insurance or guarantee
covers the Fund or the price of the Fund&#8217;s shares. Mortgage-related securities issued by non-governmental issuers generally offer
a higher rate of interest than government-agency and government-related securities because there are no direct or indirect government
guarantees of payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Non-agency MBS (also referred to as &#8220;private
label&#8221;) are subject to the risk that the value of such securities will decline because, among other things, the securities are not
guaranteed as to principal or interest by the U.S. government or a government sponsored enterprise. Non-agency MBS are not subject to
the same underwriting requirements for underlying mortgages as agency MBS and, as a result, mortgage loans underlying non-agency MBS typically
have less favorable underwriting characteristics (such as credit and default risk and collateral) and a wider range in terms (such as
interest rate, term and borrower characteristics) than agency MBS. Non-agency residential mortgage-backed securities often are issued
in the form of several different tranches. Depending on their respective seniority, individual tranches are subject to increased (and
sometimes different) credit, prepayment and liquidity and valuation risks as compared to other tranches. These securities are often subject
to greater credit, prepayment and liquidity and valuation risks than agency MBS. In addition, these securities may be less readily marketable
as the market for these securities is typically smaller and less liquid than the market for agency MBS, thus these securities may be subject
to greater price fluctuation than agency MBS, especially during periods of weakness or perceived weakness in the mortgage and real estate
sectors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Collateralized Mortgage Obligations</span>. A
CMO is a multi-class bond backed by a pool of mortgage pass-through certificates or mortgage loans. CMOs may be collateralized by (a)
Ginnie Mae, Fannie Mae or Freddie Mac pass-through certificates, (b) unsecuritized mortgage loans insured by the Federal Housing Administration
or guaranteed by the Department of Veterans&#8217; Affairs, (c) unsecuritized conventional mortgages, (d) other mortgage-related securities
or (e) any combination thereof. Each class of CMOs, often referred to as a &#8220;tranche,&#8221; is issued at a specific coupon rate
and has a stated maturity or final distribution date. Principal prepayments on collateral underlying a CMO may cause it to be retired
substantially earlier than the stated maturities or final distribution </p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">dates. The principal and interest on the underlying mortgages may
be allocated among the several classes of a series of a CMO in many ways. One or more tranches of a CMO may have coupon rates which reset
periodically at a specified increment over an index, such as the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) or another rate
(or sometimes more than one index). These floating rate CMOs typically are issued with lifetime caps on the coupon rate thereon. The Fund
also may invest in inverse floating rate CMOs. Inverse floating rate CMOs constitute a tranche of a CMO with a coupon rate that moves
in the reverse direction to an applicable index. Accordingly, the coupon rate thereon will increase as interest rates decrease. Inverse
floating rate CMOs are typically more volatile than fixed or floating rate tranches of CMOs. Many inverse floating rate CMOs have coupons
that move inversely to a multiple of the applicable indexes. The effect of the coupon varying inversely to a multiple of an applicable
index creates a leverage factor. Inverse floaters based on multiples of a stated index are designed to be highly sensitive to changes
in interest rates and can subject the holders thereof to extreme reductions of yield and loss of principal. The markets for inverse floating
rate CMOs with highly leveraged characteristics at times may be very thin. The Fund&#8217;s ability to dispose of its positions in such
securities will depend on the degree of liquidity in the markets for such securities. It is impossible to predict the amount of trading
interest that may exist in such securities, and therefore the future degree of liquidity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Stripped Mortgage-Backed Securities</span>. Stripped
mortgage-backed securities are created by segregating the cash flows from underlying mortgage loans or mortgage securities to create two
or more new securities, each with a specified percentage of the underlying security&#8217;s principal or interest payments. Mortgage securities
may be partially stripped so that each investor class receives some interest and some principal. When securities are completely stripped,
however, all of the interest is distributed to holders of one type of security, known as an interest-only security (&#8220;IO&#8221;),
and all of the principal is distributed to holders of another type of security known as a principal-only security (&#8220;PO&#8221;).
Strips can be created in a pass-through structure or as tranches of a CMO. The yields to maturity on IOs and POs are very sensitive to
the rate of principal payments (including prepayments) on the related underlying mortgage assets. If the underlying mortgage assets experience
greater than anticipated prepayments of principal, the Fund may not fully recoup its initial investment in IOs. Conversely, if the underlying
mortgage assets experience less than anticipated prepayments of principal, the yield on POs could be materially and adversely affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Sub-Prime Mortgages</span>. Sub-prime mortgages
are mortgages rated below &#8220;A&#8221; by S&amp;P, Moody&#8217;s or Fitch. Historically, sub-prime mortgage loans have been made to
borrowers with blemished (or non-existent) credit records, and the borrower is charged a higher interest rate to compensate for the greater
risk of delinquency and the higher costs of loan servicing and collection. Sub-prime mortgages are subject to both state and federal anti-predatory
lending statutes that carry potential liability to secondary market purchasers such as the Fund. Sub-prime mortgages have certain characteristics
and associated risks similar to below investment grade securities, including a higher degree of credit and default risk, and certain characteristics
and associated risks similar to mortgage-backed securities, including prepayment risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Mortgage REITs</span>. Mortgage REITs are pooled
investment vehicles that invest the majority of their assets in real property mortgages and which generally derive income primarily from
interest payments thereon. Mortgage REITs are generally not taxed on income timely distributed to shareholders, provided they comply with
the applicable requirements of the Code. The Fund will indirectly bear its proportionate share of any management and other expenses paid
by mortgage REITs in which it invests. Investing in mortgage REITs involves certain risks related to investing in real property mortgages.
Mortgage REITs are subject to interest rate risk and the risk of default on payment obligations by borrowers. Mortgage REITs whose underlying
assets are mortgages on real properties used by a particular industry, of a particular property type, or concentrated in a particular
geographic region are subject to risks associated with such industry, property type or region. Real property mortgages may be relatively
illiquid, limiting the ability of mortgage REITs to vary their portfolios promptly in response to changes in economic or other conditions.
Mortgage REITs may have limited financial resources, their securities may trade infrequently and in limited volume, and they may be subject
to more abrupt or erratic price movements than securities of larger or more broadly based companies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Other Mortgage-Related Securities</span>. Other
mortgage-related securities include securities other than those described above that directly or indirectly represent a participation
in, or are secured by and payable from, mortgage loans on real property, including CMO residuals. Other mortgage-related securities may
be equity or debt securities issued by agencies or instrumentalities of the U.S. Government or by private originators of, or investors
in, mortgage loans, including savings and loan associations, homebuilders, mortgage banks, commercial banks, investment banks, partnerships,
trusts and special purpose entities of the foregoing.</p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Loans. </i>The Fund may invest a portion of
its assets in loans directly, loan participations and other direct claims against a borrower. The Sub-Adviser believes corporate loans
to be high-yield debt instruments if the issuer has outstanding debt securities rated below-investment grade or has no rated securities.
The corporate loans in which the Fund invests primarily consist of direct obligations of a borrower and may include debtor in possession
financings pursuant to Chapter 11 of the U.S. Bankruptcy Code, obligations of a borrower issued in connection with a restructuring pursuant
to Chapter 11 of the U.S. Bankruptcy Code, leveraged buy-out loans, leveraged recapitalization loans, receivables purchase facilities,
and privately placed notes. The Fund may invest in a corporate loan at origination as a co-lender or by acquiring in the secondary market
participations in, assignments of or novations of a corporate loan. By purchasing a participation, the Fund acquires some or all of the
interest of a bank or other lending institution in a loan to a corporate or government borrower. The participations typically will result
in the Fund having a contractual relationship only with the lender, not the borrower. The Fund will have the right to receive payments
of principal, interest and any fees to which it is entitled only from the lender selling the participation and only upon receipt by the
lender of the payments from the borrower. Many such loans are secured, although some may be unsecured. Such loans may be in default at
the time of purchase. Loans that are fully secured offer the Fund more protection than an unsecured loan in the event of non-payment of
scheduled interest or principal. However, there is no assurance that the liquidation of collateral from a secured loan would satisfy the
corporate borrower&#8217;s obligation, or that the collateral can be liquidated. The Fund may have limited rights to exercise remedies
against collateral or against an obligor when payments are delayed or missed. Direct debt instruments may involve a risk of loss in case
of default or insolvency of the borrower and may offer less legal protection to the Fund in the event of fraud or misrepresentation. In
addition, loan participations involve a risk of insolvency of the lending bank or other financial intermediary. The markets in loans are
not regulated by federal securities laws or the SEC. As in the case of other high-yield investments, such corporate loans may be rated
in the lower rating categories of the established rating services (such as &#8220;Ba&#8221; or lower by Moody&#8217;s or &#8220;BB&#8221;
or lower by S&amp;P), or may be unrated investments determined to be of comparable quality by the Sub-Adviser. As in the case of other
high-yield investments, such corporate loans can be expected to provide higher yields than lower yielding, higher rated fixed-income securities,
but may be subject to greater risk of loss of principal and income. There are, however, some significant differences between corporate
loans and high-yield bonds. Corporate loan obligations are frequently secured by pledges of liens and security interests in the assets
of the borrower, and the holders of corporate loans are frequently the beneficiaries of debt service subordination provisions imposed
on the borrower&#8217;s bondholders. These arrangements are designed to give corporate loan investors preferential treatment over high-yield
investors in the event of deterioration in the credit quality of the issuer. Even when these arrangements exist, however, there can be
no assurance that the borrowers of the corporate loans will repay principal and/or pay interest in full. The Fund&#8217;s interest in
a particular loan and/or in particular collateral securing a loan may be subordinate to the interests of other creditors of the obligor,
which leads to the risk of subordination to other creditors. Corporate loans generally bear interest at rates set at a margin above a
generally recognized base lending rate that may fluctuate on a day-to-day basis, in the case of the prime rate of a U.S. bank, or which
may be adjusted on set dates, typically 30 days but generally not more than one year. Consequently, the value of corporate loans held
by the Fund may be expected to fluctuate significantly less than the value of other fixed rate high-yield instruments as a result of changes
in the interest rate environment; however, the secondary dealer market for certain corporate loans may not be as well developed as the
secondary dealer market for high-yield bonds and, therefore, presents increased market risk relating to liquidity and pricing concerns.
Investments in loans can also be difficult to value accurately because of, among other factors, limited public information regarding the
loan or the borrowers. Risks associated with investments in loans are increased if the loans are secured by a single asset.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Loans may offer a fixed rate or floating rate
of interest. Loans may decline in value if their interest rates do not rise as much or as fast as interest rates in general. For example,
the interest rates on floating rate loans typically adjust only periodically and therefore the interest rate payable under such loans
may significantly trail market interest rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Mezzanine Investments. </i>The Fund may invest
in certain lower grade securities known as &#8220;Mezzanine Investments,&#8221; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.</p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In connection with its purchase of Mezzanine
Investments, the Fund may participate in rights offerings and may purchase warrants, which are privileges issued by corporations enabling
the owners to subscribe and purchase a specified number of shares of the corporation at a specified price during a specified period of
time. Subscription rights normally have a short life span to expiration. The purchase of rights or warrants involves the risk that the
Fund could lose the purchase value of a right or warrant if the right to subscribe to additional shares is not exercised prior to the
rights&#8217; and warrants&#8217; expiration. Also, the purchase of rights and/or warrants involves risks such as that the effective price
paid for the right and/or warrant added to the subscription price of the related security may exceed the value of the subscribed security&#8217;s
market price such as when there is no movement in the level of the underlying security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Short Sales. </i>The Fund is authorized to
make short sales of securities. A short sale is a transaction in which the Fund sells a security it does not own in anticipation that
the market price of that security will decline. To the extent the Fund engages in short sales, the Fund will not make a short sale, if,
after giving effect to such sale, the market value of all securities sold short exceeds 25% of the value of its total assets. Also, the
market value of the securities sold short of any one issuer will not exceed either 10% of the Fund&#8217;s total assets or 5% of such
issuer&#8217;s voting securities. The Fund may also make short sales &#8220;against the box&#8221; without respect to such limitations.
In this type of short sale, at the time of the sale, the Fund owns, or has the immediate and unconditional right to acquire at no additional
cost, the identical security. If the price of the security sold short increases between the time of the short sale and the time the Fund
replaces the borrowed security, the Fund will incur a loss; conversely, if the price declines, the Fund will realize a capital gain. Any
gain will be decreased, and any loss will be increased, by the transaction costs incurred by the Fund, including the costs associated
with providing collateral to the broker-dealer (usually cash and liquid securities) and the maintenance of collateral with its custodian.
Although the Fund&#8217;s gain is limited to the price at which it sold the security short, its potential loss is theoretically unlimited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As discussed in more detail below, an SEC rule
related to the use of derivatives, short sales, reverse repurchase agreements and certain other transactions by registered investment
companies regulates and imposes certain limits on such transactions. (See &#8220;Legislation and Regulation Risk Related to Derivatives
and Certain Other Instruments.&#8221;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Securities Subject To Reorganization. </i>The
Fund may invest in securities of companies for which a tender or exchange offer has been made or announced and in securities of companies
for which a merger, consolidation, liquidation or reorganization proposal has been announced if, in the judgment of the Adviser, there
is a reasonable prospect of high total return significantly greater than the brokerage and other transaction expenses involved. In general,
securities which are the subject of such an offer or proposal sell at a premium to their historic market price immediately prior to the
announcement of the offer or may also discount what the stated or appraised value of the security would be if the contemplated transaction
were approved or consummated. Such investments may be advantageous when the discount significantly overstates the risk of the contingencies
involved; significantly undervalues the securities, assets or cash to be received by shareholders of the prospective portfolio company
as a result of the contemplated transaction; or fails adequately to recognize the possibility that the offer or proposal may be replaced
or superseded by an offer or proposal of greater value. The evaluation of such contingencies requires unusually broad knowledge and experience
on the part of the Sub-Adviser which must appraise not only the value of the issuer and its component businesses as well as the assets
or securities to be received as a result of the contemplated transaction but also the financial resources and business motivation of the
offer and/or the dynamics and business climate when the offer or proposal is in process. Since such investments are ordinarily short-term
in nature, they will tend to increase the turnover ratio of the Fund, thereby increasing its brokerage and other transaction expenses.
The Sub-Adviser intends to select investments of the type described which, in its view, have a reasonable prospect of capital appreciation
which is significant in relation to both the risk involved and the potential of available alternative investments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Special Purpose Acquisition Companies. </i>&#8212;The
Fund may invest in stock, warrants, rights and other securities of special purpose acquisition companies (&#8220;SPACs&#8221;) or similar
special purpose entities in a private placement transaction or as part of a public offering. A SPAC, sometimes referred to as &#8220;blank
check company,&#8221; is a private or publicly traded company that raises investment capital for the purpose of acquiring or merging with
an existing company. The shares of a SPAC are typically issued in &#8220;units&#8221; that include one share of common stock and one right
or warrant (or partial right or warrant) conveying the right to purchase additional shares of common stock. At a specified time, the rights
and warrants may be separated from the common stock at the election of the holder, after which time each security typically is freely
tradeable. Private companies can combine with a SPAC to go public by taking the SPAC&#8217;s place on an exchange as an alternative to
making an initial public offering.</p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As an alternative to obtaining a public listing
through a traditional IPO, SPAC investments carry many of the same risks as investments in IPO securities. These may include, but are
not limited to, erratic price movements, greater risk of loss, lack of information about the issuer, limited operating history and liquidity,
and little public or no trading history, and higher transaction costs. Because of the price volatility of these investments, the Fund
may hold a SPAC for a short period of time. This may increase the turnover of the Fund&#8217;s portfolio and may lead to increased expenses
to the Fund, such as commissions and transaction costs, which decrease the value of investments and may result in additional taxable gains
for the Fund and adversely affect the Fund&#8217;s performance. The Fund may not be able to invest in SPACs, or invest to the extent desired,
because, for example, only a small portion (if any) of the securities being offered in a SPAC may be made available to the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Investments in SPACs also have risks peculiar
to the SPAC structure and investment process. Until an acquisition or merger is completed, a SPAC generally invests its assets, less a
portion retained to cover expenses, in U.S. government securities, money market securities and cash and does not typically pay dividends
in respect of its common stock. To the extent a SPAC is invested in cash or similar securities, this may impact the Fund&#8217;s ability
to meet its investment objective. SPAC shareholders may not approve any proposed acquisition or merger, or an acquisition or merger, once
effected, may prove unsuccessful. If an acquisition or merger is not completed within a pre-established period (typically, two years),
the remainder of the funds invested in the SPAC are returned to its shareholders unless shareholders approve alternative options. While
a SPAC investor may receive both stock in the SPAC, as well as warrants or other rights at no marginal cost, those warrants or other rights
may expire worthless or may be repurchased or retired by the SPAC at an unfavorable price. The Fund may also be delayed in receiving any
redemption or liquidation proceeds from a SPAC to which it is entitled. An investment in a SPAC is typically subject to a higher risk
of dilution by additional later offerings of interests in the SPAC or by other investors exercising existing rights to purchase shares
of the SPAC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">SPAC investments are also subject to the risk
that a significant portion of the funds raised by the SPAC may be expended during the search for a target acquisition or merger. Because
SPACs only business is to seek acquisitions, the value of their securities is particularly dependent on the ability of the SPAC&#8217;s
management to identify and complete a profitable acquisition or merger target. Among other conflicts of interest, the economic interests
of the management, directors, officers and related parties of a SPAC can differ from the economic interests of public shareholders, which
may lead to conflicts as they evaluate, negotiate and recommend business combination transactions to shareholders. For example, since
the sponsor, directors and officers of a SPAC may directly or indirectly own interests in a SPAC, the sponsor, directors and officers
may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate
a business combination. This risk may become more acute as the deadline for the completion of a business combination nears. In addition,
the requirement that a SPAC complete a business combination within a prescribed time frame may give potential target businesses leverage
over the SPAC in negotiating a business combination, and may limit the time the SPAC has in which to conduct due diligence on potential
business combination targets, which could undermine the SPAC&#8217;s ability to complete a business combination on terms that would produce
value for its shareholders. Some SPACs pursue acquisitions and mergers only within certain market sectors or regions, which can increase
the volatility of their prices. Conversely, other SPACs may invest without such limitations, in which case management may have limited
experience or knowledge of the market sector or region in which the transaction is contemplated. Moreover, interests in SPACs may be illiquid
and/or be subject to restrictions on resale, which may remain for an extended time, and may only be traded in the over-the-counter market.
If there is no market for some interests in a SPAC, or only a thinly traded market, the Fund may not be able to sell its interest, or
may be able to sell its interest only at a price below what the Fund believes is the SPAC interest&#8217;s value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Warrants and Rights. </i>The Fund may invest
in warrants or rights (including those acquired in units or attached to other securities) that entitle the holder to buy equity securities
at a specific price for a specific period of time but will do so only if such equity securities are deemed appropriate by the Sub-Adviser
for inclusion in the Fund&#8217;s portfolio.</p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Availability
and Quality of Data&#8212;</i>The Sub-Adviser faces the general risk regarding the availability and quality of information
concerning a particular asset or investment, and employs a variety of policies, practices and methodologies designed to minimize
that risk. This is particularly relevant in fixed income strategies. For example, there is less readily available and reliable
information about most bank loans than is the case for many other types of instruments, including listed securities. Another example
is the consideration of Environmental, Social, and Governance (&#8220;ESG&#8221;) criteria where the Sub-Adviser believes it could
have a material impact on an investment&#8217;s return or issuer&#8217;s financial performance (though, for avoidance of doubt, the
Sub-Adviser does not offer any ESG products). Similar to the Sub-Adviser&#8217;s ability to evaluate traditional factors in making
investment decisions, the ability for the Sub-Adviser to identify and evaluate ESG characteristics and risks, or to engage with an
issuer, is limited to the availability and quality of information on an asset or issuer. In some cases, the Sub-Adviser may decline
to consider ESG criteria in an investment decision due to the unavailability of information on an issuer, or the quality of that
information. In addition, the Sub-Adviser often uses data and insights from third-party research to provide additional input in the
analysis of ESG-related criteria. Third-party information and data will, from time to time, be incomplete, inaccurate or
unavailable. As a result, there is a risk that the Sub-Adviser could incorrectly assess the ESG criteria or risks associated with a
particular asset or issuer. Additionally, the Sub-Adviser expects from time to time to directly engage with certain corporate credit
issuers by requesting improved issuer disclosure relating to ESG factors, as well as discussing potential opportunities to improve
various ESG metrics and other related topics. Direct engagement will occur with only a minority of portfolio investments and issuers
the Sub-Adviser considers for investment and will depend on a variety of considerations, including the materiality of ESG criteria
to the specific issuer or sector and the size of the Sub-Adviser client investments in the issuer. There can be no assurance that
the Sub-Adviser&#8217;s engagement efforts will be successful or provide benefits to clients. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">The application
of ESG criteria and risk factors to portfolio investments (if any) could result in one or more assets or issuers being excluded from the
Fund, which could have an adverse effect on the performance of the Fund. Additionally, in some circumstances a client mandate or applicable
regulations can cause the Sub-Adviser to restrict specific investments based on particular ESG characteristics. The Sub-Adviser also reserves
the right, in the future, to implement restrictions or prohibitions on investments within certain industries for all or a sub-set of all
client accounts which could be based on particular ESG criteria or other relevant factors. As a result of any of the aforementioned circumstances,
clients may be limited as to available investments, which could hinder performance when compared to investments with no such restrictions.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Derivative Instruments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Swaps. </i>A swap is an agreement that obligates
two parties to exchange a series of cash flows at specified intervals based upon or calculated by reference to changes in specified prices
or rates for a specified amount of an underlying asset. The Fund may enter in to cleared and exchange-traded swaps (where applicable)
and bilaterally-traded OTC swaps. When utilizing OTC swaps, the Fund bears the risk of loss of the amount expected to be received under
a swap agreement in the event of the default or bankruptcy of a swap agreement counterparty or if the underlying asset declines in value.
Certain standardized swaps are subject to mandatory central clearing and are executed on a multi-lateral or other trade facility platform,
such as a registered exchange. There is limited counterparty credit risk with respect to centrally-cleared swaps as the transaction is
facilitated through a central clearinghouse, much like exchange-traded futures contracts. If the Fund utilizes centrally-cleared swaps,
the exchange bears the risk of loss resulting from a counterparty not being able to pay. There is no guarantee that the Fund could eliminate
its exposure under an outstanding swap agreement by entering into an offsetting swap agreement with the same or another party. Swap contracts
may be purchased or sold to obtain investment exposure and/or to hedge against fluctuations in securities prices, currencies, interest
rates or market conditions, to change the duration of the overall portfolio or to mitigate default risk. In a standard &#8220;swap&#8221;
transaction, two parties agree to exchange the returns (or differentials in rates of return) on different currencies, securities, baskets
of currencies or securities, indices or other instruments, which returns are calculated with respect to a &#8220;notional value&#8221;
(i.e<i>., </i>the designated reference amount of exposure to the underlying instruments). The Fund intends to enter into swaps primarily
on a net basis (i.e., the two payment streams are netted out), with the Fund receiving or paying, as the case may be, only the net amount
of the payments. The Fund may use swaps for risk management purposes and as a speculative investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser generally requires counterparties
to have a minimum credit rating of A3 from Moody&#8217;s Investors Service (or comparable rating from another rating agency) and monitors
such rating on an on-going basis. If the other party to a swap contract defaults, the Fund&#8217;s risk of loss will consist of the net
amount of payments that </p>

<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">the Fund is contractually entitled to receive. Under such circumstances, the Fund will have contractual remedies
pursuant to the agreements related to the transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Interest rate swaps</span>. Interest rate swaps involve the
exchange by the Fund with another party of respective commitments to pay or receive interest (e.g<i>.</i>, an exchange of fixed rate payments
for floating rate payments).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Total return swaps</span>. Total return swaps are contracts
in which one party agrees to make payments of the total return from the designated underlying asset(s), which may include securities,
baskets of securities, or securities indices, during the specified period, in return for receiving payments equal to a fixed or floating
rate of interest or the total return from the other designated underlying asset(s).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Currency swaps</span>. Currency swaps involve the exchange
of the two parties&#8217; respective commitments to pay or receive fluctuations with respect to a notional amount of two different currencies
(e.g., an exchange of payments with respect to fluctuations in the value of the U.S. dollar relative to the Japanese yen).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Credit default swaps</span>. The Fund may be either the buyer
or seller in a credit default swap transaction. The &#8220;buyer&#8221; in a credit default contract is obligated to pay the &#8220;seller&#8221;
a periodic stream of payments over the term of the contract provided that no specified credit event with respect to a reference issuer
has occurred. When the Fund acts as a seller of a credit default swap agreement with respect to a debt security, it is subject to the
risk that an adverse credit event may occur with respect to the issuer of the debt security and the Fund may be required to pay the buyer
the full notional value of the debt security under the swap net of any amounts owed to the Fund by the buyer under the swap (such as the
buyer&#8217;s obligation to deliver the debt security to the Fund). As a result, the Fund bears the entire risk of loss due to a decline
in value of a referenced debt security on a credit default swap it has sold if there is a credit event with respect to the issuer of the
security. If the Fund is a buyer of a credit default swap and no credit event occurs, the Fund may recover nothing if the swap is held
through its termination date. However, if a credit event occurs, the buyer generally may elect to receive the full notional value of the
swap in exchange for an equal face amount of deliverable obligations of the reference entity whose value may have significantly decreased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The use of interest rate, total return, currency,
credit default and other swaps is a highly specialized activity which involves investment techniques and risks different from those associated
with ordinary portfolio securities transactions. If the Sub-Adviser is incorrect in its forecasts of market values, interest rates and
other applicable factors, the investment performance of the Fund would be unfavorably affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Credit-Linked Notes. </i>The Fund may invest
in credit-linked notes (&#8220;CLN&#8221;) for risk management purposes, including diversification. A CLN may be viewed as a derivative
instrument. It is a synthetic obligation between two or more parties where the payment of principal and/or interest is based on the performance
of some obligation (a reference obligation). In addition to the credit risk of the reference obligations and interest rate risk, the buyer/seller
of the CLN is subject to counterparty risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Forward Foreign Currency Exchange Contracts.</i>
A forward foreign currency exchange contract is an agreement between two parties to exchange two designated currencies at a specific time
in the future. Certain types of contracts may be cash settled, in an amount equal to the change in exchange rates during the term of the
contract. The contracts can be used to hedge or manage exposure to foreign currency risks with portfolio investments or to gain exposure
to foreign currencies. The market value of a forward foreign currency exchange contract changes with fluctuations in foreign currency
exchange rates. Furthermore, the Fund may be exposed to risk if the counterparties cannot meet the contract terms or if the currency value
changes unfavorably as compared to the U.S. dollar.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Futures and Options on Futures. </i>The Fund
may purchase and sell various kinds of financial futures contracts (including, but not limited to, futures on rates such as SOFR, securities,
indices, currencies and other investments) and options thereon to obtain investment exposure and/or to seek to hedge against changes in
interest rates or for other risk management purposes. Futures contracts may be based on various securities and securities indices. Such
transactions involve a risk of loss or depreciation due to adverse changes in prices of the reference securities or indices, and such
losses may exceed the Fund&#8217;s initial investment in these contracts. The Fund will only purchase or sell futures contracts or related
options in compliance with the rules of the Commodity Futures Trading Commission. Transactions in financial futures and options on futures
involve certain costs. There can be no assurance that the Fund&#8217;s use of futures contracts will be advantageous. Financial covenants
related to future Fund borrowings may limit use of these transactions.</p>

<!-- Field: Page; Sequence: 69; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Options. </i>The Fund may purchase or sell
(i.e<i>.</i>, write) options on securities and securities indices or on currencies, which options are listed on a national securities
exchange or in the OTC market, as a means of achieving additional return or of hedging the value of the Fund&#8217;s portfolio.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may purchase or write (sell) exchange
traded and OTC options. Writing call options involves giving third parties the right to buy securities from the Fund for a fixed price
at a future date and writing put options involves giving third parties the right to sell securities to the Fund for a fixed price at a
future date. Buying an options contract gives the Fund the right to purchase securities from third parties or gives the Fund the right
to sell securities to third parties for a fixed price at a future date. The number of call options the Fund can write is limited by the
amount of Fund assets that can cover such options, and further limited by the fact that call options normally represent 100 share lots
of the underlying common stock. In addition to options on individual securities, the Fund may buy and sell put and call options on currencies,
baskets of securities or currencies, indices and other instruments. Options bought or sold by the Fund may be &#8220;cash settled,&#8221;
meaning that the purchaser of the option has the right to receive a cash payment from the writer of the option to the extent that the
value of the underlying position rises above (in the case of a call) or falls below (in the case of a put) the exercise price of the option.
There can be no assurance that the Fund&#8217;s use of options will be successful.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the case of a call option on a common stock
or other security, the option is &#8220;covered&#8221; if the Fund owns the security or instrument underlying the call or has an absolute
and immediate right to acquire that security or instrument without additional cash consideration (or, if additional cash consideration
is required, cash or other assets determined to be liquid by the Investment Adviser (in accordance with procedures established by the
board of trustees of the Fund (the &#8220;Board of Trustees&#8221; or the &#8220;Board&#8221;)) in such amount are segregated by the Fund&#8217;s
custodian) upon conversion or exchange of other securities held by the Fund. A call option is also covered if the Fund holds a call on
the same security as the call written where the exercise price of the call held is (i) equal to or less than the exercise price of the
call written, or (ii) greater than the exercise price of the call written, provided the difference is maintained by the Fund in segregated
assets determined to be liquid by the Investment Adviser as described above. A written put option on a security is &#8220;covered&#8221;
if the Fund segregates assets determined to be liquid by the Investment Adviser as described above equal to the exercise price. A put
option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held is (i)
equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided the
difference is maintained by the Fund in segregated assets determined to be liquid by the Investment Adviser as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Fund has written an option, it may terminate
its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option
previously written. However, once the Fund has been assigned an exercise notice, the Fund will be unable to effect a closing purchase
transaction. Similarly, if the Fund is the holder of an option it may liquidate its position by effecting a closing sale transaction.
This is accomplished by selling an option of the same series as the option previously purchased. There can be no assurance that either
a closing purchase or sale transaction can be effected when the Fund so desires.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the Fund writes covered call
options, the Fund forgoes, during the option&#8217;s life, the opportunity to profit from increases in the market value of the security
<span style="background-color: white">or instrument</span> covering the call option above the sum of the premium and the strike price
of the call, but has retained the risk of loss should the price of the underlying security decline. The writer of an option has no control
over the time when it may be required to fulfill its obligation as a writer of the option. Once an option writer has received an exercise
notice, it cannot effect a closing purchase transaction in order to terminate its obligation under the option and must deliver the underlying
security <span style="background-color: white">or instrument</span> at the exercise price. Thus, the use of options may require the Fund
to sell portfolio securities at inopportune times or for prices other than current market values, may limit the amount of appreciation
the Fund can realize on an investment or may cause the Fund to hold a security that it might otherwise sell.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will not write &#8220;naked&#8221; or
uncovered call options, except in connection with the Fund&#8217;s Debt Overlay Strategy. The Fund&#8217;s options transactions will be
subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which such options are traded
(if exchange-traded). These limitations govern the maximum number of options in each class which may be written or purchased by a single
investor or group of investors acting in concert, regardless of whether the options are written or purchased on the same or different
exchanges, boards of trade or other trading facilities or are held or written in one or more accounts or through one or more brokers.
Thus, the number of options which the Fund may write or purchase may be affected by options written or purchased by other investment advisory
clients of the Investment Adviser. An exchange, board </p>

<!-- Field: Page; Sequence: 70; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">of trade or other trading facility may order the liquidation of positions found
to be in excess of these limits, and it may impose certain other sanctions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the Fund writes covered put
options, the Fund will bear the risk of loss if the value of the underlying stock declines below the exercise price. If the option is
exercised, the Fund could incur a loss if it is required to purchase the stock underlying the put option at a price greater than the market
price of the stock at the time of exercise. While the Fund&#8217;s potential gain in writing a covered put option is limited to the interest
earned on the liquid assets securing the put option plus the premium received from the purchaser of the put option, the Fund risks a loss
equal to the entire value of the stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will realize a profit from a closing
transaction if the price of the transaction is less than the premium received from writing the option or is more than the premium paid
to purchase the option; the Fund will realize a loss from a closing transaction if the price of the transaction is more than the premium
received from writing the option or is less than the premium paid to purchase the option. Since call option prices generally reflect increases
in the price of the underlying security or currency, any loss resulting from the repurchase of a call option may also be wholly or partially
offset by unrealized appreciation of the underlying security or currency. Other principal factors affecting the market value of a put
or a call option include supply and demand, interest rates, the current market price and price volatility of the underlying security or
currency and the time remaining until the expiration date. Gains and losses on investments in options depend, in part, on the ability
of the Adviser to correctly predict the effect of these factors. The use of options cannot serve as a complete hedge since the price movement
of securities underlying the options will not necessarily follow the price movements of the portfolio securities subject to the hedge.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">There are several risks associated with transactions
in options on securities. For example, there are significant differences between the securities and options markets that could result
in an imperfect correlation between these markets, causing a given transaction not to achieve its objectives. A decision as to whether,
when and how to use options involves the exercise of skill and judgment, and even a well-conceived transaction may be unsuccessful to
some degree because of market behavior or unexpected events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">There can be no assurance that a liquid market
will exist when the Fund seeks to close out an option position. Reasons for the absence of a liquid secondary market on an exchange include
the following: (i) there may be insufficient trading interest in certain options; (ii) restrictions may be imposed by an exchange on opening
transactions or closing transactions or both; (iii) trading halts, suspensions or other restrictions may be imposed with respect to particular
classes or series of options; (iv) unusual or unforeseen circumstances may interrupt normal operations on an exchange; (v) the facilities
of an exchange or the Options Clearing Corporation (the &#8220;OCC&#8221;) may not at all times be adequate to handle current trading
volume; or (vi) one or more exchanges could, for economic or other reasons, decide or be compelled at some future date to discontinue
the trading of options (or a particular class or series of options). If trading were discontinued, the secondary market on that exchange
(or in that class or series of options) would cease to exist. However, outstanding options on that exchange that had been issued by the
OCC as a result of trades on that exchange would continue to be exercisable in accordance with their terms. The market value of an option
also may be adversely affected if the market for the option is reduced or becomes less liquid. Additionally, the market for an option
may be impacted by the availability of additional expiry cycles, which may lead trading volume into contracts closer to expiration, including
zero days to expiration contracts ("0DTE" contracts). 0DTE contracts may involve substantially greater volatility than other
options contracts. The Fund&#8217;s ability to terminate OTC options is more limited than with exchange-traded options and may involve
the risk that broker-dealers participating in such transactions will not fulfill their obligations. If the Fund were unable to close out
a covered call option that it had written on a security, it would not be able to sell the underlying security unless the option expired
without exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The hours of trading for options may not conform
to the hours during which the underlying securities are traded. To the extent that the options markets close before the markets for the
underlying securities, significant price and rate movements can take place in the underlying markets that cannot be reflected in the options
markets. Call options are marked-to-market daily and their value will be affected by changes in the value of and dividend rates of the
underlying common stocks, an increase in interest rates, changes in the actual or perceived volatility of the stock market and the underlying
common stocks and the remaining time to the options&#8217; expiration. Additionally, the exercise price of an option may be adjusted downward
before the option&#8217;s expiration as a result of the occurrence of certain corporate events affecting the underlying equity security,
such as extraordinary dividends, stock splits, </p>

<!-- Field: Page; Sequence: 71; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">merger or other extraordinary distributions or events. A reduction in the exercise price
of an option would reduce the Fund&#8217;s capital appreciation potential on the underlying security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the Fund purchases options,
the Fund will be subject to the following additional risks. If a put or call option purchased by the Fund is not sold when it has remaining
value, and if the market price of the underlying security remains equal to or greater than the exercise price (in the case of a put),
or remains less than or equal to the exercise price (in the case of a call), the Fund will lose its entire investment in the option. Also,
where a put or call option on a particular security is purchased to hedge against price movements in a related security, the price of
the put or call option may move more or less than the price of the related security. If restrictions on exercise were imposed, the Fund
might be unable to exercise an option it had purchased. If the Fund were unable to close out an option that it had purchased on a security,
it would have to exercise the option in order to realize any profit or the option may expire worthless.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An option position may be closed out only on
an exchange that provides a secondary market for an option of the same series or in a private transaction. Although the Fund will generally
purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary
market on an exchange will exist for any particular option. In such event it might not be possible to effect closing transactions in particular
options, so that the Fund would have to exercise its options in order to realize any profit and would incur brokerage commissions upon
the exercise of call options and upon the subsequent disposition of underlying securities for the exercise of put options. If the Fund,
as a covered call option writer, is unable to effect a closing purchase transaction in a secondary market, it will not be able to sell
the underlying security until the option expires or it delivers the underlying security upon exercise or otherwise covers the position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Options on Securities Indices. </i>The Fund
may purchase and sell options on securities indices. One effect of such transactions may be to hedge all or part of the Fund&#8217;s securities
holdings against a general decline in the securities market or a segment of the securities market. Options on securities indices are similar
to options on stocks except that, rather than the right to take or make delivery of stock at a specified price, an option on a securities
index gives the holder the right to receive, upon exercise of the option, an amount of cash if the closing level of the securities index
upon which the option is based is greater than, in the case of a call, or less than, in the case of a put, the exercise price of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s successful use of options on
indices depends upon its ability to predict the direction of the market and is subject to various additional risks. The correlation between
movements in the index and the price of the securities being hedged against is imperfect and the risk from imperfect correlation increases
as the composition of the Fund diverges from the composition of the relevant index. Accordingly, a decrease in the value of the securities
being hedged against may not be wholly offset by a gain on the exercise or sale of a securities index put option held by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Futures Contracts and Options on Futures.
</i>The Fund may, without limit, enter into futures contracts or options on futures contracts. It is anticipated that these investments,
if any, will be made by the Fund primarily for the purpose of hedging against changes in the value of its portfolio securities and in
the value of securities it intends to purchase. Such investments will only be made if they are economically appropriate to the reduction
of risks involved in the management of the Fund. In this regard, the Fund may enter into futures contracts or options on futures for the
purchase or sale of securities indices or other financial instruments including but not limited to U.S. government securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A &#8220;sale&#8221; of a futures contract (or
a &#8220;short&#8221; futures position) means the assumption of a contractual obligation to deliver the instrument underlying the contract
at a specified price at a specified future time. A &#8220;purchase&#8221; of a futures contract (or a &#8220;long&#8221; futures position)
means the assumption of a contractual obligation to acquire the instrument underlying the contract at a specified price at a specified
future time. Certain futures contracts, including stock and bond index futures, are settled on a net cash payment basis rather than by
the payment vs. delivery of the instrument underlying the futures contracts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">No consideration will be paid or received by
the Fund upon the purchase or sale of a futures contract. Initially, the Fund will be required to deposit with the broker an amount of
cash or cash equivalents equal to approximately 1% to 10% of the contract amount (this amount is subject to change by the exchange or
board of trade on which the contract is traded and brokers or members of such board of trade may charge a higher amount). This amount
is known as the &#8220;initial margin&#8221; and is in the nature of a performance bond or good faith deposit on the contract. Subsequent
payments, known as &#8220;variation margin,&#8221; to and from the broker will be made daily as the price </p>

<!-- Field: Page; Sequence: 72; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">of the instrument underlying
the futures contract fluctuates. At any time prior to the expiration of the futures contract, the Fund may elect to close the position
by taking an opposite position, which will operate to terminate its existing position in the contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An option on a futures contract gives the purchaser
the right, in return for the premium paid, to assume a position in a futures contract at a specified exercise price at a specified time
or times prior to the expiration of the option. Upon exercise of an option, the delivery of the futures position by the writer of the
option to the holder of the option will be accompanied by delivery of the accumulated balance in the writer&#8217;s futures margin account
attributable to that contract, which represents the amount by which the market price of the futures contract exceeds, in the case of a
call, or is less than, in the case of a put, the exercise price of the option on the futures contract. The potential loss related to the
purchase of an option on futures contracts is limited to the premium paid for the option (plus transaction costs). Because the value of
the option purchased is fixed at the point of sale, there are no daily cash payments by the purchaser to reflect changes in the value
of the underlying contract; however, the value of the option does change daily and that change would be reflected in the net assets of
the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">SOFR futures contracts are U.S. dollar-denominated
futures contracts or options on those contracts that are based on SOFR. These contracts enable purchasers to obtain a fixed rate for the
lending of funds and sellers to obtain a fixed rate for borrowings. The Fund may use SOFR futures contracts and options thereon to hedge
against changes in SOFR, to which many interest rate swaps and fixed income instruments are linked, or for other purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">There are significant risks associated with the
Fund&#8217;s use of futures contracts and options on futures contracts, including the following: (1) the success of a hedging strategy
may depend on the ability of the Sub-Adviser to predict movements in the prices of individual securities, fluctuations in markets and
movements in interest rates, and there is no assurance that futures contracts or options on futures contracts can be offset at favorable
prices; (2) the use of hedging may result in a reduction of the yield of the Fund and/or in value of both the securities hedged and the
hedging instrument; (3) there may be an imperfect or no correlation between the changes in market value of the securities held by the
Fund and the prices of futures and options on futures; (4) there may not be a liquid secondary market for a futures contract or option;
(5) trading restrictions or limitations may be imposed by an exchange; and (6) government regulations may restrict trading in futures
contracts and options on futures. In addition, some strategies reduce the Fund&#8217;s exposure to price fluctuations, while others tend
to increase its market exposure. Losses from investing in futures transactions are potentially unlimited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The purchase of a call option on a futures contract
is similar in some respects to the purchase of a call option on an individual security. Depending on the pricing of the option compared
to either the price of the futures contract upon which it is based or the price of the underlying instrument, it may or may not be less
risky than ownership of the futures contract or underlying instrument. As with the purchase of futures contracts, when the Fund is not
fully invested it may purchase a call option on a futures contract to hedge against a market advance due to declining interest rates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The purchase of a put option on a futures contract
is similar to the purchase of protective put options on portfolio securities. The Fund may purchase a put option on a futures contract
to hedge the Fund&#8217;s portfolio against the risk of rising interest rates and consequent reduction in the value of portfolio securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s ability to establish and close
out positions in futures contracts and options thereon will be subject to the development and maintenance of liquid markets. Although
the Fund generally will purchase or sell only those futures contracts and options thereon for which there appears to be a liquid market,
there is no assurance that a liquid market on an exchange will exist for any particular futures contract or option thereon at any particular
time. In the event no liquid market exists for a particular futures contract or option thereon in which the Fund maintains a position,
it will not be possible to effect a closing transaction in that contract or to do so at a satisfactory price, and the Fund would either
have to make or take delivery under the futures contract or, in the case of a written option, wait to sell the underlying securities until
the option expires or is exercised or, in the case of a purchased option, exercise the option. In the case of a futures contract or an
option thereon that the Fund has written and that the Fund is unable to close, the Fund would be required to maintain margin deposits
on the futures contract or option thereon and to make variation margin payments until the contract is closed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Successful use of futures contracts and options
thereon by the Fund is subject to the ability of the Investment Adviser to predict correctly movements in the direction of interest rates.
If the Investment Adviser&#8217;s expectations are not met, the Fund will be in a worse position than if a hedging strategy had not been
pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely affect the</p>

<!-- Field: Page; Sequence: 73; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">
price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of the benefit
of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in such situations,
if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet the requirements.
These sales may be, but will not necessarily be, at increased prices which reflect the rising market. The Fund may have to sell securities
at a time when it is disadvantageous to do so, which may result in losses to the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Interest Rate Futures Contracts and Options
Thereon. </i>The Fund may purchase or sell interest rate futures contracts to take advantage of or to protect the Fund against fluctuations
in interest rates affecting the value of securities that the Fund holds or intends to acquire. For example, if interest rates are expected
to increase, the Fund might sell futures contracts on securities, the values of which historically have a high degree of positive correlation
to the values of the Fund&#8217;s portfolio securities. Such a sale would have an effect similar to selling an equivalent value of the
Fund&#8217;s portfolio securities. If interest rates increase, the value of the Fund&#8217;s portfolio securities will decline, but the
value of the futures contracts to the Fund will increase at approximately an equivalent rate thereby keeping the net asset value of the
Fund from declining as much as it otherwise would have. The Fund could accomplish similar results by selling securities with longer maturities
and investing in securities with shorter maturities when interest rates are expected to increase. However, since the futures market may
be more liquid than the cash market, the use of futures contracts as a risk management technique allows the Fund to maintain a defensive
position without having to sell its portfolio securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Similarly, the Fund may purchase interest rate
futures contracts when it is expected that interest rates may decline. The purchase of futures contracts for this purpose constitutes
a hedge against increases in the price of securities (caused by declining interest rates) that the Fund intends to acquire. Since fluctuations
in the value of appropriately selected futures contracts should approximate that of the securities that will be purchased, the Fund can
take advantage of the anticipated rise in the cost of the securities without actually buying them. Subsequently, the Fund can make its
intended purchase of the securities in the cash market and currently liquidate its futures position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Securities Index Futures Contracts and Options
Thereon. </i>Purchases or sales of securities index futures contracts are used for hedging purposes to attempt to protect the Fund&#8217;s
current or intended investments from broad fluctuations in stock or bond prices. For example, the Fund may sell securities index futures
contracts in anticipation of or during a market decline to attempt to offset the decrease in market value of the Fund&#8217;s securities
portfolio that might otherwise result. If such decline occurs, the loss in value of portfolio securities may be offset, in whole or part,
by gains on the futures position. When the Fund is not fully invested in the securities market and anticipates a significant market advance,
it may purchase securities index futures contracts in order to gain rapid market exposure that may, in part or entirely, offset increases
in the cost of securities that the Fund intends to purchase. As such purchases are made, the corresponding positions in securities index
futures contracts will be closed out. The Fund may write put and call options on securities index futures contracts for hedging purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Additional Risks of Foreign Options, Futures
Contracts and Options on Futures Contracts and Forward Contracts. </i>Options, futures contracts and options thereon and forward contracts
on securities may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the
United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting
trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by, among other things:
(i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to
make trading decisions, (iii) delays in the Fund&#8217;s ability to act upon economic events occurring in the foreign markets during non-business
hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than
in the United States and (v)&#160;lesser trading volume.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Exchanges on which options, futures and options
on futures are traded may impose limits on the positions that the Fund may take in certain circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Legislation and Regulation Risk Related to
Derivative and Certain Other Instruments. </i>The laws and regulations that apply to derivatives (e.g., swaps, futures, etc.) and persons
who use them (including the Fund, Adviser and others) are continuously changing in the U.S. and abroad. As a result, restrictions and
additional regulations may be imposed on these parties, trading restrictions may be adopted and additional trading costs are possible.
The impact of these changes on the Fund, its investment strategies and performance is difficult to predict.</p>

<!-- Field: Page; Sequence: 74; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The CFTC and various exchanges have rules limiting
the maximum net long or short positions which any person or group may own, hold or control in any given futures contract or option on
such futures contract. The Adviser must consider the effect of these limits in managing the Fund. In addition, the CFTC has position limits
rules that establish position limits for 25 specified physical commodity futures and related options contracts traded on exchanges, other
futures contracts and related options directly or indirectly linked to such contracts, and any OTC transactions that are economically
equivalent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The SEC rule related to the use of derivatives,
reverse repurchase agreements and certain other transactions by registered investment companies requires the Fund to trade derivatives
and other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing
transactions) subject to value-at-risk (&#8220;VaR&#8221;) leverage limits and derivatives risk management program and reporting requirements.
Generally, these requirements apply unless the Fund satisfies a &#8220;limited derivatives users&#8221; exception that is included in
the final rule. When the Fund trades reverse repurchase agreements or similar financing transactions, including certain tender option
bonds, it needs to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions
with the aggregate amount of any other senior securities representing indebtedness when calculating the Fund&#8217;s asset coverage ratio
or treat all such transactions as derivatives transactions. Reverse repurchase agreements or similar financing transactions aggregated
with other indebtedness do not need to be included in the calculation of whether a fund satisfies the limited derivatives users exception,
but for funds subject to the VaR testing requirement, reverse repurchase agreements and similar financing transactions must be included
for purposes of such testing whether treated as derivatives transactions or not. SEC guidance in connection with the rule regarding the
use of securities lending collateral may limit the Fund&#8217;s potential securities lending activities. In addition, the Fund is permitted
to invest in a security on a when-issued or forward-settling basis, or with a non-standard settlement cycle, and the transaction will
be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction and (ii) the transaction
will settle within 35 days of its trade date (the &#8220;Delayed-Settlement Securities Provision&#8221;). The Fund may otherwise engage
in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long as the Fund treats any such
transaction as a &#8220;derivatives transaction&#8221; for purposes of compliance with the rule. Furthermore, under the rule, the Fund
will be permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not be subject to the asset
coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement, that it will have
sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Regulatory changes may negatively impact the
Fund&#8217;s ability to meet its investment objective either through limits or requirements imposed on it or upon its counterparties.
New requirements, even if not directly applicable to the Fund, including capital requirements, changes to the CFTC speculative position
limits regime, mandatory clearing requirements, trade execution requirements and margin requirements, may increase the cost of the Fund&#8217;s
investments and cost of doing business, which would adversely affect the performance of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Investment Adviser has filed with the National
Futures Association a notice of eligibility claiming an exclusion from the definition of &#8220;commodity pool operator&#8221; (&#8220;CPO&#8221;)
under CFTC Rule 4.5 under the Commodity Exchange Act, as amended (the &#8220;CEA&#8221;), with respect to the Fund&#8217;s operation.
Accordingly, the Investment Adviser with respect to the Fund is not subject to registration or regulation as a CPO. Changes to the Fund&#8217;s
investment strategies or investments may cause the Investment Adviser with respect to the Fund to lose the benefits of the exclusion under
CFTC Rule 4.5 under the CEA and may trigger additional CFTC regulation as a CPO. If the Fund becomes subject to CFTC regulation, the Fund
or the Investment Adviser may incur additional expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In December 2023, the SEC adopted rule amendments
providing that any covered clearing agency (&#8220;CCA&#8221;) for U.S. Treasury securities must adopt policies and procedures designed
to require that every direct participant of the CCA (which generally would be a bank or broker-dealer) submit for clearance and settlement
all eligible secondary market transactions in U.S. Treasury securities to which it is a counterparty. The clearing mandate includes in
its scope all repurchase or reverse repurchase agreements of such direct participants collateralized by U.S. Treasury securities (collectively,
&#8220;Treasury repo transactions&#8221;) of a type accepted for clearing by a registered CCA, including both bilateral Treasury repo
transactions and triparty Treasury repo transactions where a bank agent provides custody, collateral management and settlement services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Treasury repo transactions of registered
funds with any direct participants of a CCA will be subject to the mandatory clearing requirement. Currently, the Fixed Income Clearing
Corporation (&#8220;FICC&#8221;) is the only CCA for U.S. Treasury securities. FICC currently operates a &#8220;Sponsored Program&#8221;
for clearing of Treasury repo</p>

<!-- Field: Page; Sequence: 75; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> transactions pursuant to which a registered fund may enter into a clearing arrangement with a &#8220;sponsoring
member&#8221; bank or broker-dealer that is a direct participant of FICC as a &#8220;sponsored member&#8221; of FICC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Compliance with the clearing mandate for Treasury
repo transactions is scheduled to be required by June 30, 2027. The clearing mandate is expected to result in the Fund being required
to clear all or substantially all of its Treasury repo transactions as of the compliance date. There are currently substantial regulatory
and operational uncertainties associated with the implementation which may affect the cost, terms and/or availability of cleared repo
transactions.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Loans of Portfolio Securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Consistent with applicable regulatory requirements
and the Fund&#8217;s investment restrictions, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions,
provided that such loans are callable at any time by the Fund (subject to notice provisions described below), and are at all times secured
by cash or cash equivalents, which are maintained in a segregated account pursuant to applicable regulations and that are at least equal
to the market value, determined daily, of the loaned securities. The advantage of such loans is that the Fund continues to receive the
income on the loaned securities while at the same time earns interest on the cash amounts deposited as collateral, which will be invested
in short-term obligations. The Fund will not lend its portfolio securities if such loans are not permitted by the laws or regulations
of any state in which its shares are qualified for sale. The Fund&#8217;s loans of portfolio securities will be collateralized in accordance
with applicable regulatory requirements and no loan will cause the value of all loaned securities to exceed 33% of the value of the Fund&#8217;s
total assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A loan may generally be terminated by the borrower
on one business day&#8217;s notice, or by the Fund on five business days&#8217; notice. If the borrower fails to deliver the loaned securities
within five days after receipt of notice, the Fund could use the collateral to replace the securities while holding the borrower liable
for any excess of replacement cost over collateral. As with any extensions of credit, there are risks of delay in recovery and in some
cases even loss of rights in the collateral should the borrower of the securities fail financially. However, these loans of portfolio
securities will only be made to firms deemed to be creditworthy and when the income that can be earned from such loans justifies the attendant
risks. Upon termination of the loan, the borrower is required to return the securities to the Fund. Any gain or loss in the market price
during the loan period would inure to the Fund. The risks associated with loans of portfolio securities are substantially similar to those
associated with repurchase agreements. Thus, if the counterparty to the loan petitions for bankruptcy or becomes subject to the U.S. Bankruptcy
Code, the law regarding the rights of the Fund is unsettled. As a result, under extreme circumstances, there may be a restriction on the
Fund&#8217;s ability to sell the collateral, and the Fund would suffer a loss. When voting or consent rights that accompany loaned securities
pass to the borrower, the Fund will follow the policy of calling the loaned securities, to be delivered within one day after notice, to
permit the exercise of such rights if the matters involved would have a material effect on the Fund&#8217;s investment in such loaned
securities. The Fund will pay reasonable finder&#8217;s, administrative and custodial fees in connection with a loan of its securities.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIInvestmentRestrictions"></span>Investment
Restrictions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Please refer to the section of the Fund&#8217;s
most recent annual report on Form N-CSR entitled &#8220;Additional Information Regarding the Fund&#8212;Fundamental Investment Restrictions,&#8221;
which is incorporated by reference herein, for a discussion of the investment restrictions of the Fund that constitute fundamental policies.</p>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIManagementFund"></span>Management
of the Fund</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Board of Trustees</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Overall responsibility for management and supervision
of the Fund rests with the Board of Trustees of the Fund (the &#8220;Board&#8221;). The Board approves all significant agreements between
the Fund and the companies that furnish the Fund with services, including agreements with the Investment Adviser and the Sub-Adviser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Trustees are divided into two classes. Trustees
serve until their successors have been duly elected. Please refer to the section of the Fund&#8217;s <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000077/cef-def14a.htm">February
28, 2025, definitive proxy statement on Schedule 14A</a> for the annual meeting of shareholders entitled &#8220;The Proposal: Election
of Trustees&#8212;Trustees,&#8221; which is incorporated herein by reference, for a list of the names, business addresses, dates of birth,
present positions with the Fund, length of time served with the Fund, principal occupations during the past five years and other directorships
held by each Trustee during the past five years.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Trustee Qualifications</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Please refer
to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000077/cef-def14a.htm"><span style="font-weight: normal">February
28, 2025, definitive proxy statement on Schedule 14A</span></a> <span style="font-weight: normal">for the annual meeting of shareholders
entitled &#8220;The Proposal: Election of Trustees&#8212;Trustee Qualifications,&#8221; which is incorporated herein by reference, for
a discussion of the experience, qualifications, attributes and skills of each Trustee that support the conclusion, as of the date of this
SAI, that each Trustee should serve as a Trustee in light of the Fund&#8217;s business and structure. References to the qualifications,
attributes and skills of Trustees do not constitute the holding out of any Trustee as being an expert under Section 7 of the Securities
Act or the rules and regulations of the SEC.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Executive Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Please refer
to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000077/cef-def14a.htm"><span style="font-weight: normal">February
28, 2025, definitive proxy statement on Schedule 14A</span></a> <span style="font-weight: normal">for the annual meeting of shareholders
entitled &#8220;The Proposal: Election of Trustees&#8212;Executive Officers,&#8221; which is incorporated herein by reference for information
relating to the executive officers of the Fund who are not Trustees. The Fund&#8217;s officers receive no compensation from the Fund but
may also be officers or employees of the Investment Adviser, the Sub-Adviser or affiliates of the Investment Adviser or the Sub-Adviser
and may receive compensation in such capacities.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Board Leadership Structure and Oversight</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Please refer
to the sections of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000077/cef-def14a.htm"><span style="font-weight: normal">February
28, 2025, definitive proxy statement on Schedule 14A</span></a> <span style="font-weight: normal">for the annual meeting of shareholders
entitled &#8220;The Proposal: Election of Trustees&#8212;Board Leadership Structure,&#8221; &#8220;The Proposal: Election of Trustees&#8212;Board
Committees&#8221; and &#8220;The Proposal: Election of Trustees&#8212;Board&#8217;s Role in Risk Oversight,&#8221; which is incorporated
herein by reference, for a discussion of the Board&#8217;s leadership structure and oversight.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Remuneration of Trustees and Officers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Please refer
to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000077/cef-def14a.htm"><span style="font-weight: normal">February
28, 2025, definitive proxy statement on Schedule 14A</span></a> <span style="font-weight: normal">for the annual meeting of shareholders
entitled &#8220;The Proposal: Election of Trustees&#8212;Trustees Compensation,&#8221; which is incorporated herein by reference, for
a discussion of the remuneration of Trustees and Officers.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Trustee Share Ownership</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Please refer
to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000077/cef-def14a.htm"><span style="font-weight: normal">February
28, 2025, definitive proxy statement on Schedule 14A</span></a> <span style="font-weight: normal">for the annual meeting of shareholders
entitled &#8220;The Proposal: Election of Trustees&#8212;Trustee Beneficial Ownership of Securities,&#8221; which is incorporated herein
by reference, for information relating to each Trustee&#8217;s share of ownership in the Fund and in all registered investment companies
in the family of investment companies overseen by the Trustees as of December 31, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As of October 31, 2025, the Trustees and officers
of the Fund as a group owned less than 1% of the outstanding Shares of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Indemnification of Officers and Trustees;
Limitations on Liability</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The governing documents of the Fund provide that
the Fund will indemnify its Trustees and officers and may indemnify its employees or agents against liabilities and expenses incurred
in connection with litigation in </p>

<!-- Field: Page; Sequence: 77; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">which they may be involved because of their positions with the Fund, to the fullest extent permitted
by law. However, nothing in the governing documents of the Fund protects or indemnifies a trustee, officer, employee or agent of the Fund
against any liability to which such person would otherwise be subject in the event of such person&#8217;s willful misfeasance, bad faith,
gross negligence or reckless disregard of the duties involved in the conduct of his or her position.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has entered into an Indemnification
Agreement with each Independent Trustee, which provides that the Fund shall indemnify and hold harmless such Trustee against any and all
expenses actually and reasonably incurred by the Trustee in any proceeding arising out of or in connection with the Trustee&#8217;s service
to the Fund, to the fullest extent permitted by the Declaration of Trust and By-Laws and the laws of the State of Delaware, the Securities
Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the 1940 Act, unless it has been finally adjudicated that (i) the Trustee
is subject to such expenses by reason of the Trustee&#8217;s not having acted in good faith in the reasonable belief that his or her action
was in the best interests of the Fund or (ii) the Trustee is liable to the Fund or its shareholders by reason of willful misfeasance,
bad faith, gross negligence, or reckless disregard of the duties involved in the conduct of his or her office, as defined in Section 17(h)
of the 1940 Act.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Portfolio Management</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s personnel primarily responsible
for the day-to-day management of the Fund&#8217;s portfolio are Anne B. Walsh, CFA, JD, Managing Partner, Chief Investment Officer and
Portfolio Manager; Steven H. Brown, CFA, Chief Investment Officer, Fixed Income, and Senior Managing Director and Portfolio Manager; Adam
J. Bloch, Managing Director and Portfolio Manager; and Evan L. Serdensky, Managing Director and Portfolio Manager.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Portfolio Manager Compensation</i>. The Sub-Adviser
compensates the portfolio managers for their management of the Fund&#8217;s portfolio. Compensation is evaluated 1) quantitatively based
on their contribution to investment performance and portfolio risk control and 2) qualitatively based on factors such as teamwork and
client service efforts. The Sub-Adviser&#8217;s staff incentives may include: a competitive base salary, bonus determined by individual
and firm wide performance, equity participation, and participation opportunities in various investments of the Sub-Adviser. Some portfolio
managers earn compensations that vary based on the performances of certain accounts or investments. All employees of the Sub-Adviser are
also eligible to participate in a 401(k) plan to which the Sub-Adviser may make a discretionary match after the completion of each plan
year. The&#160;Sub-Adviser&#8217;s deferred compensation programs include equity that vests over a period of years, including&#160;equity
in the form of shares of funds managed by the particular portfolio manager. The value of the fund shares&#160;under the deferred compensation
program is awarded annually and each award vests over a period of years&#160;(generally 4 years). As discussed below, a portfolio manager&#8217;s
ownership of shares of a Fund managed by the&#160;portfolio manager may create conflicts of interest that incentivize the portfolio manager
to favor such fund over the Fund or other accounts.</p>

<p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 25.9pt">Other Accounts Managed by the Portfolio
Managers. <span style="font-style: normal">The following table sets forth information about funds and accounts (including the Fund) for
which the portfolio managers are primarily responsible for the day-to-day portfolio management as of May 31, 2025.</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="3">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of Other Accounts Managed</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>and Assets by Account Type</b></p></td>
    <td colspan="3">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Number of Other Account Assets for Which Advisory
    Fee is</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Performance-Based</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 12%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Name of Portfolio
    Manager</b></p></td>
    <td style="width: 20%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Other Registered
    Investment Companies</b></p></td>
    <td style="width: 15%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Other Pooled Investment
    Vehicles</b></p></td>
    <td style="width: 15%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Other Accounts</b></p></td>
    <td style="width: 12%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Other Registered
    Investment Companies</b></p></td>
    <td style="width: 13%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Other Pooled Investment
    Vehicles</b></p></td>
    <td style="width: 13%">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Other Accounts</b></p></td></tr>
  <tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center"><b>Anne B. Walsh</b></td>
    <td style="text-align: center">23</td>
    <td style="text-align: center">11</td>
    <td style="text-align: center">69</td>
    <td style="text-align: center">0</td>
    <td style="text-align: center">3</td>
    <td style="text-align: center">1</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$49,387,087,246</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$3,089,562,183</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$130,551,683,092</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$0</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$1,709,313,462</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$115,959,692</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center"><b>Steven H. Brown</b></td>
    <td style="text-align: center">23</td>
    <td style="text-align: center">10</td>
    <td style="text-align: center">46</td>
    <td style="text-align: center">0</td>
    <td style="text-align: center">3</td>
    <td style="text-align: center">1</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$49,387,087,246</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$3,077,921,672</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$25,377,194,258</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$0</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$1,709,313,462</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$115,959,692</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 78; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; text-align: center; width: 12%">&#160;</td>
    <td style="width: 20%">&#160;</td>
    <td style="text-align: center; width: 15%">&#160;</td>
    <td style="text-align: center; width: 15%">&#160;</td>
    <td style="text-align: center; width: 12%">&#160;</td>
    <td style="text-align: center; width: 13%">&#160;</td>
    <td style="text-align: center; width: 13%">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center"><b>Adam J. Bloch</b></td>
    <td style="text-align: center">19</td>
    <td style="text-align: center">10</td>
    <td style="text-align: center">46</td>
    <td style="text-align: center">0</td>
    <td style="text-align: center">3</td>
    <td style="text-align: center">1</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$48,332,751,425</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$3,077,921,672</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$25,377,194,258</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$0</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$1,709,313,462</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="background-color: white">$115,959,692</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center"><b>Evan L. Serdensky </b></td>
    <td style="text-align: center">19</td>
    <td style="text-align: center">3</td>
    <td style="text-align: center">38</td>
    <td style="text-align: center">0</td>
    <td style="text-align: center">1</td>
    <td style="text-align: center">1</td></tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$48,332,751,425</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$1,544,075,813</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$24,283,301,424</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$0</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$206,187,622</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">$115,959,692</td></tr>
  </table>
<p style="font: italic 10pt/15pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.3in">Information Regarding Potential Conflicts
of Interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Potential Conflicts Related to the Sale of
Fund Shares</span>. The Advisers, their affiliates and their respective employees may have relationships with distributors, consultants and
others who recommend, or engage in transactions with or for, the Fund. The Fund and/or an Adviser or its affiliates may compensate such
distributors, consultants and other parties in connection with such relationships. As a result of these relationships, distributors, consultants
and other parties may have conflicts that create incentives for them to promote the Fund over other funds or financial products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">To the extent permitted by applicable law, the
Advisers and their affiliates and the Fund may make payments to authorized dealers and other financial intermediaries and to salespersons
to promote the Fund. These payments may be made out of the assets of an Adviser or its affiliates or amounts payable to an Adviser or
its affiliates. These payments may create an incentive for such persons to highlight, feature or recommend the Fund over other funds or
financial products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Potential Conflicts Related to Management
of the Fund by the Advisers</span>. The following are descriptions of certain conflicts, financial or otherwise, that the Advisers and their
employees may have in managing the Fund. The descriptions below are not intended to be a complete enumeration or explanation of all of
the conflicts of interests that may arise from the business activities of the Advisers, their affiliates, or their respective clients.
To address these and other actual or potential conflicts, the Advisers and the Fund have established various policies and procedures that
are reasonably designed to identify and mitigate such conflicts and to ensure that such conflicts are appropriately resolved taking into
consideration the best interest of all clients involved, consistent with the Advisers&#8217; fiduciary obligations and in accordance with
applicable law. However, there can be no guarantee that these policies and procedures will be successful in every instance. In certain
cases, transactions involving potential conflicts of interest described below may be elevated for review by a conflicts review committee,
the members of which are senior personnel of the Advisers&#8217; affiliates and are not employees or clients of the Advisers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Additional information about potential conflicts
of interest regarding the Advisers is set forth in each Adviser&#8217;s Form ADV. A copy of Part 1 and Part 2A of each of the Adviser&#8217;s
Form ADV is available on the SEC&#8217;s website at www.adviserinfo.sec.gov.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">The Advisers and Their Affiliates Provide
a Broad Array of Services and Have Various Investment Banking, Advisory and Other Relationships</span>. The Advisers are affiliates of Guggenheim
Partners, LLC (&#8220;Guggenheim Partners&#8221;), which is a global, full service financial services firm. Guggenheim Partners and its
affiliates, including the Advisers (collectively, &#8220;Guggenheim Entities&#8221;), provide their clients with a broad array of investment
management, insurance, broker-dealer, investment banking and other similar services (&#8220;Other Business Activities&#8221;). These Other
Business Activities create actual and potential conflicts of interest for the Advisers in managing the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">For example, the Other Business Activities may
create conflicts between the interests of the Fund, on the one hand, and the interests of the Advisers, their affiliates and their respective
other clients, on the other hand. The Advisers and their affiliates may act as advisers to clients in investment banking, loan arranging
and structuring, financial advisory, restructuring, liability management, asset management and other capacities related to securities
and instruments that may be purchased, sold or held by the Fund, and the Advisers or an affiliate may issue, or be engaged as underwriter
for the issuer of, securities and instruments that the Fund may (in accordance with applicable rules) purchase, sell or hold. At times,
these activities may cause the Advisers and their affiliates to give advice to their clients that may cause these clients to take actions
in conflict with or adverse to the interest of the Fund. In addition, Guggenheim Entities may take action that differs from, potentially
conflicts with or is adverse to advice given or action taken for the Advisers&#8217; clients. The Guggenheim Entities and their respective
officers, directors, </p>

<!-- Field: Page; Sequence: 79; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">managing directors, partners, employees and consultants may act in a proprietary capacity with long or short positions
in securities and instruments of all types, including those that may be purchased, sold or held by the Fund. Such activities can give
rise to interests different from or adverse to those of the Fund, and they could affect the prices and availability of the securities
and instruments that the Fund holds or that an Adviser seeks to buy or sell for the Fund&#8217;s account, which could adversely impact
the financial returns of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">These Other Business Activities may create other
potential conflicts of interests in managing the Fund, may cause the Fund to be subject to additional regulatory limits and, in certain
circumstances, may prevent the Fund from participating or limit the Fund&#8217;s participation in an investment opportunity that the Fund&#8217;s
portfolio managers view to be favorable. As a result, activities and dealings of the Advisers and their affiliates may affect the Fund
in ways that may disadvantage or restrict the Fund or be deemed to benefit an Adviser, its affiliates or other client accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Advisers&#8217; and Their Affiliates&#8217;
Activities on Behalf of Other Clients</span>. The Advisers and their affiliates currently manage and expect to continue to manage a variety
of other client accounts, including (without limitation) separately managed accounts (including through the Investment Adviser&#8217;s
participation in third-party sponsored separately managed account programs through which the Investment Adviser provides discretionary
sub-advisory services to individuals and other investors), open-end registered funds, closed-end registered funds, private funds and other
collective investment vehicles, and may serve as asset or collateral manager or in other capacities for certain non-registered structured
products (collectively, &#8220;Other Clients&#8221;). Investors in such Other Clients include insurance companies affiliated with or related
to the Advisers, as described below. Other Clients invest pursuant to the same or different investment objective, strategies and philosophies
as those employed by the Fund and may seek to make or sell investments in the same securities, instruments, sectors or strategies as the
Fund. This &#8220;side-by-side&#8221; management of multiple accounts may create potential conflicts, particularly in circumstances where
the availability or liquidity of investment opportunities is limited, or when accounts trade in opposite directions. For example, there
is a risk that sales (including short sales) of one client portfolio security adversely affects the market value of securities held in
another client portfolio, or trading terms could be adversely affected when opposite trades are executed. In addition, other Clients may
also be subject to different legal restrictions or regulatory regimes than the Fund. Regardless of the similarity in investment objective
and strategies between the Fund and Other Clients, the Advisers may give advice and recommend investments to Other Clients that may differ
from advice given to, or investments bought or sold for, the Fund, and the Fund and Other Clients may vote differently on or take or refrain
from taking different actions with respect to the same security or instrument. Furthermore, the manner in which the Advisers execute a
strategy for the Fund may differ from how that same or similar strategy is executed for Other Clients due to, for example, investment
restrictions imposed the Fund or the Other Clients. These practices, limitations and conflicts may be disadvantageous to the Fund and
adversely affect their performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">The investment policies, fee arrangements and
other characteristics of the Fund may also vary from those of Other Clients. In some cases, the Advisers or an affiliate may receive a
potentially larger financial benefit from managing one or more such Other Clients as compared to the Fund (for example, some Other Clients
are charged performance or incentive fees constituting a percentage of profits or gains), which may provide an incentive to favor such
Other Clients over the Fund or to recommend favorable investments to Other Clients who pay higher fees or who have the potential to generate
greater fees over the Fund. The Advisers on behalf of the Fund or Other Clients may, pursuant to one transaction or in a series of transactions
over time, invest in different parts of an issuer&#8217;s or borrower&#8217;s capital structure (including but not limited to investments
in public versus private securities, investments in debt versus equity, or investments in senior versus subordinated debt or when the
same or similar investments have different rights or benefits), depending on the respective client&#8217;s investment objective and policies.
Relevant issuers or borrowers may also include special purpose issuers or borrowers in structured finance, asset backed, collateralized
loan obligation, collateralized debt obligation or similar transactions. As a result of the foregoing, the interests of one group of clients
could conflict with those of other clients with respect to the same issuer or borrower. In managing such investments, the Advisers will
consider the interests of all affected clients in deciding what actions to take with respect to a given issuer or borrower, but at times
will pursue or enforce rights on behalf of some clients in a manner that may have an adverse effect on, or result in asymmetrical financial
outcomes to, other clients owning a different, including more senior or junior, investment in the same issuer or borrower. In these types
of scenarios, the Advisers may occasionally engage and appoint an independent party to provide independent analysis or recommendations
with respect to consents, proxy voting, or other similar shareholder or debt holder rights decision (or a series of consents, votes or
similar decisions) pertaining to the Fund and other clients. These potential conflicts of interests between the Advisers&#8217; clients
may become more pronounced in situations in which an</p>

<!-- Field: Page; Sequence: 80; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"> issuer or borrower experiences financial or operational challenges, or as a result
of the Fund&#8217;s use of certain investment strategies, including small capitalization, emerging market, distressed or less liquid strategies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Adviser Activities on Behalf of Affiliated
or Related Accounts</span>. To the extent permitted by the 1940 Act and other laws, the Advisers, from time to time, may initiate or recommend
transactions in the loans or securities of companies in which the Advisers, their related persons, or their respective affiliates have
a controlling or other material direct or indirect interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Sammons Enterprises, Inc., a diversified company
with several insurance company subsidiaries (together with its subsidiaries, &#8220;Sammons&#8221;), holds indirect economic and voting
interests in Guggenheim Capital, LLC (&#8220;Guggenheim Capital&#8221;), the Advisers&#8217; ultimate parent company. As a result of its
ownership stake in Guggenheim Capital, Sammons is the largest individual stakeholder of the Advisers. Certain of Sammons&#8217; wholly
owned insurance company and other subsidiaries are advisory clients of, and pay fees to, the Advisers. As a result, Sammons is the largest
individual source of annual advisory fees paid to the Advisers. Sammons also has other relationships with the Advisers and various Guggenheim
Entities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Furthermore, some officers and directors of
Guggenheim Capital and its subsidiaries, including the Advisers (&#8220;Guggenheim Related Persons&#8221;), have economic interests or
voting interests in companies, including insurance companies that are advisory clients of the Advisers. Guggenheim Related Persons from
time to time enter into transactions, including loans and other financings, with these companies. Some Guggenheim Related Persons also
may have economic interests or voting interests in issuers, which may be controlling or otherwise material interests, or may serve as
a director on the board of issuers, in which the Advisers have invested or will invest on behalf of their clients or to which the Advisers
have provided or will provide financing on behalf of their clients. Additionally, Guggenheim Related Persons may have direct or indirect
investments in and/or have financial or other relationships with some of the Advisers&#8217; clients or other investment vehicles that
may create potential conflicts of interest. Sammons and certain advisory or other clients in which Guggenheim Related Persons have interests
have provided, and from time to time may provide, significant loans and other financing to an Adviser and its affiliates. In addition,
Guggenheim Related Persons have direct or indirect proprietary or personal investments in and/or have financial or other relationships
with financial industry participants or other entities (including trading platforms) that may perform services on behalf of, or in connection
with, investments made by the Advisers on behalf of their clients. The Advisers do not expect these transactions to be material.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">The relationships described above create potential
conflicts of interest for the Advisers in managing the Fund and could create an incentive for an Adviser to favor the interests of these
companies over its clients. These incentives are more pronounced where an Adviser has multiple relationships with the client. For example,
the Advisers have invested, and may in the future invest, on behalf of its clients in issuers or transactions in which Affiliated Insurance
Companies or Guggenheim Related Persons have direct and/or indirect interests, which may include a controlling or significant beneficial
interest. In addition, Guggenheim Related Persons and the accounts of Affiliated Insurance Companies and other Adviser clients have invested,
and may in the future invest, in securities at different levels of the capital structure of the same issuer, in some cases at the same
time and in other cases at different times as the Fund and other clients of the Advisers. The following conflicts may arise in such situations:
(i) enforcement of rights or determination not to enforce rights by the Advisers on behalf of the Fund and other clients may have an adverse
effect on the interests of its affiliates or related persons, and vice versa, (ii) the Advisers may have an incentive to invest client
funds in the issuer or borrower to either facilitate or obtain preferable terms for a proposed investment by an affiliate or related person
in such issuer or borrower, or (iii) the Advisers may have an incentive to preserve or protect the value or rights associated with an
existing economic interest of an affiliate or related person in the issuer or borrower, which may have an adverse effect on the interests
of other clients, including the Fund. In addition, the Advisers may be subject to conflicts of interest with respect to financial industry
participants or other entities (including trading platforms) because transactions on or through such platforms may result in compensation
directly being paid to these entities that indirectly benefits Guggenheim Related Persons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">The Advisers mitigate potential conflicts of
interest in the foregoing and similar situations, including through policies and procedures (i) designed to identify and mitigate conflicts
of interest on a transaction-by-transaction basis and (ii) that require investment decisions for all client accounts be made independently
from those of other client accounts and be made with specific reference to the individual needs and objectives of each client account,
without consideration of the Advisers&#8217; pecuniary or investment interests (or those of their respective employees or </p>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">affiliates).
The Fund and the Advisers also maintain procedures to comply with applicable laws, notably relevant provisions of the 1940 Act that prohibit
Fund transactions with affiliates (or exemptive rules thereunder).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Allocation of Investment Opportunities</span>.
As described above, the Advisers and their affiliates currently manage and expect to continue to manage Other Clients that may invest
pursuant to the same or different strategies as those employed by the Fund, and such Other Clients could be viewed as being in competition
with the Fund for appropriate investment opportunities, particularly where there is limited capacity with respect to such investment opportunities.
The investment policies, fee arrangements and other circumstances of the Fund may vary from those of the Other Clients, and the Advisers
may face potential conflicts of interest because the Advisers may have an incentive to favor particular client accounts (such as client
accounts that pay performance-based fees) over other client accounts that may be less lucrative in the allocation of investment opportunities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">At times, in order to minimize execution costs
for clients, trades in the same security transacted on behalf of more than one client will generally be aggregated (i.e., blocked or bunched)
by the Advisers unless the Advisers believe that doing so would conflict or otherwise be inconsistent with its duty to seek best execution
for the clients and/or the terms of the respective investment advisory contracts and other agreements and understandings relating to the
clients for which trades are being aggregated. In particular, the Advisers&#160;expect that trades will be aggregated between the Advisers&#8217;
clients and the Advisers&#8217;&#160;affiliates&#8217; clients, unless they believe that doing so would conflict or otherwise be inconsistent
with their duty to seek&#160;best execution for the clients and/or the terms of the respective investment advisory contracts and other
agreements&#160;and understandings relating to the clients for which trades are being aggregated. When the Advisers believe that it can
effectively obtain best execution for the clients by aggregating trades, it will do so for all clients participating in the trade for
which aggregated trades are consistent with the respective investment advisory contracts, investment guidelines, and other agreements
and understandings relating to the clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">The Advisers have implemented policies and procedures
that govern the allocation of investment opportunities among clients in a fair and equitable manner, taking into account the needs and
financial objectives of the clients, their specific objectives and constraints for each account, as well as prevailing market conditions.
If an investment opportunity would be appropriate for more than one client, an Adviser may be required to choose among those clients in
allocating the opportunity, or to allocate less of the opportunity to a client than it would ideally allocate if it did not have to allocate
to multiple clients. In addition, an Adviser may determine that an investment opportunity is appropriate for a particular client account,
but not for another.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">The Advisers allocate transactions on an objective
basis and in a manner designed to assure that no participating client is favored over any other participating client. If an investment
is suitable and desirable for more than one client account, an initial allocation study will be determined based upon demand ascertained
from the portfolio managers. With respect to fixed income and private equity, this initial allocation study is overseen by a central allocation
group and generally reflects a pro rata participation in the investment opportunity among the participating client accounts that expressed
demand. Final allocation decisions are made or verified independently by the central allocation group. With respect to public equity securities
and public equity-related securities, the allocation generally reflects a pro rata participation in the investment opportunity among participating
client accounts. Allocations may be adjusted under specific circumstances, such as situations of scarcity where pro rata allocations would
result in de minimis positions or odd lots.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">The application of relevant allocation factors
may result in non-pro rata allocations, and particular client accounts (including client accounts in which the Advisers and their affiliates
or related persons, or their respective officers, directors or employees, including portfolio managers or senior managers, have an interest)
may receive an allocation when other client accounts do not or receive a greater than pro-rata allocation. There can be no assurance that
a particular investment opportunity will be allocated in any particular manner, and circumstances may occur in which an allocation could
have adverse effects on the Fund with respect to the price or size of securities positions obtainable or saleable. All of the foregoing
procedures could in certain circumstances adversely affect the price paid or received by the Fund or the size of the position purchased
or sold by the Fund (including prohibiting the Fund from purchasing a position) or may limit the rights that the Fund may exercise with
respect to an investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">In addition, the Advisers and the Fund have
filed an application seeking exemptive relief from the SEC that would permit the Fund to, among other things, participate in co-investment
transactions in portfolio companies with certain affiliated investment entities, including certain affiliates of the Advisers and certain
public or private funds or </p>

<!-- Field: Page; Sequence: 82; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">other accounts managed by the Advisers and their affiliates, subject to certain terms and conditions (such
as the adoption and implementation of certain policies and procedures). However, there is no assurance that such relief will be granted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Allocation of Limited Time and Attention</span>.
The portfolio managers for the Fund may devote as much time to the Fund as the Advisers deem appropriate to perform their duties in accordance
with reasonable commercial standards and the Advisers&#8217; duties. However, as described above, these portfolio managers are presently
committed to and expect to be committed in the future to providing investment advisory and other services for Other Clients and engage
in Other Business Activities in which the Fund may have no interest. As a result of these separate business activities, an Adviser may
have conflicts of interest in allocating management time, services and functions among the Fund and Other Business Activities or Other
Clients in that the time and effort of the Fund&#8217;s portfolio managers would not be devoted exclusively to the business of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Potential Restrictions and Issues Related
to Material Non-Public Information</span>. By reason of Other Business Activities as well as services and advice provided to Other Clients,
the Advisers and their affiliates may acquire confidential or material non-public information and may be restricted from initiating transactions
in certain securities and instruments. The Advisers will not be free to divulge, or to act upon, any such confidential or material non-public
information and, due to these restrictions, an Adviser may be unable to initiate a transaction for the Fund&#8217;s account that it otherwise
might have initiated. As a result, the Fund may be frozen in an investment position that it otherwise might have liquidated or closed
out or may not be able to acquire a position that it might otherwise have acquired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Valuation of the Fund&#8217;s Investments</span>.
Fund assets are valued in accordance with the Fund&#8217;s valuation policy and procedures and Advisers&#8217; Rule 2a-5 fair valuation
policy and procedures. The valuation of a security or other asset for the Fund may differ from the value ascribed to the same asset by
affiliates of an Adviser (particularly difficult-to-value assets) or Other Clients because, among other things, they may have procedures
that differ from the Fund&#8217;s and Advisers&#8217; procedures or may have access to different information or pricing vendors or use
different models or techniques. The Advisers have been designated as the valuation designee to perform fair value determinations for the
Fund with respect to the Fund&#8217;s investments and may face a potential conflict with respect to such valuations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Investments in Other Guggenheim Funds</span>.
To the extent permitted by applicable law, the Fund may invest in other funds sponsored, managed, advised or sub-advised by the Advisers.
Investments by the Fund in such funds present potential conflicts of interest, including potential incentives to invest in smaller or
newer funds to increase asset levels or provide greater viability and to invest in funds managed by the portfolio manager(s) of the Fund.
As disclosed in the Prospectus and this SAI, the Advisers have agreed to waive certain fees associated with these investments, which will
reduce, but will not eliminate, these types of conflicts. In other circumstances, the Advisers may make investments for clients for various
portfolio management purposes in limited partnerships or similar vehicles that are managed or otherwise serviced by affiliates of the
Advisers that will be compensated for such services.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.3in"><span style="text-decoration: underline">Potential Conflicts Associated with the Advisers
and Their Affiliates Acting in Multiple Capacities Simultaneously.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">Principal and Cross Transactions</span>. The
Advisers may, to the extent permitted under applicable law, effect client cross transactions where an Adviser causes a transaction to
be effected between the Fund and an Other Client; provided, that conditions set forth in SEC rules under the 1940 Act are followed. Cross
transactions present an inherent conflict of interest because an Adviser represents the interests of both the selling account and the
buying account in the same transaction, and the Adviser could seek to treat one party to the cross transaction more favorably than the
other party. The Advisers have policies and procedures designed to mitigate these conflicts and help ensure that any cross transactions
are in the best interests of, and appropriate for, all clients involved and the transactions are consistent with the Advisers&#8217; fiduciary
duties and obligation to seek best execution and applicable rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in"><span style="text-decoration: underline">The Advisers and Their Affiliates May Act
in Multiple Commercial Capacities</span>. Subject to applicable law, the provisions of the 1940 Act and rules thereunder and the Fund&#8217;s
and Other Clients&#8217; investment guidelines, an Adviser may cause the Fund to invest in securities, bank loans or other obligations
of companies or structured product vehicles that result in commissions, initial or ongoing fees, or other remuneration paid to (and retained
by) an</p>

<!-- Field: Page; Sequence: 83; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"> Adviser or one of its affiliates. Such investments may include (i) investments that an Adviser or one of its affiliates originated,
arranged or placed; (ii) investments in which the Advisers&#8217; affiliate provided investment banking, financial advisory or similar
services to a party involved in the transaction to which the investment relates (such as acquisition financing in a transaction in which
the Advisers&#8217; affiliate represented the buyer or seller); (iii) investments where an Adviser or its affiliates provided other services
to a transaction participant or other third party; (iv) investments where an Adviser or one of its affiliates acts as the collateral agent,
administrator, originator, manager, or other service provider; and (v) investments that are secured or otherwise backed by collateral
that could include assets originated, sold or financed by an Adviser or its affiliates, investment funds or pools managed by an Adviser
or its affiliates or assets or obligations managed by an Adviser or its affiliates. Commissions, fees, or other remuneration payable to
an Adviser or its affiliates in these transactions may present a potential conflict in that the Adviser may be viewed as having an incentive
to purchase such investments to earn, or facilitate its affiliates&#8217; ability to earn, such additional fees or compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">In some circumstances, and also subject to applicable
law, the Advisers may cause the Fund to invest in or provide financing to issuers or borrowers, or otherwise participate in transactions,
in which the issuer, borrower or another transaction party (such as a placement agent or arranger) is, or is a subsidiary or affiliate
of or otherwise related to, (a) an Other Client or (b) a company with which Guggenheim Related Persons, or officers or employees of the
Advisers, have investment, financial or other interests or relationships (including but not limited to directorships or equivalent roles).
The financial interests of the Advisers&#8217; affiliates or their related persons in issuers or borrowers create potential conflict between
the economic interests of these affiliates or related persons and the interests of the Advisers&#8217; clients. In addition, to the extent
that a potential issuer or borrower (or one of its affiliates) is an advisory client of an Adviser, or an Adviser&#8217;s advisory client
is a lender or financing provider to an Adviser or its affiliates (including a parent), a potential conflict may exist as the Adviser
may have an incentive to favor the interests of those clients relative to those of its other clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Because of limitations imposed by applicable
law, notably by provisions of the 1940 Act and rules thereunder, the involvement or presence of the Advisers&#8217; affiliates in the
offerings described above or the financial markets more broadly may restrict the Fund&#8217;s ability to acquire some securities or loans,
even if they would otherwise be desirable investments for the Fund, or affect the timing or price of such acquisitions or the sale of
an investment, which may adversely affect Fund performance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Subject to applicable law and regulation, personnel
of the Guggenheim Entities may support the overall investment management functions of the Advisers but may be subject to potential conflicts
of interest with respect to certain investment opportunities and, as such, may have an incentive to identify investment opportunities
for, and allocate investment opportunities to, third-parties. Similarly, to the extent that other Guggenheim Entities sponsor and manage
funds that compete with the Fund&#8217;s investment programs, these funds may reduce capacity otherwise available to the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">To the extent permitted by applicable law, the
Advisers and their affiliates may create, write, sell, issue, invest in or act as placement agent or distributor of derivative instruments
related to the Fund, or with respect to portfolio holdings of the Fund, or which may be otherwise based on or seek to replicate or hedge
the performance of the Fund. Such derivative transactions, and any associated hedging activity, may differ from and be adverse to the
interests of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Some of the Adviser&#8217;s employees (and others
acting as consultants or advisors) may serve as directors or otherwise serve a role within the portfolio company in which the Fund invests.
These services are separate from the services the Advisers render to the Fund and may thus create conflicts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Certain professionals, including investment
professionals, of the Advisers may, from time to time, also serve as investment professionals of affiliates. These arrangements, and the
relationship between the Advisers and the affiliates, present potential conflicts of interest, including those described herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.3in">Present and future activities of the Advisers
and their affiliates (and the role and relationships of the Advisers&#8217; personnel with other Guggenheim Entities), in addition to
those described in this SAI, may give rise to additional or different conflicts of interest.</p>

<!-- Field: Page; Sequence: 84; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="text-decoration: underline">Portfolio Manager Compensation</span>. As discussed
above, portfolio managers may own Fund shares and a portion of their compensation may include equity in the form of shares of certain
funds (other than the Fund) managed by the particular portfolio manager. As a result, a potential conflict of interest may arise to the
extent a portfolio manager owns or has an interest in shares of a specific fund that he or she manages. These personal investments may
create an incentive for a portfolio manager to favor such fund(s) over other advisory clients, including the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Securities Ownership of the Portfolio Managers.
</i>As of May 31, 2025, the dollar range of equity securities of the Fund beneficially owned by each portfolio manager is shown below:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 35%; text-align: center"><b>Portfolio Manager</b></td>
    <td style="width: 65%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Dollar Range of Equity Securities of the Fund</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Beneficial Owned</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center">Anne B. Walsh</td>
    <td style="text-align: center">$500,001-$1,000,000</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">Steve H. Brown</td>
    <td style="text-align: center">None</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center">Adam J. Bloch</td>
    <td style="text-align: center">None</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center">Evan L. Serdensky </td>
    <td style="text-align: center">None</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Advisers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Investment Adviser</i>. Guggenheim Funds Investment
Advisors, LLC acts as the Fund&#8217;s investment adviser pursuant to an advisory agreement between the Fund and the Investment Adviser
(the &#8220;Advisory Agreement&#8221;). The Investment Adviser is a registered investment adviser and acts as investment adviser to a
number of closed-end and open-end management investment companies. The Investment Adviser is a Delaware limited liability company with
principal offices located at 227 West Monroe Street, Chicago, Illinois 60606.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sub-Adviser</i>. Guggenheim Partners Investment
Management, LLC acts as an investment sub-adviser to the Fund pursuant to an investment sub-advisory agreement among the Fund, the Investment
Adviser and Sub-Adviser (the &#8220;Sub-Advisory Agreement&#8221;). Guggenheim Partners Investment Management, LLC is a Delaware limited
liability company, with its principal offices located at 100 Wilshire Boulevard, Santa Monica, California 90401.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Guggenheim Partners</i>. Each of the Investment
Adviser and Sub-Adviser is a wholly-owned subsidiary of Guggenheim Partners, LLC. Guggenheim Partners, LLC is a diversified financial
services firm with wealth management, capital markets, investment management and proprietary investing businesses, the clients of which
are a mix of individuals, family offices, endowments, investment funds, foundations, insurance companies and other institutions that have
entrusted Guggenheim Partners, LLC with the supervision of approximately $357 billion of assets as of September 30, 2025. Guggenheim Partners,
LLC is headquartered in Chicago and New York with a global network of offices throughout the United States, Europe, and Asia.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In rendering investment advisory services to
the Fund, the Investment Adviser and Sub-Adviser will use the resources of&#160;Guggenheim Partners Europe Limited (&#8220;GPE&#8221;)
to research, select, and effect some investments for the Fund in&#160;Europe and other non-U.S. jurisdictions, an affiliate of the Investment
Adviser and Sub-Adviser based in the United Kingdom that is&#160;not registered under the Investment Advisers Act of 1940, as amended.
Under the terms of a participating affiliate&#160;arrangement, GPE is considered to be a &#8220;Participating Affiliate&#8221; of the
Investment Adviser, as that term is used in&#160;relief granted by the staff of the SEC allowing US-registered advisers to use investment
advisory and trading&#160;resources of unregistered advisory affiliates, subject to the regulatory supervision of the registered adviser.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#8220;Guggenheim Investments&#8221; refers to
the global asset management and investment advisory division of Guggenheim Partners and includes the Investment Adviser, the Sub-Adviser
and other affiliated investment management businesses of Guggenheim Partners.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Advisory Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to the Advisory Agreement between the
Fund and the Investment Adviser, the Fund pays the Investment Adviser a fee, payable monthly in arrears at an annual rate equal to 1.00%
of the Fund&#8217;s average daily Managed Assets (from which the Investment Adviser will pay the Sub-Adviser&#8217;s fees). &#8220;Managed
Assets&#8221; means </p>

<!-- Field: Page; Sequence: 85; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">the total assets of the Fund (other than assets attributable to any investments by the Fund in Affiliated Investment
Funds), including the assets attributable to the proceeds from any borrowings or other forms of financial leverage, minus liabilities,
other than liabilities related to any financial leverage. &#8220;Affiliated Investment Funds&#8221; means investment companies, including
registered investment companies, private investment funds and/or other pooled investment vehicles, advised or managed by the Investment
Adviser, the Sub-Adviser or any of either&#8217;s affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under the terms of the Advisory Agreement, the
Investment Adviser is responsible for the management of the Fund. The Investment Adviser furnishes office facilities and equipment and
clerical, bookkeeping and administrative services on behalf of the Fund and oversees the activities of the Sub-Adviser. The Investment
Adviser provides all services through the medium of any directors, officers or employees of the Investment Adviser or its affiliates as
the Investment Adviser deems appropriate in order to fulfill its obligations and pays the compensation of all officers and Trustees of
the Fund who are its affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Advisory Agreement continues from year to
year if approved annually by both (i) the vote of a majority of the Fund&#8217;s Board of Trustees or by a vote of a majority of the outstanding
voting securities (as defined in the 1940 Act) of the Fund at the time outstanding and entitled to vote and (ii) the vote of a majority
of the Trustees who are not parties to the Advisory Agreement or &#8220;interested persons&#8221; (as defined in the 1940 Act) of any
such party, cast in person at a meeting called for the purpose of voting on such approval. The Advisory Agreement terminates automatically
on its assignment and may be terminated without penalty on 60 days&#8217; written notice at the option of either party thereto. Termination
by the Fund shall be directed or approved by a vote of a majority of the Trustees of the Fund in office at the time or by a vote of the
holders of a majority of the voting securities (as defined in the 1940 Act) of the Fund at the time outstanding and entitled to vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Advisory Agreement provides that, the Investment
Adviser will not be liable for any error or judgment or mistake of law or for any loss suffered by the Investment Adviser or by the Fund
in connection with the performance of the Advisory Agreement, except loss resulting from the breach of fiduciary duty with respect to
the receipt of compensation for services or loss resulting from willful malfeasance, bad faith or gross negligence on its part in the
performance of its duties or from reckless disregard by it of its duties under the Advisory Agreement</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Advisory Fees</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><b>Fiscal Year Ended May 31,</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 36%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 20%; text-align: center"><b>2025</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; width: 22%; text-align: center"><b>2024</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; width: 22%; text-align: center"><b>2023</b></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center">The Investment Adviser received advisory fees of</td>
    <td style="text-align: center">$22,295,074</td>
    <td style="text-align: center">$19,752,305</td>
    <td style="text-align: center">$18,782,204</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center">Sub-Advisory Agreement</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to the Sub-Advisory Agreement among
the Fund, the Investment Adviser and the Sub-Adviser, the Investment Adviser pays the Sub-Adviser a fee, payable monthly in arrears at
an annual rate equal to 0.50% of the Fund&#8217;s average daily Managed Assets, less 0.50% of the Fund&#8217;s average daily assets attributable
to any investments by the Fund in Affiliated Investment Funds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Under the terms of the Sub-Advisory Agreement,
the Sub-Adviser, under the oversight and supervision of the Board and the Investment Adviser, manages the investment of the assets of
the Fund in accordance with its investment policies, places orders to purchase and sell securities on behalf of the Fund, and, at the
request of the Investment Adviser, consults with the Investment Adviser as to the overall management of the assets of the Fund and its
investment policies and practices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Advisory Agreement continues from year
to year if approved annually (i) by a vote of a majority of the Fund&#8217;s Board of Trustees or by a vote of a majority of the outstanding
voting securities (as defined in the 1940 Act) of the Fund at the time outstanding and entitled to vote and (ii) by a vote of a majority
of the Trustees who are not parties to the Sub-Advisory Agreement or &#8220;interested persons&#8221; (as defined in the 1940 Act) of
any such party, cast in person at a meeting called for the purpose of voting on such approval. The Sub-Advisory Agreement terminates automatically
on its assignment and may be terminated without penalty on 60 days&#8217; written notice at the option of either party thereto. Termination
by the Fund shall be directed or approved by a vote of a majority of the Trustees of the Fund in office at the time or by a vote of the
holders of a majority of the voting securities (as defined in the 1940 Act) of the Fund at the time outstanding and entitled to vote.</p>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Advisory Agreement provides that, the
Sub-Adviser will not be liable for any error of judgment or mistake of law or for any loss suffered by the Investment Adviser or by the
Fund (or their respective agents) in connection with the performance of the Sub-Advisory Agreement, except a loss resulting from a breach
of fiduciary duty with respect to the receipt of compensation for services or a loss resulting from willful misfeasance, bad faith or
gross negligence on its part in the performance of its duties or from reckless disregard by it of its duties under the Sub-Advisory Agreement.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Sub-Advisory Fees</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 61%; text-align: center">&#160;</td>
    <td style="width: 12%; text-align: center">&#160;</td>
    <td style="width: 10%; text-align: center">&#160;</td>
    <td style="width: 17%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><b>Fiscal Year Ended May 31,</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center"><b>2025</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center"><b>2024</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center"><b>2023</b></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center">The Sub-Adviser received sub-advisory fees of:</td>
    <td style="vertical-align: top; text-align: center">$11,147,537&#160;&#160;</td>
    <td style="vertical-align: top; text-align: center">$9,876,153</td>
    <td style="vertical-align: bottom; text-align: center">$9,391,102</td></tr>
  </table>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-align: center">Other Agreements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Administration Agreement. </i>MUFG Investor Services
(US) LLC (&#8220;MUFG&#8221;), acts as administrator to the Fund. Pursuant to an accounting and administration agreement, MUFG is responsible
for providing administrative services to the Fund, including assisting the Fund with regulatory filings. For the services, the Fund pays
MUFG a fee, accrued daily and paid monthly, at the annual rate equal to 0.0275% of the first $200 million in average daily Managed Assets,
0.0200% of the next $300 million in average daily Managed Assets, 0.0150% of the next $500 million in average daily Managed Assets, and
0.0100% of average daily Managed Assets above $1 billion, along with an annual fixed fee ranging from $500 to $11,000 for assisting the
Fund with certain regulatory filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in"><i>Administration Fee.</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 50%">&#160;</td>
    <td style="width: 16%; text-align: center">&#160;</td>
    <td style="width: 18%; text-align: center">&#160;</td>
    <td style="width: 16%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><b>Fiscal Year Ended May 31,</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center"><b>2025</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center"><b>2024</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center"><b>2023</b></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center">MUFG received administration fees of:</td>
    <td style="vertical-align: top; text-align: center">$338,411</td>
    <td style="vertical-align: top; text-align: center">$287,523</td>
    <td style="vertical-align: bottom; text-align: center">$277,259</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in"><i>Fund Accounting Agreement. </i>MUFG also acts
as fund accounting agent to the Fund. Pursuant to an accounting and administration agreement, MUFG performs certain accounting services.
For the services, the Fund pays MUFG a fee, accrued daily and paid monthly, at the annual rate equal to 0.0300% of the first $200 million
in average daily Managed Assets, 0.0150% of the next $300 million in average daily Managed Assets, 0.0100% of the next $500 million in
average daily Managed Assets, and 0.0075% of average daily Managed Assets above $1 billion, subject to a minimum fee of $50,000 per year,
and reimburses MUFG for certain out-of-pocket expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in"><i>Fund Accounting Fee.</i></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 52%">&#160;</td>
    <td style="width: 16%; text-align: center">&#160;</td>
    <td style="width: 16%; text-align: center">&#160;</td>
    <td style="width: 16%; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td colspan="3" style="border-bottom: black 1.5pt solid; text-align: center"><b>Fiscal Year Ended May 31,</b></td></tr>
  <tr>
    <td style="vertical-align: bottom; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center"><b>2025</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: top; text-align: center"><b>2024</b></td>
    <td style="border-bottom: black 1.5pt solid; vertical-align: bottom; text-align: center"><b>2023</b></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: bottom; text-align: center">MUFG received fund accounting fees of:</td>
    <td style="vertical-align: top; text-align: center">$267,123</td>
    <td style="vertical-align: top; text-align: center">$240,586</td>
    <td style="vertical-align: bottom; text-align: center">$228,854</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>


<!-- Field: Page; Sequence: 87; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIPortTransactions"></span>Portfolio
Transactions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Subject to policies established by the Board
of Trustees, the Sub-Adviser is responsible for placing purchase and sale orders and the allocation of brokerage on behalf of the Fund.
Transactions in equity securities are in most cases effected on U.S. stock exchanges and involve the payment of negotiated brokerage commissions.
In general, there may be no stated commission in the case of securities traded in OTC markets, but the prices of those securities may
include undisclosed commissions or mark-ups. The Fund has no obligations to deal with any broker or group of brokers in executing transactions
in portfolio securities. In executing transactions, the Sub-Adviser seeks to obtain best price and execution for the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In furtherance of seeking the most favorable
execution, the Sub-Adviser has adopted a Counterparty Approval Policy pursuant to which it maintains an Approved Counterparty List. Transactions
may only be executed with counterparties/broker-dealers on the Approved Counterparties List unless an exception is granted by an authorized
person under the Counterparty Approval Policy. Initially and on an ongoing basis, the Sub-Adviser consults a variety of information relating
to a counterparty/broker-dealer, including regulatory reports and financial information, in connection with adding and maintaining a counterparty
to the Approved Counterparty List. Generally, counterparties on the Approved Counterparty List must, in the Sub-Adviser&#8217;s opinion,
have financial stability and a positive reputation in the industry. When reviewing brokers, the Sub-Adviser may consider, including, without
limitation, the size and type of transaction, access to liquidity, execution efficiency and capability, and other factors it may deem
appropriate. The Sub-Adviser uses its judgment to select a broker or dealer on the basis of how a transaction can be executed to achieve
the most favorable execution for the Fund under the circumstances. Accordingly, the Sub-Adviser is not obligated to choose the broker
or dealer offering the lowest available commission rate or the lowest possible execution cost on a transaction. The sale of Fund shares
by a broker or dealer is not a factor in the selection of brokers and dealers to execute portfolio transactions for the Fund. The Sub-Adviser
and its affiliates do not currently participate in soft dollar arrangements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser may aggregate trade orders for
the Fund and its other clients in a particular security when it believes that doing so is in the best interests of all participating accounts
and is in furtherance of its duty to seek best execution. Aggregation of trade orders may result in an overall benefit to the Fund because
it may achieve efficiencies in execution and reduce trading costs. When aggregating trades, the Sub-Adviser will continue to seek best
execution, treat all participating accounts fairly and ensure participating accounts pay the same price, net of transaction costs. Although
investment decisions for the Fund are made independently from those of the other accounts managed by the Sub-Adviser and its affiliates,
investments of the kind made by the Fund may also be made by those other accounts. When the same securities are purchased for or sold
by the Fund and any of such other accounts, it is the policy of the Sub-Adviser and its affiliates to allocate such purchases and sales
in the manner deemed fair and equitable to all of the accounts, including the Fund, taking into account the needs and investment objective
of the accounts as well as prevailing market conditions. There can be no assurance that a particular investment opportunity will be allocated
in a particular manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Commissions Paid. </i>Unless otherwise disclosed
below, the Fund paid no commissions to affiliated brokers during the last three fiscal years. The Fund paid approximately the following
commissions to brokers during the fiscal years shown:</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 66%">&#160;</td>
    <td style="width: 16%">&#160;</td>
    <td style="width: 18%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><b>Fiscal Year Ended May 31,</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><b>All Brokers</b></td>
    <td style="border-bottom: Black 1pt solid; text-align: right"><b>Affiliated Brokers</b></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">2025</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">$28,211</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">$0</td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">2024</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">$115,700</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">$0</td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">2023</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">$143,262 </td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right">$0</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: Black 1pt solid; width: 66%"><b>Fiscal Year Ended May 31, 2025 Percentages:</b></td>
    <td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 18%; text-align: right">&#160;</td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">Percentage of aggregate brokerage commissions paid to affiliated broker</td>
    <td colspan="2" rowspan="2" style="border-right: Black 1pt solid; border-bottom: Black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white">0%</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; background-color: white">0%</p></td></tr>
  <tr>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid">Percentage of aggregate dollar amount of transactions involving the payment of commissions effected through affiliated broker</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in">During the fiscal year ended May 31, 2025, the
Fund paid $0 in brokerage commissions on transactions totaling $0 to brokers selected primarily on the basis of research services provided
to the Adviser or the Sub-Adviser.</p>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0; text-indent: 0.5in">Guggenheim Investments has created a Best Execution
Committee (the &#8220;Committee&#8221;) in connection with the broker-dealer selection process and oversight of the best execution policies.
The Committee examines the performance of broker-dealers and, for equity trades, makes recommendations regarding the addition of potential
broker-dealers. In addition, the Committee works to mitigate potential conflicts of interest that could exist.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIUSFederalIncTaxCons"></span>U.S.
Federal Income Tax Considerations</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following discussion is a brief summary of
certain U.S. federal income tax considerations affecting the Fund and the ownership and disposition of the Fund&#8217;s Common Shares.
Except as otherwise noted, this discussion assumes you are a taxable U.S. person (as defined for U.S. federal income tax purposes) and
that you hold your Common Shares as capital assets for U.S. federal income tax purposes (generally, assets held for investment). This
discussion is based upon current provisions of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), the regulations
promulgated thereunder and judicial and administrative authorities, all of which are subject to change or differing interpretations by
the courts or the Internal Revenue Service (the &#8220;IRS&#8221;), possibly with retroactive effect. No attempt is made to present a
detailed explanation of all U.S. federal, state, local and foreign tax concerns affecting the Fund and its Common Shareholders (including
Common Shareholders subject to special treatment under U.S. federal income tax law). No assurance can be given that the IRS would not
assert, or that a court would not sustain, a position contrary to any of the tax aspects set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The discussions set forth herein and in the
Prospectus do not constitute tax advice and potential investors are urged to consult their own tax advisers to determine the specific
U.S. federal, state, local and foreign tax consequences to them of investing in the Fund.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of the Fund</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has elected to be treated and intends
to continue to qualify each year as a regulated investment company (&#8220;RIC&#8221;) under Subchapter M of the Code. Accordingly, the
Fund must, among other things, (i) derive in each taxable year at least 90% of its gross income from (a) dividends, interest (including
tax-exempt interest), payments with respect to certain securities loans, and gains from the sale or other disposition of stock, securities
or foreign currencies, or other income (including gain from options, futures and forward contracts) derived with respect to its business
of investing in such stock, securities or foreign currencies and (b) net income derived from interests in &#8220;qualified publicly traded
partnerships&#8221; (as defined in the Code); and (ii) diversify its holdings so that, at the end of each quarter of each taxable year
(a) at least 50% of the market value of the Fund&#8217;s total assets is represented by cash and cash items, U.S. Government securities,
the securities of other RICs and other securities, with such other securities limited, in respect of any one issuer, to an amount not
greater than 5% of the value of the Fund&#8217;s total assets and not more than 10% of the outstanding voting securities of such issuer
and (b) not more than 25% of the market value of the Fund&#8217;s total assets is invested in the securities (other than U.S. government
securities and the securities of other RICs) of (I) any one issuer, (II) any two or more issuers that the Fund controls and that are determined
to be engaged in the same business or similar or related trades or businesses or (III) any one or more &#8220;qualified publicly traded
partnerships.&#8221; Generally, a qualified publicly traded partnership includes a partnership the interests of which are traded on an
established securities market or readily tradable on a secondary market (or the substantial equivalent thereof) and that derives less
than 90% of its gross income from the items described in (a) above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As long as the Fund qualifies as a RIC, the Fund
generally will not be subject to U.S. federal income tax on income and gains that the Fund distributes to its Common Shareholders, provided
that it distributes each taxable year at least the sum of (i) 90% of the Fund&#8217;s investment company taxable income (which includes,
among other items, dividends, interest, the excess of any net short-term capital gain over net long-term capital loss, and other taxable
income, other than any net capital gain (defined below), reduced by deductible expenses) determined without regard to the deduction for
dividends and distributions paid and (ii) 90% of the Fund&#8217;s net tax-exempt interest (the excess of its gross tax-exempt interest
over certain disallowed deductions). The Fund intends to distribute substantially all of such income each year. The Fund will be subject
to income tax at regular corporate rates on any taxable income or gains that it does not distribute to its Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Code imposes a 4% nondeductible excise tax
on the Fund to the extent the Fund does not distribute by the end of any calendar year at least the sum of (i) 98% of its ordinary income
(not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss
(adjusted for certain ordinary losses) for a one-year period generally ending on October 31 of the calendar year. In addition, the minimum
amounts that must be distributed in any year to avoid the excise tax will be increased or decreased to </p>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">reflect any under-distribution
or over-distribution, as the case may be, from the previous year. For purposes of the excise tax, the Fund will be deemed to have distributed
any income on which it paid federal income tax in the taxable year ending within the calendar year. While the Fund intends to distribute
income and capital gain in order to minimize imposition of the 4% nondeductible excise tax, there can be no assurance that amounts of
the Fund&#8217;s taxable income and capital gain will be distributed to avoid entirely the imposition of the excise tax. In that event,
the Fund will be liable for the excise tax only on the amount by which it does not meet the foregoing distribution requirement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If for any taxable year the Fund does not qualify
as a RIC, all of its taxable income (including its net capital gain, which consists of the excess of its net long-term capital gain over
its net short-term capital loss) will be subject to tax at regular corporate rates without any deduction for distributions to Common Shareholders,
and such distributions will be taxable to the Common Shareholders as ordinary dividends to the extent of the Fund&#8217;s current or accumulated
earnings and profits. As described below, such dividends, however, would generally be eligible (i) to be treated as &#8220;qualified dividend
income&#8221; in the case of Common Shareholders taxed as individuals and (ii) for the dividends received deduction in the case of corporate
Common Shareholders, subject, in each case, to certain holding period and other requirements. To qualify again to be taxed as a RIC in
a subsequent year, the Fund would generally be required to distribute to its Common Shareholders its earnings and profits attributable
to non-RIC years. If the Fund fails to qualify as a RIC for a period greater than two taxable years, the Fund may be required to recognize
and pay tax on any net built-in gains with respect to certain of its assets (i.e., the excess of the aggregate gains, including items
of income, over aggregate losses that would have been realized with respect to such assets if the Fund had been liquidated) or, alternatively,
to elect to be subject to taxation on such built-in gain recognized for a period of five years, in order to qualify as a RIC in a subsequent
year.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of the Fund&#8217;s Investments</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain of the Fund&#8217;s investment practices
are subject to special and complex U.S. federal income tax provisions (including mark-to-market, constructive sale, straddle, wash sale,
short sale and other rules) that may, among other things, (i) disallow, suspend or otherwise limit the allowance of certain losses or
deductions, including the dividends received deduction, (ii) convert lower taxed long-term capital gains or &#8220;qualified dividend
income&#8221; into higher taxed short-term capital gains or ordinary income, (iii) convert ordinary loss or a deduction into capital loss
(the deductibility of which is more limited), (iv) cause the Fund to recognize income or gain without a corresponding receipt of cash,
(v) adversely affect the time as to when a purchase or sale of stock or securities is deemed to occur, (vi) adversely alter the characterization
of certain complex financial transactions and (vii) produce income that will not be &#8220;qualified&#8221; income for purposes of the
90% annual gross income requirement described above. These U.S. federal income tax provisions could therefore affect the amount, timing
and character of distributions to Common Shareholders. The Fund intends to monitor its transactions and may make certain tax elections
and may be required to dispose of securities to mitigate the effect of these provisions and prevent disqualification of the Fund as a
RIC. Additionally, the Fund may be required to limit its activities in derivative instruments in order to enable it to maintain its RIC
status.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest a portion of its net assets
in below investment grade securities, commonly known as &#8220;junk&#8221; securities. Investments in these types of securities may present
special tax issues for the Fund. U.S. federal income tax rules are not entirely clear about issues such as when the Fund may cease to
accrue interest, original issue discount or market discount, when and to what extent deductions may be taken for bad debts or worthless
securities, how payments received on obligations in default should be allocated between principal and income and whether exchanges of
debt obligations in a bankruptcy or workout context are taxable. These and other issues will be addressed by the Fund, to the extent necessary,
in order to seek to ensure that it distributes sufficient income to preserve its status as a RIC and does not become subject to U.S. federal
income or excise tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain debt securities acquired by the Fund
may be treated as debt securities that were originally issued at a discount. Generally, the amount of the original issue discount is treated
as interest income and is included in taxable income (and required to be distributed by the Fund in order to qualify as a RIC or avoid
the 4% excise tax) over the term of the security, even though payment of that amount is not received until a later time, usually when
the debt security matures. Other investments may similarly require the Fund to recognize taxable income without a corresponding receipt
of cash. If the Fund purchases a debt security on a secondary market at a price lower than its adjusted issue price, the excess of the
adjusted issue price over the purchase price is &#8220;market discount.&#8221; Unless the Fund makes an election to accrue market discount
on a current basis, generally, any gain realized on the disposition of, and any partial payment of principal on, a debt security having
market discount is treated as ordinary income to </p>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">the extent the gain, or principal payment, does not exceed the &#8220;accrued market
discount&#8221; on the debt security. Market discount generally accrues in equal daily installments unless a constant yield method is
elected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain types of income received by the Fund
from REITs, REMICs, taxable mortgage pools or other investments may cause the Fund to report some or all of its distributions as &#8220;excess
inclusion income.&#8221; To Fund Common Shareholders such excess inclusion income will (i) constitute taxable income, as &#8220;unrelated
business taxable income&#8221; (&#8220;UBTI&#8221;) for those Common Shareholders who would otherwise be tax-exempt such as individual
retirement accounts, 401(k) accounts, Keogh plans, pension plans and certain charitable entities, (ii) not be offset against net operating
losses for tax purposes, (iii) not be eligible for reduced U.S. withholding for non-U.S. Common Shareholders even from tax treaty countries
and (iv) cause the Fund to be subject to tax if certain &#8220;disqualified organizations,&#8221; as defined by the Code (which includes
charitable remainder trusts), are Fund Common Shareholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest in preferred securities or
other securities the U.S. federal income tax treatment of which may not be clear or may be subject to recharacterization by the IRS. To
the extent the tax treatment of such securities or the income from such securities differs from the tax treatment expected by the Fund,
it could affect the timing or character of income recognized by the Fund, requiring the Fund to purchase or sell securities, or otherwise
change its portfolio, in order to comply with the tax rules applicable to RICs under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Gain or loss on the sales of securities by the
Fund will generally be long-term capital gain or loss if the securities have been held by the Fund for more than one year. Gain or loss
on the sale of securities held for one year or less will be short-term capital gain or loss. Gain or loss on debt instruments denominated
in, or derivatives the value of which is determined based on, foreign currency may be treated as foreign currency gain or loss in part
or in whole.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">For federal income tax purposes, the Fund is
generally permitted to carry forward a net capital loss in any taxable year to offset its own capital gains, if any. These amounts are
available to be carried forward to offset future capital gains to the extent permitted by the Code and applicable tax regulations. Any
such loss carryforwards will retain their character as short-term or long-term. In the event that the Fund were to experience an ownership
change as defined under the Code, the capital loss carryforwards and other favorable tax attributes of the Fund, if any, may be subject
to limitation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Because the Fund may invest in foreign securities,
its income from such securities may be subject to non-U.S. taxes. The Fund will not be eligible to elect to &#8220;pass-through&#8221;
to Common Shareholders of the Fund the ability to use the foreign tax deduction or foreign tax credit for foreign taxes paid with respect
to qualifying taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Private Investment Funds Taxed as Partnerships</i>.
Certain of the private investment funds in which the Fund may invest will be treated as partnerships for U.S. federal income tax purposes.
Consequently, the Fund&#8217;s income, gains, losses, deductions and expenses will depend upon the corresponding items recognized by such
private investment funds. In addition, the Fund&#8217;s proportionate share of the assets of each such private investment fund will be
treated as if held directly by the Fund. In these instances, the Fund will be required to meet the diversification test with respect to
the assets of such private investment funds. The Fund generally will not invest in private investment funds that are treated as partnerships
for U.S. federal income tax purposes unless the terms of such investment provide, or the managers of such private investment funds agree
to provide, the Fund with information on a regular basis as reasonably necessary to monitor the Fund&#8217;s qualification as a RIC for
U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Private Investment Funds Taxed as PFICs</i>.
The Fund anticipates that certain of the private investment funds (including certain CLOs) in which it invests will be treated as &#8220;passive
foreign investment companies&#8221; (&#8220;PFICs&#8221;) for U.S. federal income tax purposes. In general, a PFIC is any foreign corporation
that has 75% or more of its gross income for the taxable year which consists of passive income or that has 50% or more of the average
fair market value of its assets which consists of assets that produce, or are held for the production of, passive income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Fund makes an election to treat the PFIC
as a &#8220;qualified electing fund&#8221; (a &#8220;QEF Election&#8221;), the Fund would be taxed currently on the PFIC&#8217;s income
without regard to whether the Fund received any distributions from the PFIC. If the Fund makes a QEF Election with respect to a private
investment fund and the private investment fund complies with certain annual reporting requirements, the Fund will be required to include
in its gross income each year its pro rata share of the private investment fund&#8217;s ordinary income and net capital gains (at ordinary
income and capital gain rates, respectively) for each year in which the private investment fund is a PFIC, regardless of whether the Fund
receives distributions from the private investment fund. Treasury Regulations generally treat income inclusion from a PFIC with respect
to which the Fund has made such an election as qualifying income for </p>

<!-- Field: Page; Sequence: 91; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">purposes of the income requirement applicable to RICs under the Code
if (i) there is a current distribution out of the earnings and profits of the PFIC that are attributable to such income inclusion or (ii)
such income inclusion is derived with respect to the Fund&#8217;s business of investing in stock, securities, or currencies. By reason
of such inclusions, the Fund would be deemed to have received net investment income, which would be subject to the 90% distribution requirement,
and to have received net capital gains, possibly without a corresponding receipt of cash. The Fund&#8217;s basis in the shares it owns
in the private investment fund will be increased to reflect any such deemed distributed income. Because some of the private investment
funds in which the Fund may invest may defer the payment of management and/or incentive compensation fees, during the deferral period
the Fund&#8217;s pro rata share of the private investment fund&#8217;s ordinary income will be higher than it would be if the private
investment fund had not deferred the payment of such fees. A QEF Election is subject to a number of specific rules and requirements, and
not all of the private investment funds in which the Fund may invest may provide their investors with the information required to satisfy
the reporting requirements necessary for the Fund to make a QEF Election.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In lieu of making a QEF Election, the Fund could
elect to mark-to-market its PFIC stock and include in income any resulting gain or loss (a &#8220;Mark-to-Market Election&#8221;). The
Fund anticipates that it will make a Mark-to-Market Election with respect to the stock of any PFICs in which it invests that do not provide
the Fund with the information necessary for the Fund to make a QEF Election. Unlike in the case of a QEF Election, under a Mark-to-Market
Election the Fund will not be deemed to have received distributions of net investment income or net capital gains from the PFIC. If the
Fund makes a Mark-to-Market Election with respect to a PFIC, the Fund will be deemed to have sold the shares of that PFIC as of the last
day of the Fund&#8217;s taxable year and will be required to include in the Fund&#8217;s net investment income the positive difference,
if any, between the fair market value of shares as of the end of the Fund&#8217;s taxable year and the adjusted basis of such shares.
All of such positive difference will be treated as ordinary income and will be a dividend in the hands of the Fund. Moreover, any gain
from the Fund&#8217;s actual sale of PFIC shares with respect to which the Fund has made a Mark-to-Market Election will be ordinary income
in the Fund&#8217;s hands. Thus, unlike the case of a QEF Election, the Fund cannot generate long-term capital gains with respect to PFIC
stock for which the Fund has made a Mark-to-Market Election. The Fund will recognize income regardless of whether the PFIC has made any
distributions to the Fund and such income will constitute net investment income subject to the 90% distribution requirement described
above. The Fund&#8217;s basis in the shares it owns in the private investment fund will be increased to reflect any such recognized income.
The Fund may deduct any decrease in value equal to the excess of its adjusted basis in the shares over the fair market value of the shares
of the private investment fund as of the end of the Fund&#8217;s taxable year, but only to the extent of any previously unreversed net
mark-to-market gains included in the Fund&#8217;s income for prior taxable years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">The Fund intends
to borrow funds or to redeem a sufficient amount of its investments in private investment funds that are PFICs and for which the Fund
has made either a QEF Election or a Mark-to-Market Election so that the Fund has sufficient cash to meet the distribution requirements
to maintain its qualification as a RIC and minimize U.S. federal income and excise taxes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">In the event
that the Fund does not make a QEF Election or a Mark-to-Market Election with respect to PFIC stock held by the Fund, the Fund would be
taxed at ordinary income rates and pay an interest charge if it received an &#8220;excess distribution&#8221; (generally, a distribution
in excess of a base amount) or if it realized gain on the sale of its PFIC stock. The amount of the excess distribution or gain would
be allocated ratably to each day in the Fund&#8217;s holding period for the PFIC stock, and the Fund would be required to include the
amount allocated to the current taxable year in its income as ordinary income for such year. The amounts allocated to prior taxable years
generally would be taxed at the highest ordinary income tax rate in effect for each such prior taxable year and would also be subject
to an interest charge computed as if such tax liability had actually been due with respect to each such prior taxable year. The Fund expects
to make a QEF Election or a Mark-to-Market Election with respect to the PFICs in which it invests and, accordingly, does not expect to
be subject to this &#8220;excess distribution&#8221; regime.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Risk-Linked
Securities</i>. The treatment of risk-linked securities for U.S. federal income tax purposes is uncertain and will depend on the particular
features of each such securities. The Fund expects that it will generally treat the risk-linked securities in which it invests as equity
of the issuer for U.S. federal income tax purposes, whether that treatment is mandated by the terms of the applicable bond indentures
or otherwise, although this determination will necessarily be made on an investment by investment basis. It is possible that the IRS will
provide future guidance with respect to the treatment of instruments like the risk-linked securities or challenge the</span></p>

<!-- Field: Page; Sequence: 92; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-weight: normal"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><span style="font-weight: normal">treatment adopted by the Fund for
one or more of its risk-linked securities investments. A change in the treatment of the Fund&#8217;s risk-linked securities investments
that is required as a result of such guidance or an IRS challenge could affect the timing, character and amount of the Fund&#8217;s income
from the risk-linked securities. This, in turn, could affect whether the Fund has satisfied the distribution requirements necessary to
qualify as a RIC and to avoid a Fund-level tax.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Risk-linked
securities that are treated as equity may be subject to special U.S. federal income tax rules applicable to equity investments in a PFIC,
and will generally be subject to the PFIC rules described above under the caption &#8220;Private Investment Funds Taxed as PFICs.&#8221;
In cases in which the Fund treats such risk-linked securities as an equity interest in a PFIC, the Fund generally expects to make a Mark-to-Market
Election, which would require the Fund to recognized income or (subject to certain limitations) loss annually based on the difference
between the fair market value of the risk-linked securities at the end of the year and the Fund&#8217;s adjusted basis in the risk-linked
securities. Because the Mark-to-Market Election can result in recognition of income without the concurrent receipt of cash, the Fund may
have to borrow funds or sell portfolio securities, thereby possibly resulting in the recognition of additional income or gain to satisfy
the distribution requirements necessary to qualify as a RIC and to avoid a Fund-level tax. If the Fund were not able to meet such distribution
requirements, the Fund would run the risk of losing its qualification as a RIC.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Taxation of U.S. Common Shareholders</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will either distribute or retain for
reinvestment all or part of its net capital gain. If any such gain is retained, the Fund will be subject to a corporate income tax (at
regular corporate rates) on such retained amount. In that event, the Fund expects to designate the retained amount as undistributed capital
gain in a notice to its Common Shareholders, each of whom, if subject to U.S. federal income tax on long-term capital gains, (i) will
be required to include in income for U.S. federal income tax purposes as long-term capital gain its share of such undistributed amounts,
(ii) will be entitled to credit its proportionate share of the tax paid by the Fund against its U.S. federal income tax liability and
to claim refunds to the extent that the credit exceeds such liability and (iii) will increase its basis in its Common Shares by the amount
of undistributed capital gain included in such Common Shareholder&#8217;s gross income net of the tax deemed paid by the shareholder under
clause (ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Distributions paid to you by the Fund from its
net capital gains, if any, that the Fund properly reports as capital gains dividends (&#8220;capital gain dividends&#8221;) are taxable
as long-term capital gains, regardless of how long you have held your Common Shares. All other dividends paid to you by the Fund from
its current or accumulated earnings and profits (including individuals from net short-term capital gains) (&#8220;ordinary income dividends&#8221;)
are generally subject to tax as ordinary income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Properly reported ordinary income dividends received
by corporate holders of Common Shares generally will be eligible for the dividends received deduction to the extent that the Fund&#8217;s
income consists of dividend income from U.S. corporations and certain holding period and other requirements are satisfied by both the
Fund and the corporate shareholders. In case of Common Shareholders who are individuals, properly reported ordinary income dividends that
you receive from the Fund generally will be eligible for taxation at the rates applicable to long-term capital gains to the extent that
(i) the ordinary income dividend is attributable to &#8220;qualified dividend income&#8221; (i.e<i>., </i>generally dividends paid by
U.S. corporations and certain foreign corporations) received by the Fund, (ii) the Fund satisfies certain holding period and other requirements
with respect to the stock on which such qualified dividend income was paid and (iii) you satisfy certain holding period and other requirements
with respect to your Common Shares. The reduced rates for &#8220;qualified dividend income&#8221; are not applicable to (i) dividends
paid by a foreign corporation that is a PFIC, (ii) income inclusions from a QEF Election with respect to a PFIC, (iii) ordinary income
from a Mark-to-Market Election with respect to a PFIC, and (iv) dividend income from REITs. In addition, for dividends to be eligible
for the dividends received deduction or for reduced rates applicable to individuals, the Fund cannot have an option to sell or be under
a contractual obligation to sell (pursuant to a short sale or otherwise) substantially identical stock or securities. Accordingly, the
Fund&#8217;s writing of call options may, depending on the terms of the option, adversely impact the Fund&#8217;s ability to pay dividends
eligible for the dividends received deduction or for reduced rates applicable to individuals. Qualified dividend income eligible for these
special rules is not actually treated as capital gains, however, and thus will not be included in the computation of your net capital
gain and generally cannot be used to offset any capital losses. There can be no assurance as to what portion of the Fund&#8217;s distributions
will qualify for favorable treatment as qualified dividend income or for the corporate dividends received deduction.</p>

<!-- Field: Page; Sequence: 93; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A dividend (whether paid in cash or reinvested
in additional Fund Common Shares) will not be treated as qualified dividend income (whether received by the Fund or paid by the Fund to
a Common Shareholder) if (1) the dividend is received with respect to any share held for fewer than 61 days during the 121-day period
beginning on the date which is 60 days before the date on which such share becomes ex-dividend with respect to such dividend, (2) to the
extent that the Common Shareholder is under an obligation (whether pursuant to a short sale or otherwise) to make related payments with
respect to positions in substantially similar or related property, or (3) if the Common Shareholder elects to have the dividend treated
as investment income for purposes of the limitation on deductibility of investment interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain distributions reported by the Fund as
Section 163(j) interest dividends may be treated as interest income by Common Shareholders for purposes of the tax rules applicable to
interest expense limitations under Section 163(j) of the Code. Such treatment by the Common Shareholder is generally subject to holding
period requirements and other potential limitations, although the holding period requirements are generally not applicable to dividends
declared by money market funds and certain other funds that declare dividends daily and pay such dividends on a monthly or more frequent
basis. The amount that the Fund is eligible to report as a Section 163(j) dividend for a tax year is generally limited to the excess of
the Fund&#8217;s business interest income over the sum of the Fund&#8217;s (i) business interest expense and (ii) other deductions properly
allocable to the Fund&#8217;s business interest income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Individuals (and certain other non-corporate
entities) are generally eligible for a 20% deduction with respect to taxable ordinary REIT dividends. Applicable Treasury regulations
allow the Fund to pass through to its Common Shareholders such taxable ordinary REIT dividends. Accordingly, individual (and certain other
non-corporate) Common Shareholders of the Fund that have received such taxable ordinary REIT dividends may be able to take advantage of
this 20% deduction with respect to any such amounts passed through.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Any distributions you receive that are in excess
of the Fund&#8217;s current and accumulated earnings and profits will be treated as a tax-free return of capital to the extent of your
adjusted tax basis in your Common Shares, and thereafter as capital gain from the sale of Common Shares (assuming the Common Shares are
held as a capital asset). The amount of any Fund distribution that is treated as a tax-free return of capital will reduce your adjusted
tax basis in your Common Shares, thereby increasing your potential gain or reducing your potential loss on any subsequent sale or other
disposition of your Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Common Shareholders may be entitled to offset
their capital gain dividends with capital losses. The Code contains a number of statutory provisions affecting when capital losses may
be offset against capital gain, and limiting the use of losses from certain investments and activities. Accordingly, Common Shareholders
that have capital losses are urged to consult their tax advisers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Dividends and other taxable distributions are
taxable to you even though they are reinvested in additional Common Shares of the Fund. Dividends and other distributions paid by the
Fund are generally treated under the Code as received by you at the time the dividend or distribution is made. If, however, the Fund pays
you a dividend in January that was declared in the previous October, November or December and you were the Common Shareholder of record
on a specified date in one of such months, then such dividend will be treated for U.S. federal income tax purposes as being paid by the
Fund and received by you on December 31 of the year in which the dividend was declared. In addition, certain other distributions made
after the close of the Fund&#8217;s taxable year may be &#8220;spilled back&#8221; and treated as paid by the Fund (except for purposes
of the 4% nondeductible excise tax) during such taxable year. In such case, you will be treated as having received such dividends in the
taxable year in which the distributions were actually made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The price of Common Shares purchased at any time
may reflect the amount of a forthcoming distribution. Those purchasing Common Shares just prior to the record date for a distribution
will receive a distribution which will be taxable to them even though it represents in part a return of invested capital.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will send you information after the
end of each year setting forth the amount and tax status of any distributions paid to you by the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Ordinary income dividends and capital gain dividends
also may be subject to state and local taxes. Common Shareholders are urged to consult their own tax advisers regarding specific questions
about U.S. federal (including the application of the alternative minimum tax rules), state, local or foreign tax consequences to them
of investing in the Fund.</p>

<!-- Field: Page; Sequence: 94; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The sale or other disposition of Common Shares
will generally result in capital gain or loss to you and will be long-term capital gain or loss if you have held such Common Shares for
more than one year at the time of sale. Any loss upon the sale or other disposition of Common Shares held for six months or less will
be treated as long-term capital loss to the extent of any capital gain dividends received (including amounts credited as an undistributed
capital gain dividend) by you with respect to such Common Shares. Any loss you recognize on a sale or other disposition of Common Shares
will be disallowed if you acquire other Common Shares (whether through the automatic reinvestment of dividends or otherwise) within a
61-day period beginning 30 days before and ending 30 days after your sale or exchange of the Common Shares. In such case, your tax basis
in the Common Shares acquired will be adjusted to reflect the disallowed loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Current U.S. federal income tax law taxes both
long-term and short-term capital gain of corporations at the rates applicable to ordinary income. For non-corporate taxpayers, short-term
capital gain is currently taxed at rates applicable to ordinary income while long-term capital gain generally is taxed at a reduced maximum
rate. The deductibility of capital losses is subject to limitations under the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain U.S. Common Shareholders who are individuals,
estates or trusts and whose income exceeds certain thresholds will be required to pay a 3.8% Medicare tax on all or a part of their &#8220;net
investment income,&#8221; which includes dividends received from the Fund and capital gains from the sale or other disposition of the
Fund&#8217;s Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A Common Shareholder that is a nonresident alien
individual or a foreign corporation (a &#8220;foreign investor&#8221;) generally will be subject to U.S. federal withholding tax at the
rate of 30% (or possibly a lower rate provided by an applicable tax treaty) on ordinary income dividends (except as discussed below).
In general, U.S. federal withholding tax and U.S. federal income tax will not apply to any gain or income realized by a foreign investor
in respect of any distribution of net capital gain (including amounts credited as an undistributed capital gain dividend) or upon the
sale or other disposition of Common Shares of the Fund. Different tax consequences may result if the foreign investor is engaged in a
trade or business in the United States or, in the case of an individual, is present in the United States for 183 days or more during a
taxable year and certain other conditions are met. Foreign investors should consult their tax advisers regarding the tax consequences
of investing in the Fund&#8217;s Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Dividends properly reported by the Fund are generally
exempt from U.S. federal withholding tax where they (i) are paid in respect of the Fund&#8217;s &#8220;qualified net interest income&#8221;
(generally, the Fund&#8217;s U.S.-source interest income, other than certain contingent interest and interest from obligations of a corporation
or partnership in which the Fund is at least a 10% shareholder, reduced by expenses that are allocable to such income) or (ii) are paid
in respect of the Fund&#8217;s &#8220;qualified short-term capital gains&#8221; (generally, the excess of the Fund&#8217;s net short-term
capital gain over the Fund&#8217;s long-term capital loss for such taxable year). Depending on its circumstances, the Fund may report
all, some or none of its potentially eligible dividends as such qualified net interest income or as qualified short-term capital gains,
and/or treat such dividends, in whole or in part, as ineligible for this exemption from withholding. In order to qualify for this exemption
from withholding, a foreign investor needs to comply with applicable certification requirements relating to its non-U.S. status (including,
in general, furnishing an IRS Form W-8BEN, W-8BEN-E or substitute Form). In the case of Common Shares held through an intermediary, the
intermediary may withhold even if the Fund reports the payment as qualified net interest income or qualified short-term capital gain.
Foreign investors should contact their intermediaries with respect to the application of these rules to their accounts. There can be no
assurance as to what portion of the Fund&#8217;s distributions will qualify for favorable treatment as qualified net interest income or
qualified short-term capital gains.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, withholding at a rate of 30% is
required on dividends in respect of Common Shares held by or through certain foreign financial institutions (including investment funds),
unless such institution enters into an agreement with the Secretary of the Treasury to report, on an annual basis, information with respect
to shares in, and accounts maintained by, the institution to the extent such shares or accounts are held by certain U.S. persons or by
certain non-U.S. entities that are wholly or partially owned by U.S. persons and to withhold on certain payments. Accordingly, the entity
through which Common Shares are held will affect the determination of whether such withholding is required. Similarly, dividends in respect
of Common Shares held by an investor that is a non-financial non-U.S. entity will be subject to withholding at a rate of 30%, unless such
entity either (i) certifies that such entity does not have any &#8220;substantial U.S. owners&#8221; or (ii) provides certain information
regarding the entity&#8217;s &#8220;substantial U.S. owners,&#8221; which the applicable withholding agent will in turn provide to the
Secretary of the Treasury. An intergovernmental agreement between the United States and an applicable foreign country, or future Treasury
regulations or other guidance, may modify these requirements. Non-U.S. Common Shareholders are</p>

<!-- Field: Page; Sequence: 95; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> encouraged to consult with their tax advisers
regarding the possible implications of these rules on their investment in our Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may be required to withhold, for U.S.
federal backup withholding tax purposes, a portion of the dividends, distributions and redemption proceeds payable to certain non-exempt
Common Shareholders who fail to provide the Fund (or its agent) with their correct taxpayer identification number (in the case of individuals,
generally, their social security number) or to make required certifications, or who are otherwise subject to backup withholding. Backup
withholding is not an additional tax and any amount withheld may be refunded or credited against your U.S. federal income tax liability,
if any, provided that you timely furnish the required information to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><b>The foregoing is a general summary of the
provisions of the Code and the Treasury regulations in effect as they directly govern the taxation of the Fund and its Common Shareholders.
These provisions are subject to change by legislative or administrative action, and any such change may be retroactive. Ordinary income
and capital gain dividends may also be subject to state and local taxes. Common Shareholders are urged to consult their tax advisers regarding
specific questions as to U.S. federal, state, local and foreign income or other taxes.</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIGeneralInfo"></span>General
Information</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Proxy Voting Policy and Procedures and Proxy
Voting Record</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has delegated the voting of proxies
relating to its portfolio securities to the Sub-Adviser. The Sub-Adviser&#8217;s Proxy Voting Policy and Procedures are included as Appendix
B to this SAI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Information on how the Fund voted proxies relating
to portfolio securities during the most recent twelve-month period ended June 30 is available without charge, upon request, by calling
(800) 345-7999 or by visiting our website at www.guggenheiminvestments.com. This information is also available on the SEC&#8217;s website
at www.sec.gov.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Principal Holders of Securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As of October 31, 2025, to the knowledge of the
Fund, no person beneficially owned more than 5% of the voting securities of any class of equity securities of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Legal Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal">Certain legal
matters will be passed on by Dechert LLP as counsel to the Fund in connection with the offering of the Common Shares. If certain legal
matters in connection with an offering of Common Shares are passed upon by counsel for the underwriters of such offering, that counsel
will be named in the Prospectus Supplement related to that offering.</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Custodian</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Bank of New York Mellon, 101 Barclay Street,
New York, New York 10286, acts as the custodian of the Fund&#8217;s assets pursuant to a custody agreement. Under the custody agreement,
the custodian holds the Fund&#8217;s assets in compliance with the 1940 Act.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Independent Registered Public Accounting
Firm</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Ernst &amp; Young LLP, 1775 Tysons Blvd, Tysons,
Virginia 22102, has been engaged as the Fund&#8217;s Independent Registered Public Accounting Firm. Ernst &amp; Young LLP has audited
the Fund&#8217;s financial statements and financial highlights, including the notes thereto, included in the Fund&#8217;s annual report
to shareholders for the year ended May 31, 2025, as set forth in their report, which is incorporated by reference into this SAI. The Fund&#8217;s
financial statements and financial highlights are incorporated by reference in reliance on Ernst &amp; Young LLP&#8217;s report, given
on their authority as experts in accounting and auditing.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Codes of Ethics</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Pursuant to Rule 17j-1 under the 1940 Act, the
Fund, the Investment Adviser and the Sub-Adviser have adopted a written code of ethics (the &#8220;Codes of Ethics&#8221;) which governs
the personal securities transactions of &#8220;access persons&#8221; of the Fund. Access persons may invest in securities, including securities
that may be purchased or held by the Fund, provided that they obtain prior clearance before engaging in securities transactions, subject
to </p>

<!-- Field: Page; Sequence: 96; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">certain de minimis exceptions. Access persons include officers and Trustees of the Fund and the Investment Adviser and Sub-Adviser
and employees that participate in, or obtain information regarding, the purchase or sale of securities by the Fund or whose job relates
to the making of any recommendations with respect to such purchases or sales. All access persons must report their personal securities
transactions within thirty days of the end of each calendar quarter. Subject to certain de minimis exceptions for access persons not involved
in the fund accounting or asset management activities of the Investment Adviser and Sub-Adviser, access persons will not be permitted
to effect transactions in a security if it: (1) is being considered for purchase or sale by the Fund; (2) is being purchased or sold by
the Fund; or (3) is being offered in an initial public offering. Portfolio managers, research analysts and traders are also prohibited
from purchasing or selling a security within seven calendar days before or after any fund in the Guggenheim Family of Funds or any funds
managed by an affiliated investment adviser trades in that security. Any material violation of the Codes of Ethics is reported to the
Board of Trustees. The Board of Trustees also reviews the administration of the Code of Ethics on an annual basis and approves any material
changes to the Code of Ethics pursuant to the requirements of Rule 17j-1 of the 1940 Act. The Codes of Ethics of the Fund, the Investment
Adviser and the Sub-Adviser are on file with the SEC and are also available on the EDGAR Database on the SEC&#8217;s Internet site at
www.sec.gov, and copies of the Codes of Ethics may be obtained, after paying a duplicating fee, by electronic request at the following
email address: publicinfo@sec.gov.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Incorporation by Reference</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">This SAI is part of a registration statement
filed with the SEC. The Fund is permitted to &#8220;incorporate by reference&#8221; the information that it files with the SEC, which
means that the Fund can disclose important information to you by referring to those documents. The information incorporated by reference
is considered to be part of this SAI, and later information that the Fund files with the SEC will automatically update and supersede this
information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The documents listed below and any reports and
other documents subsequently filed with the SEC under Sections 13(a), 13(c), 14, or 15(d) of the Securities Exchange Act of 1934, as amended,
or pursuant to Section 30(b)(2) under the 1940 Act, prior to the termination of this offering, will be incorporated by reference into
this SAI and deemed to be a part of this SAI from the date of the filing of such reports and documents:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Fund&#8217;s Prospectus, dated November 21, 2025, filed with this SAI;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000173/gug88924gof.htm">Fund&#8217;s annual report on Form
N-CSR for the fiscal year ended May 31, 2025</a>, filed with the SEC on August 4, 2025;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000077/cef-def14a.htm">Fund&#8217;s definitive proxy statement
on Schedule 14A, filed with the SEC on February 28, 2025</a>; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The <a href="https://www.sec.gov/Archives/edgar/data/1380936/000134100407001955/chi551212.htm">description of the Fund&#8217;s common
shares contained in its Registration Statement on Form 8-A</a> (File No. 001-33565), filed with the SEC on June 27, 2007, including any
amendment or report filed for the purpose of updating such description prior to the termination of the offering registered hereby.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The complete Registration Statement, other documents
incorporated by reference, and other information the Fund has filed electronically with the SEC, may be obtained from the SEC upon payment
of the fee prescribed by its rules and regulations or free of charge through the SEC website (http://www.sec.gov),
by calling (800) 345-7999, by writing to the Investment Adviser at Guggenheim Investment Advisors, LLC, 227 West Monroe Street, Chicago,
Illinois 60606, or by visiting our website at www.guggenheiminvestments.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIFinancialStatements"></span>Financial
Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s audited financial statements
appearing in the Fund&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000173/0001821268-25-000173-index.htm">annual
report to shareholders for the fiscal year ended May 31, 2025</a>, including accompanying notes thereto and the report of Ernst &amp;
Young LLP thereon, as contained in the Fund&#8217;s Form N-CSR filed with the SEC on August 4, 2025 are incorporated by reference into
this SAI. Shareholder reports are available upon request and without charge by calling (800) 345-7999 or by writing the Fund at 227 West
Monroe Street, Chicago, Illinois 60606.</p>


<!-- Field: Page; Sequence: 97; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0; text-align: center">This page intentionally left blank.</p>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">S-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIAppendixA"></span>Appendix
A<br/>
Description of Securities Ratings</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase">Standard
&amp; Poor&#8217;s Corporation</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">A brief description of the applicable S&amp;P
Global Ratings and its affiliates (together, &#8220;S&amp;P&#8221;) rating symbols and their meanings (as published by S&amp;P) follows.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Issue Credit Ratings Definition</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An S&amp;P issue credit rating is a forward-looking
opinion about the creditworthiness of an obligor with respect to a specific financial obligation, a specific class of financial obligations,
or a specific financial program (including ratings on medium-term note programs and commercial paper programs). It takes into consideration
the creditworthiness of guarantors, insurers, or other forms of credit enhancement on the obligation and takes into account the currency
in which the obligation is denominated. The opinion reflects S&amp;P&#8217;s view of the obligor&#8217;s capacity and willingness to meet
its financial commitments as they come due, and this opinion may assess terms, such as collateral security and subordination, which could
affect ultimate payment in the event of default.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Issue credit ratings can be either long-term
or short-term. Short-term issue credit ratings are generally assigned to those obligations considered short-term in the relevant market,
typically with an original maturity of no more than 365 days. Short-term issue credit ratings are also used to indicate the creditworthiness
of an obligor with respect to put features on long-term obligations. S&amp;P would typically assign a long-term issue credit rating to
an obligation with an original maturity of greater than 365 days. However, the ratings S&amp;P assigns to certain instruments may diverge
from these guidelines based on market practices.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Long-Term Issue Credit Ratings*</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Issue credit ratings are based, in varying degrees,
on S&amp;P&#8217;s analysis of the following considerations:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The likelihood of payment&#8212;the capacity and willingness of the obligor to meet its financial commitments on an obligation in
accordance with the terms of the obligation.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The nature and provisions of the financial obligation, and the promise S&amp;P imputes; and<span style="font-family: Symbol">&#183;</span><span style="font-family: Times New Roman, Times, Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span>&#160;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The protection afforded by, and relative position of, the financial obligation in the event of a bankruptcy, reorganization, or other
arrangement under the laws of bankruptcy and other laws affecting creditors&#8217; rights.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An issue rating is an assessment of default risk,
but may incorporate an assessment of relative seniority or ultimate recovery in the event of default. Junior obligations are typically
rated lower than senior obligations, to reflect lower priority in bankruptcy, as noted above. (Such differentiation may apply when an
entity has both senior and subordinated obligations, secured and unsecured obligations, or operating company and holding company obligations.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>AAA</b> An obligation rated &#8216;AAA&#8217; has the highest
rating assigned by S&amp;P. The obligor&#8217;s capacity to meet its financial commitments on the obligation is extremely strong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>AA</b> An obligation rated &#8216;AA&#8217; differs from the highest-rated
obligations only to a small degree. The obligor&#8217;s capacity to meet its financial commitments on the obligation is very strong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>A</b> An obligation rated &#8216;A&#8217; is somewhat more susceptible
to the adverse effects of changes in circumstances and economic conditions than obligations in higher-rated categories. However, the obligor&#8217;s
capacity to meet its financial commitments on the obligation is still strong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>BBB</b> An obligation rated &#8216;BBB&#8217; exhibits adequate
protection parameters. However, adverse economic conditions or changing circumstances are more likely to weaken the obligor&#8217;s capacity
to meet its financial commitments on the obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>BB, B, CCC, CC, and C</b> Obligations rated &#8216;BB&#8217;,
&#8216;B&#8217;, &#8216;CCC&#8217;, &#8216;CC&#8217;, and &#8216;C&#8217; are regarded as having significant speculative characteristics.
&#8216;BB&#8217; indicates the least degree of speculation and &#8216;C&#8217; the highest. While such obligations will likely have some
quality and protective characteristics, these may be outweighed by large uncertainties or major exposure to adverse conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">A-1</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<!-- Field: Page; Sequence: 99 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>BB </b>An obligation rated &#8216;BB&#8217; is less vulnerable
to nonpayment than other speculative issues. However, it faces major ongoing uncertainties or exposure to adverse business, financial,
or economic conditions that could lead to the obligor&#8217;s inadequate capacity to meet its financial commitments on the obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>B </b>An obligation rated &#8216;B&#8217; is more vulnerable to
nonpayment than obligations rated &#8216;BB&#8217;, but the obligor currently has the capacity to meet its financial commitments on the
obligation. Adverse business, financial, or economic conditions will likely impair the obligor&#8217;s capacity or willingness to meet
its financial commitments on the obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>CCC </b>An obligation rated &#8216;CCC&#8217; is currently vulnerable
to nonpayment and is dependent upon favorable business, financial, and economic conditions for the obligor to meet its financial commitments
on the obligation. In the event of adverse business, financial, or economic conditions, the obligor is not likely to have the capacity
to meet its financial commitments on the obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>CC </b>An obligation rated &#8216;CC&#8217; is currently highly
vulnerable to nonpayment. The &#8216;CC&#8217; rating is used when a default has not yet occurred but S&amp;P expects default to be a
virtual certainty, regardless of the anticipated time to default.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>C </b>An obligation rated &#8216;C&#8217; is currently highly
vulnerable to nonpayment, and the obligation is expected to have lower relative seniority or lower ultimate recovery compared with obligations
that are rated higher.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>D </b>An obligation rated &#8216;D&#8217; is in default or in
breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217; rating category is used when payments on an obligation
are not made on the date due, unless S&amp;P believes that such payments will be made within the next five business days in the absence
of a stated grace period or within the earlier of the stated grace period or the next 30 calendar days. The &#8216;D&#8217; rating also
will be used upon the filing of a bankruptcy petition or the taking of similar action and where default on an obligation is a virtual
certainty, for example due to automatic stay provisions. A rating on an obligation is lowered to &#8216;D&#8217; if it is subject to a
distressed debt restructuring.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.4in"><b>*</b></td><td>Ratings from &#8216;AA&#8217; to &#8216;CCC&#8217; may be modified by the addition of a plus (+) or minus (-) sign to show relative
standing within the rating categories.</td></tr></table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Short-Term Issue Credit Ratings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>A-1 </b>A short-term obligation rated &#8216;A-1&#8217; is rated
in the highest category by S&amp;P. The obligor&#8217;s capacity to meet its financial commitments on the obligation is strong. Within
this category, certain obligations are designated with a plus sign (+). This indicates that the obligor&#8217;s capacity to meet its financial
commitments on these obligations is extremely strong.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>A-2 </b>A short-term obligation rated &#8216;A-2&#8217; is somewhat
more susceptible to the adverse effects of changes in circumstances and economic conditions than obligations in higher rating categories.
However, the obligor&#8217;s capacity to meet its financial commitments on the obligation is satisfactory.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>A-3 </b>A short-term obligation rated &#8216;A-3&#8217; exhibits
adequate protection parameters. However, adverse economic conditions or changing circumstances are more likely to weaken an obligor&#8217;s
capacity to meet its financial commitments on the obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>B </b>A short-term obligation rated &#8216;B&#8217; is regarded
as vulnerable and has significant speculative characteristics. The obligor currently has the capacity to meet its financial commitments;
however, it faces major ongoing uncertainties that could lead to the obligor&#8217;s inadequate capacity to meet its financial commitments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>C </b>A short-term obligation rated &#8216;C&#8217; is currently
vulnerable to nonpayment and is dependent upon favorable business, financial, and economic conditions for the obligor to meet its financial
commitments on the obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>D </b>A short-term obligation rated &#8216;D&#8217; is in default
or in breach of an imputed promise. For non-hybrid capital instruments, the &#8216;D&#8217; rating category is used when payments on an
obligation are not made on the date due, unless S&amp;P believes that such payments will be made within any stated grace period. However,
any stated grace period longer than five business days will be treated as five business days. The &#8216;D&#8217; rating also will be
used upon the filing of a bankruptcy petition or the taking of a similar action and where default on an obligation is a virtual certainty,
for example due to automatic stay provisions. A rating on an obligation is lowered to &#8216;D&#8217; if it is subject to a distressed
debt restructuring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>SPUR (S&amp;Ps Underlying Rating) </b>A SPUR is an opinion about
the stand-alone capacity of an obligor to pay debt service on a credit-enhanced debt issue, without giving effect to the enhancement that
applies to it. These ratings are</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">A-2</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<!-- Field: Page; Sequence: 100 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">published only at the request of the debt issuer or obligor with the designation SPUR to distinguish
them from the credit-enhanced rating that applies to the debt issue. S&amp;P maintains surveillance of an issue with a published SPUR.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Municipal Short-Term Note Ratings</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An S&amp;P&#8217;s U.S. municipal note rating
reflects S&amp;P&#8217;s opinion about the liquidity factors and market access risks unique to the notes. Notes due in three years or
less will likely receive a note rating. Notes with an original maturity of more than three years will most likely receive a long-term
debt rating. In determining which type of rating, if any, to assign, S&amp;P&#8217;s analysis will review the following considerations:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Amortization schedule &#8212; the larger the final maturity relative to other maturities, the more likely it will be treated as a
note; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Source of payment &#8212; the more dependent the issue is on the market for its refinancing, the more likely it will be treated as
a note.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Note rating symbols are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>SP-1 </b>Strong capacity to pay principal and interest. An issue
determined to possess a very strong capacity to pay debt service is given a plus (+) designation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>SP-2 </b>Satisfactory capacity to pay principal and interest,
with some vulnerability to adverse financial and economic changes over the term of the notes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>SP-3 </b>Speculative capacity to pay principal and interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>D </b>&#8216;D&#8217; is assigned upon failure to pay the note
when due, completion of a distressed debt restructuring, or the filing of a bankruptcy petition or the taking of similar action and where
default on an obligation is a virtual certainty, for example due to automatic stay provisions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Dual Ratings </b>Dual ratings may be assigned to debt issues that
have a put option or demand feature. The first component of the rating addresses the likelihood of repayment of principal and interest
as due, and the second component of the rating addresses only the demand feature. The first component of the rating can relate to either
a short-term or long-term transaction and accordingly use either short-term or long-term rating symbols. The second component of the rating
relates to the put option and is assigned a short-term rating symbol (for example, &#8216;AAA/A-1+&#8217; or &#8216;A-1+/A-1&#8217;).
With U.S. municipal short-term demand debt, the U.S. municipal short-term note rating symbols are used for the first component of the
rating (for example, &#8216;SP-1+/A-1+&#8217;).</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Active Qualifiers</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">S&amp;P uses the following qualifiers that limit the scope of a rating.
The structure of the transaction can require the use of a qualifier such as a &#8216;p&#8217; qualifier, which indicates the rating addresses
the principal portion of the obligation only. A qualifier appears as a suffix and is part of the rating.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Federal deposit insurance limit: &#8216;L&#8217; qualifier </b>Ratings
qualified with &#8216;L&#8217; apply only to amounts invested up to federal deposit insurance limits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Principal: &#8216;p&#8217; qualifier </b>This suffix is used for
issues in which the credit factors, the terms, or both that determine the likelihood of receipt of payment of principal are different
from the credit factors, terms, or both that determine the likelihood of receipt of interest on the obligation. The &#8216;p&#8217; suffix
indicates that the rating addresses the principal portion of the obligation only and that the interest is not rated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Preliminary ratings: &#8216;prelim&#8217; qualifier </b>Preliminary
ratings, with the &#8216;prelim&#8217; suffix, may be assigned to obligors or obligations, including financial programs, in the circumstances
described below. Assignment of a final rating is conditional on the receipt by S&amp;P of appropriate documentation. S&amp;P reserves
the right not to issue a final rating. Moreover, if a final rating is issued, it may differ from the preliminary rating.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Preliminary ratings may be assigned to obligations, most commonly structured and project finance issues, pending receipt of final
documentation and legal opinions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Preliminary ratings may be assigned to obligations that will likely be issued upon the obligor&#8217;s emergence from bankruptcy or
similar reorganization, based on late-stage reorganization plans, documentation, and discussions with the obligor. Preliminary ratings
may also be assigned to the obligors. These ratings consider the anticipated general credit quality of the reorganized or post-bankruptcy
issuer as well as attributes of the anticipated obligation(s).</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">A-3</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<!-- Field: Page; Sequence: 101 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Preliminary ratings may be assigned to entities that are being formed or that are in the process of being independently established
when, in S&amp;P&#8217;s opinion, documentation is close to final.<br/>
Preliminary ratings may also be assigned to the obligations of these entities.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Preliminary ratings may be assigned when a previously unrated entity is undergoing a well-formulated restructuring, recapitalization,
significant financing, or other transformative event, generally at the point that investor or lender commitments are invited. The preliminary
rating may be assigned to the entity and to its proposed obligation(s).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>These preliminary ratings consider the anticipated general credit quality of the obligor, as well as attributes of the anticipated
obligation(s), assuming successful completion of the transformative event. Should the transformative event not occur, S&amp;P would likely
withdraw these preliminary ratings.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>A preliminary recovery rating may be assigned to an obligation that has a preliminary issue credit rating.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Termination structures: &#8216;t&#8217; qualifier </b>This symbol
indicates termination structures that are designed to honor their contracts to full maturity or, should certain events occur, to terminate
and cash settle all their contracts before their final maturity date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Counterparty instrument rating: &#8216;cir&#8217; qualifier </b>This
symbol indicates a counterparty instrument rating (CIR), which is a forward-looking opinion about the creditworthiness of an issuer in
a securitization structure with respect to a specific financial obligation to a counterparty (including interest rate swaps, currency
swaps, and liquidity facilities). The CIR is determined on an ultimate payment basis; these opinions do not take into account timeliness
of payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>MOODY&#8217;S INVESTORS SERVICE, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">A brief description of the applicable Moody&#8217;s Investors Service,
Inc. (&#8220;Moody&#8217;s&#8221;) rating symbols and their meanings (as published by Moody&#8217;s) follows.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>Global Rating Scales</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Credit ratings are assigned on Moody&#8217;s global long-term and
short-term rating scales and are forward-looking opinions of the relative credit risks of financial obligations issued by non-financial
corporates, financial institutions, structured finance vehicles, project finance vehicles, and public sector entities. Moody&#8217;s defines
credit risk as the risk that an entity may not meet its contractual financial obligations as they come due and any estimated financial
loss in the event of default or impairment. The contractual financial obligations addressed by Moody&#8217;s ratings are those that call
for, without regard to enforceability, the payment of an ascertainable amount, which may vary based upon standard sources of variation
(e.g., floating interest rates), by an ascertainable date. Moody&#8217;s rating addresses the issuer&#8217;s ability to obtain cash sufficient
to service the obligation, and its willingness to pay. Moody&#8217;s ratings do not address non-standard sources of variation in the amount
of the principal obligation (e.g., equity indexed), absent an express statement to the contrary in a press release accompanying an initial
rating. Long-term ratings are assigned to issuers or obligations with an original maturity of eleven months or more and reflect both on
the likelihood of a default or impairment on contractual financial obligations and the expected financial loss suffered in the event of
default or impairment. Short-term ratings are assigned to obligations with an original maturity of thirteen months or less and reflect
both on the likelihood of a default or impairment on contractual financial obligations and the expected financial loss suffered in the
event of default or impairment. Moody&#8217;s issues ratings at the issuer level and instrument level on both the long-term scale and
the short-term scale. Typically, ratings are made publicly available although private and unpublished ratings may also be assigned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Moody&#8217;s differentiates structured finance ratings from fundamental
ratings (<i>i.e.</i>, ratings on nonfinancial corporate, financial institution, and public sector entities) on the global long-term scale
by adding (sf ) to all structured finance ratings. The addition of (sf ) to structured finance ratings should eliminate any presumption
that such ratings and fundamental ratings at the same letter grade level will behave the same. The (sf ) indicator for structured finance
security ratings indicates that otherwise similarly rated structured finance and fundamental securities may have different risk characteristics.
Through its current methodologies, however, Moody&#8217;s aspires to achieve broad</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">A-4</p>

<!-- Field: Page; Sequence: 102 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">expected equivalence in structured finance and fundamental
rating performance when measured over a long period of time.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>Global Long-Term Rating Scale</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Aaa </b>Obligations rated Aaa are judged to be of the highest
quality, subject to the lowest level of credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Aa </b>Obligations rated Aa are judged to be of high quality and
are subject to very low credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>A </b>Obligations rated A are judged to be upper-medium grade
and are subject to low credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Baa </b>Obligations rated Baa are judged to be medium-grade and
subject to moderate credit risk and as such may possess certain speculative characteristics.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Ba </b>Obligations rated Ba are judged to be speculative and are
subject to substantial credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>B </b>Obligations rated B are considered speculative and are subject
to high credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Caa </b>Obligations rated Caa are judged to be speculative of
poor standing and are subject to very high credit risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Ca </b>Obligations rated Ca are highly speculative and are likely
in, or very near, default, with some prospect of recovery of principal and interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>C </b>Obligations rated C are the lowest rated and are typically
in default, with little prospect for recovery of principal or interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b><span style="text-decoration: underline">Note: </span></b>Moody&#8217;s appends numerical modifiers 1,
2, and 3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation ranks in the higher end
of its generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking in the lower end
of that generic rating category. Additionally, a &#8220;(hyb)&#8221; indicator is appended to all ratings of hybrid securities issued
by banks, insurers, finance companies, and securities firms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">By their terms, hybrid securities allow for the omission of scheduled
dividends, interest, or principal payments, which can potentially result in impairment if such an omission occurs. Hybrid securities may
also be subject to contractually allowable write-downs of principal that could result in impairment. Together with the hybrid indicator,
the long-term obligation rating assigned to a hybrid security is an expression of the relative credit risk associated with that security.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>Global Short-Term Rating Scale</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>P-1 </b>Ratings of Prime-1 reflect a superior ability to repay
short-term obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>P-2 </b>Ratings of Prime-2 reflect a strong ability to repay short-term
obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>P-3 </b>Ratings of Prime-3 reflect an acceptable ability to repay
short-term obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>NP </b>Issuers (or supporting institutions) rated Not Prime do
not fall within any of the Prime rating categories.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b><i>US Municipal Short-Term Debt and Demand Obligation Ratings.
</i></b>Moody&#8217;s uses the global short-term Prime rating scale for commercial paper issued by U.S. municipalities and nonprofits.
These commercial paper programs may be backed by external letters of credit or liquidity facilities, or by an issuer&#8217;s self-liquidity.
For other short-term municipal obligations, Moody&#8217;s uses one of two other short-term rating scales, the Municipal Investment Grade
(MIG) and Variable Municipal Investment Grade (VMIG) scales discussed below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>MIG Ratings</b>. Moody&#8217;s uses the MIG scale for US municipal
cash flow notes, bond anticipation notes and certain other short-term obligations, which typically mature in three years or less.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b><i>MIG Scale </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>MIG 1 </b>This designation denotes superior credit quality. Excellent
protection is afforded by established cash flows, highly reliable liquidity support, or demonstrated broad-based access to the market
for refinancing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>MIG 2 </b>This designation denotes strong credit quality. Margins
of protection are ample, although not as large as in the preceding group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>MIG 3 </b>This designation denotes acceptable credit quality.
Liquidity and cash-flow protection may be narrow, and market access for refinancing is likely to be less well-established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">A-5</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<!-- Field: Page; Sequence: 103 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>SG </b>This designation denotes speculative-grade credit quality.
Debt instruments in this category may lack sufficient margins of protection.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b><i>VMIG Ratings. </i></b>For variable rate demand obligations
(VRDOs), Moody&#8217;s assigns both a long-term rating and a short-term payment obligation rating. The long-term rating addresses the
issuer&#8217;s ability to meet scheduled principal and interest payments. The short-term payment obligation rating addresses the ability
of the issuer or the liquidity provider to meet any purchase price payment obligation resulting from optional tenders (&#8220;on demand&#8221;)
and/or mandatory tenders of the VRDO. The short-term payment obligation rating uses the VMIG scale. Transitions of VMIG ratings with conditional
liquidity support differ from transitions of Prime ratings reflecting the risk that external liquidity support will terminate if the issuer&#8217;s
long-term rating drops below investment grade.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">For VRDOs, Moody&#8217;s typically assigns a VMIG rating if the frequency
of the payment obligation is less than every three years. If the frequency of the payment obligation is less than three years, but the
obligation is payable only with remarketing proceeds, the VMIG short-term rating is not assigned and it is denoted as &#8220;NR.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Industrial development bonds in the US where the obligor is a corporate
entity may carry a VMIG rating that reflects Moody&#8217;s view of the relative likelihood of default and loss. In these cases, liquidity
assessment is based on the liquidity of the corporate obligor.</p>

<p style="font: 11pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b><i>VMIG Scale </i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>VMIG 1</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">This designation denotes superior credit quality. Excellent protection
is afforded by the superior short-term credit strength of the liquidity provider and structural and legal protections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>VMIG 2</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">This designation denotes strong credit quality. Good protection is
afforded by the strong short-term credit strength of the liquidity provider and structural and legal protections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>VMIG 3</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">This designation denotes acceptable credit quality. Adequate protection
is afforded by the satisfactory short-term credit strength of the liquidity provider and structural and legal protections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>SG</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">This designation denotes speculative-grade credit quality. Demand
features rated in this category may be supported by a liquidity provider that does not have a sufficiently strong short-term rating or
may lack the structural or legal protections.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>Other Rating Symbols</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Provisional Ratings - (P)</b>. Moody&#8217;s will often assign
a provisional rating to an issuer or an instrument when the change to a definitive rating is subject to the fulfilment of contingencies
that could affect the rating. Examples of such contingencies are the finalization of transaction documents/terms where a rating is sensitive
to changes at closing. When such contingencies are not present, a definitive rating may be assigned based upon documentation that is not
yet in final form. Moody&#8217;s will also often assign provisional ratings to program ratings, such as shelf registrations and medium
term note programs. A provisional rating is denoted by placing a (P) in front of the rating. The (P) notation provides additional information
about the rating, but does not indicate a different rating. For example, a provisional rating of (P)Aa1 is the same rating as Aa1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">For provisional ratings assigned to an issuer or instrument, the
(P) notation is removed when the applicable contingencies have been fulfilled. A Credit Rating Action to remove the (P) notation indicates
that the rating is no longer subject to contingencies, and changes the provisional rating to a definitive rating. Program ratings for
shelf registrations and other issuance programs remain provisional, while the subsequent ratings of issuances under these programs are
assigned as definitive ratings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Refundeds - <b>#</b>. Issues that are secured by escrowed funds held
in trust, reinvested in direct, non-callable US government obligations or non-callable obligations unconditionally guaranteed by the US
Government or Resolution Funding Corporation are identified with a # (hash mark) symbol, <i>e.g., </i>#Aaa.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt">A-6</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<!-- Field: Page; Sequence: 104 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Withdrawn - <b>WR</b>. When Moody&#8217;s no longer rates an obligation
on which it previously maintained a rating, the symbol WR is employed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Not Rated - <b>NR</b>. NR is assigned to an unrated issuer, obligation
and/or program.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Not Available - <b>NAV</b>. An issue that Moody&#8217;s has not yet
rated is denoted by the NAV symbol.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Terminated Without Rating - <b>TWR</b>. The symbol TWR applies primarily
to issues that mature or are redeemed without having been rated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>FITCH RATINGS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">A brief description of the applicable Fitch Ratings, Inc. (&#8220;Fitch&#8221;)
ratings symbols and meanings (as published by Fitch) follows.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Rated entities in a number of sectors, including financial and non-financial
corporations, sovereigns, insurance companies and certain sectors within public finance, are generally assigned Issuer Default Ratings
(IDRs). IDRs are also assigned to certain entities or enterprises in global infrastructure, project finance and public finance. IDRs opine
on an entity&#8217;s relative vulnerability to default (including by way of a distressed debt exchange) on financial obligations. The
threshold default risk addressed by the IDR is generally that of the financial obligations whose non-payment would best reflect the uncured
failure of that entity. As such, IDRs also address relative vulnerability to bankruptcy, administrative receivership or similar concepts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">In aggregate, IDRs provide an ordinal ranking of issuers based on
the agency&#8217;s view of their relative vulnerability to default, rather than a prediction of a specific percentage likelihood of default.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><i>Long-Term Credit Ratings Scales</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>AAA Highest Credit Quality. </b>&#8216;AAA&#8217; ratings denote
the lowest expectation of default risk. They are assigned only in cases of exceptionally strong capacity for payment of financial commitments.
This capacity is highly unlikely to be adversely affected by foreseeable events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>AA Very High Credit Quality. </b>&#8216;AA&#8217; ratings denote
expectations of very low default risk. They indicate very strong capacity for payment of financial commitments. This capacity is not significantly
vulnerable to foreseeable events.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>A High Credit Quality. </b>&#8216;A&#8217; ratings denote expectations
of low default risk. The capacity for payment of financial commitments is considered strong. This capacity may, nevertheless, be more
vulnerable to adverse business or economic conditions than is the case for higher ratings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>BBB Good Credit Quality. </b>&#8216;BBB&#8217; ratings indicate
that expectations of default risk are currently low. The capacity for payment of financial commitments is considered adequate but adverse
business or economic conditions are more likely to impair this capacity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>BB Speculative. </b>&#8216;BB&#8217; ratings indicate an elevated
vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time; however, business
or financial flexibility exists that supports the servicing of financial commitments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>B Highly Speculative. </b>&#8216;B&#8217; ratings indicate that
material default risk is present, but a limited margin of safety remains. Financial commitments are currently being met; however, capacity
for continued payment is vulnerable to deterioration in the business and economic environment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>CCC Substantial Credit Risk.</b> Very low margin for safety. Default
is a real possibility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>CC Very High Levels of Credit Risk. </b>Default of some kind appears
probable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>C Near Default. </b>A default or default-like process has begun,
or for a closed funding vehicle, payment capacity is irrevocably impaired. Conditions that are indicative of a &#8216;C&#8217; category
rating for an issuer include:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the issuer has entered into a grace or cure period following non-payment of a material financial obligation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the formal announcement by the issuer or their agent of a distressed debt exchange; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a closed financing vehicle where payment capacity is irrevocably impaired such that it is not expected to pay interest and/or principal
in full during the life of the transaction, but where no payment default is imminent.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 6pt"><b></b>A-7&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"></p>

<!-- Field: Page; Sequence: 105 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>RD Restricted Default. </b>&#8216;RD&#8217; ratings indicate an
issuer that in Fitch&#8217;s opinion has experienced:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>an uncured payment default or distressed debt exchange on a bond, loan or other material financial obligation but</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>has not entered into bankruptcy filings, administration, receivership, liquidation or other formal winding-up procedure, and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>has not otherwise ceased operating. This would include:</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the selective payment default on a specific class or currency of debt;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>the uncured expiry of any applicable original grace period, cure period or default forbearance period following a payment default
on a bank loan, capital markets security or other material financial obligation.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>D Default. </b>&#8216;D&#8217; ratings indicate an issuer that
in Fitch Ratings&#8217; opinion has entered into bankruptcy filings, administration, receivership, liquidation or other formal winding-up
procedure or that has otherwise ceased business and debt is still outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Default ratings are not assigned prospectively to entities or their
obligations; within this context, non-payment on an instrument that contains a deferral feature or grace period will generally not be
considered a default until after the expiration of the deferral or grace period, unless a default is otherwise driven by bankruptcy or
other similar circumstance, or by a distressed debt exchange.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">In all cases, the assignment of a default rating reflects the agency&#8217;s
opinion as to the most appropriate rating category consistent with the rest of its universe of ratings, and may differ from the definition
of default under the terms of an issuer&#8217;s financial obligations or local commercial practice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b><i>Short-Term Ratings Assigned to Issuers and Obligations. </i></b>A
short-term issuer or obligation rating is based in all cases on the short-term vulnerability to default of the rated entity and relates
to the capacity to meet financial obligations in accordance with the documentation governing the relevant obligation. Short-term deposit
ratings may be adjusted for loss severity. Short-Term Ratings are assigned to obligations whose initial maturity is viewed as &#8220;short
term&#8221; based on market convention (a long-term rating can also be used to rate an issue with short maturity). Typically, this means
a timeframe of up to 13 months for corporate, sovereign, and structured obligations, and up to 36 months for obligations in U.S. public
finance markets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>F1: Highest Short-Term Credit Quality. </b>Indicates the strongest
intrinsic capacity for timely payment of financial commitments; may have an added &#8220;+&#8221; to denote any exceptionally strong credit
feature.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>F2: Good Short-Term Credit Quality. </b>Good intrinsic capacity
for timely payment of financial commitments.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>F3: Fair Short-Term Credit Quality. </b>The intrinsic capacity
for timely payment of financial commitments is adequate.</p>

<p style="font: 10pt/15pt Times New Roman, Times, Serif; margin: 0"><b>B: Speculative Short-Term Credit Quality. </b>Minimal capacity
for timely payment of financial commitments, plus heightened vulnerability to near term adverse changes in financial and economic conditions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>C: High Short-Term Default Risk. </b>Default is a real possibility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>RD: Restricted Default. </b>Indicates an entity that has defaulted
on one or more of its financial commitments, although it continues to meet other financial obligations. Typically, applicable to entity
ratings only.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>D: Default. </b>Indicates a broad-based default event for an entity,
or the default of a short-term obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">A-8</p>


<!-- Field: Page; Sequence: 106 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-transform: uppercase; text-align: center; text-indent: 0in"><span id="SAIAppendixB"></span>Appendix
B<br/>
<br/>
Guggenheim Partners Investment Management, LLC</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase">Proxy
Voting Policy and Procedures</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>1. &#160;&#160;&#160;&#160;&#160;&#160;&#160;Policy Statement
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0">Guggenheim Partners Investment Management, LLC (&#8220;GPIM&#8221;)
generally is responsible for voting proxies with respect to securities held in client accounts, including clients registered as investment
companies under the Investment Company Act of 1940 (the &#8220;1940 Act&#8221;) and clients that are pension plans (&#8220;Plans&#8221;)
subject to the Employee Retirement Income Security Act of 1974 (&#8220;ERISA&#8221;). GPIM also generally has a fiduciary duty to vote
proxies in the best interests of its clients. This document sets forth GPIM&#8217;s policies and guidelines with respect to proxy voting
and its procedures to comply with SEC Rule 206(4)-6 under the Investment Advisers Act of 1940. Rule 206(4)-6 requires each registered
investment adviser that exercises proxy voting authority with respect to client securities to:</p>

<ul style="margin-top: 0in; list-style-type: disc">

<li style="margin: 10pt 0">Adopt and implement written policies and procedures reasonably designed to ensure that the adviser votes client
securities in the best interest of clients; such policies and procedures must address the manner in which the adviser will resolve material
conflicts of interest that can arise during the proxy voting process;</li>

<li style="margin: 10pt 0">Disclose to clients how they may obtain information from the adviser about how the adviser voted proxies with
respect to their securities;</li>

<li style="margin: 10pt 0">Describe to clients the adviser&#8217;s proxy voting procedures and, upon request, furnish a copy of the policies
and procedures; and</li>

<li style="margin: 10pt 0">Retain certain records.</li>

</ul>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0">Where GPIM has been delegated the responsibility for voting proxies,
it must take reasonable steps under the circumstances to ensure that proxies are received and voted in the best interests of its clients
and not in its own interest, consistent with GPIM&#8217;s fiduciary duty. This generally means voting proxies with a view to enhancing
the value of the securities held in client accounts, considering all relevant factors and without giving undue weight to the opinions
of individuals or groups who may have an economic interest in the outcome of the proxy vote. GPIM&#8217;s authority is initially established
by its advisory contracts or comparable documents, and GPIM may, under certain circumstances, have a duty to vote proxies even where the
advisory contract is silent on the question of GPIM&#8217;s proxy voting authority. Clients, however, may change their proxy voting direction
at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0">The financial interest of GPIM&#8217;s clients is the primary consideration
in determining how proxies should be voted. Any material conflicts of interest between GPIM and its clients with respect to proxy voting
are resolved in the best interests of the clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0">This policy covers only proxy voting. It does not cover corporate
actions, such as rights offerings, tender offers, and stock splits, or actions initiated by holders of a security rather than the issuer
(such as reset rights for a CLO). This policy also does not cover legal actions, such as bankruptcy proceedings or class action lawsuits.
Corporate and legal actions involve decisions about a security itself, rather than decisions about the governance of the security&#8217;s
issuer. As such, the investment team managing the client&#8217;s account will decide whether and how to respond to a corporate or legal
action about which they are notified, with assistance from GPIM Compliance or Legal as needed.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>1.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Proxy
Voting Advisory Group</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Guggenheim Investments (&#8220;GI&#8221;) has established
the Proxy Voting Advisory Group (&#8220;PVAG&#8221;) to oversee the proxy voting activities and policies and procedures of certain GI
registered investment advisers, including GPIM. The PVAG comprises of representatives from Investment Management, Legal, Compliance, Operations
and Operational Due Diligence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-1</p>

<!-- Field: Page; Sequence: 107 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">The PVAG&#8217;s primary responsibility will be to seek
to ensure that the GI Advisors, including GPIM, fulfill their fiduciary duties in voting proxies in the best interests of their clients,
and has certain responsibilities including, but not limited to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Oversee GPIM&#8217;s proxy voting policies and procedures and ensure that a review of GPIM&#8217;s proxy voting policies and procedures
is conducted no less frequently than annually;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Determine how GPIM should vote proxies on behalf of clients in certain conflict situations and evaluate recommendations, proposals
and issues that may not be covered by the proxy voting policies and procedures;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Review situations and documentation where Portfolio Managers/Investment Management has determined to override a voting recommendation
contrary to the Guidelines; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Oversee evaluation of GPIM&#8217;s third-party proxy advisory firm&#8217;s policies and procedures, due diligence and Guidelines on
an annual basis.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">The PVAG is authorized to meet two times annually and at
such other times as the PVAG may deem necessary or appropriate under its authorities and responsibilities. In general, the PVAG&#8217;s
two regular meetings are to be held before and after proxy season.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0"><b>2&#160;&#160;&#160;&#160;&#160;&#160;&#160;Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Guggenheim Partners Investment Management, LLC (&#8220;GPIM&#8221;)
has adopted the proxy voting guidelines of an outside proxy voting firm, Institutional Shareholder Services Inc. (&#8220;ISS&#8221;),
as GPIM&#8217;s proxy voting guidelines (&#8220;Guidelines&#8221;). Proxies are voted in accordance with the Guidelines unless otherwise
contemplated in these procedures, and GPIM believes that this approach is consistent with its fiduciary obligations with respect to the
voting of proxies for clients. GPIM has also engaged ISS to act as agent for the proxy process, to maintain records on proxy votes for
its clients, and to provide independent research on corporate governance, proxy and corporate responsibility issues. At account inception,
depending on the objective of the client account and the portfolio team managing, GPIM will assess the proxy voting guidelines in Appendix
A to determine which Guidelines will be followed. GPIM reviews the Guidelines and conducts a due diligence assessment of ISS and the performance
of its duties as agent at least annually.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">GPIM may override the Guidelines recommending a vote on
a particular proposal if GPIM determines a different vote to be in the best interest of the client or if required to deviate under applicable
rule, law or regulation. If a proposal is voted in a manner different than set forth in the Guidelines, the reasons therefore shall be
documented in writing by the appropriate investment team(s) and retained by Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">GPIM seeks to vote securities in the best interest of clients
and will apply the Guidelines regardless whether the issuer, a third party, or both solicit GPIM&#8217;s vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">In the absence of contrary instructions received from GPIM,
ISS will vote proxies in accordance with the Guidelines, attached as Appendix A hereto, as such Guidelines may be revised from time to
time. ISS will employ these Guidelines based on account set up instructions received from Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;GPIM Voting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">GPIM, consistent with its fiduciary duty, typically will
vote proxies itself in two scenarios: (1) the Guidelines do not address the proposal; and (2) GPIM has decided to vote some or all of
the shares contrary to the Guidelines.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Proposals not Addressed by Guidelines: ISS will notify
Operations of all proxy proposals that do not fall within the Guidelines (i.e. proposals which are either not addressed in the Guidelines
or proposals for which GPIM has indicated that a decision will be made on a case-by-case basis, such as fixed-income</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-2</p>

<!-- Field: Page; Sequence: 108 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">securities). Operations
will forward such proposals to the investment team(s) responsible for the client account. If the investment team(s) responsible, together
with the PVAG, determines that there is no material conflict of interest, the proposal will be voted in accordance with the recommendation
of said team(s) and approval from the PVAG. If there is a material conflicts of interest, GPIM will follow the procedure below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Proposal to be Voted Contrary to Guidelines: When an investment
team decides that a proposal should be voted contrary to the Guidelines, because it believes it is in the best interest of the client
to do so, the team will consult with the PVAG to determine whether there is a material conflict of interest as to that proposal. If the
investment team(s) responsible, together with the PVAG, determines that there is no material conflict of interest, the team(s) will notify
Operations to override the proposal from ISS in accordance with the recommendation of said team(s) and approval from the PVAG. If there
is a material conflicts of interest, GPIM will follow the procedure below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">In either case, the investment team(s) responsible will
document the rationale for voting the proposal in a particular manner. The PVAG will review instances of either scenario.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Resolving
Material Conflicts of Interest</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">GPIM may occasionally be subject to material conflicts
of interest in the voting of proxies due to relationships it maintains with persons having an interest in the outcome of certain votes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Common examples of material conflicts in the voting of
proxies are<b>:</b> (a) GPIM or a GPIM affiliate provides or is seeking to provide services to the company on whose behalf proxies are
being solicited, and the amount of fees involved is or would be material to GPIM or its affiliate, (b) an employee of GPIM or its affiliate
has a personal relationship with the company&#8217;s management or another proponent of a proxy issue, and the employee may be in a position
to influence the proxy voting decision, (c) an immediate family member of the employee is a director or executive officer of the company,
and the employee may be in a position to influence the proxy voting decision. Senior members of the investment team responsible for voting
the proxy, in consultation with GPIM Compliance, will decide whether a material conflict of interest exists. If a material conflict of
interest exists, the investment team will consult the PVAG to determine how to resolve the conflict consistent with the procedures below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">If the Guidelines do not address a proposal, or GPIM wishes
to vote a proposal contrary to the Guidelines, or ISS does not provide a recommendation on a proposal, and GPIM has a material conflict
of interest as to the vote, then GPIM may resolve the conflict in any of the following ways, as recommended by the PVAG:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Refer Proposal to the Client</b> &#8211; GPIM may refer the proposal to the client and obtain instructions from the client on how
to vote the proxy relating to that proposal.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Obtain Client Ratification</b> &#8211; If GPIM is in a position to disclose the conflict to the client (<i>i.e.</i>, such information
is not confidential), GPIM may determine how it proposes to vote the proposal on which it has a conflict, fully disclose the nature of
the conflict to the client, and obtain the client&#8217;s consent for how GPIM will vote on the proposal (or otherwise obtain instructions
from the client on how the proxy on the proposal should be voted).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Abstain from Voting</b></td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Use another Independent Third Party for All Proposals</b> &#8211; Subject to any client imposed proxy voting policies, GPIM may
vote all proposals in a single proxy according to the policies of an independent third party other than ISS (or have the third party vote
such proxies).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Use another Independent Third Party to Vote Only the Specific Proposals that Involve a Conflict</b> &#8211; Subject to any client
imposed proxy voting policies, GPIM may use an independent third party other than ISS to recommend how the proxy for specific proposals
that involve a conflict should be voted (or have the third party vote such proxies).</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-3</p>

<!-- Field: Page; Sequence: 109 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><b>Demonstrate that its Vote was Not the Product of a Material Conflict </b>&#8211; in limited situations, generally involving SPAC
transactions, GPIM may be able to demonstrate that its vote was not the product of a conflict. For example, GPIM may be able to demonstrate
that an investment team recommending an override of a proxy voting recommendation was insulated from the conflict or used a predetermined
policy to arrive at its view.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">The method selected by the PVAG to resolve the conflict
may vary from one instance to another depending upon the facts and circumstances of the situation, but in each case, consistent with its
duty of loyalty and care.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Special
Situations (As Applicable)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Securities
Subject to Lending Arrangements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">For various legal or administrative reasons, GPIM is often
unable to vote securities that are, at the time of such vote, on loan pursuant to a client&#8217;s securities lending arrangement with
the client&#8217;s custodian. GPIM is usually unable to recall securities in order to vote proxies when a third party securities lending
agent has arranged the loan of the client&#8217;s shares. If GPIM has arranged the loan, GPIM will refrain from voting such securities
where the cost to the client and/or administrative inconvenience of retrieving securities then on loan outweighs the benefit of voting,
assuming retrieval under such circumstances is even feasible and/or possible. In certain extraordinary situations, GPIM may seek to have
securities then on loan pursuant to such securities lending arrangements retrieved by the clients&#8217; custodians for voting purposes.
This decision will generally be made on a case-by-case basis depending on whether, in the PVAG&#8217;s judgment, the matter to be voted
on has critical significance to the potential value of the securities in question, the relative cost and/or administrative inconvenience
of retrieving the securities, the significance of the holding, and whether the stock is considered a long-term holding. There can be no
guarantee that any such securities can be retrieved for such purpose.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Special Issues
with Voting Foreign Proxies</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Voting proxies with respect to shares of foreign stocks may
involve significantly greater effort and corresponding cost due to the variety of regulatory schemes and corporate practices in foreign
countries with respect to proxy voting. Because the cost of voting on a particular proxy proposal could exceed the expected benefit to
a client (including an ERISA Plan), GPIM will weigh the costs and benefits of voting on proxy proposals relating to foreign securities
and make an informed decision on whether voting a given proxy proposal is prudent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Blocking</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">In certain countries the exercise of voting rights could
restrict the ability of an account&#8217;s portfolio manager to freely trade the security in question (&#8220;share blocking&#8221;).
If the client has not indicated at account set-up whether it wants shares voted regardless of the potential for share blocking, then the
portfolio manager retains the final authority to determine whether to vote the shares in the client&#8217;s account or to forego voting
the shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Lack of Adequate
Information, Untimely Receipt of Proxy or Excessive Costs</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">GPIM may be unable to enter an informed vote in certain circumstances
due to the lack of information provided in the proxy statement or by the issuer or other resolution sponsor, and may abstain from voting
in those instances. Proxy materials not delivered in a timely manner may prevent analysis or entry of a vote by voting deadlines. GPIM&#8217;s
practice is to abstain from voting a proxy in circumstances where, in its judgment, the costs exceed the expected benefits to the client.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Formation
of a Group</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-4</p>

<!-- Field: Page; Sequence: 110 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">If GPIM owns shares of a public company and enters into a
written or oral agreement with one or more shareholders to vote its shares in line with such shareholder(s) or in line with company management
recommendations, several issues arise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">First, if GPIM agrees to vote its shares at the direction
of or in line with another member of the group, or in line with management, then GPIM must consider whether its vote is in the best long-term
financial interests of its clients. If it is not, then GPIM will have a conflict of interest that it must resolve using the procedures
set out in Section 2.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Second, if GPIM holds an irrevocable proxy for the other
members of the group, or has the right to designate director nominees for which the other group members must vote, GPIM will be viewed
as the beneficial owner of all of the other members&#8217; shares as well as its own shares. This will affect the number of shares that
GPIM must report on a Schedule 13D or 13G.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.6&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fixed Income
Securities</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">The issuers of fixed income securities generally do not solicit
proxies. If such an issuer were to solicit a proxy, GPIM would seek to apply these proxy voting procedures in determining how to vote
the proxy. If the subject of the proxy is not covered in ISS Standard Guidelines or any other third-party guidelines GPIM uses, and assuming
that voting the proxy does not present GPIM with a material conflict of interest, GPIM may vote the proxy in a manner it believes is in
its clients&#8217; best long-term interests. If voting the proxy presents GPIM with a material conflict of interest, it will follow the
conflict resolution procedures in this policy.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.4.7&#160;&#160;&#160;&#160;&#160;&#160;&#160;Special Purpose
Acquisition Companies (SPACs)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">SPACs typically issue a proxy when they have identified an
acquisition. The proxy may ask shareholders to vote separately on the acquisition and on certain governance proposals, or it may bundle
the proposals or make them dependent on each other. GPIM clients at times will own SPAC shares when GPIM or its affiliates provide services
to the SPAC, such as financing or investment banking services. GPIM&#8217;s policy is that it will vote with the SPAC&#8217;s management
on acquisition matters (including corporate governance matters or other matters related to a proposed acquisition), whether or not GPIM
or its affiliates have other roles in the transaction, and whether or not it may have a conflict of interest in voting the proxy. GPIM
believes that SPAC management generally is a better judge than a third party proxy voting service of the merits of the acquisition and
need for certain corporate governance mechanisms.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">If the investment team(s) decides to override this policy
of voting with management, it will consult with the PVAG to analyze whether GPIM has a material conflict in voting the proxy. If the investment
team(s) responsible, together with the PVAG, determines that there is no material conflict of interest, the team(s) will notify Operations
to vote the proposal in accordance with the recommendation of said team(s) and approval from the PVAG. If it does have a material conflict
in voting the proxy, then GPIM must use the one of the mechanisms in Section 2.3 to resolve its conflict.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">In either case, the investment team(s) responsible will document
the rationale for voting the proposal in a particular manner and the PVAG will review the matter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Investment
in Funds </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.5.1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trust-Wide
Approval Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Certain Guggenheim Funds (&#8220;Funds&#8221;) managed by
GPIM may invest in other Guggenheim Funds. With respect to a proposal that applies on a trust-wide basis (i.e., all series of a Guggenheim
trust will vote together on the proposal, e.g., election of trustees), GPIM will cause the investing Funds to vote their shares in the
underlying Fund in the same proportion as the vote (in the aggregate) of all the other shareholders in the Fund that are not themselves
funds managed by GPIM or its</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-5</p>

<!-- Field: Page; Sequence: 111 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">affiliates (also called &#8220;mirror&#8221; or &#8220;echo&#8221; voting). GPIM may, however, elect to follow
the fund or class-specific methodologies described below when deemed appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.5.2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Fund or Class-Specific
Approval Matters</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">The following voting methods are applicable to proposals
that are Fund or class-specific (i.e., each Fund or class votes separately).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">As a general matter, for those Guggenheim Funds that invest
in other Guggenheim Funds, GPIM will cause the investing Guggenheim Funds to mirror or echo vote their shares in the underlying Fund in
the same proportion as the vote of all the shareholders in that underlying Fund (or class) that are not themselves funds managed by GPIM
or its affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">With regard to Guggenheim Funds that hold shares in underlying
funds offered exclusively to Funds managed by GPIM or its affiliates and institutional accounts managed by GPIM or its affiliates, GPIM
will cause the investing Funds to: (i) mirror vote in proportion to votes of the shareholders of the investing Funds in the event that
both Funds are voting on substantially identical proposals; or, in all other cases, (ii) seek voting instructions from the independent
board members of the investing Funds or an independent proxy voting service, if deemed appropriate by the independent board members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.5.3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Voting Conditions
Pursuant to Rule 12d1-4</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Rule 12d1-4 under the 1940 Act allows registered investment
companies (and BDCs), including the Guggenheim Funds (each, an &#8220;Acquiring Fund&#8221; and, with respect to each such Guggenheim
Fund or any such series of a Guggenheim Fund, a &#8220;Guggenheim Acquiring Fund&#8221;), to invest in other registered investment companies
and BDCs (each, an &#8220;Acquired Fund&#8221;) beyond the limits of Section 12(d)(1) of the 1940 Act, subject to certain terms and conditions.
Where a Guggenheim Acquiring Fund invests, in reliance on Rule 12d1-4, in an Acquired Fund that is not part of the same &#8220;group of
investment companies&#8221; as defined in Rule 12d1-4 (a &#8220;Non-Guggenheim Acquired Fund&#8221;), the following voting conditions
(hereinafter, the &#8220;Rule 12d1-4 Voting Conditions&#8221;) shall apply:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">The Guggenheim Acquiring Fund and its &#8220;Advisory Group&#8221;
(defined as comprising the Guggenheim Acquiring Fund&#8217;s Adviser or depositor and any person controlling, controlled by or under common
control with such Adviser or depositor) or, if applicable, its &#8220;Sub-Advisory Group&#8221; (defined as comprising the Guggenheim
Acquiring Fund&#8217;s Sub-Adviser and any person controlling, controlled by, or under common control with such Sub-Adviser) must vote
their respective securities in a Non-Guggenheim Acquired Fund in the same proportion as the vote of all other holders of such securities
under the following circumstances:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">&#167; If a Guggenheim Acquiring Fund and its Advisory Group
(or Sub-Advisory Group, if applicable), in the aggregate, hold more than 25% of the outstanding voting securities of a Non-Guggenheim
Acquired Fund that is a registered open-end management investment company or registered UIT as a result of a decrease in the outstanding
voting securities of such Non-Guggenheim Acquired Fund; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">&#167; If a Guggenheim Acquiring Fund and its Advisory Group
(or Sub-Advisory Group, if applicable), in the aggregate, hold more than 10% of the outstanding voting securities of a Non-Guggenheim
Acquired Fund that is a registered closed-end management investment company or BDC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Notwithstanding these Rule 12d1-4 Voting Conditions, in circumstances
where all holders of the outstanding voting securities of the Non-Guggenheim Acquired Fund are required by Rule 12d1-4 or otherwise under
Section 12(d)(1) to vote securities of the Non-Guggenheim Acquired Fund in the same proportion as the vote of all other holders of such
securities, the Guggenheim Acquiring Fund will seek instructions from its security holders with regard to the voting of all proxies with</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-6</p>

<!-- Field: Page; Sequence: 112 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">
respect to such Non-Guggenheim Acquired Fund securities and vote such proxies only in accordance with such instructions (i.e., pass thru
voting).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">For the avoidance of doubt, the Rule 12d1-4 Voting Conditions
do not apply where: (1) the Guggenheim Acquiring Fund is in the same &#8220;group of investment companies,&#8221; as defined in Rule 12d1-4,
as the Acquired Fund; or (2) the Guggenheim Acquiring Fund has a Sub-Adviser and that Sub-Adviser (or any other member of its Sub-Advisory
Group) acts as the Non-Guggenheim Acquired Fund&#8217;s investment adviser or depositor.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">In addition, the terms of investment agreements entered into
by a Guggenheim Acquiring Fund pursuant to Rule 12d1-4 with an Acquired Fund may also need to be accounted for in voting securities of
the Acquired Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">2.5.4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Voting Conditions
Pursuant to Section 12(d)(1)(F)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Section 12(d)(1)(F) of, and Rule 12d1-3 under, the 1940 Act
allows registered investment companies (and BDCs), including the Guggenheim Funds to invest in other registered investment companies and
BDCs beyond the applicable limits of Section 12(d)(1) of the 1940 Act, subject to certain terms and conditions. Where a Guggenheim Acquiring
Fund invests in an Acquired Fund in reliance on Section 12(d)(1)(F), the following voting conditions shall apply:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">The Guggenheim Acquiring Fund must exercise its voting rights
(by proxy or otherwise) with respect to any security purchased or acquired in reliance on Section 12(d)(1)(F) by either:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">&#167; seeking instructions from its security holders with
regard to the voting of all proxies with respect to such security and to vote such proxies only in accordance with such instructions (i.e.,
pass thru voting); or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">&#167; to vote the shares held by it in the same proportion
as the vote of all other holders of such security (i.e., mirror voting).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in"><i>Additional Considerations</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 1in">Where a Guggenheim Fund is required under Section 12(d)(1)(F)
or Rule 12d1-4 to vote shares held by the Guggenheim Fund in the same proportion as the vote of all other holders of such security (i.e.,
mirror voting), and GPIM has determined, in its discretion and consistent with its fiduciary duty, that it is not possible or practicable
to vote in such a manner (e.g., lack of knowledge, proxy contests), a Guggenheim Fund may, from time to time, not vote shares in this
manner. In these situations, GPIM may submit do not vote (&#8220;DNV&#8221;) or similar instructions where the GPIM believes (i) it is
consistent with its fiduciary obligations with respect to the voting of proxies for its clients and (ii) it reasonably fulfills the intended
purpose of mirror voting requirements, if DNV or similar instructions do not impact the results of a given shareholder vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Undue
Influence</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">If at any time any person involved in the GPIM&#8217;s
proxy voting process is pressured or lobbied either by GPIM&#8217;s personnel or affiliates or third parties with respect to a particular
proposal, he or she should provide information regarding such activity to GPIM Compliance or Legal Departments. A determination will then
be made regarding this information, keeping in mind GPIM&#8217;s duty of loyalty and care to its clients.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Recordkeeping</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">GPIM is required to keep the following records:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>a copy of this policy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>proxy statements received regarding client securities;</td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 10pt; margin-bottom: 10pt">B-7</p>

<!-- Field: Page; Sequence: 113 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>records of votes cast on behalf of clients;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>records of how material conflicts were resolved;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>any documents prepared by GPIM that were material to making a decision how to vote, or that memorialized the basis for the decision;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 10pt; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>records of client requests for proxy voting information and a copy of any written response by GPIM to any client request (regardless
of whether such client request was written or oral).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">The foregoing records will be retained for such period
of time as is required to comply with applicable laws and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">GPIM may rely on proxy statements filed on the SEC&#8217;s
EDGAR system instead of keeping its own copies, and may rely on proxy statements and records of proxy votes cast by GPIM that are maintained
with a third party, such as ISS, provided that GPIM has obtained an undertaking from the third party to provide a copy of the documents
promptly upon request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in"><b>2.8.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Rule 206(4)-6 requires GPIM to disclose in response to
any client request how the client can obtain information from GPIM on how the client&#8217;s securities were voted. GPIM will disclose
in Form ADV Part 2 that clients can obtain information on how their securities were voted by submitting a written request to GPIM. Upon
receipt of a written request from a client, GPIM Compliance Department will provide the information requested by the client within a reasonable
amount of time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">Rule 206(4)-6 also requires GPIM to describe its proxy
voting policies and procedures to clients, and upon request, to provide clients with a copy of those policies and procedures. GPIM will
provide such a description in its Form ADV Part 2. Upon receipt of a written request from a client, GPIM Compliance Department will provide
a copy of this policy within a reasonable amount of time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0 10pt 0.5in">If approved by the client, this policy and any requested
records may be provided electronically.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0"><b>3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;APPENDIX A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">ISS Standard Guidelines for the various relevant local markets, including
the U.S., are available upon request. In addition, the Taft-Hartley Guidelines and the Socially Responsible Investor Guidelines are also
available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center">B-8</p>

<!-- Field: Page; Sequence: 114 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; text-align: center"></p>

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><b>PART C</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><b>OTHER INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 25. Financial Statements And Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.4in">Incorporated by reference into Part B of the Registration Statement,
as described in the Statement of Additional Information, included herein, are the Registrant&#8217;s audited financial statements, notes
to such financial statements and the report of independent registered public accounting firm thereon, by reference to the Registrant&#8217;s
<a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126825000173/gug88924gof.htm">Annual Report for the period ended May 31,
2025</a>, as contained in the Registrant&#8217;s Form N-CSR filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;)
on August 4, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/ex99a.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Amended and Restated Agreement and Declaration of Trust of Registrant</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126820000077/ex99b.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Amended and Restated By-Laws of Registrant</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000110465907050002/a07-16972_1ex99de.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Dividend Reinvestment Plan of Registrant</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)(i)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000089180410003574/exgi.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Investment Advisory Agreement <span style="background-color: white">between Registrant and Guggenheim Funds&#160;&#160;Investment Advisors, LLC (the &#8220;Investment Adviser&#8221;)</span></span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)(ii) </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000089180410003574/exgii.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Investment Sub-Advisory Agreement <span style="background-color: white">among Registrant, the Investment Adviser and Guggenheim Partners Investment Management, LLC (the &#8220;Sub-Adviser&#8221;)</span></span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)(i)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000089180419000222/ex99h.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Controlled Equity Offering<sup>SM&#160;</sup>Sale Agreement among the Registrant, the Investment Adviser and Cantor Fitzgerald &amp; Co.</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)(ii)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/0001380936/000182126821000029/ex99hii.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">First Amendment to Controlled Equity Offering<sup>SM</sup> Sales Agreement among the Registrant, the Investment Adviser and Cantor Fitzgerald &amp; Co.</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)(iii)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/gug87438exhiii.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amendment to Controlled Equity Offering<sup>SM</sup> Sales Agreement among the Registrant, the Investment Adviser and Cantor Fitzgerald &amp; Co.</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)(iv)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000119312523097503/d683081dex991.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Third Amendment to Controlled Equity Offering<sup>SM</sup> Sales Agreement among the Registrant, the Investment Adviser and Cantor Fitzgerald &amp; Co</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.(14)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)(v)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000089/exhibit11.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fourth Amendment to Controlled Equity Offering<sup>SM</sup> Sales Agreement Among the Registrant, the Investment Adviser and Cantor Fitzgerald &amp; Co.</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)(i)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000138093613000002/custodyagreement.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Custody Agreement</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)(ii)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000138093613000002/foreigncustodymanageragree.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Foreign Custody Manager Agreement</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(i)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000138093613000002/stocktransferagencyagreeme.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Stock Transfer Agency Agreement</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(ii)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/gug87438exkii.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Closed-End Fund Accounting and Administration Agreement</span></a> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)(1)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000089180419000096/ex99kiv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Amended and Restated Committed Facility Agreement between Registrant and BNP Paribas Prime Brokerage</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1"><span style="text-decoration: underline">, Inc. (&#8220;BNP Prime Brokerage&#8221;) </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)(2) </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126821000399/ex99kiv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Amendment to the Amended and Restated Committed Facility Agreement between Registrant and BNP Prime Brokerage</span></a> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1"><span style="text-decoration: underline">dated March 12, 2021</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(13)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)(3) </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/exkiii3.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to the Amended and Restated Committed Facility Agreement between Registrant and BNP Prime Brokerage dated November 18, 2021</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)(4) </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/exkiii4.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to the Amended and Restated Committed Facility Agreement between Registrant and BNP Prime Brokerage dated December 31, 2021</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)(5)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/exkiii5.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to the Amended and Restated Committed Facility Agreement between Registrant and BNP Prime Brokerage dated September 1, 2022</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iii)(6)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000182126824000079/exkiii6.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to the Amended and Restated Committed Facility Agreement between Registrant and BNP Prime Brokerage dated May 12, 2023</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(iv) </span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000089180419000096/ex99kv.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Amended and Restated Account Agreement between Registrant and BNP Prime Brokerage</span></a> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7)</span></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 115 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(v)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000089180410003574/exkvii.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Special Custody and Pledge Agreement among Registrant, BNP Prime Brokerage and The Bank of New York Mellon</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)(vi)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000138093613000002/offeringexpenselimitationa.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Offering Expense Limitation Agreement</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99l.htm">Opinion and Consent of Dechert LLP</a>(*)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99n.htm">Consent of Independent Registered Public Accounting Firm</a>(*)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><a href="https://www.sec.gov/Archives/edgar/data/1380936/000138093613000002/initialsubscriptionagreeme.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: #0563C1">Initial Subscription Agreement</span></a><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not applicable</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99r.htm">Combined Code of Ethics of the Registrant, the Investment Adviser and the Sub-Adviser</a>(*)&#160;&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Calculation of Filing Fee Tables(*)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99t.htm">Power of Attorney</a>(*)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0">___________</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left">(*)</td><td style="text-align: left; width: 5pt"/><td style="text-align: left">Filed herewith.</td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Pre-Effective Amendment No. 2
to the Registrant&#8217;s Registration Statement on Form N-2<span style="background-color: white">, filed June 26, 2007 (File No. 333-138686)</span>.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt; background-color: white">Incorporated by reference to the Registrant&#8217;s
Registration Statement on Form N-2, filed on July 9, 2010 (File No. 333-168044)</span><span style="font-size: 10pt">.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Pre-Effective Amendment No. 2
to the Registrant&#8217;s Registration Statement on Form N-2, filed on March 16, 2011 (File No. 333-168044).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(4)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to the Registrant&#8217;s Registration
Statement on Form N-2, filed on August 28, 2013 (File No. 333-190872).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(5)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Pre-Effective Amendment No. 1
to the Registrant&#8217;s Registration Statement on Form N-2, filed on October 14, 2016 (File No. 333-213452).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(6)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Post-Effective Amendment No. 2
to the Registrant&#8217;s Registration Statement on Form N-2, filed September 10, 2018 (File No. 333-221873).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(7)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to the Registrant&#8217;s Registration
Statement on Form N-2, filed March 22, 2019 (File No. 333-230474).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(8)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Post-Effective Amendment No. 1
to the Registrant&#8217;s Registration Statement on Form N-2, filed July 1, 2019 (File No. 333-230474).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(9)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s
Current Report on Form 8-K, filed March 1, 2016 (File No. 811-21982).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(10)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt">Incorporated by reference to Post-Effective Amendment No. 3
to the Registrant&#8217;s Registration Statement on Form N-2, filed July 31, 2020 (File No. 333-230474).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(11)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt; background-color: white">Incorporated by reference to Post-Effective
Amendment No. 4 to the Registrant&#8217;s Registration Statement on Form N-2, filed September 30, 2020 (File No. 333-230474).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(12)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt; background-color: white">Incorporated by reference to Post-Effective
Amendment No. 5 to the Registrant&#8217;s Registration Statement on Form N-2, filed February 1, 2021 (File No. 333-230474).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(13)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt; background-color: white">Incorporated by reference to the Registrant&#8217;s
Registration Statement on Form N-2, filed September 16, 2021 (File No. 333-259592).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(14)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt; background-color: white">Incorporated by reference to Exhibit
1.1 to the Registrant&#8217;s Current Report on Form 8-K, filed April 11, 2023 (File No. 811-21982).</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(15)</span></td><td style="text-align: left; width: 5pt"/><td style="text-align: left"><span style="font-size: 10pt; background-color: white">Incorporated by reference to the Registrants
Registration Statement on Form N-2, filed May 3, 2024 (File No. 333-279126).</span></td>
</tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><span style="font-size: 10pt; background-color: white"></span></p>

<!-- Field: Page; Sequence: 116 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 12pt Times New Roman, Times, Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><span style="font-size: 10pt; background-color: white">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 55pt; text-align: left"><span style="font-size: 10pt">(16)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-size: 10pt; background-color: white">Incorporated by reference to Exhibit
1.1 to the Registrant&#8217;s Current Report on Form 8-K, filed May 9, 2024 (File No. 811-21982).</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 26. Marketing Arrangements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 12pt 0.5in">Reference is made to Exhibit (h) to this Registration Statement
and the section entitled &#8220;Plan of Distribution&#8221; contained in Registrant&#8217;s Prospectus, filed herewith as Part A of Registrant&#8217;s
Registration Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 27. Other Expenses of Issuance and Distribution</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The following table sets forth the estimated expenses
to be incurred in connection with the offering described in this Registration Statement:</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 77%; padding-right: 5.4pt; padding-left: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE Listing Fees</span></td>
    <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$	50,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SEC Registration Fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$	131,643</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Registered Public Accounting Firm Fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$	27,500</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$	350,000</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">FINRA Fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$	150,500</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 40pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$	709,643</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 28. Persons Controlled by or Under Common Control with Registrant</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">None</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 29. Number of Holders of Securities</b></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Title of Class</span></b></span></td>
    <td style="width: 200px; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Record Shareholders <br/>
<span style="text-decoration: underline">as of November 14, 2025</span></b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common shares of beneficial interest, par value $0.01 per share</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26</span></td></tr>
  </table>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 6pt; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 1in"><b>Item 30.</b></td><td><b>Indemnification</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Article V of the Registrant&#8217;s Amended and
Restated Agreement and Declaration of Trust provides as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">5.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="text-decoration: underline">No
Personal Liability of Shareholders, Trustees, etc</span>. No Shareholder of the Trust shall be subject in such capacity to any personal liability
whatsoever to any Person in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders shall have the
same limitation of personal liability as is extended to stockholders of a private corporation for profit incorporated under the Delaware
General Corporation Law. No Trustee or officer of the Trust shall be subject in such capacity to any personal liability whatsoever to
any Person, save only liability to the Trust or its Shareholders arising from bad faith, willful misfeasance, gross negligence or reckless
disregard for his duty to such Person; and, subject to the foregoing exception, all such Persons shall look solely to the Trust Property
for satisfaction of claims of any nature arising in connection with the affairs of the Trust. If any Shareholder, Trustee or officer,
as such, of the Trust, is made a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, he
shall not, on account thereof, be held to any personal liability. Any repeal or modification of this Section 5.1 shall not adversely affect
any right or protection of a Trustee or officer of the Trust existing at the time of such repeal or modification with respect to acts
or omissions occurring prior to such repeal or modification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">5.2&#160;&#160;&#160;&#160;&#160;&#160;&#160;Mandatory
Indemnification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Trust hereby agrees to indemnify each person who at any time serves as a Trustee or officer of the Trust (each such person being an &#8220;indemnitee&#8221;)
against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and
reasonable counsel fees reasonably incurred</p>

<!-- Field: Page; Sequence: 117 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0">by such indemnitee in connection with the defense or disposition of any action, suit or other
proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved
as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity set forth in this Article V
by reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good faith
in the reasonable belief that his action was in the best interest of the Trust or, in the case of any criminal proceeding, as to which
he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee shall be indemnified
hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i) willful misfeasance, (ii) bad
faith, (iii) gross negligence, or (iv) reckless disregard of the duties involved in the conduct of his position (the conduct referred
to in such clauses (i) through (iv) being sometimes referred to herein as &#8220;disabling conduct&#8221;). Notwithstanding the foregoing,
with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory
only if the prosecution of such action, suit or other proceeding by such indemnitee (1) was authorized by a majority of the Trustees or
(2) was instituted by the indemnitee to enforce his or her rights to indemnification hereunder in a case in which the indemnitee is found
to be entitled to such indemnification. The rights to indemnification set forth in this Declaration shall continue as to a person who
has ceased to be a Trustee or officer of the Trust and shall inure to the benefit of his or her heirs, executors and personal and legal
representatives. No amendment or restatement of this Declaration or repeal of any of its provisions shall limit or eliminate any of the
benefits provided to any person who at any time is or was a Trustee or officer of the Trust or otherwise entitled to indemnification hereunder
in respect of any act or omission that occurred prior to such amendment, restatement or repeal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding
the foregoing, no indemnification shall be made hereunder unless there has been a determination (i) by a final decision on the merits
by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that
such indemnitee is entitled to indemnification hereunder or, (ii) in the absence of such a decision, by (1) a majority vote of a quorum
of those Trustees who are neither &#8220;interested persons&#8221; of the Trust (as defined in Section 2(a)(19) of the 1940 Act) nor parties
to the proceeding (&#8220;Disinterested Non-Party Trustees&#8221;), that the indemnitee is entitled to indemnification hereunder, or (2)
if such quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion concludes
that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection with the
expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph (c) below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might
be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee&#8217;s good faith belief that the
standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless it is subsequently
determined that the indemnitee is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards
of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (i)
the indemnitee shall provide adequate security for his undertaking, (ii) the Trust shall be insured against losses arising by reason of
any lawful advances, or (iii) a majority of a quorum of the Disinterested Non-Party Trustees, or if a majority vote of such quorum so
direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a
full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The
rights accruing to any indemnitee under these provisions shall not exclude any other right which any person may have or hereafter acquire
under this Declaration, the By-Laws of the Trust, any statute, agreement, vote of stockholders or Trustees who are &#8220;disinterested
persons&#8221; (as defined in Section 2(a)(19) of the 1940 Act) or any other right to which he or she may be lawfully entitled.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject
to any limitations provided by the 1940 Act and this Declaration, the Trust shall have the power and authority to indemnify and provide
for the advance payment of expenses to employees, agents and other Persons providing services to the Trust or serving in any capacity
at the request of the Trust to the full extent corporations organized under the Delaware General Corporation Law may indemnify or provide
for the advance payment of expenses for such Persons, provided that such indemnification has been approved by a majority of the Trustees.</p>

<!-- Field: Page; Sequence: 118 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">5.3&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
Bond Required of Trustees. No Trustee shall, as such, be obligated to give any bond or other security for the performance of any of his
duties hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">5.4&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
purchaser, lender, transfer agent or other person dealing with the Trustees or with any officer, employee or agent of the Trust shall
be bound to make any inquiry concerning the validity of any transaction purporting to be made by the Trustees or by said officer, employee
or agent or be liable for the application of money or property paid, loaned, or delivered to or on the order of the Trustees or of said
officer, employee or agent. Every obligation, contract, undertaking, instrument, certificate, Share, other security of the Trust, and
every other act or thing whatsoever executed in connection with the Trust shall be conclusively taken to have been executed or done by
the executors thereof only in their capacity as Trustees under this Declaration or in their capacity as officers, employees or agents
of the Trust. The Trustees may maintain insurance for the protection of the Trust Property, its Shareholders, Trustees, officers, employees
and agents in such amount as the Trustees shall deem adequate to cover possible tort liability, and such other insurance as the Trustees
in their sole judgment shall deem advisable or is required by the 1940 Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">5.5&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each
Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully and completely justified and protected
with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Trust,
upon an opinion of counsel, or upon reports made to the Trust by any of the Trust&#8217;s officers or employees or by any advisor, administrator,
manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Trustees,
officers or employees of the Trust, regardless of whether such counsel or expert may also be a Trustee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">In addition, the Registrant has entered into an
Indemnification Agreement with each trustee who is not an &#8220;interested person,&#8221; as defined in the Investment Company Act of
1940, as amended, of the Registrant, which provides as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The Fund shall indemnify and hold harmless the
Trustee against any and all Expenses actually and reasonably incurred by the Trustee in any Proceeding arising out of or in connection
with the Trustee&#8217;s service to the Trust, to the fullest extent permitted by the Trust Agreement and By-Laws and the laws of the
State of Delaware, the Securities Act of 1933, as amended, and the Investment Company Act of 1940, as amended, as now or hereafter in
force, subject to the provisions of the following sentence and the provisions of paragraph (b) of Section 4 of this Agreement. The Trustee
shall be indemnified pursuant to this Section I against any and all of such Expenses unless (i) the Trustee is subject to such Expenses
by reason of the Trustee&#8217;s not having acted in good faith in the reasonable belief that his or her action was in the best interests
of the Fund or (ii) the Trustee is liable to the Fund or its shareholders by reason of willful misfeasance, bad faith, gross negligence,
or reckless disregard of the duties involved in the conduct of his or her office, as defined in Section 17(h) of the Investment Company
Act of 1940, as amended, and with respect to each of (i) and (ii), there has been a final adjudication in a decision on the merits in
the relevant Proceeding that the Trustee&#8217;s conduct fell within (i) or (ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 31. Business and Other Connections of the Investment Adviser
and the Sub-Adviser</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The Investment Adviser, a limited liability company
organized under the laws of Delaware, acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this
Item 31 to provide a list of the officers and directors of the Investment Adviser, together with information as to any other business,
profession, vocation or employment of a substantial nature engaged in by the Investment Adviser or those officers and directors during
the past two years, by incorporating by reference the information contained in the Form ADV of the Investment Adviser filed with the commission
pursuant to the Investment Advisers Act of 1940 (Commission File No. 801-62515).</p>

<!-- Field: Page; Sequence: 119 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The Sub-Adviser, a limited liability company organized
under the laws of Delaware, acts as investment Sub-Adviser to the Registrant. The Registrant is fulfilling the requirement of this Item
31 to provide a list of the officers and directors of the Sub-Adviser, together with information as to any other business, profession,
vocation or employment of a substantial nature engaged in by the Sub-Adviser or those officers and directors during the past two years,
by incorporating by reference the information contained in the Form ADV of the Sub-Adviser filed with the commission pursuant to the Investment
Advisers Act of 1940 (Commission File No. 801-66786).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 32. Location of Accounts and Records</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">The accounts and records of the Registrant are
maintained in part at the offices of the Fund at 227 West Monroe Street, Chicago, IL 60606, in part at the offices of the Investment Adviser
at 227 West Monroe Street, Chicago, IL 60606, in part at the offices of the Sub-Adviser at 100 Wilshire Boulevard, 5th Floor, Santa Monica,
California 90401 and in part at the offices of BNY, as custodian, at&#160;One Wall Street, New York, NY 10286, and in part at the offices
of the Transfer Agent and Dividend Disbursing Agent at&#160;P.O. Box 30170, College Station, TX 77842-3170, and in part at the offices
of MUFG Investor Services, LLC, 805 King Farm Blvd. Rockville, MD, 20850.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 33. Management Services</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-indent: 0.5in">Not applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 6pt 0"><b>Item 34. Undertakings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> </p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not
applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Not
applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Registrant
undertakes:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(a)</td><td>to file, during any period in which offers or sales are being made, a post-effective amendment to the Registration Statement:</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(1)</td><td>to include any prospectus required by Section 10(a)(3) of the Securities Act;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(2)</td><td>to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth
in the Registration Statement;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 2in">Notwithstanding the foregoing, any increase or decrease in volume
of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from
the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant
to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering
price set forth in the &#8220;Calculation of Filing Fee Tables&#8221; in the effective registration statement.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(3)</td><td>to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement
or any material change to such information in the Registration Statement;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(b)</td><td>that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to
be a new registration statement relating to the securities offered therein, and the offering of those securities at that time shall be
deemed to be the initial bona fide offering thereof;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(c)</td><td>to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(d)</td><td>that, for the purpose of determining liability under the Securities Act to any purchaser:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">(1) &#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Registrant
is relying on Rule 430B under the Securities Act:</p>

<!-- Field: Page; Sequence: 120 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 144pt"/><td style="width: 40.5pt">(A)</td><td>Each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of
the date the filed prospectus was deemed part of and included in the registration statement; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 144pt"/><td style="width: 40.5pt">(B)</td><td>Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (x), or (xi) for the purpose of providing the information required
by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the
date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering
described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter,
such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement
to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement
that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately
prior to such effective date; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(2)</td><td>if the Registrant is subject to Rule 430C under the Securities Act: Each prospectus filed pursuant to Rule 424(b) under the Securities
Act as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than
prospectuses filed in reliance on Rule 430A under the Securities Act, shall be deemed to be part of and included in the registration statement
as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus
that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such
first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration
statement or made in any such document immediately prior to such date of first use;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1in"/><td style="width: 0.5in">(e)</td><td>that for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution
of securities:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in">The undersigned Registrant undertakes that in a primary offering
of securities of the undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications,
the undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to the purchaser:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in"></p>

<!-- Field: Page; Sequence: 121 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(1)</td><td>any preliminary prospectus or prospectus of the undersigned Registrant relating to the offering required to be filed pursuant to Rule
424 under the Securities Act;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(2)</td><td>free writing prospectus relating to the offering prepared by or on behalf of the undersigned Registrant or used or referred to by
the undersigned Registrant;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(3)</td><td>the portion of any other free writing prospectus or advertisement pursuant to Rule 482 under the Securities Act relating to the offering
containing material information about the undersigned Registrant or its securities provided by or on behalf of the undersigned Registrant;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 1.5in"/><td style="width: 0.5in">(4)</td><td>any other communication that is an offer in the offering made by the undersigned Registrant to the purchaser.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">4.</td><td>Registrant undertakes that:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;for the purpose
of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of the Registration
Statement in reliance upon Rule 430A and contained in the form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) will be
deemed to be a part of the Registration Statement as of the time it was declared effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt 1in">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;for the purpose
of determining any liability under the Securities Act, each post-effective amendment that contains a form of prospectus will be deemed
to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time will be
deemed to be the initial bona fide offering thereof.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">5.</td><td>The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
of the Registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 that is incorporated
by reference into the registration statement shall be deemed to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">6.</td><td>Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless
in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the
question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication
of such issue.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in">7.</td><td>The Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business
days of receipt of a written or oral request, any prospectus or Statement of Additional Information.</td></tr></table>


<!-- Field: Page; Sequence: 122 -->
    <div style="margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933 and/or the Investment Company Act of 1940, the Registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of Chicago, and State of Illinois, on the 21st day of November, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in">GUGGENHEIM STRATEGIC OPPORTUNITIES FUND</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in">By:	<span style="text-decoration: underline">/s/ Brian E. Binder</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in">Brian E. Binder</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 13.5pt 0 3in">President and Chief Executive Officer (Principal Executive
Officer)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2.5in; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">Pursuant to the requirements of the Securities
Act of 1933, this registration statement has been signed by the following persons in the capacities and on the date indicated.</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Randall C. Barnes</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td>
    <td rowspan="9" style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">/s/ Brian E. Binder<br/>
    </span>Brian E. Binder</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">President and Chief Executive Officer (Principal Executive Officer)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 21, 2025</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">/s/ James M. Howley</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">James M. Howley</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 16.85pt 0 0; text-indent: -0.9pt">Chief Financial Officer, Treasurer and
    Chief Accounting Officer (Principal Financial and Accounting Officer)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 21, 2025</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 16.85pt 0 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">/s/ Amy J. Lee</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Amy J. Lee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee, Vice President and Chief Legal Officer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 21, 2025</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">* Signed by Mark E. Mathiasen, pursuant to a power of attorney filed herewith.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">/s/ Mark E. Mathiasen</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Mark E. Mathiasen</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Attorney-In-Fact</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: November 21, 2025</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Angela-Brock Kyle</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Thomas Lydon, Jr.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Ronald A. Nyberg</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Sandra G. Sponem</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline">*</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Ronald E. Toupin Jr.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Trustee</p></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt"></p>

<!-- Field: Page; Sequence: 123 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 6pt"><b>Exhibit List</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex99l.htm">(l)	Opinion and Consent of Dechert LLP</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex99n.htm">(n)	Consent of Independent Registered Public Accounting Firm</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex99r.htm">(r)	Combined Code of Ethics of the Registrant, the Investment Adviser and the Sub-Adviser</a></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="ex99s.htm">(s)	Calculation of Filing Fee Tables</a></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt"><a href="ex99t.htm">(t)	Power of Attorney</a></p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">&#160;</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101	Inline Interactive Data File - the instance document
does not appear on the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101.INS	XBRL Taxonomy Instance Document</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101.SCH	XBRL Taxonomy Schema Document</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101.CAL	XBRL Taxonomy Calculation Linkbase Document</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101.DEF	XBRL Taxonomy Definition Linkbase Document</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101.LAB	XBRL Taxonomy Label Linkbase Document</p>

<p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 8pt">EX-101.PRE	XBRL Taxonomy Presentation Linkbase Document</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJyVkNFqwjAUhp/Adwi9Fm06HFvvXHUyVp1Ukd2m6dEdTHNKcursI+0tFytjV4MZAiH5z/edcKJoGC3oGQ048f5U5GILdWMUgyhgDw6shlCRvbymIpwFHNCzU5b76w+YUWAgMPejOxXe+8oTeqhSIeVYPo6TiYgnqXwQ62U0uOQZ2T1WYBmVEcpWYu2ocQisXHc1bNWZLNVd32kHziPZoBvF1/hLJLFMxIpO6pPc0Ys8z6LBsF+DaOGobULV/MxgL6SYG6hDO3+lf3f/G916pjpdO7QaG2UK9Ee/hLoEF1IZJ4mMp/Gf3FK5I/AMvabW8tRWQaRhR2GOaJC7i+7/thmU/HYCZ1S3CbNmONwo2HSWP4BRT1smrYxRpYF5vrrB9g0lXJz+ -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>ex99l.htm
<DESCRIPTION>OPINION OF CONSENT OF DECHERT LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%"><IMG SRC="dechert.gif" ALT="">&nbsp;</TD>
  <TD STYLE="width: 50%"><P STYLE="font: 7.5pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; letter-spacing: 0.1pt">1900 K Street, NW<BR>
Washington, DC 20006-1110</P>

<P STYLE="font: 7.5pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; letter-spacing: 0.1pt">+1 202 261 3300 Main</P>

<P STYLE="font: 7.5pt/10pt Arial, Helvetica, Sans-Serif; margin: 0; letter-spacing: 0.1pt">+1 202 261 3333 Fax</P>

<P STYLE="margin: 0; font: 7.5pt/10pt Arial, Helvetica, Sans-Serif">www.dechert.com</P>
</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">November 21, 2025</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">Guggenheim Strategic
Opportunities Fund</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">227 West Monroe Street</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">Chicago, Illinois 60606</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">Re:</TD><TD STYLE="text-align: justify">Guggenheim Strategic Opportunities Fund</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0in">Registration Statement
on Form N-2</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify">File No. 811-21982</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">Dear Ladies and Gentlemen:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">We have acted as counsel to Guggenheim
Strategic Opportunities Fund, a Delaware statutory trust (the &ldquo;<U>Fund</U>&rdquo;), in connection with the preparation and filing
of a Registration Statement on Form N-2 (the &ldquo;<U>Registration Statement</U>&rdquo;), filed on the date hereof, with the U.S. Securities
and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;) under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;),
relating to offerings from time to time of up to $1,000,000,000 aggregate initial offering price of common shares of beneficial interest,
par value $0.01 per share, of the Fund (&ldquo;<U>Common Shares</U>&rdquo;).</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 1in">The Registration Statement provides
that the Common Shares may be offered in one or more offerings in amounts, at prices and on terms to be set forth in one or more supplements
to the prospectus included in the Registration Statement (each, a &ldquo;<U>Prospectus Supplement</U>&rdquo;). This opinion letter is
being furnished to the Fund in accordance with the requirements of Item&nbsp;25 of Form N-2 under the Securities Act and the Investment
Company Act of 1940, as amended, and we express no opinion herein as to any matter other than as to the legality of the Common Shares.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">In rendering the opinion
expressed below, we have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of such
documents, trust records and other instruments and such agreements, certificates and/or receipts of public officials, certificates of
officers or other representatives of the Fund and others, and such other documents as we have deemed necessary or appropriate as a basis
for the opinion set forth below, including the following documents:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.5pt">(i)</TD><TD STYLE="text-align: justify">the Registration
Statement;</TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.5pt">(ii)</TD><TD STYLE="text-align: justify">the Certificate of Trust of the Fund and all amendments thereto;</TD></TR></TABLE>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;<IMG SRC="dechert.gif" ALT=""></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.5pt">(iii)</TD><TD STYLE="text-align: justify">the Amended and Restated Agreement and Declaration of Trust of the Fund, dated February 29, 2024 (the
&ldquo;<U>Declaration of Trust</U>&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.5pt">(iv)</TD><TD STYLE="text-align: justify">the Amended and Restated By-Laws of the Fund, dated August 27, 2020 (the &ldquo;<U>By-Laws</U>&rdquo;);
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.5pt">(v)</TD><TD STYLE="text-align: justify">a certificate of good standing with respect to the Fund issued by the Secretary of State of the State
of Delaware as of November 20, 2025; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 35.5pt">(vi)</TD><TD STYLE="text-align: justify">resolutions of the Board of Trustees of the Fund relating to, among other things, the approval of the
preparation and filing of the Registration Statement and the registration, offering, sale and issuance of the Common Shares.</TD></TR></TABLE>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">As to the facts upon which
this opinion is based, we have relied upon certificates of public officials and certificates and written statements of agents, officers,
trustees and/or representatives of the Fund.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">In our examination, we have
assumed the genuineness of all signatures, the authenticity of all certificates and other documents submitted to us as original documents,
the conformity to original documents of all certificates and other documents submitted to us as copies, the legal capacity of natural
persons who are signatories to the certificates and other documents examined by us and the legal power and authority of all persons signing
on behalf of the parties to such certificates and other documents.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">On the basis of the foregoing
and subject to the assumptions, qualifications and limitations set forth in this letter, we are of the opinion that the Common Shares,
when (a) duly issued and sold in accordance with the Registration Statement and applicable Prospectus Supplement and (b) delivered to
the purchaser or purchasers thereof against receipt by the Fund of such consideration therefor as set forth in the Registration Statement
and applicable Prospectus Supplement and at a price per share not less than the per share par value of the Common Shares, will be validly
issued, fully paid and, except as provided in the last sentence of Section 3.8 of the Declaration of Trust, nonassessable. In this regard,
we note that, pursuant to Section 3.8 of the Declaration of Trust, the Trustees have the power, as frequently as they may determine, to
cause each Shareholder (as defined therein) to pay directly, in advance or arrears, for charges of distribution, of the custodian or transfer,
Shareholder servicing or similar agent, a pro rata amount as defined from time to time by the Trustees, by setting off such charges due
from such Shareholder from declared but unpaid dividends or distributions owed such Shareholder and/or by reducing the number of shares
in the account of such Shareholder by that number of full and/or fractional Shares which represents the outstanding amount of such charges
due from such Shareholder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;<IMG SRC="dechert.gif" ALT=""></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The opinion set forth herein
is subject to the following assumptions, qualifications, limitations and exceptions being true and correct at or before the time of the
delivery of any Common Shares offered pursuant to the Registration Statement and appropriate Prospectus Supplement:</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; font: 11pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; font: 11pt Times New Roman, Times, Serif; text-align: justify">(i)</TD>
    <TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: justify">the resolutions establishing the definitive terms and authorizing the Fund to register, offer, sell and issue the Common Shares shall remain in effect and unchanged at all times during which the Common Shares are offered, sold or issued by the Fund;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(ii)</TD>
    <TD STYLE="text-align: justify">the Common Shares and any certificates representing the Common Shares have been duly authenticated, executed, countersigned, registered and delivered upon payment of the agreed-upon legal consideration therefor and have been duly issued and sold in accordance with any relevant agreement and, if applicable, duly executed and delivered by the Fund and any other appropriate party;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(iii)</TD>
    <TD STYLE="text-align: justify">each subscription agreement and any other relevant agreement has been duly authorized, executed and delivered by, and will constitute a valid and binding obligation of, each party thereto (other than the Fund);</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(iv)</TD>
    <TD STYLE="text-align: justify">the Registration Statement, as amended (including all necessary post-effective amendments), and any additional registration statement filed under Rule 462 under the Securities Act, shall be effective under the Securities Act, and such effectiveness shall not have been terminated or rescinded;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(v)</TD>
    <TD STYLE="text-align: justify">an appropriate Prospectus Supplement shall have been prepared, delivered and filed in compliance with the Securities Act and the applicable rules and regulations thereunder describing the Common Shares offered thereby;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(vi)</TD>
    <TD STYLE="text-align: justify">the Common Shares shall be issued and sold in compliance with all U.S. federal and state securities laws and solely in the manner stated in the Registration Statement and the applicable Prospectus Supplement and there shall not have occurred any change in law affecting the validity of the opinion rendered herein;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(vii)</TD>
    <TD STYLE="text-align: justify">if the Common Shares will be sold pursuant to a firm commitment underwritten offering, the underwriting agreement with respect to the Common Shares in the form filed as an exhibit to the Registration Statement or any post-effective amendment thereto, or incorporated by reference therein, has been duly authorized, executed and delivered by the Fund and the other parties thereto; and</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;&nbsp;</P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;<IMG SRC="dechert.gif" ALT=""></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 12px; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 36px; text-align: justify">(viii)</TD>
    <TD STYLE="text-align: justify">in the case of an agreement or instrument pursuant to which any Common Shares are to be issued, there shall be no terms or provisions contained therein which would affect the validity of the opinion rendered herein.</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">The opinion set forth herein
as to enforceability of obligations of the Fund is subject to: (i)&nbsp;bankruptcy, insolvency, reorganization, fraudulent conveyance,
moratorium or similar laws now or hereinafter in effect affecting the enforcement of creditors&rsquo; rights generally, and by general
principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law) and the discretion of the court
or other body before which any proceeding may be brought; (ii)&nbsp;the unenforceability under certain circumstances under law or court
decisions of provisions providing for the indemnification of, or contribution to, a party with respect to a liability where such indemnification
or contribution is contrary to public policy; (iii)&nbsp;provisions of law which may require that a judgment for money damages rendered
by a court in the United States be expressed only in U.S. dollars; and (iv)&nbsp;governmental authority to limit, delay or prohibit the
making of payments outside the United States or in foreign currency or composite currency.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">We express no opinion as
to the validity, legally binding effect or enforceability of any provision in any agreement or instrument that (i)&nbsp;requires or relates
to payment of any interest at a rate or in an amount which a court may determine in the circumstances under applicable law to be commercially
unreasonable or a penalty or forfeiture or (ii)&nbsp;relates to governing law and submission by the parties to the jurisdiction of one
or more particular courts.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">This opinion is limited to
the Delaware Statutory Trust Act statute, and we express no opinion with respect to the laws of any other jurisdiction or to any other
laws of the State of Delaware. Further, we express no opinion as to compliance with any state or federal securities laws, including the
securities laws of the State of Delaware.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">This opinion letter has been
prepared for your use solely in connection with the Registration Statement. We assume no obligation to advise you of any changes in the
foregoing subsequent to the effectiveness of the Registration Statement.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">We hereby consent to the
filing of this opinion as an exhibit to the Registration Statement and to the references to this firm under the captions &ldquo;Legal
Matters&rdquo; and &ldquo;General Information&mdash;Legal Matters&rdquo; in the Registration Statement. In giving such consent, we do
not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules
and regulations of the Commission thereunder.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>
<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">&nbsp;<IMG SRC="dechert.gif" ALT=""></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 1in">&nbsp;</P>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">Very truly yours,</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><U>/s/ Dechert LLP</U></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">Dechert LLP</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>4
<FILENAME>ex99n.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Consent of Independent Registered Public Accounting
Firm</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We consent to the references to our firm under the
captions &ldquo;Financial Highlights&rdquo;, &ldquo;Senior Securities&rdquo;, and &ldquo;Independent Registered Public Accounting Firm&rdquo;
in the Prospectus and &ldquo;Independent Registered Public Accounting Firm&rdquo; and &ldquo;Financial Statements&rdquo; in the Statement
of Additional Information, each dated November 21, 2025, and each included in this Amendment No 35 to the Registration
Statement (Form N-2) (File No. 811-21982) of Guggenheim Strategic Opportunities Fund (the &ldquo;Registration Statement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">We also consent to the incorporation by reference
of our report dated July 25, 2025, with respect to the financial statements and financial highlights of Guggenheim Strategic Opportunities
Fund included in the Annual Report to Shareholders&nbsp;(Form N-CSR) for the year ended&nbsp;May 31, 2025, into this Registration Statement,
filed with the Securities and Exchange Commission.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">/s/ Ernst &amp; Young LLP&#9;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tysons, Virginia</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">November 21, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>5
<FILENAME>ex99r.htm
<DESCRIPTION>COMBINED CODE OF ETHICS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><IMG SRC="guggenheimlogonew2.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Guggenheim Funds, Guggenheim Partners Investment
Management LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Investment
Advisors, LLC, Guggenheim Investor Services, LLC, Guggenheim Corporate Funding, LLC, GS Gamma Advisors, LLC, Guggenheim Private Investments,
LLC, and Guggenheim Wealth Solutions, LLC</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Code of Ethics</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B>Sponsor<BR>
</B>Head of GI Compliance</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B>Owner<BR>
</B>Chief Compliance Officers of Guggenheim Investments Entities</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B>Contact<BR>
</B><U>Margaux.misantone@guggenheimpartners.com</U> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><U><BR>
</U></FONT><U>Lisa.buley@guggenheimpartners.com <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
</FONT>Scott.Fusco@guggenheimpartners.com</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B>Effective Date <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
</FONT></B>June 30, 2025</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left">Innovative Solutions. <B>Enduring Values.&reg;</B></P>


<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: left"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: right"><B>CODE OF ETHICS</B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: left; text-indent: 0in">BUSINESS
UNIT RESPONSIBLE:&#9;GI COMPLIANCE DEPARTMENT (&ldquo;COMPLIANCE&rdquo;)</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">PROCEDURE:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Rydex Dynamic Funds, Rydex Series Funds, Rydex
Variable Trust, Guggenheim Funds Trust, Guggenheim Variable Funds Trust, Guggenheim Strategy Funds Trust, Guggenheim Taxable Municipal
Bond &amp; Investment Grade Debt Trust, Guggenheim Strategic Opportunities Fund and Guggenheim Active Allocation Fund (each a &ldquo;Fund&rdquo;
and jointly the &ldquo;Funds&rdquo; or Guggenheim Funds), and Guggenheim Funds Investment Advisors, LLC, Guggenheim Funds Distributors,
LLC, Security Investors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Investment Advisors, LLC<SUP>1</SUP>, Guggenheim Investor
Services, LLC, GS Gamma Advisors, LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Private Investments, LLC, and Guggenheim
Wealth Solutions, LLC (each a &ldquo;Company,&rdquo; jointly the &ldquo;Companies,&rdquo; and together with the Funds, &ldquo;Guggenheim
Investments&rdquo; or &ldquo;GI&rdquo;) are confident that their officers, trustees, directors and employees act with integrity and good
faith. GI recognizes, however, that personal interests may conflict with a Fund&rsquo;s or Company&rsquo;s interests where trustees,
directors, officers or employees:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Know about present or future portfolio transactions or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Have the power to influence portfolio transactions; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Engage in personal transactions in securities.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">In an effort to prevent these conflicts from
arising and in accordance with Rule 17j-1(c)(1) under the Investment Company Act of 1940 (the &ldquo;1940 Act&rdquo;) and Rule 204A-1
under the Investment Advisers Act of 1940 (the &ldquo;Advisers Act&rdquo;), GI has adopted this Code of Ethics and all amendments thereto
(together, the &ldquo;Code&rdquo;) to prohibit transactions that create, may create, or appear to create conflicts of interest, and to
establish reporting requirements and enforcement procedures. Additionally, Guggenheim Investors Services, LLC has adopted this Code of
Ethics to effectuate the purposes and objectives of FINRA Rule 3210 and in accordance with industry best practices. This Combined Code
of Ethics adopted under Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act covers the Companies listed in Appendix A.
Each trustee, director, officer and employee of GI should carefully read and review this Code.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>About GI</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.1.</B></FONT>The
Funds are separately registered open-end and closed-end management investment companies. Each Fund may consist of multiple investment
portfolios (each a &ldquo;Fund&rdquo; and together, the &ldquo;Funds&rdquo;).</P>
<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><SUP>1</SUP> For purposes of this Code of Ethics, Guggenheim Investment
Advisers, LLC is considered part of Guggenheim Investments, whereas Guggenheim Investment Advisers, LLC may be excluded from the definition
of Guggenheim Investments in other business and compliance policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><IMG SRC="guggenheimlogonew2.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.2.</B></FONT>Guggenheim
Funds Investment Advisors, LLC, Security Investors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Investment Advisors, LLC, GS Gamma
Advisors, LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Private Investments, LLC, and Guggenheim Wealth Solutions, LLC
(each an &ldquo;Adviser&rdquo; and together, the &ldquo;Advisers&rdquo;) are registered investment advisers. Guggenheim Funds Investment
Advisors, LLC, Security Investors, LLC, and/or Guggenheim Partners Investment Management, LLC are the investment adviser or sub-adviser
to certain of the Funds. Security Investors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Investment Advisors, LLC, GS Gamma Advisors,
LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Private Investments, LLC, and Guggenheim Wealth Solutions, LLC offer investment
advisory services to client accounts that are not the Funds.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.3.</B></FONT>Guggenheim
Funds Distributors, LLC, a registered broker-dealer, (the &ldquo;Distributor&rdquo;) serves as distributor to certain Funds and depositor
of certain unit investment trusts. Guggenheim Investor Services, LLC, a broker-dealer registered with the SEC and FINRA, is approved to
engage in private placement activities by structuring and privately placing new issue unregistered securities or loans.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>About this Code of Ethics</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.1.</B></FONT><B>Transaction-Related
and Reporting Provisions</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">As a condition of employment, all individual
employees, officers, principals, partners and directors of Guggenheim Investments (generally referred to as &ldquo;Employees&rdquo;) are
required to comply with the Code. The following categories of persons are considered to be Adviser Access Persons and are required to
comply with the Code together with Employees. &ldquo;<U>Adviser Access Person</U>&rdquo; includes any:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">a</FONT></TD><TD STYLE="text-align: justify">Employee, Director, officer, manager, principal and partner of the Adviser or Distributor (or other persons
occupying a similar status or performing similar functions), or other person who provides advice on behalf of the Adviser or is subject
to the Adviser&rsquo;s supervision and control; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">b</FONT></TD><TD STYLE="text-align: justify">Any person who:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Has access to nonpublic information regarding any of the Adviser&rsquo;s client&rsquo;s purchases or sales
of securities, or nonpublic information regarding the portfolio holdings of any client account the Adviser or their affiliates manage,
or any fund which is advised or sub-advised by the Adviser (or certain affiliates, where applicable);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Makes recommendations or investment decisions on behalf of the Adviser;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Has the power to exercise a controlling influence over the management and policies of the Adviser, or
over investment decisions, who obtains information concerning recommendations made to a client with regard to the purchase or sale of
a security;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">The Compliance Officer shall determine on a case-by-case basis whether a temporary employee (e.g., consultant
or intern) should be considered an Adviser Access Person. Such determination shall be made based upon an application of the criteria provided</TD></TR></TABLE>
<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="guggenheimlogonew2.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext"></FONT></TD><TD STYLE="text-align: justify">above, whether an appropriate confidentiality agreement is in place, and such other information as may be necessary to ensure that proprietary
information is protected. As such, temporary employees may only be subject to certain sections of the Code, such as certifying to it,
or may be exempt from certain reporting requirements such as not having to hold their reportable accounts at the permitted broker-dealers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any person deemed to be an Adviser Access Person by the Compliance Officer; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">All Trustees of the Funds, both <U>Interested</U> and <U>Independent</U>.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">In addition to <U>Adviser Access Persons</U>,
persons qualifying as <U>Natural Control Persons, which</U> include natural persons in a <U>control</U> relationship with a Company who
obtain information concerning recommendations made to a Fund or client about the <U>purchase or sale</U> of a <U>security </U> <I>and
who are not specifically covered by any other section of the Code</I>, are required to comply with the Code<I>.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>In addition to the general principles and
limitations set forth below, for the prohibitions and reporting requirements that specifically apply to you, please refer to Parts A-C,
as indicated below. (Definitions of <U>underlined</U> terms are included in Appendix B.)</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Independent Trustees of the Funds - Part A</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify"><B><U>Adviser Access Persons</U> (Other than Independent Trustees of the Funds) - Part B</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify"><B>Natural Control Persons - Part C</B></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.2.</B></FONT><B>Other
Provisions</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The remainder of this Code sets forth general
principles and limitations, required course of conduct, reporting obligations, and GI&rsquo;s review, enforcement and recordkeeping responsibilities
as well as other related information.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Statement of General Principles</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">In recognition of the trust and confidence
placed in GI by its clients and shareholders of the Funds, and because GI believes that its operations should benefit clients and shareholders,
GI has adopted the following universally applicable principles.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">1.</FONT></TD><TD STYLE="text-align: justify">Shareholders&rsquo; and clients&rsquo; interests are paramount. You must place shareholder and client
interests before your own.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">2.</FONT></TD><TD STYLE="text-align: justify">You must accomplish all personal <U>securities</U> transactions in a manner that avoids an actual conflict
or even the appearance of a conflict of your personal interests with those of a Company&rsquo;s clients, including a Fund&rsquo;s shareholders.</TD></TR></TABLE>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"><IMG SRC="guggenheimlogonew2.jpg" ALT=""></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">3.</FONT></TD><TD STYLE="text-align: justify">You
                                            must avoid actions or activities that allow (or appear to allow) you or your <U>immediate
                                            <SUP>2</SUP>family</U> to profit or benefit from your position with GI, or that bring into
                                            question your independence or judgment.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">4.</FONT></TD><TD STYLE="text-align: justify">You must comply with all applicable federal and state securities laws, including the prohibitions against
the misuse of material nonpublic information, in conducting yourself and the operations of GI.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">This Code does not attempt to identify all
possible conflicts of interest, and literal compliance with each of its specific provisions will not shield investment personnel from
liability for personal trading or other conduct that violates a fiduciary duty to a Company&rsquo;s clients or a Fund&rsquo;s shareholders.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Required Course of Conduct and General Limits</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.1.</B></FONT><B>Prohibition
Against Fraud, Deceit and Manipulation</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You may not, in connection with the <U>purchase
or sale</U>, directly or indirectly, of a <U>security held or to be acquired</U> by any Fund or client account:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">a</FONT></TD><TD STYLE="text-align: justify">employ any device, scheme or artifice to defraud a Fund or client account;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">b</FONT></TD><TD STYLE="text-align: justify">make any untrue statement of a material fact to a Fund or client or omit to state a material fact necessary
in order to make the statements made to a Fund or client, in light of the circumstances under which they are made, not misleading;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">c</FONT></TD><TD STYLE="text-align: justify">engage in any act, practice or course of business which would operate as a fraud or deceit upon a Fund
or client; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">d</FONT></TD><TD STYLE="text-align: justify">engage in any manipulative practice with respect to a Fund or client account.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.2.</B></FONT><B>Prohibition
on Front Running</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Front-running, trading opposite a Fund or
Adviser&rsquo;s client account(s), or engaging in conduct that may be construed as front-running, is strictly prohibited under the Code.
For example, front-running would include an Access Person purchasing a <U>security</U> any time within seven days ahead of when the Fund
or Adviser&rsquo;s client account(s) purchases the same <U>security</U>, or the sale of a <U>security</U> any time within seven days
ahead of when the Fund or Adviser&rsquo;s client account(s) sells the same <U>security</U>. An example of trading opposite the Fund or
Adviser&rsquo;s client account(s) would include the sale of a <U>security</U> any time within seven days after the Fund or Adviser&rsquo;s
client account(s) purchases the same <U>security</U> or the purchase of a <U>security</U> any time within seven days after the Fund or
Adviser&rsquo;s client account(s) sells the same <U>security</U>. Proprietary, Access Persons&rsquo;, and discretionary accounts will
be monitored for front-running.</P>
<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">2
<U>Immediate Family</U> includes, but is not limited to, a spouse, child, grandchild, stepchild, parent, grandparent, sibling, mother
or father-in-law, son or daughter-in-law, or brother or sister-in-law, and adoptive relationships, living in the same household. Please
refer to Appendix B &ndash; Definitions for more information.</P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><IMG SRC="guggenheimlogonew2.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.3.</B></FONT><B>Outside
Business Activities</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The Advisers and Distributor have separate
policies with respect to employees&rsquo; outside business activities. Employees are prohibited from taking part in any outside employment
without prior approval from their Supervisor and Compliance. Employees should refer to the applicable outside business activities policy.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Employee participation in outside activities
related to <U>cryptocurrency</U> (<I>e.g</I>., blockchain entities, cryptocurrency mining, etc.) requires pre-approval under the Advisers&rsquo;
and Distributor&rsquo;s outside business activities policy.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.4.</B></FONT><B>Excessive
Trading</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Adviser Access Persons</U> shall not engage
in excessive trading or market timing of the Funds; provided, however, that this prohibition does not apply to the <U>Tradable Funds</U>.
Market timing may take many forms, including arbitrage activity involving the frequent buying and selling of a fund&rsquo;s shares in
order to take advantage of the fact that there may be a lag between a change in the value of a fund&rsquo;s portfolio securities and the
reflection of that change in the fund&rsquo;s share price. Such activity is inconsistent with the fiduciary principles of this Code, which
require that <U>Adviser Access Persons</U> place the interests of clients above their own interests.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Adviser Access Persons</U> shall not make
more than 60 <U>securities</U> trades in any calendar quarter. Transactions of <U>Broad-based Exchange Traded Funds</U> that meet certain
criteria as defined in Appendix B or securities that do not require pre-clearance are not included in the 60 securities trades permitted
during any calendar quarter.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.5.</B></FONT><B>Section
16 Reporting on Closed-End Fund Shares</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">For all Closed End Fund (&ldquo;CEF&rdquo;)
Trustees and Officers, please be reminded that Section 16 of the Securities Exchange Act of 1934 (&ldquo;1934 Act&rdquo;) imposes reporting
requirements with respect to your ownership of the CEFs. Section 16(a) requires each Trustee and Officer to file (i) an initial report
with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;) on Form 3 disclosing his or her status as a reporting person under
Section 16(a), and his or her beneficial ownership of all equity securities of the Closed-End Funds at the time of attaining such status;
(ii) changes in such beneficial ownership on Form 4; and (iii) an annual statement of changes in beneficial ownership on Form 5 (if such
changes were not previously reported on Forms 3 or 4). The Trustees and Officers should review the Closed-End Funds&rsquo; Section 16
policies and procedures for more information relating to their reporting requirements under those policies and procedures as well as Section
16 of the 1934 Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.6.</B></FONT><B>Use
of Compliance Platform</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">GI utilizes an electronic Compliance Platform
to manage certain reporting and certification obligations required of Adviser Access Persons. Adviser Access Persons are required to use
the Compliance Platform specified by Compliance to complete reporting specified by the Code of Ethics.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><IMG SRC="guggenheimlogonew2.jpg" ALT=""></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">At the time of designation as an Adviser Access
Person, Adviser Access Persons will be provided with login information and instructions for using the Compliance Platform.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Confidentiality</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">All personal <U>securities</U> transactions
reports and any other information filed with GI under this Code will be treated as confidential, provided, however, that such reports
and related information may be produced to the SEC and other regulatory agencies or as otherwise required by law.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Interpretation of Provisions and Interrelationship with Other Codes of Ethics</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The Boards of Trustees of the Funds may from
time to time adopt such interpretations of this Code as they deem appropriate.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">To the extent that any of the Advisers delegate
certain of their advisory responsibilities to an investment sub-adviser, such sub-adviser must:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">establish, maintain and enforce a code of ethics that meets the minimum requirements set forth in Rule
204A-1 under the Advisers Act and Rule 17j-1 under the 1940 Act, and submit such code of ethics to the Fund&rsquo;s Board of Trustees;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">on a quarterly basis provide the appropriate Fund(s) or the Adviser of such Fund a written attestation
that the sub-adviser is in compliance with its code of ethics adopted pursuant to Rule 17j-1 under the 1940 Act;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">promptly report, in writing, to the appropriate Fund(s) any material amendments to such code(s) of ethics;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">promptly furnish to such Fund or the Adviser to such Fund, upon request, copies of any reports made pursuant
to such code of ethics by any person who is a <U>Sub-Adviser Access Person</U>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">immediately furnish to such Fund or the Adviser to such Fund, upon request, all material information regarding
any violation of such code of ethics by any person who is a Sub-Adviser Access Person; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">at least once a year, provide such Fund or the Adviser of such Fund a <I>written </I>report that describes
any issue(s) that arose during the previous year under its code of ethics, including any material code violations and any resulting sanction(s),
and a certification that it has adopted measures reasonably necessary to prevent its personnel from violating its code of ethics.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The sub-adviser should also establish a policy
or adopt in its code of ethics that <U>Sub-Adviser Access Persons</U> shall not engage in excessive trading. Such activity is inconsistent
with the fiduciary principles of this Code, which require that <U>Sub-Adviser Access Persons</U> place the interests of clients above
their own interests.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Acknowledgment of Receipt and Annual Certification</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Each director, officer, employee and member
of the Companies will receive a copy of the Code and any subsequent material amendments to the Code, and each such person must acknowledge
receipt of the Code in writing on an annual basis. Each such person is required to certify annually that he/she (i) has read and understands
the Code, (ii) is aware that he/she is subject to the provisions of this Code, (iii) has complied with the Code at all times during the
previous calendar year, and (iv) has, during the previous calendar year, reported all holdings and transactions that he/she is required
to report pursuant to the Code. The acknowledgement of receipt and certification may be made electronically through a manner specified
by Compliance.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">EXCEPTION
HANDLING:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">A <U>Compliance Officer</U>, in his or her
discretion, may exempt any person from any specific provision of the Code, if the <U>Compliance Officer</U> determines that: (a) granting
the exemption does not detrimentally affect any client or the shareholders of the Funds, (b) the failure to grant the exemption will result
in an undue burden on the person or limit the person&rsquo;s ability to render services to GI and (c) the exception is consistent with
Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act. In order to request an exemption from a provision of the Code, an
Adviser Access Person must submit a written request for the exemption to <U>Compliance</U>.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">REPORTING
REQUIREMENTS:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Individual Reporting Obligations - See Parts A, B, or C as appropriate, for your specific reporting obligations.</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.1.</B></FONT>Obligation
to Report Violations of the Code - In addition to the individual reporting requirements referenced above, any violation of the Code must
be promptly reported to <U>Compliance</U>.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext"><B>1.1.1.</B></FONT></TD><TD STYLE="text-align: justify">As has been GI&rsquo;s ongoing policy, nothing in this Code, any agreement between GI and its employees,
or any GI policy or program, prohibits or restricts any person in any way from reporting possible violations of law or regulation to any
governmental agency or entity, or otherwise prevents anyone from participating, assisting, or testifying in any proceeding or investigation
by any such agency or entity or from making other disclosures that are protected and/or permitted under law or regulation. For more information,
please refer to the Guggenheim Capital, LLC Code of Conduct, available on OneGuggenheim.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.2.</B></FONT>Reports
of individual securities transactions are required only if you <I>knew </I>at the time of the transaction or, in the ordinary course of
fulfilling your official duties as a Trustee, <I>should have known</I>, that during the 15-calendar day period immediately preceding or
following the date of your transaction, the same security was purchased or sold, or was being considered for purchase or sale, by a Fund.
Note: The &ldquo;<I>should have known</I>&rdquo; standard does not:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Imply a duty of inquiry;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Presume you should have deduced or extrapolated from discussions or memoranda dealing with the Fund&rsquo;s
investment strategies; or</TD></TR></TABLE>
<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Impute knowledge from your prior knowledge of the Fund&rsquo;s portfolio holdings, market considerations,
or investment policies, objectives and restrictions.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Annual Written Report to the Boards of Trustees of the Funds -</B> At least once a year or more frequently as deemed
necessary by a <U>Compliance Officer</U>, a <U>Compliance Officer</U>, on behalf of the Companies that provide services to the Funds,
including the Advisers, will provide the Board of Trustees of each Fund a <I>written </I>report (&ldquo;Annual Written Report&rdquo;)
that includes:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.1.</B></FONT>Issues
Arising Under the Code - The Annual Written Report will describe any issue(s) that arose during the previous year under the Code, including
any material Code violations, and any resulting sanctions.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.2.</B></FONT>Certification
- The Annual Written Report will certify to the Boards of Trustees that each Company has adopted measures reasonably necessary to prevent
its personnel from violating the Code currently and in the future.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Periodic Review and Reporting -</B> A <U>Compliance Officer</U> (or his or her designee) will report to the Boards
of Trustees at least annually as to the operation of this Code and will address in any such report the need (if any) for further changes
or modifications to this Code.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">TESTING
AND REVIEW:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Duties of Compliance</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.1.</B></FONT><U>Compliance</U>
will review electronic reports generated by the Compliance Platform that compares all reported personal <U>securities</U> transactions
with the Funds&rsquo; portfolios and client accounts, as applicable, transactions completed by the Advisers, and the restricted securities
list, maintained by Compliance, to determine whether a Code violation may have occurred. A <U>Compliance Officer</U> or their designee
may request additional information or take any other appropriate measures that the <U>Compliance Officer</U> or their designee decides
is necessary to aid in this determination. Before determining that a person has violated the Code, <U>Compliance </U> must give the person
an opportunity to supply explanatory material.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.2.</B></FONT>No
person is required to participate in a determination of whether he or she has committed a Code violation or of the imposition of any sanction
against himself or herself. If a securities transaction of a <U>Compliance Officer</U> is under consideration, a separate <U>Compliance
Officer</U> other than the individual under consideration will act as the <U>Compliance Officer</U> for purposes of this Section.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.3.</B></FONT>Sanctions
This Code is designed to facilitate compliance with applicable laws and to reinforce the Companies&rsquo; reputation for integrity in
the conduct of their businesses. For violations of this Code, sanctions may be imposed as deemed appropriate by Compliance and as applicable
in coordination with senior management. Escalation will depend on the severity and frequency of the infraction considering the facts and
circumstances such as potential or actual harm or reputational risk to clients, prospects, Fund shareholders or the Companies. A pattern
of violations that individually do not violate the law, but which taken together demonstrate a pattern of lack of respect for the Code,
may result in disciplinary action, including termination of employment.</P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Specifically, the Adviser Access Person shall
be subject to remedial actions which may include, but are not limited to, any one or more of the following: (1) verbal warning and/or
letter of instruction; (2) written memo or letter of caution (including requirement for additional training) or other measures; (3) enhanced
supervision or management plan; (4) decrease in compensation, performance measure or other penalty; (5) personal securities trading restriction;
(6) termination of employment; or (7) referral to civil or governmental authorities for possible civil or criminal prosecution. If the
Adviser Access Person is normally eligible for a discretionary bonus, violations of the Code may also reduce or eliminate the discretionary
portion of his/her bonus.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">RECORDKEEPING:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The Companies will maintain records as set
forth below. These records will be maintained in accordance with Rule 31a-2 under the 1940 Act and Rule 204-2(a)(12) under the Advisers
Act and will be available for examination by representatives of the SEC.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A copy of this Code and any other code which is, or at any time within the past five years has been, in
effect will be preserved in an easily accessible place;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A list of all persons who are, or within the past five years have been, required to submit reports under
this Code will be maintained in an easily accessible place;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A copy of each report made by a person under this Code will be preserved for a period of not less than
five years from the end of the fiscal year in which it is made, the first two years in an easily accessible place;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A copy of each duplicate brokerage confirmation and each periodic statement provided under this Code will
be preserved for a period of not less than five years from the end of the fiscal year in which it is made, the first two years in an easily
accessible place.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A record of any Code violation and of any sanctions taken will be preserved in an easily accessible place
for a period of not less than five years following the end of the fiscal year in which the violation occurred;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A copy of each Annual Written Report to the Boards of Trustees will be maintained for at least five years
from the end of the fiscal year in which it is made, the first two years in an easily accessible place;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">A copy of all Acknowledgements of Receipt and Annual Certifications as required by this Code for each
person who is currently, or within the past five years was required to provide such Acknowledgement of Receipt or Annual Certification;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">The Companies will maintain a record of any decision, and the reasons supporting the decision, to approve
the acquisition of <U>securities</U> in a <U>private investment</U>, for at least five years after the end of the fiscal year in which
the approval is granted.</TD></TR></TABLE>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">DISCLOSURE:</P>
<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The Code of Ethics will be disclosed in accordance
with the requirements of applicable federal law and all rules and regulations thereunder with the applicable disclosure documents.</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">REVISIONS:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">These procedures shall remain in effect until
amended, modified or terminated. The Boards of Trustees must approve any material amendments to the Code within six months of the amendment.</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>


<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">PART
A&#9;PROCEDURES FOR INDEPENDENT TRUSTEES</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">GENERAL
OBLIGATIONS.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Limitations</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.1.</B></FONT>You
are subject to Sections 4.1 and 4.5 of the &ldquo;Procedure&rdquo; section of the Code.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Required Transaction Reports</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.1.</B></FONT>On
a quarterly basis you must report any <U>securities</U> transactions, unless such transaction is excepted from reporting as described
in 2.2 below. If reporting is required, you must submit your report of securities transactions and information about the relevant securities
account to <U>Compliance </U> no later than 30 calendar days after the end of the calendar quarter in which the transaction to which the
report relates was effected. Reports must include information consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.2.</B></FONT>Reports
of individual <U>securities</U> transactions are required only if you <I>knew </I>at the time of the transaction or, in the ordinary course
of fulfilling your official duties as a Trustee, <I>should have known</I>, that during the 15-calendar day period immediately preceding
or following the date of your transaction, the same <U>security</U> was <U>purchased or sold</U>, or was <U>being considered for purchase
or sale</U>, by a Fund.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in">Note: The &ldquo;<I>should have known</I>&rdquo; standard
does not:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">imply a duty of inquiry;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">presume you should have deduced or extrapolated from discussions or memoranda dealing with the Fund&rsquo;s
investment strategies; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">impute knowledge from your prior knowledge of the Fund&rsquo;s portfolio holdings, market considerations,
or investment policies, objectives and restrictions.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.3.</B></FONT>If
you had no reportable transactions during the quarter, you are not required to submit a report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>What Securities Are Covered Under Your Quarterly Reporting Obligation?</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If the transaction is reportable because it
came within Section (2), above, you must report all transactions in <U>securities</U> that: (i) you directly or indirectly <U>beneficially
own</U> or (ii) because of the transaction, you acquire direct or indirect <U>beneficial ownership</U>. The report must also contain any
<U>investment account</U> you established in which any <U>securities</U> were held during the quarter. You are not required to detail
or list <U>purchases or sales</U> effected for any account over which you have no direct or indirect influence or <U>control</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You may include a statement in your report
that the report shall not be construed as your admission that you have any direct or indirect <U>beneficial ownership</U> in the <U>security</U>
included in the report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Other Recommended Practices</B></P>
<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Although not strictly prohibited, it is recommended
that Independent Trustees refrain from trading in shares of the Funds they oversee for a period of seven calendar days before and after
meetings of the Board of Trustees of such Funds.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">In lieu of the sanctions contemplated under
Section 2 of the &ldquo;Testing and Review&rdquo; section of the Code, Independent Trustees shall be subject to sanctions as determined
by the Board of Trustees of the relevant Fund.</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="gugglogop.jpg" ALT="">&nbsp;</B></P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.1in"><B></B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">PART
B&#9;ADVISER ACCESS PERSONS (OTHER THAN INDEPENDENT TRUSTEES OF THE FUNDS)</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">GENERAL
OBLIGATIONS</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Providing a List of Securities &ndash; Initial and Annual Holdings Reports</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.1.</B></FONT><B>Initial
Holdings Reports</B>. You must submit the initial listing within 10 calendar days of the date you first become an <U>Adviser Access Person</U>.
The initial listing should be a complete listing of all <U>investment accounts</U> and <U>securities, </U> including <U>private investments,</U>
you <U>beneficially own</U> as of a date no more than 45 days prior to the date you become an Adviser Access Person. Reports must include
information consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.2.</B></FONT><B>Annual
Holdings Reports</B>. In addition to the Initial Holdings Report, each following year, you must submit a revised list showing the investment
<U>accounts</U> and <U>securities</U> you <U>beneficially own</U> as of December 31. You must submit each annual update listing no later
than 30 calendar days after December 31. Adviser Access Persons must also certify annually that they have complied with the requirements
and have disclosed all holdings required to be disclosed pursuant to the requirements of this Code. In addition, Adviser Access Persons
will respond to personal disciplinary history questions. Reports must include information consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The Initial Holdings Report and Annual Holdings
Reports, as applicable, will be submitted electronically, through the Compliance Platform. You will receive notification via email when
the applicable report is due, including instructions on how to access the information and complete the report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Brokerage Accounts</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">All <U>investment accounts</U> of new Adviser
Access Persons and any <U>investment accounts</U> of current Adviser Access Persons must be maintained with brokerage firms designated
and approved by Compliance. Compliance may grant specific exceptions in writing in limited circumstances however, in general, trading
in such accounts will be prohibited.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Existing <U>investment accounts</U> of new
Adviser Access Persons which are not held at the permitted broker-dealers must be transferred within 90 calendar days from the date the
Adviser Access Person is so designated; the failure to transfer within this time will be considered a violation of this Code. Any request
to extend the 90-day transfer deadline must be accompanied by a written explanation by the current broker-dealer as to the reason for
delay. Compliance may grant specific exceptions in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Prior to opening a new reportable <U>investment
account,</U> you are required to submit the Personal Account Pre-Clearance Form through the Compliance Platform to obtain written consent
from Compliance. You are also required to notify in writing the broker-dealer or financial institution with which you are seeking to open
such reportable investment account of your association with Guggenheim Investments.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">&nbsp;</P>
<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Upon opening a reportable <U>investment account</U>
or obtaining an interest in an investment account that requires reporting, the account number must be reported within 5 calendar days
of funding the <U>investment account</U> via the Compliance Platform or as otherwise permitted by Compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Duplicate Brokerage Confirmations and Statements</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If your brokerage firm provides automatic feeds
for your investment accounts to the Compliance Platform, the Adviser will obtain account information electronically, after the Adviser
Access Person has completed the appropriate authorizations as required by the brokerage firm. Further, you are required to provide duplicate
statements upon request from Compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If the brokerage firm does not provide automatic
feeds to the Compliance Platform, you are responsible for providing duplicate statements for such investment accounts to Compliance within
20 days after each</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Quarter End. The Compliance Officer or his
designee may provide exceptions to this policy on a limited basis.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Independently Managed/Third-Party Discretionary Account Reporting:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Adviser Access Persons must disclose independently managed/third-party discretionary accounts, i.e., where
the person has &ldquo;no direct or indirect influence or control&rdquo;.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Adviser Access Persons are required to obtain a signed copy of the Managed Account Letter (template letter
provided by GI Employee Activities) from their third-party investment adviser confirming that the adviser has authority to effect transactions
on behalf of the independently managed/third-party discretionary account without obtaining prior consent of the Adviser Access Person
and that the Adviser Access Person does not direct trades in the independently managed/third-party discretionary account. Adviser Access
Persons are required to maintain an updated Managed Account Letter on file confirming third-party discretion.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Adviser Access Persons should immediately notify GI Employee Activities if there are any changes in control
over the independently managed/third-party discretionary account or if there are any changes to the relationship between the trustee or
third-party investment adviser and the Adviser Access Person (i.e., independent professional or friend or relative, unaffiliated versus
affiliated firm). Please note that an <U>immediate family</U> member with discretion over an independently managed/third-party discretionary
account is not considered a third-party adviser.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Trades in independently managed/third-party discretionary accounts are not subject to the preclearance
requirements and trading restrictions of the Code.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Certain Adviser Access Persons (as determined by Compliance) are required to maintain independently managed/third-party
discretionary accounts with brokerage</TD></TR></TABLE>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext"></FONT></TD><TD STYLE="text-align: justify">firms designated and approved by Compliance. Compliance will advise impacted Adviser Access Persons.</TD></TR></TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Required Transaction Reports &ndash; Quarterly Personal Securities Transaction Reports</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">On a quarterly basis you must report transactions
in <U>securities</U>, as well as any <U>investment accounts (&ldquo;Quarterly Personal Securities Transaction Reports&rdquo;)</U>. You
must submit your report no later than 30 calendar days after the end of the calendar quarter in which the transaction to which the report
relates was effected or the investment account was opened. The Quarterly Personal Securities Transaction Reports are required in addition
to delivery of duplicate brokerage confirmations and statements (via automatic feed or hard copy). Adviser Access Persons must submit
Quarterly Personal Securities Transaction Reports electronically, through the Compliance Platform. You will receive notification via email
when the Quarterly Personal Securities Transaction Report is due, including instructions on how to access the information and complete
the report. Reports must include information consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If you had no reportable transactions or did
not open any investment accounts during the quarter, you are still required to report that you did not have any reportable transactions
or open any investment accounts.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>What Securities Are Covered Under Your Quarterly Reporting Obligation?</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You must report all transactions in <U>securities</U>
that: (i) you directly or indirectly <U>beneficially own</U> or (ii) because of the transaction, you acquire direct or indirect <U>beneficial
ownership</U>. The report must contain any <U>investment account</U> you established during the quarter if the account has not already
been reported. You are not required to detail or list <U>purchases or sales</U> effected for any account over which you have no direct
or indirect influence or control.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You may include a statement in your report
that the report shall not be construed as your admission that you have any direct or indirect <U>beneficial ownership</U> in the <U>security</U>
included in the report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Pre-Clearance Requirement</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You must submit a report detailing every proposed
<U>securities</U> transaction in which you will acquire a <U>beneficial ownership</U> interest through the Compliance Platform and obtain
pre-clearance for each securities transaction prior to engaging in the transaction. The report shall include the name of the security,
date of the proposed transaction, quantity, price, and broker-dealer through which the transaction is to be effected.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Pre-cleared transactions are valid for the
day on which such transaction was approved as noted on the pre-clearance request form, unless otherwise specified by Compliance. </B>If
the transaction, or any portion thereof, is not executed within the specified time, the Adviser Access Person must obtain written approval
for the transaction again. The Companies reserve the right to rescind previously pre-approved trades if an actual conflict arises or in
certain other limited circumstances, and Adviser Access Persons may be obliged to sell previously pre-cleared positions. The Companies
will not be responsible for any losses as a result of such rescission of approval and all profits received by the Adviser Access Person
from such sale will be disgorged and donated to a charity approved by <U>Compliance.</U></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Securities and Transactions Subject to the Pre-Clearance Requirement: Securities:</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 45%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Security Type:</B></TD>
    <TD STYLE="width: 25%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Pre-Clearance Required:</B></TD>
    <TD STYLE="width: 30%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Include on Quarterly <BR>
Transaction &amp; Annual <BR>
Holdings Reports:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Equities/Stocks</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Corporate, U.S. (Government) Agency and Municipal Bonds and Notes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">U.S. Government Obligations and Debt</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">High Quality Short-term Bonds (maturity at issuance of less than 366 days)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">All Exchange Traded Funds (ETFs)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Options and Futures on any Covered Security, ETF or on any group or (broad-based) index of securities</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes &ndash; See Supplement 1</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes &ndash; See Supplement 1</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Futures on U.S. Government Obligations</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Certain Futures on Currencies and Commodities</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes, if not prohibited (see <BR>
Section 11)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes, if not prohibited (see <BR>
Section 11)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Private Investments, including certain Loans</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Unit Investment Trusts (UITs)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Unit Investment Trusts (UITs) investing exclusively in open-end mutual funds.</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Foreign Unit Trusts (i.e. UCITS) or Foreign Mutual Fund</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Closed-end Mutual Funds (regardless of whether advised or sub-advised by the Advisers or an affiliate)</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Open-end Mutual Funds</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Open-end Mutual Funds advised or sub-advised by the Advisers or an affiliate</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Money Market Funds</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Indirect investments in Cryptocurrencies*</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Direct investments in Cryptocurrencies</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Miscellaneous: Treasury Stock; Debenture; Evidence of Indebtedness; Investment Contract; Voting Trust Certificate; Certificate of Deposit for a Security; Limited Partnerships; Certificate of Interest or Participation in any Profit-Sharing</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="border-top: Black 1pt solid; vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 45%">Agreement; Collateral-RIC Certificate; Fractional Undivided interest in Oil, Gas or other Mineral Right; Pre-Organizational Certificate or Subscription; Transferable Shares</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 25%">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 30%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">-Bank Loans; Bankers Acceptances; Bank</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Certificates of Deposit; Commercial Paper;</P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">Repurchase Agreements</P></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Special Transaction Types:</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 47%; border: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Special Transaction Type**:</B></TD>
    <TD STYLE="width: 24%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Pre-Clearance Required:</B></TD>
    <TD STYLE="width: 29%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Include on Quarterly <BR>
Transaction &amp; Annual <BR>
Holdings Reports:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">IPOs (issued directly from the underwriting syndicate)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Prohibited</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Prohibited</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Initial Coin Offerings (&ldquo;ICOs&rdquo;)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Prohibited</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Prohibited</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Participation in Investment Clubs</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Prohibited</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Prohibited</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Automatic Dividend Reinvestments</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No***</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Non-Automatic Dividend Reinvestments</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Automatic Investment Plan</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No***</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No***</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Tender offer transactions**</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Acquisition of securities by gift or inheritance</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Sale of securities acquired by gift or <BR>
inheritance****</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Guggenheim Capital LLC membership interests</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Guggenheim 401K****</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Purchases arising from the exercise of rights <BR>
issued by an issuer <I>pro rata </I>to all holders of a <BR>
class of its securities, as long as you acquired</TD>
    <TD ROWSPAN="2" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD ROWSPAN="2" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">these rights from the issuer, and sales of such rights so acquired.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>
<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="border-top: Black 1pt solid; vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 47%">Transactions which are non-volitional on your part, including sales from a margin account due to a <I>bona fide </I>margin call.</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 24%">No</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 29%">Yes</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Transactions effected for any account over which you have no direct or indirect influence or control.</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Acquisition through corporate actions or actions applicable to all holders of the same class of securities.</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">No</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Yes</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">* Cryptocurrency-related entities deriving a substantial amount
of revenue therefrom, or private investments, ETFs and investment trusts investing directly and primarily in cryptocurrencies.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">**You will be required to provide additional supporting documentation
to the extent the information is not available on your brokerage statements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">***Any transaction that overrides the pre-set schedule of the automatic
investments plan must be pre-cleared and reported. Annual Holdings report must represent updated holdings resulting from any automatic
investment plans.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">****Pre-clearance is required to the extent that it is for a security
type listed above under &lsquo;Pre-Clearance required&rsquo;.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The above investments and transactions that
are not subject to pre-clearance are also <B>NOT </B>subject to the 30-day prohibition on selling/buying securities (discussed in section
12 below), the seven-day blackout period on personal securities transactions (discussed in section 13 below), or the excessive trading
limitation (discussed in section 14 below).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Private Investments</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You must obtain approval from <U>Compliance
</U> before acquiring <U>beneficial ownership</U> of any <U>securities </U> offered in connection with a <U>private investment</U>. Adviser
Access Persons should contact Compliance with any questions regarding investments in loans that would need to be pre-cleared. In determining
whether to grant pre-approval, <U>Compliance</U> will consider, among other factors, whether the investment opportunity could be offered
to a client.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">New Adviser Access Persons must disclose all
of their existing <U>private investments</U>, as well as those of their <U>immediate family</U> members, within 10 days of becoming an
Adviser Access Person. Compliance will send an email to all new Adviser Access Persons with the <B>Private Investments Disclosure Form,
</B>which they must complete. Existing Adviser Access Persons are required to disclose existing <U>private investments</U> that were entered
into prior to policy changes and seek prior written approval to invest in any new <U>private investments</U> on their own behalf, and
on behalf of their i<U>mmediate family</U> members, and must complete the <B>Private Investment and Loan Pre-Clearance Form </B>(template
available through OneGuggenheim), and provide information about the investment to assist Compliance with the review of the request. The
Guggenheim Capital Conflicts Review Committee (&ldquo;<U>CRC</U>&rdquo;) may also review private investment requests for approval,</P>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">as
necessary. Approval by the CRC is required in the event that it is determined that a proposed or existing private investment involves
one or more potential or actual significant conflicts of interest.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Prohibition of Participation in IPOs and Investment Clubs</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You shall not acquire <U>beneficial ownership</U>
of any <U>securities</U> offered in connection with an <U>IPO</U> or Investment Club. For the avoidance of doubt, the prohibition on IPOs
also extends to initial issuances of securities issued as digital assets (sometimes referred to as &ldquo;Initial Coin Offerings&rdquo;
or &ldquo;ICOs&rdquo;). You should contact Compliance if you are not certain whether a particular digital asset is a security. You shall
not participate in any <U>Investment Clubs</U>. If you have any questions regarding whether an arrangement is an Investment Club, please
contact Compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Prohibition on Trading in Commodity Interests and Related Futures</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Trading in Commodity Interests and related
Futures as well as futures and options on cryptocurrency are generally prohibited, except for the following types of futures:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing broad-based securities indices: for example, S&amp;P 500, NASDAQ 100, and Russell
2000;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing major currencies: for example, Euro, Yen, Australian dollar, and British pound;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing the following physical commodities: Silver, Gold, Oil, and Natural Gas; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing U.S. Government debt obligations: for example, 30 year Treasury bond, 10/5 year Treasury
notes and long-term Treasury bonds.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Adviser Access Persons should consult with
Compliance with regard to whether a particular instrument is a commodity interest. Senior management, together with the Compliance Officer,
may grant exceptions to this prohibition on a case-by-case basis and such exceptions will be conditioned on compliance with certain requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Thirty-Day Prohibition on Selling/Buying Securities</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Adviser Access Persons are prohibited from
purchasing and then selling, or selling and then purchasing the same <U>security</U> <B><I>within 30 calendar days of the most recent
opposite-way transaction</I></B>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">In situations where multiple transactions
have occurred in the same security, the holding period will calculate from the date of the most recent opposite-way transaction of the
relevant security across all accounts, regardless of the holding period of prior transactions in the same security. This prohibition
does not apply to independently managed/third-party discretionary accounts, transactions of <U>Broad-based Exchange Traded Funds</U>
that meet certain criteria as defined in Appendix B, or to securities and transactions that are not subject to the pre-clearance requirement
(discussed in section 8 above).</P>
<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Seven-Day Blackout Period on Personal Securities Transactions</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You cannot <U>purchase or sell</U>, directly
or indirectly, any <U>security</U> in which you had (or by reason of such transaction acquire) any <U>beneficial ownership</U>, at any
time within seven calendar days before or after the time that the same (or a related): (i) <U>security is being purchased or sold</U>
by any Fund or client account; (ii) <U>security</U> is being purchased for initial deposit in a Fund that is a unit investment trust or
(iii) security is in a unit investment trust being terminated and is being sold prior to termination date.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">This prohibition does not apply to independently
managed/third-party discretionary accounts, transactions of <U>Broad-based Exchange Traded Funds</U> that meet certain criteria as defined
in Appendix B, or to securities and transactions that are not subject to the pre-clearance requirement (discussed in section 8 above).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>13.1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Exception to Blackout Period</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt">The seven-day blackout period does not apply to trading in a <U>security</U>
meeting all of the following criteria:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">the market value of the proposed transaction is less than $25,000;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">the 30-day rolling average trading volume is over 1 million shares; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Guggenheim Investments&rsquo; trade activity is less than 5% of the 7-day rolling average trade volume
for the security.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0.1in 12pt 0">The exception to the seven-day blackout period does not apply
to the purchase or sale of options, transactions in a <U>security</U> listed on the Guggenheim Investments Restricted List, and any derivatives
and futures.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Excessive Trading</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You shall not make more than 60 <U>securities</U>
trades in any calendar quarter. Transactions of <U>Broad-based Exchange Traded Funds</U> that meet certain criteria as defined in Appendix
B or that do not require preclearance are not included in the 60 securities trades permitted during any calendar quarter. For the purposes
of this restriction, transactions executed in the same security, in the same direction on the same day are considered to be one transaction
(i.e., an approved transaction executed in lots throughout the day is considered one transaction).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The multiple transactions that make up an option
trading strategy, such as option spreads, will be counted as individual transactions towards the excessive trading limit.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Cryptocurrencies Trading</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Cryptocurrency</U> (sometimes referred
to as &ldquo;virtual currency&rdquo;) is one type of digital asset and herein refers to any virtual or digital representation of value,
token or other asset where (i) encryption techniques are used to regulate the generation of such assets and to verify the transfer of
assets and (ii) the digital asset has been interpreted under relevant law not to be (A) a <U>security</U> or (B) otherwise</P>
<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">characterized as a
&ldquo;security&rdquo; as defined under the relevant law. Examples of cryptocurrency currently include, but are not limited to, bitcoin
(BTC) and ethereum (ETH). You should contact Compliance if you are not certain whether a particular digital asset is a security.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Purchases and sales of direct investments in
<U>cryptocurrency</U> are not required to be pre-cleared or reported. Indirect investments in Cryptocurrencies through cryptocurrency-related
entities (e.g., entities deriving a substantial amount of revenue therefrom) or funds investing primarily in cryptocurrency (e.g., private
funds or ETFs) are permitted but must be pre-cleared prior to investment and reported in the Initial Holdings Report, Quarterly Personal
Securities Transactions Report, and Annual Holdings Report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Adviser Access persons should consult with
Compliance with regard to whether a particular interest is a cryptocurrency for purposes of this Code. A Compliance Officer, in consultation
with senior management and the Legal Department as necessary, may grant exceptions to this prohibition on a case-by-case basis and such
exceptions may be conditioned on compliance with certain requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The standards above are subject to change depending
on emerging regulatory requirements and firm and client activities, and certain cryptocurrencies may be restricted and require pre-clearance
and reporting in the future.</P>


<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT="">&nbsp;&nbsp;</B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">PART
C&#9;NATURAL CONTROL PERSONS</P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">GENERAL
OBLIGATIONS.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Providing a List of Securities &ndash; Initial and Annual Holdings Reports</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.1.</B></FONT>Initial
Holdings Reports. You must submit the initial listing within 10 calendar days of the date you first become a <U>Natural Control Person</U>.
The initial listing should be a complete listing of all <U>investment accounts and securities,</U> including <U>private investments,</U>
you <U>beneficially own</U> as of a date no more than 45 days prior to the date you become a <U>Natural Control Person</U>. Reports must
include information consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>1.2.</B></FONT>Annual
Holdings Reports. In addition to the Initial Holdings Report, each following year, you must submit a revised list showing the investment
<U>accounts</U> and <U>securities</U> you <U>beneficially own</U> as of December 31. You must submit each annual update listing no later
than 30 calendar days after December 31. Natural Control Persons must also certify annually that they have complied with the requirements
and have disclosed all holdings required to be disclosed pursuant to the requirements of this Code. In addition, Natural Control Persons
will respond to personal disciplinary history questions. Reports must include information consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The Initial Holdings Report and Annual Holdings
Reports, as applicable, will be submitted electronically, through the Compliance Platform (or as specified by Compliance). You will receive
notification via email when the applicable report is due, including instructions on how to access the information and complete the report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Brokerage Accounts</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">All <U>investment accounts</U> of new Natural
Control Persons and any <U>investment accounts</U> of current Natural Control Persons must be maintained with brokerage firms designated
and approved by Compliance. Compliance may grant specific exceptions in writing in limited circumstances however, in general, trading
in such accounts will be prohibited.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Existing <U>investment accounts</U> of new
Natural Control Persons which are not held at the permitted broker-dealers must be transferred within 90 calendar days from the date the
Natural Control Person is so designated; the failure to transfer within this time will be considered a violation of this Code. Any request
to extend the 90-day transfer deadline must be accompanied by a written explanation by the current broker-dealer as to the reason for
delay. Compliance may grant specific exceptions in writing.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Prior to opening a new reportable <U>investment
account,</U> you are required to submit the Personal Account Pre-Clearance Form through the Compliance Platform to obtain written consent
from Compliance. You are also required to notify in writing the broker-dealer or financial institution with which you are seeking to
open such reportable investment account of your association with Guggenheim Investments.</P>
<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Upon opening a reportable investment account
or obtaining an interest in an investment account that requires reporting, the account number must be reported within 5 calendar days
of funding the <U>investment account</U> via the Compliance Platform or as otherwise permitted by Compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Duplicate Brokerage Confirmations and Statements</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If your brokerage firm provides automatic feeds
for your investment accounts to the Compliance Platform, the Adviser will obtain account information electronically, after the Natural
Control Person has completed the appropriate authorizations as required by the brokerage firm. Further, you are required to provide duplicate
statements upon request from Compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If the brokerage firm does not provide automatic
feeds to the Compliance Platform, you are responsible for providing duplicate statements for such investment accounts to Compliance within
20 days after each Quarter End. The Compliance Officer or his designee may provide exceptions to this policy on a limited basis.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Independently Managed/Third-Party Discretionary Account Reporting:</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Natural Control Persons must disclose independently managed/third-party discretionary accounts, i.e.,
where the person has &ldquo;no direct or indirect influence or control&rdquo;.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Natural Control Persons are required to obtain a signed copy of the Managed Account Letter (template letter
provided by Compliance) from their third-party investment adviser confirming that the adviser has authority to effect transactions on
behalf of the independently managed/third-party discretionary account without obtaining prior consent of the Natural Control Person and
that the Natural Control Person does not direct trades in the independently managed/third-party discretionary account. Natural Control
Persons are required to maintain an updated Managed Account Letter on file confirming third-party discretion.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Natural Control Persons should immediately notify Compliance in writing if there are any changes in control
over the independently managed/third-party discretionary account or if there are any changes to the relationship between the trustee or
third-party investment adviser and the Natural Control Person (i.e., independent professional or friend or relative, unaffiliated versus
affiliated firm). Please note that an <U>immediate family</U> member with discretion over an independently managed/third-party discretionary
account is not considered a third-party adviser.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Trades in independently managed/third-party discretionary accounts are not subject to the preclearance
requirements and trading restrictions of the Code.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Certain Natural Control Persons (as determined by Compliance) are required to maintain independently managed/third-party
discretionary accounts with brokerage firms designated and approved by Compliance. Compliance will advise impacted Natural Control Persons.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Required Transaction Reports &ndash; Quarterly Personal Securities Transaction Reports</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">On a quarterly basis you must report any <U>securities</U>
transactions, as well as any <U>investment accounts</U>. You must submit your report no later than 30 calendar days after the end of the
calendar</P>
<P STYLE="margin: 0"></P>
<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">quarter in which the transaction to which the report relates was effected or the investment account was opened. The Quarterly
Personal Securities Transaction Reports are required in addition to delivery of duplicate brokerage confirmations and statements (via
automatic feed or hard copy). Natural Control Persons must submit Quarterly Personal Securities Transactions Reports electronically, through
the Compliance Platform (or as specified by Compliance). You will receive notification via email when the Quarterly Personal Securities
Transaction Report is due, including instructions on how to access the information and complete the report. Reports must include information
consistent with regulatory requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">If you had no reportable transactions or did
not open any <U>investment accounts</U> during the quarter, you are still required to report that you did not have any reportable transactions
or open any investment accounts.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>What Securities Are Covered Under Your Quarterly Reporting Obligation?</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You must report all transactions in <U>securities</U>
that: (i) you directly or indirectly <U>beneficially own</U> or (ii) because of the transaction, you acquire direct or indirect <U>beneficial
ownership</U>. The report must contain any <U>investment account</U> you established during the quarter if the account has not already
been reported. You are not required to detail or list <U>purchases or sales</U> effected for any account over which you have no direct
or indirect influence or control.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You may include a statement in your report
that the report shall not be construed as your admission that you have any direct or indirect <U>beneficial ownership</U> in the <U>security</U>
included in the report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Private Investments</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You must obtain approval from <U>Compliance
</U> before acquiring <U>beneficial ownership</U> of any <U>securities </U> offered in connection with a <U>private investment</U>. Natural
Control Persons should contact Compliance with any questions regarding investments in loans that would need to be pre-cleared. In determining
whether to grant pre-approval, Compliance will consider, among other factors, whether the investment opportunity could be offered to a
client.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">New Natural Control Persons must disclose all
of their existing <U>private investments</U>, as well as those of their <U>immediate family</U> members, within 10 days of becoming a
Natural Control Person. Compliance will send an email to all new Natural Control Persons with the <B>Private Investments Disclosure Form,
</B>which they must complete. Existing Natural Control Persons are required to disclose existing <U>private investments</U> that were
entered into prior to policy changes and seek prior written approval to invest in any new <U>private investments</U> on their own behalf,
and on behalf of their <U>immediate family</U> members, and must complete the <B>Private Investment and Loan Pre-Clearance Form </B>(template
form provided by Compliance), and provide information about the investment to assist Compliance with the review of the request. The Guggenheim
Capital Conflicts Review Committee (&ldquo;<U>CRC</U>&rdquo;) may also review private investment requests for approval, as necessary.
Approval by the CRC is required in the event that it is determined that a proposed or existing private investment involves one or more
potential or actual significant conflicts of interest.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Prohibition of Participation in IPOs and Investment Clubs</B></P>
<P STYLE="margin: 0"></P>
<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">You shall not acquire <U>beneficial ownership</U>
of any <U>securities</U> offered in connection with an <U>IPO</U> or Investment Club. For the avoidance of doubt, the prohibition on IPOs
also extends to initial issuances of securities issued as digital assets (sometimes referred to as &ldquo;Initial Coin Offerings&rdquo;
or &ldquo;ICOs&rdquo;). You should contact Compliance if you are not certain whether a particular digital asset is a security. You shall
not participate in any <U>Investment Clubs</U>. If you have any questions regarding whether an arrangement is an Investment Club, please
contact Compliance.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT></B></FONT><B>Prohibition on Trading in Commodity Interests and Related Futures</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Trading in Commodity Interests and related
Futures as well as futures and options on cryptocurrency are generally prohibited, except for the following types of futures:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing broad-based securities indices: for example, S&amp;P 500, NASDAQ 100, and Russell
2000;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing major currencies: for example, Euro, Yen, Australian dollar, and British pound;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing the following physical commodities: Silver, Gold, Oil, and Natural Gas; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Futures referencing U.S. Government debt obligations: for example, 30-year Treasury bond, 10/5 year Treasury
notes and long-term Treasury bonds.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Natural Control Persons should consult with
Compliance with regard to whether a particular instrument is a commodity interest. Senior management, together with Compliance, may grant
exceptions to this prohibition on a case-by-case basis and such exceptions will be conditioned on compliance with certain requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><FONT STYLE="color: windowtext"><B>10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt">&nbsp;
</FONT></B></FONT><B>Cryptocurrencies Trading</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Cryptocurrency </U> (sometimes referred
to as &ldquo;virtual currency&rdquo;) is one type of digital asset and herein refers to any virtual or digital representation of value,
token or other asset where (i) encryption techniques are used to regulate the generation of such assets and to verify the transfer of
assets and (ii) the digital asset has been interpreted under relevant law not to be (A) a <U>security</U> or (B) otherwise characterized
as a &ldquo;security&rdquo; as defined under the relevant law. Examples of cryptocurrency currently include, but are not limited to, bitcoin
(BTC) and ethereum (ETH). You should contact Compliance if you are not certain whether a particular digital asset is a security.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Purchases and sales of direct investments in
<U>cryptocurrency</U> are not required to be pre-cleared or reported. Indirect investments in cryptocurrencies through cryptocurrency-related
entities (e.g., entities deriving a substantial amount of revenue therefrom) or funds investing primarily in cryptocurrency (e.g., private
funds or ETFs) are permitted but must be pre-cleared prior to investment and reported in the Initial Holdings Report, Quarterly Personal
Securities Transactions Report, and Annual Holdings Report.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Natural Control Persons should consult with
Compliance with regard to whether a particular interest is a cryptocurrency for purposes of this Code. A Compliance Officer in consultation
with</P>
<P STYLE="margin: 0"></P>
<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">senior management and the Legal Department as necessary, may grant exceptions to this prohibition on a case-by-case basis and such
exceptions may be conditioned on compliance with certain requirements.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">The standards above are subject to change depending
on emerging regulatory requirements and firm and client activities, and certain cryptocurrencies may be restricted and require pre-clearance
and reporting in the future.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Appendix A</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>Guggenheim Entities &amp; Revisions</B></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">COVERED
ENTITIES:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">This Combined Code of Ethics adopted under
Rule 17j-1 under the 1940 Act and Rule 204A-1 under the Advisers Act covers the following companies:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 32%; border: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Funds</B></TD>
    <TD STYLE="width: 33%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Advisers</B></TD>
    <TD STYLE="width: 35%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Other</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Rydex Dynamic Funds</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Security Investors, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Funds <BR>
Distributors, LLC*</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Rydex Series Funds</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Funds Investment Advisors, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Investor <BR>
Services, LLC</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Rydex Variable Trust</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Funds Distributors, LLC*</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Funds Trust</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Partners Investment Management, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Variable Funds <BR>
Trust</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Investment Advisors, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Strategy Funds <BR>
Trust</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Wealth <BR>
Solutions, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Active <BR>
Allocation Fund</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>GS Gamma Advisors, LLC</TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Taxable Municipal Bond &amp; Investment Grade Debt Trust</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Corporate Funding, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Strategic Opportunities Fund</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>Guggenheim Private Investments, LLC</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 12pt; padding-left: 0.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase">&#183;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 7pt; text-transform: uppercase">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">*This code also covers those unit investment trusts for which Guggenheim Funds Distributors, LLC serves as depositor and references to &ldquo;clients&rdquo; herein include the unit investment trusts.</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt"></P>

<P STYLE="font: bold 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-transform: uppercase; text-align: justify; text-indent: 0in">PROCEDURE
CREATION AND REVISIONS:</P>
<P STYLE="margin: 0"></P>
<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%; text-align: right"><B>Procedure Creation Date:</B></TD><TD STYLE="width: 1%"></TD><TD STYLE="text-align: justify; width: 79%"><B></B>Adopted
April 23, 2014 (by the Security Investors, LLC and Guggenheim Funds Investment Advisers, LLC); Adopted January 1, 2024 (by Guggenheim
Corporate Funding, LLC, Guggenheim Investment Advisors, LLC, Guggenheim Investor Services, LLC, GS Gamma Advisors, LLC, Guggenheim Partners
Advisors, LLC, and Guggenheim Partners Investment Management, LLC); Adopted August 7, 2024 (by Guggenheim Wealth Solutions, LLC); Adopted
October 28, 2024 (by Guggenheim Private Investments, LLC)</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 20%; text-align: right"><B>Procedure Revised As Of:</B></TD><TD STYLE="width: 1%"></TD><TD STYLE="text-align: justify; width: 79%">October
1, 2014; March 20, 2015; May 9, 2016; November 2016; April 2017; February 2018; August 2018; October 2018; August 2019; July 2020; September
2020 April 2021; July 2021; August 2021; September 2021, April 2022; Nov 2022; June 2023; November 2023 (effective Jan 2024); January
2024; August 2024; October 2024 (effective November 2024); June 2025</TD>
</TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in"><B>&nbsp;</B></P>


<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><B>Appendix B&#9;Definitions</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Adviser Access Person includes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">a</FONT></TD><TD STYLE="text-align: justify">Employee, Director, officer, manager, principal and partner of the Adviser or Distributor (or other persons
occupying a similar status or performing similar functions), or other person who provides advice on behalf of the Adviser or is subject
to the Adviser&rsquo;s supervision and control; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="color: windowtext">b</FONT></TD><TD STYLE="text-align: justify">Any person who:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Has access to nonpublic information regarding any of the Adviser&rsquo;s client&rsquo;s purchase or sale
of securities, or nonpublic information regarding the portfolio holdings of any client account the Adviser or their affiliates manage,
or any fund which is advised or sub-advised by the Adviser (or certain affiliates, where applicable);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Makes recommendations or investment decisions on behalf of the Adviser;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Has the power to exercise a controlling influence over the management and policies of the Adviser, or
over investment decisions, who obtains information concerning recommendations made to a client with regard to the purchase or sale of
a security;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">The Compliance Officer shall determine on a case-by-case basis whether a temporary employee (e.g., consultant
or intern) should be considered an Adviser Access Person. Such determination shall be made based upon an application of the criteria provided
above, whether an appropriate confidentiality agreement is in place, and such other information as may be necessary to ensure that proprietary
information is protected. As such, temporary employees may only be subject to certain sections of the Code, such as certifying to it,
or may be exempt from certain reporting requirements such as not having to hold their reportable accounts at the permitted broker-dealers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any person deemed to be an Adviser Access Person by the Compliance Officer; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">All Trustees of the Funds, both <U>Interested</U> and <U>Independent.</U></TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Broad-based Exchange Traded Funds (&ldquo;ETFs&rdquo;)</U>:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Broad-based ETFs that meet the following parameters:
more than 250 holdings and less than 35% of assets concentrated in the top 10 holdings are exempt from any holding period requirement
or other personal trading requirement as noted within this Code of Ethics.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Sub-Adviser Access Person</U> includes any
trustee, director, officer or employee of any sub-adviser who, in connection with his or her regular functions or duties, makes, participates
in, or obtains access to nonpublic information regarding recommendations of, the purchase or sale of a Security by a Fund, or whose functions
relate to the making of any recommendations with respect to such purchases or sales.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>
<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Automatic Investment Plan </U> means a program
in which regular periodic purchases (or withdrawals) are made automatically in (or from) investment accounts in accordance with a predetermined
schedule and allocation. An automatic investment plan includes a dividend reinvestment plan.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Beneficial ownership</U> means the same
as under Section 16 of the Securities Exchange Act of 1934 and Rule 16a-1(a)(2) thereunder. You should generally consider yourself the
beneficial owner of any <U>security</U> in which you have a direct or indirect pecuniary interest, which is the opportunity to profit
directly or indirectly or share in any profit derived from a transaction in securities. In addition, you should consider yourself the
beneficial owner of <U>securities</U> held by your spouse, your minor children, a relative who shares your home, or other persons by reason
of any contract, arrangement, understanding or relationship that provides you with sole or shared voting or investment power.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Compliance Officer</U> means, as applicable,
the chief compliance officer of Rydex Dynamic Funds, Rydex Series Funds, Rydex Variable Trust, Guggenheim Funds Trust, Guggenheim Variable
Funds Trust,</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">Guggenheim Strategy Funds Trust, Guggenheim
Taxable Municipal Bond &amp; Investment Grade Debt Trust, Guggenheim Strategic Opportunities Fund, and Guggenheim Active Allocation Fund
pursuant to Rule 38a-1 under the 1940 Act, or the chief compliance officer of Security Investors, LLC, Guggenheim Funds Investment Advisors,
LLC, Guggenheim Funds Distributors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Investment Advisors, LLC, Guggenheim Investor Services,
LLC, GS Gamma Advisors, LLC, Guggenheim Partners Investment Management, LLC, Guggenheim Private Investments, LLC, and Guggenheim Wealth
Solutions, LLC pursuant to Rule 206(4)-7 under the Advisers Act, or any person designated by such chief compliance officer to act in the
chief compliance officer&rsquo;s absence.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Control</U> means the same as that under
Section 2(a)(9) of the 1940 Act. Section 2(a)(9) provides that &ldquo;control&rdquo; means the power to exercise a controlling influence
over the management or policies of a company, unless such power is solely the result of an official position with such company. Ownership
of 25% or more of a company&rsquo;s outstanding voting <U>securities</U> is presumed to give the holder of such <U>securities</U> control
over the company. This presumption may be countered by the facts and circumstances of a given situation.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Cryptocurrency</U> sometimes referred to
as &ldquo;virtual currency&rdquo;) is one type of digital asset and herein refers to any virtual or digital representation of value, token
or other asset where (i) encryption techniques are used to regulate the generation of such assets and to verify the transfer of assets
and (ii) the digital asset has been interpreted under relevant law not to be (A) a <U>security</U> or (B) otherwise characterized as a
&ldquo;security&rdquo; as defined under the relevant law. Examples of cryptocurrency currently include, but are not limited to, bitcoin
(BTC) and ethereum (ETH).</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Immediate family</U> means any parent, spouse
of a parent, child, spouse of a child, spouse, brother, or sister, and includes step and adoptive relationships.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Investment Account</U> generally means any
account over which the Adviser Access Persons has <U>Beneficial Ownership</U> which can, even if the account does not currently, hold
<U>Securities</U>. It includes the following accounts:</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"></P>
<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any investment account with a broker-dealer or bank over which the Adviser Access Person has investment
decision-making authority (including accounts that the Adviser Access Person is named on, such as being a guardian, executor or trustee,
as well as accounts that Adviser Access Person is not named on such as an account owned by another person but for which the Adviser Access
Person has been granted trading authority).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any investment account with a broker-dealer or bank established by partnership, corporation, or other
entity in which the Adviser Access Person has a direct or indirect interest through any formal or informal understanding or agreement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any college savings account in which the Adviser Access Person has investment discretion issued under
Section 529 of the Internal Revenue Code, which can hold <U>Securities</U>, and in which the Adviser Access Person has a direct or indirect
interest.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any other account that the Compliance Officer deems appropriate in light of the Adviser Access Person&rsquo;s
interest or involvement.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any account in which the Adviser Access Person&rsquo;s <U>immediate family</U> is the owner. Adviser Access
Persons are presumed to have investment decision-making authority for, and therefore should report, any investment account of a member
of their immediate family if they live in the same household.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Any 401(k) accounts from a previous employer which can or offer the ability to hold <U>Securities</U>.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Independent Trustee</U> means a trustee
or director of a Fund who is not an &ldquo;interested person&rdquo; of the Fund within the meaning of Section 2(a)(19) of the 1940 Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Initial public offering (&ldquo;IPO&rdquo;)</U>
means an offering of <U>securities</U> registered under the Securities Act of 1933, the issuer of which, immediately before registration,
was not subject to the reporting requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Interested Trustee</U> means a trustee or
director of a Fund who is an &ldquo;interested person&rdquo; of the Fund within the meaning of Section 2(a)(19) of the 1940 Act.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Investment Club </U> means a group of people
who pool their money to make investments. Usually investment clubs are organized as partnerships and after the members study different
investments, the group decides to buy or sell based on a majority vote of the members.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Natural Control Persons</U> are natural
persons in a <U>control</U> relationship with a Company who obtain information concerning recommendations made to a Fund or client about
the <U>purchase or sale</U> of a <U>security </U> <I>and are not specifically covered by any other section of the Code.</I></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Private Investments</U> include, but are
not limited to investments in: hedge funds, private equity funds, venture capital funds, other private fund vehicles (including Investment
Trusts that invest directly and primarily in cryptocurrencies), privately-held companies, and private placement offerings of cryptocurrencies
or other digital assets (e.g., agreements for future cryptocurrencies or other digital assets). Private Investments also include: (i)
loans to or from such entities, and any</P>
<P STYLE="margin: 0"></P>
<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">other entities formed for the purpose of engaging in business activity; (ii) loans to or from
individuals who are not <U>immediate family</U> of the Adviser Access Person; and (iii) loans to or from individuals who are <U>immediate
family</U> of the Adviser Access Person for the purpose of engaging in business activity. Loans to or from <U>immediate family</U> of
the Adviser Access Person that are entirely of a personal nature and loans that are covered within one of the following exceptions are
not included in the definition of private investments:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">An Employee or <U>immediate family</U> member obtaining a loan, such as a standard home mortgage loan
or home equity loan, from a bank, broker-dealer, or other financial institution, if (i) the loan is made in the ordinary course of the
lender&rsquo;s business using standard form loan documentation (ii) the loan is made on terms generally comparable to those provided to
similarly situated members of the public; and (iii) the Employee or <U>immediate family</U> member obtains the loan through the normal-course
lending division (i.e. as opposed to obtaining the loan through an Adviser&rsquo;s (or Adviser&rsquo;s affiliate&rsquo;s) client representative
or contact);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Employee or <U>immediate family</U> member purchases of publicly offered debt securities that are listed
on a securities exchange;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">Loans to or from an entity in which an Employee or <U>immediate family</U> member owns a beneficial interest,
where such persons have no knowledge of, no involvement in and no control over any loan to or from the entity; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; text-transform: uppercase; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">An Employee or <U>immediate family</U> member obtaining a loan from an insurance company pursuant to the
loan or cash value provision of any life insurance policy or other insurance policy issued by that insurance company.</TD></TR></TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Purchase or sale of a security</U> includes,
among other things, the writing of an option to purchase or sell a <U>security</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Reportable fund</U> means any fund, except
money market funds, for which an Adviser serves as investment adviser, any fund whose investment adviser or principal underwriter controls,
is controlled by, or is under common control with the Advisers, or any closed-end fund regardless of affiliation. For purposes of this
Code definition, control has the same meaning as it does above.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Security</U> means the same as that set
forth in Section 2(a)(36) of the 1940 Act, except that it does not include direct obligations of the U.S. Government, bankers&rsquo; acceptances,
bank certificates of deposit, commercial paper, shares of registered open-end mutual funds other than <U>reportable funds</U>, and high
quality short-term debt instruments, including repurchase agreements. A high quality short-term debt instrument is an instrument that
has a maturity <B>at issuance </B>of less than 366 days and that is rated in one of the two highest rating categories by a NRSRO. For
purposes of this Code, a <U>security </U> includes shares issued by exchange-traded funds, futures, index futures, commodities futures,
commodities, options on futures, and other types of derivatives. A <U>security </U> also includes options on securities and single stock
futures. A <U>security</U> also does not include shares issued by UITs that are invested exclusively in one or more unaffiliated open-end
funds, none of which are <U>reportable funds</U>.</P>
<P STYLE="margin: 0"></P>
<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">A <U>security held or to be acquired </U> by
any Fund or any client account means any <U>security</U> which, within the most recent 15 days, (i) is or has been held by any Fund or
any client account or (ii) is being or has been considered by an Adviser or sub-adviser for purchase by a Fund or client account, and
any option to purchase or sell, and any <U>security</U> convertible into or exchangeable for any <U>security</U>.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">A <U>security</U> is being <U>purchased or
sold </U> by a Fund or a client account from the time a <U>purchase or sale </U>program has been communicated to the person who places
buy and sell orders for the Fund or client account until the program has been fully completed or terminated.</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify"><U>Tradable Funds</U> are those Funds that
are designed for active trading and do not impose limits on shareholder transactions.</P>


<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.05in; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Code of Ethics Certification of Compliance</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify">This is to certify that I have reviewed the
Code of Ethics (&ldquo;Code&rdquo;) and that I understand its terms and requirements. I hereby certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">I have complied with the Code during the course of my association with the entities covered by the Code;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">I will continue to comply with the Code in the future;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">I will promptly report to a Compliance Officer any violation or possible violation of the Code of which
I become aware; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 12pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; color: windowtext">&#183;</FONT></TD><TD STYLE="text-align: justify">I understand that a violation of the Code may be grounds for disciplinary action or termination of my
employment and may also be a violation of federal and/or state securities laws.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt"><B>Name:&#9;</B><U>&#9;__________________</U></P>
    <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 24pt"><B>Signature: &#9;</B><U>&#9;______________</U></P></TD>
    <TD STYLE="width: 49%; padding-right: 5.4pt; padding-bottom: 24pt; padding-left: 5.4pt"><B>Date:&#9;</B><U>&#9;_____________</U></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.05in"><B>&nbsp;</B></P>


<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center">Supplement 1 - Options</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 59%; border: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Buying a Call Option</B></TD>
    <TD STYLE="width: 41%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Pre-Clearance Required</B></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Entering into Transaction</B></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Closing Transaction</B></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Sell to Close</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Let it Expire</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">NO</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercise (i.e., buy underlying) and Hold</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercise (i.e., buy underlying) and Immediately Sell</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES for each trade (prohibited because of 30-day holding period)</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 59%; border: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Writing/Selling a Call Option</B></TD>
    <TD STYLE="width: 41%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Pre-Clearance Required</B></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Entering into Transaction</B></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Write/Sell Option</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Closing Transaction</B></TD>
    <TD STYLE="vertical-align: top; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Expires</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">NO</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercised (if own underlying)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">NO</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercised (if naked/do not own underlying &ndash; i.e., buy security to deliver)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Buy same Call Option</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 59%; border: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Buying a Put Option</B></TD>
    <TD STYLE="width: 41%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Pre-Clearance Required</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Entering into Transaction</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Buy to Open</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Closing Transaction</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Sell to Close</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Let it Expire</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">NO</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercise (if own underlying - i.e., sell underlying)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercise (if do not own underlying &ndash; i.e., buy underlying first)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES for each trade (prohibited because of 30-day holding period)</TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: justify; text-indent: 0in"><B><IMG SRC="guggenheimlogonew2.jpg" ALT=""></B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 1pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 59%; border: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Writing/Selling a Put Option</B></TD>
    <TD STYLE="width: 41%; border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Pre-Clearance Required</B></TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt"><B>Entering into Transaction</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Write/Sell Option</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">YES</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Closing Transaction</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Expires</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">NO</TD></TR>
  <TR>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">Exercised (i.e., buy underlying)</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 6pt; padding-left: 5.4pt">NO</TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>6
<FILENAME>ex99s.htm
<DESCRIPTION>FILING FEE IXBRL
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024-2025 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.4a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: e86e42f8b07dcd26b792914c3d6f8980 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025">
<head>
  <title>Filing Fee Exhibit</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="fee_001">N-2ASR</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="fee_002">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="fee_003">0001380936</ix:nonNumeric>
      <ix:nonNumeric name="ffd:OfferingTableNa" contextRef="c_report" xs:nil="true" id="fee_004"></ix:nonNumeric>
      <ix:nonNumeric name="ffd:OffsetTableNa" contextRef="c_report" id="fee_005">N/A</ix:nonNumeric>
      <ix:nonNumeric name="ffd:CombinedProspectusTableNa" contextRef="c_report" id="fee_006">N/A</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-20</xbrli:startDate>
          <xbrli:endDate>2025-11-20</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-20</xbrli:startDate>
          <xbrli:endDate>2025-11-20</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0001380936</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-20</xbrli:startDate>
          <xbrli:endDate>2025-11-20</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: right">Ex-Filing Fees</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center">CALCULATION OF FILING FEE TABLES</p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; text-align: center"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="fee_007">N-2</ix:nonNumeric></p>

<p style="font: bold 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="fee_008">Guggenheim Strategic Opportunities Fund</ix:nonNumeric></p>

<p style="font: bold 11pt Times New Roman, Times, Serif; border-top: Gray 3pt double; padding-top: 6pt; text-align: center; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 12%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 3%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 4%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 3%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/>
or Carry Forward Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount of Registration Fee</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Carry Forward Form Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Carry Forward File Number</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Carry Forward Initial Effective Date</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Filing Fee Previously Paid in Connection with<br/>Unsold Securities<br/>to be<br/>Carried Forward</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="31" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="fee_009">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-343">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-344">Common shares of beneficial interest, $0.01 par value per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457oFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="fee_010">457(o)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-346">969,300,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-347">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-348">133,860.33</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="31" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Carry Forward Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap">Carry Forward Securities</td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-349">Equity</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-350">Common shares of beneficial interest, $0.01 par value per share</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule415a6Flg" contextRef="c_offering_2" format="ixt:booleantrue" id="fee_011">415(a)(6)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-352">30,700,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center">&#160;</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right">&#160;</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:CfwdFormTp" contextRef="c_offering_2" id="ixv-353">N-2</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:CfwdPrrFileNb" contextRef="c_offering_2" id="ixv-354">333-279126</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:CfwdPrrFctvDt" format="ixt:datemonthdayyear" contextRef="c_offering_2" id="ixv-355">05/06/2024</ix:nonNumeric></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:CfwdPrevslyPdFee" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-356">4,531.32</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 10%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 12%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 3%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 4%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 3%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-top: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-top: Black 1pt solid; width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-top: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-top: Black 1pt solid; width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-357">1,000,000,000.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-358">133,860.33</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-359">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-360">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-361">133,860.33</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
</table>



<p style="font: bold 8pt Times New Roman, Times, Serif; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-362">Estimated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, solely for the purpose of determining the registration fee. The proposed maximum offering price per security will be determined, from time to time, by the Registrant in connection with the sale by the Registrant of the securities registered under the registration statement.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-363">Pursuant to Rule 415(a)(6) under the Securities Act, the Registrant is carrying forward $46,758,272 aggregate principal offering price of unsold common shares of beneficial interest (the &#8220;Unsold Shares&#8221;) that were previously registered for sale under a Registration Statement on Form N-2 effective on May 3, 2024 (File No. 333-279126) (the &#8220;Prior Registration Statement&#8221;). Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid with respect to the Unsold Shares will continue to be applied to such Unsold Shares. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Shares under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.</ix:nonNumeric></td></tr>
  </table>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>7
<FILENAME>ex99t.htm
<DESCRIPTION>POWER OF ATTORNEY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">BY THESE PRESENTS, that each of the undersigned constitutes
and appoints Amy J. Lee, Mark E. Mathiasen and Michael P. Megaris to act as attorney-in-fact and agent with full power of substitution
and resubstitution of him or her in his or her name, place and stead, to sign any and all registration statements on Form N-2 applicable
to Guggenheim Active Allocation Fund, Guggenheim Strategic Opportunities Fund, and Guggenheim Taxable Municipal Bond &amp; Investment
Grade Debt Trust, including any and all pre-effective amendments, post-effective amendments or supplements thereto, any and all subsequent
registration statements pursuant to Rule 462(b) of the Securities Act of 1933, as amended, and any and all other filings in connection
therewith, and to file the same with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite
and necessary to be done, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all
that said attorney-in-fact and agent, or their substitutes, may lawfully do or cause to be done by virtue thereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">This Power of Attorney may be executed in multiple
counterparts, each of which shall be deemed an original, but which taken together shall constitute one instrument.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IN WITNESS WHEREOF, each of the undersigned has executed
this Power of Attorney as of this 19th day of November, 2025.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="width: 34%"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Randall C. Barnes</U></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Randall C. Barnes</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Trustee</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Angela Brock-Kyle</U></P></TD>
    <TD STYLE="width: 33%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 33%"><P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Thomas F. Lydon, Jr.</U></P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Thomas F. Lydon, Jr.</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Trustee</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Ronald A. Nyberg</U></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">Angela Brock-Kyle</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Trustee</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Sandra G. Sponem</U></P></TD>
    <TD STYLE="font: 10pt/12.2pt Times New Roman, Times, Serif; padding-top: 0.85pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Ronald A. Nyberg</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">Trustee</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">&nbsp;</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Ronald E. Toupin, Jr.</U></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Sandra G. Sponem</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Trustee</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P></TD>
    <TD STYLE="font: 10pt/12.2pt Times New Roman, Times, Serif; padding-top: 0.85pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Ronald E. Toupin, Jr.</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">Trustee</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">&nbsp;</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">&nbsp;</P>
    <P STYLE="font: 11pt/12.2pt Times New Roman, Times, Serif; margin: 0.85pt 0 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>POWER OF ATTORNEY</B></P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">BY THESE PRESENTS, that the undersigned constitutes
and appoints Mark E. Mathiasen and Michael P. Megaris to act as attorney-in-fact and agent with full power of substitution and resubstitution
of him in her name, place and stead, to sign any and all registration statements on Form N-2 applicable to Guggenheim Active Allocation
Fund, Guggenheim Strategic Opportunities Fund, and Guggenheim Taxable Municipal Bond &amp; Investment Grade Debt Trust, including any
and all pre-effective amendments, post-effective amendments or supplements thereto, any and all subsequent registration statements pursuant
to Rule 462(b) of the Securities Act of 1933, as amended, and any and all other filings in connection therewith, and to file the same
with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done,
as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorney-in-fact
and agent, or their substitutes, may lawfully do or cause to be done by virtue thereof.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">IN WITNESS WHEREOF, the undersigned has executed this
Power of Attorney as of this 19th day of November, 2025.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-size: 11pt">/s/ Amy J. Lee</FONT></TD>
    <TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD COLSPAN="2">
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Amy J. Lee</P>
    <P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">Trustee</P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>dechert.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dechert.gif
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MDR==$(<A$J\+'9F"(154!8#T<$C' KGH01LJM*S"RA[$+',;$:0PR!6()&*
M(B@/M$@/.P =] Y#$[V#%RPP4@(A7630B$8]#^2("%13_4C553^"P@M01^WU
MUV"'+?;89)=M]MEHH\7 VFMOQ/;;D! TQ (;0-TV07>_S;9 >@__I/?;D7#
MB"1"3$+)0#94DH@EC%^"B4"8N,8"%YEH<@ $FW R4">;[""0)T0(P?@G41P
M2BA1,&Z)*!H-,HHEB43A "F5Y%!*"@,0P$(<7I@BT"E7H)(*"*JL(A K45Q1
MA"FMN/+* ;#($,M FL@@BT .I&""%B#,\C@M&-1BRRV!?$#! 5T4D HN*>2B
MRRZ\#+!#+P+Y\DL/>0$30# ;"6/)%</P&S&@%X=B#,08<3@&]@* C(W0H@?)
M&$@ 6J",@2PC ,P8B !VT(R!.",2SS@ ,(H #09$XP4T.( TD%"+CL "$-/P
M 0HT@ E X$(@C$ $-:H1#6L(A!8[,)Y _Y# @FL,!!L!R,9 Y-=!@6@# UX0
MX39B( 1N=,,;!X &!IC@0@H$8@11&$$1'J#  SA 6D(0PC? <0!:%"$<XAA'
M&G1P!X)@(P[DT" '!U(.1.A A!<@P S,T04W'. <&$"'"RV0CBFH8QWL&$09
M'5 !;X!!#.UP1QL100$'E, "L^C: 9"H1(%L\!T#8<<';"'" ,!C(]/P P9<
M&(=X#$0>"<1A .;AP#B4@AX\", L[8A'#2*B'DNPQSVN\ DCB% &)<0'/E)X
M  Y4(!\9H8$^]D' Z0E$$[DT(P;J)LUHM'$'_!"(+BX "V+F42#]&(071E""
M. @A/ ?PAQ\=X'4 1OQC>@NPQ 4", (B9"*/K2C!.P^@B3X)Q!(4X (C'""$
M?QR@'$0HQ4 X0 1]#,0 "AT(&+Q1 V_<8!I=\X4M:L#2&N3!& (Y@0U@08@"
HX.!.PS!%.6YI"G,(! 0MK<$?6"F'-)QC()A0QX4$8@=3@&(@ 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>gugglogop.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gugglogop.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  < .8# 2(  A$! Q$!_\0
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MO(O'G_)9_#7_ &S_ /0C4I7,X)2=CT?Q+XNT?PG;0S:M.T8G<I$B(79R!DX
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>guggenheimlogonew2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 guggenheimlogonew2.jpg
M_]C_X0QX17AI9@  34T *@    @ # $   ,    ! K@   $!  ,    ! )0
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   A    M $R  (    4    U8=I  0    !    [    4  "  (  @ %?D
M   G$  5^0   "<0061O8F4@4&AO=&]S:&]P(#(R+C(@*$UA8VEN=&]S:"D
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M1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$
M A$#$0 _ /3,WJ/3^GUMMS\JG$K>=K7WV-K:7<[6NM<WW(&/]8.@Y7J#&ZEB
M7^C6ZZWT[ZW[*V_SEUFQYV5,GWV.6-];<;('6^A]3'3[>I8>$<MN350QEKP;
MZV5T_H;7LW-W,^G^8LC Q?K!FGK%#<2]N)D=-R*J1E8F-AV?:+3MQ\:I^,[=
M;3Z7Y]C_ /C4:T7"(J[>Y?GX+,9F6_(J;BV;#7>7M%;A9'H[+9V.]7>WTO\
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M       0Z/%<\R_!&*&B>V>MQ635NCA"24T$.@      Y0   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    ,
M %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !
M $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7
M $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B
M;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L
M  !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0
M %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M          !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
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M8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M    "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 )     !  $
MD     $  3A"24T$)@      #@             _@   .$))300-       $
M    'CA"24T$&0      !    !XX0DE- _,       D           $ .$))
M32<0       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M     0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U
M 0 M    !@       3A"24T#^       <   ________________________
M_____P/H     /____________________________\#Z     #_________
M____________________ ^@     _____________________________P/H
M   X0DE-! @      !     !   "0    D      .$))300>       $
M #A"24T$&@     #5P    8              #L   $6    $0!G '4 9P!G
M &4 ;@!H &4 :0!M &P ;P!G &\ ;@!E '<    !
M      $              18    [                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!0
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M'_5L=C?2?[W.>_\ [=57J.)T:WJ]@=FW8_4[;L7T36V?2N;5E?9_3WTV4O\
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M65H@!^D  0 !  ,    686-S<$%04$P     05!03
M     /;6  $     TRUA<'!L
M                           19&5S8P   5    !B9'-C;0   ;0   'J
M8W!R=    Z     C=W1P=    \0    4<EA96@   ]@    49UA96@   ^P
M   48EA96@  !      4<E120P  !!0   @,86%R9P  #"     @=F-G=
M#$     P;F1I;@  #'     ^;6UO9   #+     H=F-G<   #-@    X8E12
M0P  !!0   @,9U120P  !!0   @,86%B9P  #"     @86%G9P  #"     @
M9&5S8P         (1&ES<&QA>0
M
M             &UL=6,         )@    QH<DA2    "    =AK;TM2
M"    =AN8DY/    "    =AI9       "    =AH=4A5    "    =AC<T-:
M    "    =AD841+    "    =AN;$Y,    "    =AF:49)    "    =AI
M=$E4    "    =AE<T53    "    =AR;U)/    "    =AF<D-!    "
M =AA<@      "@   >!U:U5!    "    =AH94E,    "    =AZ:%17
M"    =AV:59.    "    =AS:U-+    "    =AZ:$-.    "    =AR=5)5
M    "    =AE;D="    "    =AF<D92    "    =AM<P      "    =AH
M:4E.    "    =AT:%1(    "    =AC8453    "    =AE;D%5    "
M =AE<UA,    "    =AD941%    "    =AE;E53    "    =AP=$)2
M"    =AP;%!,    "    =AE;$=2    "    =AS=E-%    "    =AT<E12
M    "    =AP=%!4    "    =AJ84I0    "    =@ :0!- &$ 8R / &D
M30!A &,  '1E>'0     0V]P>7)I9VAT($%P<&QE($EN8RXL(#(P,C4  %A9
M6B        #S%@ !     1;*6%E:(        (.'   ]J?___[M865H@
M    2^4  +/O   *W5A96B         G:@  #F@  ,B58W5R=@        0
M    !0 *  \ %  9 !X (P H "T ,@ V #L 0 !% $H 3P!4 %D 7@!C &@
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M)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#8Y=CZV1
M9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J]VM/:Z=K
M_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F<P%S77.X
M=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[!'MC>\)\
M(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*@6N!S8(P@I*"](-7@[J$'82
MA..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,8XS*C3&-
MF(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?E<F6-):?
MEPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY GJZ?'9^+G_J@
M::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$J3>IJ:H<
MJH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P=;#JL6"QUK)+LL*S.+.NM"6T
MG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/O@J^A+[_
MOWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(O,DZR;G*
M.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&U$G4R]5.
MU='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<BMT0W9;>'-ZBWRG?K^ VX+WA
M1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MPZ_OLANT1
M[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX&?BH^3CY
MQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M__]P87)A       #     F9F  #RIP
M#5D  !/0   *6W9C9W0          0 !          $    !          $
M   !          $  &YD:6X         -@  K@   %(   !#P   L,   "9
M   -@   4    %1   (S,P ",S,  C,S          !M;6]D        !A
M *X'_.2PE-&Z+X                      =F-G<        P    )F9@ #
M     F9F  ,    "9F8    ",S,T      (S,S0      C,S- #_[@ .061O
M8F4 9$     !_]L A  " @(" @(" @(" P(" @,$ P(" P0%! 0$! 0%!@4%
M!04%!08&!P<(!P<&"0D*"@D)# P,# P,# P,# P,# P, 0,# P4$!0D&!@D-
M"@D*#0\.#@X.#P\,# P,# \/# P,# P,#PP,# P,# P,# P,# P,# P,# P,
M# P,# P,# S_P  1"  [ 18# 1$  A$! Q$!_]T !  C_\0!H@    <! 0$!
M 0          ! 4# @8!  <("0H+ 0 " @,! 0$! 0         !  (#! 4&
M!P@)"@L0  (! P,"! (&!P,$ @8"<P$" Q$$  4A$C%!408382)Q@10RD:$'
M%;%"(\%2T>$S%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*
M&!F$E$5&I+16TU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=W
MAY>GM\?7Y_<X2%AH>(B8J+C(V.CX*3E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZ
MRMKJ^A$  @(! @,%!00%!@0( P-M 0 "$0,$(1(Q0051$V$B!G&!D3*AL? 4
MP='A(T(54F)R\3,D-$."%I)3):)CLL('<](UXD2#%U23" D*&!DF-D4:)V1T
M53?RH[/#*"G3X_.$E*2TQ-3D]&5UA96EM<75Y?5&5F9VAI:FML;6YO9'5V=W
MAY>GM\?7Y_<X2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*
MVNKZ_]H # ,!  (1 Q$ /P#[^8J[%78J[%78J[%78J[%78J[%78J[%78J[%7
M8J[%78J[%78J[%78J[%78J[%78J[%78J[%78J^0_^<DO^<R?RY_YQOU'R]Y?
MU6PO_.GFS5W6]U7RKH($UYIFA1M6[U:Z6A"I$@)1&H9"#0@ L+\6"63?DY.#
M32RV1L/TOI?R=YQ\L?F!Y8T3SGY,UNU\Q>5_,5JEYHVLV;\XIHG[CH592"K*
MP#*P*L P(RF43$T6B43$T>;)<#%V*NQ5V*O_T/OYBKX\\V_\Y[_\XH>2?,6K
M>5M>_-BU36-#N9;+4TM+*^NX8[B!BDT0N(+=XG:-AQ;@QH=CN,OCILDA8#DQ
MT>60L!CG_12'_G#G_P NTO\ W"M4_P"R7)?E,G<R_(YNY[\O_.0?Y3O^2X_Y
MR"3S,S_E.UE^D!YE6SNB?J_UGZIR^K"+U_[[X:<*]^F5>'+BX>K3X,N/@ZLR
M_+G\Q/*7YL>3-$_,#R+J;:QY4\Q),^D:DT$UL95@FDMY"8ITCD6DD;#XE'2O
M3(SB8FCS8S@8&CS85^8/_.0WY2_E;YW\D_EUYW\ROI'F_P#,-XH_*6F+97=P
M+EIKE+1 98(7CCK-(J_&P\>F2CBE($CD&4,,YQ,@-@K?G#_SD#^4'Y"6.DW_
M .:WG.V\K)KLDL>C6S13W-Q<F !IFC@MHY9.$88<G(XK45-2,88I3^D+BPSR
M?2+?/W_12'_G#G_R[2_]PK5/^R7+/RF3N;OR.;N>J_D__P Y;_D%^?'F:_\
M)_Y6^>1YE\PZ;IKZM>6 L;VVXVB2QPM)SN(8U-'E44!KOD,F"<!9#7ETT\8N
M0I)?S'_YS:_YQD_*CS5J7DGSM^9]K8>9=&=8M7TZVM+R]%M,R"3T99;:"2-9
M K E.7):_$!AAIYS%@)QZ7),6!LP3_HI#_SAS_Y=I?\ N%:I_P!DN3_*9.YG
M^1S=SZ'_ "__ #W_ "N_-'\N=2_-CR/YD_3/D/2/TA^D-:%K<PE/T6I:Z_<R
MQI*> !.R[]JY3+&8GA/-HGBE&7">;YY/_/R#_G#L+$[_ )K&(31K+$)-'U5"
M485!HUH#OEOY3)W-_P"1S=R?^4O^<^O^<5///FKRWY*\L?F<NI>9/-NHP:5H
M.GC3-1C]>[N6X11\Y+947D=JL0,$M-.(LAC+298BR&1_F?\ \YF_\XZ_DYYP
MU/R)^8GGMM \S:/!:W&HV)TW4)TCCO8_4@/K06[QGDN] VW?!#!.8L!&/2Y,
M@N(V>=_]%(O^<.#0#\VE).P TK4ZDGL/]%R?Y3)W,_R.;N?2_DS\Y_RS_,+\
MOKO\T?)?FJW\P>2-/AO)=0U:W24-;FP0O=1S6[HLR21J*E&0-TH-Q6F6.431
MYM$L4HRX2-U#\G?SM_+;\^_*UQYS_*W7G\Q>7;6_?39[Y[2YLR+F.**9D].Z
MCB<T29#6E-\<F.4#4ERXI8S4N::_FA^:7DC\F_*%YY[_ ##U=M#\KV$]M;76
MH+;SW166[E6&%?2MTD<\G8"H7;O@A S-!&/'+(:CS8IK/_.1'Y2>7_RBT?\
M/35?,SVWY8Z]#8SZ7Y@%E=NTB:BZQVQ^K)"9UYLP&Z"G>F2&*1EP]60P3,^
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M6&GQ8HS!C.RSW\W_ /Y%7^5=30?HKR;4^'^EPY"']^?BPQ?XT?BQK\H?.O\
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M>4O^<K_^<;//7F#3O*GE+\[/*6N>8]7D]+2M&@U&(3W,O:.%7*\W/95J3V&
MXICF$2P9(BR"]'_,'\T?RY_*?2(=>_,KSMHWD?1[F<6UK?ZS=Q6J33$5].+U
M""[4WHH)IOTR,8F7(-<(2GR%L"\D_P#.47_.._YC^8+7RIY&_.7RIYE\R7P8
MV.B6>HQ&YGX"K"&-BID( J0M33?)2Q2B+(9RP3B+(3'\Q?\ G(K\C?RDUJV\
MN_F7^:&@>2M<O+-+^UTS5;H02R6TCO&LJJ1NI:-A7Q!P1Q2D+ 6&&<Q8%A#>
M0O\ G)?_ )Q__-#75\K_ )??F_Y7\U^8Y(GFAT.PU")[J6.,5=HXB0S\1N>(
M-!N<98I1YA989Q%D/G;6_P#G);1/RN_YR_\ S-\I_FW^:UCY-_+2#R!Y=O/*
M6DZS+#;VOZ5N;FY^M/ Y0.SM&B\@6.V],L&(R@" V# 98P8B]WU!'^?/Y,2?
MEU%^;?\ RLWR[%^6<\KP0>=YKZ*+3Y)8Y7@:))I"H9Q(C+Q&Y(-!E?!*ZK=I
M\.5\-;L:\F_\Y4_\XY?F%YET[R=Y*_.;RMYD\T:P9%TK0[._C>XN&B0R.L2F
MG(A%+4&] 3VPRQ2B+(92P3B+(>_Y6U/S[_YR _YQ_P#/?D/SW<?\Y4_\XJV\
M=M^:-LG+\TORM6J:=YXTY#RE#1+0"^ %58;N=Q^]_O,G%E$AP3Y=#W.9AS1E
M'P\G+H>YD=S?_E5_S\3_ .<;]6T31M<O/+$UU<6PUK3G16U3RUKMA()E@O;1
MRH<!U(H:+(A/$JWV1ZL$[_!0!+2Y+._Z0\CT[_G"G_G*+1]/L-)TK_G.?S/I
MNEZ7;Q6FFZ=;:<Z0V]O @CBBC7ZX:*BJ% KL!DSJ,9_@;#JL1W.,)MY3_P"<
M#_/<_P":GY>_F5^=?_.2.N?F\OY:7JZEY=TN[L1!+Z\;K-'&;EYY2L/JHCNJ
MK5^('(#&6I'"1&-6B6LCPF,(U:9_GI^>OG[\Y?/VH?\ .*W_ #BKJ A\R0#T
MOSI_.J*KV/E&Q<E);:VE0@/?. 5 4U0_"M'#O",>,0''/X#O1BQ1QQ\3)\!W
MOK#\B_R*\@_\X]^0=/\ (/D'3S#:PGZQK6M7%'OM5OG ]6\O)J O(Y^A115
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MBUBS"3P2(H9' 8BH/0D8=,;R ,M&2<H!>9?G_P":+30/^<S/R&U?7?R]U_\
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8BKL5=BKL5=BKL5=BKL5=BKL5=BK_ /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>gof-20251121.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aMpw7xRiXgOn8uPaXpMSaCOWbOdwJd1KekxtGh0bXn6fy0tMM3IHSy3muuGQa4M -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:GOF="http://guggenheiminvestments.com/20251121" elementFormDefault="qualified" targetNamespace="http://guggenheiminvestments.com/20251121">
    <annotation>
      <appinfo>
        <link:linkbaseRef xlink:type="simple" xlink:href="gof-20251121_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gof-20251121_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="gof-20251121_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
    <import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
    <import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/cef/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025.xsd" />
    <import namespace="http://xbrl.sec.gov/cef-pre/2025" schemaLocation="https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
    <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
    <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
    <element id="GOF_PrincipalRisksMember" name="PrincipalRisksMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GOF_MarketDiscountAndPriceVolatilityRiskMember" name="MarketDiscountAndPriceVolatilityRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GOF_DebtOverlayStrategyRiskMember" name="DebtOverlayStrategyRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="GOF_SyntheticAutocallableELNStrategyRiskMember" name="SyntheticAutocallableELNStrategyRiskMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>gof-20251121_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#SecurityOnly" roleURI="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#AddressTypeOnly" roleURI="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#RiskOnly" roleURI="http://xbrl.sec.gov/cef/role/RiskOnly" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/SecurityOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/AddressTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/RiskOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_PrincipalRisksMember" xlink:label="loc_GOFPrincipalRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFPrincipalRisksMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:label="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_DebtOverlayStrategyRiskMember" xlink:label="loc_GOFDebtOverlayStrategyRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFDebtOverlayStrategyRiskMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:label="loc_GOFSyntheticAutocallableELNStrategyRiskMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFSyntheticAutocallableELNStrategyRiskMember" xlink:type="arc" order="30" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>gof-20251121_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_PrincipalRisksMember" xlink:label="GOF_PrincipalRisksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_PrincipalRisksMember" xlink:to="GOF_PrincipalRisksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_PrincipalRisksMember_lbl" xml:lang="en-US">Principal Risks [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:label="GOF_MarketDiscountAndPriceVolatilityRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:to="GOF_MarketDiscountAndPriceVolatilityRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_MarketDiscountAndPriceVolatilityRiskMember_lbl" xml:lang="en-US">Market Discount And Price Volatility Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_DebtOverlayStrategyRiskMember" xlink:label="GOF_DebtOverlayStrategyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_DebtOverlayStrategyRiskMember" xlink:to="GOF_DebtOverlayStrategyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_DebtOverlayStrategyRiskMember_lbl" xml:lang="en-US">Debt Overlay Strategy Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:label="GOF_SyntheticAutocallableELNStrategyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:to="GOF_SyntheticAutocallableELNStrategyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="GOF_SyntheticAutocallableELNStrategyRiskMember_lbl" xml:lang="en-US">Synthetic Autocallable E L N Strategy Risk [Member]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>gof-20251121_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.3a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2Cover" roleURI="http://xbrl.sec.gov/cef/role/N2Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#N2" roleURI="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" xlink:title="995470 - Disclosure - N-2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_ProspectusLineItems" xlink:label="loc_cefProspectusLineItems" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cef/role/N2">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cef/2025/cef-2025.xsd#cef_AllRisksMember" xlink:label="loc_cefAllRisksMember" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_PrincipalRisksMember" xlink:label="loc_GOFPrincipalRisksMember" />
      <link:presentationArc order="1000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFPrincipalRisksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_MarketDiscountAndPriceVolatilityRiskMember" xlink:label="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" />
      <link:presentationArc order="1010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFMarketDiscountAndPriceVolatilityRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_DebtOverlayStrategyRiskMember" xlink:label="loc_GOFDebtOverlayStrategyRiskMember" />
      <link:presentationArc order="1020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFDebtOverlayStrategyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="gof-20251121.xsd#GOF_SyntheticAutocallableELNStrategyRiskMember" xlink:label="loc_GOFSyntheticAutocallableELNStrategyRiskMember" />
      <link:presentationArc order="1030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cefAllRisksMember" xlink:to="loc_GOFSyntheticAutocallableELNStrategyRiskMember" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>N-2 - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="9">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 21, 2025</div></th>
<th class="th"><div>Aug. 31, 2025</div></th>
<th class="th"><div>May 31, 2025</div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
<th class="th"><div>Nov. 30, 2024</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>May 31, 2024</div></th>
<th class="th"><div>Feb. 29, 2024</div></th>
<th class="th"><div>Nov. 30, 2023</div></th>
<th class="th"><div>Aug. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">0001380936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">333-000000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActFileNumber', window );">Investment Company Act File Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">811-21982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">N-2ASR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyActRegistration', window );">Investment Company Act Registration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendment', window );">Investment Company Registration Amendment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_InvestmentCompanyRegistrationAmendmentNumber', window );">Investment Company Registration Amendment Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Guggenheim Strategic
Opportunities Fund<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">227 West Monroe Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Chicago<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">IL<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">60606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">(312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">827-0100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic', window );">Approximate Date of Commencement of Proposed Sale to Public</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">From time to time after the effective date of this Registration Statement.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DividendOrInterestReinvestmentPlanOnly', window );">Dividend or Interest Reinvestment Plan Only</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DelayedOrContinuousOffering', window );">Delayed or Continuous Offering</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfFlag', window );">Primary Shelf [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveUponFiling462e', window );">Effective Upon Filing, 462(e)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AdditionalSecuritiesEffective413b', window );">Additional Securities Effective, 413(b)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EffectiveWhenDeclaredSection8c', window );">Effective when Declared, Section 8(c)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RegisteredClosedEndFundFlag', window );">Registered Closed-End Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BusinessDevelopmentCompanyFlag', window );">Business Development Company [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_IntervalFundFlag', window );">Interval Fund [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PrimaryShelfQualifiedFlag', window );">Primary Shelf Qualified [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_NewCefOrBdcRegistrantFlag', window );">New CEF or BDC Registrant [Flag]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FeeTableAbstract', window );"><strong>Fee Table [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ShareholderTransactionExpensesTableTextBlock', window );">Shareholder Transaction Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecef--ShareholderTransactionExpensesTableTextBlock_dD_zz77PYEUFEuf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - ShareholderTransactionExpenses">
  <tr style="vertical-align: top">
    <td style="width: 77%; padding-right: 5.75pt; padding-left: 5.75pt"><b>Shareholder Transaction Expenses</b></td>
    <td style="width: 23%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Sales load paid by you (<span id="xdx_90C_ecef--BasisOfTransactionFeesNoteTextBlock_c20251121__20251121_zz07hEA50uO7">as a percentage of offering price</span>) <span style="background-color: #CCEEFF"><sup>(</sup></span><sup>1)</sup></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt"><span style="background-color: #CCEEFF">&#160;&#160;<span id="xdx_908_ecef--SalesLoadPercent_d0_c20251121__20251121_fKDEp_zyfdVofshWLe">&#8212;</span></span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Offering expenses borne by the Fund (as a percentage of offering price) <span style="font-size: 8.5pt"><sup>(1),(2)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt"><span id="xdx_90C_ecef--OtherTransactionExpensesPercent_c20251121__20251121_fKDEpICgyKQ_____zUpO5bKA7Gz1">0.60%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt">Dividend Reinvestment Plan fees<span style="font-size: 8.5pt"><sup>(3)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 0.5pt"><span id="xdx_906_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20251121__20251121_fKDMp_zQMeiEuGd3m6">None</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SalesLoadPercent', window );">Sales Load [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_DividendReinvestmentAndCashPurchaseFees', window );">Dividend Reinvestment and Cash Purchase Fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesAbstract', window );"><strong>Other Transaction Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherTransactionExpensesPercent', window );">Other Transaction Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AnnualExpensesTableTextBlock', window );">Annual Expenses [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_ecef--AnnualExpensesTableTextBlock_zBYwZFwGJFMa" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - AnnualExpenses">
  <tr>
    <td style="vertical-align: top; width: 60%; padding-right: 5.75pt; padding-left: 5.75pt"><b>Annual Expenses</b></td>
    <td style="vertical-align: bottom; width: 40%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>As a Percentage of Average Net Assets Attributable to Common Shares<span style="font-size: 8.5pt"><sup>(4)</sup></span></b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Management fees<span style="font-size: 8.5pt"><sup>(5)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_906_ecef--ManagementFeesPercent_c20251121__20251121_fKDQpICg1KQ_____zfKKvMdVxobj">1.21%</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Acquired fund fees and expenses<sup>(6)</sup></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_908_ecef--AcquiredFundFeesAndExpensesPercent_c20251121__20251121_fKDQpICg2KQ_____za6zbiqFfCJ7">0.05%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Interest expenses<span style="font-size: 8.5pt"><sup>(7)</sup></span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90E_ecef--InterestExpensesOnBorrowingsPercent_c20251121__20251121_fKDQpICg3KQ_____zebqI9YnDV3g">1.08%</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Other expenses<span style="font-size: 8.5pt"><sup>(8)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90D_ecef--OtherAnnualExpensesPercent_c20251121__20251121_fKDQpICg4KQ_____zl8YdKj8vxs8">0.10%</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">Total annual expenses<sup>(9)</sup></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_901_ecef--TotalAnnualExpensesPercent_c20251121__20251121_fKDkp_z3N7wjCi6Bg2">2.44%</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ManagementFeesPercent', window );">Management Fees [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[5]</sup></td>
<td class="nump">1.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InterestExpensesOnBorrowingsPercent', window );">Interest Expenses on Borrowings [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[6]</sup></td>
<td class="nump">1.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_AcquiredFundFeesAndExpensesPercent', window );">Acquired Fund Fees and Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[7]</sup></td>
<td class="nump">0.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesAbstract', window );"><strong>Other Annual Expenses [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OtherAnnualExpensesPercent', window );">Other Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4],[8]</sup></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_TotalAnnualExpensesPercent', window );">Total Annual Expenses [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="nump">2.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleTableTextBlock', window );">Expense Example [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">As required by relevant SEC regulations, the
following example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#8220;Total annual
expenses&#8221; of 2.44% of net assets attributable to Common Shares and (2) a 5% annual return*:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 56%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>1 Year</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>3 Years</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>5 Years</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>10 Years</b></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Total Annual Expense Paid by Common Shareholders</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90A_ecef--ExpenseExampleYear01_c20251121__20251121_fKCop_zxndvVx0QlR1">$25</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_901_ecef--ExpenseExampleYears1to3_c20251121__20251121_fKCop_zd3IUPNP5Oy9">$76</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_906_ecef--ExpenseExampleYears1to5_c20251121__20251121_fKCop_zvSbJWqyJnU8">$130</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90B_ecef--ExpenseExampleYears1to10_c20251121__20251121_fKCop_z3yX9gJWOFyh">$277</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYear01', window );">Expense Example, Year 01</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to3', window );">Expense Example, Years 1 to 3</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to5', window );">Expense Example, Years 1 to 5</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_ExpenseExampleYears1to10', window );">Expense Example, Years 1 to 10</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[10]</sup></td>
<td class="nump">$ 277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_PurposeOfFeeTableNoteTextBlock', window );">Purpose of Fee Table , Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of May 31, 2025. The following table should not be considered a representation of the Fund&#8217;s future expenses. Actual expenses
may be greater or less than shown. The following table shows estimated Fund expenses as a percentage of average net assets attributable
to Common Shares, and not as a percentage of Managed Assets. See &#8220;Management of the Fund.&#8221;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_BasisOfTransactionFeesNoteTextBlock', window );">Basis of Transaction Fees, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">as a percentage of offering price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_FinancialHighlightsAbstract', window );"><strong>Financial Highlights [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SeniorSecuritiesNoteTextBlock', window );">Senior Securities, Note [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">For information about the Fund&#8217;s senior
securities as of the end of the last ten fiscal years, please refer to the section of the<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Other Information (unaudited)&#8212;Senior Securities&#8221;
which is incorporated by reference herein. Information regarding the Fund&#8217;s senior securities is also contained in the Financial
Highlights in the Fund&#8217;s most recent annual report on Form N-CSR, which has been audited by Ernst &amp; Young LLP for the last five
fiscal years. The Fund&#8217;s audited financial statements, including the report of Ernst &amp; Young LLP thereon and accompanying notes
thereto, are included in the Fund&#8217;s most recent annual report to shareholders and incorporated by reference in the SAI. A copy of
the report is available upon request and without charge by calling (888) 991-0091 or by writing the Fund at 227 West Monroe Street, Chicago,
Illinois 60606.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_InvestmentObjectivesAndPracticesTextBlock', window );">Investment Objectives and Practices [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Investment Objective<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Investment Objective,&#8221; which is
incorporated by reference herein, for a discussion of the investment objective of the Fund.</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Policies</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Principal Investment Strategies and Portfolio
Composition</span><span style="font-weight: normal">&#8212;Investment Policies<span style="color: windowtext">&#8221; which is incorporated
by reference herein, for a discussion of the investment policies of the Fund. With respect to the Fund&#8217;s policies relating to rated
fixed-income securities, please refer to Appendix A to the SAI for more information regarding Moody&#8217;s and S&amp;P&#8217;s ratings.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><span style="color: windowtext">Rating agencies, such as Moody&#8217;s or S&amp;P, are private services that provide ratings of the credit quality of debt obligations.
Ratings assigned by an NRSRO are not absolute standards of credit quality but represent the opinion of the NRSRO as to the quality of
the obligation. Ratings do not evaluate market risks or the liquidity of securities. Rating agencies may fail to make timely changes in
credit ratings and an issuer&#8217;s current financial condition may be better or worse than a rating indicates. To the extent that the
issuer of a security pays an NRSRO for the analysis of its security, an inherent conflict of interest may exist that could affect the
reliability of the rating. Ratings are relative and subjective and, although ratings may be useful in evaluating the safety of interest
and principal payments, they do not evaluate the market value risk of such obligations. Although these ratings may be an initial criterion
for selection of portfolio investments, the Sub-Adviser also will independently evaluate these securities and the ability of the issuers
of such securities to pay interest and principal. To the extent that the Fund invests in unrated lower grade securities, the Fund&#8217;s
ability to achieve its investment objective will be more dependent on the Sub-Adviser&#8217;s credit analysis than would be the case when
the Fund invests in rated securities.</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Principal Investment Strategies</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund pursues a relative value-based investment
philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate
from their perceived fair value and/or historical norms. The Sub-Adviser seeks to combine a credit managed fixed-income portfolio with
access to a diversified pool of alternative investments and equity strategies. The Fund&#8217;s investment philosophy is predicated</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> upon
the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform benchmark
indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s analysis of a fixed-income
security&#8217;s credit quality is comprised of multiple elements, including, but not limited to: (i) sector analysis, including regulatory
developments and sector health, (ii) collateral, business, and counterparty risk, which includes payment history, collateral performance,
and borrower credit profile, (iii) structural analysis, which includes securitization structure review and forms of credit enhancement,
and (iv) stress analysis, including historical collateral performance during extreme market stress and identifying tail risks. This analysis
is applied against the macroeconomic outlook, geopolitical issues as well as considerations that more directly affect the company&#8217;s
industry to determine the Sub-Adviser&#8217;s internal judgment as to the security&#8217;s credit quality. In addition to the process
described above, the Sub-Adviser selects securities using a rigorous portfolio construction approach designed to tightly control independent
risk exposures such as fixed income sector weights, sector specific yield curves, credit spreads, prepayment risks, and other risk exposures
the Sub-Adviser deems relevant. Within those risk constraints, the Sub-Adviser estimates the relative value of different securities to
select individual securities that, in the Sub-Adviser&#8217;s judgment, may provide risk-adjusted outperformance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser&#8217;s process for determining
whether to buy or sell a security is a collaborative effort between various groups including: (i) economic research, which focus on key
economic themes and trends, regional and country-specific analysis, and assessments of event-risk and policy impacts on asset prices,
(ii) the Portfolio Construction Group, which utilizes proprietary portfolio construction and risk modeling tools to determine allocation
of assets among a variety of sectors, (iii) its Sector Specialists, who are responsible for identifying investment opportunities in particular
securities within these sectors, including the structuring of certain securities directly with the issuers or with investment banks and
dealers involved in the origination of such securities, and (iv) portfolio managers, who determine which securities best fit the Fund
based on the Fund&#8217;s investment objective and top-down sector allocations. In managing the Fund, the Sub-Adviser uses a process for
selecting securities for purchase and sale that is based on intensive credit research and involves extensive due diligence on each issuer,
region and sector. The Sub-Adviser also considers macroeconomic outlook and geopolitical issues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Sub-Adviser generally decides which securities
to sell for the Fund based on one of three factors:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>In the Sub-Adviser&#8217;s judgment, the relative value measure of the instrument no longer indicates that the instrument is cheap
relative to similar instruments and a substitution of the instrument with a similar but cheaper instrument enhances the risk-adjusted
return potential of the portfolio.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental analysis suggests that the embedded credit risk in an instrument has increased and the instrument
no longer properly compensates the holder for this increased risk.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>The Sub-Adviser&#8217;s fundamental sector allocation decisions result in the rebalancing of existing positions to achieve the Sub-Adviser&#8217;s
desired sector exposures.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"><b>Additional Information About
the Fund&#8217;s Principal Investment Strategies &amp; Portfolio Composition</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>In seeking to achieve its investment objective,
the Fund will or may ordinarily invest in, among other investment categories, the following categories of investments:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Income Securities Strategy. </i>The Fund seeks
to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#8220;Income
Securities&#8221;) selected from a variety of sectors and credit qualities. The Fund may invest in non-U.S. dollar-denominated Income Securities issued by sovereign entities and corporations, including Income
Securities of issuers in emerging market countries. The Fund may invest in Income Securities of any credit quality,
including, without limitation, Income Securities rated below-investment grade (commonly referred to as &#8220;high-yield&#8221; or &#8220;junk&#8221;
bonds), which are considered speculative with respect to the issuer&#8217;s capacity to pay interest and repay principal. The sectors
and types of Income Securities in which the Fund may invest, include, but are not limited to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Corporate bonds;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Loans and loan participations (including senior secured floating rate loans, &#8220;second lien&#8221; secured floating rate loans, and other types of secured and unsecured loans with fixed and variable interest rates, including &#8220;debtor-in-possession&#8221; financings) (collectively, &#8220;Loans&#8221;);</td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Structured finance investments (including residential and commercial mortgage-related securities, asset- backed securities, collateralized debt obligations and risk-linked securities);</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">U.S. government and agency securities and sovereign or supranational debt obligations;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Mezzanine and preferred securities; and</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
  <tr style="vertical-align: top">
    <td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"><span style="font-size: 12pt">&#8226;</span></td>
    <td style="width: 7px">&#160;</td>
    <td style="padding-bottom: 6pt; text-indent: 0in">Convertible securities.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Debt Overlay Strategy. </i>As part of its
Income Securities strategy, the Fund may employ a strategy of investing in a basket of debt securities and other instruments (the &#8220;Debt
Overlay Basket&#8221;) and writing (selling) out-of-the-money call options (i.e., call options for which the current price of the underlying
asset is below the strike price) or near at-the-money call options (i.e., call options for which the current price of the underlying asset
is close to the strike price) on a fixed-income ETF (the &#8220;Underlying Bond ETF&#8221;) in an amount that creates a notional exposure
approximately equal to the investment exposure created by the Debt Overlay Basket (the &#8220;Debt Overlay Strategy&#8221;). The Debt
Overlay Strategy is intended to generate current income in the form of options premiums.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The composition of the Debt Overlay Basket and
the Underlying Bond ETF are expected to be generally similar (i.e., a portfolio of high yield corporate bonds), although they would have
differences. The Fund considers an ETF to be eligible to be an Underlying Bond ETF for purposes of the Debt Overlay Strategy when the
ETF is passively managed and consists of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. or if the ETF is designed
to track an index (or subset thereof) that provides a representation of the U.S. dollar-denominated high yield corporate bond market.
GPIM seeks to select investments for the Debt Overlay Basket with the objective of constructing a Debt Overlay Basket that is designed
to achieve, before fees and expenses, returns that exceed those of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Debt Overlay Basket is intended
to outperform the Underlying Bond ETF (and the performance of the Debt Overlay Basket is otherwise intended to generally be correlated
with that of the Underlying Bond ETF), the options sold as part of the Debt Overlay Strategy are not intended to be &#8220;covered,&#8221;
meaning that the Fund will generally not hold shares in the Underlying Bond ETF as part of the Debt Overlay Strategy (or have an absolute
and immediate right to purchase the Underlying Bond ETF&#8217;s shares) in the amount necessary to meet the Fund&#8217;s contingent obligation
to deliver cash or shares of the Underlying Bond ETF to the Fund&#8217;s options counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Equity Securities and Covered Call
Options Strategy. </i>The Fund may also invest in common stocks, limited liability company interests, trust certificates and other equity
investments (&#8220;Common Equity Securities&#8221;) that the Sub-Adviser believes offer attractive yield and/or capital appreciation
potential. As part of its Common Equity Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered
call options and may, from time to time, buy or sell put options on individual Common Equity Securities. In addition to its covered call
option strategy, the Fund may, to a lesser extent, pursue a strategy that includes the sale (writing) of both covered call and put options
on indices of securities and sectors of securities. This covered call option strategy is intended to generate current gains from option
premiums as a means to generate total returns as well as to enhance distributions payable to the Common Shareholders. As the Fund writes
covered calls over more of its portfolio, its ability to benefit from capital appreciation becomes more limited. As part of Common Equity
Securities strategy, the Fund may not sell &#8220;naked&#8221; call options on individual Common Equity securities. A substantial portion
of the options written by the Fund may be over-the-counter options (&#8220;OTC options&#8221;). Under current market conditions, the Fund
implements its covered call writing strategy primarily by investing in exchange-traded funds (&#8220;ETFs&#8221;) or index futures which
provide exposure to Common Equity Securities and writing covered call options on those ETFs or index futures, and the Fund may also write
call options on individual securities, securities indices, ETFs futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Autocallable ELN Strategy.</i> The
Fund may employ a synthetic autocallable equity linked-note (&#8220;ELN&#8221;) strategy designed to generate current income based on
equity market performance rather than traditional fixed income and credit factors, such as duration and interest rates (the &#8220;Synthetic
Autocallable ELN Strategy&#8221;). The Synthetic Autocallable ELN Strategy is designed to convert equity market performance into an income
source, which may provide the potential for higher income than traditional fixed income assets and which exposes the Fund to risks such
as those associated with the autocallable structure and equity markets such as market downturns interrupting coupon payments or resulting
in principal loss as described below. As part of the Synthetic Autocallable </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">ELN Strategy, the Fund intends to synthetically replicate
exposure similar to autocallable ELNs by investing in derivatives instruments, such as swaps (&#8220;Synthetic Autocallable Contracts&#8221;),
and will typically not invest directly in autocallable ELNs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An autocallable ELN (i.e., the instrument that
the Fund intends to synthetically replicate by investing in derivatives instruments) is a debt instrument with coupon payments (i.e.,
income) made at regular intervals and linked to equity market performance. The autocallable ELNs that the Fund seeks to replicate synthetically,
as further described below, are typically linked to one or more broad-based equity market indexes (e.g., the S&amp;P 500 Index, Russell
2000 Index, or &#8220;worst of&#8221; two or more indices) (the &#8220;Autocallable ELN Reference Index&#8221;). These autocallable ELNs
provide coupon payments at predefined intervals (which may be deferred to maturity) so long as the value of the Autocallable ELN Reference
Index does not fall below certain prescribed thresholds at specified dates. In such circumstances, the autocallable ELNs would be automatically
called (i.e., cancelled without further coupon payments and with principal returned) or no coupon payment will be made, respectively.
Autocallable ELNs may also provide for the return of a reduced amount of principal when the Autocallable ELN Reference Index falls below
a certain prescribed threshold at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable Contracts are designed
to provide exposure similar to autocallable ELNs, with the value of the Autocallable ELN Reference Index at the beginning of the Synthetic
Autocallable Contract defining when a contract is automatically called, when the counterparty will make its coupon payment(s) for such
period, when no coupon payments are made for such period and a &#8220;Maturity Barrier&#8221; (as defined below) below which the Fund
would be exposed to a loss corresponding to a reduced return of principal. A Synthetic Autocallable Contract is a bespoke product agreed
to between the Fund as &#8220;buyer&#8221; and its counterparty as &#8220;seller". The description below is generally representative
of Synthetic Autocallable Contracts, but the Fund&#8217;s Synthetic Autocallable Contracts may be structured differently. Additionally,
notwithstanding the description below, the Fund&#8217;s Synthetic Autocallable Contracts will typically provide for a single net payment
at maturity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">At each payment date, the buyer will owe to the
Synthetic Autocallable Contract counterparty a financing amount based on a financing rate (which may be a fixed rate or otherwise). At
any payment date prior to the final scheduled payment date, the buyer will receive scheduled coupon payments and potentially an early
principal payment (as applicable, a &#8220;Coupon Payment&#8221; and a &#8220;Principal Payment&#8221;) net of the financing amount owed
to the counterparty, subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Autocall Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index reaches or exceeds
a certain level, typically the initial value of the Autocallable ELN Reference Index at the time of the Synthetic Autocallable Contract
(the &#8220;Autocall Barrier"), then the Synthetic Autocallable Contract will automatically terminate early and the buyer will receive
both a Coupon Payment for the observation period and the Principal Payment, but will not receive future Coupon Payments for that Synthetic
Autocallable Contract.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Coupon Zone</i>. If on a specified observation date the price level of the Autocallable ELN Reference Index equals or exceeds a
certain level (the &#8220;Coupon Barrier&#8221;) but is below the Autocall Barrier, the buyer will receive a Coupon Payment for the observation
period. The Synthetic Autocallable Contract will not automatically terminate early (and the buyer will not receive an early Principal
Payment).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>No-Coupon Zone</i>. If on a specified observation date the price level of the Synthetic Autocallable Contract Reference Index is
below the Coupon Barrier, the buyer will not receive a Coupon Payment for the observation period (such unpaid coupon, a &#8220;Missed
Coupon&#8221;), but the buyer would still be obligated to pay the financing amount to the counterparty. Certain Synthetic Autocallable
Contracts may have memory features in which the buyer may receive a Missed Coupon if the price level of the Synthetic Autocallable ELN
Reference Index equals or exceeds the Coupon Barrier at a subsequent observation date.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If the Synthetic Autocallable Contract has not
been terminated early, then at the maturity date of the Synthetic Autocallable Contract, the buyer will receive a Principal Payment and
Coupon Payment subject to the following structure:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Full Principal Zone</i>. If on the final specified observation date the price level of the Autocallable ELN Reference Index is
above a certain level (the &#8220;Maturity Barrier&#8221;), which may be the same as the Coupon Barrier, the buyer will receive the scheduled
Principal Payment.</td></tr></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td><i>Reduced Principal Zone</i>. If on the final specified observation date/maturity date the price level of the Autocallable ELN Reference
Index is below the Maturity Barrier, the buyer will receive a reduced Principal Payment, which will result in losses to the buyer.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Real Property Asset Companies. </i>The Fund
may invest in Income Securities and Common Equity Securities issued by companies that own, produce, refine, process, transport and market
&#8220;real property assets,&#8221; such as real estate and the natural resources upon or within real estate (&#8220;Real Property Asset
Companies&#8221;). These Real Property Asset Companies include:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real
estate (or that have assets primarily invested in such real estate), including real estate investment trusts (&#8220;REITs&#8221;); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Companies engaged in energy, natural resources and basic materials businesses and companies engaged in associated businesses. These
companies include, but are not limited to, those engaged in businesses such as oil and gas exploration and production, gold and other
precious metals, steel and iron ore production, energy services, forest products, chemicals, coal, alternative energy sources and environmental
services, as well as related transportation companies and equipment manufacturers.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Personal Property Asset Companies. </i>The
Fund may invest in Income Securities and Common Equity Securities issued by companies that seek to profit primarily from the ownership,
rental, leasing, financing or disposition of personal (as opposed to real) property assets (&#8220;Personal Property Asset Companies&#8221;).
Personal (as opposed to real) property includes any tangible, movable property or asset. The Fund will typically seek to invest in Income
Securities and Common Equity Securities of Personal Property Asset Companies the investment performance of which is not expected to be
highly correlated with traditional market indexes because the personal property asset held by such company is non-correlated with traditional
debt or equity markets. Such personal property assets include special situation transportation assets (e.g., railcars, airplanes and ships)
and collectibles (e.g., antiques, wine and fine art).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Private Securities. </i>The Fund may invest
in privately issued Income Securities and Common Equity Securities of both public and private companies (&#8220;Private Securities&#8221;),
including those issued on a private placement basis pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities
Act&#8221;), or securities eligible for resale pursuant to Rule 144A thereunder. Private Securities have additional risk considerations
in addition to those of comparable public securities, including the availability of financial information about the issuer and valuation
and liquidity issues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><i>Investment Funds. </i>As an alternative to holding
investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities by investing in other
investment companies, including registered investment companies, private investment funds and/or other pooled investment vehicles (collectively,
&#8220;Investment Funds&#8221;), which may be managed by the Investment Adviser, Sub-Adviser and/or their affiliates. The Fund may invest
up to 30% of its total assets in Investment Funds that primarily hold (directly or indirectly) investments in which the Fund may invest
directly. The 1940 Act generally limits a registered investment company&#8217;s investments in other registered investment companies to
10% of its total assets. However, pursuant to exemptions set forth in the 1940 Act and rules and regulations promulgated under the 1940
Act, the Fund may invest in excess of this and other applicable limitations provided that the conditions of such exemptions are met. The
Fund will invest in private investment funds, commonly referred to as &#8220;hedge funds,&#8221; or &#8220;private equity funds&#8221;
(including &#8220;single asset continuation funds&#8221;) only to the extent permitted by applicable rules, regulations and interpretations
of the SEC and the NYSE. The Fund may invest up to the lower of 10% of its total assets or 15% of its net assets, measured at the time
of investment, in private investment funds that provide exposure to Common Equity Securities of private companies (i.e., exposure to private
equity investments). Investments in other Investment Funds involve operating expenses and fees at the Investment Fund level that are in
addition to the expenses and fees borne by the Fund and are borne indirectly by holders of the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Synthetic Investments. </i>As an alternative
to holding investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities through
the use of customized derivative instruments (including swaps, options, forwards, futures (including, but not limited to, futures on rates
such as Secured Overnight Financing Rate (&#8220;SOFR&#8221;), securities, indices, currencies and other investments) or other financial
instruments) to seek to replicate, modify or replace the economic attributes associated with an investment in Income Securities and Common
Equity Securities (including interests in Investment Funds). The Fund may be</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> exposed to certain additional risks to the extent the Sub-Adviser
uses derivatives as a means to synthetically implement the Fund&#8217;s investment strategies, including a lack of liquidity in such derivative
instruments and additional expenses associated with using such derivative instruments. If the Fund enters into a derivative instrument
whereby it agrees to receive the return of a security or financial instrument or a basket of securities or financial instruments, it will
typically contract to receive such returns for a predetermined period of time. During such period, the Fund may not have the ability to
increase or decrease its exposure. In addition, such customized derivative instruments will likely be highly illiquid, and it is possible
that the Fund will not be able to terminate such derivative instruments prior to their expiration date or that the penalties associated
with such a termination might impact the Fund&#8217;s performance in a material adverse manner. Furthermore, certain derivative instruments
contain provisions giving the counterparty the right to terminate the contract upon the occurrence of certain events. Such events may
include a decline in the value of the reference securities and material violations of the terms of the contract or the portfolio guidelines
as well as other events negotiated between the parties. If a termination were to occur, the Fund&#8217;s return could be adversely affected
as it would lose the benefit of the indirect exposure to the reference securities and it may incur significant termination expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In the event the Fund seeks to obtain investment
exposure to Investment Funds (including private investment funds) through the use of such synthetic derivative instruments, the Fund will
not acquire any voting interests or other shareholder rights that would be acquired with a direct investment in the underlying Investment
Fund. Accordingly, the Fund will not participate in matters submitted to a vote of the shareholders. In addition, the Fund may not receive
all of the information and reports to shareholders that the Fund would receive with a direct investment in such Investment Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Further, the Fund will pay the counterparty to
any such customized derivative instrument structuring fees and ongoing transaction fees, which will reduce the investment performance
of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Finally, certain tax aspects of such customized
derivative instruments are uncertain and a Common Shareholder&#8217;s return could be adversely affected by an adverse tax ruling.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><b>Portfolio Contents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>The Fund&#8217;s investment portfolio consists
of investments in the following types of securities:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Corporate Bonds. </i>Corporate bonds are debt
obligations issued by corporations and other business entities. Corporate bonds may be either secured or unsecured. Collateral used for
secured debt includes, but is not limited to, real property, machinery, equipment, accounts receivable, stocks, bonds or notes. If a bond
is unsecured, it is known as a debenture. Bondholders, as creditors, have a priority legal claim over common and preferred stockholders as
to both income and assets of the corporation for the principal and interest due them and may have a prior claim over other creditors if
liens or mortgages are involved. Interest on corporate bonds may be fixed or floating, or the bonds may be zero coupons. Interest on corporate
bonds is typically paid semi-annually and is fully taxable to the bondholder. Corporate bonds contain elements of both interest-rate risk
and credit risk and are subject to the risks associated with Income Securities, among other risks. The market value of a corporate bond
generally is expected to rise and fall inversely with interest rates and be affected by the credit rating of the corporation, the corporation&#8217;s
performance and perceptions of the corporation in the marketplace. <i>Investment Grade Bonds. </i>The Fund may invest in a wide variety
of fixed-income, floating or variable rate securities rated or determined by the Sub-Adviser to be investment grade quality that are issued
by corporations and other non-governmental entities and issuers (&#8220;Investment Grade Bonds&#8221;). Investment Grade Bonds are subject
to market and credit risk. Market risk relates to changes in a security&#8217;s value. Investment Grade Bonds have varying levels of sensitivity
to changes in interest rates and varying degrees of credit quality. In general, bond prices rise when interest rates fall, and fall when
interest rates rise. Longer-term and zero coupon bonds are generally more sensitive to interest rate changes. Credit risk relates to the
ability of the issuer to make payments of principal and interest. The values of Investment Grade Bonds, like those of other fixed-income
securities, may be affected by changes in the credit rating or financial condition of an issuer. Investment Grade Bonds are generally
considered medium- and high-quality securities. Some, however, may possess speculative characteristics, and may be more sensitive to economic
changes and changes in the financial condition of issuers. The market prices of Investment Grade Bonds in the lowest investment grade
categories may fluctuate more than higher-quality securities and may decline significantly in periods of general or regional economic
difficulty or other adverse issuer-specific or market developments. Investment Grade Bonds in the lowest investment grade categories may
be thinly traded, making them difficult to sell promptly at an acceptable price. Investment Grade Bonds include certain investment grade
quality mortgage-related securities, asset-backed </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">securities, and other hybrid securities and instruments that are treated as debt obligations
for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Below-Investment Grade Bonds. </i>The Fund
may invest without limitation in a wide variety of fixed-income securities that are rated or determined by the Sub-Adviser to be below-investment
grade quality (&#8220;Below-Investment Grade Bonds&#8221;). The credit quality of most Below-Investment Grade Bonds reflects a greater
than average possibility that adverse changes in the financial condition of an issuer, or in general economic conditions, or both, may
impair the ability of the issuer to make payments of interest and principal. The inability (or perceived inability) of issuers to make
timely payment of interest and principal would likely make the values of Below-Investment Grade Bonds held by the Fund more volatile and
could limit the Fund&#8217;s ability to sell such Bonds at favorable prices. In the absence of a liquid trading market for its Below-Investment
Grade Bonds, the Fund may have difficulties determining the fair market value of such investments. Below-Investment Grade Bonds include
certain below-investment grade quality mortgage-related securities, asset-backed securities, and other hybrid securities and instruments
that are treated as debt obligations for U.S. federal income tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition to pre-existing outstanding debt
obligations of below-investment grade issuers, the Fund may also invest in &#8220;debtor-in-possession&#8221; or &#8220;DIP&#8221; financings
newly issued in connection with &#8220;special situation&#8221; restructuring and refinancing transactions. DIP financings are Loans to
a debtor-in-possession in a proceeding under the U.S. Bankruptcy Code that have been approved by the bankruptcy court. DIP financings
are typically fully secured by a lien on the debtor&#8217;s otherwise unencumbered assets or secured by a junior lien on the debtor&#8217;s
encumbered assets (so long as the Loan is fully secured based on the most recent current valuation or appraisal report of the debtor).
The bankruptcy court can authorize the debtor to grant the DIP lender a claim with super-priority over administrative expenses incurred
during bankruptcy and of other claims, thus a DIP financing may constitute senior debt even if not secured. DIP financings are often required
to close with certainty and in a rapid manner in order to satisfy existing creditors and to enable the issuer to emerge from bankruptcy
or to avoid a bankruptcy proceeding. These financings allow the entity to continue its business operations while reorganizing under Chapter
11 of the U.S. Bankruptcy Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Distressed and Defaulted Securities. </i>The
Fund may invest in the securities of financially distressed and bankrupt issuers. Such debt obligations may be in covenant or payment
default. Such investments generally trade significantly below par and are considered speculative. The repayment of defaulted obligations
is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy workout or bankruptcy proceedings, during
which the issuer might not make any interest or other payments. Typically such workout or bankruptcy proceedings result in only partial
recovery of cash payments or an exchange of the defaulted obligation for other debt or equity securities of the issuer or its affiliates,
which may in turn be illiquid or speculative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Structured Finance Investments. </i>The Fund
may invest in structured finance investments, which are Income Securities and Common Equity Securities typically issued by special purpose
vehicles that hold income-producing securities (e.g., mortgage loans, consumer debt payment obligations and other receivables) and other
financial assets. Structured finance investments are designed to meet certain financial goals of investors. Typically, these investments
provide investors with the potential for capital protection, income generation and/or the opportunity to generate capital growth. The
Sub-Adviser believes that structured finance investments may provide attractive risk-adjusted returns, frequent sector rotation opportunities
and prospects for adding value through security selection. For purposes of the Fund&#8217;s investment policies, structured finance investments
are not deemed to be &#8220;private investment funds&#8221; (as discussed below). Structured finance investments primarily include (among
others):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Mortgage-Related Securities</span>. Mortgage-related securities
are a form of derivative collateralized by pools of commercial or residential mortgages. Pools of mortgage loans are assembled as securities
for sale to investors by various governmental, government-related and private organizations. These securities may include complex instruments
such as collateralized mortgage obligations, REITs (including debt and preferred stock issued by REITs), and other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates, and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential and
commercial mortgage-related securities issued by governmental entities (i.e., agency mortgage-related securities) and private issuers
(i.e. non-agency mortgage-related securities), including subordinated mortgage-related securities. The underlying assets of certain mortgage-related
securities are subject to prepayments, which shorten the weighted average maturity and may lower the</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> return of such securities, and extension,
which lengthens expected maturity as payments on principal may occur at a slower rate or later than expected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Asset-Backed Securities</span>. Asset-backed securities (&#8220;ABS&#8221;)
are a form of structured debt obligation. ABS are payment claims that are securitized in the form of negotiable paper that is issued by
a financing company (generally called a special purpose vehicle). Collateral assets are brought into a pool according to specific diversification
rules. A special purpose vehicle is founded for the purpose of securitizing these payment claims and the assets of the special purpose
vehicle are the diversified pool of collateral assets. The special purpose vehicle issues marketable securities that are intended to represent
a lower level of risk than an underlying collateral asset individually, due to the diversification in the pool. The redemption of the
securities issued by the special purpose vehicle takes place out of the cash flow generated by the collected assets. A special purpose
vehicle may issue multiple securities with different priorities to the cash flows generated and the collateral assets. The collateral
for ABS may include, among other assets, home equity loans, automobile and credit card receivables, boat loans, computer leases, airplane
leases, mobile home loans, recreational vehicle loans and hospital account receivables. The Fund may invest in these and other types of
ABS that may be developed in the future. There is the possibility that recoveries on the underlying collateral may not, in some cases,
be available or may be insufficient to support payments on these securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Collateralized Debt Obligations</span>. A collateralized debt
obligation (&#8220;CDO&#8221;) is an asset-backed security whose underlying collateral is typically a portfolio of bonds, bank loans,
other structured finance securities and/or synthetic instruments. Where the underlying collateral is a portfolio of bonds, a CDO is referred
to as a collateralized bond obligation (&#8220;CBO&#8221;). Where the underlying collateral is a portfolio of bank loans, a CDO is referred
to as a collateralized loan obligation (&#8220;CLO&#8221;). Investors in CBOs and CLOs bear the credit risk of the underlying collateral.
Multiple tranches of securities are issued by the CLO, offering investors various maturity and credit risk characteristics. Tranches are
categorized as senior, mezzanine, and subordinated/ equity, according to their degree of risk. If there are defaults or the CLO&#8217;s
collateral otherwise underperforms, scheduled payments to senior tranches take precedence over those of mezzanine tranches, and scheduled
payments to mezzanine tranches take precedence over those to subordinated/equity tranches. This prioritization of the cash flows from
a pool of securities among the several tranches of the CLO is a key feature of the CLO structure. If there are funds remaining after each
tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar
covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#8220;equity&#8221; tranche). </p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#8217;s indenture. These provisions
are referred to as the &#8220;priority of payments&#8221; or the &#8220;waterfall&#8221; and determine the terms of payment of any other
obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition,
for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which
are different for each CLO. If a CLO breaches one of these tests excess cash flow that would otherwise be available for distribution to
the subordinated tranche investors is diverted to prepay CLO debt investors in order of seniority until such time as the covenant breach
is cured. If the covenant breach is not or cannot be cured, the subordinated tranche investors (and potentially other investors in lower
priority rated tranches) may experience a partial or total loss of their investment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">CLOs are subject to the same risk of prepayment and
extension described with respect to certain mortgage-related and asset-backed securities. The value of CLOs may be affected by, among
other developments, changes in the market&#8217;s perception of the creditworthiness of the servicing agent for the pool, the originator
of the pool, or the financial institution or fund providing the credit support or enhancement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The Fund may invest in senior, rated tranches as well as mezzanine
and subordinated tranches of CLOs. Investment in the subordinated tranche is subject to additional risks. The subordinated tranche does
not receive ratings and is considered the riskiest portion of the capital structure of a CLO because it bears the bulk of defaults from
the loans in the CLO and serves to protect the other, more senior tranches from default in many but not all circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="text-decoration: underline">Risk-Linked Securities</span>. Risk-linked securities (&#8220;RLS&#8221;)
are a form of derivative issued by insurance companies and insurance-related special purpose vehicles that apply securitization techniques
to catastrophic property and casualty damages. RLS are typically debt obligations for which the return of principal and the payment of
interest are contingent on the non-occurrence of a pre-defined &#8220;trigger event.&#8221; Depending on the specific terms and structure
of the RLS, this trigger could be the result of a hurricane, earthquake or some other catastrophic event. Insurance companies securitize
this risk to transfer to the capital markets the truly catastrophic part of the risk exposure. A typical RLS provides for income and return
of capital similar to other fixed-income investments, but would involve full or partial default if losses resulting from a certain catastrophe
exceeded a predetermined amount. RLS typically have relatively high yields compared with similarly rated fixed-income securities, and
also have low correlation with the returns of traditional securities. The Sub-Adviser believes that inclusion of RLS in the Fund&#8217;s
portfolio could lead to significant improvement in its overall risk-return profile. Investments in RLS may be linked to a broad range
of insurance risks, which can be broken down into three major categories: natural risks (such as hurricanes and earthquakes), weather
risks (such as insurance based on a regional average temperature) and non-natural events (such as aerospace and shipping catastrophes).
Accordingly, depending on the specific terms and structure of the RLS, this trigger could be the result of a hurricane, earthquake or
some other</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"> catastrophic event. Although property-casualty RLS have been in existence for over a decade, significant developments have
started to occur in securitizations done by life insurance companies. In general, life insurance industry securitizations could fall into
a number of categories. Some are driven primarily by the desire to transfer risk to the capital markets, such as the transfer of extreme
mortality risk (mortality bonds). Others, while also including the element of risk transfer, are driven by other considerations. For example,
a securitization could be undertaken to relieve the capital strain on life insurance companies caused by the regulatory requirements of
establishing very conservative reserves for some types of products. Another example is the securitization of the stream of future cash
flows from a particular block of business, including the securitization of embedded values of life insurance business or securitization
for the purpose of funding acquisition costs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Senior Loans. </i>Senior Loans are floating
rate Loans made to corporations and other non-governmental entities and issuers. Senior Loans typically hold the most senior position
in the capital structure of the issuing entity, are typically secured with specific collateral and typically have a claim on the assets
of the borrower, including stock owned by the borrower in its subsidiaries, that is senior to that held by junior lien creditors, subordinated
debt holders and stockholders of the borrower. The proceeds of Senior Loans primarily are used to finance leveraged buyouts, recapitalizations,
mergers, acquisitions, stock repurchases, dividends, and, to a lesser extent, to finance internal growth and for other corporate purposes.
Senior Loans typically have rates of interest that are redetermined daily, monthly, quarterly or semi-annually by reference to a base
lending rate, plus a premium or credit spread. Base lending rates in common usage today are primarily SOFR, and secondarily the prime
rate offered by one or more major U.S. banks (the &#8220;Prime Rate&#8221;) and the certificate of deposit (&#8220;CD&#8221;) rate or
other base lending rates used by commercial lenders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Second Lien Loans. </i>Second Lien Loans are
Loans made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Second Lien Loans
are second in right of payment to one or more Senior Loans of the related borrower. Second Lien Loans typically are secured by a second
priority security interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the Loan and typically
have similar protections and rights as Senior Loans. Second Lien Loans are not (and by their terms cannot) become subordinate in right
of payment to any obligation of the related borrower other than Senior Loans of such borrower. Second Lien Loans, like Senior Loans, typically
have floating rate interest payments. Because Second Lien Loans are second to Senior Loans, they present a greater degree of investment
risk but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below-investment grade
quality. Other than their subordinated status, Second Lien Loans have many characteristics and risks similar to Senior Loans discussed
above. In addition, Second Lien Loans and debt securities of below-investment grade quality share many of the risk characteristics of
Non-Investment Grade Bonds.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Subordinated Secured Loans. </i>Subordinated
secured Loans are made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Subordinated
secured Loans may rank lower in right of payment to one or more Senior Loans and Second Lien Loans of the borrower. Subordinated secured
Loans typically are secured by a lower priority security interest or lien to or on specified collateral securing the borrower&#8217;s
obligation under the Loan, and typically have more subordinated protections and rights than Senior Loans and Second Lien Loans. Subordinated
secured Loans may become subordinated in right of payment to more senior obligations of the borrower issued in the future. Subordinated
secured Loans may have fixed or floating rate interest payments. Because Subordinated secured Loans may rank lower as to right of payment
than Senior Loans and Second Lien Loans of the borrower, they may present a greater degree of investment risk than Senior Loans and Second
Lien Loans but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below investment
grade quality. Other than their more subordinated status, such investments have many characteristics and risks similar to Senior Loans
and Second Lien Loans discussed above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Unsecured Loans. </i>Unsecured Loans are loans
made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Unsecured Loans generally
have lower priority in right of payment compared to holders of secured debt of the borrower. Unsecured Loans are not secured by a security
interest or lien to or on specified collateral securing the borrower&#8217;s obligation under the loan. Unsecured Loans by their terms
may be or may become subordinate in right of payment to other obligations of the borrower, including Senior Loans, Second Lien Loans and
Subordinated Secured Loans. Unsecured Loans may have fixed or floating rate interest payments. Because unsecured Loans are subordinate
to the secured debt of the borrower, they present a greater degree of investment risk but often pay interest at higher rates reflecting
this additional risk. Such investments generally are of below investment grade quality. Other than their subordinated and unsecured status,
</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">such investments have many characteristics and risks similar to Senior Loans, Second Lien Loans and Subordinated Secured Loans discussed
above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Mezzanine Investments. </i>The Fund may invest
in certain lower grade securities known as &#8220;Mezzanine Investments,&#8221; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Convertible Securities. </i>Convertible securities
include bonds, debentures, notes, preferred stocks and other securities that entitle the holder to acquire common stock or other equity
securities of the issuer. Convertible securities have general characteristics similar to both debt and equity securities. A convertible
security generally entitles the holder to receive interest or preferred dividends paid or accrued until the convertible security matures
or is redeemed, converted or exchanged. Before conversion, convertible securities have characteristics similar to non-convertible debt
obligations. Convertible securities rank senior to common stock in a corporation&#8217;s capital structure and, therefore, generally entail
less risk than the corporation&#8217;s common stock, although the extent to which such risk is reduced depends in large measure upon the
degree to which the convertible security sells above its value as a debt obligation. A convertible security may be subject to redemption
at the option of the issuer at a predetermined price. If a convertible security held by the Fund is called for redemption, the Fund would
be required to permit the issuer to redeem the security and convert it to underlying common stock, or would sell the convertible security
to a third party, which may have an adverse effect on the Fund&#8217;s ability to achieve its investment objective. The price of a convertible
security often reflects variations in the price of the underlying common stock in a way that non-convertible debt may not. The value of
a convertible security is a function of (i) its yield in comparison to the yields of other securities of comparable maturity and quality
that do not have a conversion privilege and (ii) its worth if converted into the underlying common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Stocks. </i>Preferred stocks represent
the senior residual interest in the assets of an issuer after meeting all claims, with priority to corporate income and liquidation payments
over the issuer&#8217;s common stock. As such, preferred stock is inherently more risky than the bonds and loans of the issuer, but less
risky than its common stock. Preferred stocks often contain provisions that allow for redemption in the event of certain tax or legal
changes or at the issuers&#8217; call. Preferred stocks typically do not provide any voting rights, except in cases when dividends are
in arrears beyond a certain time period. Preferred stock in some instances is convertible into common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although they are equity securities, preferred
stocks have certain characteristics of both debt and common stock. They are debt-like in that their promised income is contractually fixed.
They are common stock-like in that they do not have rights to precipitate bankruptcy proceedings or collection activities in the event
of missed payments. Furthermore, they have many of the key characteristics of equity due to their subordinated position in an issuer&#8217;s
capital structure and because their quality and value are heavily dependent on the profitability of the issuer rather than on any legal
claims to specific assets or cash flows. In order to be payable, dividends on preferred stock must be declared by the issuer&#8217;s board
of directors. In addition, distributions on preferred stock may be subject to deferral and thus may not be automatically payable. Income
payments on some preferred stocks are cumulative, causing dividends and distributions to accrue even if not declared by the board of directors
or otherwise made payable. Other preferred stocks are non-cumulative, meaning that skipped dividends and distributions do not continue
to accrue. There is no assurance that dividends on preferred stocks in which the Fund invests will be declared or otherwise made payable.
If the Fund owns preferred stock that is deferring its distributions, the Fund may be required to report income for U.S. federal income
tax purposes while it is not receiving cash payments corresponding to such income. When interest rates fall below the rate payable on
an issue of preferred stock or for other reasons, the issuer may redeem the preferred stock, generally after an initial period of call
protection in which the stock is not redeemable. Preferred stocks may be significantly less liquid than many other securities, such as
U.S. Government securities, corporate bonds and common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>U.S. Government Securities. </i>The Fund may
invest in debt securities issued or guaranteed by the U.S. government, its agencies or instrumentalities including: (1) U.S. Treasury
obligations, which differ in their interest rates, maturities and times of issuance, such as U.S. Treasury bills (maturity of one year
or less), U.S. Treasury notes (maturity of one to ten years), and U.S. Treasury bonds (generally maturities of greater than ten years),
including the principal components or the interest components issued by the U.S. government under the separate trading of registered interest
and principal securities program (i.e., &#8220;STRIPS&#8221;), all of which are backed by the full faith and</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> credit of the United States;
and (2) obligations issued or guaranteed by U.S. government agencies or instrumentalities, including government guaranteed mortgage-related
securities, some of which are backed by the full faith and credit of the U.S. Treasury, some of which are supported by the right of the
issuer to borrow from the U.S. government, and some of which are backed only by the credit of the issuer itself.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Securities. </i>While the Fund invests
primarily in securities of U.S. issuers, the Fund may invest up to 20% of its total assets in non-U.S. dollar-denominated fixed-income
securities of corporate and governmental issuers located outside the United States, including up to 10% in emerging markets. Foreign securities
include securities issued or guaranteed by companies organized under the laws of countries other than the United States and securities
issued or guaranteed by foreign governments, their agencies or instrumentalities and supra-national governmental entities, such as the
World Bank. Foreign securities also may be traded on foreign securities exchanges or in over-the-counter capital markets. The value of
foreign securities and obligations is affected by, among other factors, changes in currency rates, foreign tax laws (including withholding
tax), government policies (in this country or abroad), relations between nations and trading, settlement, custodial and other operational
risks. In addition, the costs of investing abroad are generally higher than in the United States, and foreign securities markets may be
less liquid, more volatile and less subject to governmental supervision than markets in the United States. Foreign investments also could
be affected by other factors not present in the United States, including expropriation, armed conflict, confiscatory taxation, lack of
uniform accounting and auditing standards, less publicly available financial and other information and potential difficulties in enforcing
contractual obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Since the Fund may invest in securities and obligations
that are denominated or quoted in currencies other than the U.S. dollar, the Fund may be affected by changes in foreign currency exchange
rates (and exchange control regulations) which affect the value of investments in the Fund and the accrued income and appreciation or
depreciation of the investments in U.S. dollars. Changes in foreign currency exchange rates relative to the U.S. dollar will affect the
U.S. dollar value of the Fund&#8217;s assets denominated in that currency and the Fund&#8217;s return on such assets as well as any temporary
uninvested reserves in bank deposits in foreign currencies. In addition, the Fund will incur costs in connection with conversions between
various currencies. The Fund may seek to hedge its exposures to foreign currencies but may, at the discretion of the Sub-Adviser, at any
time limit or eliminate foreign currency hedging activity. See &#8220;&#8212;Derivative Transactions&#8212;Foreign Currency Transactions.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Sovereign and Supranational Obligations. </i>The
Fund may invest in sovereign debt securities, which are debt securities issued or guaranteed by foreign governmental entities, such as
foreign government debt or foreign treasury bills. Investments in sovereign debt securities involve special risks in addition to those
risks usually associated with investments in debt securities, including risks associated with economic or political uncertainty and the
risk that the governmental authority that controls the repayment of sovereign debt may be unwilling or unable to repay the principal and/or
interest when due. The Fund may also invest in securities or other obligations issued or backed by supranational organizations, which
are international organizations that are designated or supported by government entities or banking institutions typically to promote economic
reconstruction or development. These obligations are subject to the risk that the government(s) on whose support the organization depends
may be unable or unwilling to provide the necessary support. With respect to both sovereign and supranational obligations, the Fund may
have little recourse against the foreign government or supranational organization that issues or backs the obligation in the event of
default. These obligations may be denominated in foreign currencies and the prices of these obligations may be more volatile than corporate
debt obligations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Sovereign debt instruments in which the Fund
may invest may involve great risk and may be deemed to be the equivalent in terms of credit quality to securities rated below investment
grade by Moody&#8217;s and S&amp;P. Governmental entities may depend on expected disbursements from foreign governments, multilateral
agencies and international organizations to reduce principal and interest arrearages on their debt obligations. The commitment on the
part of these governments, agencies and others to make such disbursements may be conditioned on a governmental entity&#8217;s implementation
of economic or other reforms and/or economic performance and the timely service of the governmental entity&#8217;s obligations. Failure
to implement such reforms, achieve such levels of economic performance or repay principal or interest when due may result in the cancellation
of the commitments to lend funds or other aid to the governmental entity, which may further impair the governmental entity&#8217;s ability
or willingness to service its debts in a timely manner. Some of the countries in which the Fund may invest have encountered difficulties
in servicing their sovereign debt obligations and have withheld payments of interest and/or principal of sovereign debt. These difficulties
have also led to agreements to restructure external debt obligations, which may result in costs to the holders of the sovereign debt.
Consequently, a government obligor may default on its obligations and/or the values of its obligations may decline significantly.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Common Stocks and Other Common Equity Securities.
</i>The Fund may also invest in common stocks and other Common Equity Securities that the Sub-Adviser believes offer attractive yield
and/or capital appreciation potential. Common stock represents the residual ownership interest in the issuer. Holders of common stocks
and other Common Equity Securities are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred stockholders are satisfied. The Fund may invest in companies of any market capitalization.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Options. </i>As part of its Common Equity
Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered call options and may, from time to time,
buy or sell put options on individual Common Equity Securities. In addition to its covered call option strategy, the Fund may, to a lesser
extent, pursue a strategy that includes the sale (writing) of both covered call and put options on indices of securities and sectors of
securities. This covered call option strategy is intended to generate current gains from option premiums as a means to generate total
returns as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. The Fund may also write call options and
put options on individual securities, securities indices, ETFs, futures and baskets of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">An option on a security is a contract that gives
the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the
writer of the option the security underlying the option at a specified exercise or &#8220;strike&#8221; price. The writer of an option
on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or
to pay the exercise price upon delivery of the underlying security. The buyer of an option acquires the right, but not the obligation,
to buy (a call option) or sell (a put option) a certain quantity of a security (the underlying security) or instrument, including a futures
contract or swap, at a certain price up to a specified point in time or on expiration, depending on the terms. For certain types of options,
the writer of the option will have no control over the time when it may be required to fulfill its obligation under the option. Certain
options, known as &#8220;American style&#8221; options may be exercised at any time during the term of the option. Other options, known
as &#8220;European style&#8221; options, may be exercised only on the expiration date of the option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">If an option written by the Fund expires unexercised,
the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written.
If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier
of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series
(type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction
can be effected when the Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net
gain or loss depending on whether the amount realized on the sale is more or less than the premium and other transaction costs paid on
the put or call option when purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing
option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium
received from a closing sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or,
if it is less, the Fund will realize a capital loss. Net gains from the Fund&#8217;s option strategy will be short-term capital gains
which, for U.S. federal income tax purposes, will constitute net investment company taxable income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will follow a strategy known as &#8220;covered
call option writing,&#8221; which is a strategy designed to generate current gains from option premiums as a means to generate total returns
as well as to enhance distributions payable to the Fund&#8217;s Common Shareholders. As the Fund writes covered calls over more of its
portfolio, its ability to benefit from capital appreciation becomes more limited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Except as disclosed further below and in connection
with the Fund&#8217;s Debt Overlay Strategy, the Fund may not sell &#8220;naked&#8221; call options on individual securities (i.e., options
representing more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#8220;covered&#8221;
if the Fund owns the security <span style="background-color: white">or instrument</span> underlying the call or has an absolute and immediate
right to acquire that security <span style="background-color: white">or instrument</span> without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Sub-Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#8217;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Sub-Adviser
as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Put options are contracts that give the holder
of the option, in return for a premium, the right to sell to the writer of the option the security underlying the option at a specified
exercise price at a specific time or times during the term of the option. These strategies may produce a considerably higher return than
the Fund&#8217;s primary strategy of covered call writing, but involve a higher degree of risk and potential volatility.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will write (sell) put options on individual
Common Equity securities only if the put option is &#8220;covered.&#8221; A put option written by the Fund on a security is &#8220;covered&#8221;
if the Fund segregates or earmarks assets determined to be liquid by the Sub-Adviser, as described above, equal to the exercise price.
A put option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held
is (i) equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided
the difference is maintained by the Fund in segregated or earmarked assets determined to be liquid by the Sub-Adviser, as described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may sell (covered and uncovered) put
and call options on indices of securities, futures on indices of securities, and index ETFs. Options on an index or index ETF differ from
options on securities because (i) the exercise of an index option requires cash payments and does not involve the actual purchase or sale
of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the index
upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option
and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather than price fluctuations
in a single security.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may purchase and write exchange-listed
and OTC options. Options written by the Fund with respect to non-U.S. securities, indices or sectors and other instruments generally will
be OTC options. OTC options differ from exchange-listed options in several respects. They are transacted directly with the dealers and
not with a clearing corporation, and therefore entail the risk of nonperformance by the dealer. OTC options are available for a greater
variety of securities and for a wider range of expiration dates and exercise prices than are available for exchange-traded options. Because
OTC options are not traded on an exchange, pricing is done normally by reference to information from a market maker. OTC options are subject
to heightened counterparty, credit, liquidity and valuation risks. The Fund&#8217;s ability to terminate OTC options is more limited than
with exchange-traded options and may involve the risk that broker-dealers participating in such transactions will not fulfill their obligations.
The hours of trading for options may not conform to the hours during which the underlying securities are traded. The Fund&#8217;s options
transactions will be subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which
such options are traded.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Restricted and Illiquid Securities. </i>The
Fund may invest in securities for which there is no readily available trading market or that are otherwise illiquid. Illiquid securities
include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#8220;Securities Act&#8221;), and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2)
and Rule 144A securities may, however, be treated as liquid by the Investment Adviser after consideration of factors such as trading activity,
availability of market quotations and number of dealers willing to purchase the security. If the Fund invests in Rule 144A securities,
the level of portfolio illiquidity may be increased to the extent that eligible buyers become uninterested in purchasing such securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">It may be difficult to sell such securities at
a price representing the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable
period may elapse between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be
able to obtain as favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through
private placements under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent
their sale at a time when such sale would otherwise be desirable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Government Sponsored Investment Programs</i>.
From time to time, the Fund may seek to invest in credit securities through one or more programs that may from time to time be sponsored,
established or operated by the U.S. Department of the Treasury, the Board of Governors of the Federal Reserve System and other governmental
agencies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Derivatives Transactions</i>. The Fund may
purchase and sell various derivative instruments (which derive their value by reference to another instrument, asset or index), such as
swaps, futures, options and other derivatives contracts, for investment purposes, such as obtaining investment exposure to an investment
category; risk management purposes, such as hedging against fluctuations in asset prices, currencies or interest rates; </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">diversification
purposes; or to change the duration of the Fund. The Fund may, but is not required to, use various strategic transactions in swaps, futures,
options and other derivative contracts in order to seek to earn income, facilitate portfolio management and mitigate risks. These strategies
may be executed through the use of derivative contracts. In the course of pursuing these investment strategies, the Fund may purchase
and sell exchange-listed and OTC put and call options on securities, equity and fixed-income indices and other instruments, purchase and
sell futures contracts and options thereon, and enter into various transactions such as swaps, caps, floors or collars. In addition, derivative
transactions may also include new techniques, instruments or strategies that are permitted as regulatory changes occur. In order to help
protect the soundness of derivative transactions and outstanding derivative positions, the Sub-Adviser generally requires derivative counterparties
to have a minimum credit rating of A3 from Moody&#8217;s (or a comparable rating from another NRSRO) and monitors such rating on an ongoing
basis. In addition, the Sub-Adviser seeks to allocate derivatives transactions to limit exposure to any single counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is required to trade derivatives and
other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions)
subject to value-at-risk (&#8220;VaR&#8221;) leverage limits and derivatives risk management program and reporting requirements. Generally,
these requirements apply unless the Fund satisfies a &#8220;limited derivatives users&#8221; exception that is included in Rule 18f-4
under the 1940 Act. The Fund is not classified as a &#8220;limited derivatives user&#8221; and, as required by Rule 18f-4, has implemented
a Derivatives Risk Management Program, which is reasonably designed to manage the Fund&#8217;s derivatives risks and to reasonably segregate
the functions associated with the Derivatives Risk Management Program from the portfolio management of the Fund. The Board, including
a majority of the trustees who are not &#8220;interested persons&#8221; of the Fund, as such term is defined in the 1940 Act, approved
the designation of a Derivatives Risk Manager, which is responsible for administering the Derivatives Risk Management Program for the
Fund. To facilitate the Board&#8217;s oversight, the Board reviews, no less frequently than annually, a written report on the effectiveness
of the Derivatives Risk Management Program and also more frequent reports regarding certain derivatives risk matters.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse
repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation
of whether a fund satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase
agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions
or not. SEC guidance regarding the use of securities lending collateral may limit the Fund&#8217;s securities lending activities. In addition,
the Fund is permitted to invest in a security on a when issued or forward-settling basis, or with a non-standard settlement cycle, and
the transaction will be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction
and (ii) the transaction will settle within 35 days of its trade date (the &#8220;Delayed-Settlement Securities Provision&#8221;). The
Fund may otherwise engage in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long
as the Fund treats any such transaction as a &#8220;derivatives transaction&#8221; for purposes of compliance with Rule 18f-4. Furthermore,
under the rule, the Fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not
be subject to the asset coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement,
that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Credit Derivatives. </i>Credit default derivatives
are linked to the price of reference securities or loans after a default by the issuer or borrower, respectively. Market spread derivatives
are based on the risk that changes in market factors, such as credit spreads, can cause a decline in the value of a security, loan or
index. There are three basic transactional forms for credit derivatives: swaps, options and structured instruments. The use of credit
derivatives is a highly specialized activity which involves strategies and risks different from those associated with ordinary portfolio
security transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may invest in credit default swap transactions
and credit-linked notes (described below) for hedging and investment purposes. The &#8220;buyer&#8221; in a credit default swap contract
is obligated to pay the &#8220;seller&#8221; a periodic stream of payments over the term of the contract provided that no event of default
on an underlying reference obligation has occurred. If an event of default occurs, the seller must pay the buyer the full notional value,
or &#8220;par value,&#8221; of the reference obligation. Credit default swap transactions are either &#8220;physical delivery&#8221; settled
or </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#8220;cash&#8221; settled. Physical delivery entails the actual delivery of the reference asset to the seller in exchange for the
payment of the full par value of the reference asset. Cash settled entails a net cash payment from the seller to the buyer based on the
difference of the par value of the reference asset and the current value of the reference asset that may, after a default, have lost some,
most, or all of its value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund may be either the buyer or seller in
a credit default swap transaction and generally will be a buyer in instances in which the Fund actually owns the underlying debt security
and seeks to hedge against the risk of default in that debt security. If the Fund is a buyer and no event of default occurs, the Fund
will have made a series of periodic payments (in an amount more or less than the value of the cash flows received on the underlying debt
security) and recover nothing of monetary value. However, if an event of default occurs, the Fund (if the buyer) will receive the full
notional value of the reference obligation either through a cash payment in exchange for such asset or a cash payment in addition to owning
the reference asset. The Fund generally will be a seller when it seeks to take the credit risk of a particular debt security and, as a
seller, the Fund receives a fixed rate of income throughout the term of the contract, which typically is between six months and ten years,
provided that there is no event of default. If an event of default occurs, the seller must pay the buyer the full notional value of the
reference obligation through either physical settlement and/or cash settlement. Credit default swap transactions involve greater risks
than if the Fund had invested in the reference obligation directly, including counterparty credit risk and leverage risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Foreign Currency Transactions. </i>The Fund
may (but is not required to) hedge some or all of its exposure to non-U.S. currencies through the use of forward foreign currency exchange
contracts, options on foreign currencies, foreign currency futures contracts and swaps and other derivatives transactions. Suitable hedging
transactions may not be available in all circumstances and there can be no assurance that the Fund will engage in such transactions at
any given time or from time to time when they would be beneficial. Although the Fund has the flexibility to engage in such transactions,
the Investment Adviser or Sub-Adviser may determine not to do so or to do so only in unusual circumstances or market conditions. These
transactions may not be successful and may eliminate any chance for the Fund to benefit from favorable fluctuations in relevant foreign
currencies. The Fund may also use derivatives transactions for purposes of increasing exposure to a foreign currency or to shift exposure
to foreign currency fluctuations from one currency to another.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Although the Sub-Adviser seeks to use derivatives
to further the Fund&#8217;s investment objective, there is no assurance that the use of derivatives will achieve this result. For a more
complete discussion of the Fund&#8217;s investment practices involving transactions in derivatives and certain other investment techniques,
see &#8220;Investment Objective and Policies&#8212;Derivative Instruments&#8221; in the Fund&#8217;s SAI.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Municipal Securities</i>. The Fund may invest
directly or indirectly in municipal securities. Municipal securities include securities issued by or on behalf of states, territories
and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the
payments from which, in the opinion of bond counsel to the issuer, are excludable from gross income for federal income tax purposes. Municipal
securities also include taxable securities issued by such issuers. Municipal bonds may include those backed by, among other things, state
taxes and essential service revenues as well as health care and higher education issuers, among others, or be supported by dedicated revenue
streams and/or statutory liens.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Temporary Investments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">At any time when a temporary posture is believed
by the Sub-Adviser to be warranted (a &#8220;temporary period&#8221;), the Fund may, without limitation, hold cash or invest its assets
in money market instruments and repurchase agreements in respect of those instruments. The money market instruments in which the Fund
may invest are obligations of the U.S. government, its agencies or instrumentalities; commercial paper rated A-1 or higher by S&amp;P
or Prime-1 by Moody&#8217;s; and certificates of deposit and bankers&#8217; acceptances issued by domestic branches of U.S. banks that
are members of the Federal Deposit Insurance Corporation. During a temporary period, the Fund may also invest in shares of money market
mutual funds. Money market mutual funds are investment companies, and the investments in those companies by the Fund are in some cases
subject to the 1940 Act&#8217;s limitations on investments in other investment companies. See &#8220;Investment Restrictions&#8221; in
the Fund&#8217;s SAI. As a shareholder in a mutual fund, the Fund will bear its ratable share of its expenses, including management fees,
and will remain subject to payment of the fees to the Investment Adviser, with respect to assets so invested. See &#8220;Management of
the Fund.&#8221; The Fund may not achieve its investment objective during a temporary period or be able to sustain its historical distribution
levels.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Certain Other Investment Practices</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>When Issued, Delayed Delivery Securities
and Forward Commitments</i>. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#8220;when
issued&#8221; or &#8220;delayed delivery&#8221; basis, in excess of customary settlement periods for the type of security involved. In
some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a
merger, corporate reorganization or debt restructuring (i.e., a when, as and if issued security). When such transactions are negotiated,
the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after
the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security,
the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are
subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Forward commitments involve
a risk of loss if the value of the security to be purchased declines prior to the settlement date, which risk is in addition to the risk
of decline in value of the Fund&#8217;s other assets. In addition, FINRA rules include mandatory margin requirements that require the
Fund to post collateral in connection with certain of these transactions. There is no similar requirement that the Fund&#8217;s counterparties
post collateral in connection with such transactions. The required collateralization of these transactions could increase the cost of
such transactions to the Fund and impose added operational complexity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Loans of Portfolio Securities</i>. To seek
to increase income, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions if (i) the loan
is collateralized in accordance with applicable regulatory requirements and (ii) no loan will cause the value of all loaned securities
to exceed 33 1/3% of the value of the Fund&#8217;s total assets. If the borrower fails to maintain the requisite amount of collateral,
the loan automatically terminates and the Fund could use the collateral to replace the securities while holding the borrower liable for
any excess of replacement cost over the value of the collateral. As with any extension of credit, there are risks of delay in recovery
and in some cases even loss of rights in collateral should the borrower of the securities fail financially. There can be no assurance
that borrowers will not fail financially. On termination of the loan, the borrower is required to return the securities to the Fund, and
any gain or loss in the market price during the period of the loan would inure to the Fund. If the other party to the loan petitions for
bankruptcy or becomes subject to the United States Bankruptcy Code, the law regarding the rights of the Fund is unsettled. As a result,
under extreme circumstances, there may be a restriction on the Fund&#8217;s ability to sell the collateral and the Fund would suffer a
loss. See &#8220;Investment Objective and Policies Loans of Portfolio Securities&#8221; in the Fund&#8217;s SAI.<br/>
<br/>
</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Offsetting. </i>In the normal course of business,
the Fund enters into transactions subject to enforceable master netting arrangements or other similar arrangements. Generally, the right
to offset in those agreements allows the Fund to counteract the exposure to a specific counterparty with collateral received from or delivered
to that counterparty based on the terms of the arrangements. These arrangements provide for the right to liquidate upon the occurrence
of an event of default, credit event upon merger or additional termination event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In order to better define its contractual rights
and to secure rights that will help the Fund mitigate its counterparty risk, the Fund may enter into an International Swaps and Derivatives
Association, Inc. Master Agreement (&#8220;ISDA Master Agreement&#8221;) or similar agreement with its derivative contract counterparties.
An ISDA Master Agreement is a bilateral agreement between the Fund and a counterparty that governs OTC derivatives, including foreign
exchange contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default
and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default
(close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">For derivatives traded under an ISDA Master
Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement
and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty. For financial reporting purposes,
cash collateral that has been pledged to cover obligations of the Fund and cash collateral received from the counterparty, if any, are
reported separately on the Statement of Assets and Liabilities as segregated cash from broker/receivable for variation margin, or segregated
cash due to broker/payable for variation margin. Generally, the amount of collateral due from or to a counterparty must exceed a minimum
transfer amount threshold before a transfer is required to be made. To the extent amounts due to the Fund from its counterparties are
not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Fund attempts
to mitigate counterparty risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring
the financial stability of those counterparties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Repurchase Agreements</i>. The Fund may enter
into bilateral and tri-party repurchase agreements. Repurchase agreements may be seen as loans by the Fund collateralized by underlying
debt securities. Under the terms of a typical repurchase agreement, the Fund buys an underlying debt obligation or other security subject
to an obligation of the seller to repurchase, and the Fund to resell, the obligation at an agreed price and time (usually not more than
one week later). This arrangement results in a fixed rate of return to the Fund. In the event of the insolvency of the counterparty to
a repurchase agreement, recovery of the repurchase price owed to the Fund may be delayed. Such an insolvency may result in a loss to the
extent that the value of the purchased securities or other assets decreases during the delay or that value has otherwise not been maintained
at an amount equal to the repurchase price. The Sub-Adviser reviews the creditworthiness of the counterparties with which the Fund enters
into repurchase agreements to evaluate these risks and monitors on an ongoing basis the value of the securities subject to repurchase
agreements to ensure that the value is maintained at the required level. The Fund will not enter into repurchase agreements with the Investment
Adviser, the Sub-Adviser or their affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in">Repurchase agreements collateralized fully by
cash items, U.S. government securities or by securities issued by an issuer that the Investment Adviser or the Sub-Adviser has determined
at the time the repurchase agreement is entered into has an exceptionally strong capacity to meet its financial obligations (&#8220;Qualifying
Collateral&#8221;) and meet certain liquidity standards generally may be deemed to be &#8220;collateralized fully&#8221; and may be deemed
to be investments in the underlying securities for certain purposes. The Fund may accept collateral other than Qualifying Collateral determined
by the Investment Adviser or the Sub-Adviser to be in the best interests of the Fund to accept as collateral for such repurchase agreement
(which may include high yield debt instruments that are rated below investment grade) (&#8220;Alternative Collateral&#8221;). Repurchase
agreements secured by Alternative Collateral are not deemed to be &#8220;collateralized fully&#8221; under applicable regulations and
the repurchase agreement is therefore considered a separate security issued by the counterparty to the Fund. Accordingly, the Fund must
include repurchase agreements that are not &#8220;collateralized fully&#8221; in its calculations of securities issued by the selling
institution held by the Fund for purposes of various portfolio diversification and concentration requirements applicable to the Fund.
In addition, Alternative Collateral may not qualify as permitted or appropriate investments for the Fund under the Fund&#8217;s investment
strategies and limitations. Accordingly, if a counterparty to a repurchase agreement defaults and the Fund takes possession of Alternative
Collateral, the Fund may need to promptly dispose of the Alternative Collateral (or other securities held by the Fund, if the Fund exceeds
a limitation on a permitted investment by virtue of taking possession of the Alternative Collateral). The Alternative Collateral may be
particularly illiquid, especially in times of market volatility or in the case of a counterparty insolvency or bankruptcy, which may restrict
the Fund&#8217;s ability to dispose of Alternative Collateral received from the counterparty. Depending on the terms of the repurchase
agreement, the Fund may determine to sell the collateral during the term of the repurchase agreement and then purchase the same collateral
at the market price at the time of the resale. In tri-party repurchase agreements, an unaffiliated third-party custodian maintains accounts
to hold collateral for the Fund and its counterparties and, therefore, the Fund may be subject to the credit risk of those custodians.
Securities subject to repurchase agreements (other than tri-party repurchase agreements) and purchase and sale contracts will be held
by the Fund&#8217;s custodian (or sub-custodian) in the Federal Reserve/Treasury book-entry system or by another authorized securities
depository.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"><i>Reverse Repurchase Agreements</i>. The Fund
may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund sells a portfolio instrument to another party,
such as a bank or broker-dealer, in return for cash or other assets. At the same time, the Fund agrees to repurchase the instrument at
an agreed upon time and price (which may be effected by an exchange of the repurchased instrument for assets other than cash), for which
the effective difference in price reflects an interest payment. Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and Fund expenses associated with the repurchase agreement,
that the market value of the securities or other assets sold by the Fund may decline below the price at which the Fund is obligated to
repurchase such securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements
can be successfully employed. In the event of the insolvency of the counterparty to a reverse repurchase agreement, recovery of the securities
or other assets sold by the Fund may be delayed. The counterparty&#8217;s insolvency may result in a loss equal to the amount by which
the value of the securities or other assets sold by the Fund exceeds the repurchase price payable by the Fund; if the value of the purchased
securities or other assets increases during such a delay, that loss </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">may also be increased. When the Fund enters into a reverse repurchase
agreement, any fluctuations in the market value of either the instruments transferred to another party or the instruments in which the
proceeds may be invested would affect the market value of the Fund&#8217;s assets. As a result, such transactions may increase fluctuations
in the net asset value of the Fund&#8217;s Common Shares. Because reverse repurchase agreements may be considered to be the practical
equivalent of borrowing funds, they constitute a form of leverage. If the Fund reinvests the proceeds of a reverse repurchase agreement
at a rate lower than the cost of the agreement, entering into the agreement will lower the Fund&#8217;s cash available for distribution.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal"><i>Sleeve Structure.
</i>The Sub-Adviser may from time to time utilize a sleeve structure in managing the Fund. In this structure, the Sub-Adviser implements
the Fund&#8217;s investment strategies using component sleeves of investments comprising distinct sub-strategies or grouping similar investments
in sub-accounts of the Fund that, collectively, comprise the Fund&#8217;s overall portfolio and investment strategies. This approach facilitates
internal allocations and tracking of investments within a portfolio. </span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Interest Rate <span style="color: windowtext">Transactions</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Please refer to the section of the <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">Fund&#8217;s
most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Interest Rate Transactions,&#8221;
which is incorporated by reference herein, for a discussion of the Fund&#8217;s use of interest rate transactions in connection with the
Fund&#8217;s use of Financial Leverage.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Portfolio Turnover</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund will buy and sell securities to seek
to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover
rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities
owned during the year (excluding securities whose maturities at acquisition were one year or less). The Fund&#8217;s portfolio turnover
rate may vary greatly from year to year. Higher portfolio turnover may decrease the after-tax return to individual investors in the Fund
to the extent it results in a decrease of the long-term capital gains portion of distributions to shareholders. For the fiscal years ended
May 31, 2025 and May 31, 2024, the Fund&#8217;s portfolio turnover rate was 25% and 30%, respectively.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Investment Restrictions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund has adopted certain other investment
limitations. These limitations are fundamental and may not be changed without the approval of the holders of a majority of the outstanding
Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together as a single class). See &#8220;Investment Restrictions&#8221;
in the SAI for a complete list of the fundamental investment policies of the Fund.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="ProUseLeverage"></span>Use of Leverage</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><span style="font-weight: normal; color: windowtext">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Use of Leverage,&#8221; which is incorporated
by reference herein, for a discussion of the Fund&#8217;s use of leverage.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in">See the section of <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm">the
Fund&#8217;s most recent annual report on Form N-CSR</a> entitled &#8220;Additional Information Regarding the Fund&#8212;Principal Risks
of the Fund&#8212;Financial Leverage and Leveraged Transactions Risk,&#8221; which is incorporated by reference herein, for a discussion
of associated risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Borrowing</i>. The Fund is authorized to borrow
or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund
may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, the Fund generally is not permitted to
issue commercial paper or notes or engage in other Borrowings, other than temporary borrowings as defined under the 1940 Act, unless,
immediately after the Borrowing, the Fund would have asset coverage (as defined in the 1940 Act) of less than 300%, as measured at the
time of borrowing and calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness not represented
by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness. In addition,
other than with respect to privately arranged Borrowings, the Fund generally is not permitted to declare any cash dividend or other distribution
on any class of the Fund&#8217;s capital stock, including the Common Shares, or purchase any such capital stock, unless, at the time of
such declaration, the Fund would have asset coverage (as described above) of at least 300% after deducting the </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">amount of such dividend
or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal amount
of any outstanding commercial paper, notes or other Borrowings to the extent necessary to maintain the required asset coverage.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The terms of any such Borrowings may require
the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any
such requirements would increase the cost of such Borrowings over the stated interest rate. Such lenders would have the right to receive
interest on and repayment of principal of any such Borrowings, which right will be senior to those of the Common Shareholders. Any such
Borrowings may contain provisions limiting certain activities of the Fund, including the payment of dividends to Common Shareholders in
certain circumstances. Any Borrowings will likely be ranked senior or equal to all other existing and future Borrowings of the Fund.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Certain types of Borrowings subject the Fund
to covenants in credit agreements relating to asset coverage and portfolio composition requirements. Certain Borrowings issued by the
Fund also may subject the Fund to certain restrictions on investments imposed by guidelines of one or more rating agencies, which may
issue ratings for such Borrowings. Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent
than those imposed by the 1940 Act. It is not anticipated that these covenants or guidelines will impede the Sub-Adviser from managing
the Fund&#8217;s portfolio in accordance with the Fund&#8217;s investment objective and policies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The 1940 Act grants to the holders of senior
securities representing indebtedness issued by the Fund, other than with respect to privately arranged Borrowings, certain voting rights
in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements
under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Borrowings under the committed
facility provided to the Fund by BNP Paribas are collateralized by portfolio assets which are maintained by the Fund in a separate account
with the Fund&#8217;s custodian for the benefit of the lender, which collateral exceeds the amount borrowed. Securities deposited in the
collateral account may, subject to certain conditions, be rehypothecated by the lender up to the amount of the loan balance outstanding
and subject to the terms and conditions of the facility agreements. The Fund continues to receive dividends and interest on rehypothecated
securities. The Fund also has the right to recall rehypothecated securities on demand and such securities shall be returned to the collateral
account within the ordinary settlement cycle. In the event a recalled security is not returned by the lender, the loan balance outstanding
will be reduced by the amount of the recalled security failed to be returned. The Fund receives a portion of the fees earned by BNP Paribas
in connection with the rehypothecation of portfolio securities. Rehypothecation of the Fund&#8217;s pledged portfolio securities entails
risks, including the risk that the lender will be unable or unwilling to return rehypothecated securities which could result in, among
other things, the Fund&#8217;s inability to find suitable investments to replace the unreturned securities, thereby impairing the Fund&#8217;s
ability to achieve its investment objective. In the event of a default by the Fund under the committed facility, the lender has the right
to sell such collateral assets to satisfy the Fund&#8217;s obligation to the lender. The amounts drawn under the committed facility may
vary over time and such amounts will be reported in the Fund&#8217;s audited and unaudited financial statements contained in the Fund&#8217;s
annual and semi-annual reports to shareholders. The committed facility agreement includes usual and customary covenants. These covenants
impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations.
These covenants place limits or restrictions on the Fund&#8217;s ability to (i) enter into additional indebtedness with a party other
than BNP Paribas, (ii) change its fundamental investment policy, or (iii) pledge to any other party, other than to the counterparty, securities
owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information to
the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) greater
than 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#8220;closed-end
management investment company&#8221; as defined in the 1940 Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#8217;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#8217;s
Financial Leverage, but the Fund&#8217;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Reverse Repurchase Agreements and Dollar Roll
Transactions. </i>The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund temporarily transfers
possession of a portfolio instrument to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund
</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">agrees to repurchase the instrument at an agreed upon time and price, which reflects an interest payment. Such agreements have the economic
effect of borrowings. The Fund may enter into reverse repurchase agreements when the Sub-Adviser believes it is able to invest the cash
acquired at a rate higher than the cost of the agreement, which would increase earned income.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Borrowings may be made by the Fund through dollar
roll transactions. A dollar roll transaction involves a sale by the Fund of a mortgage-backed or other fixed-income security concurrently
with an agreement by the Fund to repurchase a similar security at a later date at an agreed-upon price. The securities that are repurchased
will bear the same interest rate and stated maturity as those sold, but pools of mortgages collateralizing those securities may have different
prepayment histories than those sold. During the period between the sale and repurchase, the Fund will not be entitled to receive interest
and principal payments on the securities sold. Proceeds of the sale will be invested in additional instruments for the Fund, and the income
from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation and gain or
loss that would have been realized on the securities sold as part of the dollar roll, the use of this technique will diminish the investment
performance of the Fund compared with what the performance would have been without the use of dollar rolls.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">With respect to any reverse repurchase agreement,
dollar roll or similar transaction, the Fund&#8217;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to
a counterparty in such a transaction, in addition to the value of the underlying asset as of the relevant measuring date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#8217;s asset coverage ratio or treat all such transactions as derivatives transactions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"><i>Preferred Shares.</i> The Fund&#8217;s Governing
Documents provide that the Board may authorize and issue Preferred Shares with rights as determined by the Board, by action of the Board
without prior approval of the holders of the Common Shares. Common Shareholders have no preemptive right to purchase any Preferred Shares
that might be issued. Any such Preferred Share offering would be subject to the limits imposed by the 1940 Act. Although the Fund has
no present intention to issue Preferred Shares, it may in the future utilize Preferred Shares to the maximum extent permitted by the 1940
Act. Under the 1940 Act, the Fund may not issue Preferred Shares if, immediately after issuance, the Fund would have asset coverage (as
defined in the 1940 Act) of less than 200%, calculated as the ratio of the Fund&#8217;s total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of the Fund&#8217;s outstanding senior securities representing indebtedness
plus the aggregate liquidation preference of any outstanding shares of preferred stock. In addition, the Fund generally is not permitted
to declare any cash dividend or other distribution on the Fund&#8217;s Common Shares, or purchase any such Common Shares, unless, at the
time of such declaration, the Fund would have asset coverage (as described above) of at least 200% after deducting the amount of such
dividend or other distribution. The 1940 Act grants to the holders of senior securities representing stock issued by the Fund certain
voting rights. Failure to maintain certain asset coverage requirements under the 1940 Act could entitle the holders of Preferred Shares
to elect a majority of the Board.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_EffectsOfLeverageTextBlock', window );">Effects of Leverage [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-weight: normal"><i>Effects
of Financial Leverage</i><span style="color: windowtext">. Please refer to the section of the </span></span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; color: windowtext">entitled &#8220;</span><span style="font-weight: normal">Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; color: windowtext">Effects of Leverage,&#8221; which is
incorporated by reference herein, for a discussion of the effects of leverage.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SharePriceTableTextBlock', window );">Share Price [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s currently outstanding Common
Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(the &#8220;NYSE&#8221;) under the symbol &#8220;GOF&#8221;. The Fund&#8217;s Common Shares commenced trading on the NYSE on July 27,
2007.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Common Shares have traded both at a premium
and at a discount in relation to the Fund&#8217;s net asset value per share. Although the Common Shares recently have generally traded
at a premium to net asset value, there can be no assurance that this will continue after the offering nor that the Common Shares will
not trade at a discount in the future. Shares of closed-end investment companies frequently trade at a premium or discount to net asset
value and the market price for the Common Shares will change based on a variety of factors. The net asset value and market price of the
Common Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market
price of the Common Shares will either be above (premium) or below (discount) their net asset value. The Fund cannot predict whether the
Common Shares will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a
variety of factors. The Fund&#8217;s net asset value would be reduced following an offering of the Common Shares due to the costs of such
</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">offering, to the extent those costs are borne by the Fund. The sale of Common Shares by the Fund (or the perception that such sales may
occur) may increase the volatility of or have an adverse effect on prices of Common Shares in the secondary market. An increase in the
number of Common Shares available may put downward pressure on the market price for Common Shares. See &#8220;Risks&#8212;Market Discount
and Price Volatility Risk.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table sets forth, for each of the
periods indicated, the high and low closing market prices for the Common Shares on the NYSE, as well as the net asset value per Common
Share and the premium or discount to net asset value per Common Share at which the Common Shares were trading on the date of the high
and low closing prices. The Fund calculates its net asset value as of the close of business, usually 4:00 p.m. Eastern Time, every day
on which the NYSE is open. See &#8220;Net Asset Value&#8221; for information as to the determination of the Fund&#8217;s net asset value.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt">&#160;</td>
    <td id="xdx_481_ecef--HighestPriceOrBid_zxfWIoRT9Bf6" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_483_ecef--LowestPriceOrBid_zdEkVbWyTsC2" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_48A_ecef--HighestPriceOrBidNav_z3at9YAoAYga" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_485_ecef--LowestPriceOrBidNav_zNwfcMYcaK3l" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_488_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zVx38qbKKH76" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td>
    <td id="xdx_487_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zvgFwov0feRl" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Fiscal Quarter Ended</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Market Price</b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>NAV per Common<br/>
Share on Date of Market<br/>
Price High and Low<span style="font-size: 8.5pt"><sup>(1)</sup></span></b></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Premium/(Discount) on<br/>
Date of Market Price</b><br/>
<b>High and Low<span style="font-size: 8.5pt"><sup>(2)</sup></span></b></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>High</b></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Low</b></td></tr>
  <tr id="xdx_414_20250601__20250831_z1ahzOQZabn7" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.10</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.55</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.50</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.38</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">31.30%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">27.86%</span></td></tr>
  <tr id="xdx_410_20250301__20250531_zarexPXdOTR6" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.91</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$13.74</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.67</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.06</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">36.33%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">24.23%</span></td></tr>
  <tr id="xdx_41E_20241201__20250228_z2M1HcaTxGDg" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 28, 2025</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.99</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.00</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.74</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">33.14%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">27.77%</span></td></tr>
  <tr id="xdx_41E_20240901__20241130_zQH4n0ppKR71" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$16.03</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.26</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.99</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.01</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">33.69%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">27.06%</span></td></tr>
  <tr id="xdx_41C_20240601__20240831_z4g8GRppMwa2" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.75</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.65</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.06</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.93</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">30.60%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">22.80%</span></td></tr>
  <tr id="xdx_41F_20240301__20240531_zU0ZoA2jKCi9" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">May 31, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.90</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$13.80</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.26</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.82</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">21.53%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">16.75%</span></td></tr>
  <tr id="xdx_411_20231201__20240229_zsKPfS7pKMdg" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">February 29, 2024</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$14.29</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.67</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.12</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.34</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">17.90%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">2.67%</span></td></tr>
  <tr id="xdx_414_20230901__20231130_zIECh2mE4rS2" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">November 30, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.96</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.16</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.30</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$11.71</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">29.76%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">-4.70%</span></td></tr>
  <tr id="xdx_418_20230601__20230831_z36VwxvLer89" style="vertical-align: top">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"><span style="color: #4D4D4D">August 31, 2023</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$16.28</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$15.51</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.48</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">$12.30</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">30.45%</span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span style="color: #4D4D4D">26.10%</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBid', window );">Lowest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.55<span></span>
</td>
<td class="nump">$ 13.74<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.26<span></span>
</td>
<td class="nump">$ 14.65<span></span>
</td>
<td class="nump">$ 13.80<span></span>
</td>
<td class="nump">$ 12.67<span></span>
</td>
<td class="nump">$ 11.16<span></span>
</td>
<td class="nump">$ 15.51<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBid', window );">Highest Price or Bid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.10<span></span>
</td>
<td class="nump">15.91<span></span>
</td>
<td class="nump">15.99<span></span>
</td>
<td class="nump">16.03<span></span>
</td>
<td class="nump">15.75<span></span>
</td>
<td class="nump">14.90<span></span>
</td>
<td class="nump">14.29<span></span>
</td>
<td class="nump">15.96<span></span>
</td>
<td class="nump">16.28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidNav', window );">Lowest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.38<span></span>
</td>
<td class="nump">11.06<span></span>
</td>
<td class="nump">11.74<span></span>
</td>
<td class="nump">12.01<span></span>
</td>
<td class="nump">11.93<span></span>
</td>
<td class="nump">11.82<span></span>
</td>
<td class="nump">12.34<span></span>
</td>
<td class="nump">11.71<span></span>
</td>
<td class="nump">12.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidNav', window );">Highest Price or Bid, NAV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.67<span></span>
</td>
<td class="nump">$ 12.01<span></span>
</td>
<td class="nump">$ 11.99<span></span>
</td>
<td class="nump">$ 12.06<span></span>
</td>
<td class="nump">$ 12.26<span></span>
</td>
<td class="nump">$ 12.12<span></span>
</td>
<td class="nump">$ 12.30<span></span>
</td>
<td class="nump">$ 12.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent', window );">Highest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.30%<span></span>
</td>
<td class="nump">36.33%<span></span>
</td>
<td class="nump">33.14%<span></span>
</td>
<td class="nump">33.69%<span></span>
</td>
<td class="nump">30.60%<span></span>
</td>
<td class="nump">21.53%<span></span>
</td>
<td class="nump">17.90%<span></span>
</td>
<td class="nump">29.76%<span></span>
</td>
<td class="nump">30.45%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent', window );">Lowest Price or Bid, Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.86%<span></span>
</td>
<td class="nump">24.23%<span></span>
</td>
<td class="nump">27.77%<span></span>
</td>
<td class="nump">27.06%<span></span>
</td>
<td class="nump">22.80%<span></span>
</td>
<td class="nump">16.75%<span></span>
</td>
<td class="nump">2.67%<span></span>
</td>
<td class="num">(4.70%)<span></span>
</td>
<td class="nump">26.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_LatestPremiumDiscountToNavPercent', window );">Latest Premium (Discount) to NAV [Percent]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13.44%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract', window );"><strong>Capital Stock, Long-Term Debt, and Other Securities [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityDividendsTextBlock', window );">Security Dividends [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">All Common Shares are equal as to
dividends, assets and voting privileges and shall not entitle the holders to preference, preemptive, appraisal, conversion or exchange
rights, except as otherwise required by law or permitted by the Declaration of Trust.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_SecurityVotingRightsTextBlock', window );">Security Voting Rights [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><i>Voting
Rights</i>. Until any Preferred Shares are issued, holders of the Common Shares will vote as a single class to elect the
Fund&#8217;s Board of Trustees and on additional matters with respect to which the 1940 Act mandates a vote by the Fund&#8217;s
shareholders. If Preferred Shares are issued, holders of Preferred Shares will have a right to elect at least two of the
Fund&#8217;s Trustees, and will have certain other voting rights. See &#8220;Anti-Takeover Provisions in the Fund&#8217;s Governing
Documents.&#8221;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecuritiesTableTextBlock', window );">Outstanding Securities [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Capitalization</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The following table provides information about
the outstanding securities of the Fund as of November 14, 2025:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Capitalization">
  <tr style="vertical-align: bottom">
    <td style="width: 37%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Title of Class</b></td>
    <td style="width: 19%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount</b><br/>
<b>Authorized</b></td>
    <td style="width: 24%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Held by the<br/>
Fund or for its Account</b></td>
    <td style="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><b>Amount Outstanding</b></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_904_ecef--OutstandingSecurityTitleTextBlock_c20251121__20251121_zkUzmOJ13as9">Common shares of beneficial interest, par value $0.01 per share</span></td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">Unlimited</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center">&#8212;</td>
    <td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"><span id="xdx_90D_ecef--OutstandingSecurityAuthorizedShares_c20251121__20251121_zPkprTPwwap7">199,267,847</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityTitleTextBlock', window );">Outstanding Security, Title [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Common shares of beneficial interest, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_OutstandingSecurityAuthorizedShares', window );">Outstanding Security, Authorized [Shares]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">199,267,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_PrincipalRisksMember', window );">Principal Risks [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><span style="font-weight: normal; text-transform: none">Please
refer to the section of the </span><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"><span style="font-weight: normal; text-transform: none">Fund&#8217;s
most recent annual report on Form N-CSR</span></a> <span style="font-weight: normal; text-transform: none">entitled &#8220;Additional
Information Regarding the Fund</span>&#8212;<span style="font-weight: normal; text-transform: none">Principal Risks of the Fund,&#8221;
which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund, in addition to the
following.</span><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_MarketDiscountAndPriceVolatilityRiskMember', window );">Market Discount And Price Volatility Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><b>Market Discount and Price Volatility Risk</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The net asset value and market price of the Common
Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market price
of the Common Shares may experience volatility (sometimes high volatility) driven by market forces that may be unrelated to changes in
the Fund&#8217;s net asset value or other internal Fund factors. The market price of the Common Shares will either be above (premium)
or below (discount) their net asset value. Although the net asset value of Common Shares is often</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> considered in determining whether to
purchase or sell shares, whether investors will realize gains or losses upon the sale of Common Shares will depend upon whether the market
price of Common Shares at the time of sale is above or below the investor&#8217;s purchase price, taking into account transaction costs
for the Common Shares, and is not directly dependent upon the Fund&#8217;s net asset value. Market price movements of Common Shares are
thus material to investors and may result in losses, even when net asset value has increased.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund cannot predict whether the Common Shares
will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a variety of factors.
If the Common Shares are trading at a premium to net asset value at the time you purchase Common Shares, the net asset value per share
of the Common Shares purchased will be less than the purchase price paid. Shares of closed-end investment companies frequently trade at
a discount from their net asset value, but in some cases have traded above net asset value. The risk of the Common Shares trading at a
discount is a risk separate and distinct from the risk of a decline in the Fund&#8217;s net asset value as a result of the Fund&#8217;s
investment activities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Because the market price of the Common Shares
will be determined by factors such as net asset value, dividend and distribution levels (which are dependent, in part, on expenses), supply
of and demand for Common Shares, stability of dividends or distributions, trading volume of Common Shares, general market and economic
conditions and other factors beyond the Fund&#8217;s control, the Fund cannot predict whether the Common Shares will trade at, below or
above net asset value, or at, below or above the public offering price for the Common Shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s net asset value would be reduced
following an offering of the Common Shares due to the costs of such offering, to the extent those costs are borne by the Fund. The sale
of Common Shares by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of Common Shares in the
secondary market, including by resulting in increased trading of the Common Shares, which may increase volatility in the market price
of the Common Shares. An increase in the number of Common Shares available may put downward pressure on the market price for Common Shares.
The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of Common Shares
at a price below the Fund&#8217;s then-current net asset value, subject to certain conditions, and such sales of Common Shares at price
below net asset value, if any, may increase downward pressure on the market price for Common Shares. These sales, if any, also might make
it more difficult for the Fund to sell additional Common Shares in the future at a time and price it deems appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund is designed for long-term investors
and investors in Common Shares should not view the Fund as a vehicle for trading purposes.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_DebtOverlayStrategyRiskMember', window );">Debt Overlay Strategy Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><b>Debt Overlay Strategy Risk</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Debt Overlay Strategy is subject
to risks associated with investing in the investments comprising the Debt Overlay Basket as well as the risks associated with selling
call options on the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The risks of the Debt Overlay Strategy include,
among others, Income Securities Risk, Corporate Bond Risk, Below Investment Grade Securities Risk, Investment Funds Risk, Derivatives
Transactions Risk and Options Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">Additionally, the Debt Overlay Strategy is subject
to imperfect matching or price correlation between the Underlying Bond ETF and the Debt Overlay Basket, which could reduce the Fund&#8217;s
returns and expose the Fund to additional losses. In particular, the Debt Overlay Strategy is subject to the risk of loss associated with
the Underlying Bond ETF outperforming the Debt Overlay Basket because the Fund&#8217;s obligation under the options on the Underlying
Bond ETF at expiration is determined by the market price of the shares of the Underlying Bond ETF.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s potential gain in selling a
call option on the Underlying Bond ETF is the premium received from the purchaser of the option; however, the Fund risks a loss equal
to the entire exercise price of the option minus the call premium (although the extent of such loss could be offset by the performance
of the Debt Overlay Basket).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The call options sold as part of the Debt Overlay
Strategy are generally not &#8220;covered.&#8221; For cash-settled call options sold by the Fund referencing the Underlying Bond ETF,
if the market price of the Underlying Bond ETF is above the strike price of the options, the Fund would owe the difference between the
market price of the shares of the Underlying Bond ETF and the strike price of the options. For physically-settled call options sold by
the Fund</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> referencing the Underlying Bond ETF, if the options are exercised and assigned, the Fund will be obligated to sell to the options&#8217;
counterparty shares of the Underlying Bond ETF at the strike price. Pursuant to this sale upon assignment, the Fund will not be able to
deliver the Debt Overlay Basket to satisfy its delivery obligations and will be required to buy shares of the Underlying Bond ETF at the
prevailing market price, which may be greater in aggregate cost than the value of the corresponding Debt Overlay Basket. To the extent
that the market price of the shares of the Underlying Bond ETF experiences proportionately greater appreciation than the value of the
Debt Overlay Basket, the Fund is subject to additional risks associated with selling &#8220;naked&#8221; call options on the Underlying
Bond ETF. Selling naked, or uncovered, call options can be considerably riskier than selling covered call options. Although the Debt Overlay
Basket is intended to outperform the Underlying Bond ETF and the performance of the Debt Overlay Basket is otherwise intended to generally
be correlated with that of the Underlying Bond ETF, it is possible that the market price of the shares of the Underlying Bond ETF will
experience greater appreciation than the value of the Debt Overlay Basket, subjecting the Fund to the risk of a loss that is uncovered
by the Debt Overlay Basket. The potential appreciation of the market price of the shares of the Underlying Bond ETF is theoretically unlimited,
and the Fund is therefore subject to the risk of total loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">To the extent that the market price of the shares
of the Underlying Bond ETF experience less appreciation than the Debt Overlay Basket, the Fund is subject to risks similar to those described
in &#8220;Risks Associated with the Fund&#8217;s Covered Call Option Strategy and Put Options,&#8221; including the risk of losing the
ability to benefit from the capital appreciation of its Debt Overlay Basket (i.e., net of any losses from the call options sold by the
Fund referencing the Underlying Bond ETF). Additionally, for certain types of options, the Fund has no control over the time when it may
be required to fulfill its obligation under the option. There can be no assurance that a liquid market will exist for the options if and
when the Fund seeks to close out an option position.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskAxis=GOF_SyntheticAutocallableELNStrategyRiskMember', window );">Synthetic Autocallable E L N Strategy Risk [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_GeneralDescriptionOfRegistrantAbstract', window );"><strong>General Description of Registrant [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cef_RiskTextBlock', window );">Risk [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><b>Synthetic Autocallable ELN Strategy Risk</b><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Fund&#8217;s Synthetic Autocallable ELN Strategy
is subject to risks associated with investing in autocallable ELNs directly, derivatives instruments on the Autocallable ELN Reference
Index, including Common Equity Securities Risk, Synthetic Investments Risk, Derivatives Transactions Risk, Counterparty Risk and Swap
Risk.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in">The Synthetic Autocallable ELN Strategy is also
subject to certain additional or heightened risks, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Contingent Income Risk. Coupon Payments from the Synthetic Autocallable Contract are not guaranteed and will not be made if the price
level of the Autocallable ELN Reference Index falls below the Coupon Barrier on one or more observation dates. This means the Fund may
generate significantly less income than anticipated from a Synthetic Autocallable Contract during equity market downturns. The Coupon
Payments of Synthetic Autocallable Contracts are not linked to the performance of the Autocallable ELN Reference Index at any time other
than on maturity dates&#160;and observation dates. Moreover, because the payoff of the Synthetic Autocallable Contract is linked to the
price level of the Autocallable ELN Reference Index, the Fund is exposed to the market risk of the Autocallable ELN Reference Index and
may not receive any return on the Synthetic Autocallable Contract and may lose&#160;a portion or all of the notional value of the Synthetic
Autocallable Contract even if the performance of one or more of component securities of the Autocallable ELN Reference Index has exceeded&#160;the
initial value of such security.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Early Redemption Risk. Synthetic Autocallable Contracts may be called (i.e., cancelled) before their scheduled maturity if the Autocallable
ELN Reference Index reaches or exceeds the Autocall Barrier on an observation date. Synthetic Autocallable Contracts limit the positive
investment return that can be achieved due to this automatic call feature. This automatic early redemption could result in significantly
less income than anticipated from a Synthetic Autocallable Contract and force reinvestment of that principal investment amount at less
advantageous terms based on prevailing market conditions. For example, if the automatic call feature is triggered, the Fund would forego
any remaining Coupon Payments and may be unable to invest in another Synthetic Autocallable Contract (or other investment) with a similar
level of risk and comparable return potential. If the automatic call feature is not triggered, and the&#160;Maturity Barrier has been
breached as of the maturity date, the Fund will receive less than the initial notional amount&#160;regardless of any outperformance of
the Autocallable ELN Reference Index (or any component security thereof) throughout the term of the Synthetic Autocallable Contract.&#160;</td></tr></table>

    <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">


<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Barrier Risk. The Coupon Barrier and Maturity Barrier levels of a Synthetic Autocallable Contract set forth the threshold amount&#160;of
loss the Autocallable ELN Reference Index could experience before the Fund&#160;would forfeit Coupon Payments and/or pay a portion or
all of the initial notional amount of such contract.&#160;If the Coupon Barrier level is breached on an observation date, the Fund will
not receive the Coupon Payment for such period (subject to any features that may provide the Fund to receive a Missed Coupon under certain
conditions).&#160;Accordingly, it is possible that the Fund may not receive any Coupon Payments under a Synthetic Autocallable Contract.
If the&#160;Maturity Barrier level is breached on the maturity date, the Fund may be required to pay a percentage of the initial notional
amount of the Synthetic Autocallable Contract. If the Autocallable ELN Reference Index falls below the Maturity Barrier at the maturity
of a Synthetic Autocallable Contract, the Fund is exposed to the negative performance of the Autocallable ELN Reference Index from a specified
level. This could result in sudden, significant losses if the Maturity Barrier is breached. Under some Synthetic Autocallable Contracts,
it is possible that the Fund could be required to pay the entire initial notional amount, in addition to forfeiting some or all&#160;of
the Coupon Payments.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>Limited Available Counterparty Risk. Synthetic Autocallable Contracts are bespoke contracts and the Fund may have limited available
counterparties. The Fund will be subject to credit and default risk with respect to the counterparties to the Synthetic Autocallable Contracts
entered into by the Fund. If a Synthetic Autocallable Contract counterparty becomes bankrupt or otherwise fails to perform its obligations,
the Fund may experience significant delays in obtaining any recovery, may obtain only a limited recovery, or may obtain no recovery at
all. The Fund may have substantial exposure to one or a limited number of counterparties, which may result in the Fund being more susceptible
to a single economic or regulatory occurrence affecting such counterparty(ies).</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">If Common Shares to which this Prospectus relates are sold to or through underwriters, the Prospectus Supplement will set forth any
applicable sales load to be paid by investors and the estimated offering expenses borne by the Fund.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Common Shareholders will pay brokerage charges if they direct Computershare Trust Company, N.A. (the &#8220;Plan Agent&#8221;) to
sell Common Shares held in a dividend reinvestment account. See &#8220;Dividend Reinvestment Plan.&#8221;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#8217;s registration statement and any
offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under this registration statement,
to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#8217;s behalf in an amount up
to the lesser of the Fund&#8217;s actual offering costs or 0.60% of the total offering price of the Common Shares sold in such offerings.
Amounts in excess of 0.60% of the total offering price of shares sold pursuant to this registration statement will not be subject to recoupment
from the Fund. This agreement will be in effect for the life of the registration statement with respect to all Common Shares sold pursuant
to the registration statement and may only be terminated by the Board of Trustees of the Fund.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Based upon average net assets attributable to Common Shares during the fiscal year ended May 31, 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to 1.00% of the Fund&#8217;s average daily Managed
Assets (as defined herein). Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with
the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other forms of debt (&#8220;Borrowings&#8221;)
or reverse repurchase agreements, dollar rolls or similar transactions or a combination of the foregoing (collectively &#8220;Financial
Leverage&#8221;), which means that Common Shareholders effectively bear the entire advisory fee. Because <span style="background-color: white">the
management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#8217;s Managed Assets, the management fee as
a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial Leverage. If Financial
Leverage of more than 16% of the Fund&#8217;s Managed Assets is used, the management fee shown would be higher.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is estimated based upon the Fund&#8217;s outstanding Borrowings as of May 31, 2025, which included Borrowings under the Fund&#8217;s
committed facility agreement in an amount equal to 2.08% of the Fund&#8217;s Managed Assets, at an average interest rate of 5.08%. Interest
expense on reverse repurchase agreements is estimated based on the Fund&#8217;s outstanding reverse repurchase agreements as of May 31,
2025, which included leverage in the form of reverse repurchase agreements in an amount equal to 13.77% of the Fund&#8217;s Managed Assets,
at a weighted average interest rate cost to the Fund of 4.52%. The actual amount of interest payments and expenses borne by the Fund will
vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the Fund
as an investor in other investment companies during the fiscal year ended May 31, 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">Other expenses are based on estimated amounts for the current fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">The total annual expenses in this fee table may not correlate to the expense ratios in the Fund&#8217;s financial highlights and financial
statements because the financial highlights and financial statements reflect only the operating expenses of the Fund and do not include
Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly by the Fund through its investments in certain underlying
investment companies.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed and shown. Moreover, the Fund&#8217;s actual rate of return may be higher or lower than the hypothetical 5% return shown
in the example. The example assumes that all dividends and distributions are reinvested at net asset value. See &#8220;Distributions&#8221;
and &#8220;Dividend Reinvestment Plan.&#8221;</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AcquiredFundFeesAndExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 10<br> -Subparagraph a, g, h<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AcquiredFundFeesAndExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_AnnualExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_AnnualExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BasisOfTransactionFeesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BasisOfTransactionFeesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_BusinessDevelopmentCompanyFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_BusinessDevelopmentCompanyFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_DividendReinvestmentAndCashPurchaseFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_DividendReinvestmentAndCashPurchaseFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_EffectsOfLeverageTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_EffectsOfLeverageTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYear01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYear01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to10">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to10</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ExpenseExampleYears1to5">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ExpenseExampleYears1to5</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FeeTableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FeeTableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_FinancialHighlightsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_FinancialHighlightsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_GeneralDescriptionOfRegistrantAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_GeneralDescriptionOfRegistrantAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_HighestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_HighestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InterestExpensesOnBorrowingsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InterestExpensesOnBorrowingsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_IntervalFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_IntervalFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_InvestmentObjectivesAndPracticesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 2<br> -Paragraph b, d<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_InvestmentObjectivesAndPracticesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LatestPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LatestPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidNav">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instruction 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidNav</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_LowestPriceOrBidPremiumDiscountToNavPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph Instructions 4, 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_LowestPriceOrBidPremiumDiscountToNavPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ManagementFeesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 7<br> -Subparagraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ManagementFeesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_NewCefOrBdcRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_NewCefOrBdcRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OtherTransactionExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OtherTransactionExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecuritiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecuritiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityAuthorizedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityAuthorizedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_OutstandingSecurityTitleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 5<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_OutstandingSecurityTitleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PrimaryShelfQualifiedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PrimaryShelfQualifiedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_PurposeOfFeeTableNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_PurposeOfFeeTableNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RegisteredClosedEndFundFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RegisteredClosedEndFundFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 3<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SalesLoadPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SalesLoadPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityDividendsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityDividendsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SecurityVotingRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 10<br> -Subsection 1<br> -Paragraph a<br> -Subparagraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SecurityVotingRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SeniorSecuritiesNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 3<br> -Paragraph Instruction 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 4<br> -Subsection 1<br> -Paragraph Instruction 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SeniorSecuritiesNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_SharePriceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 8<br> -Subsection 5<br> -Paragraph b<br> -Subparagraph 4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_SharePriceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_ShareholderTransactionExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_ShareholderTransactionExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_TotalAnnualExpensesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br> -Section Item 3<br> -Subsection 1<br> -Paragraph Instruction 8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_TotalAnnualExpensesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cef_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AdditionalSecuritiesEffective413b">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 413<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AdditionalSecuritiesEffective413b</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ApproximateDateOfCommencementOfProposedSaleToThePublic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ApproximateDateOfCommencementOfProposedSaleToThePublic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:dateOrAsapItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DelayedOrContinuousOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DelayedOrContinuousOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DividendOrInterestReinvestmentPlanOnly">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form S-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form F-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DividendOrInterestReinvestmentPlanOnly</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveUponFiling462e">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 462<br> -Subsection e<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveUponFiling462e</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EffectiveWhenDeclaredSection8c">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Section 8<br> -Subsection c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EffectiveWhenDeclaredSection8c</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-3<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-4<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form N-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyActRegistration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyActRegistration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_InvestmentCompanyRegistrationAmendmentNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Investment Company Act<br> -Number 270<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_InvestmentCompanyRegistrationAmendmentNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:sequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_PrincipalRisksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_PrincipalRisksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_MarketDiscountAndPriceVolatilityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_MarketDiscountAndPriceVolatilityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_DebtOverlayStrategyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_DebtOverlayStrategyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cef_RiskAxis=GOF_SyntheticAutocallableELNStrategyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cef_RiskAxis=GOF_SyntheticAutocallableELNStrategyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 20, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001380936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Guggenheim Strategic Opportunities Fund<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">N-2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">N-2ASR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 20, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457oFlg', window );">Rule 457(o)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common shares of beneficial interest, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 969,300,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 133,860.33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Estimated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, solely for the purpose of determining the registration fee. The proposed maximum offering price per security will be determined, from time to time, by the Registrant in connection with the sale by the Registrant of the securities registered under the registration statement.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule415a6Flg', window );">Rule 415(a)(6)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Equity<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Common shares of beneficial interest, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 30,700,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdFormTp', window );">Carry Forward Form Type</a></td>
<td class="text">N-2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFileNb', window );">Carry Forward File Number</a></td>
<td class="text">333-279126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrrFctvDt', window );">Carry Forward Initial Effective Date</a></td>
<td class="text">May  06,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CfwdPrevslyPdFee', window );">Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward</a></td>
<td class="nump">$ 4,531.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">Pursuant to Rule 415(a)(6) under the Securities Act, the Registrant is carrying forward $46,758,272 aggregate principal offering price of unsold common shares of beneficial interest (the &#8220;Unsold Shares&#8221;) that were previously registered for sale under a Registration Statement on Form N-2 effective on May 3, 2024 (File No. 333-279126) (the &#8220;Prior Registration Statement&#8221;). Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid with respect to the Unsold Shares will continue to be applied to such Unsold Shares. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Shares under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdFormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., "Form S-3" in the human-readable and "S-3ASR" in the XBRL).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdFormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:formTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrevslyPdFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrevslyPdFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFctvDt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFctvDt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CfwdPrrFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CfwdPrrFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule415a6Flg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is claiming a 415(a)(6) carryforward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 415<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule415a6Flg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457oFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection o<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457oFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 20, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 1,000,000,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">133,860.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">$ 133,860.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>17</ContextCount>
  <ElementCount>90</ElementCount>
  <EntityCount>2</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>5</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="gugg89389n2asr.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995470 - Disclosure - N-2</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cef/role/N2</Role>
      <ShortName>N-2</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ex99s.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ex99s.htm">
      <IsDefault>true</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ex99s.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>gof-20251121.xsd</File>
    <File>gof-20251121_def.xml</File>
    <File>gof-20251121_lab.xml</File>
    <File>gof-20251121_pre.xml</File>
    <File doctype="N-2ASR" isN2Prospectus="true" isUsgaap="true" original="gugg89389n2asr.htm">gugg89389n2asr.htm</File>
    <File doctype="EX-FILING FEES" original="ex99s.htm">ex99s.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>guggenheimlogonew2.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="91">http://xbrl.sec.gov/cef/2025</BaseTaxonomy>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "gugg89389n2asr.htm": {
   "nsprefix": "GOF",
   "nsuri": "http://guggenheiminvestments.com/20251121",
   "dts": {
    "schema": {
     "local": [
      "gof-20251121.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/2006/xbrldi-2006.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025.xsd",
      "https://xbrl.sec.gov/cef/2025/cef-2025_pre.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "gof-20251121_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "gof-20251121_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gof-20251121_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "gugg89389n2asr.htm"
     ]
    }
   },
   "keyStandard": 64,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 4,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 14,
   "entityCount": 1,
   "segmentCount": 4,
   "elementCount": 198,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/cef/2025": 91,
    "http://xbrl.sec.gov/dei/2025": 24
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/cef/role/N2",
     "longName": "995470 - Disclosure - N-2",
     "shortName": "N-2",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-11-21",
      "name": "dei:InvestmentCompanyActFileNumber",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gugg89389n2asr.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-11-21",
      "name": "dei:InvestmentCompanyActFileNumber",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "gugg89389n2asr.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "cef_AcquiredFundFeesAndExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "cef_AcquiredFundFeesAndExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesAndExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees and Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "cef_AcquiredFundFeesEstimatedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundFeesEstimatedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Fees Estimated, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "cef_AcquiredFundIncentiveAllocationNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundIncentiveAllocationNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Incentive Allocation, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Fund Total Annual Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AllCoregistrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllCoregistrantsMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Coregistrants [Member]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_AllRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AllRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Risks:"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "cef_AnnualCoverageReturnRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualCoverageReturnRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Coverage Return Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "cef_AnnualDividendPayment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPayment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentCurrent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentCurrent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Current"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualDividendPaymentInitial": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualDividendPaymentInitial",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Dividend Payment, Initial"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_AnnualInterestRateCurrentPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateCurrentPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Current [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRateInitialPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRateInitialPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate, Initial [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "cef_AnnualInterestRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "AnnualInterestRatePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Interest Rate [Percent]"
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "cef_BasisOfTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BasisOfTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basis of Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "cef_BdcFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BdcFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "BDC File Number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r3"
     ]
    },
    "cef_BusinessDevelopmentCompanyFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "BusinessDevelopmentCompanyFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Development Company [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "cef_CapitalStockTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CapitalStockTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Stock [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "cef_CoregistrantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "CoregistrantAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Coregistrant [Axis]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "auth_ref": []
    },
    "GOF_DebtOverlayStrategyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251121",
     "localname": "DebtOverlayStrategyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Overlay Strategy Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DistributionServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distribution/Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DistributionsMayReducePrincipalTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DistributionsMayReducePrincipalTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Distributions May Reduce Principal [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "cef_DividendAndInterestExpensesOnShortSalesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendAndInterestExpensesOnShortSalesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend and Interest Expenses on Short Sales [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_DividendExpenseOnPreferredSharesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendExpenseOnPreferredSharesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Expenses on Preferred Shares [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r5",
      "r74"
     ]
    },
    "cef_DividendReinvestmentAndCashPurchaseFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "DividendReinvestmentAndCashPurchaseFees",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend Reinvestment and Cash Purchase Fees"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "cef_EffectsOfLeveragePurposeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeveragePurposeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage, Purpose [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_EffectsOfLeverageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "EffectsOfLeverageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effects of Leverage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r59"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "cef_ExpenseExampleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_ExpenseExampleYear01": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYear01",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Year 01"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to10": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to10",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 10"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to3": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to3",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 3"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_ExpenseExampleYears1to5": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ExpenseExampleYears1to5",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Example, Years 1 to 5"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "cef_FeeTableAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FeeTableAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Table [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_FinancialHighlightsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "FinancialHighlightsAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Highlights [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "cef_GeneralDescriptionOfRegistrantAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "GeneralDescriptionOfRegistrantAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Description of Registrant [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "cef_HighestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_HighestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_HighestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "HighestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_IncentiveAllocationMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationMinimumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationMinimumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation Minimum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveAllocationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveAllocationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Allocation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "cef_IncentiveFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IncentiveFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incentive Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_InterestExpensesOnBorrowingsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InterestExpensesOnBorrowingsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Expenses on Borrowings [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_InterestRateRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestRateRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_IntervalFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "IntervalFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interval Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "cef_InvestmentObjectivesAndPracticesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "InvestmentObjectivesAndPracticesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Objectives and Practices [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "cef_LatestPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LatestPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latest Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "cef_LoanServicingFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LoanServicingFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loan Servicing Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "cef_LongTermDebtDividendsAndCovenantsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtDividendsAndCovenantsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Dividends and Covenants [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Issuance and Substitution [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "cef_LongTermDebtPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtPrincipal",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Principal"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "cef_LongTermDebtStructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtStructuringTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Structuring [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "cef_LongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LongTermDebtTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LongTermDebtTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Debt, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "cef_LowestPriceOrBid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBid",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "cef_LowestPriceOrBidNav": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidNav",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, NAV"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "cef_LowestPriceOrBidPremiumDiscountToNavPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "LowestPriceOrBidPremiumDiscountToNavPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fee not based on Net Assets, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "cef_ManagementFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ManagementFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "GOF_MarketDiscountAndPriceVolatilityRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251121",
     "localname": "MarketDiscountAndPriceVolatilityRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Discount And Price Volatility Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetAssetValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetAssetValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "NAV Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "cef_NetExpenseOverAssetsPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NetExpenseOverAssetsPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Expense over Assets [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_NewCefOrBdcRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NewCefOrBdcRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New CEF or BDC Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r71",
      "r72",
      "r73"
     ]
    },
    "cef_NoPublicTradingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoPublicTradingTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Public Trading [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "cef_NoTradingHistoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "NoTradingHistoryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading History [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "cef_OtherAnnualExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": "cef_OtherAnnualExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherAnnualExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Ae": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherExpensesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherExpensesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "cef_OtherFeederFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherFeederFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Feeder Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherMasterFundExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherMasterFundExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Master Fund Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_OtherSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_OtherTransactionExpense1Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense1Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 1 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense2Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense2Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 2 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpense3Percent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpense3Percent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": "cef_OtherTransactionExpensesPercent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expense 3 [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesAbstract",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionExpensesPercent",
     "calculation": {
      "http://xbrl.sec.gov/cef/role/Item3Te": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximum": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximum",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisMaximumPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisMaximumPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Maximum [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesBasisNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesBasisNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees Basis, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OtherTransactionFeesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OtherTransactionFeesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Transaction Fees, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_OutstandingSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "cef_OutstandingSecurityAuthorizedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityAuthorizedShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Authorized [Shares]"
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "cef_OutstandingSecurityHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "cef_OutstandingSecurityNotHeldShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityNotHeldShares",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Not Held [Shares]"
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "cef_OutstandingSecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "OutstandingSecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Security, Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r26"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "us-gaap_PreferredStockLiquidationPreference": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockLiquidationPreference",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Liquidating Preference"
       }
      }
     },
     "auth_ref": []
    },
    "cef_PreferredStockRestrictionsArrearageTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsArrearageTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Arrearage [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "cef_PreferredStockRestrictionsOtherTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PreferredStockRestrictionsOtherTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Preferred Stock Restrictions, Other [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "cef_PrimaryShelfFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PrimaryShelfQualifiedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PrimaryShelfQualifiedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Primary Shelf Qualified [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "GOF_PrincipalRisksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251121",
     "localname": "PrincipalRisksMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Risks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_ProspectusLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ProspectusTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ProspectusTable",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_PurposeOfFeeTableNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "PurposeOfFeeTableNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purpose of Fee Table , Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "cef_RegisteredClosedEndFundFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RegisteredClosedEndFundFlag",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registered Closed-End Fund [Flag]"
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "cef_ReturnAtMinusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtMinusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtMinusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Minus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusFivePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusFivePercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Five [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtPlusTenPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtPlusTenPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Plus Ten [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_ReturnAtZeroPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ReturnAtZeroPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Return at Zero [Percent]"
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "cef_RightsLimitedByOtherSecuritiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsLimitedByOtherSecuritiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Limited by Other Securities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rights Subject to Other than Majority Vote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "cef_RiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Axis]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskFactorsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskFactorsTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk Factors [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_RiskTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "RiskTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risk [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "cef_SalesLoadPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SalesLoadPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales Load [Percent]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "cef_SecurityDividendsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityDividendsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Dividends [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "cef_SecurityLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiabilitiesTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liabilities [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "cef_SecurityLiquidationRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityLiquidationRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Liquidation Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "cef_SecurityObligationsOfOwnershipTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityObligationsOfOwnershipTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Obligations of Ownership [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "cef_SecurityPreemptiveAndOtherRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityPreemptiveAndOtherRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Preemptive and Other Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "cef_SecurityTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Title [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "cef_SecurityVotingRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SecurityVotingRightsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Voting Rights [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "cef_SeniorSecuritiesAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "cef_SeniorSecuritiesAverageMarketValuePerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAverageMarketValuePerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Average Market Value per Unit"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Averaging Method, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "cef_SeniorSecuritiesCvgPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesCvgPerUnit",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Coverage per Unit"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "cef_SeniorSecuritiesHeadingsNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHeadingsNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Headings, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Annualized, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities Highlights Audited, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesNoteTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesNoteTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities, Note [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r46",
      "r53"
     ]
    },
    "cef_SeniorSecuritiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SeniorSecuritiesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Senior Securities [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price"
       }
      }
     },
     "auth_ref": []
    },
    "cef_SharePriceTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePriceTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "cef_SharePricesNotActualTransactionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "SharePricesNotActualTransactionsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Prices Not Actual Transactions [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "cef_ShareholderTransactionExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "ShareholderTransactionExpensesTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholder Transaction Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "GOF_SyntheticAutocallableELNStrategyRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://guggenheiminvestments.com/20251121",
     "localname": "SyntheticAutocallableELNStrategyRiskMember",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Synthetic Autocallable E L N Strategy Risk [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "cef_TotalAnnualExpensesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "TotalAnnualExpensesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Annual Expenses [Percent]"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "cef_UnderwritersCompensationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "UnderwritersCompensationPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriters Compensation [Percent]"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "cef_WaiversAndReimbursementsOfFeesPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WaiversAndReimbursementsOfFeesPercent",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Waivers and Reimbursements of Fees [Percent]"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "cef_WarrantsOrRightsCalledAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledAmount",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Amount"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledPeriodDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledPeriodDate",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Period [Date]"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsCalledTitleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsCalledTitleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Called Title"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "cef_WarrantsOrRightsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/cef/2025",
     "localname": "WarrantsOrRightsExercisePrice",
     "presentation": [
      "http://xbrl.sec.gov/cef/role/N2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants or Rights, Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    }
   }
  },
  "ex99s.htm": {
   "dts": {
    "inline": {
     "local": [
      "ex99s.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 26,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2025": 5,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 28,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99s.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99s.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99s.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99s.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99s.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ex99s.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r86"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r88"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "4"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "5"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "a",
   "Subparagraph": "Instruction 2"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "c"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "1",
   "Paragraph": "d"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "a"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "c"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "2",
   "Paragraph": "e"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "3"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "1"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "3"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 10",
   "Subsection": "5",
   "Paragraph": "4"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 1"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "a, g, h"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "f"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "g"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 10",
   "Subparagraph": "i"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 11"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 4"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 5"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 6"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "a"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 7",
   "Subparagraph": "b"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 3",
   "Subsection": "1",
   "Paragraph": "Instruction 9"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 3"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "1",
   "Paragraph": "Instruction 8"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "3",
   "Subparagraph": "Instruction 2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "5"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 4"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 4",
   "Subsection": "3",
   "Paragraph": "Instruction 5"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "2",
   "Paragraph": "b, d"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "a"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "1"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "2"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "3",
   "Paragraph": "b",
   "Subparagraph": "3"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "4"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 3"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instruction 4"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "b",
   "Subparagraph": "Instructions 4, 5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "c"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2",
   "Section": "Item 8",
   "Subsection": "5",
   "Paragraph": "e"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>29
<FILENAME>0001821268-25-000250-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001821268-25-000250-xbrl.zip
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MN[*/BC87U13Q9]5Z4/,"2Q,D-1$0M('C$F(]S")S\ #@2S!HH+:+L71HE^!
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M+#CF@UI8JR1B>:@CH&YVRM$J0<70X[*"+,GC >$FT1+Q4 %ZDSG()X Q32)
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MMP_@:3G@QR[W3J2^F6PY4Q2?FK,A7TP)HQ/$B7H;*T4( =+*PV"D+7!-]ZM
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MU UQ>?D:SZM^RQQIL>+;9<,G).#:8 ?XD\BG]!O)^%/*_P=02P,$%     @
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M=L1\:+?@#[!P@W0(AS'N=ERE!%QR.!UYQ'2P1[#,?0XYPY#ZV@>-G79AZOP
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M8B<;9SH$,?$Y:79F(QZG((-!BMII+J_VXL,>2#XZ!!P_P9EE7YYU+0:-X*U
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M2$AE>>[[QLH;9"(1#2_:;MUG&<PJ%"BW'QW7;>;DIA4X+5#6G0KF1.[:$5J
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M1&HRQ:&X@[ T2@KE"U:2\KB2 L<[YO8R%5/^5DVTEUB'OEE@*K;#^^,/QGQ
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MB-+5C4_?J>GH(I1]"E.._9\J[7=P@WZRSJ,Z\,9!AG"MSY\/+*+WP+0Y\*[
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M*:)GGB)ZS"8J83:DWC.H\-B8I?@*TZ=C\)&QB4FQO41E'D=<1X\ZU>9Y$SW
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M(@O*#3"KH &/."$QNTGA'Q RFS(MA("B5+.ER4:L9@O)H>Y3UU6ULS6]P6C
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MV%FLN)J9L,6,^;U>8/(NB_LN2LTMAL!!AS\5[=>+#R<8V;B)L:L<.ZBK(">
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M,=^SM#[6^IM<4&T:AK_@1YAZ9IRH&<_GEF:PF* R8'6&7CB@T#9(B?F[6/
M;C1SP3WB>G-FKWD=Z%HLCJITI<$EH?-Z#>S/,3H"<-Y;0]6XCB>1+G* ZQTQ
MT]E +G4S[N$17-FZ*$(I=BJ>4E#<=O(J@#D3@U/ZR5$KLG:K)J-\("W3L%2
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M4+IZ9C%\'F3].$##8__B8)V4"2%.=#Y2:T<7O\\-&3Z'L\:A0'2)YFI[+,-
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M._WS;M=#VA 1$2X%M#TAO;,?7[\@>[6^^3ZZ9,"C$%U(ZG?%4)ZB&Q)#B*Y
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M<'RN;T<S9=-X=#%])'BXKWK2,-^->:;#3"T>C"ZXP_8&3(#D<^%#H>NR[OW
MZ!)C(=5 \V@%S'X<6.<9%$58]"M&_VXZKZ+_[,K?83$%=46DS^=,M5F@J_OP
MQ*E^#J!$K8R%G7DH0BXK)<4;2K.3G_DI$E78[G;.8@&4*B M@2(-]"H21?!C
M$W@%0W6OWS8H7@V4?CF \?[0'<"7E;-<MM-H[05_BC3E<;@=(,-!"0FEK!(2
M,U@Q-0%%_/9<:1+5ZA2NN[U<\2E"+BM+Q1M*@Y6?^2E25MCN=N0R ;2N@*Y1
M%_7R1W!]R3R-F5=Z9^.=7J_\ 5!+ P04    " !YF75;>)@X +0"  #]#
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M],T@+.+9WP@<P04!;P1/, 4972\JDU2,$8 :X3P8H>4#F!Z.<P/T\D4@7K]
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ML&N"DF\JP^T%)NY$57Z@* W>P1'SS34068:^Z_A">!P,B'7[2<0PIR"3X-$
M36*!Q[<DWE6NUP!;!I7+# 4JLCQ(<T\"L,28(HP#+F%,*1(5XY1=APUE2(3/
ML04N)[."P9BFQ,LS972#\ GX/:((YX#=@F0K"^;#[I)\A:&I-!C*VCC!U(_P
M!&%G8<'^+!(/&GT0+\9<5L>6\W"L- Y(%&/3]6]AEV]40RZ"@W\Y\ /9IP#W
MBJ,YH,0-"DP4"A_R^Q-P,UHX0Z]U>JYXUXR!Y:$JP#QL)"+VS@]"X481 6S6
M8.PP/(XHL;WJ#M:>E&)=2'SB)$K=4(F6QGW@HK+$OT<)T<&P8Y!/X$A)989M
MU=&7-I\'"-NL']''D'D.7!N)C?'5W%1.4\+\6'M1]#"4"AA=30ON8> P&(3'
M8M'6$S&B^R3(@X/[Y<ADX8K9GT6DO[E \;A;JX*( ?>,-$'?L^%YUP?5 \<R
M\"^0^E"A<::$.O SMYK. J6Z)2Y;Q?Q4NZR9(\0KCS8/@8*K[0T2ZZ7-P(<8
ML#HB3+,I[*(E LUHP_P^\$$QK3%A7[Y8'M$,I*D!&[( 84B-"7H,:6 HD<8_
M5<2%1 R?4*2</[C&I8I]<!VKSR^,=-_)! -X"-8; F_!48=$!4(C/EEQDCJY
MD4<I>/8Q?R+G1 7M6$ OB<C<4,#=$$/TH@BC11 1YRCA&H(*YS&@F'YH&& R
MT,9]4L<M20L)@VX1-/AV$[",-![8B!O2K[#]ENE/Z11H%R<6<*>AEDECX+^(
M6W,Z1Q@ 6%ZDW@%0T-8 2CR@I%FT*3ATA9-VU,]P9]&P$%7D^X-,V"&_3QSS
M_:$1_Z+Q7@ 6V$+HBP.B*PNC1U5,ETYBCSRV@\-+=4*T7B :(T#@*I'/Q#LT
M4:@CFH$3\NUFW/;![N SWAEQ/8BN$JUU<;C 0OX>SY) >J#2L&6,XCIU>D08
M&4/\X?CT8XQ5F^JT#45VM.N"F \\#202;A/$=[<J&JW2YLQ;\OH)MHSQ3Q%I
MW%FZ!AKV&2*/JP)\&9$G*9H#V1D%;,0WSR%6ZHNQ84>< 9.VHL3]DR2"1&U\
M I@@@XN/KTNJ4$&J*"2AG^JU>L.8HG2#KZ2O/Q?9XXP1P$"LY."CQ2%@"B#*
M4;$F:/]":A5Q #F2H\3!0+B"8R +!C#ZU"A / '3",-H2]!T<1'XX12NQPP0
M!4/08%0I9VL_7:HW)8@U\V]_!FOQ9R[FJ%AV9CBBZ$ C)7;D#@?R 2#=S'7G
M)K<?F',8U@;R9%/Z77PA90B[VJQUXU@6I9+SFYN-+1 P@91&[ASW4]]JZ1''
M$A.;S:U841@1\4_0=)K 9B&PN%BFUM,/8=#-UA8)>($:B8Q82)#1X>ZC\&"Y
M\&?-0+AS]UHH%FBT0@+*.?;,!115^"X20^,UDGBFE 0\3K$"F#$! 1R4[][P
M;"98F!$"-)GA. &A,6,DI4&GV)>1#$0JEH!0&VXQ8Q6Z;2)W 9<J6LN"G$PB
M%2U.JBIJ5U$T*0 6XQP JE'F6Q+9*1>,)'BN77%:3)>.CJK/D-T-N#$QQ450
M;"+>EEBWD3S^2M'AD8P.0CQFJ:'F,E?NYM2]B@K/&/!H$#A];IIDYH3!@#9_
M!XF#(6A9X8G7X(XH31N3_?")-VA2=4 L1)554("U&;*R%HOULA+9QDK(ZAE*
MGSQ)@><A27H69@QB/VQ=>"+'"'Z),H2/<I;>]2PQ](Q"9D"4@;,&U*B9!Y[.
MP#5HT H!(A\J&"A+:0_A5.GIIS[<%;Q,H)V&DGWA'0[H6HF:5 *EB18AU>6#
M)A" FGV+ T<&@[9=L]60:&GDH*6,I<YCFA.?<G$'7.#W9F1(0?4=QZ9DEK/J
MT>4' C7"W!0I;,6Y):<>]S/@%!^ :P<DPLB9T+I%LS5?41\"N51:APY212Z*
M7W%*_E0J#HD\) NAC=[$?"O'2S"\F&N!)A$ZPIT0,H,??.2/&$E)W"#ANG)J
M+CLYVAK0HV*1Z]7Q,E==L,2)=<UE<>2+1 2!@"LZ68"PAN*2ZS?X+6%Z7F*N
M/+N^[D:HY]=T<8JJ]Z1=+:T?I0Z-."Q><N9)CO^,.2+%>:F^CBI?^OA(*20>
M,F5,[R8U1M.X--Z/1B_*C+CA+CT0!.*/0WX%4Y9,FR'?XQ<LPTL--(8&LV@,
M=]F4;FAX 0DQ4H I6NJ\B-]4DI@97=C "N;<\@R\%AOS<I7!"]FJKMN3L<;\
MB30:9!-!S&G#N::I5]:*%*O)-)>S^!T(0PKBZ^6L7Q6?,RZ*=!TY,U%'KBBM
M08P6FPL&:&T.LX1;X^J6!A$E68139#3(TX'8$+_3G!L:8ZN9FA?L D1\#^5*
M#9KWZK4LT-K:=0=+:G8S.;N1Q^ECFWS"&E,SCS'-2;Q1< )$1&)(^$6['?O
M;JO^+=YDD(2 Z3H6%Y"U Y(+%DL3R\K9D5B-S=NNM%-)BSX)>3TZ]/E3B0G@
M[[<@O,,_\8Y4#&EJ0Z,XBT@\5$O5SHT;73#/BT5$4I0@*I,&$+&)ZF IJXA$
M&"ZQH W!,B?.'7X56\[@<1XJ@@0)X:P8S+/]6V%6TL 8SLB,.\1:@-*0Y*"5
MGFRUW, I:;@46P"V:,;M=<()<4-R)1J:8)?RME(*OD8XF^+6A4(VM.+B/ #L
M3ZW.CMD'O5#^BM8WNB3PX9)-(TY\6G5.? I/#=LA_S.C$MJRGC;5-*15 ,DP
M_O:#:UEB8^3Z??1(@>*(W\),8L^DCHV:&&[^)X_,OU37!W;I> 9'QK@N>Q Z
M%E<!ET1F[MKA9C8T&G#ADNQ\W'D NR%H@Q)^.3%:G=[U ,IX 7=X0!<W8V4#
ML=9'.[?AT$GQ R.M6K@[--<#]U>D18,B*V]*IQ8V(*D;DS6>LV38N#YS_=NJ
MYK@=!9:=$ (V66U4J^C?"!D?WS0/+:N%XOY[W[?GBGR=*C^5J#])Q51A%/'2
MX6$57[H4\6?FOZS)]!5LEA_((8P/9&H),:)N-D7AXL2)X-[*KX6T8056'TY<
M:1V6Q^^:=''@;VS@CSPR_Z)L!*HX.5(#;LKQ@Q'<TR_"8Q=44,J9>31>11-^
MC/X\@XH\6PF=U1(0)AQ"<Z"+A[12C6!D-A91F9M!W;G":;(MA1)WQ\YH7"4G
MA,!> ]8M?OL\\ZZE%D8^)6XQI$&Y3H4K!BED)MSA=&V1%W$EF-9#)FJUZ>CB
ML :(3*@@6;%_AH8&>0Z^4OHOMY05,&!N:/7FDE7IOK-H/N4FWRQ6.])F%.4@
ML&;TK^1@<\5(XW)FRVLF=>DB)[KB+KA=7#T6O(+F)2,;6J/DY*A(8CC;GMFI
M_TQ, ^V0%,P@+B^22ZXZ9OTN="2<-7&$4?ZQ5T"5"\>3C",5>Y%T..HII+F/
M&G!F-RGG!K$O&5_ IT$'?W*(&P:'X;+P%7"-0A@]WZN2-])&7TM0!6KHHTR/
M-S)SP@:M7KI"$1MB'R9:_@D=0Y-31AL=\B%9LM-<Y!6]VRB&*HM;^* 8WO$,
M)B-VA8CQ!!Z7E)U09PCQ!>1Q+^[<P*4C>408DS9E^)^*XHW)G[226&E;B"@B
M4=',8(C?PC^#.X.""SIK21;A\1<&+IIX_B5YM)0RJDN]9W]?'BMQ-XX-#2G"
M5C[T]OQ$<F#B3B U\-,2_AU!)U(KC83PYH<,,4>E@L(C2J-JM+E08]X"W?RI
MT:BU>F;L)Y+[Y%IPB<FHGO!)I;:/&PQQ0?@W&:ZI3B$?NEG;;50,I=9RFQ)\
MF#BS"6UG=DV-5JW=_CEA$WS/J0Z7J$#8H1?^H!<TX]QJQ95%:'FB9/-WRHZ:
M$58P=@/%+9 9>0R-%L5%<N8M&NV%X(7V6%=>3!G)96LV\!!9-0^ZPDV,M0-I
MR9429$5(1+( '++^/6/3V5+,BQ>;&^J^5^%=4EXX^4/:1[CIP#A]/PAX91RA
MF.F#(IUF 4$VM1"G%*W$<R)B1LY?.=>A'"PY"TP3X,)"IN=Z6J. ,:%7<-)I
M!O /CQ\#KH9?4+2_-1 N_@ &N]G*!,L9O,(/< &?@@L$,'(O[<0H\@[R*(Y8
M:*ZHZ, ,.L2Z7@(E1-"<J5XPY O"34RH@.P9".Z$E[814M3B\@85RON>\'P'
MG=!0[0.MN,$K<^S?XIR<;RL_M"$L\S!>=C6HYB!?5Y369'=3E7[.[@8,_FJU
M<FIR\5J?O5H'38,-$4&_?<]S+?'<S[EJ_GL1CW? ^9:>2<05FRU1.Y5(D4)-
MP;85[CZA*]<A<WO(D1#.ED*E0&;D<7 2I0V2-0_/+E"[=/H6<B+TQ!X&_C4_
M!4JJEE)ZQ7P7V;7X&L7OQ?=(3R[-D1'Y7J@ A4X=='M2A[F82N&G0*4%9E@W
M%MPO%-A1B!>O*LZ5LS*<0K"^K']9!PW?YV$$XKSC/>&2CO0Q92>I 1K@6^]A
MKI8P$U9,70Z(Z8L&;2:LHNA0@$8'<#>2AH-XHRIFDK,EGFO^G.N02N$OMS<H
MMJFDE(!ST,20QD^MYJZ<FY<.74 B]6U8"&BC_4!(#80T?^LS@W"NET-3%$!8
MM"()3W<9>-9]@;_6*/Q8UY)SOU>I_>-YE9Z&6!=YR54$C+APQC(R"05W@Q(+
MFMV K"JY$HJL&"RT=-"BL7B8#/:0E"\!7([TH(@&.6_EF#*(5(@02;^XH.Y(
M8-%;G'-#2285 30B"&4X"TB62XYL:+$T <:=!I("B8S'XR,*H)F%H>+2Z[Z^
MIYXJ#UE)LCWF43@C6D!%/ 6P!53V0:@+C<3A:!9G<9!:730TBH7QH?I:3$4&
MG[382<&&B.)G,0'%K#XS-',4KJL/>TU*'+I" /-0,E2[*T4\+=*)CQ+CE)/%
MJ#@",9;\TDAB9)&"1VH7195D%R7P1L,7GNO=&U;;&D.6:U"Z9P%&&3%&/94
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M(%PPWI*#-V914U%]7]0"\W9 K2JNDX_O<5RA,$*M1EE2Q<%&@+*Y8(4 ",?
M3JI(YWC%LJJH;AP6M8$D$\U,-#Q7H* # =MWXEJDSB>+LF>*#%MS8;(A"!(=
MG2K)7H%"?84797%>+,Z9JE(\L$*L?>TFBOKKDRZZ!UA^F,"8A3,R@,U$%65L
M4IAL-I6#(!F#E/X&QY"YWBO DCHT:LM\FRJJ@JR\@:(.MA M8KU;=H(1O6=R
M:B4G,$'9G?***F,C7XZ:-RQU**:5.994W\&<5<@%QD9"9R+]80ISYZ+M*LXJ
MSR5ADB2S 9;S#_RA$Q$8U/I!O0N"0H[9(GE, A)9G9T*L&?.Z9ZI^2021PB0
MC&*)A)@*369+?5*:&&]?1E5.8\ME;.*.JU1E!)]4<P;1_P"!D/1.UES5C0R)
M Q,UZ?%:4F$G],'!77)\<0. E]6>6AI!B^136$"_D9UU@2MOYY5YSCW[>SBQ
M<*&^XIF$ -97]*Z9+O)])=R3.4-0](X.N 3YE?EQ/@7(#@*K[PQ>F6?6A/%E
MG?D(;"/A)9-OX2^Q1W7E;76FR9T1X.=/N,Z^.SEGO\)^/NN1UA?+ZMD8-R'@
MYYCD4W%+U*J.]SK?NV_)6EN[1EU(YGF^HT1,$Y?2<VWUJP0EPU3RY#X Y(D,
MXP/+XS$;X2S0B_@A*T4H1/<':S#&6)M"036'6>;*LTZH=WO&IKZ6:*5K)9B0
M*CXH5&X )>*=:0+_ADQRN1T<],,448*/Q,<5GKB\Q&D\6^L4I5D]5NY3;1&T
M2WBI@M?R;^$*0;APJ<\-Q?>IH*2X-05^?*KV%(GX /,;-:?(/06 AGO2@PCT
M9(?:C5 9:QATN1%6TJG"S'6_JR;N.E6)PQ\+8B%4M ;9Z!)Q'<FN$''P!Z^\
M;Q;4W\U&2:15S@1:)0V#Z?.[9S=E0* )U!#X-P\T]4B.,1M-V:]"Q5RH(KVD
M4DHC;68CD^;$4A*,'YY<:NB@;N,+C7PN-#+OMU501GD*$>A+(2>3FLE-[X !
M=%'%PZ=;#Y,P1QU YO /;($5 +H(JOI0,HI"V4)"^A1D-#YB $<_Y(-$4)2B
M@/<<L?DO:P(WO?"(\11S"')+-1 R2T.2D^[6U#=E(G@/:HI51 E7H1DG[,\R
MB(=Y8]Y'3=/ R)UPB_8TBYOEN W.'QJH($DM+&DN[,L6])1LH9:<;G.;[%.)
M!O]1N&=N.EO<V"E;JL/-F!+10#U*!+]L*LE"_& D0T8K, R,H]JP2Y>J/BA%
M= 4$V=2:<L.A:)GI"Q<EMD2->Y^K%M^)66":;']LH[!=+UHG\QKTHB?=N=G*
M*KH(-EZWD8_KD,"X"F/T4?0('K14<%74G5=DLD46_^(@VP1*B$BPQ1TSJ=TJ
M;T\6QKUA-&)S)"+H5 I#NUXQ"E(89&]6"= K<^S?XIS<=)O72#:OCZ4(=E8.
M+YXBP_T/[ []%6:K93:V6S]G>M;E-"/?M# Y:4BT7'1G$WXH[EV2Z"3BTQ2^
MK2[S(G%555>P>[K)(X<Z/+LP+X#G]:W0 $XP8>9AX%_S73JEEF(69R85\UUD
MURJ)C)04+R7[/ZU-!1+%W>DYYLA&S]*5HI*A,.J'7C5B1T8.]-0ME2PAV3B3
M!&@D&>@Q!/&Z1ZK44/XDV$O>R/22UQI9FO$=U]PNF2"\XHW' /-DE_F?XHV2
M;BFM);V1?+BY3$=ZT1=#=:FHQ&VYS5N\7,GY6\U="0"*(UE:I;46-Q)-/3/0
MIH9NM!\#+AZ"F3F$3$9!81OD!?!TEX%G?6V^7EJ\/]L6[X]NY&YF&KD;WZ"1
MNUG0R-U8U,A]Y7W<\SH1T]GDI;(;.;ZGHN3!1S^PP'_8>\:NPN9S=Q5JY[6R
ML[[W@?)[ 3-J;*Y_;CV,JY]G01#,*TM[,+$LR18^S&!S&[UAM:U)3@E2([Q:
M]Y#WU5#S#$$M%">0PM]@HB1&.3M# ([4!JIQB;*G(3/]D]HJ"'\1-7@EL&?]
MJN@)FPA8"4,9_S.)Z__'G$'5&JB8>NV V)>HIS<97*<KZCJ?ZE>'P4&T611Z
M)>-V1 1+ON9$03T@(^IR64HI='C'/E$^079D7ZPC3H']31B%%\>1UH)QFP<R
M+1^?%,A68"+)5W@-32#A*@0ME2(3U>Y1:0 %KIUT,.-/Z1R'B$?DP8>9RVV+
M6C9B7-4"&]!.+,2:.>V+"#(33>%</Z38NH+U:"O.7UI.&0V14JJXO1 0< E:
MB^.P8B1-C*YSS5QG[/LVSB:1 0:W(J[ P+<8O,5CK"AWJ"(Q5N:!<-G-%@7C
M0E-*2:F@[8]ZXSM#BZ7E>Q^25WVA E]\UF9".9'N^K[(_P4]WP]5)890;!LA
ML%%\;19,EPFQ3$9(:O?4XMV>YY@A #>/&\*D[DM4CQ0/0PKZ6N]P/83RH="%
MR)<\AL0W+T @>1;JEA@/.(O$AF=#\KB'0D:14FD*GKWG1?2VAE5A>E^,9. ?
MS^X0D-&A48H9-7CV?*KCPML+4]RC)3>%U]0@@_9<H8,P76$/T0K&"<K/%?4$
M\#/L&3V<N35#2S-(M:Q(I\.5P4?T;3Q$E%B>D?B;KPK4QWQK-HWR</=0KG<(
M\,'' !]XA5]SKF9\G<R@"8NE\QM\9!/<(Z QL75U_=$D!Q%Q,C+!D3'!@N5*
M0(#<<C% E%RZB95X4Y>(1-K?+:5(X8EMJA0^;3"*HXWMZCI/KZAD)!(W+:ZB
M(YGC8>J^C-'F!(V3&\<C?ZK'YI*3Z=Y"Q-)<PPNWD)$#CN.[3[D6ZLV<)*O[
MXL4 #GL6<#=9>L$(NY9R$<Y"LB_@4(NCD!/I41EA5\,1<5,5_I#G4/T:)U&5
M,#[@AX^.*&I#L^9;KY5:P/ET=#(/N*@#;[][=Y1PW\0/ 4":,D3%%ZP!MP-G
M9(BT%,6"A*W?\F+A*N7>4!1"!^) /GP@'U;N+8#J(N5%R#Y=23NP) T#(H=D
M >5NO*NR%MPD]X1X8J2HOLP"OFQKB.4,PF345TZC:)YK(M2:O@^LF5X(@#2P
M9&G/Q,H/Y9,?Q9.2T0I(]<?T/3D@CP9*<%P:($TI0ETMN,$,;HT43ZUY6+0_
M%L^.A4>(EE'&%@5;8&8LLP+22/$TA<R".AK#I"D4!4VS4:O7\VWWEI K; N#
M-U*6?+FJY-=RY6G;9]JD.<3]E!"3S4*$WBJ\P'-4G"R!*/F>0:R2R+>(JYB"
M%R7.3#J[<3/R)6.3F&Y\,T+=ZHY;>C <@D1+TH]V%'17M]):2_X<J40S]+?A
MG,I]26B:\8;GF'=-0/)9"(S9ZJ,J2?49M15JWZOB2G2MY[DF#'F+U?H2W(JO
M4)XNW^M,M18GF1L7Q-6?\Q^=DB4_H<X-B>@)CZZ,DISZOIL<Y(:!".M2*CE=
M IL'&W%,S/.3:._JXA&*MQZO]84')=>>P6ZZK&G\IC DVF^%Z?<CX=?@" 9I
MQC[2;X C/'H/P'B)W\O1S@ (.N$51>&E]:Q<$EUHM\N+\%JE^V>!=V?W&7MW
M6B_>G:]TWGR'%=<6%)196Z&U"RN(/)1?-1X<ZR19%2#E!EDL^8?P<*[('_^R
M2.J71KD<6307I'RE(*,2Y#^?\?(\3!^(<SM4J&TBI+FVI!2>LU8ED^O ?8TP
MCMFXCQ#%*R85VUCVY0*)X_%R[_.M]Y0<A[^\BJC!8PL8OSB)/(5-W)\$WF#
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M'&.%/&$#BZZJX MY7 AIO,_R%J;CG2A@281'++6-@!D%&%O1I"6ZAQR%@6H
MO(').Q#Q<"PE/8G0L^1E)?(G#V7@!(/9!*ENTB5!X=FNP)J <>>I C%!PN",
M"92I-=<>87<#K*8'D.*^4)PCC*O(JBWB8RA2C6?,4#J5V-<,A4O<.6'8U8J9
M$IVGV$F$1$8NJ6I:<2Q.?BDM423;BA3#X%YDTA\M$:Z6O;KW7UN)+9GR:6LI
MG78"P%%)/=E%2BP/#T'5M^-HDU,4+;$.@#!F&WA#)&.(XP^3X>I9(.,(49B>
M5USET#HR+I!3&U'Y&D/F*6D8Q-S9@(G06/EJ)2Y6S6LABY0S58Z03R#CD"(*
MQ;-YY!1AJ:R#KJK6ZH#(*#LN8<K0R:+*<2*H7^Q('# 7;Y@*X+QG9Z8^4G!'
MW"0J^BM6'XGRDTN]C &1%;QFN#\H1)%E,Q)+E9X$.%^9A)Q3%/:>LGM<NADG
M2^]]L[)[_%K)^G=A7MV]O/6(K'1)\"=,S2J9=G95"F]4=ZH$0$*H21?DT[2%
MA!R1TUMDN5;:NG;!!?''F?X76/8;]6=LVF]_?Z;]YV>8_UK-5:^EO"K+GU[\
M>)4Z[)OEM+"T!)U6@@KT+N$C+Q %I0Q(;X"LZHFBG9S\$2Q$MF*ZQ%]C5N"1
MDU)1<R)JH@H0"+]!DM1JP17<JCD+>2*NGL_&G=D8R\XGAMEHI,0V;,G6E G1
MCHLB@8BCYP7U!P."0H\53&YH'.M-\<IQ"&7&,IZ*O%=VU+.#/Z3=E" (V- E
M]1KWA[SO2M?'W!UD%YK@FKL2R=KDH8 .#.?%LP>YD9'WM%(I*C%SQ,U*8<6*
M35>9*,8$@R/%V5&=S,@ $V<5D; EI=A4\6/:=9L-0  O",S(Q$Y1<#U(*)^%
M9L'STF58.D%ACF86Q;,RF>\ALF+TV:4 H/BW+)>A2FM03D5ZF2JO0>3[,WO%
M6WU*Y\E#:+.W /&:OO5O/=.S^-5T4J]DQ+Y0&G;[JLH &>QI[5P'XKU-]1NK
MCN"-5# _,.UN4]U_W9V'7\1!PC.J\$Z0(&R:(LAK,&-T,%>'-/M5:L<%Z;.H
M@UP61\Q-O)[H X#%X>+AAFS%I=)GP"FL2"1E!TSJ.]+^K64-);=*CPA+US;
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M[.00RL+(*2QO%U<%P.;C(Z0(HO *#Z):(O!_<> ^=JFA!*LD2HX9O[=6094
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M1GE5SA*=K!ZG-,:8N5,R7\8T9I%W0+NUG$[HM3BE2T)-!",Z-ZK+2/&HL8.
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M==Y""P8-&)*0_GSO'D0+U]-V8]6]EY=NK]M;27?=>ZQ+KYU]WAS#N3<O8VG
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MR[=?+8"KV7[^6>G$C0IZB?C#EY#0[WGP9\J/,B&A"QO0?UN%:;F>Y>@\*YO
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M@W/=[/C5\Z9PA5GL[LJA'8R8G1;BZX6_6!G"[P1!(+@Q$ G6(>M,",\">UL
MRI@5#;H>''HD!WO3P+N#XXJ1.#XW<";X# :)O] 4?,9!#GJ>PXA?*-_8,=M/
MT(2M$19E3!D4QSD%K_=XY\[*T[,=#),)JLYO-'_VV[+ZP']UP[H:M]OBQ8.'
M+$X)"$CO02_9 +OH <RE *$<M!Q!(CJ(#(S)1;B,,W69,7J\6,UI\7JVN^+Q
M+;I[(+M;4$Q?H%LFKM^Q\*TR3I7UERGG83[Z<(HU<3N"?3OSP[@G1!_7X>[@
M!Q_LS3^&"EJCYZ^*T&O+3Y!U/9@+PO+A]YLJ@/FUC^8?0[*QYVM7&! ,YYG@
M-S,\:-_WEKC>HMC]8^O_95O_8YU7+>='<PF@^:M/9MI6D,FLA5#]@$+Q7T>%
MAL<&?NM7G"57"R$2_\"RJ$2L;?Q9T'DJ7>3[\-&RDO_"[Y.,HT0$? PZ#4^.
M"C)X=J1/>%R@4>O&SW_'VU<0<_5SE $R7+(Z;;=!:D^G4N6HL\*5$LW:?T76
M1GMN^^ILPG0\^9HQ'8=?*:;CMO;;H/(N!QF41^^:DP?#_,F[ZX#R]O<[ <3]
M/71'_Y#/=R^?3R3'/V81%</&MBSPH:4TB6:=9MY,1@3XS/N6I_YP[F"@+D*<
M#BAILX,KGWP2TO]^!<8=>+YFB':F917_=HU\_,.$^!:/*#J$I^#A582&@&@O
MI%PB9Q4]674#P9)8SKT+G',<)3U<?QR@W\\!>EU\^I17F$[&H@!QE</I^1X^
M^>-$_&Y.A+<]<+*P]%%UQ-V>@/*'YR"6WOBQ3/-5$@D\;M%;XLHFUXV',(Y[
M-8@#(L5L/JU7D.GBST.@4P.$P[R%N);4Q"5B5,*I(<&V!6]@/P6&[&3(3_%!
M&@^$7U_ D_R+MB 'Z_^Q#8GLG7JRXY^Q,ZNK8I7Y,S;-ZKGX@+O%[B#^&^1;
M0JQ'2LX0DB)9-V <:J: V' $6(%,OI"<P-S+#P7]8ANT057D398O;FT09.8
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M _A+4KEGKMWVKI$=YA)V! HW)\K 4B0"7.'S((L-63X6J>C#=:98+<XNQPH
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MV+@GNM_]Z7?I8>\5PFAC$&D[.MUL93O\.6;WK_ $6\SAK5N$J.)W-OR(UL.
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M/ !U8HP7Z"9.DRJ]"IEGX@K!#:[.P$*_G1U?XU"*K1<?5IN\4//'I49@9'C
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M"$R6%QY;N0TBV_Q$!V1IRD.59(.FA9@M',B9'Q: U;SMXV_-XNR?2W"1(+@
MT2$&B-HUIN%Y@='=XA!6=_ARBK?6!&6>%$T((M(M9B9^LB.;)<;.[6[F 5.+
MCPK<8\>RA[BG#&.AW3,4!;1]#B%H+#?(&4&.HD5:6QJCJ;"7,JZ:L+X"5I@
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M&U%<;<KNHY5O31_OC]=$"#XM)T6?E1733B3?XKYPJ4'5\M5D8A8L**JP?(;
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MC#EHH"9IE(CM#V,7PMWQI://NJ,/P\3>8;W#A')R0*(K@7$!#1*\MX ]K*P
MMA<-^[Y3$GI'X$(T8 GC^3<2M M)EB#E.9$.A3(GO/Q@"44B3>(3.?83@4"/
MVX([.^@3-H-4HN:R.CC0;2G4X/X:ME@#VC]? "<R\SCG..;>\2U"7M3QDPJ!
M(:  T*4G;OIN[EC,TR:V4<H%*B6_%^>0?89"'-EO[0R")<HAII-G5;%P>.P
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M&7##%1FWI5=V_C4)V# YW,-5/[(W%]ALV('^@I%T<<YRV^[-V:1X<K1S&R?
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M)\O-GA4NIX.46VX@/)#&7+ #G;7RZ*H@1"M9^S05UMU)D",AR[.\S+WF>8O
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M<&?!(OV"[@Q$Y?(2#EHE$=#KDLJ>>7Z=/LPK;T@1.>AK)&Q/M^3XF[Z70"5
M_(])Y/C@4[;+QF[>#U:MAA06IM.N@3GWL<3O$E0]A!5"'AKB@/A%,-(1#E4D
M('>B>-658VFVY5^XB @C"+QT\I&D;4D@E5P&]J9'>Z(Y9PDQ11U)6>W.RP_8
M^YVMQ "Y"3"FT.?ZI][?3,;7N#A$96]["Q(I5I\3DWIZ4M@H$*"31:,K#M2O
M!K2@JZ(AU<X:%OV!C[A#^,C5_O63F@K9J"L,?$]?9.D2,6J-S462/H5[PT;,
M/NDGR<?>/@(3U7]]CH &Q3\[P:F$F#!5ZFEU(^\PM[:]A'*DV,-7(IV)K;[#
M8)C9<6HOP'UW21/W&O/N!T:/7$O??@PNV'J7=/F-QI*T4C6[FY)"+K&<%/>+
MBB FD5SL)GV8>R:VX0V%J85#*B0((SI'A!ENR+#,SEM\).]UC=^E1;F)T4L(
M1\'0, =S\@ 6T 3(1"@-&CP7CN\LH-+?KCSU?T?!A-2F%\05RB6+_P1(E[6*
M]C.2GG>_YJ3GP_^*I.>M?M+S_OCIG;]_]_+5SR?O/B;I>;^?]+SWA1J@!5U"
MLLWGT&7/89P (VUI#SWW)QX5<:@#X*#U*;:Z!052+3'/.J/>12:>P1@4MG)H
M9(Y+O*UB2V^M4;BSTILJ&<FB I (W%59_B>\$J+#>QT-QT)IG2@C,WZ"?N#8
M GL+-ZPL@=(WF@E@=A>F3:FAA;1$?_YG(ZZPUI]R-;6&]D[+&?%5<^OK&3:]
M/RQ.%AO'A0<&Y7TQR-#6FY%>:$A6/XDCY%R01B_KK%+%31(:%<;1.OTMX]!1
MML0""Z*47]O _@=/%?@6WYHH-P9?;>\0C;"=\$-=LF',DV&9*C#@@\++4:+0
MQ]Q>:.G59::C-(LPMLQP@)9:'AX1+M$XS1 I:5R_J[!;LU]W[,3*$P?#3Y!%
M>$CQ1%4?:F+T0%L8J36C/;TT\O+%3HQPX0+9*K[8#$/!MB;D"B?9&_?,1D;(
M70,=:"L BF,D*[VWJ<^%!#XQ%\OA:"OZAX6,R PD*KP@XD8$EB"[9S)(I(W@
M1Q@JK#Y].?(8XD//UC5P%RUH 2 N+IRF+4U&J/ -A)TM?OI"%^J'PJCY[)F'
M(Z*#Z1/CM6G:'9:FT(H6'!M,S1N,BY5CQ /V"0BSBGV;%]J"RV\>=L58F5YM
M6-0M&PLI[C!HE&[_V&I2]1+Q&/67''X_%V^QNCVJPVV9^R;B$I. Y'5<'AJO
M/6M++OQ, L)TKMTN;D!2,$0*Z=.= 9%JCA4S!U1*N!,UI8PTGM7N33N@W ^+
MYV4]8RHPO<U4RP[WM'=]QY1I&PW4,M/TKR00&,1R\,<83Y#UAKI; $MDPO"/
MF[*]<NW82X@9I13F2Z8 ^)P,O-B8/M6F6-S+P>,?7GG+W!N )24J^OP!!NY!
M[B^I'#SVH=+8XDO14-$".T:>N/PA"P4+4L@A/<HD3X:F@B@Z4_AA4:P"CR66
MQTE$C<SU"1H]<)9;D,9&_51,*8?>L]J1;430YO/-$L[+6,)G883%>IF =2W[
M(UM;4:X&4]]QY4G@TPIOUNR(;*4M6M"PF/@6G3&?C$E1+B;1<8MGXM+T<[C1
MI'F>-<U*[$81+86% $/7KWG)U3@I@+P[+\D.2V'BMN*(=X6!/YCC@I!I0L\^
MWHREX$CU3<GC,Y3EH=,COS#:MM'V/1*KL06_/?PVWN'^*X&@5%&*\F*SM*8K
M:N(?81,/KDF(CZ?+XTFBG> 'Y6B#H62B]\7^#<E45UGBX8K:4#L, :>6+%9+
M:6D GPE9OO4"(8K^A*\7\#<VR#BY/BQ+<N@CK<WL=!K%BB-3YOHVI7O3&F61
MNUY:LRLA[%TO5$YL^P%X576*UE(9^-VC')5YVV6M4/IU"\I*%RG2C$97-3"R
MZQR=4B>E@13X,MJ.]#=\["6@FV;JQVR+VL:\@617>;/:\F*Q=71HD2(@@]Q!
MJ3,B=Y4?$PX7TY[E:%=++V(8HL7UD']%=$ K)7N0VRCS(,?Y&P(<S>N#*)^3
M@5>\S4_,%)=3M3<DRN3!H8V$6J^""- _.+:X#17N-C,FXEV,/^A#+S?)-VS+
MQ2P%Q*%+1L=-%M"=[<@JBUV6_@8%N0=^<5-P9ZA+(RN4(PZ,<X>C11Z#478C
MHA3GBC-DL-@"#MA@M,/_PO^$-!CAZ3>653E.:LBE8ZGX>N FZ!N6%M"C/(<"
MJJBT"-$BV/@NZ0X03*.8GXX9:B/*]I J7#6N]PJ^$RM@P0)8'+9"*"?H&HU,
MH*AO&F-N(TFFO.'+Y-:#O;-]N1!"=H4[2#N374'@QL;</MCQ0%!F$%PWA8)2
MKP#[QVW'P&P$S$=%S-IAQ%BV"_%_PSS0A4XOR-4Y.:@PQ::-J7J=O@*=R&#2
MZ!I(<S,;3[6HDG"3,QFU@HV:'! !I;]#*J_5FCEP'_L%]!_[7T!/N4[!WL Z
MK 4,/?_ TKT8)L[H9<H"=(I-J:7&(CJS*6]$Y%9ICS*&-+%FQ*57^@J^,W=)
M<[E^IMO;W^M,SPK&*.2+54Y9CY$I]=I+JA?TZ<&=3,I261PBEA'C3/(HWSQ[
M<@VY[ZU%SD1T#'="Z]\RF[GA;N<I<_*7K8"6Q' -?1*XE G;AAANB%WKHXM/
MJ(_>5@_M/B.U=N\K3JW=/OJO2*W=[J?6;F]>GY_\4/_\[)^YU%J:/KO_I=)G
M.Y75%UO+ZC4/L;6@_4U$D-R%I(A< ([*Y2,<0TIPM>M9IZZU:?14F3FIX91P
M^G#K4#1%_+%SU..*T!5<Z,;=52^K=*-U2'))[.Q2.?Y5*]<DD</\P)&!MSIO
ML8?[!%6L:QL@68E4[ E_5J2?A6*#DN#_D>$XI5[K*S "#KC1LZ8TD5GR@%M0
M:QP!>)>$\-IQ6Q?+$F^''1.0J'F@S\+=0D>"&HM9L3U L354BK8:0\G# N&#
M"]U-50''E3#H9E$"D&'_&T+9@.L#I09TH2^;9L:]:&EA8LH^,AKP)S'7 )X.
M88U8N66('7/'T$HY&N2%VC 7H]#4H,72[..&Q4V0TW:N;-XHTL^$VF3VCH\]
M9R:UA[D4A<3U%H?%*U-7JJ,0QUAK>DWC,F[K)#7!EO[&MN!%;@MA(>KBD <^
MG@ \*_EN]"#$ 5#K<OIPTE041&-R[O".D2)K +-><<,%' @WS''$+XI-($*Z
M%[D^O0*@,'-^=9 /K&Q5DYA31SNSEOPM\+Q5X_-%[:\[FMZDAH1W)[WZ%*MO
MN+6C4D@BHQ>*C@N)8]FOIZ.W@'T>B1GAE6>'?DG;^2XVVRTW9[66:71@%%@F
MC$9M@"?".4_Q6R&Z@W=J9;1R7DGEDSJA,>&AZ_%S"2M$-)),L[ZHK-RP0-);
M2D.DY3VB$N+Z" 3$\ED 'USUCD1$ MB-H;N$W<1L \< 0$'9^D439A6O<45!
MOP:I/[TQ@)"<>H4<<FBK!!\K#E9''EW ]#H32]YF-%PZV! 6R'EY(1ZS';GH
MXF 1+&KJ1/;I"]) !V@SB%X@QB'3K=0V;NGB^_WJ_;M76G;#/ C@M/5]]^^0
MDQ96Y&DS7L>=AS32CFE'8C<56#1E>Q .D+Z)4[S4F"<BHA5C I\W0LZGJ$ $
M_^Y$YU'7S2UE2O#/A.LAAVE!;;I U!@0S\--JIFF",293H2XDN;X7;@I,;$=
M$#OI]_V0ID2R0%J\3_K&$<]!O,+)#&9^9FB3_-@<#;VC6)0TA 6;.;OZ>$J)
M1H.2/02T$;QX;[,NPXR;0;K+ >-2<S8@&?74#Z^'UX8OP^VW*Q+6[0;5/J9@
MXM4BL%V"P"Y^0P2V6\[67?(6:196H^VMA1@91"0'3Q$7H15[$&P=BC,/P[/=
MQ\.SLV'_74#7R7=BT+6B\J\&='T\!+J.$;%N^]3)&]H5A#,H"108[Z-OY$IW
M$83FDR$ON< F)4\MH,4,NZ]5=\&W;(FK+36(\_#!K5^];S0].'B&<8ONQZG$
M<M]Z1?9XYE?DUS$4*-^Z=7SKUU_UO_Y3G[U\^_?F[O'?)N<WKK24TL]BT2Q^
M\#=KB[T%%_"MUU!G=N)'"P,ZN'7KX/C6C<(+6KF$6%Z[K@BK_=S?CAALNGNC
M6'CW]R\W_%P?#4]U1V8;?H#+<D* E7 9_XCW*'?@ Y%*OC]J/K^2FD^6BZUU
MG^[3F4VJ\/A^N6=T3$+Y)]=%8['BESVGE$SPB_&H6"_]Q06\SOD*;7QY-")2
M/8]9]<#GV[7-K_J]DP]UY_^)&?R# ZW&Q%>\K.:G5?OK?\KSV^,7WTV^&W]W
M?-U3GE73C]=CS[U+'O18^"^>YJ^Y66[5=O>LMHM6=Y?2]'2J?M35UUB=/C23
MJ]=?^?<.EQY_8<TTL(%QY7)4[_ %Z9>XKT["IEM:%+T%_N0B2&[:0.MAZ*B\
MBWHC97+WLY7)2V1@?.IG!*;GR6+R"B+M/RN'/?R"5<S9X^>OWSX^^.7[%__X
MVZ__N7?KNQ]>/_GENY^>/+C1#T?<O'5T_T\?HV\>8+;NT]7%[O.X,5#L]O#@
M:+LY]7";@CG]ED90R!"HM3?RUH91H!3^^>;IT-[&J<8'R9)/[V^._EZNGS^[
M=;IS"9^?U7%2PH<3_1(YR&$<>$JW27 :P](?A6&<!H"\URSLG=ZM!UHLZJX
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M"WYK(:_]N+CEO=Y:__OGO__GX?'?[]W?-6X)TTCBEC2SJXU;1HHPOQ*U<OT
M(B$?^*>SQ+=;\-A[C5/@H^@MC\ON'<%%+U#G2.ET[B724QDY#PAPJ5CNGP(
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M&3B4 9()-IZ4M0.,KYH<"I;G.=>V'A#/S23S0NMY2/)<#EU&+D:.FW?F#L*
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M@[ #4-68!R0I$(;JCXF&W_GL:/B;S<(/SRN-D_6J@8T%0^C9]S\,A\;_\3=
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MU[-ZC\T;WD!"!12!/U0CP$K6_A@OZK)X>'3GZ%9O6"-GH'QP?+!NGU@&>L9
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MMM#%@X>@XN5F@NT[7)FBV_@K@I /O EDXM"7P3#=N[4OJ1VCC=UKT9>4AT2
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M=! >NG_G&WH^G0(3V.WLHA**\/F)7UCR/J^<,QFR=BNL[OOK8?&X;2[\8_P
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M_*#ZX(_MXJR2>,H/93<I_UV\637C=X) D0K2'T[>/#WYA[J:<;?D 0L$<T=
MYA64E/^.8RF"*F,ZV78<K-YL&B*L;=V?Y#>2 _5[;IIDEZO<RBP*F@9Q[ ;3
M20*A]"'60$+ 7L+2O;:DH),7B"B5H@:^:7-3OFI!^%%8KG+45KA1T2S]"1J.
MJ&KT/ 3VF]!/,M 5'Q;/>,\.6-9(/Q%3E))P#8XHQ*WC'<"EP^MK<HTK"#X\
MV Q^RY?EDHLW(+:*FF(!EZE4S%KJ76G B3SZ]XXH?0*::NR/)C%F),O/-ROI
M,^P6!(%?:>50:SH(4O9U.RF(J%-L"2DLL)(H!@NN'F'9F%!K,P(6$KXQ\2[U
M/T1T54>8:+GD$6LE75KX=H<B-7@$\)\N03G+O-G,VF#UKU\5(/ ))@/O'*17
M*[][4/Q\S@0(7 =.5,#!]$4@QP[K[Y+UA_'*DB,BK+MDZ;W:;U?(3P"]@T?0
M/+3J!DLY_;)JJ:_]L</&PYIKB<]]/]!CS%8Z;[6H-8 B8'(D]N'H?L=Z2)6%
M(B,+4H1_Y2?C^Q_]+YX\A?_[\O&;47$"_R<870:]QT08EL$F>TD,3Y%""EF9
MO^IYXC5$U4),11)-@H=^NOF(,ZJF&BDU49.PWWR?-&T@M0)# MY03_B>Y$]4
M(2LE9ZJ/W>0:0A1O-TMJNCMB&*99%9JH,;^=W,BP8)?+LJP9';4U9+,B/V94
M4.FOF/G@2VCJ>\=S F8EIC?;<'B%$=]&G,G\#^DJG"WN%"JM\$4(-GU$B,+A
MS\UU6'<J5,'[Q/D*K3JMP0$I4DS'=4;#;"%X-?E!>B$J7=RV$*LY@!(P3&H$
M0>]PX@4WSAVN ,2D2$3S'/'A8\U9:$2IEYT9O!L>_!4+\NLJ$-!)]>^ HBJQ
MYCRZ-%2PR96=$T;.>AA1_.RJ/8#$!)/&O#V3#[L/2EMI4#$D!N_4"%B(9\<\
MAL$@-V;X!A],[SK$2LH#_]<#)JU61^''MT_42] 1+71T#DJ!+LIEIS^ ?^%'
MD7,1WQ:L%"/%<MUWQ/,UM=0P)/+M4/#5Y5P?,K,5V#1D6;^@/U/.3MU4W9(X
MV>+M[GA4!0,"&%I#;14-F H-E?0W01OYM^V01+G]-2=1[O^.DRBP^^K>^FM@
M124T<1MZ$34#_8$_KT.7<\M2Z&\K%USUGF@I_))BCQ,\-,P-A[?GJIZ9,X&U
M*QS] L!1 AT@+%&XN9%_7_(T3K]W]1D;J ;TIYM@^EZ!V=NDBILTA(3-L+X8
M")6(6L90258IT\NQ=1[K9;++\T-R:=^(2TSTBE:TFN3T[\Z&W94KYJ:] +0*
MG$JO0SB7-38K%JEL"3D00XJ:7XF_IK_%+>8=,D= 7G+5D_M.-F>D4+9ZH5,U
M!Y$=;.XN+KTO9J8P(H!\RY5RHJYPC$NI+LD&@<BBQ&5#8<V\G0+*&BPO.Y=&
ME"C3P;^4:  ''C-A)W_V^0J#>+9M3JEA!K,.O!N)OU8O*.0Y@;1"VV4/W;#0
MM(B8-NTM4Y<,GQU:):R,&GMV^/8PJDL?VK.-I,FX#SPY)A13 !P)H/. -+$'
MPL@$+3"6$+0GCI73NA*5<-$NF)& 3BC?D72MFB0/)DW0)4\5PD^![ /6A*E[
M8/]/O2\=18A6%G3M0IXON';=HS@1:2*_6 N@,6U.B,2B-)*20X!?(6$ML$B\
MAN#]<B5'9V2#DU,$S<@'PW(0XFF2892#&&)H@?U#:]O5[UG5E&/IKSK:>E*Y
M8QF^LSF;06XJ:C![WK1$OTDP(!Y;/C\&U5:S>EB/'Z >=Z+'WP.!(K*<"- F
M,Y?KJFL L4/>$1-N2S+\!$7F//_%>;5(W%4RK8,+[Y<,R5"Y,\_$X%T)D3[%
MR&.,8C!]6; ;7Q9D0$+KFD5/\S&-<N8WEP$G["6\XPW,/)*NI/F@:-:)UL=/
M<+'4.%!=0OCB'TY^1MTSD*6K%W3!8&B3,C#IFG>:>%'NZJ'2KR\F. :L<3G\
MSEGL'36>D:,2**QRZWXPM.[+90/PCTFO10%3)D%)N_:V88*Q@"[,($DC^(F5
MA6PX;'!<D=VG1I"@5FQNV(0WW)=,H!:7)5"+7T ::8JHAG3>SB#51[M/&O2B
MV#T41QS)C$<"E-B"#I/+;BC4&47LK.KE<PQYD!:5_H[C];=D%> !_CJ:S:K%
M616UPS!:V>7U2:E9^MG&0G4LKYU.:#BPFA]D)K#J=@JL!H-FU_ JERK%0=2M
M$5'7CXCJ[4'4+D%CRGQX\-2L F5"S1^+.R$7B64F<EIQ1%$8T/UR7L^JONI9
MDQF9N+AUE^#%I/6<%%4P,BE-XN)YA&=A/GI*?06"S2X8N0R57AP#YH,I%Q_O
MMZG0X1T_6Y=>[P.I5P3/L,ZZU_5Y($:L1Z)&[_ZK:RZ903[QO-HP0_;/QXX@
MU^#V_P/S$12@3P[[7GU8'8[$ZA*MX#!.V8OD1UJ!SD2]+.$D!&7#/0^Y2D:0
M\-2XE=*\K(+QE4#ABB4SC,:>SB MIQA%-_:+Y2=:*@9+R)XH,<QX/1/4Z$;A
MJ)@J'1&UK9=H F WJ^8R*I*-2UXYO8FB%!#:&^^)'QR;PJ.8>@7E[\R]ZO#L
M<!2')J0#8_0ZJF>>MA3PV[CTAZ%<RN]#5;V;<>=)9G5%KY&2=E+MID5F8!RW
M\@]<1[]0^P:(]>]!R7$[KP'Z$I*'"WQ8^$R_;5Y%0C>O24:NTOHZ$"HT>-F9
M673^R[@FL,5U=9$&.QC 1]+)5 TD2C2VP^*-,?7(;R)L[+:<%AUX6R3'JLYU
M^:?ED^P*5[UJQN*VX4;A>4O21BC@9+HDZ640HF2%-_2_XE7J]I@I#J79L.W4
M$%0\.G[N;>^P!H):3CQ3N!:N.(RG]@@D^G.%GR./3BZ[)Y$/"!5TY[C)W)*)
ML='R5C0*LL05U*3'2"#!BVH;^=3UHH4?;>7 H&B(!0R['?(<=[[F/,>#WW&>
M@_U8"$KUA A$9MU%FD2,6D:U8T<(]6>3!^@9X+H( E0W^-_K*V+I_T0BDZ=0
MW@:\WZ"SE,@D^NMU16W(I.VDU7H<H:8.ADYJF*V%SX2B-5*-C.#GEHI#:+:%
M^D'NZHF=8AQELXZ3#DF_#]IX@_A(* D_ %-#.YF<807WP B\%IQ5D+\A/O#9
MQO@<Y JSKHR&YM>BQIL^YA?!0&Z 2'+M(^C]O7J_#ZJ$T.T'=N20',O_$V/P
M@+.N%V0VT3J2]I0^%C&R9G5.U&G(C"(M5-4HI">X<CQN.7]EN+B9FMXK^W;5
M7S3IG0%#P^M/'"IOK9QI?Z@HI6: X?ZY>[6?=F]#G#[;?UY#]2LR1@&0D;Z
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M$YU/4V>FQY!HPK!K9C,FDJ.K07TFIRM:JM_A.8E;F, [XA/@^"$VH1+71:/
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MG7%I"LD*J&,6>%QDA7$WIKTD5&;YVVX)JTK%@V7= 6K(SQA;KL*A;Y6FP6'
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M/P3_>"_+L'JZ#N1\26LSJ0U-(ET2%W3W[_Y)/NXDE%XMHG@3/D+8HW&)35+
MU#+R"*Z<Y":-\.9*\20.V%'OP"GPK)0X2EJ0=GME0U_J[:KF'SFXQH5?8XF=
M1ZZN6GLDY<+$PJ(-X=,V\8-'H;1B"5/&Q$2'2.;H-R/MQ(K5D(#HQ!(,L3E<
M5@GBX;V+17-,^QY-)S<PG@-GDFOL(]:,:VH)R %(5 ?A/7BS8)21!TA]#V6Q
M'AS]*=X%0T0E_;RP9[!HL=[F;:U$$3W7S\VX*#>C^I-J4$\M=.(Y1?>1VSQ4
M! ;-">TM<LMXV2KNE<J))$E9"XNVS&><(T:^4KPB@1D9J[TY9@_UF+.-+=V<
M;2@>RU\I9Z#L$+]U1G_![<>F"EZV9S757V#L1;?4!;\$'G[AA>9N5&0Y+..8
M7!F<>M[EL1MQ';65?BZ\4]&YB*O" )?'86S->*9(VD>] )$-"*4!H\^+^D3Q
MY8&@[;#_[G_F/?1^>.'H\!B6Y>:W@Q]E\MS3<E[/-H^*-YNYM\'12']P^YO(
MJ?#_'W;4NQ!G!!\$/8QE#&F_(NF=">SA]:0&8A+[*4HKBC>? STS-I/P37!E
MQ(_Y8UN&MZ4V&1]<^WPT=MN*%V3<=.?%GNG[$_/5; +]6IZFR %-T?X?F_=1
MFP=(]1'>HI6E.L"]Y,XKBZB7'C+'R<8RE&#7;3;,"?@[[_B!5PC5_9K0[_6V
MCD$/_W-K='1TA/]??X2%ZN%ZC4JKUBM.',P4^ "E7#SEB9WSQ%$G%7O1>#<4
M.+U[%@^BDE<7U>Q]=8"$W\S!_8U_X!\"^"4$T(+9MBIU"A'(SZ8Q@B#Z'NNG
M(+30-N<C!+7XPH+:Y235[2*IQ>=+ZF%63*^P(X @=2JS(T.>F-3K=X-NTS6X
M7Q(1N3;WRY9C6ER3]WU<Y/L4&=\GQ\%[-:Z/R\'2MK@^.U13//R:$16W?X>(
MBFMB^7C. 22K, 7P"'+:D^E<R&10I@/2*\]S2'%G/*5$E9,>;19VU"7J$</9
M=I8!(1"<10W-+$M.A#9KAL?4HT'8ZB ?NA?(TL1ZA\99!WX>[M85BCR7VGX^
M]K+A:SUMQ<M*A _RBMZWH/;#29U!B(:<R-9]DC*:5^6B8^A[UU&,!#(#]^[W
MX@H18KI/,2((,2S-U%AQW;L70KWUW1!J&L2T]M^#[(3T+D=H>@NH]>O^8?,-
MYQ/V/_=EUQ'TZ%^VYS%$G-B^-;KE4L'-W]A27&*)Q036::,E"6I5"HAR7X65
MEX@:K"E>Z5*J&'TSPPW6I$!P9 >AZ^^46E:'H%/$@Z!@S,/BM:*2N8$7DM-/
M*FE(FSWHT+JKGADFAC?/GF@\'=N;PM;D HDQ4T@HL']A2+6OIT_&VU1LLS/E
M.J'.LGW8DG@_:K]3G>00DKZ-O:.1?4?$MQ3%F E!3&%]R*<Y(0=1!FN3NP#[
M?^8W?$$V)(YL)#JXGD/WKW4-]6PF0\B]E; XIFQKN!C,Q1/0?:CZQ7AR2N,$
M9338>%Z+=*1G)J%X"9W<!B?\IP62CKY982C6__$$,^\E9>;\&GBK2%<GL$71
M*D/^"7LXU40QX8@^D[^0,/Y!L32EYG#:6L!,]5W1=W,4>5!P0(4"M'K4D^M?
M?CDZZ/S$W(LX+F+]L^6!2-"XJ(6GF.C[H]&=5K.Z>D\IOFGYOFDML6&7A)[X
M@JOG5U,Z_XGP@"=('O%L,0$A34BNZ;,#_R&*L+LN=NLG@?TF))K[1#@@T-)_
M)1#FN*D?:J<I"6H=P%E.+V>[/9589V9,H<Q%Z"%!/5]C<^?X334W9TR'8C#S
M,VC20^DH-GQ0,-H2+UF((-G[7.,-R!O4<)7,I*KF\3.X3*.)V*DM?ZM[O*')
M>;&'W*0=/D/5HX((>(5TJT_I(RY[&1V5S9+[5P1T0PGD*%[KK8%OQC*/V+D<
M%B_MV-*2X_  &I+W6*;>^V9.K_6*_T7;4"Z('9O(F;6%G N;CVDI*.2W?$OI
MGHTQZE1N2"<0R[#MR6%6CMLP@2P%<J/XR6HF&KEKB$OA/6TT]H,!"RNN&*H7
M9@L1$2#"C ,>]:> B!>Q2J:SZD/->E$[R;*B=-)43W.OWA=%M1ZU(0[%LN;/
M"+^942#A&LW#OTJO]^ _].8/AZU"2FEWZ0F;MM0&%AI&M4!.A:I>N+I"6[6(
M!I':*!<=],$";=O9WWK;>UZOYW0C4@3/$2V+= V4L,[I1C7 ^V:V#HU#.R['
M8EF4." (B?9]LO1(< ;0.YQZTZ!I(9>]:=C8#=@DEY%*(;YOJ[,&XX?\@+C;
M_$IGP@0SN?I)_U)X@K6&1R9B*=6Y(',II]!U0<GR_9DP\4=5R,(#[YB%BE<5
MXVPAPD@I0HAP2ZHO/I,QK,SJ,>,-2Z(6J19Z)&<]YS+CS<14N,BQG/EEENU_
M $=UCL]\7U<73"O7R;UOH6T%<C_ XC6]?IUYC:;U9ZD+ETAD>)VVO8X=(:WB
M3Y@6<0 @M^P#V0;&-?*A 6$^M84;KEVFNC".M^@6Q[FGG"GA^DQ]_ZLLO=>5
M%'X^4>9Q-?7"AZ BHA/]31&^#[/_$:8N-N%U5,E'8XNUS6\2A>!.FG! .,]!
MQHYC/!&J\E8M-R:?R*,V.UL&'R(7<)YZEA>[/BM[58L3")UGD<*P<=P1'30M
M>$D+='^DTE>N-._ AXZWI.BY^2**MNCY5I<>_<P5<RM-$>8C3DV/@,R/W$5D
M<6^Q)1]84J=01H\'L\5T_K9SB"VZJS%2#33DS^+<L>A:8A+&"R:_NYZ&KRY&
MMK&O'.WX1HM'+]MG:-2430(4/F@I]$K3W8&2!_NH:VJE\I$'\TOFVCY+,^X
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MR5Z_>")^*S8 SHDOXFX!F'^ @+W*3W]A87I7;@1[CW?*7)_1O=^W:1E)X4)
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M[GL+\;]UNXF(Q@PS9$?AKTD-(NB7A>J&%77>Q]$1FY;+R+^@&2T\+TM !FU
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MG-TATL=L3<ILJ(U/>;6%CQVNKFK1X7W[Q[)_U+)+QR!H,>A51XWW/EFQ4VQ
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M% @;N>R&<@[3+V5R[]%[.P3V5P0ZS]K\4HQL'YVW"AS9FRTU\DA "^)RK6\
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MXFDMH^.-A5+UC,A(;XT4[%ET-VO2P17GSN/O_M)187P3'QE=X%45X $OHQ[
MM<<1H>MVB?.UZ\\A9-QW@:(_;9_66G2>K(E0F_(Z;$%ACRW[S:BWIRGD= ?M
M1E%B=PF3W"'N?C)?QMV19%>?YTTR3@>5 >J]8&9=(<W=>CH0=CK+7X]@JTNU
M,:,V$?PKL[;P(+.R!"<(CS,EM.I+(O'>.K.*[K!F(IA2C%(:RJ07A;0LOM-
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MY!8#\#*I\*B1T_R3;]P@S1P(">QZ8.>3XZX%-#BC6W&^ZFE@7$;9^Z5 &DZ
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M<>GV.DOVR[-GND">D)=([)GN>8O6)F^/MQ@L 6I/:B##0=UG@@NN.;/IAD0
MF739Y@>XF&S*1L)?8["DIE Q8NGC47/]3DTPKF7>$0X!8>N9RHM?L0]ZU12O
M3ZXA3&#VABCSC?HPQ.7-V0UYF#$+U).W>-$T4@:MWM^0V+$P*&-($XD8N"$1
MQ\8S BCH0?H)9WYI)!N%NP:5)PFJJR]N3T]3_-%J9%.+(K'B*#5 ;<0NK[1/
M! QS 2,UB"79[^3#N _J(];<[1<9>5H7.5*GX$EPS:<X0FP-9P@DZ<+(TO+3
MNL1PD#<-0NLI\!.N::7RJVY]DJH80NK:FB2V]UF3OVHR9*LU2--X?$\[B6)8
M@QUA:>M9-BJN*QWBUX<+WI<D\;H#*;9J&K-B*+PR+*1W2'I"!]$L"KV3^6A2
M48LTL-!K*K=FT+LR;S=L-ZB015!- 6633'PX;[VL]YSQ7T553F/XCB^<T94I
MJI B%Z3;/;D^:?\H"\&'%&"-TY<I#-OES:/LSF+Q8/@GBJ/''83DALP%XJ*O
M=SIH\V2$F^/Y.B04ZY3),9[$>*2J[G(EF!SEUNA*^GV>9C>[1QM]"3<5>RL:
M)O;])8GW74+9KY\]12M>[5@K%%#2F239,UGQ%HY[:65H0 *U3?*XJ:8ASF,@
MQ&H4%(3OY4M"?.J Y9)=^+9V%'3\W#B[47I!O_VM?#OX;TM6XA@'Q+21AG52
MY;X1E2BZ@DFQE%?_?W?,12(X3&<@'ES*\$%+*>=4NTI[(A>)?FN"D+093T];
MC5:^&F7!\)J349.2*FAM[GD6JYKL9#%1QD6/TP*D*':N@30TO6\TK[#U.>I:
MN).J33BD3B!NA=#+]-28#L7T\28A]'X*";FP ?.$<?"&>@A*.Q;)W:KZMEUB
MWR$4ZB+EBES.N-RE8@SX/7IFQ?.J4BYV/1,9I^9)PCI\S6T>&"]"G-CK;!0F
MU[0>,A %MGF.[!$>"%UH"\,QM4)CPCA)!&UIPQ-J+VU"2#\H=2&.1ZL<E'FO
M:ST;G7=W3F?/B/\&E\%V/'QD[)P(;5U=6YB^1UV3$T5HY9LCMAUUXQNUH-K4
M21!H^&1 3*")W%="%B!F0US;6>6LWG8?LLC!C,3WTUG3;D>)XDAETA0O+V:7
MIB?W:16TYWJ],#IA/:NY>%F%ASVK/%!#UF6W=JG/6G%B\6PPS)-==XGRU:Y!
M#B57XUD'=IX4GN>I3Y F+89@%LG9HMY3HYE%;3U "YTI2(Y50C/4[*_1[0CM
MC750- R7B'/NAX:\8!!^LO0?/Z!W#B DR'-&.7B4*"7+OA1;7X56BAF5<P??
MO5A&Y%5WFKQ3B\"\*>@@>X5>_._X4FSR6SA91Z[4"R-+8+\,B8-'N!8>7V?G
MS+F&BZ9>-E;?#VY_S9U.W/0@Z6V,G%\8(:26[@I5* >?6VIZ+ETS8%NEK/<Y
MX3]^#EGW-.UYP1%%]*7-0!P\92*>YX0\Z7X%<K?LQ"P]SZD3#3OIY]8?.J\M
MM/:C:BUO=O&$$L<D".&YYDFI'=BCZKC*-M->I[-7D\FA=FK4S(AHW2'$;"R=
M+DYT22\HW&[WG9WXP82"C>O:"V\)[ VN/E8].>9AX$I.ZW#>:I*Y1!TS'S"8
M/Z*LK<A^8BS514VJ:P13CD^4(W\Z^]ZUU JC8X*40HXLEN9:"3(.3<-^<PZ&
M'T$S\Q.HF0SF:TG^,E18KA>V/;71$('/!WCOB:;VFQ^;?_ZS7M-6N*-S,!A+
MZD;5!-NA)7ACQ"H]^0*K_7%LX;XO8!D?-><_-8E-<4'-LB#"9H=H%"U<:[8G
M(?N:T\O32C[>;FOR^HTJ]]@Y#=))I&78.+G(V9,0B9V<IX4Y7-D!2N^YW3HE
M?;7H2QSPT]GKA$J1R-CD0E=9G='%S-Z?Z< <CT\E).SWQO^ARV]@TAZ8>WJ%
MU8)9I_((\"MDTJI]_V"8$2*';CRR/_&XTUN&L:.>7A1_LE ,]SEPVVY3GFAZ
M+:;E'7)-3W[7N:;/_YUKNL<>F:56 %S'<6%/BF\!4TW1'MQ?2D5'EZ&E:O$]
M?:ZJE,JI.U):[;*YS%+-K@/'P/Q@RA1%/0QZ;ONX.^<D/%M ^@X/2W?]94"!
M43I-TI,O0[(#&[%0%R:#N,=;CX*B%)@%')!>OW$J*U[0_0I'6_B,H"-8?P#)
M@)CBINU=FP6_YHG+SVC*#<!D#H^Z@B!#$OSMLA,N+'N:6=6U!-W30]6"LF!\
M6DAN8ZB<U[)FPK*KP5 L4=>+$Q9XS-83?IWN#?V;GS%Q=U?Y2-.\Q;,<SUU
MBH;(%%^82Y601J!-"P0:,Z@JSRY_)$VNL6X:@]_ C#RE@$GLI3IEWC!<+J?!
MM-5+WU=/.BBLM.<H"(]?HP$6+E<@CCJ#E'$S7/]$'<5',(9>0W!?U\07EYM
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MGWR3F7@"*>/YY);D1HE=KK45F"&SM,V7%:YO>ZK3XA"!NXPYWT"G+!%(7Q4
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M2=^M&B 4CJ[;XRR48G$<5F'295.[4+F=@.A6T#7LS9YS8R*J75J QY#.N8<
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M<-BKU4Q9YM3R"3%(Z'#8*]YXU:DV$0",F+2D^C7:_=$*U^D\O$Y[]ER)..Y
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M=O'BL/A7->O];K_\_GE9_.TO)4T<#O6;JELM0,^]O()C:R+J; TC>W&Z8MZ
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M(,T=@4,)1KP?Y\ <W&*XA?./E&/0IQCZR^J5G3:]:0W=:3^WJ$0=FRR&-J?
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MVJC><*@6D7C51U.NR4\*A60-C;_):IO4@Y?5W/9;IXZ+02%-ZJ=2IVYK&]T
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MVEVBCI>?V+$D[D8+67-Q3^QX!T*NC.PKV$R3 V?[LP)C59 8)D/N: C-7$4
M?#N(0# [!*M$\>W0"*R#2JFNO39_\P8N@#*#"6O5_L2[,9#&9DLCIH;$J-5R
M/0% )UQ\P&&P>1Z;99'I-JTG*_DZ4>H-5 @&PS#MSM_S6KB%'#3:N/@ L7C
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MK:[,Y2^UYP^GD"-4FA$2#-'7CFCT+4*?4!FZE"Z9'CZ$;L3NB\6\^9FB#]*
M ?!FU;P!KY2.0EE Q>3U7-ST&!SGOPV:70C"<KT> X\#I(R:U9J[CF$8 CB!
M_,,ZXF<;74_-\O7K):Q?+]6R4"#P,_9;]2/^^O3L2>$/^4P^Y;)?G/6[>KFJ
M4?Z>'I'?GM\_Q_MW55?3_UG[O[+$%PF(\X&S^]]M]X')]XO+63O!YA6K:_@K
MP)KX(G$3$"C*AO'_<X&2^=V*PN>OUG[S:@K"/^^;ZKYOS>L%9TO&2#<,^-:-
MR;1B[")A49E@V;J:&KC"XI-EE!-CM #*OJ*]2=^\$O'G,-/7UU4'6>R^!@;!
M4E@L(*^(^(@Q@(/_@%[.+PJ'$5@$_GGX[K#XR?O3_=32!)C.0CL+$4I0<E"1
M=_G_^56>8NH*BNR9FAD@8<:4" 5,&:,.L2Q^#(!KP51^!;VIZ^FA^Z?^3*FC
MJX1;4F?!E- AZU,6?GWAC$O?%$K=0B)35-*;Z%'/PZ-P4P0V-QQR2?8=0$;]
MN. =:UH7&@1S C$7D(1/^Y4?JZPUU'95TE+LG^\.S%I56L+8XC$S:;2(-89[
M'\DKPSGTJYT^#G^3)U6B4XP8$;P:L>CA3Y.QW?<%'O;N-37(LCO87T>O,,LF
MJ@9.=$=.!( FD$GFKBS]#F/I_<C!)8EAKH<S#-E9%C4SKJ"Y1D8PLL9WZV(-
M[;%[WMDW26.1X0"LQ^-N\'A,Z?NRVHSM$U!SUY!I812Y-V575S/,C7AQX44N
M-@D$B4@=N#MFVO7_]*,\/CPZ^L:U&2*."H!1EW4QK<"0^)&3)<])'>]A.CO@
M #+#HE;!U28]1OH"[)AQ*,**7^#H!7(+YC44>.V0YCS[LM.<CW^;:4X<!RK
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MY=3L_M!GY=,GC\OCL].=GK-M+?RC3I_Y(1Z=/'RDC<@J5:_<1576:/G#<X/
M\,HS*+,"JB!^_.?W?V6+Q"O+=T(CO/?/=_N(J!>D-7Q/H-9EJ)6Q#+\1"5;Q
M)BG,HF8&.5@(>'W!.,$!Q1@6(!8S32#'("41JY1A3NR!W#]JJ\R&C$)V(32V
MN.P/B^^%LXZ?F< C'0Z.0X1^1AVT"..H''ZEF4K$4$(X8X'"HY,G9QKMNV@Z
M[P1_?7)TY"TA*DN L-.VF*&#1QR%@.'";W[Q]>DMG@"#.#Y+GW!VFR< ] >>
MPN/8"N<D[L.OCZ7P KB)H"***B,TH'K1_ P>?UTC0X(:BC@NOW @5([\/R^(
M.SELK&F,)81WF0V^=]3U>&7GITJ.&R^T-Q$/X29_"6:B/VX[&6>?D+R3GS[]
M])_N\-;?3<+?3<+_728AJC23((UDRQU9@J>G3\M'Q\>_\"DG3[TQ>7('AM_)
MDR?ER=FSNR_ZWRZW44,]#W90SA)#OCZPKJ /.](P6<,)V3;OSLKBN$FO&M/\
M7"R@0W>#353<H4UT:@R:H4WD/LVBN;5--+"J8IO(W6@3P5..V+R[I4UD^P$
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MTHISIR[+FN\0&#I88)Y#Q3LIAY-V)#([Z"*+S(/FG+3D1I5%K48CO9.> \>
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M  Y]L^#D"EK/;[H6Q[D.Z>:6>Y3Q-*8?!4(55%_#5=64NUIWEYSK)P0-$[Q
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M-%%7["VZBGZXQ7"@?42;$8R-9R/,U!G[1YXG^IC1]7Q$2V?M&1;I&2.$5A%
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MREEJMF :'YBKZ'82C%2$G6Q+O,21%$GQ5JAEH=A_*7(6/5^@^.2(C*NTM2D
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M0$MZ0K\S19Z\SQG$97 KA2N+&M7.VRD(>]8SQAHX+/XNIV0DR[=# NSLRTZ
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M*:.VL%C)>.Y?Z4>(B)9N!3&:=\,.'=D=ID+1>)@06/>RJIU])'(WQ):N TH
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MJ']T"YG3,>OZDL*+%XSQD'%7!DZ 2,95-)C$V>>5F.+)C\T43_\\3+$R/VQ
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M+K(+<U_#4G 0V ;BM[H(L*3?/T/"**WF"J+H@I0:F+Q*0"I-*#19"UFZWU!
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M)AL!RVG9HD2!K%SG'^O^W$06A_XB>P(IB\D2NRLT9MNW16@Q&]E5<Y[M"%;
M/<?/N 0 H^[<RO@LLKFX0<V1BFE8;QEEX%D6N&%%_"O*J-\S^^S?'% D#"%O
M*-D+KHZVZ.#P42H7((^$G"W04968S7 1V/[7AT;]3@2X6#!XLL\V'BB89;!
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MF#);F-\#J^HJD6 ^TI(#+E2YW!*-)C4.SS#=!-R-7L,#;[PZIA[%<XL8+=#
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M73229/2L[/N$%:^6\DI'8']@2V6 ]X3)=W(T?[%MTNWAT$ELM9Q$O>IZ>=M
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M+?4,?O<%YC0$?P\J.#A8*EA."H5VA\JHJ*A I66ALK*28 W)@! DQOF")#)
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MF+&R;I?]3IA9_^<W9FH0+FH(VU_?F E1VB"Y()OT?WU%!M#04E/108#?;\Q
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MX;+MS]F&V9/I8+*9U$MO\^?4:ES2)^63\@=M":QDM!J!)8+_:(@@CWJ03(/
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M(@,FJ7 /VL-S@S1KGA;^C$B"R<CS,?79UH>V9(=&T1S6O_S^G;EB?'\Y*?G
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M     &5X.3EL+FAT;5!+ 0(4 Q0    ( 'F9=5M:#OL7M0(  %D*   )
M          "  3X2  !E>#DY;BYH=&U02P$"% ,4    " !YF75;[M&^.\1Q
M  !I30, "0              @ $:%0  97@Y.7(N:'1M4$L! A0#%     @
M>9EU6^^%1F%$#   .DL   D              ( !!8<  &5X.3ES+FAT;5!+
M 0(4 Q0    ( 'F9=5NPZER'F@8  )\H   )              "  7"3  !E
M>#DY="YH=&U02P$"% ,4    " !YF75;#=$2/*@#  #-#P  $
M    @ $QF@  9V]F+3(P,C4Q,3(Q+GAS9%!+ 0(4 Q0    ( 'F9=5O_O*#E
M! ,  !41   4              "  0>>  !G;V8M,C R-3$Q,C%?9&5F+GAM
M;%!+ 0(4 Q0    ( 'F9=5M'GLGQ_P(   <1   4              "  3VA
M  !G;V8M,C R-3$Q,C%?;&%B+GAM;%!+ 0(4 Q0    ( 'F9=5MXF#@ M (
M /T,   4              "  6ZD  !G;V8M,C R-3$Q,C%?<')E+GAM;%!+
M 0(4 Q0    ( 'F9=5MO62%Z%=<" 'V=#@ 2              "  52G  !G
M=6=G.#DS.#EN,F%S<BYH=&U02P$"% ,4    " !YF75;.10$$=A$  #^9
M%@              @ &9?@, 9W5G9V5N:&5I;6QO9V]N97<R+FIP9U!+!08
1    "P + )L"  "EPP,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>gugg89389n2asr_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:GOF="http://guggenheiminvestments.com/20251121"
  xmlns:cef="http://xbrl.sec.gov/cef/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gof-20251121.xsd" xlink:type="simple"/>
    <context id="AsOf2025-11-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-06-012025-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-03-012025-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-03-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="From2024-12-012025-02-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-12-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2024-09-012024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-09-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="From2024-06-012024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-03-012024-05-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-05-31</endDate>
        </period>
    </context>
    <context id="From2023-12-012024-02-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2023-12-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="From2023-09-012023-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2023-09-01</startDate>
            <endDate>2023-11-30</endDate>
        </period>
    </context>
    <context id="From2023-06-012023-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-08-31</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_PrincipalRisksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:PrincipalRisksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:MarketDiscountAndPriceVolatilityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:DebtOverlayStrategyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <context id="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:explicitMember dimension="cef:RiskAxis">GOF:SyntheticAutocallableELNStrategyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-21</startDate>
            <endDate>2025-11-21</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-11-21" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-11-21" id="Fact000004">0001380936</dei:EntityCentralIndexKey>
    <dei:EntityFileNumber contextRef="AsOf2025-11-21" id="xdx2ixbrl0010">333-000000</dei:EntityFileNumber>
    <dei:DocumentType contextRef="AsOf2025-11-21" id="xdx2ixbrl0012">N-2ASR</dei:DocumentType>
    <dei:EntityWellKnownSeasonedIssuer contextRef="AsOf2025-11-21" id="xdx2ixbrl0035">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:InvestmentCompanyActFileNumber contextRef="AsOf2025-11-21" id="Fact000011">811-21982</dei:InvestmentCompanyActFileNumber>
    <dei:DocumentRegistrationStatement contextRef="AsOf2025-11-21" id="Fact000013">true</dei:DocumentRegistrationStatement>
    <dei:InvestmentCompanyActRegistration contextRef="AsOf2025-11-21" id="Fact000014">true</dei:InvestmentCompanyActRegistration>
    <dei:InvestmentCompanyRegistrationAmendmentNumber contextRef="AsOf2025-11-21" id="Fact000015">35</dei:InvestmentCompanyRegistrationAmendmentNumber>
    <dei:InvestmentCompanyRegistrationAmendment contextRef="AsOf2025-11-21" id="Fact000016">true</dei:InvestmentCompanyRegistrationAmendment>
    <dei:EntityRegistrantName contextRef="AsOf2025-11-21" id="Fact000017">Guggenheim Strategic Opportunities Fund</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-11-21" id="Fact000018">227 West Monroe Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-11-21" id="Fact000019">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-11-21" id="Fact000020">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-11-21" id="Fact000021">60606</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-11-21" id="Fact000022">(312)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-11-21" id="Fact000023">827-0100</dei:LocalPhoneNumber>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic contextRef="AsOf2025-11-21" id="Fact000024">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly contextRef="AsOf2025-11-21" id="Fact000025">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering contextRef="AsOf2025-11-21" id="Fact000026">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag contextRef="AsOf2025-11-21" id="Fact000027">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e contextRef="AsOf2025-11-21" id="Fact000028">true</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b contextRef="AsOf2025-11-21" id="Fact000029">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c contextRef="AsOf2025-11-21" id="Fact000030">false</dei:EffectiveWhenDeclaredSection8c>
    <cef:RegisteredClosedEndFundFlag contextRef="AsOf2025-11-21" id="Fact000031">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag contextRef="AsOf2025-11-21" id="Fact000032">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag contextRef="AsOf2025-11-21" id="Fact000033">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag contextRef="AsOf2025-11-21" id="Fact000034">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-11-21" id="Fact000036">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag contextRef="AsOf2025-11-21" id="Fact000037">false</cef:NewCefOrBdcRegistrantFlag>
    <cef:PurposeOfFeeTableNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000038">The following table contains information about
the costs and expenses that Common Shareholders will bear directly or indirectly. The table is based on the capital structure of the Fund
as of May 31, 2025. The following table should not be considered a representation of the Fund&#x2019;s future expenses. Actual expenses
may be greater or less than shown. The following table shows estimated Fund expenses as a percentage of average net assets attributable
to Common Shares, and not as a percentage of Managed Assets. See &#x201c;Management of the Fund.&#x201d;</cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock contextRef="AsOf2025-11-21" id="Fact000040">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecef--ShareholderTransactionExpensesTableTextBlock_dD_zz77PYEUFEuf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - ShareholderTransactionExpenses"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 77%; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;b&gt;Shareholder Transaction Expenses&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 23%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt"&gt;Sales load paid by you (&lt;span id="xdx_90C_ecef--BasisOfTransactionFeesNoteTextBlock_c20251121__20251121_zz07hEA50uO7"&gt;as a percentage of offering price&lt;/span&gt;) &lt;span style="background-color: #CCEEFF"&gt;&lt;sup&gt;(&lt;/sup&gt;&lt;/span&gt;&lt;sup&gt;1)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="background-color: #CCEEFF"&gt;&#160;&#160;&lt;span id="xdx_908_ecef--SalesLoadPercent_d0_c20251121__20251121_fKDEp_zyfdVofshWLe"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: white"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt"&gt;Offering expenses borne by the Fund (as a percentage of offering price) &lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(1),(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span id="xdx_90C_ecef--OtherTransactionExpensesPercent_c20251121__20251121_fKDEpICgyKQ_____zUpO5bKA7Gz1"&gt;0.60%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 9pt"&gt;Dividend Reinvestment Plan fees&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-indent: 0.5pt"&gt;&lt;span id="xdx_906_ecef--DividendReinvestmentAndCashPurchaseFees_dn_c20251121__20251121_fKDMp_zQMeiEuGd3m6"&gt;None&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000042">as a percentage of offering price</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000043"
      unitRef="Ratio">0</cef:SalesLoadPercent>
    <cef:OtherTransactionExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000044"
      unitRef="Ratio">0.0060</cef:OtherTransactionExpensesPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000045"
      unitRef="USD">0</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:AnnualExpensesTableTextBlock contextRef="AsOf2025-11-21" id="Fact000047">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_ecef--AnnualExpensesTableTextBlock_zBYwZFwGJFMa" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - AnnualExpenses"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 60%; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;b&gt;Annual Expenses&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 40%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;As a Percentage of Average Net Assets Attributable to Common Shares&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;Management fees&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_906_ecef--ManagementFeesPercent_c20251121__20251121_fKDQpICg1KQ_____zfKKvMdVxobj"&gt;1.21%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;Acquired fund fees and expenses&lt;sup&gt;(6)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_908_ecef--AcquiredFundFeesAndExpensesPercent_c20251121__20251121_fKDQpICg2KQ_____za6zbiqFfCJ7"&gt;0.05%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;Interest expenses&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(7)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_90E_ecef--InterestExpensesOnBorrowingsPercent_c20251121__20251121_fKDQpICg3KQ_____zebqI9YnDV3g"&gt;1.08%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;Other expenses&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(8)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_90D_ecef--OtherAnnualExpensesPercent_c20251121__20251121_fKDQpICg4KQ_____zl8YdKj8vxs8"&gt;0.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;Total annual expenses&lt;sup&gt;(9)&lt;/sup&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_901_ecef--TotalAnnualExpensesPercent_c20251121__20251121_fKDkp_z3N7wjCi6Bg2"&gt;2.44%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000048"
      unitRef="Ratio">0.0121</cef:ManagementFeesPercent>
    <cef:AcquiredFundFeesAndExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000049"
      unitRef="Ratio">0.0005</cef:AcquiredFundFeesAndExpensesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000050"
      unitRef="Ratio">0.0108</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000051"
      unitRef="Ratio">0.0010</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000052"
      unitRef="Ratio">0.0244</cef:TotalAnnualExpensesPercent>
    <cef:ExpenseExampleTableTextBlock contextRef="AsOf2025-11-21" id="Fact000063">
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;As required by relevant SEC regulations, the
following example illustrates the expenses that you would pay on a $1,000 investment in Common Shares, assuming (1) &#x201c;Total annual
expenses&#x201d; of 2.44% of net assets attributable to Common Shares and (2) a 5% annual return*:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 56%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;1 Year&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;3 Years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;5 Years&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt solid; width: 11%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;10 Years&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;Total Annual Expense Paid by Common Shareholders&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_90A_ecef--ExpenseExampleYear01_c20251121__20251121_fKCop_zxndvVx0QlR1"&gt;$25&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_901_ecef--ExpenseExampleYears1to3_c20251121__20251121_fKCop_zd3IUPNP5Oy9"&gt;$76&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_906_ecef--ExpenseExampleYears1to5_c20251121__20251121_fKCop_zvSbJWqyJnU8"&gt;$130&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_90B_ecef--ExpenseExampleYears1to10_c20251121__20251121_fKCop_z3yX9gJWOFyh"&gt;$277&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000064"
      unitRef="USD">25</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000065"
      unitRef="USD">76</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000066"
      unitRef="USD">130</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="AsOf2025-11-21"
      decimals="0"
      id="Fact000067"
      unitRef="USD">277</cef:ExpenseExampleYears1to10>
    <cef:SeniorSecuritiesNoteTextBlock contextRef="AsOf2025-11-21" id="Fact000069">For information about the Fund&#x2019;s senior
securities as of the end of the last ten fiscal years, please refer to the section of the&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;
Fund&#x2019;s most recent annual report on Form N-CSR&lt;/a&gt; entitled &#x201c;Other Information (unaudited)&#x2014;Senior Securities&#x201d;
which is incorporated by reference herein. Information regarding the Fund&#x2019;s senior securities is also contained in the Financial
Highlights in the Fund&#x2019;s most recent annual report on Form N-CSR, which has been audited by Ernst &amp;amp; Young LLP for the last five
fiscal years. The Fund&#x2019;s audited financial statements, including the report of Ernst &amp;amp; Young LLP thereon and accompanying notes
thereto, are included in the Fund&#x2019;s most recent annual report to shareholders and incorporated by reference in the SAI. A copy of
the report is available upon request and without charge by calling (888) 991-0091 or by writing the Fund at 227 West Monroe Street, Chicago,
Illinois 60606.</cef:SeniorSecuritiesNoteTextBlock>
    <cef:SharePriceTableTextBlock contextRef="AsOf2025-11-21" id="Fact000071">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s currently outstanding Common
Shares are, and the Common Shares offered by this Prospectus will be, subject to notice of issuance, listed on the New York Stock Exchange
(the &#x201c;NYSE&#x201d;) under the symbol &#x201c;GOF&#x201d;. The Fund&#x2019;s Common Shares commenced trading on the NYSE on July 27,
2007.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Common Shares have traded both at a premium
and at a discount in relation to the Fund&#x2019;s net asset value per share. Although the Common Shares recently have generally traded
at a premium to net asset value, there can be no assurance that this will continue after the offering nor that the Common Shares will
not trade at a discount in the future. Shares of closed-end investment companies frequently trade at a premium or discount to net asset
value and the market price for the Common Shares will change based on a variety of factors. The net asset value and market price of the
Common Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market
price of the Common Shares will either be above (premium) or below (discount) their net asset value. The Fund cannot predict whether the
Common Shares will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a
variety of factors. The Fund&#x2019;s net asset value would be reduced following an offering of the Common Shares due to the costs of such
&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;offering, to the extent those costs are borne by the Fund. The sale of Common Shares by the Fund (or the perception that such sales may
occur) may increase the volatility of or have an adverse effect on prices of Common Shares in the secondary market. An increase in the
number of Common Shares available may put downward pressure on the market price for Common Shares. See &#x201c;Risks&#x2014;Market Discount
and Price Volatility Risk.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The following table sets forth, for each of the
periods indicated, the high and low closing market prices for the Common Shares on the NYSE, as well as the net asset value per Common
Share and the premium or discount to net asset value per Common Share at which the Common Shares were trading on the date of the high
and low closing prices. The Fund calculates its net asset value as of the close of business, usually 4:00 p.m. Eastern Time, every day
on which the NYSE is open. See &#x201c;Net Asset Value&#x201d; for information as to the determination of the Fund&#x2019;s net asset value.&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_481_ecef--HighestPriceOrBid_zxfWIoRT9Bf6" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_483_ecef--LowestPriceOrBid_zdEkVbWyTsC2" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_48A_ecef--HighestPriceOrBidNav_z3at9YAoAYga" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_485_ecef--LowestPriceOrBidNav_zNwfcMYcaK3l" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_488_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zVx38qbKKH76" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_487_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zvgFwov0feRl" style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Fiscal Quarter Ended&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Market Price&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;NAV per Common&lt;br/&gt;
Share on Date of Market&lt;br/&gt;
Price High and Low&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Premium/(Discount) on&lt;br/&gt;
Date of Market Price&lt;/b&gt;&lt;br/&gt;
&lt;b&gt;High and Low&lt;span style="font-size: 8.5pt"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;High&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Low&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20250601__20250831_z1ahzOQZabn7" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; width: 27%; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;August 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.10&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.50&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 13%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.38&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;31.30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; width: 12%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;27.86%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_410_20250301__20250531_zarexPXdOTR6" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;May 31, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.91&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$13.74&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.06&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;36.33%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;24.23%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20241201__20250228_z2M1HcaTxGDg" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;February 28, 2025&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.99&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.00&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.74&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;33.14%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;27.77%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41E_20240901__20241130_zQH4n0ppKR71" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;November 30, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$16.03&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.99&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.01&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;33.69%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;27.06%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41C_20240601__20240831_z4g8GRppMwa2" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;August 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.75&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.65&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.06&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.93&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;30.60%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;22.80%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_41F_20240301__20240531_zU0ZoA2jKCi9" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;May 31, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$13.80&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.26&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;21.53%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;16.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20231201__20240229_zsKPfS7pKMdg" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;February 29, 2024&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$14.29&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.67&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;17.90%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;2.67%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_414_20230901__20231130_zIECh2mE4rS2" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.96&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.16&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$11.71&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;29.76%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;-4.70%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_418_20230601__20230831_z36VwxvLer89" style="vertical-align: top"&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt"&gt;&lt;span style="color: #4D4D4D"&gt;August 31, 2023&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$16.28&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$15.51&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.48&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;$12.30&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;30.45%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span style="color: #4D4D4D"&gt;26.10%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000072"
      unitRef="USDPShares">15.10</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000073"
      unitRef="USDPShares">14.55</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000074"
      unitRef="USDPShares">11.50</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000075"
      unitRef="USDPShares">11.38</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000076"
      unitRef="Ratio">0.3130</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-06-012025-08-31"
      decimals="INF"
      id="Fact000077"
      unitRef="Ratio">0.2786</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000078"
      unitRef="USDPShares">15.91</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000079"
      unitRef="USDPShares">13.74</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000080"
      unitRef="USDPShares">11.67</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000081"
      unitRef="USDPShares">11.06</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000082"
      unitRef="Ratio">0.3633</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2025-03-012025-05-31"
      decimals="INF"
      id="Fact000083"
      unitRef="Ratio">0.2423</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000084"
      unitRef="USDPShares">15.99</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000085"
      unitRef="USDPShares">15.00</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000086"
      unitRef="USDPShares">12.01</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000087"
      unitRef="USDPShares">11.74</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000088"
      unitRef="Ratio">0.3314</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-12-012025-02-28"
      decimals="INF"
      id="Fact000089"
      unitRef="Ratio">0.2777</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000090"
      unitRef="USDPShares">16.03</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000091"
      unitRef="USDPShares">15.26</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000092"
      unitRef="USDPShares">11.99</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000093"
      unitRef="USDPShares">12.01</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000094"
      unitRef="Ratio">0.3369</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-09-012024-11-30"
      decimals="INF"
      id="Fact000095"
      unitRef="Ratio">0.2706</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000096"
      unitRef="USDPShares">15.75</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000097"
      unitRef="USDPShares">14.65</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000098"
      unitRef="USDPShares">12.06</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000099"
      unitRef="USDPShares">11.93</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000100"
      unitRef="Ratio">0.3060</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-06-012024-08-31"
      decimals="INF"
      id="Fact000101"
      unitRef="Ratio">0.2280</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000102"
      unitRef="USDPShares">14.90</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000103"
      unitRef="USDPShares">13.80</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000104"
      unitRef="USDPShares">12.26</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000105"
      unitRef="USDPShares">11.82</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000106"
      unitRef="Ratio">0.2153</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2024-03-012024-05-31"
      decimals="INF"
      id="Fact000107"
      unitRef="Ratio">0.1675</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000108"
      unitRef="USDPShares">14.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000109"
      unitRef="USDPShares">12.67</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000110"
      unitRef="USDPShares">12.12</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000111"
      unitRef="USDPShares">12.34</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000112"
      unitRef="Ratio">0.1790</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-12-012024-02-29"
      decimals="INF"
      id="Fact000113"
      unitRef="Ratio">0.0267</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000114"
      unitRef="USDPShares">15.96</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000115"
      unitRef="USDPShares">11.16</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000116"
      unitRef="USDPShares">12.30</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000117"
      unitRef="USDPShares">11.71</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000118"
      unitRef="Ratio">0.2976</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-09-012023-11-30"
      decimals="INF"
      id="Fact000119"
      unitRef="Ratio">-0.0470</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000120"
      unitRef="USDPShares">16.28</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000121"
      unitRef="USDPShares">15.51</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000122"
      unitRef="USDPShares">12.48</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000123"
      unitRef="USDPShares">12.30</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000124"
      unitRef="Ratio">0.3045</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="From2023-06-012023-08-31"
      decimals="INF"
      id="Fact000125"
      unitRef="Ratio">0.2610</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000126"
      unitRef="Ratio">0.1344</cef:LatestPremiumDiscountToNavPercent>
    <cef:InvestmentObjectivesAndPracticesTextBlock contextRef="AsOf2025-11-21" id="Fact000154">Investment Objective&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Investment Objective,&#x201d; which is
incorporated by reference herein, for a discussion of the investment objective of the Fund.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Investment Policies&lt;/p&gt;&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Principal Investment Strategies and Portfolio
Composition&lt;/span&gt;&lt;span style="font-weight: normal"&gt;&#x2014;Investment Policies&lt;span style="color: windowtext"&gt;&#x201d; which is incorporated
by reference herein, for a discussion of the investment policies of the Fund. With respect to the Fund&#x2019;s policies relating to rated
fixed-income securities, please refer to Appendix A to the SAI for more information regarding Moody&#x2019;s and S&amp;amp;P&#x2019;s ratings.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal"&gt;&lt;span style="color: windowtext"&gt;Rating agencies, such as Moody&#x2019;s or S&amp;amp;P, are private services that provide ratings of the credit quality of debt obligations.
Ratings assigned by an NRSRO are not absolute standards of credit quality but represent the opinion of the NRSRO as to the quality of
the obligation. Ratings do not evaluate market risks or the liquidity of securities. Rating agencies may fail to make timely changes in
credit ratings and an issuer&#x2019;s current financial condition may be better or worse than a rating indicates. To the extent that the
issuer of a security pays an NRSRO for the analysis of its security, an inherent conflict of interest may exist that could affect the
reliability of the rating. Ratings are relative and subjective and, although ratings may be useful in evaluating the safety of interest
and principal payments, they do not evaluate the market value risk of such obligations. Although these ratings may be an initial criterion
for selection of portfolio investments, the Sub-Adviser also will independently evaluate these securities and the ability of the issuers
of such securities to pay interest and principal. To the extent that the Fund invests in unrated lower grade securities, the Fund&#x2019;s
ability to achieve its investment objective will be more dependent on the Sub-Adviser&#x2019;s credit analysis than would be the case when
the Fund invests in rated securities.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"&gt;&lt;b&gt;Principal Investment Strategies&lt;/b&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund pursues a relative value-based investment
philosophy, which utilizes quantitative and qualitative analysis to seek to identify securities or spreads between securities that deviate
from their perceived fair value and/or historical norms. The Sub-Adviser seeks to combine a credit managed fixed-income portfolio with
access to a diversified pool of alternative investments and equity strategies. The Fund&#x2019;s investment philosophy is predicated&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; upon
the belief that thorough research and independent thought are rewarded with performance that has the potential to outperform benchmark
indexes with both lower volatility and lower correlation of returns over time as compared to such benchmark indexes.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Sub-Adviser&#x2019;s analysis of a fixed-income
security&#x2019;s credit quality is comprised of multiple elements, including, but not limited to: (i) sector analysis, including regulatory
developments and sector health, (ii) collateral, business, and counterparty risk, which includes payment history, collateral performance,
and borrower credit profile, (iii) structural analysis, which includes securitization structure review and forms of credit enhancement,
and (iv) stress analysis, including historical collateral performance during extreme market stress and identifying tail risks. This analysis
is applied against the macroeconomic outlook, geopolitical issues as well as considerations that more directly affect the company&#x2019;s
industry to determine the Sub-Adviser&#x2019;s internal judgment as to the security&#x2019;s credit quality. In addition to the process
described above, the Sub-Adviser selects securities using a rigorous portfolio construction approach designed to tightly control independent
risk exposures such as fixed income sector weights, sector specific yield curves, credit spreads, prepayment risks, and other risk exposures
the Sub-Adviser deems relevant. Within those risk constraints, the Sub-Adviser estimates the relative value of different securities to
select individual securities that, in the Sub-Adviser&#x2019;s judgment, may provide risk-adjusted outperformance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Sub-Adviser&#x2019;s process for determining
whether to buy or sell a security is a collaborative effort between various groups including: (i) economic research, which focus on key
economic themes and trends, regional and country-specific analysis, and assessments of event-risk and policy impacts on asset prices,
(ii) the Portfolio Construction Group, which utilizes proprietary portfolio construction and risk modeling tools to determine allocation
of assets among a variety of sectors, (iii) its Sector Specialists, who are responsible for identifying investment opportunities in particular
securities within these sectors, including the structuring of certain securities directly with the issuers or with investment banks and
dealers involved in the origination of such securities, and (iv) portfolio managers, who determine which securities best fit the Fund
based on the Fund&#x2019;s investment objective and top-down sector allocations. In managing the Fund, the Sub-Adviser uses a process for
selecting securities for purchase and sale that is based on intensive credit research and involves extensive due diligence on each issuer,
region and sector. The Sub-Adviser also considers macroeconomic outlook and geopolitical issues.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Sub-Adviser generally decides which securities
to sell for the Fund based on one of three factors:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;In the Sub-Adviser&#x2019;s judgment, the relative value measure of the instrument no longer indicates that the instrument is cheap
relative to similar instruments and a substitution of the instrument with a similar but cheaper instrument enhances the risk-adjusted
return potential of the portfolio.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;The Sub-Adviser&#x2019;s fundamental analysis suggests that the embedded credit risk in an instrument has increased and the instrument
no longer properly compensates the holder for this increased risk.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;The Sub-Adviser&#x2019;s fundamental sector allocation decisions result in the rebalancing of existing positions to achieve the Sub-Adviser&#x2019;s
desired sector exposures.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"&gt;&lt;b&gt;Additional Information About
the Fund&#x2019;s Principal Investment Strategies &amp;amp; Portfolio Composition&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;In seeking to achieve its investment objective,
the Fund will or may ordinarily invest in, among other investment categories, the following categories of investments:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Income Securities Strategy. &lt;/i&gt;The Fund seeks
to achieve its investment objective by investing in a wide range of fixed-income and other debt and senior equity securities (&#x201c;Income
Securities&#x201d;) selected from a variety of sectors and credit qualities. The Fund may invest in non-U.S. dollar-denominated Income Securities issued by sovereign entities and corporations, including Income
Securities of issuers in emerging market countries. The Fund may invest in Income Securities of any credit quality,
including, without limitation, Income Securities rated below-investment grade (commonly referred to as &#x201c;high-yield&#x201d; or &#x201c;junk&#x201d;
bonds), which are considered speculative with respect to the issuer&#x2019;s capacity to pay interest and repay principal. The sectors
and types of Income Securities in which the Fund may invest, include, but are not limited to:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Corporate bonds;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Loans and loan participations (including senior secured floating rate loans, &#x201c;second lien&#x201d; secured floating rate loans, and other types of secured and unsecured loans with fixed and variable interest rates, including &#x201c;debtor-in-possession&#x201d; financings) (collectively, &#x201c;Loans&#x201d;);&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Structured finance investments (including residential and commercial mortgage-related securities, asset- backed securities, collateralized debt obligations and risk-linked securities);&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;U.S. government and agency securities and sovereign or supranational debt obligations;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Mezzanine and preferred securities; and&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 20px; padding-bottom: 6pt; text-indent: 0.5in"&gt;&lt;span style="font-size: 12pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7px"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 6pt; text-indent: 0in"&gt;Convertible securities.&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Debt Overlay Strategy. &lt;/i&gt;As part of its
Income Securities strategy, the Fund may employ a strategy of investing in a basket of debt securities and other instruments (the &#x201c;Debt
Overlay Basket&#x201d;) and writing (selling) out-of-the-money call options (i.e., call options for which the current price of the underlying
asset is below the strike price) or near at-the-money call options (i.e., call options for which the current price of the underlying asset
is close to the strike price) on a fixed-income ETF (the &#x201c;Underlying Bond ETF&#x201d;) in an amount that creates a notional exposure
approximately equal to the investment exposure created by the Debt Overlay Basket (the &#x201c;Debt Overlay Strategy&#x201d;). The Debt
Overlay Strategy is intended to generate current income in the form of options premiums.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The composition of the Debt Overlay Basket and
the Underlying Bond ETF are expected to be generally similar (i.e., a portfolio of high yield corporate bonds), although they would have
differences. The Fund considers an ETF to be eligible to be an Underlying Bond ETF for purposes of the Debt Overlay Strategy when the
ETF is passively managed and consists of U.S. dollar-denominated, high yield corporate bonds for sale in the U.S. or if the ETF is designed
to track an index (or subset thereof) that provides a representation of the U.S. dollar-denominated high yield corporate bond market.
GPIM seeks to select investments for the Debt Overlay Basket with the objective of constructing a Debt Overlay Basket that is designed
to achieve, before fees and expenses, returns that exceed those of the Underlying Bond ETF.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Although the Debt Overlay Basket is intended
to outperform the Underlying Bond ETF (and the performance of the Debt Overlay Basket is otherwise intended to generally be correlated
with that of the Underlying Bond ETF), the options sold as part of the Debt Overlay Strategy are not intended to be &#x201c;covered,&#x201d;
meaning that the Fund will generally not hold shares in the Underlying Bond ETF as part of the Debt Overlay Strategy (or have an absolute
and immediate right to purchase the Underlying Bond ETF&#x2019;s shares) in the amount necessary to meet the Fund&#x2019;s contingent obligation
to deliver cash or shares of the Underlying Bond ETF to the Fund&#x2019;s options counterparties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Common Equity Securities and Covered Call
Options Strategy. &lt;/i&gt;The Fund may also invest in common stocks, limited liability company interests, trust certificates and other equity
investments (&#x201c;Common Equity Securities&#x201d;) that the Sub-Adviser believes offer attractive yield and/or capital appreciation
potential. As part of its Common Equity Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered
call options and may, from time to time, buy or sell put options on individual Common Equity Securities. In addition to its covered call
option strategy, the Fund may, to a lesser extent, pursue a strategy that includes the sale (writing) of both covered call and put options
on indices of securities and sectors of securities. This covered call option strategy is intended to generate current gains from option
premiums as a means to generate total returns as well as to enhance distributions payable to the Common Shareholders. As the Fund writes
covered calls over more of its portfolio, its ability to benefit from capital appreciation becomes more limited. As part of Common Equity
Securities strategy, the Fund may not sell &#x201c;naked&#x201d; call options on individual Common Equity securities. A substantial portion
of the options written by the Fund may be over-the-counter options (&#x201c;OTC options&#x201d;). Under current market conditions, the Fund
implements its covered call writing strategy primarily by investing in exchange-traded funds (&#x201c;ETFs&#x201d;) or index futures which
provide exposure to Common Equity Securities and writing covered call options on those ETFs or index futures, and the Fund may also write
call options on individual securities, securities indices, ETFs futures and baskets of securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Synthetic Autocallable ELN Strategy.&lt;/i&gt; The
Fund may employ a synthetic autocallable equity linked-note (&#x201c;ELN&#x201d;) strategy designed to generate current income based on
equity market performance rather than traditional fixed income and credit factors, such as duration and interest rates (the &#x201c;Synthetic
Autocallable ELN Strategy&#x201d;). The Synthetic Autocallable ELN Strategy is designed to convert equity market performance into an income
source, which may provide the potential for higher income than traditional fixed income assets and which exposes the Fund to risks such
as those associated with the autocallable structure and equity markets such as market downturns interrupting coupon payments or resulting
in principal loss as described below. As part of the Synthetic Autocallable &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;ELN Strategy, the Fund intends to synthetically replicate
exposure similar to autocallable ELNs by investing in derivatives instruments, such as swaps (&#x201c;Synthetic Autocallable Contracts&#x201d;),
and will typically not invest directly in autocallable ELNs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;An autocallable ELN (i.e., the instrument that
the Fund intends to synthetically replicate by investing in derivatives instruments) is a debt instrument with coupon payments (i.e.,
income) made at regular intervals and linked to equity market performance. The autocallable ELNs that the Fund seeks to replicate synthetically,
as further described below, are typically linked to one or more broad-based equity market indexes (e.g., the S&amp;amp;P 500 Index, Russell
2000 Index, or &#x201c;worst of&#x201d; two or more indices) (the &#x201c;Autocallable ELN Reference Index&#x201d;). These autocallable ELNs
provide coupon payments at predefined intervals (which may be deferred to maturity) so long as the value of the Autocallable ELN Reference
Index does not fall below certain prescribed thresholds at specified dates. In such circumstances, the autocallable ELNs would be automatically
called (i.e., cancelled without further coupon payments and with principal returned) or no coupon payment will be made, respectively.
Autocallable ELNs may also provide for the return of a reduced amount of principal when the Autocallable ELN Reference Index falls below
a certain prescribed threshold at maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Synthetic Autocallable Contracts are designed
to provide exposure similar to autocallable ELNs, with the value of the Autocallable ELN Reference Index at the beginning of the Synthetic
Autocallable Contract defining when a contract is automatically called, when the counterparty will make its coupon payment(s) for such
period, when no coupon payments are made for such period and a &#x201c;Maturity Barrier&#x201d; (as defined below) below which the Fund
would be exposed to a loss corresponding to a reduced return of principal. A Synthetic Autocallable Contract is a bespoke product agreed
to between the Fund as &#x201c;buyer&#x201d; and its counterparty as &#x201c;seller". The description below is generally representative
of Synthetic Autocallable Contracts, but the Fund&#x2019;s Synthetic Autocallable Contracts may be structured differently. Additionally,
notwithstanding the description below, the Fund&#x2019;s Synthetic Autocallable Contracts will typically provide for a single net payment
at maturity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;At each payment date, the buyer will owe to the
Synthetic Autocallable Contract counterparty a financing amount based on a financing rate (which may be a fixed rate or otherwise). At
any payment date prior to the final scheduled payment date, the buyer will receive scheduled coupon payments and potentially an early
principal payment (as applicable, a &#x201c;Coupon Payment&#x201d; and a &#x201c;Principal Payment&#x201d;) net of the financing amount owed
to the counterparty, subject to the following structure:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Autocall Zone&lt;/i&gt;. If on a specified observation date the price level of the Autocallable ELN Reference Index reaches or exceeds
a certain level, typically the initial value of the Autocallable ELN Reference Index at the time of the Synthetic Autocallable Contract
(the &#x201c;Autocall Barrier"), then the Synthetic Autocallable Contract will automatically terminate early and the buyer will receive
both a Coupon Payment for the observation period and the Principal Payment, but will not receive future Coupon Payments for that Synthetic
Autocallable Contract.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Coupon Zone&lt;/i&gt;. If on a specified observation date the price level of the Autocallable ELN Reference Index equals or exceeds a
certain level (the &#x201c;Coupon Barrier&#x201d;) but is below the Autocall Barrier, the buyer will receive a Coupon Payment for the observation
period. The Synthetic Autocallable Contract will not automatically terminate early (and the buyer will not receive an early Principal
Payment).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;No-Coupon Zone&lt;/i&gt;. If on a specified observation date the price level of the Synthetic Autocallable Contract Reference Index is
below the Coupon Barrier, the buyer will not receive a Coupon Payment for the observation period (such unpaid coupon, a &#x201c;Missed
Coupon&#x201d;), but the buyer would still be obligated to pay the financing amount to the counterparty. Certain Synthetic Autocallable
Contracts may have memory features in which the buyer may receive a Missed Coupon if the price level of the Synthetic Autocallable ELN
Reference Index equals or exceeds the Coupon Barrier at a subsequent observation date.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;If the Synthetic Autocallable Contract has not
been terminated early, then at the maturity date of the Synthetic Autocallable Contract, the buyer will receive a Principal Payment and
Coupon Payment subject to the following structure:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Full Principal Zone&lt;/i&gt;. If on the final specified observation date the price level of the Autocallable ELN Reference Index is
above a certain level (the &#x201c;Maturity Barrier&#x201d;), which may be the same as the Coupon Barrier, the buyer will receive the scheduled
Principal Payment.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;i&gt;Reduced Principal Zone&lt;/i&gt;. If on the final specified observation date/maturity date the price level of the Autocallable ELN Reference
Index is below the Maturity Barrier, the buyer will receive a reduced Principal Payment, which will result in losses to the buyer.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Real Property Asset Companies. &lt;/i&gt;The Fund
may invest in Income Securities and Common Equity Securities issued by companies that own, produce, refine, process, transport and market
&#x201c;real property assets,&#x201d; such as real estate and the natural resources upon or within real estate (&#x201c;Real Property Asset
Companies&#x201d;). These Real Property Asset Companies include:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Companies engaged in the ownership, construction, financing, management and/or sale of commercial, industrial and/or residential real
estate (or that have assets primarily invested in such real estate), including real estate investment trusts (&#x201c;REITs&#x201d;); and&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Companies engaged in energy, natural resources and basic materials businesses and companies engaged in associated businesses. These
companies include, but are not limited to, those engaged in businesses such as oil and gas exploration and production, gold and other
precious metals, steel and iron ore production, energy services, forest products, chemicals, coal, alternative energy sources and environmental
services, as well as related transportation companies and equipment manufacturers.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Personal Property Asset Companies. &lt;/i&gt;The
Fund may invest in Income Securities and Common Equity Securities issued by companies that seek to profit primarily from the ownership,
rental, leasing, financing or disposition of personal (as opposed to real) property assets (&#x201c;Personal Property Asset Companies&#x201d;).
Personal (as opposed to real) property includes any tangible, movable property or asset. The Fund will typically seek to invest in Income
Securities and Common Equity Securities of Personal Property Asset Companies the investment performance of which is not expected to be
highly correlated with traditional market indexes because the personal property asset held by such company is non-correlated with traditional
debt or equity markets. Such personal property assets include special situation transportation assets (e.g., railcars, airplanes and ships)
and collectibles (e.g., antiques, wine and fine art).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Private Securities. &lt;/i&gt;The Fund may invest
in privately issued Income Securities and Common Equity Securities of both public and private companies (&#x201c;Private Securities&#x201d;),
including those issued on a private placement basis pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the &#x201c;Securities
Act&#x201d;), or securities eligible for resale pursuant to Rule 144A thereunder. Private Securities have additional risk considerations
in addition to those of comparable public securities, including the availability of financial information about the issuer and valuation
and liquidity issues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&lt;i&gt;Investment Funds. &lt;/i&gt;As an alternative to holding
investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities by investing in other
investment companies, including registered investment companies, private investment funds and/or other pooled investment vehicles (collectively,
&#x201c;Investment Funds&#x201d;), which may be managed by the Investment Adviser, Sub-Adviser and/or their affiliates. The Fund may invest
up to 30% of its total assets in Investment Funds that primarily hold (directly or indirectly) investments in which the Fund may invest
directly. The 1940 Act generally limits a registered investment company&#x2019;s investments in other registered investment companies to
10% of its total assets. However, pursuant to exemptions set forth in the 1940 Act and rules and regulations promulgated under the 1940
Act, the Fund may invest in excess of this and other applicable limitations provided that the conditions of such exemptions are met. The
Fund will invest in private investment funds, commonly referred to as &#x201c;hedge funds,&#x201d; or &#x201c;private equity funds&#x201d;
(including &#x201c;single asset continuation funds&#x201d;) only to the extent permitted by applicable rules, regulations and interpretations
of the SEC and the NYSE. The Fund may invest up to the lower of 10% of its total assets or 15% of its net assets, measured at the time
of investment, in private investment funds that provide exposure to Common Equity Securities of private companies (i.e., exposure to private
equity investments). Investments in other Investment Funds involve operating expenses and fees at the Investment Fund level that are in
addition to the expenses and fees borne by the Fund and are borne indirectly by holders of the Common Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Synthetic Investments. &lt;/i&gt;As an alternative
to holding investments directly, the Fund may also obtain investment exposure to Income Securities and Common Equity Securities through
the use of customized derivative instruments (including swaps, options, forwards, futures (including, but not limited to, futures on rates
such as Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;), securities, indices, currencies and other investments) or other financial
instruments) to seek to replicate, modify or replace the economic attributes associated with an investment in Income Securities and Common
Equity Securities (including interests in Investment Funds). The Fund may be&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; exposed to certain additional risks to the extent the Sub-Adviser
uses derivatives as a means to synthetically implement the Fund&#x2019;s investment strategies, including a lack of liquidity in such derivative
instruments and additional expenses associated with using such derivative instruments. If the Fund enters into a derivative instrument
whereby it agrees to receive the return of a security or financial instrument or a basket of securities or financial instruments, it will
typically contract to receive such returns for a predetermined period of time. During such period, the Fund may not have the ability to
increase or decrease its exposure. In addition, such customized derivative instruments will likely be highly illiquid, and it is possible
that the Fund will not be able to terminate such derivative instruments prior to their expiration date or that the penalties associated
with such a termination might impact the Fund&#x2019;s performance in a material adverse manner. Furthermore, certain derivative instruments
contain provisions giving the counterparty the right to terminate the contract upon the occurrence of certain events. Such events may
include a decline in the value of the reference securities and material violations of the terms of the contract or the portfolio guidelines
as well as other events negotiated between the parties. If a termination were to occur, the Fund&#x2019;s return could be adversely affected
as it would lose the benefit of the indirect exposure to the reference securities and it may incur significant termination expenses.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In the event the Fund seeks to obtain investment
exposure to Investment Funds (including private investment funds) through the use of such synthetic derivative instruments, the Fund will
not acquire any voting interests or other shareholder rights that would be acquired with a direct investment in the underlying Investment
Fund. Accordingly, the Fund will not participate in matters submitted to a vote of the shareholders. In addition, the Fund may not receive
all of the information and reports to shareholders that the Fund would receive with a direct investment in such Investment Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Further, the Fund will pay the counterparty to
any such customized derivative instrument structuring fees and ongoing transaction fees, which will reduce the investment performance
of the Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Finally, certain tax aspects of such customized
derivative instruments are uncertain and a Common Shareholder&#x2019;s return could be adversely affected by an adverse tax ruling.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"&gt;&lt;b&gt;Portfolio Contents&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;The Fund&#x2019;s investment portfolio consists
of investments in the following types of securities:&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Corporate Bonds. &lt;/i&gt;Corporate bonds are debt
obligations issued by corporations and other business entities. Corporate bonds may be either secured or unsecured. Collateral used for
secured debt includes, but is not limited to, real property, machinery, equipment, accounts receivable, stocks, bonds or notes. If a bond
is unsecured, it is known as a debenture. Bondholders, as creditors, have a priority legal claim over common and preferred stockholders as
to both income and assets of the corporation for the principal and interest due them and may have a prior claim over other creditors if
liens or mortgages are involved. Interest on corporate bonds may be fixed or floating, or the bonds may be zero coupons. Interest on corporate
bonds is typically paid semi-annually and is fully taxable to the bondholder. Corporate bonds contain elements of both interest-rate risk
and credit risk and are subject to the risks associated with Income Securities, among other risks. The market value of a corporate bond
generally is expected to rise and fall inversely with interest rates and be affected by the credit rating of the corporation, the corporation&#x2019;s
performance and perceptions of the corporation in the marketplace. &lt;i&gt;Investment Grade Bonds. &lt;/i&gt;The Fund may invest in a wide variety
of fixed-income, floating or variable rate securities rated or determined by the Sub-Adviser to be investment grade quality that are issued
by corporations and other non-governmental entities and issuers (&#x201c;Investment Grade Bonds&#x201d;). Investment Grade Bonds are subject
to market and credit risk. Market risk relates to changes in a security&#x2019;s value. Investment Grade Bonds have varying levels of sensitivity
to changes in interest rates and varying degrees of credit quality. In general, bond prices rise when interest rates fall, and fall when
interest rates rise. Longer-term and zero coupon bonds are generally more sensitive to interest rate changes. Credit risk relates to the
ability of the issuer to make payments of principal and interest. The values of Investment Grade Bonds, like those of other fixed-income
securities, may be affected by changes in the credit rating or financial condition of an issuer. Investment Grade Bonds are generally
considered medium- and high-quality securities. Some, however, may possess speculative characteristics, and may be more sensitive to economic
changes and changes in the financial condition of issuers. The market prices of Investment Grade Bonds in the lowest investment grade
categories may fluctuate more than higher-quality securities and may decline significantly in periods of general or regional economic
difficulty or other adverse issuer-specific or market developments. Investment Grade Bonds in the lowest investment grade categories may
be thinly traded, making them difficult to sell promptly at an acceptable price. Investment Grade Bonds include certain investment grade
quality mortgage-related securities, asset-backed &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;securities, and other hybrid securities and instruments that are treated as debt obligations
for U.S. federal income tax purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Below-Investment Grade Bonds. &lt;/i&gt;The Fund
may invest without limitation in a wide variety of fixed-income securities that are rated or determined by the Sub-Adviser to be below-investment
grade quality (&#x201c;Below-Investment Grade Bonds&#x201d;). The credit quality of most Below-Investment Grade Bonds reflects a greater
than average possibility that adverse changes in the financial condition of an issuer, or in general economic conditions, or both, may
impair the ability of the issuer to make payments of interest and principal. The inability (or perceived inability) of issuers to make
timely payment of interest and principal would likely make the values of Below-Investment Grade Bonds held by the Fund more volatile and
could limit the Fund&#x2019;s ability to sell such Bonds at favorable prices. In the absence of a liquid trading market for its Below-Investment
Grade Bonds, the Fund may have difficulties determining the fair market value of such investments. Below-Investment Grade Bonds include
certain below-investment grade quality mortgage-related securities, asset-backed securities, and other hybrid securities and instruments
that are treated as debt obligations for U.S. federal income tax purposes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In addition to pre-existing outstanding debt
obligations of below-investment grade issuers, the Fund may also invest in &#x201c;debtor-in-possession&#x201d; or &#x201c;DIP&#x201d; financings
newly issued in connection with &#x201c;special situation&#x201d; restructuring and refinancing transactions. DIP financings are Loans to
a debtor-in-possession in a proceeding under the U.S. Bankruptcy Code that have been approved by the bankruptcy court. DIP financings
are typically fully secured by a lien on the debtor&#x2019;s otherwise unencumbered assets or secured by a junior lien on the debtor&#x2019;s
encumbered assets (so long as the Loan is fully secured based on the most recent current valuation or appraisal report of the debtor).
The bankruptcy court can authorize the debtor to grant the DIP lender a claim with super-priority over administrative expenses incurred
during bankruptcy and of other claims, thus a DIP financing may constitute senior debt even if not secured. DIP financings are often required
to close with certainty and in a rapid manner in order to satisfy existing creditors and to enable the issuer to emerge from bankruptcy
or to avoid a bankruptcy proceeding. These financings allow the entity to continue its business operations while reorganizing under Chapter
11 of the U.S. Bankruptcy Code.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Distressed and Defaulted Securities. &lt;/i&gt;The
Fund may invest in the securities of financially distressed and bankrupt issuers. Such debt obligations may be in covenant or payment
default. Such investments generally trade significantly below par and are considered speculative. The repayment of defaulted obligations
is subject to significant uncertainties. Defaulted obligations might be repaid only after lengthy workout or bankruptcy proceedings, during
which the issuer might not make any interest or other payments. Typically such workout or bankruptcy proceedings result in only partial
recovery of cash payments or an exchange of the defaulted obligation for other debt or equity securities of the issuer or its affiliates,
which may in turn be illiquid or speculative.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Structured Finance Investments. &lt;/i&gt;The Fund
may invest in structured finance investments, which are Income Securities and Common Equity Securities typically issued by special purpose
vehicles that hold income-producing securities (e.g., mortgage loans, consumer debt payment obligations and other receivables) and other
financial assets. Structured finance investments are designed to meet certain financial goals of investors. Typically, these investments
provide investors with the potential for capital protection, income generation and/or the opportunity to generate capital growth. The
Sub-Adviser believes that structured finance investments may provide attractive risk-adjusted returns, frequent sector rotation opportunities
and prospects for adding value through security selection. For purposes of the Fund&#x2019;s investment policies, structured finance investments
are not deemed to be &#x201c;private investment funds&#x201d; (as discussed below). Structured finance investments primarily include (among
others):&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Mortgage-Related Securities&lt;/span&gt;. Mortgage-related securities
are a form of derivative collateralized by pools of commercial or residential mortgages. Pools of mortgage loans are assembled as securities
for sale to investors by various governmental, government-related and private organizations. These securities may include complex instruments
such as collateralized mortgage obligations, REITs (including debt and preferred stock issued by REITs), and other real estate-related
securities. The mortgage-related securities in which the Fund may invest include those with fixed, floating or variable interest rates,
those with interest rates that change based on multiples of changes in a specified index of interest rates, and those with interest rates
that change inversely to changes in interest rates, as well as those that do not bear interest. The Fund may invest in residential and
commercial mortgage-related securities issued by governmental entities (i.e., agency mortgage-related securities) and private issuers
(i.e. non-agency mortgage-related securities), including subordinated mortgage-related securities. The underlying assets of certain mortgage-related
securities are subject to prepayments, which shorten the weighted average maturity and may lower the&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt; return of such securities, and extension,
which lengthens expected maturity as payments on principal may occur at a slower rate or later than expected.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Asset-Backed Securities&lt;/span&gt;. Asset-backed securities (&#x201c;ABS&#x201d;)
are a form of structured debt obligation. ABS are payment claims that are securitized in the form of negotiable paper that is issued by
a financing company (generally called a special purpose vehicle). Collateral assets are brought into a pool according to specific diversification
rules. A special purpose vehicle is founded for the purpose of securitizing these payment claims and the assets of the special purpose
vehicle are the diversified pool of collateral assets. The special purpose vehicle issues marketable securities that are intended to represent
a lower level of risk than an underlying collateral asset individually, due to the diversification in the pool. The redemption of the
securities issued by the special purpose vehicle takes place out of the cash flow generated by the collected assets. A special purpose
vehicle may issue multiple securities with different priorities to the cash flows generated and the collateral assets. The collateral
for ABS may include, among other assets, home equity loans, automobile and credit card receivables, boat loans, computer leases, airplane
leases, mobile home loans, recreational vehicle loans and hospital account receivables. The Fund may invest in these and other types of
ABS that may be developed in the future. There is the possibility that recoveries on the underlying collateral may not, in some cases,
be available or may be insufficient to support payments on these securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Collateralized Debt Obligations&lt;/span&gt;. A collateralized debt
obligation (&#x201c;CDO&#x201d;) is an asset-backed security whose underlying collateral is typically a portfolio of bonds, bank loans,
other structured finance securities and/or synthetic instruments. Where the underlying collateral is a portfolio of bonds, a CDO is referred
to as a collateralized bond obligation (&#x201c;CBO&#x201d;). Where the underlying collateral is a portfolio of bank loans, a CDO is referred
to as a collateralized loan obligation (&#x201c;CLO&#x201d;). Investors in CBOs and CLOs bear the credit risk of the underlying collateral.
Multiple tranches of securities are issued by the CLO, offering investors various maturity and credit risk characteristics. Tranches are
categorized as senior, mezzanine, and subordinated/ equity, according to their degree of risk. If there are defaults or the CLO&#x2019;s
collateral otherwise underperforms, scheduled payments to senior tranches take precedence over those of mezzanine tranches, and scheduled
payments to mezzanine tranches take precedence over those to subordinated/equity tranches. This prioritization of the cash flows from
a pool of securities among the several tranches of the CLO is a key feature of the CLO structure. If there are funds remaining after each
tranche of debt receives its contractual interest rate and the CLO meets or exceeds required collateral coverage levels (or other similar
covenants), the remaining funds may be paid to the subordinated (or residual) tranche (often referred to as the &#x201c;equity&#x201d; tranche). &lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;The contractual provisions setting out this order of payments are set out in detail in the relevant CLO&#x2019;s indenture. These provisions
are referred to as the &#x201c;priority of payments&#x201d; or the &#x201c;waterfall&#x201d; and determine the terms of payment of any other
obligations that may be required to be paid ahead of payments of interest and principal on the securities issued by a CLO. In addition,
for payments to be made to each tranche, after the most senior tranche of debt, there are various tests that must be complied with, which
are different for each CLO. If a CLO breaches one of these tests excess cash flow that would otherwise be available for distribution to
the subordinated tranche investors is diverted to prepay CLO debt investors in order of seniority until such time as the covenant breach
is cured. If the covenant breach is not or cannot be cured, the subordinated tranche investors (and potentially other investors in lower
priority rated tranches) may experience a partial or total loss of their investment.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;CLOs are subject to the same risk of prepayment and
extension described with respect to certain mortgage-related and asset-backed securities. The value of CLOs may be affected by, among
other developments, changes in the market&#x2019;s perception of the creditworthiness of the servicing agent for the pool, the originator
of the pool, or the financial institution or fund providing the credit support or enhancement.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;The Fund may invest in senior, rated tranches as well as mezzanine
and subordinated tranches of CLOs. Investment in the subordinated tranche is subject to additional risks. The subordinated tranche does
not receive ratings and is considered the riskiest portion of the capital structure of a CLO because it bears the bulk of defaults from
the loans in the CLO and serves to protect the other, more senior tranches from default in many but not all circumstances.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt;&lt;span style="text-decoration: underline"&gt;Risk-Linked Securities&lt;/span&gt;. Risk-linked securities (&#x201c;RLS&#x201d;)
are a form of derivative issued by insurance companies and insurance-related special purpose vehicles that apply securitization techniques
to catastrophic property and casualty damages. RLS are typically debt obligations for which the return of principal and the payment of
interest are contingent on the non-occurrence of a pre-defined &#x201c;trigger event.&#x201d; Depending on the specific terms and structure
of the RLS, this trigger could be the result of a hurricane, earthquake or some other catastrophic event. Insurance companies securitize
this risk to transfer to the capital markets the truly catastrophic part of the risk exposure. A typical RLS provides for income and return
of capital similar to other fixed-income investments, but would involve full or partial default if losses resulting from a certain catastrophe
exceeded a predetermined amount. RLS typically have relatively high yields compared with similarly rated fixed-income securities, and
also have low correlation with the returns of traditional securities. The Sub-Adviser believes that inclusion of RLS in the Fund&#x2019;s
portfolio could lead to significant improvement in its overall risk-return profile. Investments in RLS may be linked to a broad range
of insurance risks, which can be broken down into three major categories: natural risks (such as hurricanes and earthquakes), weather
risks (such as insurance based on a regional average temperature) and non-natural events (such as aerospace and shipping catastrophes).
Accordingly, depending on the specific terms and structure of the RLS, this trigger could be the result of a hurricane, earthquake or
some other&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"&gt; catastrophic event. Although property-casualty RLS have been in existence for over a decade, significant developments have
started to occur in securitizations done by life insurance companies. In general, life insurance industry securitizations could fall into
a number of categories. Some are driven primarily by the desire to transfer risk to the capital markets, such as the transfer of extreme
mortality risk (mortality bonds). Others, while also including the element of risk transfer, are driven by other considerations. For example,
a securitization could be undertaken to relieve the capital strain on life insurance companies caused by the regulatory requirements of
establishing very conservative reserves for some types of products. Another example is the securitization of the stream of future cash
flows from a particular block of business, including the securitization of embedded values of life insurance business or securitization
for the purpose of funding acquisition costs.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Senior Loans. &lt;/i&gt;Senior Loans are floating
rate Loans made to corporations and other non-governmental entities and issuers. Senior Loans typically hold the most senior position
in the capital structure of the issuing entity, are typically secured with specific collateral and typically have a claim on the assets
of the borrower, including stock owned by the borrower in its subsidiaries, that is senior to that held by junior lien creditors, subordinated
debt holders and stockholders of the borrower. The proceeds of Senior Loans primarily are used to finance leveraged buyouts, recapitalizations,
mergers, acquisitions, stock repurchases, dividends, and, to a lesser extent, to finance internal growth and for other corporate purposes.
Senior Loans typically have rates of interest that are redetermined daily, monthly, quarterly or semi-annually by reference to a base
lending rate, plus a premium or credit spread. Base lending rates in common usage today are primarily SOFR, and secondarily the prime
rate offered by one or more major U.S. banks (the &#x201c;Prime Rate&#x201d;) and the certificate of deposit (&#x201c;CD&#x201d;) rate or
other base lending rates used by commercial lenders.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Second Lien Loans. &lt;/i&gt;Second Lien Loans are
Loans made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Second Lien Loans
are second in right of payment to one or more Senior Loans of the related borrower. Second Lien Loans typically are secured by a second
priority security interest or lien to or on specified collateral securing the borrower&#x2019;s obligation under the Loan and typically
have similar protections and rights as Senior Loans. Second Lien Loans are not (and by their terms cannot) become subordinate in right
of payment to any obligation of the related borrower other than Senior Loans of such borrower. Second Lien Loans, like Senior Loans, typically
have floating rate interest payments. Because Second Lien Loans are second to Senior Loans, they present a greater degree of investment
risk but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below-investment grade
quality. Other than their subordinated status, Second Lien Loans have many characteristics and risks similar to Senior Loans discussed
above. In addition, Second Lien Loans and debt securities of below-investment grade quality share many of the risk characteristics of
Non-Investment Grade Bonds.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Subordinated Secured Loans. &lt;/i&gt;Subordinated
secured Loans are made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Subordinated
secured Loans may rank lower in right of payment to one or more Senior Loans and Second Lien Loans of the borrower. Subordinated secured
Loans typically are secured by a lower priority security interest or lien to or on specified collateral securing the borrower&#x2019;s
obligation under the Loan, and typically have more subordinated protections and rights than Senior Loans and Second Lien Loans. Subordinated
secured Loans may become subordinated in right of payment to more senior obligations of the borrower issued in the future. Subordinated
secured Loans may have fixed or floating rate interest payments. Because Subordinated secured Loans may rank lower as to right of payment
than Senior Loans and Second Lien Loans of the borrower, they may present a greater degree of investment risk than Senior Loans and Second
Lien Loans but often pay interest at higher rates reflecting this additional risk. Such investments generally are of below investment
grade quality. Other than their more subordinated status, such investments have many characteristics and risks similar to Senior Loans
and Second Lien Loans discussed above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Unsecured Loans. &lt;/i&gt;Unsecured Loans are loans
made by public and private corporations and other non-governmental entities and issuers for a variety of purposes. Unsecured Loans generally
have lower priority in right of payment compared to holders of secured debt of the borrower. Unsecured Loans are not secured by a security
interest or lien to or on specified collateral securing the borrower&#x2019;s obligation under the loan. Unsecured Loans by their terms
may be or may become subordinate in right of payment to other obligations of the borrower, including Senior Loans, Second Lien Loans and
Subordinated Secured Loans. Unsecured Loans may have fixed or floating rate interest payments. Because unsecured Loans are subordinate
to the secured debt of the borrower, they present a greater degree of investment risk but often pay interest at higher rates reflecting
this additional risk. Such investments generally are of below investment grade quality. Other than their subordinated and unsecured status,
&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;such investments have many characteristics and risks similar to Senior Loans, Second Lien Loans and Subordinated Secured Loans discussed
above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Mezzanine Investments. &lt;/i&gt;The Fund may invest
in certain lower grade securities known as &#x201c;Mezzanine Investments,&#x201d; which are subordinated debt securities that are generally
issued in private placements in connection with an equity security (e.g., with attached warrants) or may be convertible into equity securities.
Mezzanine Investments may be issued with or without registration rights. Similar to other lower grade securities, maturities of Mezzanine
Investments are typically seven to ten years, but the expected average life is significantly shorter at three to five years. Mezzanine
Investments are usually unsecured and subordinated to other obligations of the issuer.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Convertible Securities. &lt;/i&gt;Convertible securities
include bonds, debentures, notes, preferred stocks and other securities that entitle the holder to acquire common stock or other equity
securities of the issuer. Convertible securities have general characteristics similar to both debt and equity securities. A convertible
security generally entitles the holder to receive interest or preferred dividends paid or accrued until the convertible security matures
or is redeemed, converted or exchanged. Before conversion, convertible securities have characteristics similar to non-convertible debt
obligations. Convertible securities rank senior to common stock in a corporation&#x2019;s capital structure and, therefore, generally entail
less risk than the corporation&#x2019;s common stock, although the extent to which such risk is reduced depends in large measure upon the
degree to which the convertible security sells above its value as a debt obligation. A convertible security may be subject to redemption
at the option of the issuer at a predetermined price. If a convertible security held by the Fund is called for redemption, the Fund would
be required to permit the issuer to redeem the security and convert it to underlying common stock, or would sell the convertible security
to a third party, which may have an adverse effect on the Fund&#x2019;s ability to achieve its investment objective. The price of a convertible
security often reflects variations in the price of the underlying common stock in a way that non-convertible debt may not. The value of
a convertible security is a function of (i) its yield in comparison to the yields of other securities of comparable maturity and quality
that do not have a conversion privilege and (ii) its worth if converted into the underlying common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Preferred Stocks. &lt;/i&gt;Preferred stocks represent
the senior residual interest in the assets of an issuer after meeting all claims, with priority to corporate income and liquidation payments
over the issuer&#x2019;s common stock. As such, preferred stock is inherently more risky than the bonds and loans of the issuer, but less
risky than its common stock. Preferred stocks often contain provisions that allow for redemption in the event of certain tax or legal
changes or at the issuers&#x2019; call. Preferred stocks typically do not provide any voting rights, except in cases when dividends are
in arrears beyond a certain time period. Preferred stock in some instances is convertible into common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Although they are equity securities, preferred
stocks have certain characteristics of both debt and common stock. They are debt-like in that their promised income is contractually fixed.
They are common stock-like in that they do not have rights to precipitate bankruptcy proceedings or collection activities in the event
of missed payments. Furthermore, they have many of the key characteristics of equity due to their subordinated position in an issuer&#x2019;s
capital structure and because their quality and value are heavily dependent on the profitability of the issuer rather than on any legal
claims to specific assets or cash flows. In order to be payable, dividends on preferred stock must be declared by the issuer&#x2019;s board
of directors. In addition, distributions on preferred stock may be subject to deferral and thus may not be automatically payable. Income
payments on some preferred stocks are cumulative, causing dividends and distributions to accrue even if not declared by the board of directors
or otherwise made payable. Other preferred stocks are non-cumulative, meaning that skipped dividends and distributions do not continue
to accrue. There is no assurance that dividends on preferred stocks in which the Fund invests will be declared or otherwise made payable.
If the Fund owns preferred stock that is deferring its distributions, the Fund may be required to report income for U.S. federal income
tax purposes while it is not receiving cash payments corresponding to such income. When interest rates fall below the rate payable on
an issue of preferred stock or for other reasons, the issuer may redeem the preferred stock, generally after an initial period of call
protection in which the stock is not redeemable. Preferred stocks may be significantly less liquid than many other securities, such as
U.S. Government securities, corporate bonds and common stock.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;U.S. Government Securities. &lt;/i&gt;The Fund may
invest in debt securities issued or guaranteed by the U.S. government, its agencies or instrumentalities including: (1) U.S. Treasury
obligations, which differ in their interest rates, maturities and times of issuance, such as U.S. Treasury bills (maturity of one year
or less), U.S. Treasury notes (maturity of one to ten years), and U.S. Treasury bonds (generally maturities of greater than ten years),
including the principal components or the interest components issued by the U.S. government under the separate trading of registered interest
and principal securities program (i.e., &#x201c;STRIPS&#x201d;), all of which are backed by the full faith and&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; credit of the United States;
and (2) obligations issued or guaranteed by U.S. government agencies or instrumentalities, including government guaranteed mortgage-related
securities, some of which are backed by the full faith and credit of the U.S. Treasury, some of which are supported by the right of the
issuer to borrow from the U.S. government, and some of which are backed only by the credit of the issuer itself.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Foreign Securities. &lt;/i&gt;While the Fund invests
primarily in securities of U.S. issuers, the Fund may invest up to 20% of its total assets in non-U.S. dollar-denominated fixed-income
securities of corporate and governmental issuers located outside the United States, including up to 10% in emerging markets. Foreign securities
include securities issued or guaranteed by companies organized under the laws of countries other than the United States and securities
issued or guaranteed by foreign governments, their agencies or instrumentalities and supra-national governmental entities, such as the
World Bank. Foreign securities also may be traded on foreign securities exchanges or in over-the-counter capital markets. The value of
foreign securities and obligations is affected by, among other factors, changes in currency rates, foreign tax laws (including withholding
tax), government policies (in this country or abroad), relations between nations and trading, settlement, custodial and other operational
risks. In addition, the costs of investing abroad are generally higher than in the United States, and foreign securities markets may be
less liquid, more volatile and less subject to governmental supervision than markets in the United States. Foreign investments also could
be affected by other factors not present in the United States, including expropriation, armed conflict, confiscatory taxation, lack of
uniform accounting and auditing standards, less publicly available financial and other information and potential difficulties in enforcing
contractual obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Since the Fund may invest in securities and obligations
that are denominated or quoted in currencies other than the U.S. dollar, the Fund may be affected by changes in foreign currency exchange
rates (and exchange control regulations) which affect the value of investments in the Fund and the accrued income and appreciation or
depreciation of the investments in U.S. dollars. Changes in foreign currency exchange rates relative to the U.S. dollar will affect the
U.S. dollar value of the Fund&#x2019;s assets denominated in that currency and the Fund&#x2019;s return on such assets as well as any temporary
uninvested reserves in bank deposits in foreign currencies. In addition, the Fund will incur costs in connection with conversions between
various currencies. The Fund may seek to hedge its exposures to foreign currencies but may, at the discretion of the Sub-Adviser, at any
time limit or eliminate foreign currency hedging activity. See &#x201c;&#x2014;Derivative Transactions&#x2014;Foreign Currency Transactions.&#x201d;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Sovereign and Supranational Obligations. &lt;/i&gt;The
Fund may invest in sovereign debt securities, which are debt securities issued or guaranteed by foreign governmental entities, such as
foreign government debt or foreign treasury bills. Investments in sovereign debt securities involve special risks in addition to those
risks usually associated with investments in debt securities, including risks associated with economic or political uncertainty and the
risk that the governmental authority that controls the repayment of sovereign debt may be unwilling or unable to repay the principal and/or
interest when due. The Fund may also invest in securities or other obligations issued or backed by supranational organizations, which
are international organizations that are designated or supported by government entities or banking institutions typically to promote economic
reconstruction or development. These obligations are subject to the risk that the government(s) on whose support the organization depends
may be unable or unwilling to provide the necessary support. With respect to both sovereign and supranational obligations, the Fund may
have little recourse against the foreign government or supranational organization that issues or backs the obligation in the event of
default. These obligations may be denominated in foreign currencies and the prices of these obligations may be more volatile than corporate
debt obligations.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Sovereign debt instruments in which the Fund
may invest may involve great risk and may be deemed to be the equivalent in terms of credit quality to securities rated below investment
grade by Moody&#x2019;s and S&amp;amp;P. Governmental entities may depend on expected disbursements from foreign governments, multilateral
agencies and international organizations to reduce principal and interest arrearages on their debt obligations. The commitment on the
part of these governments, agencies and others to make such disbursements may be conditioned on a governmental entity&#x2019;s implementation
of economic or other reforms and/or economic performance and the timely service of the governmental entity&#x2019;s obligations. Failure
to implement such reforms, achieve such levels of economic performance or repay principal or interest when due may result in the cancellation
of the commitments to lend funds or other aid to the governmental entity, which may further impair the governmental entity&#x2019;s ability
or willingness to service its debts in a timely manner. Some of the countries in which the Fund may invest have encountered difficulties
in servicing their sovereign debt obligations and have withheld payments of interest and/or principal of sovereign debt. These difficulties
have also led to agreements to restructure external debt obligations, which may result in costs to the holders of the sovereign debt.
Consequently, a government obligor may default on its obligations and/or the values of its obligations may decline significantly.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Common Stocks and Other Common Equity Securities.
&lt;/i&gt;The Fund may also invest in common stocks and other Common Equity Securities that the Sub-Adviser believes offer attractive yield
and/or capital appreciation potential. Common stock represents the residual ownership interest in the issuer. Holders of common stocks
and other Common Equity Securities are entitled to the income and increase in the value of the assets and business of the issuer after
all of its debt obligations and obligations to preferred stockholders are satisfied. The Fund may invest in companies of any market capitalization.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Options. &lt;/i&gt;As part of its Common Equity
Securities strategy, the Fund currently intends to employ a strategy of writing (selling) covered call options and may, from time to time,
buy or sell put options on individual Common Equity Securities. In addition to its covered call option strategy, the Fund may, to a lesser
extent, pursue a strategy that includes the sale (writing) of both covered call and put options on indices of securities and sectors of
securities. This covered call option strategy is intended to generate current gains from option premiums as a means to generate total
returns as well as to enhance distributions payable to the Fund&#x2019;s Common Shareholders. The Fund may also write call options and
put options on individual securities, securities indices, ETFs, futures and baskets of securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;An option on a security is a contract that gives
the holder of the option, in return for a premium, the right to buy from (in the case of a call) or sell to (in the case of a put) the
writer of the option the security underlying the option at a specified exercise or &#x201c;strike&#x201d; price. The writer of an option
on a security has the obligation upon exercise of the option to deliver the underlying security upon payment of the exercise price or
to pay the exercise price upon delivery of the underlying security. The buyer of an option acquires the right, but not the obligation,
to buy (a call option) or sell (a put option) a certain quantity of a security (the underlying security) or instrument, including a futures
contract or swap, at a certain price up to a specified point in time or on expiration, depending on the terms. For certain types of options,
the writer of the option will have no control over the time when it may be required to fulfill its obligation under the option. Certain
options, known as &#x201c;American style&#x201d; options may be exercised at any time during the term of the option. Other options, known
as &#x201c;European style&#x201d; options, may be exercised only on the expiration date of the option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;If an option written by the Fund expires unexercised,
the Fund realizes on the expiration date a capital gain equal to the premium received by the Fund at the time the option was written.
If an option purchased by the Fund expires unexercised, the Fund realizes a capital loss equal to the premium paid. Prior to the earlier
of exercise or expiration, an exchange-traded option may be closed out by an offsetting purchase or sale of an option of the same series
(type, underlying security, exercise price and expiration). There can be no assurance, however, that a closing purchase or sale transaction
can be effected when the Fund desires. The Fund may sell put or call options it has previously purchased, which could result in a net
gain or loss depending on whether the amount realized on the sale is more or less than the premium and other transaction costs paid on
the put or call option when purchased. The Fund will realize a capital gain from a closing purchase transaction if the cost of the closing
option is less than the premium received from writing the option, or, if it is more, the Fund will realize a capital loss. If the premium
received from a closing sale transaction is more than the premium paid to purchase the option, the Fund will realize a capital gain or,
if it is less, the Fund will realize a capital loss. Net gains from the Fund&#x2019;s option strategy will be short-term capital gains
which, for U.S. federal income tax purposes, will constitute net investment company taxable income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund will follow a strategy known as &#x201c;covered
call option writing,&#x201d; which is a strategy designed to generate current gains from option premiums as a means to generate total returns
as well as to enhance distributions payable to the Fund&#x2019;s Common Shareholders. As the Fund writes covered calls over more of its
portfolio, its ability to benefit from capital appreciation becomes more limited.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Except as disclosed further below and in connection
with the Fund&#x2019;s Debt Overlay Strategy, the Fund may not sell &#x201c;naked&#x201d; call options on individual securities (i.e., options
representing more shares of the stock than are held in the portfolio). A call option written by the Fund on a security is &#x201c;covered&#x201d;
if the Fund owns the security &lt;span style="background-color: white"&gt;or instrument&lt;/span&gt; underlying the call or has an absolute and immediate
right to acquire that security &lt;span style="background-color: white"&gt;or instrument&lt;/span&gt; without additional cash consideration (or, if
additional cash consideration is required, cash or other assets determined to be liquid by the Sub-Adviser (in accordance with procedures
established by the Board of Trustees) in such amount are segregated by the Fund&#x2019;s custodian) upon conversion or exchange of other
securities held by the Fund. A call option is also covered if the Fund holds a call on the same security as the call written where the
exercise price of the call held is (i) equal to or less than the exercise price of the call written, or (ii) greater than the exercise
price of the call written, provided the difference is maintained by the Fund in segregated assets determined to be liquid by the Sub-Adviser
as described above.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Put options are contracts that give the holder
of the option, in return for a premium, the right to sell to the writer of the option the security underlying the option at a specified
exercise price at a specific time or times during the term of the option. These strategies may produce a considerably higher return than
the Fund&#x2019;s primary strategy of covered call writing, but involve a higher degree of risk and potential volatility.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund will write (sell) put options on individual
Common Equity securities only if the put option is &#x201c;covered.&#x201d; A put option written by the Fund on a security is &#x201c;covered&#x201d;
if the Fund segregates or earmarks assets determined to be liquid by the Sub-Adviser, as described above, equal to the exercise price.
A put option is also covered if the Fund holds a put on the same security as the put written where the exercise price of the put held
is (i) equal to or greater than the exercise price of the put written, or (ii) less than the exercise price of the put written, provided
the difference is maintained by the Fund in segregated or earmarked assets determined to be liquid by the Sub-Adviser, as described above.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may sell (covered and uncovered) put
and call options on indices of securities, futures on indices of securities, and index ETFs. Options on an index or index ETF differ from
options on securities because (i) the exercise of an index option requires cash payments and does not involve the actual purchase or sale
of securities, (ii) the holder of an index option has the right to receive cash upon exercise of the option if the level of the index
upon which the option is based is greater, in the case of a call, or less, in the case of a put, than the exercise price of the option
and (iii) index options reflect price-fluctuations in a group of securities or segments of the securities market rather than price fluctuations
in a single security.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may purchase and write exchange-listed
and OTC options. Options written by the Fund with respect to non-U.S. securities, indices or sectors and other instruments generally will
be OTC options. OTC options differ from exchange-listed options in several respects. They are transacted directly with the dealers and
not with a clearing corporation, and therefore entail the risk of nonperformance by the dealer. OTC options are available for a greater
variety of securities and for a wider range of expiration dates and exercise prices than are available for exchange-traded options. Because
OTC options are not traded on an exchange, pricing is done normally by reference to information from a market maker. OTC options are subject
to heightened counterparty, credit, liquidity and valuation risks. The Fund&#x2019;s ability to terminate OTC options is more limited than
with exchange-traded options and may involve the risk that broker-dealers participating in such transactions will not fulfill their obligations.
The hours of trading for options may not conform to the hours during which the underlying securities are traded. The Fund&#x2019;s options
transactions will be subject to limitations established by each of the exchanges, boards of trade or other trading facilities on which
such options are traded.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Restricted and Illiquid Securities. &lt;/i&gt;The
Fund may invest in securities for which there is no readily available trading market or that are otherwise illiquid. Illiquid securities
include securities legally restricted as to resale, such as commercial paper issued pursuant to Section 4(a)(2) of the Securities Act
of 1933, as amended (the &#x201c;Securities Act&#x201d;), and securities eligible for resale pursuant to Rule 144A thereunder. Section 4(a)(2)
and Rule 144A securities may, however, be treated as liquid by the Investment Adviser after consideration of factors such as trading activity,
availability of market quotations and number of dealers willing to purchase the security. If the Fund invests in Rule 144A securities,
the level of portfolio illiquidity may be increased to the extent that eligible buyers become uninterested in purchasing such securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;It may be difficult to sell such securities at
a price representing the fair value until such time as such securities may be sold publicly. Where registration is required, a considerable
period may elapse between a decision to sell the securities and the time when it would be permitted to sell. Thus, the Fund may not be
able to obtain as favorable a price as that prevailing at the time of the decision to sell. The Fund may also acquire securities through
private placements under which it may agree to contractual restrictions on the resale of such securities. Such restrictions might prevent
their sale at a time when such sale would otherwise be desirable.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Government Sponsored Investment Programs&lt;/i&gt;.
From time to time, the Fund may seek to invest in credit securities through one or more programs that may from time to time be sponsored,
established or operated by the U.S. Department of the Treasury, the Board of Governors of the Federal Reserve System and other governmental
agencies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Derivatives Transactions&lt;/i&gt;. The Fund may
purchase and sell various derivative instruments (which derive their value by reference to another instrument, asset or index), such as
swaps, futures, options and other derivatives contracts, for investment purposes, such as obtaining investment exposure to an investment
category; risk management purposes, such as hedging against fluctuations in asset prices, currencies or interest rates; &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;diversification
purposes; or to change the duration of the Fund. The Fund may, but is not required to, use various strategic transactions in swaps, futures,
options and other derivative contracts in order to seek to earn income, facilitate portfolio management and mitigate risks. These strategies
may be executed through the use of derivative contracts. In the course of pursuing these investment strategies, the Fund may purchase
and sell exchange-listed and OTC put and call options on securities, equity and fixed-income indices and other instruments, purchase and
sell futures contracts and options thereon, and enter into various transactions such as swaps, caps, floors or collars. In addition, derivative
transactions may also include new techniques, instruments or strategies that are permitted as regulatory changes occur. In order to help
protect the soundness of derivative transactions and outstanding derivative positions, the Sub-Adviser generally requires derivative counterparties
to have a minimum credit rating of A3 from Moody&#x2019;s (or a comparable rating from another NRSRO) and monitors such rating on an ongoing
basis. In addition, the Sub-Adviser seeks to allocate derivatives transactions to limit exposure to any single counterparty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund is required to trade derivatives and
other transactions that create future payment or delivery obligations (except reverse repurchase agreements and similar financing transactions)
subject to value-at-risk (&#x201c;VaR&#x201d;) leverage limits and derivatives risk management program and reporting requirements. Generally,
these requirements apply unless the Fund satisfies a &#x201c;limited derivatives users&#x201d; exception that is included in Rule 18f-4
under the 1940 Act. The Fund is not classified as a &#x201c;limited derivatives user&#x201d; and, as required by Rule 18f-4, has implemented
a Derivatives Risk Management Program, which is reasonably designed to manage the Fund&#x2019;s derivatives risks and to reasonably segregate
the functions associated with the Derivatives Risk Management Program from the portfolio management of the Fund. The Board, including
a majority of the trustees who are not &#x201c;interested persons&#x201d; of the Fund, as such term is defined in the 1940 Act, approved
the designation of a Derivatives Risk Manager, which is responsible for administering the Derivatives Risk Management Program for the
Fund. To facilitate the Board&#x2019;s oversight, the Board reviews, no less frequently than annually, a written report on the effectiveness
of the Derivatives Risk Management Program and also more frequent reports regarding certain derivatives risk matters.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#x2019;s asset coverage ratio or treat all such transactions as derivatives transactions. Reverse
repurchase agreements or similar financing transactions aggregated with other indebtedness do not need to be included in the calculation
of whether a fund satisfies the limited derivatives users exception, but for funds subject to the VaR testing requirement, reverse repurchase
agreements and similar financing transactions must be included for purposes of such testing whether treated as derivatives transactions
or not. SEC guidance regarding the use of securities lending collateral may limit the Fund&#x2019;s securities lending activities. In addition,
the Fund is permitted to invest in a security on a when issued or forward-settling basis, or with a non-standard settlement cycle, and
the transaction will be deemed not to involve a senior security, provided that (i) the Fund intends to physically settle the transaction
and (ii) the transaction will settle within 35 days of its trade date (the &#x201c;Delayed-Settlement Securities Provision&#x201d;). The
Fund may otherwise engage in such transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long
as the Fund treats any such transaction as a &#x201c;derivatives transaction&#x201d; for purposes of compliance with Rule 18f-4. Furthermore,
under the rule, the Fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not
be subject to the asset coverage requirements under the 1940 Act, if the Fund reasonably believes, at the time it enters into such agreement,
that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Credit Derivatives. &lt;/i&gt;Credit default derivatives
are linked to the price of reference securities or loans after a default by the issuer or borrower, respectively. Market spread derivatives
are based on the risk that changes in market factors, such as credit spreads, can cause a decline in the value of a security, loan or
index. There are three basic transactional forms for credit derivatives: swaps, options and structured instruments. The use of credit
derivatives is a highly specialized activity which involves strategies and risks different from those associated with ordinary portfolio
security transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may invest in credit default swap transactions
and credit-linked notes (described below) for hedging and investment purposes. The &#x201c;buyer&#x201d; in a credit default swap contract
is obligated to pay the &#x201c;seller&#x201d; a periodic stream of payments over the term of the contract provided that no event of default
on an underlying reference obligation has occurred. If an event of default occurs, the seller must pay the buyer the full notional value,
or &#x201c;par value,&#x201d; of the reference obligation. Credit default swap transactions are either &#x201c;physical delivery&#x201d; settled
or &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&#x201c;cash&#x201d; settled. Physical delivery entails the actual delivery of the reference asset to the seller in exchange for the
payment of the full par value of the reference asset. Cash settled entails a net cash payment from the seller to the buyer based on the
difference of the par value of the reference asset and the current value of the reference asset that may, after a default, have lost some,
most, or all of its value.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund may be either the buyer or seller in
a credit default swap transaction and generally will be a buyer in instances in which the Fund actually owns the underlying debt security
and seeks to hedge against the risk of default in that debt security. If the Fund is a buyer and no event of default occurs, the Fund
will have made a series of periodic payments (in an amount more or less than the value of the cash flows received on the underlying debt
security) and recover nothing of monetary value. However, if an event of default occurs, the Fund (if the buyer) will receive the full
notional value of the reference obligation either through a cash payment in exchange for such asset or a cash payment in addition to owning
the reference asset. The Fund generally will be a seller when it seeks to take the credit risk of a particular debt security and, as a
seller, the Fund receives a fixed rate of income throughout the term of the contract, which typically is between six months and ten years,
provided that there is no event of default. If an event of default occurs, the seller must pay the buyer the full notional value of the
reference obligation through either physical settlement and/or cash settlement. Credit default swap transactions involve greater risks
than if the Fund had invested in the reference obligation directly, including counterparty credit risk and leverage risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Foreign Currency Transactions. &lt;/i&gt;The Fund
may (but is not required to) hedge some or all of its exposure to non-U.S. currencies through the use of forward foreign currency exchange
contracts, options on foreign currencies, foreign currency futures contracts and swaps and other derivatives transactions. Suitable hedging
transactions may not be available in all circumstances and there can be no assurance that the Fund will engage in such transactions at
any given time or from time to time when they would be beneficial. Although the Fund has the flexibility to engage in such transactions,
the Investment Adviser or Sub-Adviser may determine not to do so or to do so only in unusual circumstances or market conditions. These
transactions may not be successful and may eliminate any chance for the Fund to benefit from favorable fluctuations in relevant foreign
currencies. The Fund may also use derivatives transactions for purposes of increasing exposure to a foreign currency or to shift exposure
to foreign currency fluctuations from one currency to another.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Although the Sub-Adviser seeks to use derivatives
to further the Fund&#x2019;s investment objective, there is no assurance that the use of derivatives will achieve this result. For a more
complete discussion of the Fund&#x2019;s investment practices involving transactions in derivatives and certain other investment techniques,
see &#x201c;Investment Objective and Policies&#x2014;Derivative Instruments&#x201d; in the Fund&#x2019;s SAI.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Municipal Securities&lt;/i&gt;. The Fund may invest
directly or indirectly in municipal securities. Municipal securities include securities issued by or on behalf of states, territories
and possessions of the United States and the District of Columbia and their political subdivisions, agencies and instrumentalities, the
payments from which, in the opinion of bond counsel to the issuer, are excludable from gross income for federal income tax purposes. Municipal
securities also include taxable securities issued by such issuers. Municipal bonds may include those backed by, among other things, state
taxes and essential service revenues as well as health care and higher education issuers, among others, or be supported by dedicated revenue
streams and/or statutory liens.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;b&gt;Temporary Investments&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;At any time when a temporary posture is believed
by the Sub-Adviser to be warranted (a &#x201c;temporary period&#x201d;), the Fund may, without limitation, hold cash or invest its assets
in money market instruments and repurchase agreements in respect of those instruments. The money market instruments in which the Fund
may invest are obligations of the U.S. government, its agencies or instrumentalities; commercial paper rated A-1 or higher by S&amp;amp;P
or Prime-1 by Moody&#x2019;s; and certificates of deposit and bankers&#x2019; acceptances issued by domestic branches of U.S. banks that
are members of the Federal Deposit Insurance Corporation. During a temporary period, the Fund may also invest in shares of money market
mutual funds. Money market mutual funds are investment companies, and the investments in those companies by the Fund are in some cases
subject to the 1940 Act&#x2019;s limitations on investments in other investment companies. See &#x201c;Investment Restrictions&#x201d; in
the Fund&#x2019;s SAI. As a shareholder in a mutual fund, the Fund will bear its ratable share of its expenses, including management fees,
and will remain subject to payment of the fees to the Investment Adviser, with respect to assets so invested. See &#x201c;Management of
the Fund.&#x201d; The Fund may not achieve its investment objective during a temporary period or be able to sustain its historical distribution
levels.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"&gt;&lt;b&gt;Certain Other Investment Practices&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;When Issued, Delayed Delivery Securities
and Forward Commitments&lt;/i&gt;. The Fund may enter into forward commitments for the purchase or sale of securities, including on a &#x201c;when
issued&#x201d; or &#x201c;delayed delivery&#x201d; basis, in excess of customary settlement periods for the type of security involved. In
some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a
merger, corporate reorganization or debt restructuring (i.e., a when, as and if issued security). When such transactions are negotiated,
the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after
the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security,
the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are
subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Forward commitments involve
a risk of loss if the value of the security to be purchased declines prior to the settlement date, which risk is in addition to the risk
of decline in value of the Fund&#x2019;s other assets. In addition, FINRA rules include mandatory margin requirements that require the
Fund to post collateral in connection with certain of these transactions. There is no similar requirement that the Fund&#x2019;s counterparties
post collateral in connection with such transactions. The required collateralization of these transactions could increase the cost of
such transactions to the Fund and impose added operational complexity.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;Loans of Portfolio Securities&lt;/i&gt;. To seek
to increase income, the Fund may lend its portfolio securities to securities broker-dealers or financial institutions if (i) the loan
is collateralized in accordance with applicable regulatory requirements and (ii) no loan will cause the value of all loaned securities
to exceed 33 1/3% of the value of the Fund&#x2019;s total assets. If the borrower fails to maintain the requisite amount of collateral,
the loan automatically terminates and the Fund could use the collateral to replace the securities while holding the borrower liable for
any excess of replacement cost over the value of the collateral. As with any extension of credit, there are risks of delay in recovery
and in some cases even loss of rights in collateral should the borrower of the securities fail financially. There can be no assurance
that borrowers will not fail financially. On termination of the loan, the borrower is required to return the securities to the Fund, and
any gain or loss in the market price during the period of the loan would inure to the Fund. If the other party to the loan petitions for
bankruptcy or becomes subject to the United States Bankruptcy Code, the law regarding the rights of the Fund is unsettled. As a result,
under extreme circumstances, there may be a restriction on the Fund&#x2019;s ability to sell the collateral and the Fund would suffer a
loss. See &#x201c;Investment Objective and Policies Loans of Portfolio Securities&#x201d; in the Fund&#x2019;s SAI.&lt;br/&gt;
&lt;br/&gt;
&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Offsetting. &lt;/i&gt;In the normal course of business,
the Fund enters into transactions subject to enforceable master netting arrangements or other similar arrangements. Generally, the right
to offset in those agreements allows the Fund to counteract the exposure to a specific counterparty with collateral received from or delivered
to that counterparty based on the terms of the arrangements. These arrangements provide for the right to liquidate upon the occurrence
of an event of default, credit event upon merger or additional termination event.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In order to better define its contractual rights
and to secure rights that will help the Fund mitigate its counterparty risk, the Fund may enter into an International Swaps and Derivatives
Association, Inc. Master Agreement (&#x201c;ISDA Master Agreement&#x201d;) or similar agreement with its derivative contract counterparties.
An ISDA Master Agreement is a bilateral agreement between the Fund and a counterparty that governs OTC derivatives, including foreign
exchange contracts, and typically contains, among other things, collateral posting terms and netting provisions in the event of a default
and/or termination event. The provisions of the ISDA Master Agreement typically permit a single net payment in the event of a default
(close-out netting) or similar event, including the bankruptcy or insolvency of the counterparty.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;For derivatives traded under an ISDA Master
Agreement, the collateral requirements are typically calculated by netting the mark-to-market amount for each transaction under such agreement
and comparing that amount to the value of any collateral currently pledged by the Fund and the counterparty. For financial reporting purposes,
cash collateral that has been pledged to cover obligations of the Fund and cash collateral received from the counterparty, if any, are
reported separately on the Statement of Assets and Liabilities as segregated cash from broker/receivable for variation margin, or segregated
cash due to broker/payable for variation margin. Generally, the amount of collateral due from or to a counterparty must exceed a minimum
transfer amount threshold before a transfer is required to be made. To the extent amounts due to the Fund from its counterparties are
not fully collateralized, contractually or otherwise, the Fund bears the risk of loss from counterparty nonperformance. The &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;Fund attempts
to mitigate counterparty risk by only entering into agreements with counterparties that it believes to be of good standing and by monitoring
the financial stability of those counterparties.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;Repurchase Agreements&lt;/i&gt;. The Fund may enter
into bilateral and tri-party repurchase agreements. Repurchase agreements may be seen as loans by the Fund collateralized by underlying
debt securities. Under the terms of a typical repurchase agreement, the Fund buys an underlying debt obligation or other security subject
to an obligation of the seller to repurchase, and the Fund to resell, the obligation at an agreed price and time (usually not more than
one week later). This arrangement results in a fixed rate of return to the Fund. In the event of the insolvency of the counterparty to
a repurchase agreement, recovery of the repurchase price owed to the Fund may be delayed. Such an insolvency may result in a loss to the
extent that the value of the purchased securities or other assets decreases during the delay or that value has otherwise not been maintained
at an amount equal to the repurchase price. The Sub-Adviser reviews the creditworthiness of the counterparties with which the Fund enters
into repurchase agreements to evaluate these risks and monitors on an ongoing basis the value of the securities subject to repurchase
agreements to ensure that the value is maintained at the required level. The Fund will not enter into repurchase agreements with the Investment
Adviser, the Sub-Adviser or their affiliates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;Repurchase agreements collateralized fully by
cash items, U.S. government securities or by securities issued by an issuer that the Investment Adviser or the Sub-Adviser has determined
at the time the repurchase agreement is entered into has an exceptionally strong capacity to meet its financial obligations (&#x201c;Qualifying
Collateral&#x201d;) and meet certain liquidity standards generally may be deemed to be &#x201c;collateralized fully&#x201d; and may be deemed
to be investments in the underlying securities for certain purposes. The Fund may accept collateral other than Qualifying Collateral determined
by the Investment Adviser or the Sub-Adviser to be in the best interests of the Fund to accept as collateral for such repurchase agreement
(which may include high yield debt instruments that are rated below investment grade) (&#x201c;Alternative Collateral&#x201d;). Repurchase
agreements secured by Alternative Collateral are not deemed to be &#x201c;collateralized fully&#x201d; under applicable regulations and
the repurchase agreement is therefore considered a separate security issued by the counterparty to the Fund. Accordingly, the Fund must
include repurchase agreements that are not &#x201c;collateralized fully&#x201d; in its calculations of securities issued by the selling
institution held by the Fund for purposes of various portfolio diversification and concentration requirements applicable to the Fund.
In addition, Alternative Collateral may not qualify as permitted or appropriate investments for the Fund under the Fund&#x2019;s investment
strategies and limitations. Accordingly, if a counterparty to a repurchase agreement defaults and the Fund takes possession of Alternative
Collateral, the Fund may need to promptly dispose of the Alternative Collateral (or other securities held by the Fund, if the Fund exceeds
a limitation on a permitted investment by virtue of taking possession of the Alternative Collateral). The Alternative Collateral may be
particularly illiquid, especially in times of market volatility or in the case of a counterparty insolvency or bankruptcy, which may restrict
the Fund&#x2019;s ability to dispose of Alternative Collateral received from the counterparty. Depending on the terms of the repurchase
agreement, the Fund may determine to sell the collateral during the term of the repurchase agreement and then purchase the same collateral
at the market price at the time of the resale. In tri-party repurchase agreements, an unaffiliated third-party custodian maintains accounts
to hold collateral for the Fund and its counterparties and, therefore, the Fund may be subject to the credit risk of those custodians.
Securities subject to repurchase agreements (other than tri-party repurchase agreements) and purchase and sale contracts will be held
by the Fund&#x2019;s custodian (or sub-custodian) in the Federal Reserve/Treasury book-entry system or by another authorized securities
depository.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-indent: 0.5in"&gt;&lt;i&gt;Reverse Repurchase Agreements&lt;/i&gt;. The Fund
may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund sells a portfolio instrument to another party,
such as a bank or broker-dealer, in return for cash or other assets. At the same time, the Fund agrees to repurchase the instrument at
an agreed upon time and price (which may be effected by an exchange of the repurchased instrument for assets other than cash), for which
the effective difference in price reflects an interest payment. Reverse repurchase agreements involve the risks that the interest income
earned on the investment of the proceeds will be less than the interest expense and Fund expenses associated with the repurchase agreement,
that the market value of the securities or other assets sold by the Fund may decline below the price at which the Fund is obligated to
repurchase such securities and that the securities may not be returned to the Fund. There is no assurance that reverse repurchase agreements
can be successfully employed. In the event of the insolvency of the counterparty to a reverse repurchase agreement, recovery of the securities
or other assets sold by the Fund may be delayed. The counterparty&#x2019;s insolvency may result in a loss equal to the amount by which
the value of the securities or other assets sold by the Fund exceeds the repurchase price payable by the Fund; if the value of the purchased
securities or other assets increases during such a delay, that loss &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"&gt;may also be increased. When the Fund enters into a reverse repurchase
agreement, any fluctuations in the market value of either the instruments transferred to another party or the instruments in which the
proceeds may be invested would affect the market value of the Fund&#x2019;s assets. As a result, such transactions may increase fluctuations
in the net asset value of the Fund&#x2019;s Common Shares. Because reverse repurchase agreements may be considered to be the practical
equivalent of borrowing funds, they constitute a form of leverage. If the Fund reinvests the proceeds of a reverse repurchase agreement
at a rate lower than the cost of the agreement, entering into the agreement will lower the Fund&#x2019;s cash available for distribution.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal"&gt;&lt;i&gt;Sleeve Structure.
&lt;/i&gt;The Sub-Adviser may from time to time utilize a sleeve structure in managing the Fund. In this structure, the Sub-Adviser implements
the Fund&#x2019;s investment strategies using component sleeves of investments comprising distinct sub-strategies or grouping similar investments
in sub-accounts of the Fund that, collectively, comprise the Fund&#x2019;s overall portfolio and investment strategies. This approach facilitates
internal allocations and tracking of investments within a portfolio. &lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Interest Rate &lt;span style="color: windowtext"&gt;Transactions&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Please refer to the section of the &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/a&gt; entitled &#x201c;Additional Information Regarding the Fund&#x2014;Interest Rate Transactions,&#x201d;
which is incorporated by reference herein, for a discussion of the Fund&#x2019;s use of interest rate transactions in connection with the
Fund&#x2019;s use of Financial Leverage.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Portfolio Turnover&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund will buy and sell securities to seek
to accomplish its investment objective. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions
or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover
rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities
owned during the year (excluding securities whose maturities at acquisition were one year or less). The Fund&#x2019;s portfolio turnover
rate may vary greatly from year to year. Higher portfolio turnover may decrease the after-tax return to individual investors in the Fund
to the extent it results in a decrease of the long-term capital gains portion of distributions to shareholders. For the fiscal years ended
May 31, 2025 and May 31, 2024, the Fund&#x2019;s portfolio turnover rate was 25% and 30%, respectively.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Investment Restrictions&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund has adopted certain other investment
limitations. These limitations are fundamental and may not be changed without the approval of the holders of a majority of the outstanding
Common Shares, as defined in the 1940 Act (and preferred shares, if any, voting together as a single class). See &#x201c;Investment Restrictions&#x201d;
in the SAI for a complete list of the fundamental investment policies of the Fund.&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;&lt;span id="ProUseLeverage"&gt;&lt;/span&gt;Use of Leverage&lt;/p&gt;

&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;span style="font-weight: normal; color: windowtext"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Use of Leverage,&#x201d; which is incorporated
by reference herein, for a discussion of the Fund&#x2019;s use of leverage.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-indent: 0.5in"&gt;See the section of &lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;the
Fund&#x2019;s most recent annual report on Form N-CSR&lt;/a&gt; entitled &#x201c;Additional Information Regarding the Fund&#x2014;Principal Risks
of the Fund&#x2014;Financial Leverage and Leveraged Transactions Risk,&#x201d; which is incorporated by reference herein, for a discussion
of associated risks.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Borrowing&lt;/i&gt;. The Fund is authorized to borrow
or issue debt securities for financial leveraging purposes and for temporary purposes such as the settlement of transactions. The Fund
may utilize indebtedness to the maximum extent permitted under the 1940 Act. Under the 1940 Act, the Fund generally is not permitted to
issue commercial paper or notes or engage in other Borrowings, other than temporary borrowings as defined under the 1940 Act, unless,
immediately after the Borrowing, the Fund would have asset coverage (as defined in the 1940 Act) of less than 300%, as measured at the
time of borrowing and calculated as the ratio of the Fund&#x2019;s total assets (less all liabilities and indebtedness not represented
by senior securities) over the aggregate amount of the Fund&#x2019;s outstanding senior securities representing indebtedness. In addition,
other than with respect to privately arranged Borrowings, the Fund generally is not permitted to declare any cash dividend or other distribution
on any class of the Fund&#x2019;s capital stock, including the Common Shares, or purchase any such capital stock, unless, at the time of
such declaration, the Fund would have asset coverage (as described above) of at least 300% after deducting the &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;amount of such dividend
or other distribution. If the Fund borrows, the Fund intends, to the extent possible, to prepay all or a portion of the principal amount
of any outstanding commercial paper, notes or other Borrowings to the extent necessary to maintain the required asset coverage.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The terms of any such Borrowings may require
the Fund to pay a fee to maintain a line of credit, such as a commitment fee, or to maintain minimum average balances with a lender. Any
such requirements would increase the cost of such Borrowings over the stated interest rate. Such lenders would have the right to receive
interest on and repayment of principal of any such Borrowings, which right will be senior to those of the Common Shareholders. Any such
Borrowings may contain provisions limiting certain activities of the Fund, including the payment of dividends to Common Shareholders in
certain circumstances. Any Borrowings will likely be ranked senior or equal to all other existing and future Borrowings of the Fund.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Certain types of Borrowings subject the Fund
to covenants in credit agreements relating to asset coverage and portfolio composition requirements. Certain Borrowings issued by the
Fund also may subject the Fund to certain restrictions on investments imposed by guidelines of one or more rating agencies, which may
issue ratings for such Borrowings. Such guidelines may impose asset coverage or portfolio composition requirements that are more stringent
than those imposed by the 1940 Act. It is not anticipated that these covenants or guidelines will impede the Sub-Adviser from managing
the Fund&#x2019;s portfolio in accordance with the Fund&#x2019;s investment objective and policies.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The 1940 Act grants to the holders of senior
securities representing indebtedness issued by the Fund, other than with respect to privately arranged Borrowings, certain voting rights
in the event of default in the payment of interest on or repayment of principal. Failure to maintain certain asset coverage requirements
under the 1940 Act could result in an event of default and entitle the debt holders to elect a majority of the Board.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Borrowings under the committed
facility provided to the Fund by BNP Paribas are collateralized by portfolio assets which are maintained by the Fund in a separate account
with the Fund&#x2019;s custodian for the benefit of the lender, which collateral exceeds the amount borrowed. Securities deposited in the
collateral account may, subject to certain conditions, be rehypothecated by the lender up to the amount of the loan balance outstanding
and subject to the terms and conditions of the facility agreements. The Fund continues to receive dividends and interest on rehypothecated
securities. The Fund also has the right to recall rehypothecated securities on demand and such securities shall be returned to the collateral
account within the ordinary settlement cycle. In the event a recalled security is not returned by the lender, the loan balance outstanding
will be reduced by the amount of the recalled security failed to be returned. The Fund receives a portion of the fees earned by BNP Paribas
in connection with the rehypothecation of portfolio securities. Rehypothecation of the Fund&#x2019;s pledged portfolio securities entails
risks, including the risk that the lender will be unable or unwilling to return rehypothecated securities which could result in, among
other things, the Fund&#x2019;s inability to find suitable investments to replace the unreturned securities, thereby impairing the Fund&#x2019;s
ability to achieve its investment objective. In the event of a default by the Fund under the committed facility, the lender has the right
to sell such collateral assets to satisfy the Fund&#x2019;s obligation to the lender. The amounts drawn under the committed facility may
vary over time and such amounts will be reported in the Fund&#x2019;s audited and unaudited financial statements contained in the Fund&#x2019;s
annual and semi-annual reports to shareholders. The committed facility agreement includes usual and customary covenants. These covenants
impose on the Fund asset coverage requirements, collateral requirements, investment strategy requirements, and certain financial obligations.
These covenants place limits or restrictions on the Fund&#x2019;s ability to (i) enter into additional indebtedness with a party other
than BNP Paribas, (ii) change its fundamental investment policy, or (iii) pledge to any other party, other than to the counterparty, securities
owned or held by the Fund over which the counterparty has a lien. In addition, the Fund is required to deliver financial information to
the counterparty within established deadlines, maintain an asset coverage ratio (as defined in Section 18(g) of the 1940 Act) greater
than 300%, comply with the rules of the stock exchange on which its shares are listed, and maintain its classification as a &#x201c;closed-end
management investment company&#x201d; as defined in the 1940 Act.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;In addition, the Fund may engage in certain derivatives
transactions that have economic characteristics similar to leverage. The Fund&#x2019;s obligations under such transactions will not be
considered indebtedness for purposes of the 1940 Act and will not be included in calculating the aggregate amount of the Fund&#x2019;s
Financial Leverage, but the Fund&#x2019;s use of such transactions may be limited by Rule 18f-4 under the 1940 Act and the applicable requirements
of the SEC.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Reverse Repurchase Agreements and Dollar Roll
Transactions. &lt;/i&gt;The Fund may enter into reverse repurchase agreements. Under a reverse repurchase agreement, the Fund temporarily transfers
possession of a portfolio instrument to another party, such as a bank or broker-dealer, in return for cash. At the same time, the Fund
&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt;agrees to repurchase the instrument at an agreed upon time and price, which reflects an interest payment. Such agreements have the economic
effect of borrowings. The Fund may enter into reverse repurchase agreements when the Sub-Adviser believes it is able to invest the cash
acquired at a rate higher than the cost of the agreement, which would increase earned income.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Borrowings may be made by the Fund through dollar
roll transactions. A dollar roll transaction involves a sale by the Fund of a mortgage-backed or other fixed-income security concurrently
with an agreement by the Fund to repurchase a similar security at a later date at an agreed-upon price. The securities that are repurchased
will bear the same interest rate and stated maturity as those sold, but pools of mortgages collateralizing those securities may have different
prepayment histories than those sold. During the period between the sale and repurchase, the Fund will not be entitled to receive interest
and principal payments on the securities sold. Proceeds of the sale will be invested in additional instruments for the Fund, and the income
from these investments will generate income for the Fund. If such income does not exceed the income, capital appreciation and gain or
loss that would have been realized on the securities sold as part of the dollar roll, the use of this technique will diminish the investment
performance of the Fund compared with what the performance would have been without the use of dollar rolls.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;With respect to any reverse repurchase agreement,
dollar roll or similar transaction, the Fund&#x2019;s Managed Assets shall include any proceeds from the sale of an asset of the Fund to
a counterparty in such a transaction, in addition to the value of the underlying asset as of the relevant measuring date.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;When the Fund trades reverse repurchase agreements
or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated
with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing
indebtedness when calculating the Fund&#x2019;s asset coverage ratio or treat all such transactions as derivatives transactions.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;&lt;i&gt;Preferred Shares.&lt;/i&gt; The Fund&#x2019;s Governing
Documents provide that the Board may authorize and issue Preferred Shares with rights as determined by the Board, by action of the Board
without prior approval of the holders of the Common Shares. Common Shareholders have no preemptive right to purchase any Preferred Shares
that might be issued. Any such Preferred Share offering would be subject to the limits imposed by the 1940 Act. Although the Fund has
no present intention to issue Preferred Shares, it may in the future utilize Preferred Shares to the maximum extent permitted by the 1940
Act. Under the 1940 Act, the Fund may not issue Preferred Shares if, immediately after issuance, the Fund would have asset coverage (as
defined in the 1940 Act) of less than 200%, calculated as the ratio of the Fund&#x2019;s total assets (less all liabilities and indebtedness
not represented by senior securities) over the aggregate amount of the Fund&#x2019;s outstanding senior securities representing indebtedness
plus the aggregate liquidation preference of any outstanding shares of preferred stock. In addition, the Fund generally is not permitted
to declare any cash dividend or other distribution on the Fund&#x2019;s Common Shares, or purchase any such Common Shares, unless, at the
time of such declaration, the Fund would have asset coverage (as described above) of at least 200% after deducting the amount of such
dividend or other distribution. The 1940 Act grants to the holders of senior securities representing stock issued by the Fund certain
voting rights. Failure to maintain certain asset coverage requirements under the 1940 Act could entitle the holders of Preferred Shares
to elect a majority of the Board.&lt;/p&gt;</cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:EffectsOfLeverageTextBlock contextRef="AsOf2025-11-21" id="Fact000155">&lt;span style="font-weight: normal"&gt;&lt;i&gt;Effects
of Financial Leverage&lt;/i&gt;&lt;span style="color: windowtext"&gt;. Please refer to the section of the &lt;/span&gt;&lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; color: windowtext"&gt;entitled &#x201c;&lt;/span&gt;&lt;span style="font-weight: normal"&gt;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; color: windowtext"&gt;Effects of Leverage,&#x201d; which is
incorporated by reference herein, for a discussion of the effects of leverage.&lt;/span&gt;</cef:EffectsOfLeverageTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_PrincipalRisksMember"
      id="Fact000156">&lt;span style="font-weight: normal; text-transform: none"&gt;Please
refer to the section of the &lt;/span&gt;&lt;a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/0001380936/000182126825000173/gug88924gof.htm"&gt;&lt;span style="font-weight: normal; text-transform: none"&gt;Fund&#x2019;s
most recent annual report on Form N-CSR&lt;/span&gt;&lt;/a&gt; &lt;span style="font-weight: normal; text-transform: none"&gt;entitled &#x201c;Additional
Information Regarding the Fund&lt;/span&gt;&#x2014;&lt;span style="font-weight: normal; text-transform: none"&gt;Principal Risks of the Fund,&#x201d;
which is incorporated by reference herein, for a discussion of the risks associated with an investment in the Fund, in addition to the
following.&lt;/span&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_MarketDiscountAndPriceVolatilityRiskMember"
      id="Fact000159">&lt;b&gt;Market Discount and Price Volatility Risk&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The net asset value and market price of the Common
Shares will fluctuate, sometimes independently, based on market and other factors affecting the Fund and its investments. The market price
of the Common Shares may experience volatility (sometimes high volatility) driven by market forces that may be unrelated to changes in
the Fund&#x2019;s net asset value or other internal Fund factors. The market price of the Common Shares will either be above (premium)
or below (discount) their net asset value. Although the net asset value of Common Shares is often&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; considered in determining whether to
purchase or sell shares, whether investors will realize gains or losses upon the sale of Common Shares will depend upon whether the market
price of Common Shares at the time of sale is above or below the investor&#x2019;s purchase price, taking into account transaction costs
for the Common Shares, and is not directly dependent upon the Fund&#x2019;s net asset value. Market price movements of Common Shares are
thus material to investors and may result in losses, even when net asset value has increased.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund cannot predict whether the Common Shares
will trade at a premium or discount to net asset value and the market price for the Common Shares will change based on a variety of factors.
If the Common Shares are trading at a premium to net asset value at the time you purchase Common Shares, the net asset value per share
of the Common Shares purchased will be less than the purchase price paid. Shares of closed-end investment companies frequently trade at
a discount from their net asset value, but in some cases have traded above net asset value. The risk of the Common Shares trading at a
discount is a risk separate and distinct from the risk of a decline in the Fund&#x2019;s net asset value as a result of the Fund&#x2019;s
investment activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Because the market price of the Common Shares
will be determined by factors such as net asset value, dividend and distribution levels (which are dependent, in part, on expenses), supply
of and demand for Common Shares, stability of dividends or distributions, trading volume of Common Shares, general market and economic
conditions and other factors beyond the Fund&#x2019;s control, the Fund cannot predict whether the Common Shares will trade at, below or
above net asset value, or at, below or above the public offering price for the Common Shares.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s net asset value would be reduced
following an offering of the Common Shares due to the costs of such offering, to the extent those costs are borne by the Fund. The sale
of Common Shares by the Fund (or the perception that such sales may occur) may have an adverse effect on prices of Common Shares in the
secondary market, including by resulting in increased trading of the Common Shares, which may increase volatility in the market price
of the Common Shares. An increase in the number of Common Shares available may put downward pressure on the market price for Common Shares.
The Fund may, from time to time, seek the consent of Common Shareholders to permit the issuance and sale by the Fund of Common Shares
at a price below the Fund&#x2019;s then-current net asset value, subject to certain conditions, and such sales of Common Shares at price
below net asset value, if any, may increase downward pressure on the market price for Common Shares. These sales, if any, also might make
it more difficult for the Fund to sell additional Common Shares in the future at a time and price it deems appropriate.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund is designed for long-term investors
and investors in Common Shares should not view the Fund as a vehicle for trading purposes.&lt;/p&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_DebtOverlayStrategyRiskMember"
      id="Fact000162">&lt;b&gt;Debt Overlay Strategy Risk&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Debt Overlay Strategy is subject
to risks associated with investing in the investments comprising the Debt Overlay Basket as well as the risks associated with selling
call options on the Underlying Bond ETF.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The risks of the Debt Overlay Strategy include,
among others, Income Securities Risk, Corporate Bond Risk, Below Investment Grade Securities Risk, Investment Funds Risk, Derivatives
Transactions Risk and Options Risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;Additionally, the Debt Overlay Strategy is subject
to imperfect matching or price correlation between the Underlying Bond ETF and the Debt Overlay Basket, which could reduce the Fund&#x2019;s
returns and expose the Fund to additional losses. In particular, the Debt Overlay Strategy is subject to the risk of loss associated with
the Underlying Bond ETF outperforming the Debt Overlay Basket because the Fund&#x2019;s obligation under the options on the Underlying
Bond ETF at expiration is determined by the market price of the shares of the Underlying Bond ETF.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s potential gain in selling a
call option on the Underlying Bond ETF is the premium received from the purchaser of the option; however, the Fund risks a loss equal
to the entire exercise price of the option minus the call premium (although the extent of such loss could be offset by the performance
of the Debt Overlay Basket).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The call options sold as part of the Debt Overlay
Strategy are generally not &#x201c;covered.&#x201d; For cash-settled call options sold by the Fund referencing the Underlying Bond ETF,
if the market price of the Underlying Bond ETF is above the strike price of the options, the Fund would owe the difference between the
market price of the shares of the Underlying Bond ETF and the strike price of the options. For physically-settled call options sold by
the Fund&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"&gt; referencing the Underlying Bond ETF, if the options are exercised and assigned, the Fund will be obligated to sell to the options&#x2019;
counterparty shares of the Underlying Bond ETF at the strike price. Pursuant to this sale upon assignment, the Fund will not be able to
deliver the Debt Overlay Basket to satisfy its delivery obligations and will be required to buy shares of the Underlying Bond ETF at the
prevailing market price, which may be greater in aggregate cost than the value of the corresponding Debt Overlay Basket. To the extent
that the market price of the shares of the Underlying Bond ETF experiences proportionately greater appreciation than the value of the
Debt Overlay Basket, the Fund is subject to additional risks associated with selling &#x201c;naked&#x201d; call options on the Underlying
Bond ETF. Selling naked, or uncovered, call options can be considerably riskier than selling covered call options. Although the Debt Overlay
Basket is intended to outperform the Underlying Bond ETF and the performance of the Debt Overlay Basket is otherwise intended to generally
be correlated with that of the Underlying Bond ETF, it is possible that the market price of the shares of the Underlying Bond ETF will
experience greater appreciation than the value of the Debt Overlay Basket, subjecting the Fund to the risk of a loss that is uncovered
by the Debt Overlay Basket. The potential appreciation of the market price of the shares of the Underlying Bond ETF is theoretically unlimited,
and the Fund is therefore subject to the risk of total loss.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;To the extent that the market price of the shares
of the Underlying Bond ETF experience less appreciation than the Debt Overlay Basket, the Fund is subject to risks similar to those described
in &#x201c;Risks Associated with the Fund&#x2019;s Covered Call Option Strategy and Put Options,&#x201d; including the risk of losing the
ability to benefit from the capital appreciation of its Debt Overlay Basket (i.e., net of any losses from the call options sold by the
Fund referencing the Underlying Bond ETF). Additionally, for certain types of options, the Fund has no control over the time when it may
be required to fulfill its obligation under the option. There can be no assurance that a liquid market will exist for the options if and
when the Fund seeks to close out an option position.&lt;/p&gt;</cef:RiskTextBlock>
    <cef:RiskTextBlock
      contextRef="From2025-11-212025-11-21_custom_SyntheticAutocallableELNStrategyRiskMember"
      id="Fact000165">&lt;b&gt;Synthetic Autocallable ELN Strategy Risk&lt;/b&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Fund&#x2019;s Synthetic Autocallable ELN Strategy
is subject to risks associated with investing in autocallable ELNs directly, derivatives instruments on the Autocallable ELN Reference
Index, including Common Equity Securities Risk, Synthetic Investments Risk, Derivatives Transactions Risk, Counterparty Risk and Swap
Risk.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The Synthetic Autocallable ELN Strategy is also
subject to certain additional or heightened risks, including:&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Contingent Income Risk. Coupon Payments from the Synthetic Autocallable Contract are not guaranteed and will not be made if the price
level of the Autocallable ELN Reference Index falls below the Coupon Barrier on one or more observation dates. This means the Fund may
generate significantly less income than anticipated from a Synthetic Autocallable Contract during equity market downturns. The Coupon
Payments of Synthetic Autocallable Contracts are not linked to the performance of the Autocallable ELN Reference Index at any time other
than on maturity dates&#160;and observation dates. Moreover, because the payoff of the Synthetic Autocallable Contract is linked to the
price level of the Autocallable ELN Reference Index, the Fund is exposed to the market risk of the Autocallable ELN Reference Index and
may not receive any return on the Synthetic Autocallable Contract and may lose&#160;a portion or all of the notional value of the Synthetic
Autocallable Contract even if the performance of one or more of component securities of the Autocallable ELN Reference Index has exceeded&#160;the
initial value of such security.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Early Redemption Risk. Synthetic Autocallable Contracts may be called (i.e., cancelled) before their scheduled maturity if the Autocallable
ELN Reference Index reaches or exceeds the Autocall Barrier on an observation date. Synthetic Autocallable Contracts limit the positive
investment return that can be achieved due to this automatic call feature. This automatic early redemption could result in significantly
less income than anticipated from a Synthetic Autocallable Contract and force reinvestment of that principal investment amount at less
advantageous terms based on prevailing market conditions. For example, if the automatic call feature is triggered, the Fund would forego
any remaining Coupon Payments and may be unable to invest in another Synthetic Autocallable Contract (or other investment) with a similar
level of risk and comparable return potential. If the automatic call feature is not triggered, and the&#160;Maturity Barrier has been
breached as of the maturity date, the Fund will receive less than the initial notional amount&#160;regardless of any outperformance of
the Autocallable ELN Reference Index (or any component security thereof) throughout the term of the Synthetic Autocallable Contract.&#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

    &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;


&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Barrier Risk. The Coupon Barrier and Maturity Barrier levels of a Synthetic Autocallable Contract set forth the threshold amount&#160;of
loss the Autocallable ELN Reference Index could experience before the Fund&#160;would forfeit Coupon Payments and/or pay a portion or
all of the initial notional amount of such contract.&#160;If the Coupon Barrier level is breached on an observation date, the Fund will
not receive the Coupon Payment for such period (subject to any features that may provide the Fund to receive a Missed Coupon under certain
conditions).&#160;Accordingly, it is possible that the Fund may not receive any Coupon Payments under a Synthetic Autocallable Contract.
If the&#160;Maturity Barrier level is breached on the maturity date, the Fund may be required to pay a percentage of the initial notional
amount of the Synthetic Autocallable Contract. If the Autocallable ELN Reference Index falls below the Maturity Barrier at the maturity
of a Synthetic Autocallable Contract, the Fund is exposed to the negative performance of the Autocallable ELN Reference Index from a specified
level. This could result in sudden, significant losses if the Maturity Barrier is breached. Under some Synthetic Autocallable Contracts,
it is possible that the Fund could be required to pay the entire initial notional amount, in addition to forfeiting some or all&#160;of
the Coupon Payments.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Symbol"&gt;&#xb7;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;Limited Available Counterparty Risk. Synthetic Autocallable Contracts are bespoke contracts and the Fund may have limited available
counterparties. The Fund will be subject to credit and default risk with respect to the counterparties to the Synthetic Autocallable Contracts
entered into by the Fund. If a Synthetic Autocallable Contract counterparty becomes bankrupt or otherwise fails to perform its obligations,
the Fund may experience significant delays in obtaining any recovery, may obtain only a limited recovery, or may obtain no recovery at
all. The Fund may have substantial exposure to one or a limited number of counterparties, which may result in the Fund being more susceptible
to a single economic or regulatory occurrence affecting such counterparty(ies).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</cef:RiskTextBlock>
    <cef:SecurityDividendsTextBlock contextRef="AsOf2025-11-21" id="Fact000166">All Common Shares are equal as to
dividends, assets and voting privileges and shall not entitle the holders to preference, preemptive, appraisal, conversion or exchange
rights, except as otherwise required by law or permitted by the Declaration of Trust.</cef:SecurityDividendsTextBlock>
    <cef:SecurityVotingRightsTextBlock contextRef="AsOf2025-11-21" id="Fact000167">&lt;i&gt;Voting
Rights&lt;/i&gt;. Until any Preferred Shares are issued, holders of the Common Shares will vote as a single class to elect the
Fund&#x2019;s Board of Trustees and on additional matters with respect to which the 1940 Act mandates a vote by the Fund&#x2019;s
shareholders. If Preferred Shares are issued, holders of Preferred Shares will have a right to elect at least two of the
Fund&#x2019;s Trustees, and will have certain other voting rights. See &#x201c;Anti-Takeover Provisions in the Fund&#x2019;s Governing
Documents.&#x201d;</cef:SecurityVotingRightsTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock contextRef="AsOf2025-11-21" id="Fact000169">&lt;p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"&gt;Capitalization&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.5in"&gt;The following table provides information about
the outstanding securities of the Fund as of November 14, 2025:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center; text-indent: 0in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Capitalization"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 37%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Title of Class&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 19%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;br/&gt;
&lt;b&gt;Authorized&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 24%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Amount Held by the&lt;br/&gt;
Fund or for its Account&lt;/b&gt;&lt;/td&gt;
    &lt;td style="width: 20%; padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;b&gt;Amount Outstanding&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_904_ecef--OutstandingSecurityTitleTextBlock_c20251121__20251121_zkUzmOJ13as9"&gt;Common shares of beneficial interest, par value $0.01 per share&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;Unlimited&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="padding-right: 5.75pt; padding-left: 5.75pt; text-align: center"&gt;&lt;span id="xdx_90D_ecef--OutstandingSecurityAuthorizedShares_c20251121__20251121_zPkprTPwwap7"&gt;199,267,847&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock contextRef="AsOf2025-11-21" id="Fact000170">Common shares of beneficial interest, par value $0.01 per share</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityAuthorizedShares
      contextRef="AsOf2025-11-21"
      decimals="INF"
      id="Fact000171"
      unitRef="Shares">199267847</cef:OutstandingSecurityAuthorizedShares>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000043"
          xlink:label="Fact000043"
          xlink:type="locator"/>
        <link:footnote id="Footnote000053" xlink:label="Footnote000053" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">If Common Shares to which this Prospectus relates are sold to or through underwriters, the Prospectus Supplement will set forth any
applicable sales load to be paid by investors and the estimated offering expenses borne by the Fund.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000053"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000044"
          xlink:label="Fact000044"
          xlink:type="locator"/>
        <link:footnote id="Footnote000054" xlink:label="Footnote000054" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Investment Adviser has incurred on behalf of the Fund all costs associated with the Fund&#x2019;s registration statement and any
offerings pursuant to such registration statement. The Fund has agreed, in connection with offerings under this registration statement,
to reimburse the Investment Adviser for offering expenses incurred by the Investment Adviser on the Fund&#x2019;s behalf in an amount up
to the lesser of the Fund&#x2019;s actual offering costs or 0.60% of the total offering price of the Common Shares sold in such offerings.
Amounts in excess of 0.60% of the total offering price of shares sold pursuant to this registration statement will not be subject to recoupment
from the Fund. This agreement will be in effect for the life of the registration statement with respect to all Common Shares sold pursuant
to the registration statement and may only be terminated by the Board of Trustees of the Fund.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000044"
          xlink:to="Footnote000053"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000044"
          xlink:to="Footnote000054"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000045"
          xlink:label="Fact000045"
          xlink:type="locator"/>
        <link:footnote id="Footnote000055" xlink:label="Footnote000055" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Common Shareholders will pay brokerage charges if they direct Computershare Trust Company, N.A. (the &#x201c;Plan Agent&#x201d;) to
sell Common Shares held in a dividend reinvestment account. See &#x201c;Dividend Reinvestment Plan.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000055"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000048"
          xlink:label="Fact000048"
          xlink:type="locator"/>
        <link:footnote id="Footnote000056" xlink:label="Footnote000056" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Based upon average net assets attributable to Common Shares during the fiscal year ended May 31, 2025.</link:footnote>
        <link:footnote id="Footnote000057" xlink:label="Footnote000057" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Fund pays the Investment Adviser a monthly fee in arrears at an annual rate equal to 1.00% of the Fund&#x2019;s average daily Managed
Assets (as defined herein). Common Shareholders bear the portion of the investment advisory fee attributable to the assets purchased with
the proceeds of the issuance of Preferred Shares, borrowing or the issuance of commercial paper or other forms of debt (&#x201c;Borrowings&#x201d;)
or reverse repurchase agreements, dollar rolls or similar transactions or a combination of the foregoing (collectively &#x201c;Financial
Leverage&#x201d;), which means that Common Shareholders effectively bear the entire advisory fee. Because <xhtml:span style="background-color: white">the
management fee rate shown is based upon outstanding Financial Leverage of 16% of the Fund&#x2019;s Managed Assets, the management fee as
a percentage of net assets attributable to Common Shares is higher than if the Fund did not utilize such Financial Leverage. If Financial
Leverage of more than 16% of the Fund&#x2019;s Managed Assets is used, the management fee shown would be higher.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000048"
          xlink:to="Footnote000057"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000048"
          xlink:to="Footnote000056"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000049"
          xlink:label="Fact000049"
          xlink:type="locator"/>
        <link:footnote id="Footnote000058" xlink:label="Footnote000058" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Acquired Fund Fees and Expenses are estimated based on the fees and expenses borne by the Fund
as an investor in other investment companies during the fiscal year ended May 31, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000056"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000058"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000050"
          xlink:label="Fact000050"
          xlink:type="locator"/>
        <link:footnote id="Footnote000059" xlink:label="Footnote000059" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes interest payments on borrowed funds and interest expense on reverse repurchase agreements. Interest payments on borrowed
funds is estimated based upon the Fund&#x2019;s outstanding Borrowings as of May 31, 2025, which included Borrowings under the Fund&#x2019;s
committed facility agreement in an amount equal to 2.08% of the Fund&#x2019;s Managed Assets, at an average interest rate of 5.08%. Interest
expense on reverse repurchase agreements is estimated based on the Fund&#x2019;s outstanding reverse repurchase agreements as of May 31,
2025, which included leverage in the form of reverse repurchase agreements in an amount equal to 13.77% of the Fund&#x2019;s Managed Assets,
at a weighted average interest rate cost to the Fund of 4.52%. The actual amount of interest payments and expenses borne by the Fund will
vary over time in accordance with the amount of Borrowings and reverse repurchase agreements and variations in market interest rates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000050"
          xlink:to="Footnote000056"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000050"
          xlink:to="Footnote000059"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000051"
          xlink:label="Fact000051"
          xlink:type="locator"/>
        <link:footnote id="Footnote000060" xlink:label="Footnote000060" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Other expenses are based on estimated amounts for the current fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000056"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000060"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000052"
          xlink:label="Fact000052"
          xlink:type="locator"/>
        <link:footnote id="Footnote000061" xlink:label="Footnote000061" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The total annual expenses in this fee table may not correlate to the expense ratios in the Fund&#x2019;s financial highlights and financial
statements because the financial highlights and financial statements reflect only the operating expenses of the Fund and do not include
Acquired Fund Fees and Expenses, which are fees and expenses incurred indirectly by the Fund through its investments in certain underlying
investment companies.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000052"
          xlink:to="Footnote000061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000064"
          xlink:label="Fact000064"
          xlink:type="locator"/>
        <link:footnote id="Footnote000068" xlink:label="Footnote000068" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The example should not be considered a representation of future expenses or returns. Actual expenses may be higher or lower than
those assumed and shown. Moreover, the Fund&#x2019;s actual rate of return may be higher or lower than the hypothetical 5% return shown
in the example. The example assumes that all dividends and distributions are reinvested at net asset value. See &#x201c;Distributions&#x201d;
and &#x201c;Dividend Reinvestment Plan.&#x201d;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000064"
          xlink:to="Footnote000068"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000065"
          xlink:label="Fact000065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000068"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000066"
          xlink:label="Fact000066"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000066"
          xlink:to="Footnote000068"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000067"
          xlink:label="Fact000067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000067"
          xlink:to="Footnote000068"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>ex99s_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-11-20</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-11-20</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001380936</identifier>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-11-20</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="fee_001">N-2ASR</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="fee_002">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="fee_003">0001380936</dei:EntityCentralIndexKey>
    <ffd:OfferingTableNa contextRef="c_report" id="fee_004" xsi:nil="true"/>
    <ffd:OffsetTableNa contextRef="c_report" id="fee_005">N/A</ffd:OffsetTableNa>
    <ffd:CombinedProspectusTableNa contextRef="c_report" id="fee_006">N/A</ffd:CombinedProspectusTableNa>
    <ffd:FormTp contextRef="c_report" id="fee_007">N-2</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="fee_008">Guggenheim Strategic Opportunities Fund</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="fee_009">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-343">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-344">Common shares of beneficial interest, $0.01 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule457oFlg contextRef="c_offering_1" id="fee_010">true</ffd:Rule457oFlg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-346"
      unitRef="USD">969300000.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-347"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-348"
      unitRef="USD">133860.33</ffd:FeeAmt>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-349">Equity</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-350">Common shares of beneficial interest, $0.01 par value per share</ffd:OfferingSctyTitl>
    <ffd:Rule415a6Flg contextRef="c_offering_2" id="fee_011">true</ffd:Rule415a6Flg>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-352"
      unitRef="USD">30700000.00</ffd:MaxAggtOfferingPric>
    <ffd:CfwdFormTp contextRef="c_offering_2" id="ixv-353">N-2</ffd:CfwdFormTp>
    <ffd:CfwdPrrFileNb contextRef="c_offering_2" id="ixv-354">333-279126</ffd:CfwdPrrFileNb>
    <ffd:CfwdPrrFctvDt contextRef="c_offering_2" id="ixv-355">2024-05-06</ffd:CfwdPrrFctvDt>
    <ffd:CfwdPrevslyPdFee
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-356"
      unitRef="USD">4531.32</ffd:CfwdPrevslyPdFee>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-357"
      unitRef="USD">1000000000.00</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-358"
      unitRef="USD">133860.33</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-359"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-360"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-361"
      unitRef="USD">133860.33</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-362">Estimated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, solely for the purpose of determining the registration fee. The proposed maximum offering price per security will be determined, from time to time, by the Registrant in connection with the sale by the Registrant of the securities registered under the registration statement.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-363">Pursuant to Rule 415(a)(6) under the Securities Act, the Registrant is carrying forward $46,758,272 aggregate principal offering price of unsold common shares of beneficial interest (the &#x201c;Unsold Shares&#x201d;) that were previously registered for sale under a Registration Statement on Form N-2 effective on May 3, 2024 (File No. 333-279126) (the &#x201c;Prior Registration Statement&#x201d;). Pursuant to Rule 415(a)(6) under the Securities Act, the filing fees previously paid with respect to the Unsold Shares will continue to be applied to such Unsold Shares. Pursuant to Rule 415(a)(6) under the Securities Act, the offering of Unsold Shares under the Prior Registration Statement will be deemed terminated as of the date of effectiveness of this Registration Statement.</ffd:OfferingNote>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
